
<html lang="en"     class="pb-page"  data-request-id="315a5f61-cef6-4346-a740-d0e6eb2e516c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.8b01121;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-8"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Inhibition: An Emerging Strategy in Cancer Therapy" /></meta><meta name="dc.Creator" content="Zheng-Yu  Jiang" /></meta><meta name="dc.Creator" content="Meng-Chen  Lu" /></meta><meta name="dc.Creator" content="Qi-Dong  You" /></meta><meta name="dc.Description" content="Nuclear factor erythroid 2-related factor 2 (Nrf2) is a pleiotropic transcription factor, especially for its complex and dual effects in cancer. With the continuous growing research, new regulatory..." /></meta><meta name="Description" content="Nuclear factor erythroid 2-related factor 2 (Nrf2) is a pleiotropic transcription factor, especially for its complex and dual effects in cancer. With the continuous growing research, new regulatory..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 16, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01121" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01121" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01121" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01121" /></link>
        
    
    

<title>Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Inhibition: An Emerging Strategy in Cancer Therapy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01121" /></meta><meta property="og:title" content="Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Inhibition: An Emerging Strategy in Cancer Therapy" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0014.jpeg" /></meta><meta property="og:description" content="Nuclear factor erythroid 2-related factor 2 (Nrf2) is a pleiotropic transcription factor, especially for its complex and dual effects in cancer. With the continuous growing research, new regulatory modes and new functions of Nrf2 and tumor-promoting effects of Nrf2 in malignant transformed tumors have become increasingly clear. Accumulating evidence has established that Nrf2 contributes to the whole process of pathogenesis, progression, metastasis, and prognosis of cancer, and Nrf2 could be a promising target in cancer therapy. However, the development of Nrf2 inhibitor is still limited. In this perspective, we will briefly describe the biological function and modulating network of Nrf2, stress its oncogenic role, and point out possible ways to inhibit Nrf2, as well as summarize the reported Nrf2 inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01121"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01121">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01121&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01121&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01121&amp;href=/doi/10.1021/acs.jmedchem.8b01121" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3840-3856</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00836" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b01472" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Inhibition: An Emerging Strategy in Cancer Therapy</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Zheng-Yu Jiang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zheng-Yu Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#c5afaca4aba2bfada0aba2bcb0a6b5b085f4f3f6eba6aaa8"><span class="__cf_email__" data-cfemail="a6cccfc7c8c1dccec3c8c1dfd3c5d6d3e697909588c5c9cb">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zheng-Yu++Jiang">Zheng-Yu Jiang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1671-1582" title="Orcid link">http://orcid.org/0000-0002-1671-1582</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Meng-Chen Lu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Meng-Chen Lu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Meng-Chen++Lu">Meng-Chen Lu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Qi-Dong You</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qi-Dong You</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#5e27312b2f3a1e6f686d703d3133"><span class="__cf_email__" data-cfemail="671e08121603275651544904080a">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qi-Dong++You">Qi-Dong You</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8587-0122" title="Orcid link">http://orcid.org/0000-0002-8587-0122</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01121&amp;href=/doi/10.1021%2Facs.jmedchem.8b01121" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3840–3856</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 16, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 July 2018</li><li><span class="item_label"><b>Published</b> online</span>16 November 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 April 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01121" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01121</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3840%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZheng-Yu%2BJiang%252C%2BMeng-Chen%2BLu%252C%2BQi-Dong%2BYou%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D8%26contentID%3Dacs.jmedchem.8b01121%26title%3DNuclear%2BFactor%2BErythroid%2B2-Related%2BFactor%2B2%2B%2528Nrf2%2529%2BInhibition%253A%2BAn%2BEmerging%2BStrategy%2Bin%2BCancer%2BTherapy%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3856%26publicationDate%3DApril%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01121"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2628</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01121" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Inhibition: An Emerging Strategy in Cancer Therapy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zheng-Yu&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Meng-Chen&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Qi-Dong&quot;,&quot;last_name&quot;:&quot;You&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;3840-3856&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01121&quot;},&quot;abstract&quot;:&quot;Nuclear factor erythroid 2-related factor 2 (Nrf2) is a pleiotropic transcription factor, especially for its complex and dual effects in cancer. With the continuous growing research, new regulatory modes and new functions of Nrf2 and tumor-promoting effects of Nrf2 in malignant transformed tumors have become increasingly clear. Accumulating evidence has established that Nrf2 contributes to the whole process of pathogenesis, progression, metastasis, and prognosis of cancer, and Nrf2 could be a promising target in cancer therapy. However, the development of Nrf2 inhibitor is still limited. In this perspective, we will briefly describe the biological function and modulating network of Nrf2, stress its oncogenic role, and point out possible ways to inhibit Nrf2, as well as summarize the reported Nrf2 inhibitors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01121&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01121" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01121&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01121" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01121&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01121" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01121&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01121&amp;href=/doi/10.1021/acs.jmedchem.8b01121" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01121" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01121" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01121%26sid%3Dliteratum%253Aachs%26pmid%3D30444366%26genre%3Darticle%26aulast%3DJiang%26date%3D2019%26atitle%3DNuclear%2BFactor%2BErythroid%2B2-Related%2BFactor%2B2%2B%2528Nrf2%2529%2BInhibition%253A%2BAn%2BEmerging%2BStrategy%2Bin%2BCancer%2BTherapy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D8%26spage%3D3840%26epage%3D3856%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/jmcmar.2019.62.issue-8/20190425/jmcmar.2019.62.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Nuclear factor erythroid 2-related factor 2 (Nrf2) is a pleiotropic transcription factor, especially for its complex and dual effects in cancer. With the continuous growing research, new regulatory modes and new functions of Nrf2 and tumor-promoting effects of Nrf2 in malignant transformed tumors have become increasingly clear. Accumulating evidence has established that Nrf2 contributes to the whole process of pathogenesis, progression, metastasis, and prognosis of cancer, and Nrf2 could be a promising target in cancer therapy. However, the development of Nrf2 inhibitor is still limited. In this perspective, we will briefly describe the biological function and modulating network of Nrf2, stress its oncogenic role, and point out possible ways to inhibit Nrf2, as well as summarize the reported Nrf2 inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63056" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63056" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nuclear factor erythroid 2-related factor 2 (Nrf2) encoded by the <i>NFE2L2</i> gene is a basic region-leucine zipper (bZIP) transcription factor, which forms heterodimers with the small musculoaponeurotic fibrosarcoma (sMAF) protein.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The heterodimer can induce target gene transcription by recognizing and binding to the antioxidant response element (ARE) that locates in their regulatory regions. Traditionally, Nrf2-regulated genes are mainly related with the oxidative stress regulation, including the glutathione-based (GSH-based) and thioredoxin-based (TXN-based) antioxidant system and phase 1, 2, and 3 drug-metabolizing systems. By inducing the transcription of these genes, Nrf2 can activate the cellular defense system, protecting cells from exogenous and endogenous insults such as xenobiotics and reactive oxygen species (ROS). Thereby, Nrf2 is regarded as an important cytoprotective transcription factor that affects the fate of the cell.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">More recently, it has become apparent that Nrf2 is more than a cell protector. Nrf2 can regulate a much wider region of genes, especially the genes that control cellular metabolism.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> By regulating the expression of key metabolic enzymes, Nrf2 profoundly modulates the metabolism of lipids, carbohydrates, nucleotides, and amino acids. Moreover, Nrf2 also controls several proteasome subunits and autophagy genes, which further enhances the great significance of Nrf2 in the metabolic modulating network. Generally, Nrf2 enhances the expression of anabolic pathway genes, which is beneficial for the proliferation of cancer cells.</div><div class="NLM_p">These new findings further stressed the oncogenic role of Nrf2. Nrf2 not only enhances the survival of cancer cells by elevating the antioxidative and drug-metabolizing capacity of the cell,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> but also participates in metabolic network topology changes to prefer the aerobic glycolysis.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Not surprisingly, overactivation of Nrf2 by diverse ways is being identified in more and more different types of cancer, including p62 accumulation-induced Nrf2 activation in hepatocellular carcinoma (HCC), the mutation and hypermethylation of <i>KEAP1</i>-induced Nrf2 overactivation in nonsmall cell lung cancer (NSCLC), and promoter DNA demethylation of <i>NFE2L2</i>-induced Nrf2 elevation in colorectal cancer (CRC).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Thus, developing Nrf2 inhibitors would be a potential way to combat cancer.</div><div class="NLM_p last">However, discovery of druglike inhibitors targeting a transcription factor is quite challenging, and the complicated modulating network of Nrf2 makes it more difficult. To date, the development of Nrf2 inhibitors is still in the early stage. In this Perspective, we will briefly describe the biological function and modulating network of Nrf2, stress the oncogenic role of Nrf2, point out possible ways to inhibit Nrf2, and summarize the reported Nrf2 inhibitors. We hope that this Perspective could be beneficial for the further research of Nrf2 inhibitors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Biological Function of Nrf2</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our body is surrounded by constant oxidative and electrophilic insults from both extrinsic and intrinsic sources. For the prevention of threats, the human body has been equipped with a defense system through engagement of fine-tuned stress response pathways.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Under stress conditions, the defense system can sense the abnormalities and activate the transcription of cytoprotective enzyme genes to antagonize harmful insults. Among these stress response pathways, Nrf2, which belongs to the cap-n-collar (CNC) subfamily of bZIP transcription factors, regulates the cellular responses against stress conditions.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The Nrf2–sMAF heterodimer can activate the transcription of various cytoprotective enzyme genes by recognizing the cis-regulatory element sequence ARE (5′-GTGACnnnGC-3′) that locates in the upstream of these genes.</div><div class="NLM_p">Nrf2 simultaneously controls the two most important antioxidant systems, the GSH-dependent and TXN-dependent antioxidant systems.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In the GSH-based system, Nrf2 regulates GSH biosynthesis, usage, and recycling enzymes. Nrf2 controls the biosynthesis of GSH by controlling the transcription of genes encoding glutamate–cysteine ligase catalytic (GCLC) and glutamate–cysteine ligase modifier (GCLM) subunits. GCLC and GCLM can form a heterodimer, catalyzing the rate-limiting step in GSH.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> Nrf2 also regulates the GSH-consuming process by regulating the expression of glutathione peroxidase (GPx) 2 and 4, which reduce the hydroperoxides by utilizing GSH as the reductant (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). <i>GSR</i>, encoding the key enzyme glutathione reductase (GSR) that is responsible for the regeneration of GSH from GSSG, the oxidized form of GSH, is also a target gene of Nrf2.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Biosynthesis and regeneration of glutathione. Nrf2 regulates glutathione biosynthesis, usage, and recycling enzymes (labeled by red color).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">TXNs are ubiquitous antioxidant proteins which can promote the reduction of other proteins through cysteine thiol–disulfide exchange. The key components, TXN1, thioredoxin reductase 1 (TXNRD1), and sulfiredoxin 1 (SRXN1) are all regulated by Nrf2.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11−14)</a> In addition to these antioxidant proteins and enzymes, the Nrf2–ARE system also adjusts the transcription of various drug-metabolizing enzymes, including Phase I, Phase II, and Phase III drug-metabolizing enzymes. These drug-metabolizing enzymes catalyze a plethora of heterogeneous reactions, including reduction by aldo-keto reductases (AKRs) and NAD(P)H:quinone oxidoreductase 1 (NQO1); conjugation by UDP- glucuronosyltransferases (UGTs) and sulfotransferases (SULTs); oxidation by cytochrome P450 proteins (CYPs), aldehyde dehydrogenases (ALDHs), and alcohol dehydrogenases (ADHs); and nucleophilic trapping reactions by glutathione S-transferases (GSTs), nearly covering all kinds of drug-metabolizing processes.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Drug transporters, also known as Phase III metabolism enzymes, which can transport drugs, toxins, and conjugated metabolites across the cell membrane, are also affected by Nrf2. To date, multiple components in the ATP-binding cassette family have been proven to be target genes of Nrf2.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a></div><div class="NLM_p">In addition to these antioxidant proteins and enzymes, Nrf2 regulates the regeneration process of NADPH,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> which is the most important reducing equivalent and serves as a cofactor in multiple antioxidant and metabolism pathways. Notably, almost all the NADPH-generating enzymes, including glucose-6-phosphate dehydrogenase (G6PD), 6-phosphogluconate dehydrogenase (PGD), malic enzyme 1 (ME1), and isocitrate dehydrogenase 1 (IDH1), are regulated by Nrf2 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> G6PD and PGD are also the key enzymes in the pentose phosphate pathway (PPP), an aerobic glycolysis pathway generating NADPH and pentoses (5-carbon sugars) as well as ribose 5-phosphate. Moreover, Nrf2 also regulates some other enzymes in PPP, including transketolase (Tkt) and transaldolase 1 (Taldo1).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> This indicates the pivotal role of Nrf2 in enhancing PPP. Nrf2 also activates genes involved in the <i>de novo</i> nucleotide synthesis, including methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) and phosphoribosyl pyrophosphate amidotransferase (PPAT), promoting the production of purine nucleotides from glucose.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In addition to these genes involved in glucose metabolism, Nrf2 regulates distinct kinds of lipid metabolism related genes, positively regulating fatty acid β-oxidation related genes, while restricting those involved in fatty acid synthesis and desaturation to spare NADPH (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Nrf2 regulates NADPH and anabolic metabolism. Nrf2 reprograms the metabolic network to support cellular proliferation. Nrf2 can activate the key enzymes (labeled by red color) in the pentose phosphate pathway (G6PD, PGD, TALDO1, Tkt), nucleotide biosynthesis pathway (MTHFD2, PPAT), serine/glycine biosynthesis (PHGDH, PSAT1, SHMT), NADPH producing steps in the TCA cycle (ME1, IDH1), and TCA cycle replenishing (GLS, glutaminase; PC). Nrf2 also represses fatty acid synthesis and desaturation (ACL, ATP-citrate lyase; ACC1; FASN, fatty acid synthase; SCD1) to spare NADPH (labeled by blue color).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to these energy substances, Nrf2 also takes part in the heme and iron metabolism. <i>HMOX1</i>, encoding heme oxygenase 1 (HO-1) which is an essential enzyme in heme catabolism, cleaving heme to form biliverdin, carbon monoxide, and ferrous iron is an eminent Nrf2 target gene.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> HO-1 is an antioxidant related enzyme, which has known anti-inflammatory and cytoprotective functions against oxidative stresses.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a></div><div class="NLM_p">Nrf2 can activate the transcription of genes for some transcription factors, such as peroxisome proliferator-activated receptor γ (PPARγ),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> aryl hydrocarbon receptor (Ahr),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> retinoid X receptor α (RXRα),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and Nrf2 itself.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In addition to transcription factors, some cofactors involved in transcription, including MafG protein and CCAAT/enhancer-binding protein (C/EBP),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> are also regulated by Nrf2. These findings indicate the complex cross-talk of Nrf2–ARE signaling with these pathways.</div><div class="NLM_p last">Recent studies have revealed that Nrf2 can act as a transcription repressor. Nrf2 can directly oppose transcriptional upregulation of proinflammatory cytokine genes, including <i>IL1B</i> (encoding interleukin-1β) and <i>IL6</i> (encoding interleukin-6).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Nrf2 binds to ARE within regulatory domains of these proinflammatory cytokine genes and inhibits recruitment of RNA polymerase II to these loci, resulting in the rapid and direct suppression of proinflammatory cytokine genes.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3.  Regulation of Nrf2</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nrf2 is a modular protein composed of seven domains, Nrf2–ECH homology (Neh) domains 1–7, each with a distinct function (as shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The Neh1 domain in Nrf2 is a typical CNC–bZIP region, which mediates heterodimerization with other bZIP proteins and which is indispensable for transcription activation of target genes. The Neh2 domain in the N-terminal mediates the interaction with Kelch-like ECH-associated protein 1 (Keap1),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> the dominant regulator of Nrf2 ubiquitination. The C-terminal Neh3 domain is related with transactivation of target genes and interacts with the chromodomain helicase DNA-binding protein 6.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Neh4 and Neh5 interact with transcription coactivator CREB binding protein to modulate the rate of gene transcription. The Neh6 domain is involved in β-transducin repeat-containing protein-dependent (β-TrCP-dependent) repression of Nrf2.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> The Neh7 domain takes part in the transcription activation modulation by interacting with the DNA-binding domain of RXRα.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Domain structure of human Nrf2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While there are multiple pathways to modulate Nrf2 activity, Nrf2 ubiquitination is the most dominant way to depress Nrf2 activity in normal conditions. The protein level of Nrf2 in cells is tightly regulated by the cellular ubiquitin–proteasome system (UPS). To date, three E3 ligases, namely, Keap1–Cullins3–RING-box protein 1 (Keap1–Cul3–RBX1), β-TrCP-S-phase kinase-associated protein 1–Cul1–RBX1 (SKP1–Cul1–RBX1), and HMG-coA reductase degradation 1 homologue (Hrd1), have been identified to control the ubiquitination of Nrf2. Keap1–Cul3–RBX1 is the predominant regulator of Nrf2 ubiquitination. In this E3 ligase complex, Keap1 acts as an adaptor protein to recognize Nrf2 by a unique protein–protein interaction (PPI) mode.</div><div class="NLM_p">Currently, the detailed regulatory model of Keap1–Nrf2 has been intensively elucidated.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> In general, the Neh2 domain has two binding motifs for Keap1 with distinct binding strength, the ETGE motif with high affinity and the DLG motif with low affinity.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The Keap1–Nrf2 interaction follows a stoichiometric coefficient of 2:1; namely, Keap1 dimer binds to one Nrf2 protein.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Keap1-mediated Nrf2 ubiquitination (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) occurs only when the two motifs in Nrf2 simultaneously bind to Keap1 dimer to form a stable complex, referred to as the two-site binding model.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Disrupting the formation of the complex inhibits the ubiquitination of Nrf2, resulting in the accumulation of Nrf2 protein and activation of the Nrf2–ARE pathway. Under basal conditions, the newly synthesized Nrf2 protein can be ubiquitinated by the active Keap1–Cul3–RBX1 E3 ligase, and then, the ubiquitinated Nrf2 disassociates from the complex, resulting in the regeneration of the active E3 ligase. The recycling of E3 ligase can repress the consistently expressed Nrf2 protein at a low level. Under stress conditions, Keap1 sensors the microenvironment by the reactive cysteine residues, and ROS and electrophiles can covalently modify the cysteines in Keap1,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> impairing the E3 ligase activity. The Keap1 protein is locked by Nrf2, and the regeneration of Keap1 is inhibited; thus, the newly produced Nrf2 protein can avoid the Keap1-dependent depression and translocate to the nucleus to activate gene transcription.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Keap1-mediated regulation of Nrf2 under normal and stressed conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another E3 ligase adapter β-TrCP, compromising β-TrCP–SKP1–Cul1–RBX1 E3 ligase, also mediates the ubiquitination of Nrf2 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The two conserved peptide motifs DSGIS and DSAPGS in the Nrf2 Neh6 domain mediate the interaction with β-TrCP.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Unlike the recognition model of Nrf2–Keap1, the Nrf2−β-TrCP interaction is regulated by a phosphorylation-dependent way. The DSGIS motif can be phosphorylated by GSK-3, and this phosphorylation modification significantly enhances the ability of β-TrCP to suppress Nrf2.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> More recently, Hrd1 has been identified as another E3 ligase responsible for suppressing Nrf2 activity. Hrd1 can interact with the Neh4 and Neh5 domains of Nrf2 and mediate the degradation of Nrf2 under ER stress.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> In addition to the E3 ligase-mediated protein degradation, Nrf2 activity can be regulated by a variety of mechanisms, which have been intensively reviewed elsewhere.<a onclick="showRef(event, 'ref8 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref8 ref46 ref47 ref48">(8,46−48)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Regulation of Nrf2 ubiquitination by β-TrCP and Hrd1. GSK-3-mediated Nrf2 phosphorylation enhances the Nrf2−β-TrCP interaction, facilitating Nrf2 ubiquitination by β-TrCP–SKP1–Cul1–RBX1 E3 ligase and degradation by proteasome. Increased endoplasmic reticulum (ER) stress activates Hrd1, resulting in the ubiquitination-dependent Nrf2 degradation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">4.  Dual Roles of Nrf2 in Cancer</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The dual role of Nrf2 in cancer has been revealed for a long time;<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> activation of Nrf2 prevents the transformation of a normal cell to a cancerous one or may benefit the survival and proliferation of already transformed cancer cells.</div><div class="NLM_p">Nrf2 was first identified as a tumor suppressor. A lot of earlier studies showed that enhancing Nrf2 activity can inhibit carcinogenesis and genetic deletion of Nrf2 elevating susceptibility to cancer development by multiple carcinogens.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Nrf2 prevents carcinogenesis by accelerating metabolism of chemical carcinogens, relieving oxidative injuries, or quenching ROS and reactive nitrogen species (RNS) via the upregulation of its downstream targets.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> A lot of Nrf2 activators have been reported to prevent carcinogenesis induced by the chemical carcinogens and radiation (ionizing, ultraviolet) in Nrf2<sup>–/–</sup> mice.<a onclick="showRef(event, 'ref2 ref53'); return false;" href="javascript:void(0);" class="ref ref2 ref53">(2,53)</a></div><div class="NLM_p">As Nrf2 is a cellular protector that can enhance the survival of cells, it is logical to argue that Nrf2 activation could benefit cancer cells as well. Nrf2 significantly suppresses the oxidative stress that is important for the cytotoxic effects of chemotherapy.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> Activation of Nrf2 can enhance drug detoxification through redox and conjugating mechanisms. The elevation of the ATP-binding cassette family, such as the multidrug resistance (MDR) system, can result in the lower concentration of the drug level, which further explains the Nrf2 activation-induced drug resistance. Thus, the activity of Nrf2 could be protective for cancer cells, especially for fully malignant cells. However, it cannot fully explain the aggressive proliferation effects of Nrf2 in cancer. Further intensive biological studies revealed that Nrf2 can nourish tumor cells through more complex and all-around mechanisms.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_p">Among them, metabolic reprogramming effects of Nrf2 show promising characteristics in targeting cancer metabolism. The Warburg effect, a phenomenon that dividing cancer cells uptake more glucose and predominantly metabolize it by way of aerobic glycolysis, is a key feature for cancer cells. This metabolic iteration provides more anabolic precursors and reducing equivalents which are indispensable for rapid growth and proliferation of cancer cells. Although this metabolic character of cancer cells has been found for ages, little progress has been made in discovering therapeutic agents. Recently, transcription factor Nrf2 has been emerging as a key regulator of metabolic reprogramming in cancer cells. Overactivation of Nrf2 induces the metabolic reprogramming to anabolic pathways, guaranteeing the substance supply for cell proliferation. Upon control of the expression of G6PD, PGD, Tkt, and TALDO1, Nrf2 redirects glucose to PPP, producing NADPH as reducing equivalents and ribose 5-phosphate (R5P) as the key substrate for the nucleotide synthesis.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Inactivation of Keap1 and PTEN (phosphatase and tensin homologue) in the mouse lung promotes adenocarcinoma formation, and the tumorigenesis is associated with reprogramming of PPP.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Moreover, as mentioned above, Nrf2 also enhances NADPH production by multiple steps. IDH1 and ME1, the other two enzymes involved in NADPH production, are also regulated by Nrf2. In addition to the PPP pathway, Nrf2 can directly promote the <i>de novo</i> nucleotide synthesis by regulating the transcription of <i>MTHFD2</i> and <i>PPAT</i>.<a onclick="showRef(event, 'ref19 ref58'); return false;" href="javascript:void(0);" class="ref ref19 ref58">(19,58)</a> Glutamine metabolism, an important source of both nitrogen and carbon in cancer metabolism,<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> is also regulated by Nrf2 in several ways. Nrf2 can promote transport of glutamine by enhancing the expression of glutamine transporter, SLC1A5.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Nrf2 regulates the expression of glutaminase, which converts glutamine to glutamate in the mitochondria. Glutamate can be further metabolized by glutamate dehydrogenase or aminotransferases to α-ketoglutarate, replenishing the TCA cycle.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Upon cooperation with ATF4, Nrf2 also promotes the serine/glycine biosynthesis by enhancing the transcription of key genes in this process, including <i>PHGDH</i> encoding phosphoglycerate dehydrogenase, <i>PSAT1</i> encoding phosphoserine aminotransferase, and <i>SHMT2</i> encoding mitochondrial serine hydroxymethyltransferase (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Enhanced serine/glycine biosynthesis provides substances for glutathione synthesis and produces a one-carbon unit for nucleotide production, thus promoting tumorigenesis. Upon regulation of ATF4, Nrf2 also contributes to the addiction to the asparagine in NSCLC.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> In addition to the amino acid metabolizing, Nrf2 regulates the translation process of mRNA. In some pancreatic cancer cells, Nrf2 deficiency resulted in defects in autocrine epidermal growth factor receptor (EGFR) signaling and oxidation of specific translational regulatory proteins, leading to impaired cap-dependent and cap-independent mRNA translation.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> These metabolic alternations not only directly nourish the proliferation of cancer cells but also create an environment favorable for survival of cancer cells.</div><div class="NLM_p">In addition to the effect of tumor promotion, overexpression of Nrf2 may also lead to tumor initiation (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Available lines of evidence suggested that extent of Nrf2 activation influences susceptibility to disease. Chemoprevention by Nrf2 activation could be context-dependent, and the U-shaped Nrf2-dose response curve for the electrophilic and redox balance may best describe these influences. The physiological homeostatic range of optimal Nrf2 activation is between the biologically effective dose which minimally activates the Nrf2 pathway and a maximal-tolerated dose which not only activates the Nrf2 pathway but also disturbs the homeostatic balance and may have deleterious consequences as well.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The Phase I enzymes AKRs are among the most highly induced mRNA/proteins by Nrf2 activation.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> These enzymes can be cytoprotective by detoxifying reactive aldehydes and ketones. However, excess levels of electrophilic or redox-active agents, especially the lung carcinogens, can make AKR aggravate the oxidative stress. On the basis of the context, AKR enzymes induced by Nrf2 activation can not only lead to chemotherapy resistance, but also produce active lung carcinogens such as polycyclic aromatic hydrocarbons.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Another Nrf2-regulated metabolic enzyme, NQO1, has been proven to execute the activation of nitroarenes. In the context of air pollutants, nitroarenes can exert the genotoxicity through Nrf2-induced elevation of NQO1, which represents the “dark side” of Nrf2 activation.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Collectively, these results indicated that both too much and too little Nrf2 activity can cause adverse effects and disturb the homeostatic balance.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Roles of Nrf2 in blocking (yellow dotted lines) or promoting (blue dotted lines) the emergence of the hallmarks of cancer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Overactivation of Nrf2 has been found in different cancers types. The gain-of-function mutations of <i>NFE2L2</i> and loss-of-function mutations of <i>KEAP1</i> have been intensively investigated in lung cancer. The first identified loss-of-function mutation of <i>KEAP1</i> was found in two human lung adenocarcinoma cell lines, and the mutated Keap1 showed impaired affinity to Nrf2.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Singh et. al reported a systematic analysis of the <i>KEAP1</i> genomic locus in 12 cell lines and 54 NSCLC samples.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Their sequencing results showed somatic mutations in <i>KEAP1</i> in 6 cell lines and 10 tumor samples at a frequency of 50% and 19%. Moreover, their study showed that biallelic inactivation of <i>KEAP1</i> induced by loss of heterozygosity at 19p13.2 in lung cancer is a more common event with allelic losses in 61% of the NSCLC cell lines and 41% of the tumor samples. The analysis of different cohorts of patients gave similar results that loss-of-function mutations of <i>KEAP1</i> activate Nrf2 and benefits the growth of lung cancer.<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71,72)</a> In addition to the mutations of <i>KEAP1</i>, a study from Rui Wang et. al first demonstrated that <i>KEAP1</i> gene silencing may also be obtained by aberrant hypermethylation in the <i>KEAP1</i> promoter. Decreased mRNA levels of Keap1 were found in 3 lung cancer cell lines and 5 cancer tissues compared to normal bronchial epithelial cells. Treatment with the DNA methyltransferase inhibitor 5-Aza-dC restored the expression of Keap1 in lung cancer cell lines, suggesting that promoter methylation may contribute to the Keap1 downregulation. Furthermore, they also demonstrated that the P1 region was highly methylated in lung cancer, and found that three specific CpG sites in P1 might be occupied by proteins to regulate Keap1 expression.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Muscarella et. al carried out a comprehensive genetic and epigenetic analysis of <i>KEAP1</i> in 47 NSCLC tissues and normal specimens, and promoter methylation of <i>KEAP1</i> was observed in 22/47 NSCLC patients.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Another study from Naoyuki Hanada et. al showed that aberrant methylation of the <i>KEAP1</i> promoter was detected in 53% of tumor tissues and 25% of normal mucosae from 40 surgical human colorectal cancer (CRC) specimens. It indicated that CRC tissue may exhibit increased expression of nuclear Nrf2 and ARE gene through increased <i>KEAP1</i> promoter methylation.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> These studies also found that low <i>KEAP1</i> expression tends to be related with a worse prognosis and lower survival rates. In addition to NSCLC, loss-of-function mutations in the <i>KEAP1</i> gene have been found in approximately 20% of <i>KRAS</i> mutant lung adenocarcinoma (LUAD) tumors.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76,77)</a> Somatic mutations also occur in the <i>NEF2L2</i> coding region, especially in the Neh2 domain, and Nrf2 mutant cells constitutively express high levels of cytoprotective enzymes and drug efflux pumps, which are not affected by Keap1-mediated regulation.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> It is noteworthy that these mutations of Nrf2 and Keap1 have been found not only in the Keap1–Nrf2 interaction region but also in the whole sequence, indicating the complex modulating mechanism.<a onclick="showRef(event, 'ref70 ref79'); return false;" href="javascript:void(0);" class="ref ref70 ref79">(70,79)</a> Somatic mutations in Nrf2 have been found through whole-genome sequencing of hepatocellular carcinoma (HCC) patients. The enhanced Nrf2 activity is attributable to alterations in the ability to bind to its endogenous inhibitor Keap1.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Notably, the mechanism studies by different groups showed that Nrf2 mutation and overactivation occurs at the early stage of rat hepatocarcinogenesis.<a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81,82)</a> Particularly, papillary thyroid carcinoma sustains a remarkably high frequency (80.6%) of disruption to genes encoding the Nrf2 inhibitory complex components.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div><div class="NLM_p">Constitutive Nrf2 activation can cooperate with other oncogenic pathways to promote the carcinogenesis. Under the sustained activation of the phosphoinositide 3-kinase–Akt (PI3K–Akt) pathway, Nrf2 promotes glutamine and glucose into anabolic metabolic pathways. The active PI3K–Akt pathway enhances the nuclear availability of Nrf2, leading to the Nrf2-mediated promotion of metabolic activities that facilitate cell proliferation in addition to enhanced cytoprotection.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Comutation of <i>KRAS</i> and <i>KEAP1/NFE2L2</i> is an independent prognostic factor, predicting shorter survival, duration of response to initial platinum-based chemotherapy, and survival from start of immune therapy.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> More recently, a comprehensive analysis of oncogenic driver genes and mutations in >9000 tumors across 33 cancer types further confirmed the cancer driver function of Nrf2 activation and identified more mutation sites in both <i>NFE2L2</i> and <i>KEAP1</i> genes.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div><div class="NLM_p">Enhancing Nrf2 activity also acts as an alternative way to promote proliferation of the cancer cell, which affects the efficiency of kinase-targeted therapy to lung cancer. A recent study showed that loss of Keap1 altered cell metabolism to support cell proliferation without mitogen-activated protein kinase (MAPK) signaling, and the aberration of the Keap1–Nrf2 system can facilitate cell survival to antagonize the agents targeting the receptor tyrosine kinase (RTK)/Ras/MAPK pathway.<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85,86)</a></div><div class="NLM_p">In addition to genetic mutation or epigenetic silence of Nrf2 and Keap1, tumor cells utilize some alternative ways to enhance Nrf2 activity. Many oncogenic proteins, including K-Ras<sup>G12D</sup>, B-Raf<sup>V619E</sup>, and Myc<sup>ERT2</sup>, can increase the Nrf2 transcription to activate the Nrf2-regulated cellular antioxidant and detoxification system, thereby downregulating the level of ROS and providing a more reduced microenvironment.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></div><div class="NLM_p last">These studies together showed that Nrf2 not only protects cancer cells from various forms of stress and maintains the cellular redox homeostasis by regulating genes encoding antioxidants, detoxification enzymes, drug transporters, reductases, and other defense proteins, but also takes part in the whole process of pathogenesis, progression, metastasis, and prognosis of cancer. Thus, safe, specific, and potent Nrf2 inhibitors could be a potential option for cancer therapy.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">5.  Possible Ways To Inhibit Nrf2 Activity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23110" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23110" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The E3 ligase-mediated Nrf2 suppression by UPS provides convenient ways to develop small-molecule Nrf2 activators. There are multiple ways to inhibit E3 ligase activities. Great achievements have been made to develop therapeutic agents to inhibit Keap1 activity by either covalently targeting Keap1 cysteines<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> or competitively disrupting Keap1–Nrf2 PPI.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> However, for Nrf2 inhibition, especially for inhibiting constitutive activation of Nrf2 in tumor cells, it is the high-hanging fruit. Generally, downregulating protein levels of Nrf2 and/or repressing Nrf2 transcription activation activity is a possible way to inhibit Nrf2.</div><div class="NLM_p">Downregulating protein levels of Nrf2 can be achieved by inhibiting the transcription of the <i>NFE2L2</i> gene, decreasing the translation of Nrf2 mRNA, or enhancing the degradation of Nrf2 protein. Nrf2 mRNA is expressed broadly and independently of inducers,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and it is difficult to hinder the production of Nrf2 mRNA. Small interfering RNA targeting Nrf2 mRNA is a commonly used way to knockdown Nrf2 in cellular assays, and some miRNAs, including miR-144, miR-28, and miR-93, have been known to downregulate Nrf2.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> However, the deficiency of druglike properties of nucleic acid agents limits the further development.</div><div class="NLM_p">Enhancing Nrf2 ubiquitination is another way to inhibit Nrf2. Normally, Keap1-dependent ubiquitination and degradation of Nrf2 is the main way to restrict Nrf2 activity. Tumor cells utilize distinct mechanisms to deprive the function of Keap1. p62, an autophagy-adaptor protein, can activate Nrf2 in a Keap1-dependent manner. p62 contains a STGE motif that can be recognized by Keap1,<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> and the serine residue in this motif can be phosphorylated to further enhance the binding strength. The phosphorylated p62 has been reported to compete with Nrf2 for Keap1 binding.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Moreover, the p62–Keap1 interaction can sequester Keap1 into the autophagosome, directly downregulating protein levels of Keap1.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> p62 accumulation-induced Nrf2 activation has been found in HCC, which is important for cancer initiation.<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a> In such cases, inhibiting Nrf2 activity can be achieved by selectively disrupting the Keap1–p62 inhibition, and some pioneering work has been reported.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Further work is still needed to ensure that the compounds selectively impair Keap1–p62 interaction. Recently, the inhibitor of apoptosis stimulating protein p53 (iASPP) has also been found to activate the Nrf2 system by competing with Nrf2 with Keap1 binding, promoting the survival of cancer cells.<a onclick="showRef(event, 'ref97 ref98'); return false;" href="javascript:void(0);" class="ref ref97 ref98">(97,98)</a></div><div class="NLM_p">However, the major way to enhance Nrf2 activity is genetic mutation. As mentioned above, a lot of mutation sites in both <i>KEAP1</i> and <i>NEF2L2</i> that impair the Keap1-dependent depression of Nrf2 have been identified. For these tumors, promoting the β-TrCP-dependent ubiquitination of Nrf2 is a possible way. Like many other substrates of β-TrCP, Nrf2 is recognized by β-TrCP in a phosphorylation-dependent manner, and GSK-3 has been validated as the key kinase to phosphorylate the β-TrCP-binding motif in Nrf2. Recent studies showed that the GSK-3 inhibitors can activate Nrf2 in different cell lines,<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99,100)</a> further stressing the importance of GSK-3 kinase activity in β-TrCP-dependent Nrf2 repression. Unfortunately, there are no reported direct activators of GSK-3, and discovery of a direct kinase activator is also challenging. The activities of GSK-3α and GSK-3β are negatively regulated by phosphorylation of their Ser21 and Ser9 that are executed by protein kinase B (PKB)/Akt, and using PKB/Akt inhibitor MK-2206 or upstream kinase PI3K inhibitor LY294002 to hinder the phosphorylation of the DSGIS motif can decrease protein levels of Nrf2.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> However, the complex role of upstream kinases of GSK-3, such as PI3K-PKB/Akt, p38<sup>MAPK</sup>, and PKC,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> limits the further development of these kinase inhibitors as druglike Nrf2 inhibitors. Recently, the rapid development of small-molecule-induced protein degradation, represented by proteolysis-targeting chimaera (PROTAC) technology, may benefit the study of potent small-molecule transcription factor inhibitors.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> PROTAC is a bifunctional molecule, whereby one end binds to the target protein, and the other hijacks E3 ligase to enable the ubiquitination-dependent degradation of the target protein. Currently, the lack of small-molecule Nrf2 ligands limits the discovery of Nrf2-targeting PROTACs. In addition to the genetic mutation, the epigenetic modification of the <i>NFE2L2</i> gene is also an effective approach to Nrf2 inhibition. A study from Ziming Li et. al showed that the histone acetyltransferase hMOF can bind to Nrf2 and acetylates Nrf2, maintaining the nucleus retention of Nrf2 and mediating its transcription, subsequently regulating lung cancer growth and drug resistance.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Their detailed mechanism study showed that the enhancer of zeste homologue 2 (EZH2), the H3K27 trimethyltransferase, can bind to <i>NFE2L2</i> promoter and mediate the trimethylation of H3K27, which repressed Nrf2 transcription. In lung cancer tissues, loss of EZH2 function results in the reduction of H3K27me3 at the <i>NFE2L2</i> promoter, resulting in the increase of Nrf2 transcription.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Xiaoqian Zhao et. al explored the mechanisms underlying drug resistance in CRC cells to 5-fluorouracil (5-FU), which is a widely used anticancer drug. Their study showed that Nrf2 protein levels, nuclear translocation, as well as promoter binding were remarkably increased in fluorouracil-resistant CRC cells compared with normal CRC cells. Further methylation analysis indicated that fluorouracil-induced ROS production contributed to the upregulation of DNA demethylases, which catalyzed the promoter DNA demethylation of <i>NFE2L2</i>, leading to elevated mRNA levels of Nrf2 in drug-resistant CRC cells.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Taken together, these results suggested that epigenetic alteration in <i>NFE2L2</i> could provide a promising way to combat anticancer drug resistance.</div><div class="NLM_p">Inhibiting Nrf2 transcription activity is an alternative way. There are some key points for the transcription inducing activity of Nrf2, including translocating to the nucleus, forming a heterodimer with sMAF protein, and Nrf2–sMAF heterodimer binding to ARE.</div><div class="NLM_p">The nuclear localization of Nrf2 is also regulated by GSK-3-mediated phosphorylation. Nrf2 can be excluded from the nucleus by GSK-3β-mediated phosphorylation.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Disrupting the PPI of Nrf2–sMAF is a reasonable way to inhibit Nrf2 activity. The formation of Nrf2–sMAF protein can activate the transcription of a number of cytoprotective genes, providing protection against cytotoxic anticancer drugs. Thereby, developing the Nrf2–sMAF PPI inhibitors is a promising strategy to discover novel Nrf2 inhibitors (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). However, the unknown of detailed binding information restricts the discovery of potential inhibitors. Some other PPIs in the nucleus also modulate Nrf2 transcription activity.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> RXRα can interact with the Neh7 domain of Nrf2, and formation of the complex significantly suppresses the Nrf2–ARE pathway by impairing the binding of Nrf2 to ARE,<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> diminishing the cytoprotective effects by Nrf2 and sensitizing cells to the cytotoxic therapeutics; RXRα-specific ligands also show similar inhibitory effects.<a onclick="showRef(event, 'ref108 ref109'); return false;" href="javascript:void(0);" class="ref ref108 ref109">(108,109)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Possible ways and validated targets for inhibiting Nrf2 activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compared to apparent ways to activate Nrf2, the way to selectively and effectively inhibit Nrf2 activity is still obscure. With the in-depth study of the Nrf2 regulating network, many nodes can be targeted to inhibit Nrf2 activity, which provide many possibilities for developing Nrf2 inhibitors.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">6.  Discovery of Nrf2 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">With more and more attention regarding the oncogenic functions of Nrf2 activation, increasing efforts are being made to discover Nrf2 inhibitors. To date, a battery of molecules with distinct chemotypes and binding targets have been reported to show Nrf2 inhibitory effects.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Although most of them are reported with various biological activities, these agents provide useful information for the development of druglike Nrf2 inhibitors.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Natural Products with Nrf2 Inhibition Activity</h3><div id="sec6_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Brusatol</h4><div class="NLM_p last">Donna D. Zhang’s group first identified brusatol as a potent inhibitor of the Nrf2 pathway.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Brusatol can sensitize a vast range of cancer cells and A549 xenografts to several different chemotherapeutic drugs. However, further studies elucidated that the action mode of brusatol is not through directly inhibiting the Nrf2 pathway, and brusatol can decrease the majority of detected proteins rapidly and potently, including Nrf2, in the cellular proteome analysis of <i>KEAP1</i> mutant NSCLC cell line A549.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> The inhibition of both cap-dependent and cap-independent protein translation mechanisms of brusatol may affect many short-lived proteins, including Nrf2.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> This nonselective mechanism of action limits the further optimization of brusatol.</div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Glucocorticoids</h4><div class="NLM_p last">Glucocorticoids, represented by dexamethasone, have been reported to repress Nrf2 activity in a glucocorticoid-receptor-dependent (GCR-dependent) manner for a long time.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Unlike many other agents showing Nrf2 inhibition activity at micromolar range concentration, some glucocorticoids exhibit dramatic Nrf2 inhibition activity at nmol concentration.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> E.-J. Choi et al. comprehensively evaluated the Nrf2 inhibition activity of various glucocorticoids and found that the Nrf2 inhibition activity of these compounds correlates with the GCR activation activity, further stressing the GCR-involved mechanism in Nrf2 inhibition effects of glucocorticoids. Their detailed mechanism study showed that clobetasol propionate prevents the elevation of Nrf2 in nuclear and promotes the GSK3- and β-TrCP-dependent ubiquitination and degradation of Nrf2 in a glucocorticoid-receptor-dependent manner.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a></div></div><div id="sec6_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Flavonoids</h4><div class="NLM_p last">Some natural flavonoids have been reported with Nrf2 inhibition activity, and interestingly, many of them show distinct effects on Nrf2 activity in different studies. Luteolin has been reported to downregulate both the mRNA and the protein levels of Nrf2 by accelerating Nrf2 mRNA turnover in A549 cells.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Another study also reported that luteolin can enhance the anticancer effects of cisplatin via inhibiting Nrf2 signaling on the A549 cell-based xenograft model in Nrf2<sup>+/+</sup> mice but not in Nrf2<sup>–/–</sup> mice.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> On the contrary, luteolin can enhance the Nrf2–ARE antioxidant defense system to ameliorate acute mercuric chloride exposure-induced hepatotoxicity<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> and confer a neuroprotective effect in traumatic brain injury models by activating the Nrf2–ARE pathway.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Although context-dependent dual effects of luteolin on Nrf2 were reported, it seems likely that luteolin can inhibit Nrf2 in cancer cells, especially in those with the constitutive Nrf2 activation while active Nrf2-mediated antioxidant system in the nontransformed cells. Similar results were also observed in the study of wogonin, which can sensitize HepG2 cells<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> and MCF-7/DOX cells<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> to chemotherapy drugs through inhibiting the Nrf2–ARE pathway while inhibiting inflammation-associated colorectal carcinogenesis partly by activating the Nrf2 pathway.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></div></div><div id="sec6_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Ochratoxin A</h4><div class="NLM_p last">Ochratoxin A (OTA), a fungal-species-derived mycotoxin, also shows Nrf2 inhibition effects. Nrf2 inhibition activity of OTA is identified from its carcinogenicity mechanism study. OTA can reduce the Nrf2-regulated gene expression in the kidney by a microarray study, and the reduction of Nrf2-regulated gene caused by OTA results in oxidative DNA damages both <i>in vitro</i> and in the kidney.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> The kidney-specific Nrf2 inhibition of OTA takes part in the OTA nephrotoxicity and carcinogenicity. OTA can decrease the GST and SOD activity and enhance the ROS level,<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> and Nrf2 inhibition activity of OTA may be mediated by impaired Nrf2 nuclear translocation and/or decreased Nrf2 mRNA.<a onclick="showRef(event, 'ref126 ref127'); return false;" href="javascript:void(0);" class="ref ref126 ref127">(126,127)</a> Nevertheless, chronic exposure to OTA may enhance the somatic mutations in Nrf2 or Keap1 by acting as a selective pressure, leading to constitutive Nrf2 activation.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> The complex and unclear effects of OTA, together with its high toxicity, limit the further development of OTA as an Nrf2 inhibitor.</div></div><div id="sec6_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Camptothecin</h4><div class="NLM_p">Some natural-product-derived cytotoxic chemotherapy drugs also show Nrf2 inhibition activity (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). For example, camptothecin significantly suppresses the expression of Nrf2 and the Nrf2 transcriptional activity in various types of cancer cells including A549, HepG2, and SMMC-7721. Consequently, camptothecin can sensitize these cancer cells to chemotherapeutic drugs <i>in vitro</i> and in xenograft models.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Representative natural products with Nrf2 inhibition activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> All-<i>trans</i> Retinoic Acid</h4><div class="NLM_p last">All-<i>trans</i> retinoic acid (ATRA), also known as vitamine A acid or retinoic acid, and some other retinoic acid receptor alpha (RARα) agonists, are kinds of Nrf2 inhibitors with a clear mechanism. ATRA does not affect the protein level and the nuclear accumulation of Nrf2 but reduces the Nrf2–ARE binding as a result of forming a complex with RARα.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> RARα can bind to the Neh7 domain of Nrf2, and the formation of the Nrf2–RARα complex significantly inhibits the binding of Nrf2 to ARE sequence.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Bexarotene, an RXRα specific ligand, can also inhibit Nrf2 transcriptional activity in a RXRα-dependent manner.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> The Nrf2 inhibition of ATRA contributes to the efficacy of combined arsenic trioxide-ATRA treatment in the acute promyelocytic leukemia therapy.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></div></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Ultra-Small-Molecule Drugs Suppress Nrf2 Activity</h3><div class="NLM_p">Some well-known ultra-small-molecule (MW lower than 200 g/mol) drugs have been reported to inhibit the Nrf2–ARE pathway. Jingbo Pi’s group first reported that isoniazid, an antitubercular drug, can suppress Nrf2–ARE activity in diverse mouse and human cells. The inhibition of isoniazid on the Nrf2–ARE pathway interrupts with the transcriptional network of adipogenesis, resulting in impaired adipogenic differentiation.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> A further study reveals that isoniazid can increase the cytosolic protein level of Nrf2 while decreasing the nuclear protein level of Nrf2 in Hep3B cells, and this Nrf2 inhibitory mechanism may be associated with the extracellular signal-regulated kinase1 (ERK1) phosphorylation.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Some isoniazid analogs, including isonicotinic acid amides and ethionamide, also show Nrf2 inhibition activity, and ethionamide can sensitize acute monocytic leukemia THP-1 cells to As<sub>2</sub>O<sub>3</sub>-induced cytotoxicity in an Nrf2-dependent manner.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> To date, the detailed Nrf2–ARE inhibitory mechanism of these antitubercular small molecules is still obscure. These compounds, sharing a quite similar chemical structure, do not affect both the mRNA and the protein levels of Nrf2, which needs more studies to clarify this unique mechanism.</div><div class="NLM_p">Metformin, the first-line medication for type 2 diabetes treatment, has also been reported to suppress the Nrf2–ARE system. Minh Truong Do et al. found that metformin can reduce the mRNA and the protein levels of Nrf2 in HepG2 cells, and the downregulation of Nrf2 is mediated by a Keap1-independent and AMPK-independent but Raf-ERK signaling attenuation-involved mechanism.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Their further study showed that miR-34a induced by metformin is important to suppress the Nrf2 pathway, which can sensitize wild-type p53 cancer cells to oxidative stress and apoptosis.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> It is noteworthy that some studies also reported the Nrf2 activation effects of metformin, indicating the conditional effects of metformin on Nrf2 activity.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></div><div class="NLM_p">In addition to these approved drugs, some other bioactive ultrasmall molecules also show Nrf2–ARE inhibition activity (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Trigonelline, a zwitterion formed by the methylation of the nitrogen atom of niacin (vitamin B3), inhibits Nrf2 activity by reducing nuclear accumulation of Nrf2. Prominently, the Nrf2-dependent expression of proteasomal genes can be inhibited by trigonelline, resulting in the reduction of proteasomal activity.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> These Nrf2 inhibition-mediated effects of trigonelline can sensitize tumor cells to chemotherapy drugs both <i>in vitro</i> and <i>in vivo</i>. All of these ultrasmall molecules have multiple targets and complex biological effects, and the high concentration of these compounds is required for the effective Nrf2 inhibition <i>in vitro</i>, which limit the further development of targeting Nrf2 inhibitors.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Ultrasmall molecule with Nrf2 inhibition activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> High-Throughput Screening (HTS) To Identify Nrf2 Activators</h3><div class="NLM_p">To date, there has not been any good protein target suitable for the rational design of small-molecule Nrf2 inhibitors. The transcription activity of Nrf2 makes it convenient for constructing a cellular phenotype-based screening assay to identify novel Nrf2 inhibitors. Considering that the expression of oncogene C-Myc can increase Nrf2 expression, cMyc was overexpressed in 3T3 mouse embryonic fibroblasts harboring a stably integrated ARE which drives the expression of firefly luciferase. The obtained cell line (MYC-3T3-ARE-LUC cells) is suitable for HTS. A library containing about 30 000 diverse heterocyclic compounds together with known biologically active small molecules was screened by this cell line for Nrf2–ARE inhibition activity. Among them, 27 active hits containing three novel chemical scaffolds were discovered. Further optimization of the thienopyrimidine scaffold compound <b>CBR-031-1</b> gave a preferable analog, <b>AEM1</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), which shows an EC<sub>50</sub> of ∼650 nM in inhibiting the ARE–LUC signal. <b>AEM1</b> can decrease the expression of Nrf2 target genes, sensitize A549 cells to different chemotherapeutic agents, and inhibit the growth of A549 cells both <i>in vitro</i> and <i>in vivo</i>.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> This compound does not affect the protein level of Nrf2 and does not affect any known Nrf2-phosphorylation process.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Discovery of AEM1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In another study, ARE-driven luciferase reporter genes were stably transferred to HeLa cells, and this cell line was used to identify a series of pyrazolyl hydroxamic acids with Nrf2–ARE inhibition activity. The representative compound <b>4f</b><a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> can downregulate the protein level of Nrf2 and increase the apoptosis of acute myeloid leukemia cells (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). The apoptosis promoting effects of <b>4f</b> have been proven to be associated with Nrf2 downregulation and may be at least partly mediated by the reduction of both Bcl-2 expression and Bcl-2/Bax ratio. The mechanism of action of this series of compounds remains unknown.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Discovery of <b>4f</b> with pyrazolyl hydroxamic acid scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>ML385</b> (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>), which was discovered by Shyam Biswal and co-workers, is the first reported Nrf2 inhibitor with a direct Nrf2-binding mechanism.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> It was identified by an A549 cell-based ARE–luciferase assay from the Molecular Libraries Small Molecule Repository Library. <b>ML385</b> can concentration-dependently inhibit the binding of the Nrf2–MafG complex to DNA, and the biotin derivate of <b>ML385</b> (<b>AB-ML385</b>) shows Nrf2-binding activity in the cellular pull-down experiment. Moreover, the Nrf2 without the Neh1 domain (ΔNeh1) does not interact with <b>AB-ML385</b>. Collectively, the authors proposed that <b>ML385</b> can inhibit the Nrf2–DNA interaction by directly binding to the Nrf2 Neh1 domain. <b>ML385</b> selectively inhibits the growth of NSCLC cells with Keap1 mutations and enhances the cytotoxic effects of chemotherapy drugs both <i>in vitro</i> and <i>in vivo</i>. The further binding mode study of this Nrf2 inhibitor may promote the further optimization of <b>ML385</b>.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Discovery of <b>ML385</b> with Nrf2-binding mechanism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Very recently, James H. Matthews et al. screened the Sigma LOPAC and Spectrum Collection libraries using the MDA-MB-231 cell line expressing luciferase under the control of the ARE-containing NQO1 promoter, and they discovered three classes of compounds: cardiac glycosides, Stat3 inhibitors, and actin disrupting agents as Nrf2 inhibitors (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>).<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> In this study, the authors also screened a library of siRNAs targeting the possible druggable genomes to identify novel targets for Nrf2 inhibition, and found that the transcription factors TWIST1 and ELF4, the TAK1 kinase regulator TAB1, the protein kinase NEK8, and the dual specific phosphatase DUSP4 may be putative Nrf2 targets,<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> which provided new insights into the discovery of Nrf2 inhibitors.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Discovery of emetine, ouabain, and stattic.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">7.  Future Directions and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02744" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02744" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The dual function of Nrf2 in cancer has been proposed and investigated for a long time. With the continuous growing research of new regulatory modes and functions of Nrf2, the dual effects of Nrf2 in cancer have become increasingly clear. Although whether Nrf2 is an oncogene is still uncertain, the tumor-promoting effects of Nrf2 have been intensively validated in different kinds of tumors. Nrf2 contributes to tumor cells in a lot of hallmarks of cancer, suggesting that inhibiting Nrf2 could be a good therapeutic approach.</div><div class="NLM_p last">Compared to the rapid progress in the study of oncogenic effects of Nrf2, the development of Nrf2 inhibitors for cancer therapy is still limited. Most currently available Nrf2 inhibitors lack detailed molecular mechanisms of action, and few of them show direct and selective mechanism of action. Considering that the inactivation of the Keap1-dependent Nrf2 repression system is frequent in cancer, the panorama of the Keap1-independent Nrf2 regulating network should be explored to identify druggable targets for Nrf2 inhibition. Moreover, inhibition of Keap1-phosphorylated p62 PPI is also a promising way to restrict Nrf2 activity. However, the Nrf2 inhibition activity of Keap1-phosphorylated p62 PPI inhibitors has not yet been systematically evaluated, and the structure–activity relationship of the compounds for inhibition activity and selectivity of Keap1–p62 interaction merits further investigation. In addition, directly inhibiting Nrf2 transcription activity by targeting the Nrf2-involved PPIs in the nucleus, especially disrupting Nrf2–sMaf PPI, is a promising strategy. However, the interface of Nrf2–sMaf PPI has not been clearly elucidated, limiting the discovery of targeting inhibitors. Further structural biology study of Nrf2–sMaf PPI will facilitate the development of modulating agents. We believe that, with the efforts of many medicinal chemists, the specific and potent druglike Nrf2 inhibitors will be identified in the next few years.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01121" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07670" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07670" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zheng-Yu Jiang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
Medicines and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
School of Pharmacy, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1671-1582" title="Orcid link">http://orcid.org/0000-0002-1671-1582</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ef85868e818895878a8188969a8c9f9aafded9dcc18c8082"><span class="__cf_email__" data-cfemail="bfd5d6ded1d8c5d7dad1d8c6cadccfcaff8e898c91dcd0d2">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi-Dong You</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
Medicines and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
School of Pharmacy, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8587-0122" title="Orcid link">http://orcid.org/0000-0002-8587-0122</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#057c6a707461453433362b666a68"><span class="__cf_email__" data-cfemail="671e08121603275651544904080a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meng-Chen Lu</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
Medicines and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
School of Pharmacy, China Pharmaceutical
University, Nanjing 210009, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Z.-Y.J. and M.-C.L. contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40764" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40764" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Zheng-Yu Jiang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=BIO-d7e1065-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Zheng-Yu Jiang</b> received his Bachelor’s degree from China Pharmaceutical University, where he also obtained his Ph.D. in Medicinal Chemistry under the supervision of Professor Qi-Dong You. Currently, he is an Associate Professor of Medicinal Chemistry in the Department of Pharmacy, China Pharmaceutical University. His main research topics focus on the following: (i) discovery and development of protein–protein interaction inhibitors, and (ii) chemical biology study of the Keap1–Nrf2-related system.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Meng-Chen Lu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=BIO-d7e1070-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Meng-Chen Lu</b> earned her Ph.D. in Medicinal Chemistry from China Pharmaceutical University under the supervision of Professor Qi-Dong You. She is currently a member of the Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University. Her research interests lie in the discovery and chemical biology study of the Keap1–Nrf2 protein–protein interaction inhibitors.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Qi-Dong You</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=BIO-d7e1075-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Qi-Dong You</b> obtained his Bachelor’s degree from the Nanjing College of Pharmacy (the former China Pharmaceutical university), China, in 1982 and his Ph.D. in Medicinal Chemistry from Shanghai Institute of Pharmaceutical Industry in 1989. He did his research in medicinal chemistry as a visiting-scholar at Department of Pharmaceutical Sciences, Strathclyde University, Glasgow, UK, between 1994 and 1995. Currently, he is a Professor of Medicinal Chemistry in the Department of Medicinal Chemistry, China Pharmaceutical University and the director of Jiang Su Key Laboratory of Drug Design and Optimization. His research interests mainly focus on small-molecule inhibitors of protein–protein interactions, antitumor natural products, and targeted anticancer drugs.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52210" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52210" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by Projects 81602948, 81773581, 81773639, and 81803363 of the National Natural Science Foundation of China; the Natural Science Foundation of Jiangsu Province of China (BK20160746); China Postdoctoral Science Foundation-funded Project (1600010006 and 2018T110576); 2015ZX09101032 and 2017ZX09302003 of the National Major Science and Technology Project of China (Innovation and Development of New Drugs); the Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Outstanding Scientific and Technological Innovation Team of Jiangsu Higher Education (YY20180315004), 111 Project (B16046) and “Double First-Class” University Project (CPU2018GY02).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Nrf2</td><td class="NLM_def"><p class="first last">nuclear factor erythroid 2-related factor 2</p></td></tr><tr><td class="NLM_term">bZIP</td><td class="NLM_def"><p class="first last">basic region-leucine zipper</p></td></tr><tr><td class="NLM_term">sMAF</td><td class="NLM_def"><p class="first last">small musculoaponeurotic fibrosarcoma</p></td></tr><tr><td class="NLM_term">ARE</td><td class="NLM_def"><p class="first last">antioxidant response element</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">GCLC</td><td class="NLM_def"><p class="first last">glutamate–cysteine ligase catalytic subunit</p></td></tr><tr><td class="NLM_term">GCLM</td><td class="NLM_def"><p class="first last">glutamate–cysteine ligase modifier subunit</p></td></tr><tr><td class="NLM_term">GPx</td><td class="NLM_def"><p class="first last">glutathione peroxidase</p></td></tr><tr><td class="NLM_term">GSR</td><td class="NLM_def"><p class="first last">glutathione reductase</p></td></tr><tr><td class="NLM_term">TXN</td><td class="NLM_def"><p class="first last">thioredoxin</p></td></tr><tr><td class="NLM_term">TXNRD</td><td class="NLM_def"><p class="first last">thioredoxin reductase</p></td></tr><tr><td class="NLM_term">SRXN</td><td class="NLM_def"><p class="first last">sulfiredoxin</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450 protein</p></td></tr><tr><td class="NLM_term">ALDH</td><td class="NLM_def"><p class="first last">aldehyde dehydrogenase</p></td></tr><tr><td class="NLM_term">ADH</td><td class="NLM_def"><p class="first last">alcohol dehydrogenase</p></td></tr><tr><td class="NLM_term">NQO1</td><td class="NLM_def"><p class="first last">NAD(P)H:quinone oxidoreductase 1</p></td></tr><tr><td class="NLM_term">AKR</td><td class="NLM_def"><p class="first last">aldo-keto reductase</p></td></tr><tr><td class="NLM_term">UGT</td><td class="NLM_def"><p class="first last">UDP-glucuronosyltransferase</p></td></tr><tr><td class="NLM_term">SULT</td><td class="NLM_def"><p class="first last">sulfotransferase</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione S-transferase</p></td></tr><tr><td class="NLM_term">G6PD</td><td class="NLM_def"><p class="first last">glucose-6-phosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">PGD</td><td class="NLM_def"><p class="first last">6-phosphogluconate dehydrogenase</p></td></tr><tr><td class="NLM_term">IDH1</td><td class="NLM_def"><p class="first last">isocitrate dehydrogenase 1</p></td></tr><tr><td class="NLM_term">ME1</td><td class="NLM_def"><p class="first last">malic enzyme 1</p></td></tr><tr><td class="NLM_term">PPP</td><td class="NLM_def"><p class="first last">pentose phosphate pathway</p></td></tr><tr><td class="NLM_term">Tkt</td><td class="NLM_def"><p class="first last">transketolase</p></td></tr><tr><td class="NLM_term">Taldo1</td><td class="NLM_def"><p class="first last">transaldolase1</p></td></tr><tr><td class="NLM_term">PPAT</td><td class="NLM_def"><p class="first last">phosphoribosyl pyrophosphate amidotransferase</p></td></tr><tr><td class="NLM_term">MTHFD2</td><td class="NLM_def"><p class="first last">methylenetetrahydrofolate dehydrogenase 2</p></td></tr><tr><td class="NLM_term">HO-1</td><td class="NLM_def"><p class="first last">heme oxygenase 1</p></td></tr><tr><td class="NLM_term">Ahr</td><td class="NLM_def"><p class="first last">aryl hydrocarbon receptor</p></td></tr><tr><td class="NLM_term">PPARγ</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor γ</p></td></tr><tr><td class="NLM_term">RXRα</td><td class="NLM_def"><p class="first last">retinoid X receptor α</p></td></tr><tr><td class="NLM_term">C/EBP</td><td class="NLM_def"><p class="first last">CCAAT/enhancer-binding protein</p></td></tr><tr><td class="NLM_term">Neh</td><td class="NLM_def"><p class="first last">Nrf2–ECH homology</p></td></tr><tr><td class="NLM_term">Keap1</td><td class="NLM_def"><p class="first last">Kelch-like ECH-associated protein 1</p></td></tr><tr><td class="NLM_term">β-TrCP</td><td class="NLM_def"><p class="first last">β-transducin repeat-containing protein</p></td></tr><tr><td class="NLM_term">UPS</td><td class="NLM_def"><p class="first last">ubiquitin–proteasome system</p></td></tr><tr><td class="NLM_term">Cul</td><td class="NLM_def"><p class="first last">Cullins</p></td></tr><tr><td class="NLM_term">RBX1</td><td class="NLM_def"><p class="first last">RING-box protein 1</p></td></tr><tr><td class="NLM_term">SKP1</td><td class="NLM_def"><p class="first last">S-phase kinase-associated protein 1</p></td></tr><tr><td class="NLM_term">Hrd1</td><td class="NLM_def"><p class="first last">HMG-coA reductase degradation 1 homologue</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">RNS</td><td class="NLM_def"><p class="first last">reactive nitrogen species</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">nonsmall cell lung cancer</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">ATRA</td><td class="NLM_def"><p class="first last">all-<i>trans</i> retinoic acid</p></td></tr><tr><td class="NLM_term">EZH2</td><td class="NLM_def"><p class="first last">enhancer of zeste homologue 2.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56480" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56480" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 143 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishizawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Cloning and Characterization of a Novel Erythroid Cell-Derived Cnc Family Transcription Factor Heterodimerizing with the Small Maf Family Proteins</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">4184</span>– <span class="NLM_lpage">4193</span>, <span class="refDoi"> DOI: 10.1128/MCB.15.8.4184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.15.8.4184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=7623813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADyaK2MXntVGit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=4184-4193&author=K.+Itohauthor=K.+Igarashiauthor=N.+Hayashiauthor=M.+Nishizawaauthor=M.+Yamamoto&title=Cloning+and+Characterization+of+a+Novel+Erythroid+Cell-Derived+Cnc+Family+Transcription+Factor+Heterodimerizing+with+the+Small+Maf+Family+Proteins&doi=10.1128%2FMCB.15.8.4184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins</span></div><div class="casAuthors">Itoh, Ken; Igarashi, Kazuhiko; Hayashi, Norio; Nishizawa, Makoto; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4184-93</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The chicken β-globin enhancer is crit. for the tissue- and developmental stage-specific expression of the β-globin genes.  This enhancer contains two indispensable cis elements, one contg. two GATA sites and the other contg. an NF-E2 site.  To identify the putative transcription factor acting through the NF-E2 motif in the chicken β-globin enhancer, we screened chicken cDNA libraries with a mouse p45 NF-E2 cDNA probe and isolated cDNA clones which encode a protein of 582 amino acid residues.  This protein contain a region that includes the basic region-leucine zipper domain which is well conserved among members of the CNC family proteins (Cap 'n' collar, p45 NF-E2, LCR-F1, Nrf1, and Nrf2).  Hence, the authors named this protein ECH (erythroid cell-derived protein with CNC homol.).  ECH is expressed abundantly in cultured erythroid cells undergoing terminal differentiation, peripheral erythrocytes, and some nonhematopoietic tissues.  Since most of the cDNA clones obtained from the chicken erythrocyte cDNA library encoded ECH, ECH is likely the predominant CNC family protein present in avian peripheral erythrocytes.  Like p45 NF-E2, ECH can heterodimerize with any of the small Maf family proteins and bind the NF-E2 site as a heterodimer in vitro.  In a transfection assay, ECH transactivates transcription depending on the presence of NF-E2 sites on the reporter gene plasmid.  These results indicate that ECH is likely a key regulator of avian erythropoiesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl-mjjhRr-fLVg90H21EOLACvtfcHk0li5IO1rZ-29Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntVGit78%253D&md5=6be978f36871a9e1dab0d44455285686</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1128%2FMCB.15.8.4184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.15.8.4184%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DK.%26aulast%3DHayashi%26aufirst%3DN.%26aulast%3DNishizawa%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DCloning%2520and%2520Characterization%2520of%2520a%2520Novel%2520Erythroid%2520Cell-Derived%2520Cnc%2520Family%2520Transcription%2520Factor%2520Heterodimerizing%2520with%2520the%2520Small%2520Maf%2520Family%2520Proteins%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1995%26volume%3D15%26spage%3D4184%26epage%3D4193%26doi%3D10.1128%2FMCB.15.8.4184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">The Cytoprotective Role of the Keap1-Nrf2 Pathway</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1007/s00204-011-0674-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1007%2Fs00204-011-0674-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21365312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFKks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2011&pages=241-272&author=L.+Bairdauthor=A.+T.+Dinkova-Kostova&title=The+Cytoprotective+Role+of+the+Keap1-Nrf2+Pathway&doi=10.1007%2Fs00204-011-0674-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The cytoprotective role of the Keap1-Nrf2 pathway</span></div><div class="casAuthors">Baird, Liam; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">241-272</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  An elaborate network of highly inducible proteins protects aerobic cells against the cumulative damaging effects of reactive oxygen intermediates and toxic electrophiles, which are the major causes of neoplastic and chronic degenerative diseases.  These cytoprotective proteins share common transcriptional regulation, through the Keap1-Nrf2 pathway, which can be activated by various exogenous and endogenous small mols. (inducers).  Inducers chem. react with crit. cysteine residues of the sensor protein Keap1, leading to stabilization and nuclear translocation of transcription factor Nrf2, and ultimately to coordinate enhanced expression of genes coding for cytoprotective proteins.  In addn., inducers inhibit pro-inflammatory responses, and there is a linear correlation spanning more than six orders of magnitude of concns. between inducer and anti-inflammatory activity.  Genetic deletion of transcription factor Nrf2 renders cells and animals much more sensitive to the damaging effects of electrophiles, oxidants and inflammatory agents in comparison with their wild-type counterparts.  Conversely, activation of the Keap1-Nrf2 pathway allows survival and adaptation under various conditions of stress and has protective effects in many animal models.  Cross-talks with other signalling pathways broadens the role of the Keap1-Nrf2 pathway in detg. the fate of the cell, impacting fundamental biol. processes such as proliferation, apoptosis, angiogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8uAt10znKgrVg90H21EOLACvtfcHk0liIz4jN2YFjeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFKks7w%253D&md5=cedf16d08f2f6d9ba8e2c5975251600e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00204-011-0674-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-011-0674-5%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DThe%2520Cytoprotective%2520Role%2520of%2520the%2520Keap1-Nrf2%2520Pathway%26jtitle%3DArch.%2520Toxicol.%26date%3D2011%26volume%3D85%26spage%3D241%26epage%3D272%26doi%3D10.1007%2Fs00204-011-0674-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chartoumpekis, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span> <span> </span><span class="NLM_article-title">Keap1/Nrf2 Pathway in the Frontiers of Cancer and Non-Cancer Cell Metabolism</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">639</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1042/BST20150049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1042%2FBST20150049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26551705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=639-644&author=D.+V.+Chartoumpekisauthor=N.+Wakabayashiauthor=T.+W.+Kensler&title=Keap1%2FNrf2+Pathway+in+the+Frontiers+of+Cancer+and+Non-Cancer+Cell+Metabolism&doi=10.1042%2FBST20150049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism</span></div><div class="casAuthors">Chartoumpekis, Dionysios V.; Wakabayashi, Nobunao; Kensler, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">639-644</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Cancer cells adapt their metab. to their increased needs for energy and substrates for protein, lipid and nucleic acid synthesis.  Nuclear erythroid factor 2-like 2 (Nrf2) pathway is usually activated in cancers and has been suggested to promote cancer cell survival mainly by inducing a large battery of cytoprotective genes.  This mini review focuses on metabolic pathways, beyond cytoprotection, which can be directly or indirectly regulated by Nrf2 in cancer cells to affect their survival.  The pentose phosphate pathway (PPP) is enhanced by Nrf2 in cancers and aids their growth.  PPP has also been found to be up-regulated in non-cancer tissues and other pathways, such as de novo lipogenesis, have been found to be repressed after activation of the Nrf2 pathway.  The importance of these Nrf2-regulated metabolic pathways in cancer compared with non-cancer state remains to be detd.  Last but not least, the importance of context about Nrf2 and cancer is highlighted as the Nrf2 pathway may be activated in cancers but its pharmacol. activators are useful in chemoprevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzz40oaoJy07Vg90H21EOLACvtfcHk0liIz4jN2YFjeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsb3O&md5=c3c19b8f4a889ff9b2d85c1220a6574b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1042%2FBST20150049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20150049%26sid%3Dliteratum%253Aachs%26aulast%3DChartoumpekis%26aufirst%3DD.%2BV.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26atitle%3DKeap1%252FNrf2%2520Pathway%2520in%2520the%2520Frontiers%2520of%2520Cancer%2520and%2520Non-Cancer%2520Cell%2520Metabolism%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2015%26volume%3D43%26spage%3D639%26epage%3D644%26doi%3D10.1042%2FBST20150049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span> <span> </span><span class="NLM_article-title">Nrf2 and Keap1Mutations: Permanent Activation of an Adaptive Response in Cancer</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2008.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.tibs.2008.12.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=176-188&author=J.+D.+Hayesauthor=M.+McMahon&title=Nrf2+and+Keap1Mutations%3A+Permanent+Activation+of+an+Adaptive+Response+in+Cancer&doi=10.1016%2Fj.tibs.2008.12.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2008.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2008.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DMcMahon%26aufirst%3DM.%26atitle%3DNrf2%2520and%2520Keap1Mutations%253A%2520Permanent%2520Activation%2520of%2520an%2520Adaptive%2520Response%2520in%2520Cancer%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2009%26volume%3D34%26spage%3D176%26epage%3D188%26doi%3D10.1016%2Fj.tibs.2008.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Toward Clinical Application of the Keap1–Nrf2 Pathway</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2013.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.tips.2013.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23664668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVylu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=340-346&author=T.+Suzukiauthor=H.+Motohashiauthor=M.+Yamamoto&title=Toward+Clinical+Application+of+the+Keap1%E2%80%93Nrf2+Pathway&doi=10.1016%2Fj.tips.2013.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Toward clinical application of the Keap1-Nrf2 pathway</span></div><div class="casAuthors">Suzuki, Takafumi; Motohashi, Hozumi; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">340-346</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The Keap1-Nrf2 pathway plays a crucial role in detg. the sensitivity of cells to chem. and/or oxidative insults by regulating the basal and inducible expression of detoxification and antioxidant enzymes, ABC transporters, and other stress response enzymes and/or proteins.  Increasing attention has been focused on the roles that the Keap1-Nrf2 pathway plays in the protection of our body against drug toxicity and stress-induced diseases.  Simultaneously, Nrf2 has been recognized to promote oncogenesis and resistance to chemotherapeutic drugs.  Cancer cells hijack Nrf2 activity to support their malignant growth and thus Nrf2 has emerged as a therapeutic target.  Translational studies of the Keap1-Nrf2 system, from mechanistic understanding to clin. applications, are now important to improve human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3LyyVFE7CB7Vg90H21EOLACvtfcHk0ljtsNAHNSA5Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVylu7s%253D&md5=5834bbcb887101cbd4231e384e0580b6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DToward%2520Clinical%2520Application%2520of%2520the%2520Keap1%25E2%2580%2593Nrf2%2520Pathway%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D340%26epage%3D346%26doi%3D10.1016%2Fj.tips.2013.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menegon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Columbano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, S.</span></span> <span> </span><span class="NLM_article-title">The Dual Roles of Nrf2 in Cancer</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">593</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2016.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.molmed.2016.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27263465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVSnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=578-593&author=S.+Menegonauthor=A.+Columbanoauthor=S.+Giordano&title=The+Dual+Roles+of+Nrf2+in+Cancer&doi=10.1016%2Fj.molmed.2016.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Dual Roles of NRF2 in Cancer</span></div><div class="casAuthors">Menegon, Silvia; Columbano, Amedeo; Giordano, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">578-593</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  NRF2 has been traditionally considered as a tumor suppressor because its cytoprotective functions are deemed to be the main cellular defense mechanism against exogenous and endogenous insults, including xenobiotics and oxidative stress.  However, several recent studies demonstrate that hyperactivation of the NRF2 pathway creates an environment that favors the survival of normal as well as malignant cells, protecting them against oxidative stress, chemotherapeutic agents, and radiotherapy.  In a rapidly advancing field, this review summarizes some of the known mechanisms by which NRF2 can exert its oncogenic functions, and describes the current status of NRF2 inhibitors, providing a clear rationale for the consideration of NRF2 as a powerful putative therapeutic target in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw6FPL0WZuHbVg90H21EOLACvtfcHk0ljtsNAHNSA5Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVSnsL0%253D&md5=88b1ab6ed97e3f249fc5ea9e694b6d75</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2016.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2016.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DMenegon%26aufirst%3DS.%26aulast%3DColumbano%26aufirst%3DA.%26aulast%3DGiordano%26aufirst%3DS.%26atitle%3DThe%2520Dual%2520Roles%2520of%2520Nrf2%2520in%2520Cancer%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D578%26epage%3D593%26doi%3D10.1016%2Fj.molmed.2016.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. P.</span></span> <span> </span><span class="NLM_article-title">Oxidative Stress</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-061516-045037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1146%2Fannurev-biochem-061516-045037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28441057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFels70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2017&pages=715-748&author=H.+Siesauthor=C.+Berndtauthor=D.+P.+Jones&title=Oxidative+Stress&doi=10.1146%2Fannurev-biochem-061516-045037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress</span></div><div class="casAuthors">Sies, Helmut; Berndt, Carsten; Jones, Dean P.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">715-748</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">Oxidative stress is two sided: Whereas excessive oxidant challenge causes damage to biomols., maintenance of a physiol. level of oxidant challenge, termed oxidative eustress, is essential for governing life processes through redox signaling.  Recent interest has focused on the intricate ways by which redox signaling integrates these converse properties.  Redox balance is maintained by prevention, interception, and repair, and concomitantly the regulatory potential of mol. thiol-driven master switches such as Nrf2/Keap1 or NF-κB/IκB is used for system-wide oxidative stress response.  Nonradical species such as hydrogen peroxide (H2O2) or singlet mol. oxygen, rather than free-radical species, perform major second messenger functions.  Chemokine-controlled NADPH oxidases and metabolically controlled mitochondrial sources of H2O2 as well as glutathione- and thioredoxin-related pathways, with powerful enzymic back-up systems, are responsible for fine-tuning physiol. redox signaling.  This makes for a rich research field spanning from biochem. and cell biol. into nutritional sciences, environmental medicine, and mol. knowledge-based redox medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqYthGbEMU0LVg90H21EOLACvtfcHk0ljtsNAHNSA5Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFels70%253D&md5=910b7e9fa8ebd3b7dba6497f8212d4de</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-061516-045037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-061516-045037%26sid%3Dliteratum%253Aachs%26aulast%3DSies%26aufirst%3DH.%26aulast%3DBerndt%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DD.%2BP.%26atitle%3DOxidative%2520Stress%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2017%26volume%3D86%26spage%3D715%26epage%3D748%26doi%3D10.1146%2Fannurev-biochem-061516-045037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span> <span> </span><span class="NLM_article-title">The Keap1-Nrf2 System: A Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1169</span>– <span class="NLM_lpage">1203</span>, <span class="refDoi"> DOI: 10.1152/physrev.00023.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1152%2Fphysrev.00023.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29717933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvFektrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2018&pages=1169-1203&author=M.+Yamamotoauthor=T.+W.+Kenslerauthor=H.+Motohashi&title=The+Keap1-Nrf2+System%3A+A+Thiol-Based+Sensor-Effector+Apparatus+for+Maintaining+Redox+Homeostasis&doi=10.1152%2Fphysrev.00023.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis</span></div><div class="casAuthors">Yamamoto, Masayuki; Kensler, Thomas W.; Motohashi, Hozumi</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1169-1203</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">1522-1210</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The Kelch-like ECH-assocd. protein 1-NF-E2-related factor 2 (KEAP1-NRF2) system forms the major node of cellular and organismal defense against oxidative and electrophilic stresses of both exogenous and endogenous origins.  KEAP1 acts as a cysteine thiol-rich sensor of redox insults, whereas NRF2 is a transcription factor that robustly transduces chem. signals to regulate a battery of cytoprotective genes.  KEAP1 represses NRF2 activity under quiescent conditions, whereas NRF2 is liberated from KEAP1-mediated repression on exposure to stresses.  The rapid inducibility of a response based on a derepression mechanism is an important feature of the KEAP1-NRF2 system.  Recent studies have unveiled the complexities of the functional contributions of the KEAP1-NRF2 system and defined its broader involvement in biol. processes, including cell proliferation and differentiation, as well as cytoprotection.  In this review, we describe historical milestones in the initial characterization of the KEAP1-NRF2 system and provide a comprehensive overview of the mol. mechanisms governing the functions of KEAP1 and NRF2, as well as their roles in physiol. and pathol.  We also refer to the clin. significance of the KEAP1-NRF2 system as an important prophylactic and therapeutic target for various diseases, particularly aging-related disorders.  We believe that controlled harnessing of the KEAP1-NRF2 system is a key to healthy aging and well-being in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohbdKIhBBbkLVg90H21EOLACvtfcHk0lgEvMs9KCgsSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvFektrc%253D&md5=906947c8ad97c48f60e46bc44103664a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00023.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00023.2017%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DMotohashi%26aufirst%3DH.%26atitle%3DThe%2520Keap1-Nrf2%2520System%253A%2520A%2520Thiol-Based%2520Sensor-Effector%2520Apparatus%2520for%2520Maintaining%2520Redox%2520Homeostasis%26jtitle%3DPhysiol.%2520Rev.%26date%3D2018%26volume%3D98%26spage%3D1169%26epage%3D1203%26doi%3D10.1152%2Fphysrev.00023.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggleston, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span> <span> </span><span class="NLM_article-title">Transcription Factor Nrf2Mediates an Adaptive Response to Sulforaphane That Protects Fibroblasts in Vitro against the Cytotoxic Effects of Electrophiles, Peroxides and Redox-Cycling Agents</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2009.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.taap.2009.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=19303893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1Smtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=2009&pages=267-280&author=L.+G.+Higginsauthor=M.+O.+Kelleherauthor=I.+M.+Egglestonauthor=K.+Itohauthor=M.+Yamamotoauthor=J.+D.+Hayes&title=Transcription+Factor+Nrf2Mediates+an+Adaptive+Response+to+Sulforaphane+That+Protects+Fibroblasts+in+Vitro+against+the+Cytotoxic+Effects+of+Electrophiles%2C+Peroxides+and+Redox-Cycling+Agents&doi=10.1016%2Fj.taap.2009.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents</span></div><div class="casAuthors">Higgins, Larry G.; Kelleher, Michael O.; Eggleston, Ian M.; Itoh, Ken; Yamamoto, Masayuki; Hayes, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-280</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sulforaphane can stimulate cellular adaptation to redox stressors through transcription factor Nrf2.  Using mouse embryonic fibroblasts (MEFs) as a model, we show herein that the normal homeostatic level of glutathione in Nrf2-/- MEFs was only 20% of that in their wild-type counterparts.  Furthermore, the rate of glutathione synthesis following its acute depletion upon treatment with 3 μmol/l sulforaphane was very substantially lower in Nrf2-/- MEFs than in wild-type cells, and the rebound leading to a ∼ 1.9-fold increase in glutathione that occurred 12-24 h after Nrf2 +/+ MEFs were treated with sulforaphane was not obsd. in Nrf2-/- fibroblasts.  Wild-type MEFs that had been pre-treated for 24 h with 3 μmol/l sulforaphane exhibited between 1.4- and 3.2-fold resistance against thiol-reactive electrophiles, including isothiocyanates, α,β-unsatd. carbonyl compds. (e.g. acrolein), aryl halides and alkene epoxides.  Pre-treatment of Nrf2 +/+ MEFs with sulforaphane also protected against hydroperoxides (e.g. cumene hydroperoxide, CuOOH), free radical-generating compds. (e.g. menadione), and genotoxic electrophiles (e.g. chlorambucil).  By contrast, Nrf2-/- MEFs were typically ∼ 50% less tolerant of these agents than wild-type fibroblasts, and sulforaphane pre-treatment did not protect the mutant cells against xenobiotics.  To test whether Nrf2-mediated up-regulation of glutathione represents the major cytoprotective mechanism stimulated by sulforaphane, 5 μmol/l buthionine sulfoximine (BSO) was used to inhibit glutathione synthesis.  In Nrf2 +/+ MEFs pre-treated with sulforaphane, BSO diminished intrinsic resistance and abolished inducible resistance to acrolein, CuOOH and chlorambucil, but not menadione.  Thus Nrf2-dependent up-regulation of GSH is the principal mechanism by which sulforaphane pre-treatment induced resistance to acrolein, CuOOH and chlorambucil, but not menadione.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw-GENqs_5k7Vg90H21EOLACvtfcHk0lgEvMs9KCgsSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1Smtrc%253D&md5=708a2dee7d620aeea44048eedfb073b2</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2009.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2009.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DL.%2BG.%26aulast%3DKelleher%26aufirst%3DM.%2BO.%26aulast%3DEggleston%26aufirst%3DI.%2BM.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26atitle%3DTranscription%2520Factor%2520Nrf2Mediates%2520an%2520Adaptive%2520Response%2520to%2520Sulforaphane%2520That%2520Protects%2520Fibroblasts%2520in%2520Vitro%2520against%2520the%2520Cytotoxic%2520Effects%2520of%2520Electrophiles%252C%2520Peroxides%2520and%2520Redox-Cycling%2520Agents%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2009%26volume%3D237%26spage%3D267%26epage%3D280%26doi%3D10.1016%2Fj.taap.2009.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. C.</span></span> <span> </span><span class="NLM_article-title">Regulation of Glutathione Synthesis</span>. <i>Curr. Top. Cell. Regul.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/S0070-2137(01)80004-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2FS0070-2137%2801%2980004-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2001&pages=95-116&author=S.+C.+Lu&title=Regulation+of+Glutathione+Synthesis&doi=10.1016%2FS0070-2137%2801%2980004-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0070-2137%2801%2980004-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0070-2137%252801%252980004-2%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DS.%2BC.%26atitle%3DRegulation%2520of%2520Glutathione%2520Synthesis%26jtitle%3DCurr.%2520Top.%2520Cell.%2520Regul.%26date%3D2001%26volume%3D36%26spage%3D95%26epage%3D116%26doi%3D10.1016%2FS0070-2137%2801%2980004-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malhotra, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portales-Casamar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenillas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Happel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasserman, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswal, S.</span></span> <span> </span><span class="NLM_article-title">Global Mapping of Binding Sites for Nrf2 Identifies Novel Targets in Cell Survival Response through Chip-Seq Profiling and Network Analysis</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">5718</span>– <span class="NLM_lpage">5734</span>, <span class="refDoi"> DOI: 10.1093/nar/gkq212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1093%2Fnar%2Fgkq212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20460467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1WhsLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=5718-5734&author=D.+Malhotraauthor=E.+Portales-Casamarauthor=A.+Singhauthor=S.+Srivastavaauthor=D.+Arenillasauthor=C.+Happelauthor=C.+Shyrauthor=N.+Wakabayashiauthor=T.+W.+Kenslerauthor=W.+W.+Wassermanauthor=S.+Biswal&title=Global+Mapping+of+Binding+Sites+for+Nrf2+Identifies+Novel+Targets+in+Cell+Survival+Response+through+Chip-Seq+Profiling+and+Network+Analysis&doi=10.1093%2Fnar%2Fgkq212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis</span></div><div class="casAuthors">Malhotra, Deepti; Portales-Casamar, Elodie; Singh, Anju; Srivastava, Siddhartha; Arenillas, David; Happel, Christine; Shyr, Casper; Wakabayashi, Nobunao; Kensler, Thomas W.; Wasserman, Wyeth W.; Biswal, Shyam</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5718-5734</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Nrf2 (nuclear factor E2 p45-related factor 2) transcription factor responds to diverse oxidative and electrophilic environmental stresses by circumventing repression by Keap1, translocating to the nucleus, and activating cytoprotective genes.  Nrf2 responses provide protection against chem. carcinogenesis, chronic inflammation, neurodegeneration, emphysema, asthma and sepsis in murine models.  Nrf2 regulates the expression of a plethora of genes that detoxify oxidants and electrophiles and repair or remove damaged macromols., such as through proteasomal processing.  However, many direct targets of Nrf2 remain undefined.  Here, mouse embryonic fibroblasts (MEF) with either constitutive nuclear accumulation (Keap1-/-) or depletion (Nrf2-/-) of Nrf2 were utilized to perform chromatin-immunopptn. with parallel sequencing (ChIP-Seq) and global transcription profiling.  This unique Nrf2 ChIP-Seq dataset is highly enriched for Nrf2-binding motifs.  Integrating ChIP-Seq and microarray analyses, we identified 645 basal and 654 inducible direct targets of Nrf2, with 244 genes at the intersection.  Modulated pathways in stress response and cell proliferation distinguish the inducible and basal programs.  Results were confirmed in an in vivo stress model of cigarette smoke-exposed mice.  This study reveals global circuitry of the Nrf2 stress response emphasizing Nrf2 as a central node in cell survival response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw6XLdwMj1Z7Vg90H21EOLACvtfcHk0lgEvMs9KCgsSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1WhsLvJ&md5=31aa9c617ac76f9cf1ea4f5bfa080f45</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkq212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkq212%26sid%3Dliteratum%253Aachs%26aulast%3DMalhotra%26aufirst%3DD.%26aulast%3DPortales-Casamar%26aufirst%3DE.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DArenillas%26aufirst%3DD.%26aulast%3DHappel%26aufirst%3DC.%26aulast%3DShyr%26aufirst%3DC.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DWasserman%26aufirst%3DW.%2BW.%26aulast%3DBiswal%26aufirst%3DS.%26atitle%3DGlobal%2520Mapping%2520of%2520Binding%2520Sites%2520for%2520Nrf2%2520Identifies%2520Novel%2520Targets%2520in%2520Cell%2520Survival%2520Response%2520through%2520Chip-Seq%2520Profiling%2520and%2520Network%2520Analysis%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2010%26volume%3D38%26spage%3D5718%26epage%3D5734%26doi%3D10.1093%2Fnar%2Fgkq212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agyeman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaerkady, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visvanathan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T.</span></span> <span> </span><span class="NLM_article-title">Transcriptomic and Proteomic Profiling of Keap1 Disrupted and Sulforaphane-Treated Human Breast Epithelial Cells Reveals Common Expression Profiles</span>. <i>Breast Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1007/s10549-011-1536-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1007%2Fs10549-011-1536-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21597922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVSkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2012&pages=175-187&author=A.+Agyemanauthor=R.+Chaerkadyauthor=P.+Shawauthor=N.+Davidsonauthor=K.+Visvanathanauthor=A.+Pandeyauthor=T.+Kensler&title=Transcriptomic+and+Proteomic+Profiling+of+Keap1+Disrupted+and+Sulforaphane-Treated+Human+Breast+Epithelial+Cells+Reveals+Common+Expression+Profiles&doi=10.1007%2Fs10549-011-1536-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles</span></div><div class="casAuthors">Agyeman, Abena S.; Chaerkady, Raghothama; Shaw, Patrick G.; Davidson, Nancy E.; Visvanathan, Kala; Pandey, Akhilesh; Kensler, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-187</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Sulforaphane (SFN), an isothiocyanate found in cruciferous vegetables, is a potent inhibitor of exptl. mammary carcinogenesis and may be an effective, safe chemopreventive agent for use in humans.  SFN acts in part on the Keap1/Nrf2 pathway to regulate a battery of cytoprotective genes.  In this study, transcriptomic and proteomic changes in the estrogen receptor neg., non-tumorigenic human breast epithelial MCF10A cell line were analyzed following SFN treatment or KEAP1 knockdown with siRNA using microarray and stable isotopic labeling with amino acids in culture (SILAC), resp.  Changes in selected transcripts and proteins were confirmed by PCR and Western blot in MCF10A and MCF12A cells.  There was strong correlation between the transcriptomic and proteomic responses in both the SFN treatment (R = 0.679, P < 0.05) and KEAP1 knockdown (R = 0.853, P < 0.05) expts.  Common pathways for SFN treatment and KEAP1 knockdown were xenobiotic metab. and antioxidants, glutathione metab., carbohydrate metab., and NADH/NADPH regeneration.  Moreover, these pathways were most prominent in both the transcriptomic and the proteomic analyses.  The aldo-keto reductase family members, AKR1B10, AKR1C1, AKR1C2 and AKR1C3, as well as NQO1 and ALDH3A1, were highly upregulated at both the transcriptomic and the proteomic levels.  Collectively, these studies served to identify potential biomarkers that can be used in clin. trials to investigate the initial pharmacodynamic action of SFN in the breast.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8FEbuPtrVrbVg90H21EOLACvtfcHk0lhX0Xv3pd2gIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVSkt7s%253D&md5=d775fe08dbc87a2b368566f7427ced36</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs10549-011-1536-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-011-1536-9%26sid%3Dliteratum%253Aachs%26aulast%3DAgyeman%26aufirst%3DA.%26aulast%3DChaerkady%26aufirst%3DR.%26aulast%3DShaw%26aufirst%3DP.%26aulast%3DDavidson%26aufirst%3DN.%26aulast%3DVisvanathan%26aufirst%3DK.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DKensler%26aufirst%3DT.%26atitle%3DTranscriptomic%2520and%2520Proteomic%2520Profiling%2520of%2520Keap1%2520Disrupted%2520and%2520Sulforaphane-Treated%2520Human%2520Breast%2520Epithelial%2520Cells%2520Reveals%2520Common%2520Expression%2520Profiles%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2012%26volume%3D132%26spage%3D175%26epage%3D187%26doi%3D10.1007%2Fs10549-011-1536-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chorley, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karaca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bangura, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleeberger, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, D. A.</span></span> <span> </span><span class="NLM_article-title">Identification of Novel Nrf2-Regulated Genes by Chip-Seq: Influence on Retinoid X Receptor Alpha</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">7416</span>– <span class="NLM_lpage">7429</span>, <span class="refDoi"> DOI: 10.1093/nar/gks409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1093%2Fnar%2Fgks409" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=7416-7429&author=B.+N.+Chorleyauthor=M.+R.+Campbellauthor=X.+Wangauthor=M.+Karacaauthor=D.+Sambandanauthor=F.+Banguraauthor=P.+Xueauthor=J.+Piauthor=S.+R.+Kleebergerauthor=D.+A.+Bell&title=Identification+of+Novel+Nrf2-Regulated+Genes+by+Chip-Seq%3A+Influence+on+Retinoid+X+Receptor+Alpha&doi=10.1093%2Fnar%2Fgks409"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgks409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgks409%26sid%3Dliteratum%253Aachs%26aulast%3DChorley%26aufirst%3DB.%2BN.%26aulast%3DCampbell%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DKaraca%26aufirst%3DM.%26aulast%3DSambandan%26aufirst%3DD.%26aulast%3DBangura%26aufirst%3DF.%26aulast%3DXue%26aufirst%3DP.%26aulast%3DPi%26aufirst%3DJ.%26aulast%3DKleeberger%26aufirst%3DS.%2BR.%26aulast%3DBell%26aufirst%3DD.%2BA.%26atitle%3DIdentification%2520of%2520Novel%2520Nrf2-Regulated%2520Genes%2520by%2520Chip-Seq%253A%2520Influence%2520on%2520Retinoid%2520X%2520Receptor%2520Alpha%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3D7416%26epage%3D7429%26doi%3D10.1093%2Fnar%2Fgks409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirotsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuoka, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funayama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Nrf2-Mafg Heterodimers Contribute Globally to Antioxidant and Metabolic Networks</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">10228</span>– <span class="NLM_lpage">10239</span>, <span class="refDoi"> DOI: 10.1093/nar/gks827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1093%2Fnar%2Fgks827" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=10228-10239&author=Y.+Hirotsuauthor=F.+Katsuokaauthor=R.+Funayamaauthor=T.+Nagashimaauthor=Y.+Nishidaauthor=K.+Nakayamaauthor=J.+D.+Engelauthor=M.+Yamamoto&title=Nrf2-Mafg+Heterodimers+Contribute+Globally+to+Antioxidant+and+Metabolic+Networks&doi=10.1093%2Fnar%2Fgks827"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgks827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgks827%26sid%3Dliteratum%253Aachs%26aulast%3DHirotsu%26aufirst%3DY.%26aulast%3DKatsuoka%26aufirst%3DF.%26aulast%3DFunayama%26aufirst%3DR.%26aulast%3DNagashima%26aufirst%3DT.%26aulast%3DNishida%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DEngel%26aufirst%3DJ.%2BD.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DNrf2-Mafg%2520Heterodimers%2520Contribute%2520Globally%2520to%2520Antioxidant%2520and%2520Metabolic%2520Networks%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3D10228%26epage%3D10239%26doi%3D10.1093%2Fnar%2Fgks827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Q.</span></span> <span> </span><span class="NLM_article-title">Role of Nrf2 in Oxidative Stress and Toxicity</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-011112-140320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1146%2Fannurev-pharmtox-011112-140320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23294312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjt1Wguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=401-426&author=Q.+Ma&title=Role+of+Nrf2+in+Oxidative+Stress+and+Toxicity&doi=10.1146%2Fannurev-pharmtox-011112-140320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Nrf2 in oxidative stress and toxicity</span></div><div class="casAuthors">Ma, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">401-426</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Organismal life encounters reactive oxidants from internal metab. and environmental toxicant exposure.  Reactive oxygen and nitrogen species cause oxidative stress and are traditionally viewed as being harmful.  On the other hand, controlled prodn. of oxidants in normal cells serves useful purposes to regulate signaling pathways.  Reactive oxidants are counterbalanced by complex antioxidant defense systems regulated by a web of pathways to ensure that the response to oxidants is adequate for the body's needs.  A recurrent theme in oxidant signaling and antioxidant defense is reactive cysteine thiol-based redox signaling.  The nuclear factor erythroid 2-related factor 2 (Nrf2) is an emerging regulator of cellular resistance to oxidants.  Nrf2 controls the basal and induced expression of an array of antioxidant response element-dependent genes to regulate the physiol. and pathophysiol. outcomes of oxidant exposure.  This review discusses the impact of Nrf2 on oxidative stress and toxicity and how Nrf2 senses oxidants and regulates antioxidant defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3hN1BQDMlrbVg90H21EOLACvtfcHk0lhX0Xv3pd2gIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjt1Wguro%253D&md5=71d4fbc6734d49f3e9b2c262057d7288</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-011112-140320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-011112-140320%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DQ.%26atitle%3DRole%2520of%2520Nrf2%2520in%2520Oxidative%2520Stress%2520and%2520Toxicity%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2013%26volume%3D53%26spage%3D401%26epage%3D426%26doi%3D10.1146%2Fannurev-pharmtox-011112-140320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">The Nrf2 Regulatory Network Provides an Interface between Redox and Intermediary Metabolism</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2014.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.tibs.2014.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24647116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksVWrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=199-218&author=J.+D.+Hayesauthor=A.+T.+Dinkova-Kostova&title=The+Nrf2+Regulatory+Network+Provides+an+Interface+between+Redox+and+Intermediary+Metabolism&doi=10.1016%2Fj.tibs.2014.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The Nrf2 regulatory network provides an interface between redox and intermediary metabolism</span></div><div class="casAuthors">Hayes, John D.; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">199-218</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2, also called Nfe2l2) is a transcription factor that regulates the cellular redox status.  Nrf2 is controlled through a complex transcriptional/epigenetic and post-translational network that ensures its activity increases during redox perturbation, inflammation, growth factor stimulation and nutrient/energy fluxes, thereby enabling the factor to orchestrate adaptive responses to diverse forms of stress.  Besides mediating stress-stimulated induction of antioxidant and detoxification genes, Nrf2 contributes to adaptation by upregulating the repair and degrdn. of damaged macromols., and by modulating intermediary metab.  In the latter case, Nrf2 inhibits lipogenesis, supports β-oxidn. of fatty acids, facilitates flux through the pentose phosphate pathway, and increases NADPH regeneration and purine biosynthesis; these observations suggest Nrf2 directs metabolic reprogramming during stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLTtgJA1rMbVg90H21EOLACvtfcHk0lih3gTxFLuVTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksVWrtLg%253D&md5=790c66c48218229dc5531d24aefaceef</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2014.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2014.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DThe%2520Nrf2%2520Regulatory%2520Network%2520Provides%2520an%2520Interface%2520between%2520Redox%2520and%2520Intermediary%2520Metabolism%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2014%26volume%3D39%26spage%3D199%26epage%3D218%26doi%3D10.1016%2Fj.tibs.2014.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dieter, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleksunes, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slitt, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheffer, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manautou, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaassen, C. D.</span></span> <span> </span><span class="NLM_article-title">Oxidative and Electrophilic Stress Induces Multidrug Resistance-Associated Protein Transporters Via the Nuclear Factor-E2-Related Factor-2 Transcriptional Pathway</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1597</span>– <span class="NLM_lpage">1610</span>, <span class="refDoi"> DOI: 10.1002/hep.21831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1002%2Fhep.21831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=17668877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOhsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=1597-1610&author=J.+M.+Maherauthor=M.+Z.+Dieterauthor=L.+M.+Aleksunesauthor=A.+L.+Slittauthor=G.+Guoauthor=Y.+Tanakaauthor=G.+L.+Schefferauthor=J.+Y.+Chanauthor=J.+E.+Manautouauthor=Y.+Chenauthor=T.+P.+Daltonauthor=M.+Yamamotoauthor=C.+D.+Klaassen&title=Oxidative+and+Electrophilic+Stress+Induces+Multidrug+Resistance-Associated+Protein+Transporters+Via+the+Nuclear+Factor-E2-Related+Factor-2+Transcriptional+Pathway&doi=10.1002%2Fhep.21831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway</span></div><div class="casAuthors">Maher, Jonathan M.; Dieter, Matthew Z.; Aleksunes, Lauren M.; Slitt, Angela L.; Guo, Grace; Tanaka, Yuji; Scheffer, George L.; Chan, Jefferson Y.; Manautou, Jose E.; Chen, Ying; Dalton, Timothy P.; Yamamoto, Masayuki; Klaassen, Curtis D.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1597-1610</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Multidrug resistance-assocd. proteins (Mrps) are ATP-dependent transporters that efflux chems. out of cells.  In the liver, Mrp2 transports bilirubin-glucuronide, glutathione (GSH), and drug conjugates into bile, whereas Mrp3 and Mrp4 efflux these entities into blood.  The purpose of this study was to det. whether oxidative conditions (i.e., the disruption of hepatic GSH synthesis) or the administration of nuclear factor-E2-related factor-2 (Nrf2) activators (oltipraz and butylated hydroxyanisole) can induce hepatic Mrp transporters and whether that induction is through the Nrf2 transcriptional pathway.  Livers from hepatocyte-specific glutamate-cysteine ligase catalytic subunit-null mice had increased nuclear Nrf2 levels, marked gene and protein induction of the Nrf2 target gene NAD(P)H:quinone oxidoreductase 1, as well as Mrp2, Mrp3, and Mrp4 expression.  The treatment of wild-type and Nrf2-null mice with oltipraz and butylated hydroxyanisole demonstrated that the induction of Mrp2, Mrp3, and Mrp4 is Nrf2-dependent.  In Hepa1c1c7 cells treated with the Nrf2 activator tert-Bu hydroquinone, chromatin immunopptn. with Nrf2 antibodies revealed the binding of Nrf2 to antioxidant response elements in the promoter regions of mouse Mrp2 [-185 base pairs (bp)], Mrp3 (-9919 bp), and Mrp4 (-3767 bp).  Conclusion: The activation of the Nrf2 regulatory pathway stimulates the coordinated induction of hepatic Mrps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqro1b30E2bCLVg90H21EOLACvtfcHk0lih3gTxFLuVTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOhsr7E&md5=1cfd276ce75a10f6d6cc1bb1bdc6016d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fhep.21831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.21831%26sid%3Dliteratum%253Aachs%26aulast%3DMaher%26aufirst%3DJ.%2BM.%26aulast%3DDieter%26aufirst%3DM.%2BZ.%26aulast%3DAleksunes%26aufirst%3DL.%2BM.%26aulast%3DSlitt%26aufirst%3DA.%2BL.%26aulast%3DGuo%26aufirst%3DG.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DScheffer%26aufirst%3DG.%2BL.%26aulast%3DChan%26aufirst%3DJ.%2BY.%26aulast%3DManautou%26aufirst%3DJ.%2BE.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDalton%26aufirst%3DT.%2BP.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKlaassen%26aufirst%3DC.%2BD.%26atitle%3DOxidative%2520and%2520Electrophilic%2520Stress%2520Induces%2520Multidrug%2520Resistance-Associated%2520Protein%2520Transporters%2520Via%2520the%2520Nuclear%2520Factor-E2-Related%2520Factor-2%2520Transcriptional%2520Pathway%26jtitle%3DHepatology%26date%3D2007%26volume%3D46%26spage%3D1597%26epage%3D1610%26doi%3D10.1002%2Fhep.21831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yates, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osburn, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCulloch, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silkworth, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutter, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span> <span> </span><span class="NLM_article-title">Genetic Versus Chemoprotective Activation of Nrf2 Signaling: Overlapping yet Distinct Gene Expression Profiles between Keap1 Knockout and Triterpenoid-Treated Mice</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1024</span>– <span class="NLM_lpage">1031</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgp100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1093%2Fcarcin%2Fbgp100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=19386581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVWjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=1024-1031&author=M.+S.+Yatesauthor=Q.+T.+Tranauthor=P.+M.+Dolanauthor=W.+O.+Osburnauthor=S.+Shinauthor=C.+C.+McCullochauthor=J.+B.+Silkworthauthor=K.+Taguchiauthor=M.+Yamamotoauthor=C.+R.+Williamsauthor=K.+T.+Libyauthor=M.+B.+Spornauthor=T.+R.+Sutterauthor=T.+W.+Kensler&title=Genetic+Versus+Chemoprotective+Activation+of+Nrf2+Signaling%3A+Overlapping+yet+Distinct+Gene+Expression+Profiles+between+Keap1+Knockout+and+Triterpenoid-Treated+Mice&doi=10.1093%2Fcarcin%2Fbgp100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice</span></div><div class="casAuthors">Yates, Melinda S.; Tran, Quynh T.; Dolan, Patrick M.; Osburn, William O.; Shin, Soona; McCulloch, Colin C.; Silkworth, Jay B.; Taguchi, Keiko; Yamamoto, Masayuki; Williams, Charlotte R.; Liby, Karen T.; Sporn, Michael B.; Sutter, Thomas R.; Kensler, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1024-1031</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Loss of NF-E2-related factor 2 (Nrf2) signaling increases susceptibility to acute toxicity, inflammation and carcinogenesis in mice due to the inability to mount adaptive responses.  In contrast, disruption of Keap1 (a cytoplasmic modifier of Nrf2 turnover) protects against these stresses in mice, although inactivating mutations in Keap1 have been identified recently in some human cancers.  Global characterization of Nrf2 activation is important to exploit this pathway for chemoprevention in healthy, yet at-risk individuals and also to elucidate the consequences of hijacking the pathway in Keap1-mutant human cancers.  Liver-targeted conditional Keap1-null, Albumin-Cre:Keap1(flox/-) (CKO) mice provide a model of genetic activation of Nrf2 signaling.  By coupling global gene expression anal. of CKO mice with anal. of pharmacol. activation using the synthetic oleanane triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im), we are able to gain insight into pathways affected by Nrf2 activation.  CDDO-Im is an extremely potent activator of Nrf2 signaling.  CKO mice were used to identify genes modulated by genetic activation of Nrf2 signaling.  The CKO response was compared with hepatic global gene expression changes in wild-type mice treated with CDDO-Im at a maximal Nrf2 activating dose.  The results show that genetic and pharmacol. activation of Nrf2 signaling modulates pathways beyond detoxication and cytoprotection, with the largest cluster of genes assocd. with lipid metab.  Genetic activation of Nrf2 results in much larger nos. of detoxication and lipid metab. gene changes.  Addnl., anal. of pharmacol. activation suggests that Nrf2 is the primary mediator of CDDO-Im activity, though other cell-signaling targets are also modulated following an oral dose of 30 μmol/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhb8rofVQOXrVg90H21EOLACvtfcHk0lih3gTxFLuVTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVWjtr4%253D&md5=b23b7bef67f7ce9c82c0799d80264f06</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgp100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgp100%26sid%3Dliteratum%253Aachs%26aulast%3DYates%26aufirst%3DM.%2BS.%26aulast%3DTran%26aufirst%3DQ.%2BT.%26aulast%3DDolan%26aufirst%3DP.%2BM.%26aulast%3DOsburn%26aufirst%3DW.%2BO.%26aulast%3DShin%26aufirst%3DS.%26aulast%3DMcCulloch%26aufirst%3DC.%2BC.%26aulast%3DSilkworth%26aufirst%3DJ.%2BB.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DC.%2BR.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DSutter%26aufirst%3DT.%2BR.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26atitle%3DGenetic%2520Versus%2520Chemoprotective%2520Activation%2520of%2520Nrf2%2520Signaling%253A%2520Overlapping%2520yet%2520Distinct%2520Gene%2520Expression%2520Profiles%2520between%2520Keap1%2520Knockout%2520and%2520Triterpenoid-Treated%2520Mice%26jtitle%3DCarcinogenesis%26date%3D2009%26volume%3D30%26spage%3D1024%26epage%3D1031%26doi%3D10.1093%2Fcarcin%2Fbgp100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawatani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nukiwa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aburatani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.ccr.2012.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22789539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSltb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=66-79&author=Y.+Mitsuishiauthor=K.+Taguchiauthor=Y.+Kawataniauthor=T.+Shibataauthor=T.+Nukiwaauthor=H.+Aburataniauthor=M.+Yamamotoauthor=H.+Motohashi&title=Nrf2+Redirects+Glucose+and+Glutamine+into+Anabolic+Pathways+in+Metabolic+Reprogramming&doi=10.1016%2Fj.ccr.2012.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming</span></div><div class="casAuthors">Mitsuishi, Yoichiro; Taguchi, Keiko; Kawatani, Yukie; Shibata, Tatsuhiro; Nukiwa, Toshihiro; Aburatani, Hiroyuki; Yamamoto, Masayuki; Motohashi, Hozumi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-79</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Cancer cells consume large quantities of nutrients and maintain high levels of anabolism.  Recent studies revealed that various oncogenic pathways are involved in modulation of metab.  Nrf2, a key regulator for the maintenance of redox homeostasis, has been shown to contribute to malignant phenotypes of cancers including aggressive proliferation.  However, the mechanisms with which Nrf2 accelerates proliferation are not fully understood.  Here, we show that Nrf2 redirects glucose and glutamine into anabolic pathways, esp. under the sustained activation of PI3K-Akt signaling.  The active PI3K-Akt pathway augments the nuclear accumulation of Nrf2 and enables Nrf2 to promote metabolic activities that support cell proliferation in addn. to enhancing cytoprotection.  The functional expansion of Nrf2 reinforces the metabolic reprogramming triggered by proliferative signals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbor86fqwhKbVg90H21EOLACvtfcHk0ljT614-bz_cXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSltb3L&md5=e0efeee61bc55b50671f942e73d2da31</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DMitsuishi%26aufirst%3DY.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DKawatani%26aufirst%3DY.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DNukiwa%26aufirst%3DT.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DMotohashi%26aufirst%3DH.%26atitle%3DNrf2%2520Redirects%2520Glucose%2520and%2520Glutamine%2520into%2520Anabolic%2520Pathways%2520in%2520Metabolic%2520Reprogramming%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D22%26spage%3D66%26epage%3D79%26doi%3D10.1016%2Fj.ccr.2012.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaassen, C. D.</span></span> <span> </span><span class="NLM_article-title">Beneficial Role of Nrf2 in Regulating Nadph Generation and Consumption</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">590</span>– <span class="NLM_lpage">600</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfr183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1093%2Ftoxsci%2Fkfr183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21775727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1eiu7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2011&pages=590-600&author=K.+C.+Wuauthor=J.+Y.+Cuiauthor=C.+D.+Klaassen&title=Beneficial+Role+of+Nrf2+in+Regulating+Nadph+Generation+and+Consumption&doi=10.1093%2Ftoxsci%2Fkfr183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Beneficial Role of Nrf2 in Regulating NADPH Generation and Consumption</span></div><div class="casAuthors">Wu, Kai Connie; Cui, Julia Yue; Klaassen, Curtis D.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">590-600</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-0929</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that promotes the transcription of cytoprotective genes in response to oxidative and electrophilic stresses.  Most functions of Nrf2 were identified by studying biol. models with Nrf2 deficiency, however, little is known about the effects of graded Nrf2 activation.  In the present study, genomic gene expression profiles by microarray anal. were characterized with a "gene dose-response" model in livers of Nrf2-null mice, wild-type mice, Kelch-like ECH assocg. protein 1 (Keap1)-knockdown (Keap1-KD) mice with enhanced Nrf2 activation, and Keap1-hepatocyte knockout (Keap1-HKO) mice with max. hepatic Nrf2 activation.  Hepatic nuclear Nrf2 protein, glutathione concns., and known Nrf2 target genes were increased in a dose-dependent manner.  In total, 115 genes were identified to be constitutively induced and 80 genes suppressed with graded Nrf2 activation.  MRNA of genes encoding enzymes in the pentose phosphate pathway and enzyme were low with Nrf2 deficiency and high with Nrf2 activation, indicating that Nrf2 is important for NADPH prodn.  NADPH is the major reducing resource to scavenge oxidative stress, including regenerating glutathione and thioredoxin and is also used for anabolic pathways including lipid synthesis.  High performance liq. chromatog.-UV absorbance anal. confirmed that hepatic NADPH concn. was lowest in Nrf2-null mice and highest in Keap1-HKO mice.  In addn., genes involved in fatty acid synthesis and desatn. were downregulated with graded Nrf2 activation.  In conclusion, the present study suggests that Nrf2 protects against environmental insults by promoting the generation of NADPH, which is preferentially consumed by aiding scavenging of oxidative stress rather than fatty acid synthesis and desatn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwujrTdvxJRrVg90H21EOLACvtfcHk0ljT614-bz_cXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1eiu7nJ&md5=193847ff699d64b2b5b7975370731ffa</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfr183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfr183%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DK.%2BC.%26aulast%3DCui%26aufirst%3DJ.%2BY.%26aulast%3DKlaassen%26aufirst%3DC.%2BD.%26atitle%3DBeneficial%2520Role%2520of%2520Nrf2%2520in%2520Regulating%2520Nadph%2520Generation%2520and%2520Consumption%26jtitle%3DToxicol.%2520Sci.%26date%3D2011%26volume%3D123%26spage%3D590%26epage%3D600%26doi%3D10.1093%2Ftoxsci%2Fkfr183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdullah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sison, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Proteomic Analysis of Nrf2 Deficient Transgenic Mice Reveals Cellular Defence and Lipid Metabolism as Primary Nrf2-Dependent Pathways in the Liver</span>. <i>J. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">1612</span>– <span class="NLM_lpage">1631</span>, <span class="refDoi"> DOI: 10.1016/j.jprot.2010.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.jprot.2010.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20399915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlagt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2010&pages=1612-1631&author=N.+R.+Kitteringhamauthor=A.+Abdullahauthor=J.+Walshauthor=L.+Randleauthor=R.+E.+Jenkinsauthor=R.+Sisonauthor=C.+E.+Goldringauthor=H.+Powellauthor=C.+Sandersonauthor=S.+Williamsauthor=L.+Higginsauthor=M.+Yamamotoauthor=J.+Hayesauthor=B.+K.+Park&title=Proteomic+Analysis+of+Nrf2+Deficient+Transgenic+Mice+Reveals+Cellular+Defence+and+Lipid+Metabolism+as+Primary+Nrf2-Dependent+Pathways+in+the+Liver&doi=10.1016%2Fj.jprot.2010.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver</span></div><div class="casAuthors">Kitteringham, Neil R.; Abdullah, Azman; Walsh, Joanne; Randle, Laura; Jenkins, Rosalind E.; Sison, Rowena; Goldring, Christopher E. P.; Powell, Helen; Sanderson, Christopher; Williams, Samantha; Higgins, Larry; Yamamoto, Masayuki; Hayes, John; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1612-1631</span>CODEN:
                <span class="NLM_cas:coden">JPORFQ</span>;
        ISSN:<span class="NLM_cas:issn">1874-3919</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The transcription factor Nrf2 regulates expression of multiple cellular defense proteins through the antioxidant response element (ARE).  Nrf2-deficient mice (Nrf2-/-) are highly susceptible to xenobiotic-mediated toxicity, but the precise mol. basis of enhanced toxicity is unknown.  Oligonucleotide array studies suggest that a wide range of gene products is altered constitutively, however no equiv. proteomics analyses have been conducted.  To define the range of Nrf2-regulated proteins at the constitutive level, protein expression profiling of livers from Nrf2-/- and wild type mice was conducted using both stable isotope labeling (iTRAQ) and gel electrophoresis methods.  To establish a robust reproducible list of Nrf2-dependent proteins, three independent groups of mice were analyzed.  Correlative network anal. (MetaCore) identified two predominant groups of Nrf2-regulated proteins.  As expected, one group comprised proteins involved in phase II drug metab., which were down-regulated in the absence of Nrf2.  Surprisingly, the most profound changes were obsd. amongst proteins involved in the synthesis and metab. of fatty acids and other lipids.  Importantly, we show here for the first time, that the enzyme ATP-citrate lyase, responsible for acetyl-CoA prodn., is neg. regulated by Nrf2.  This latter finding suggests that Nrf2 is a major regulator of cellular lipid disposition in the liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0NT6X4SwYnrVg90H21EOLACvtfcHk0ljT614-bz_cXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlagt7c%253D&md5=1501f77a6ce057799e3a3e6a48b22459</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.jprot.2010.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jprot.2010.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DAbdullah%26aufirst%3DA.%26aulast%3DWalsh%26aufirst%3DJ.%26aulast%3DRandle%26aufirst%3DL.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DSison%26aufirst%3DR.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DPowell%26aufirst%3DH.%26aulast%3DSanderson%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DHiggins%26aufirst%3DL.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DProteomic%2520Analysis%2520of%2520Nrf2%2520Deficient%2520Transgenic%2520Mice%2520Reveals%2520Cellular%2520Defence%2520and%2520Lipid%2520Metabolism%2520as%2520Primary%2520Nrf2-Dependent%2520Pathways%2520in%2520the%2520Liver%26jtitle%3DJ.%2520Proteomics%26date%3D2010%26volume%3D73%26spage%3D1612%26epage%3D1631%26doi%3D10.1016%2Fj.jprot.2010.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touchard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boinapally, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, A. M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. L.</span></span> <span> </span><span class="NLM_article-title">Nrf2, a Cap’n’collar Transcription Factor, Regulates Induction of the Heme Oxygenase-1 Gene</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">26071</span>– <span class="NLM_lpage">26078</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.37.26071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1074%2Fjbc.274.37.26071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=26071-26078&author=J.+Alamauthor=D.+Stewartauthor=C.+Touchardauthor=S.+Boinapallyauthor=A.+M.+K.+Choiauthor=J.+L.+Cook&title=Nrf2%2C+a+Cap%E2%80%99n%E2%80%99collar+Transcription+Factor%2C+Regulates+Induction+of+the+Heme+Oxygenase-1+Gene&doi=10.1074%2Fjbc.274.37.26071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.37.26071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.37.26071%26sid%3Dliteratum%253Aachs%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DD.%26aulast%3DTouchard%26aufirst%3DC.%26aulast%3DBoinapally%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DA.%2BM.%2BK.%26aulast%3DCook%26aufirst%3DJ.%2BL.%26atitle%3DNrf2%252C%2520a%2520Cap%25E2%2580%2599n%25E2%2580%2599collar%2520Transcription%2520Factor%252C%2520Regulates%2520Induction%2520of%2520the%2520Heme%2520Oxygenase-1%2520Gene%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D26071%26epage%3D26078%26doi%3D10.1074%2Fjbc.274.37.26071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, T.</span></span> <span> </span><span class="NLM_article-title">Heme Oxygenase-1: A Novel Therapeutic Target for Gastrointestinal Diseases</span>. <i>J. Clin. Biochem. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.3164/jcbn.10-61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.3164%2Fjcbn.10-61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21373265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlekurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2011&pages=126-133&author=Y.+Naitoauthor=T.+Takagiauthor=K.+Uchiyamaauthor=T.+Yoshikawa&title=Heme+Oxygenase-1%3A+A+Novel+Therapeutic+Target+for+Gastrointestinal+Diseases&doi=10.3164%2Fjcbn.10-61"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Heme oxygenase-1: a novel therapeutic target for gastrointestinal diseases</span></div><div class="casAuthors">Naito, Yuji; Takagi, Tomohisa; Uchiyama, Kazuhiko; Yoshikawa, Toshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Biochemistry and Nutrition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-133</span>CODEN:
                <span class="NLM_cas:coden">JCBNER</span>;
        ISSN:<span class="NLM_cas:issn">0912-0009</span>.
    
            (<span class="NLM_cas:orgname">Society for Free Radical Research Japan</span>)
        </div><div class="casAbstract">A review.  Heme oxygenase-1 (HO-1) is the rate-limiting enzyme in the catabolism of heme, followed by prodn. of biliverdin, free iron and carbon monoxide (CO).  HO-1 is a stress-responsive protein induced by various oxidative agents.  Recent studies demonstrate that the expression of HO-1 in response to different inflammatory mediators may contribute to the resoln. of inflammation and has protective effects in several organs against oxidative injury.  Although the mechanism underlying the anti-inflammatory actions of HO-1 remains poorly defined, both CO and biliverdin/bilirubin have been implicated in this response.  In the gastrointestinal tract, HO-1 is shown to be transcriptionally induced in response to oxidative stress, preconditioning and acute inflammation.  Recent studies suggest that the induction of HO-1 expression plays a crit. protective role in intestinal damage models induced by ischemia-reperfusion, indomethacin, lipo-polysaccharide-assocd. sepsis, trinitrobenzene sulfonic acid, and dextran sulfate sodium, indicating that activation of HO-1 may act as an endogenous defensive mechanism to reduce inflammation and tissue injury in the gastrointestinal tract.  In addn., CO derived from HO-1 is shown to be involved in the regulation in gastrointestinal motility.  These in vitro and in vivo data suggest that HO-1 may be a novel therapeutic target in patients with gastrointestinal diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_G-zVRhg_nbVg90H21EOLACvtfcHk0lh0bb_zBTsuHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlekurw%253D&md5=c34d26f45a5a886813330e93fe82cee3</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3164%2Fjcbn.10-61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3164%252Fjcbn.10-61%26sid%3Dliteratum%253Aachs%26aulast%3DNaito%26aufirst%3DY.%26aulast%3DTakagi%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DK.%26aulast%3DYoshikawa%26aufirst%3DT.%26atitle%3DHeme%2520Oxygenase-1%253A%2520A%2520Novel%2520Therapeutic%2520Target%2520for%2520Gastrointestinal%2520Diseases%26jtitle%3DJ.%2520Clin.%2520Biochem.%2520Nutr.%26date%3D2011%26volume%3D48%26spage%3D126%26epage%3D133%26doi%3D10.3164%2Fjcbn.10-61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span> <span> </span><span class="NLM_article-title">Salvianolic Acid a Protects Rpe Cells against Oxidative Stress through Activation of Nrf2/Ho-1 Signaling</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2014.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2014.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24486344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksVWmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=219-228&author=H.+Zhangauthor=Y.+Y.+Liuauthor=Q.+Jiangauthor=K.+R.+Liauthor=Y.+X.+Zhaoauthor=C.+Caoauthor=J.+Yao&title=Salvianolic+Acid+a+Protects+Rpe+Cells+against+Oxidative+Stress+through+Activation+of+Nrf2%2FHo-1+Signaling&doi=10.1016%2Fj.freeradbiomed.2014.01.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Salvianolic acid A protects RPE cells against oxidative stress through activation of Nrf2/HO-1 signaling</span></div><div class="casAuthors">Zhang, Hui; Liu, Yuan-yuan; Jiang, Qin; Li, Ke-ran; Zhao, Yu-xia; Cao, Cong; Yao, Jin</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">219-228</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) impair the physiol. functions of retinal pigment epithelial (RPE) cells, which is known as one major cause of age-related macular degeneration.  Salvianolic acid A (Sal A) is the main effective aq. ext. of Salvia miltiorrhiza.  The aim of this study was to test the potential role of Sal A against oxidative stress in cultured RPE cells and to investigate the underlying mechanistic signaling pathways.  We obsd. that Sal A significantly inhibited hydrogen peroxide (H2O2)-induced primary and transformed RPE cell death and apoptosis.  H2O2-stimulated mitogen-activated protein kinase activation, ROS prodn., and subsequent proapoptotic AMP-activated protein kinase activation were largely inhibited by Sal A.  Further, Sal A stimulation resulted in a fast and dramatic activation of Akt/mammalian target of rapamycin complex 1 (mTORC1) signaling, followed by phosphorylation, accumulation, and nuclear translocation of the NF-E2-related factor 2 (Nrf2), along with increased expression of the antioxidant-response element-dependent gene heme oxygenase-1 (HO-1).  Both Nrf2 and HO-1 were required for Sal A-mediated cytoprotective effect, as Nrf2/HO-1 inhibition abolished Sal A-induced beneficial effects against H2O2.  Meanwhile, the PI3K/Akt/mTORC1 chem. inhibitors not only suppressed Sal A-induced Nrf2/HO-1 activation, but also eliminated its cytoprotective effect in RPE cells.  These observations suggest that Sal A activates the Nrf2/HO-1 axis in RPE cells and protects against oxidative stress via activation of Akt/mTORC1 signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFUzZiIqkflbVg90H21EOLACvtfcHk0lh0bb_zBTsuHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksVWmtrs%253D&md5=76fd8b58942995c170b8125c5957dfa3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2014.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2014.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%2BY.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DK.%2BR.%26aulast%3DZhao%26aufirst%3DY.%2BX.%26aulast%3DCao%26aufirst%3DC.%26aulast%3DYao%26aufirst%3DJ.%26atitle%3DSalvianolic%2520Acid%2520a%2520Protects%2520Rpe%2520Cells%2520against%2520Oxidative%2520Stress%2520through%2520Activation%2520of%2520Nrf2%252FHo-1%2520Signaling%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2014%26volume%3D69%26spage%3D219%26epage%3D228%26doi%3D10.1016%2Fj.freeradbiomed.2014.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agoston, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span> <span> </span><span class="NLM_article-title">Nrf2Modulates Aryl Hydrocarbon Receptor Signaling: Influence on Adipogenesis</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">7188</span>– <span class="NLM_lpage">7197</span>, <span class="refDoi"> DOI: 10.1128/MCB.00915-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.00915-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=17709388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKjsb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=7188-7197&author=S.+Shinauthor=N.+Wakabayashiauthor=V.+Misraauthor=S.+Biswalauthor=G.+H.+Leeauthor=E.+S.+Agostonauthor=M.+Yamamotoauthor=T.+W.+Kensler&title=Nrf2Modulates+Aryl+Hydrocarbon+Receptor+Signaling%3A+Influence+on+Adipogenesis&doi=10.1128%2FMCB.00915-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis</span></div><div class="casAuthors">Shin, Soona; Wakabayashi, Nobunao; Misra, Vikas; Biswal, Shyam; Lee, Gum Hwa; Agoston, Elin S.; Yamamoto, Masayuki; Kensler, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7188-7197</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The NF-E2 p45-related factor 2 (NRF2) and the aryl hydrocarbon receptor (AHR) are transcription factors controlling pathways modulating xenobiotic metab.  AHR has recently been shown to affect Nrf2 expression.  Conversely, this study demonstrates that NRF2 regulates expression of Ahr and subsequently modulates several downstream events of the AHR signaling cascade, including (i) transcriptional control of the xenobiotic metab. genes Cyp1a1 and Cyp1b1 and (ii) inhibition of adipogenesis in mouse embryonic fibroblasts (MEFs).  Constitutive expression of AHR was affected by Nrf2 genotype.  Moreover, a pharmacol. activator of NRF2 signaling, CDDO-IM {1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole}, induced Ahr, Cyp1a1, and Cyp1b1 transcription in Nrf2+/+ MEFs but not in Nrf2-/- MEFs.  Reporter anal. and chromatin immunopptn. assay revealed that NRF2 directly binds to one antioxidant response element (ARE) found in the -230-bp region of the promoter of Ahr.  Since AHR neg. controls adipocyte differentiation, we postulated that NRF2 would inhibit adipogenesis through the interaction with the AHR pathway.  Nrf2-/- MEFs showed markedly accelerated adipogenesis upon stimulation, while Keap1-/- MEFs (which exhibit higher NRF2 signaling) differentiated slowly compared to their congenic wild-type MEFs.  Ectopic expression of Ahr and dominant-pos. Nrf2 in Nrf2-/- MEFs also substantially delayed differentiation.  Thus, NRF2 directly modulates AHR signaling, highlighting bidirectional interactions of these pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXZNSeWW3XE7Vg90H21EOLACvtfcHk0ljos-xAJdT_Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKjsb%252FF&md5=9a29fb294218db94a8f9fdf7e54610e8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FMCB.00915-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00915-07%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DS.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DMisra%26aufirst%3DV.%26aulast%3DBiswal%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DG.%2BH.%26aulast%3DAgoston%26aufirst%3DE.%2BS.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26atitle%3DNrf2Modulates%2520Aryl%2520Hydrocarbon%2520Receptor%2520Signaling%253A%2520Influence%2520on%2520Adipogenesis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2007%26volume%3D27%26spage%3D7188%26epage%3D7197%26doi%3D10.1128%2FMCB.00915-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwak, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span> <span> </span><span class="NLM_article-title">Enhanced Expression of the Transcription Factor Nrf2 by Cancer Chemopreventive Agents: Role of Antioxidant Response Element-Like Sequences in the Nrf2 Promoter</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2883</span>– <span class="NLM_lpage">2892</span>, <span class="refDoi"> DOI: 10.1128/MCB.22.9.2883-2892.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.22.9.2883-2892.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=11940647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFylsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=2883-2892&author=M.+K.+Kwakauthor=K.+Itohauthor=M.+Yamamotoauthor=T.+W.+Kensler&title=Enhanced+Expression+of+the+Transcription+Factor+Nrf2+by+Cancer+Chemopreventive+Agents%3A+Role+of+Antioxidant+Response+Element-Like+Sequences+in+the+Nrf2+Promoter&doi=10.1128%2FMCB.22.9.2883-2892.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: Role of antioxidant response element-like sequences in the nrf2 promoter</span></div><div class="casAuthors">Kwak, Mi-Kyoung; Itoh, Ken; Yamamoto, Masayuki; Kensler, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2883-2892</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Induction of phase 2 enzymes, which neutralize reactive electrophiles and act as indirect antioxidants, is an important mechanism for protection against carcinogenesis.  The transcription factor Nrf2, which binds to the antioxidant response element (ARE) found in the upstream regulatory region of many phase 2 genes, is essential for the induction of these enzymes.  We have investigated the effect of the potent enzyme inducer and anticarcinogen 3H-1,2-dithiole-3-thione (D3T) on the fate of Nrf2 in murine keratinocytes.  Both total and nuclear Nrf2 levels increased rapidly and persistently after treatment with D3T but could be blocked by cotreatment with cycloheximide.  Nrf2 mRNA levels increased ∼2-fold 6 h after D3T treatment.  To examine the transcriptional activation of Nrf2 by D3T, the proximal region (1 kb) of the nrf2 promoter was isolated.  Deletion and mutagenesis analyses demonstrated that nrf2 promoter-luciferase reporter activity was enhanced by treatment with D3T and that ARE-like sequences were required for this activation.  Gel shift assays with nuclear exts. from PE cells indicated that common factors bind to typical AREs and the ARE-like sequences of the nrf2 promoter.  Direct binding of Nrf2 to its own promoter was demonstrated by chromatin immuno-pptn. assay.  Overexpression of Nrf2 increased the activity of the nrf2 promoter-luciferase reporter, while expression of mutant Nrf2 protein repressed activity.  Thus, Nrf2 appears to autoregulate its own expression through an ARE-like element located in the proximal region of its promoter, leading to persistent nuclear accumulation of Nrf2 and protracted induction of phase 2 genes in response to chemopreventive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_sX0FZIyg87Vg90H21EOLACvtfcHk0ljos-xAJdT_Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFylsL0%253D&md5=11b3b59568ef338a8355ee9bd6097ba3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FMCB.22.9.2883-2892.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.22.9.2883-2892.2002%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DM.%2BK.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26atitle%3DEnhanced%2520Expression%2520of%2520the%2520Transcription%2520Factor%2520Nrf2%2520by%2520Cancer%2520Chemopreventive%2520Agents%253A%2520Role%2520of%2520Antioxidant%2520Response%2520Element-Like%2520Sequences%2520in%2520the%2520Nrf2%2520Promoter%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D22%26spage%3D2883%26epage%3D2892%26doi%3D10.1128%2FMCB.22.9.2883-2892.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funayama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Suppresses Macrophage Inflammatory Response by Blocking Proinflammatory Cytokine Transcription</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11624</span>, <span class="refDoi"> DOI: 10.1038/ncomms11624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fncomms11624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27211851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos12ms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11624&author=E.+H.+Kobayashiauthor=T.+Suzukiauthor=R.+Funayamaauthor=T.+Nagashimaauthor=M.+Hayashiauthor=H.+Sekineauthor=N.+Tanakaauthor=T.+Moriguchiauthor=H.+Motohashiauthor=K.+Nakayamaauthor=M.+Yamamoto&title=Nrf2+Suppresses+Macrophage+Inflammatory+Response+by+Blocking+Proinflammatory+Cytokine+Transcription&doi=10.1038%2Fncomms11624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription</span></div><div class="casAuthors">Kobayashi, Eri H.; Suzuki, Takafumi; Funayama, Ryo; Nagashima, Takeshi; Hayashi, Makiko; Sekine, Hiroki; Tanaka, Nobuyuki; Moriguchi, Takashi; Motohashi, Hozumi; Nakayama, Keiko; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11624</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nrf2 (NF-E2-related factor-2) transcription factor regulates oxidative/xenobiotic stress response and also represses inflammation.  However, the mechanisms how Nrf2 alleviates inflammation are still unclear.  Here, we demonstrate that Nrf2 interferes with lipopolysaccharide-induced transcriptional upregulation of proinflammatory cytokines, including IL-6 and IL-1β.  Chromatin immunopptn. (ChIP)-seq and ChIP-qPCR analyses revealed that Nrf2 binds to the proximity of these genes in macrophages and inhibits RNA Pol II recruitment.  Further, we found that Nrf2-mediated inhibition is independent of the Nrf2-binding motif and reactive oxygen species level.  Murine inflammatory models further demonstrated that Nrf2 interferes with IL6 induction and inflammatory phenotypes in vivo.  Thus, contrary to the widely accepted view that Nrf2 suppresses inflammation through redox control, we demonstrate here that Nrf2 opposes transcriptional upregulation of proinflammatory cytokine genes.  This study identifies Nrf2 as the upstream regulator of cytokine prodn. and establishes a mol. basis for an Nrf2-mediated anti-inflammation approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNH2n5UpCBKLVg90H21EOLACvtfcHk0ljos-xAJdT_Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos12ms7w%253D&md5=95c2aebdf50ed1e8dbbdf983ff50b300</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fncomms11624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11624%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DE.%2BH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DFunayama%26aufirst%3DR.%26aulast%3DNagashima%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DM.%26aulast%3DSekine%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DMoriguchi%26aufirst%3DT.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DNrf2%2520Suppresses%2520Macrophage%2520Inflammatory%2520Response%2520by%2520Blocking%2520Proinflammatory%2520Cytokine%2520Transcription%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11624%26doi%3D10.1038%2Fncomms11624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keleku-Lukwete, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">An Overview of the Advantages of Keap1-Nrf2 System Activation During Inflammatory Disease Treatment</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1746</span>, <span class="refDoi"> DOI: 10.1089/ars.2017.7358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1089%2Fars.2017.7358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28899203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVSisbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=1746&author=N.+Keleku-Lukweteauthor=M.+Suzukiauthor=M.+Yamamoto&title=An+Overview+of+the+Advantages+of+Keap1-Nrf2+System+Activation+During+Inflammatory+Disease+Treatment&doi=10.1089%2Fars.2017.7358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment</span></div><div class="casAuthors">Keleku-Lukwete, Nadine; Suzuki, Mikiko; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1746-1755</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Significance: Inflammation can be defined as a protective immune response against harmful exogenous and endogenous stimuli.  Nevertheless, prolonged or autoimmune inflammatory responses are likely to cause pathol. states that are assocd. with a prodn. of inflammation-assocd. mols. along with reactive oxygen species (ROS).  Kelch-like ECH-assocd. protein 1-nuclear factor erythroid 2-related factor 2 (KEAP1-NRF2) signaling provides a cell protection mechanism against oxidative insults when endogenous stress defense mechanisms are imbalanced.  Understanding the roles of the KEAP1-NRF2 system in inflammation caused by various types of stimuli may aid in the development of new therapies.  Recent Advances: There have been tremendous advances in understanding the mechanism by which the KEAP1-NRF2 pathway abrogates inflammation.  In addn. to the well-established ROS-dependent pathway, recent studies have provided evidence of the direct repression of the transcription of pro-inflammatory cytokine genes, such as IL1b and IL6 (encoding Interleukin-1β and Interleukin-6, resp.).  Further, the expanding functions of NRF2 have elicited interest in the development of therapeutic modalities for inflammatory diseases, including multiple sclerosis and sickle cell disease.  Crit. Issues and Future Directions: Despite progress in the understanding of mol. mechanisms supporting the roles that NRF2 plays during inflammation, the relationship between NRF2 and other transcription factors and mediators of inflammation still remains ambiguous.  Further studies are required to address the effects of functional polymorphisms in KEAP1 and NRF2 that modify susceptibility to specific disease-related inflammation.  Comprehensive analyses in the future should explore tissue- or cell-type specific NRF2 activation to elaborate effects of NRF2 induction.  Antioxid. Redox Signal. 00, 000-000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPQBAVuG5z_7Vg90H21EOLACvtfcHk0ljv50DxE5Fr2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVSisbrP&md5=d07791ace1a2d2ba45b88be8ad03345d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1089%2Fars.2017.7358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2017.7358%26sid%3Dliteratum%253Aachs%26aulast%3DKeleku-Lukwete%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DAn%2520Overview%2520of%2520the%2520Advantages%2520of%2520Keap1-Nrf2%2520System%2520Activation%2520During%2520Inflammatory%2520Disease%2520Treatment%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2018%26volume%3D29%26spage%3D1746%26doi%3D10.1089%2Fars.2017.7358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of the Negative Regulator of Nrf2, Keap1: A Historical Overview</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1665</span>– <span class="NLM_lpage">1678</span>, <span class="refDoi"> DOI: 10.1089/ars.2010.3222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1089%2Fars.2010.3222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20446768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12ltL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1665-1678&author=K.+Itohauthor=J.+Mimuraauthor=M.+Yamamoto&title=Discovery+of+the+Negative+Regulator+of+Nrf2%2C+Keap1%3A+A+Historical+Overview&doi=10.1089%2Fars.2010.3222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the negative regulator of Nrf2, Keap1: A historical overview</span></div><div class="casAuthors">Itoh, Ken; Mimura, Junsei; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1665-1678</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  An antioxidant response element (ARE) or an electrophile responsive element (EpRE) regulate the transcriptional induction of a battery of drug-detoxifying enzymes that are protective against electrophiles.  Based on the high similarity of the ARE consensus sequence to an erythroid gene regulatory element NF-E2 binding site, the authors have found that transcription factor Nrf2 is indispensable for the ARE-mediated induction of drug-metabolizing enzymes.  Recent genome-wide anal. demonstrated that Nrf2 regulates hundreds of genes that are involved in the cytoprotective response against oxidative stress.  In-depth anal. of Nrf2 regulatory mechanisms led the authors to the discovery of a novel protein, which they designated Keap1.  Keap1 suppresses Nrf2 activity by specifically binding to its evolutionarily conserved N-terminal Neh2 regulatory domain.  Here, the authors summarize findings and observations that have lead to the discovery of the Nrf2-Keap1 system.  Furthermore, the authors briefly discuss the function of the Nrf2-Keap1 system under the regulation of the endogenous electrophilic compd., 15-deoxy-Δ12,14-prostaglandin J2.  The authors propose that Nrf2-Keap1 plays a significant physiol. role in the response to endogenous, environmental, and pharmacol. electrophiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYEEgix9Qpi7Vg90H21EOLACvtfcHk0ljv50DxE5Fr2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12ltL%252FK&md5=2c3e700515df4eb5bb8414c8d69bfc9f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3222%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DMimura%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520the%2520Negative%2520Regulator%2520of%2520Nrf2%252C%2520Keap1%253A%2520A%2520Historical%2520Overview%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2010%26volume%3D13%26spage%3D1665%26epage%3D1678%26doi%3D10.1089%2Fars.2010.3222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nioi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherratt, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, C. B.</span></span> <span> </span><span class="NLM_article-title">The Carboxy-Terminal Neh3 Domain of Nrf2 Is Required for Transcriptional Activation</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">10895</span>– <span class="NLM_lpage">10906</span>, <span class="refDoi"> DOI: 10.1128/MCB.25.24.10895-10906.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.25.24.10895-10906.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=16314513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlektr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10895-10906&author=P.+Nioiauthor=T.+Nguyenauthor=P.+J.+Sherrattauthor=C.+B.+Pickett&title=The+Carboxy-Terminal+Neh3+Domain+of+Nrf2+Is+Required+for+Transcriptional+Activation&doi=10.1128%2FMCB.25.24.10895-10906.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation</span></div><div class="casAuthors">Nioi, Paul; Nguyen, Truyen; Sherratt, Philip J.; Pickett, Cecil B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10895-10906</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Nrf2 is a transcription factor crit. for the maintenance of cellular redox homeostasis.  We have previously found that Nrf2 is a labile protein, and its activation in cells under stress involves mechanisms leading to its stabilization.  As a modular protein, Nrf2 possesses distinct transactivation and DNA binding domains essential for its transcriptional activity.  In this study, we found that the C-terminal "Neh3" domain of Nrf2 is also important for its activity.  Deletion of the last 16 amino acids of the protein completely abolishes its ability to activate both reporter and endogenous gene expression.  Using site-directed mutagenesis, we have identified a stretch of amino acids within this region that are essential for its activity and that are found to be conserved across species and among other members of the CNC-bZIP family.  Importantly, deletion of the final 16 amino acids of Nrf2 does not influence its dimerizing capability, DNA binding activity, or subcellular localization, although it does increase the half-life of the protein.  In addn., this region was found to be important for interaction with CHD6 (a chromo-ATPase/helicase DNA binding protein) in a yeast two-hybrid screen.  RNA interference-mediated knockdown of CHD6 reduced both the basal and tert-butylhydroquinone-inducible expression of NQO1, a prototypical Nrf2 target gene.  These data suggest that the Neh3 domain may act as a transactivation domain and that it is possibly involved in interaction with components of the transcriptional app. to affect its transcriptional activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSukid2fpRObVg90H21EOLACvtfcHk0ljv50DxE5Fr2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlektr%252FP&md5=6244da25302b473837c82c84c87d8699</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1128%2FMCB.25.24.10895-10906.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.25.24.10895-10906.2005%26sid%3Dliteratum%253Aachs%26aulast%3DNioi%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DSherratt%26aufirst%3DP.%2BJ.%26aulast%3DPickett%26aufirst%3DC.%2BB.%26atitle%3DThe%2520Carboxy-Terminal%2520Neh3%2520Domain%2520of%2520Nrf2%2520Is%2520Required%2520for%2520Transcriptional%2520Activation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D10895%26epage%3D10906%26doi%3D10.1128%2FMCB.25.24.10895-10906.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, C.</span></span> <span> </span><span class="NLM_article-title">Dual Regulation of Transcription Factor Nrf2 by Keap1 and by the Combined Actions of Beta-Trcp and Gsk-3</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1042/BST20150011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1042%2FBST20150011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26551701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=611-620&author=J.+D.+Hayesauthor=S.+Chowdhryauthor=A.+T.+Dinkova-Kostovaauthor=C.+Sutherland&title=Dual+Regulation+of+Transcription+Factor+Nrf2+by+Keap1+and+by+the+Combined+Actions+of+Beta-Trcp+and+Gsk-3&doi=10.1042%2FBST20150011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of β-TrCP and GSK-3</span></div><div class="casAuthors">Hayes, John D.; Chowdhry, Sudhir; Dinkova-Kostova, Albena T.; Sutherland, Calum</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">611-620</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Nuclear factor-erythroid 2 p45 (NF-E2 p45)-related factor 2 (Nrf2) is a master regulator of redox homoeostasis that allows cells to adapt to oxidative stress and also promotes cell proliferation.  In this review, we describe the mol. mechanisms by which oxidants/electrophilic agents and growth factors increase Nrf2 activity.  In the former case, oxidants/electrophiles increase the stability of Nrf2 by antagonizing the ability of Kelch-like ECH-assocd. protein 1 (Keap1) to target the transcription factor for proteasomal degrdn. via the cullin-3 (Cul3)-RING ubiquitin ligase CRLKeap1.  In the latter case, we speculate that growth factors increase the stability of Nrf2 by stimulating phosphoinositide 3-kinase (PI3K)-protein kinase B (PKB)/Akt signalling, which in turn results in inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) and in doing so prevents the formation of a DSGIS motif-contg. phosphodegron in Nrf2 that is recognized by the β-transducin repeat-contg. protein (β-TrCP) Cul1-based E3 ubiquitin ligase complex SCFβ-TrCP.  We present data showing that in the absence of Keap1, the electrophile tert-Bu hydroquinone (tBHQ) can stimulate Nrf2 activity and induce the Nrf2-target gene NAD(P)H:quinone oxidoreductase-1 (NQO1), while simultaneously causing inhibitory phosphorylation of GSK-3β at Ser9.  Together, these observations suggest that tBHQ can suppress the ability of SCFβ-TrCP to target Nrf2 for proteasomal degrdn. by increasing PI3K-PKB/Akt signalling.  We also propose a scheme that explains how other protein kinases that inhibit GSK-3 could stimulate induction of Nrf2-target genes by preventing formation of the DSGIS motif-contg. phosphodegron in Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5bqpkqNAhSbVg90H21EOLACvtfcHk0ljcytCpEX0rMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsbzE&md5=5471439ca69381d4bed94f48a596055f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1042%2FBST20150011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20150011%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DChowdhry%26aufirst%3DS.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DSutherland%26aufirst%3DC.%26atitle%3DDual%2520Regulation%2520of%2520Transcription%2520Factor%2520Nrf2%2520by%2520Keap1%2520and%2520by%2520the%2520Combined%2520Actions%2520of%2520Beta-Trcp%2520and%2520Gsk-3%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2015%26volume%3D43%26spage%3D611%26epage%3D620%26doi%3D10.1042%2FBST20150011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Characterization of Nrf2 Degradation by Glycogen Synthase Kinase 3/Beta-Trcp</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.04.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2015.04.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=25937177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWrt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=147-157&author=A.+Cuadrado&title=Structural+and+Functional+Characterization+of+Nrf2+Degradation+by+Glycogen+Synthase+Kinase+3%2FBeta-Trcp&doi=10.1016%2Fj.freeradbiomed.2015.04.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional characterization of NRF2 degradation by glycogen synthase kinase 3/β-TrCP</span></div><div class="casAuthors">Cuadrado, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">147-157</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor (erythroid-derived 2)-like 2 (NRF2) is a master regulator of cellular homeostasis that controls the expression of more than 1% of human genes related to biotransformation reactions, redox homeostasis, energetic metab., DNA repair, and proteostasis.  Its activity has a tremendous impact on physiol. and pathol. and therefore it is very tightly regulated, mainly at the level of protein stability.  In addn. to the very well established regulation by the ubiquitin E3 ligase adapter KEAP1, recent advances have identified a novel mechanism based on signaling pathways that regulate glycogen synthase kinase-3 (GSK-3).  This kinase phosphorylates specific serine residues in the Neh6 domain of NRF2 to create a degrdn. domain that is then recognized by the ubiquitin ligase adapter β-TrCP and tagged for proteasome degrdn. by a Cullin1/Rbx1 complex.  Here we review the mechanistic elements and the signaling pathways that participate in this regulation by GSK-3/β-TrCP.  These pathways include those activated by ligands of tyrosine kinase, G protein-coupled, metabotropic, and ionotropic receptors that activate phosphatidyl inositol 3-kinase (PI3K)/ATK and by the canonical WNT signaling pathway, where a fraction of NRF2 interacts with Axin1/GSK-3.  Considering that free NRF2 protein is localized in the nucleus, we propose a model termed "double flux controller" to explain how KEAP1 and β-TrCP coordinate the stability of NRF2 in several scenarios.  The GSK-3/β-TrCP axis provides a novel therapeutic strategy to modulate NRF2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBD0QH5vyIm7Vg90H21EOLACvtfcHk0ljcytCpEX0rMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWrt7nJ&md5=d26bee72ad5237c0138c9f4c003b527b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.04.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.04.029%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado%26aufirst%3DA.%26atitle%3DStructural%2520and%2520Functional%2520Characterization%2520of%2520Nrf2%2520Degradation%2520by%2520Glycogen%2520Synthase%2520Kinase%25203%252FBeta-Trcp%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D147%26epage%3D157%26doi%3D10.1016%2Fj.freeradbiomed.2015.04.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span> <span> </span><span class="NLM_article-title">Discovery and Development of Kelch-Like Ech-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (Keap1:Nrf2) Protein–Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10837</span>– <span class="NLM_lpage">10858</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00586</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00586" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10837-10858&author=Z.-Y.+Jiangauthor=M.-C.+Luauthor=Q.-D.+You&title=Discovery+and+Development+of+Kelch-Like+Ech-Associated+Protein+1.+Nuclear+Factor+Erythroid+2-Related+Factor+2+%28Keap1%3ANrf2%29+Protein%E2%80%93Protein+Interaction+Inhibitors%3A+Achievements%2C+Challenges%2C+and+Future+Directions&doi=10.1021%2Facs.jmedchem.6b00586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10837-10858</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The transcription factor Nrf2 is the primary regulator of the cellular defense system, and enhancing Nrf2 activity has potential usages in various diseases, esp. chronic age-related and inflammatory diseases.  Recently, directly targeting Keap1-Nrf2 protein-protein interaction (PPI) has been an emerging strategy to selectively and effectively activate Nrf2.  This Perspective summarizes the progress in the discovery and development of Keap1-Nrf2 PPI inhibitors, including the Keap1-Nrf2 regulatory mechanisms, biochem. techniques for inhibitor identification, and approaches for identifying peptide and small-mol. inhibitors, as well as discusses privileged structures and future directions for further development of Keap1-Nrf2 PPI inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCuMv4k9xi9LVg90H21EOLACvtfcHk0liJ-AENm0nTHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO&md5=487aa677ae8a86d71e2b15561656b0b7</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00586%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.-Y.%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DYou%26aufirst%3DQ.-D.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Kelch-Like%2520Ech-Associated%2520Protein%25201.%2520Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528Keap1%253ANrf2%2529%2520Protein%25E2%2580%2593Protein%2520Interaction%2520Inhibitors%253A%2520Achievements%252C%2520Challenges%252C%2520and%2520Future%2520Directions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10837%26epage%3D10858%26doi%3D10.1021%2Facs.jmedchem.6b00586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canning, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorrell, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, A. N.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Keap1 Interactions with Nrf2</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.05.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2015.05.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26057936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=101-107&author=P.+Canningauthor=F.+J.+Sorrellauthor=A.+N.+Bullock&title=Structural+Basis+of+Keap1+Interactions+with+Nrf2&doi=10.1016%2Fj.freeradbiomed.2015.05.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of KEAP1 interactions with Nrf2</span></div><div class="casAuthors">Canning, Peter; Sorrell, Fiona J.; Bullock, Alex N.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">101-107</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  KEAP1 is a highly redox-sensitive member of the BTB-Kelch family that assembles with the Cul3 protein to form a Cullin-RING E3 ligase complex for the degrdn. of Nrf2.  Oxidative stress disables KEAP1, allowing Nrf2 protein levels to accumulate for the transactivation of crit. stress response genes.  Consequently, the KEAP1-Nrf2 system is extensively pursued for the development of protein-protein interaction inhibitors that will stabilize Nrf2 for therapeutic effect in conditions of neurodegeneration, inflammation, and cancer.  Here we review current progress toward the structure detn. of KEAP1 and its protein complexes with Cul3, Nrf2 substrate, and small-mol. antagonists.  Together the available structures establish a rational three-dimensional model to explain the two-site binding of Nrf2 as well as its efficient ubiquitination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwBBMS70b7hbVg90H21EOLACvtfcHk0liJ-AENm0nTHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7rK&md5=12b7b36caa16cf3cd3d95d84162eed80</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DCanning%26aufirst%3DP.%26aulast%3DSorrell%26aufirst%3DF.%2BJ.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26atitle%3DStructural%2520Basis%2520of%2520Keap1%2520Interactions%2520with%2520Nrf2%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D101%26epage%3D107%26doi%3D10.1016%2Fj.freeradbiomed.2015.05.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuoka, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Two-Site Substrate Recognition Model for the Keap1-Nrf2 System: A Hinge and Latch Mechanism</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>387</i></span>,  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1320</span>, <span class="refDoi"> DOI: 10.1515/BC.2006.164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1515%2FBC.2006.164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=17081101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFygtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2006&pages=1311-1320&author=K.+I.+Tongauthor=A.+Kobayashiauthor=F.+Katsuokaauthor=M.+Yamamoto&title=Two-Site+Substrate+Recognition+Model+for+the+Keap1-Nrf2+System%3A+A+Hinge+and+Latch+Mechanism&doi=10.1515%2FBC.2006.164"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism</span></div><div class="casAuthors">Tong, Kit I.; Kobayashi, Akira; Katsuoka, Fumiki; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">10/11</span>),
    <span class="NLM_cas:pages">1311-1320</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  Cells are equipped with a no. of transcriptional factors that safeguard against various environmental insults.  Proteasomal protein degrdn. plays an important role in the Keap1-Nrf2 cytoprotection system, with mol. machinery similar to that for other environmental defense systems such as inflammatory and hypoxic responses.  While Nrf2 protein stabilization is known to be redox-sensitive, the transcription factors NF-κB and HIF-1α for inflammatory and hypoxic responses, resp., are also influenced by the cellular redox conditions.  In this review the authors present the recently proposed 2-site substrate recognition model of the Keap1-Nrf2 system, which regulates the cellular responses against oxidative and xenobiotic stresses.  The implications of 2 destructive motifs in Nrf2, the ETGE and DLG motifs, which appear to function as a hinge and latch attenuating Keap1 activity in different redox states, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7KwAAahYp3LVg90H21EOLACvtfcHk0liJ-AENm0nTHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFygtLvF&md5=a7c36b5b1af9a559ca2b0c6e57449f70</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1515%2FBC.2006.164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2006.164%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DKatsuoka%26aufirst%3DF.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DTwo-Site%2520Substrate%2520Recognition%2520Model%2520for%2520the%2520Keap1-Nrf2%2520System%253A%2520A%2520Hinge%2520and%2520Latch%2520Mechanism%26jtitle%3DBiol.%2520Chem.%26date%3D2006%26volume%3D387%26spage%3D1311%26epage%3D1320%26doi%3D10.1515%2FBC.2006.164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurokawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 Is a Forked-Stem Dimer Structure with Two Large Spheres Enclosing the Intervening, Double Glycine Repeat, and C-Terminal Domains</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">2842</span>– <span class="NLM_lpage">2847</span>, <span class="refDoi"> DOI: 10.1073/pnas.0914036107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1073%2Fpnas.0914036107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20133743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXis1Cltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=2842-2847&author=T.+Oguraauthor=K.+I.+Tongauthor=K.+Mioauthor=Y.+Maruyamaauthor=H.+Kurokawaauthor=C.+Satoauthor=M.+Yamamoto&title=Keap1+Is+a+Forked-Stem+Dimer+Structure+with+Two+Large+Spheres+Enclosing+the+Intervening%2C+Double+Glycine+Repeat%2C+and+C-Terminal+Domains&doi=10.1073%2Fpnas.0914036107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains</span></div><div class="casAuthors">Ogura, Toshihiko; Tong, Kit I.; Mio, Kazuhiro; Maruyama, Yuusuke; Kurokawa, Hirofumi; Sato, Chikara; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2842-2847, S2842/1-S2842/3</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Keap1 is a substrate adaptor of a Cullin 3-based E3 ubiquitin ligase complex that recognizes Nrf2, and also acts as a cellular sensor for xenobiotics and oxidative stresses.  Nrf2 is a transcriptional factor regulating the expression of cytoprotective enzyme genes in response to such stresses.  Under unstressed conditions Keap1 binds Nrf2 and results in rapid degrdn. of Nrf2 through the proteasome pathway.  In contrast, upon exposure to oxidative and electrophilic stress, reactive cysteine residues in the IVR (intervening region) and BTB (Broad complex, Tramtrack, and Bric-a-Brac) domains of Keap1 are modified by electrophiles.  This modification prevents Nrf2 from rapid degrdn. and induces Nrf2 activity by repression of Keap1.  Here we report the structure of mouse Keap1 homodimer by single particle electron microscopy.  Three-dimensional reconstruction at 24-Å resoln. revealed two large spheres attached by short linker arms to the sides of a small forked-stem structure, resembling a cherry-bob.  Each sphere has a tunnel corresponding to the central hole of the β-propeller domain, as detd. by x-ray crystallog.  The IVR domain appears to surround the core of the β-propeller domain.  The unexpected proximity of IVR to the β-propeller domain suggests that any distortions generated during modification of reactive cysteine residues in the IVR domain may send a derepression signal to the p-propeller domain and thereby stabilize Nrf2.  This study thus provides a structural basis for the two-site binding and hinge-latch model of stress sensing by the Nrf2-Keap1 system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9F9fYqKP95LVg90H21EOLACvtfcHk0liiOlq-YeNqNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXis1Cltrg%253D&md5=2801c7099d40a720ffc3be2162ef6b3d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0914036107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0914036107%26sid%3Dliteratum%253Aachs%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DMio%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DY.%26aulast%3DKurokawa%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DC.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DKeap1%2520Is%2520a%2520Forked-Stem%2520Dimer%2520Structure%2520with%2520Two%2520Large%2520Spheres%2520Enclosing%2520the%2520Intervening%252C%2520Double%2520Glycine%2520Repeat%252C%2520and%2520C-Terminal%2520Domains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D2842%26epage%3D2847%26doi%3D10.1073%2Fpnas.0914036107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusunoki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 Recruits Neh2 through Binding to Etge and Dlg Motifs: Characterization of the Two-Site Molecular Recognition Model</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2887</span>– <span class="NLM_lpage">2900</span>, <span class="refDoi"> DOI: 10.1128/MCB.26.8.2887-2900.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.26.8.2887-2900.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=16581765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1Slsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2887-2900&author=K.+I.+Tongauthor=Y.+Katohauthor=H.+Kusunokiauthor=K.+Itohauthor=T.+Tanakaauthor=M.+Yamamoto&title=Keap1+Recruits+Neh2+through+Binding+to+Etge+and+Dlg+Motifs%3A+Characterization+of+the+Two-Site+Molecular+Recognition+Model&doi=10.1128%2FMCB.26.8.2887-2900.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model</span></div><div class="casAuthors">Tong, Kit I.; Katoh, Yasutake; Kusunoki, Hideki; Itoh, Ken; Tanaka, Toshiyuki; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2887-2900</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The expression of the phase 2 detoxification enzymes and antioxidant proteins is induced at the transcriptional level by Nrf2 and neg. regulated at the posttranslational level by Keap1 through protein-protein interactions with Nrf2 and subsequent proteolysis of Nrf2.  We found that the Neh2 domain of Nrf2 is an intrinsically disordered but biol. active regulatory domain contg. a 33-residue central α-helix followed by a mini antiparallel β-sheet.  Isothermal calorimetry anal. indicated that one Neh2 mol. interacts with two mols. of Keap1 via two binding sites, the stronger binding ETGE motif and the weaker binding DLG motif.  NMR titrn. study showed that these two motifs of the Neh2 domain bind to an overlapping site on the bottom surface of the β-propeller structure of Keap1.  In contrast, the central α-helix of the Neh2 domain does not have any observable affinity to Keap1, suggesting that this region may serve as a bridge connecting the two motifs for the assocn. with the two β-propeller structures of a dimer of Keap1.  Based on these observations, we propose that Keap1 recruits Nrf2 by the ETGE motif and that the DLG motif of the Neh2 domain locks its lysine-rich central α-helix in a correct position to benefit ubiquitin (Ub) signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW4AlViBIZg7Vg90H21EOLACvtfcHk0liiOlq-YeNqNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1Slsbw%253D&md5=f6a5af3be5757cd665f234562d48d727</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1128%2FMCB.26.8.2887-2900.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.26.8.2887-2900.2006%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DKusunoki%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DKeap1%2520Recruits%2520Neh2%2520through%2520Binding%2520to%2520Etge%2520and%2520Dlg%2520Motifs%253A%2520Characterization%2520of%2520the%2520Two-Site%2520Molecular%2520Recognition%2520Model%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D2887%26epage%3D2900%26doi%3D10.1128%2FMCB.26.8.2887-2900.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostov, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canning, P.</span></span> <span> </span><span class="NLM_article-title">Keap1, the Cysteine-Based Mammalian Intracellular Sensor for Electrophiles and Oxidants</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>617</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2016.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.abb.2016.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27497696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlags7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=617&publication_year=2017&pages=84-93&author=A.+T.+Dinkova-Kostovaauthor=R.+V.+Kostovauthor=P.+Canning&title=Keap1%2C+the+Cysteine-Based+Mammalian+Intracellular+Sensor+for+Electrophiles+and+Oxidants&doi=10.1016%2Fj.abb.2016.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Kostov, Rumen V.; Canning, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">617</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">84-93</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Kelch-like ECH assocd. protein 1 (Keap1) is a component of a Cullin3-based Cullin-RING E3 ubiquitin ligase (CRL) multisubunit protein complex.  Within the CRL, homodimeric Keap1 functions as the Cullin3 adaptor, and importantly, it is also the crit. component of the E3 ligase that performs the substrate recognition.  The best-characterized substrate of Keap1 is transcription factor NF-E2 p45-related factor 2 (Nrf2), which orchestrates an elaborate transcriptional program in response to environmental challenges caused by oxidants, electrophiles and pro-inflammatory agents, allowing adaptation and survival under stress conditions.  Keap1 is equipped with reactive cysteine residues that act as sensors for endogenously produced and exogenously encountered small mols. (termed inducers), which have a characteristic chem. signature, reactivity with sulfhydryl groups.  Inducers modify the cysteine sensors of Keap1 and impair its ability to target Nrf2 for ubiquitination and degrdn.  Consequently, Nrf2 accumulates, enters the nucleus and drives the transcription of its target genes, which encode a large network of cytoprotective proteins.  Here we summarize the early studies leading to the prediction of the existence of Keap1, followed by the discovery of Keap1 as the main neg. regulator of Nrf2.  We then describe the available structural information on Keap1, its assembly with Cullin3, and its interaction with Nrf2.  We also discuss the multiple cysteine sensors of Keap1 that allow for detection of a wide range of endogenous and environmental inducers, and provide fine-tuning and tight control of the Keap1/Nrf2 stress-sensing response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI8YYxE9xg4LVg90H21EOLACvtfcHk0liiOlq-YeNqNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlags7jF&md5=eedfc91fa4e91f74df618231a01af182</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2016.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2016.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DKostov%26aufirst%3DR.%2BV.%26aulast%3DCanning%26aufirst%3DP.%26atitle%3DKeap1%252C%2520the%2520Cysteine-Based%2520Mammalian%2520Intracellular%2520Sensor%2520for%2520Electrophiles%2520and%2520Oxidants%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2017%26volume%3D617%26spage%3D84%26epage%3D93%26doi%3D10.1016%2Fj.abb.2016.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lleres, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Regulatory Flexibility in the Nrf2-Mediated Stress Response Is Conferred by Conformational Cycling of the Keap1-Nrf2 Protein Complex</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">15259</span>– <span class="NLM_lpage">15264</span>, <span class="refDoi"> DOI: 10.1073/pnas.1305687110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1073%2Fpnas.1305687110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23986495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOhsbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=15259-15264&author=L.+Bairdauthor=D.+Lleresauthor=S.+Swiftauthor=A.+T.+Dinkova-Kostova&title=Regulatory+Flexibility+in+the+Nrf2-Mediated+Stress+Response+Is+Conferred+by+Conformational+Cycling+of+the+Keap1-Nrf2+Protein+Complex&doi=10.1073%2Fpnas.1305687110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex</span></div><div class="casAuthors">Baird, Liam; Lleres, David; Swift, Sam; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">15259-15264,S15259/1-S15259/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The transcription factor NF-E2 p45-related factor 2 (Nrf2), a master regulator of cytoprotective genes, is controlled by dimeric Kelch-like ECH assocd. protein 1 (Keap1), a substrate adaptor protein for Cullin3/RING-box protein 1 ubiquitin ligase, which normally targets Nrf2 for ubiquitination and degrdn. but loses this ability in response to electrophiles and oxidants (inducers).  By using recombinant proteins and populations of cells, some of the general features of the regulation of Nrf2 by Keap1 have been outlined.  However, how the two proteins interact at a single-cell level is presently unknown.  We now report the development of a quant. Forster resonance energy transfer-based system using multiphoton fluorescence lifetime imaging microscopy and its application for investigating the interaction between Nrf2 and Keap1 in single live cells.  By using this approach, we found that under homeostatic conditions, the interaction between Keap1 and Nrf2 follows a cycle in which the complex sequentially adopts two distinct conformations: "open," in which Nrf2 interacts with a single mol. of Keap1, followed by "closed," in which Nrf2 binds to both members of the Keap1 dimer.  Inducers disrupt this cycle by causing accumulation of the complex in the closed conformation without release of Nrf2.  As a consequence, free Keap1 is not regenerated, and newly synthesized Nrf2 is stabilized.  On the basis of these findings, we propose a model we have named the "cyclic sequential attachment and regeneration model of Keap1-mediated degrdn. of Nrf2.".  This previously unanticipated dynamism allows rapid transcriptional responses to environmental changes and can accommodate multiple modes of regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxL86wHbn7G7Vg90H21EOLACvtfcHk0liiOlq-YeNqNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOhsbbL&md5=70b4502b74247820154b693c077cfc66</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1305687110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1305687110%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DLleres%26aufirst%3DD.%26aulast%3DSwift%26aufirst%3DS.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DRegulatory%2520Flexibility%2520in%2520the%2520Nrf2-Mediated%2520Stress%2520Response%2520Is%2520Conferred%2520by%2520Conformational%2520Cycling%2520of%2520the%2520Keap1-Nrf2%2520Protein%2520Complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D15259%26epage%3D15264%26doi%3D10.1073%2Fpnas.1305687110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lleres, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Monitoring Keap1-Nrf2 Interactions in Single Live Cells</span>. <i>Biotechnol. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1133</span>– <span class="NLM_lpage">1144</span>, <span class="refDoi"> DOI: 10.1016/j.biotechadv.2014.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.biotechadv.2014.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24681086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=1133-1144&author=L.+Bairdauthor=S.+Swiftauthor=D.+Lleresauthor=A.+T.+Dinkova-Kostova&title=Monitoring+Keap1-Nrf2+Interactions+in+Single+Live+Cells&doi=10.1016%2Fj.biotechadv.2014.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring Keap1-Nrf2 interactions in single live cells</span></div><div class="casAuthors">Baird, Liam; Swift, Sam; Lleres, David; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology Advances</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1133-1144</span>CODEN:
                <span class="NLM_cas:coden">BIADDD</span>;
        ISSN:<span class="NLM_cas:issn">0734-9750</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The transcription factor NF-E2 p45-related factor 2 (Nrf2) and its neg. regulator Kelch-like ECH assocd. protein 1 (Keap1) control the expression of nearly 500 genes with diverse cytoprotective functions.  Keap1, a substrate adaptor protein for Cullin3/Rbx1 ubiquitin ligase, normally continuously targets Nrf2 for degrdn., but loses this ability in response to electrophiles and oxidants (termed inducers).  Consequently, Nrf2 accumulates and activates transcription of its downstream target genes.  Many inducers are phytochems., and cruciferous vegetables represent one of the richest sources of inducer activity among the most commonly used edible plants.  Here we summarize the discovery of the isothiocyanate sulforaphane as a potent inducer which reacts with cysteine sensors of Keap1, leading to activation of Nrf2.  We then describe the development of a quant. Forster resonance energy transfer (FRET)-based methodol. combined with multiphoton fluorescence lifetime imaging microscopy (FLIM) to investigate the interactions between Keap1 and Nrf2 in single live cells, and the effect of sulforaphane, and other cysteine-reactive inducers, on the dynamics of the Keap1-Nrf2 protein complex.  We present the exptl. evidence for the "cyclic sequential attachment and regeneration" or "conformation cycling" model of Keap1-mediated Nrf2 degrdn.  Finally, we discuss the implications of this mode of regulation of Nrf2 for achieving a fine balance under normal physiol. conditions, and the consequences and mechanisms of disrupting this balance for tumor biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4iA4Fe7Z2q7Vg90H21EOLACvtfcHk0ljPKRew_3gTsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSlsbc%253D&md5=f44b787f55a522b59013b15ca40f4659</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.biotechadv.2014.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biotechadv.2014.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DSwift%26aufirst%3DS.%26aulast%3DLleres%26aufirst%3DD.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DMonitoring%2520Keap1-Nrf2%2520Interactions%2520in%2520Single%2520Live%2520Cells%26jtitle%3DBiotechnol.%2520Adv.%26date%3D2014%26volume%3D32%26spage%3D1133%26epage%3D1144%26doi%3D10.1016%2Fj.biotechadv.2014.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebisine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, C.</span></span> <span> </span><span class="NLM_article-title">Regulation of the Cnc-Bzip Transcription Factor Nrf2 by Keap1 and the Axis between Gsk-3 and Β-Trcp</span>. <i>Current Opinion in Toxicology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.cotox.2016.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.cotox.2016.10.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2016&pages=92-103&author=J.+D.+Hayesauthor=K.+Ebisineauthor=R.+S.+Sharmaauthor=S.+Chowdhryauthor=A.+T.+Dinkova-Kostovaauthor=C.+Sutherland&title=Regulation+of+the+Cnc-Bzip+Transcription+Factor+Nrf2+by+Keap1+and+the+Axis+between+Gsk-3+and+%CE%92-Trcp&doi=10.1016%2Fj.cotox.2016.10.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.cotox.2016.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cotox.2016.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DEbisine%26aufirst%3DK.%26aulast%3DSharma%26aufirst%3DR.%2BS.%26aulast%3DChowdhry%26aufirst%3DS.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DSutherland%26aufirst%3DC.%26atitle%3DRegulation%2520of%2520the%2520Cnc-Bzip%2520Transcription%2520Factor%2520Nrf2%2520by%2520Keap1%2520and%2520the%2520Axis%2520between%2520Gsk-3%2520and%2520%25CE%2592-Trcp%26jtitle%3DCurrent%2520Opinion%2520in%2520Toxicology%26date%3D2016%26volume%3D1%26spage%3D92%26epage%3D103%26doi%3D10.1016%2Fj.cotox.2016.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Is Controlled by Two Distinct Beta-Trcp Recognition Motifs in Its Neh6 Domain, One of Which Can Be Modulated by Gsk-3 Activity</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">3765</span>– <span class="NLM_lpage">3781</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fonc.2012.388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22964642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlajsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=3765-3781&author=S.+Chowdhryauthor=Y.+Zhangauthor=M.+McMahonauthor=C.+Sutherlandauthor=A.+Cuadradoauthor=J.+D.+Hayes&title=Nrf2+Is+Controlled+by+Two+Distinct+Beta-Trcp+Recognition+Motifs+in+Its+Neh6+Domain%2C+One+of+Which+Can+Be+Modulated+by+Gsk-3+Activity&doi=10.1038%2Fonc.2012.388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity</span></div><div class="casAuthors">Chowdhry, S.; Zhang, Y.; McMahon, M.; Sutherland, C.; Cuadrado, A.; Hayes, J. D.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">3765-3781</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Identification of regulatable mechanisms by which transcription factor NF-E2 p45-related factor 2 (Nrf2) is repressed will allow strategies to be designed that counter drug resistance assocd. with its upregulation in tumors that harbor somatic mutations in Kelch-like ECH-assocd. protein-1 (Keap1), a gene that encodes a joint adaptor and substrate receptor for the Cul3-Rbx1/Roc1 ubiquitin ligase.  We now show that mouse Nrf2 contains two binding sites for β-transducin repeat-contg. protein (β-TrCP), which acts as a substrate receptor for the Skp1-Cul1-Rbx1/Roc1 ubiquitin ligase complex.  Deletion of either binding site in Nrf2 decreased β-TrCP-mediated ubiquitylation of the transcription factor.  The ability of one of the two β-TrCP-binding sites to serve as a degron could be both increased and decreased by manipulation of glycogen synthase kinase-3 (GSK-3) activity.  Biotinylated-peptide pull-down assays identified DSGIS338 and DSAPGS378 as the two β-TrCP-binding motifs in Nrf2.  Significantly, our pull-down assays indicated that β-TrCP binds a phosphorylated version of DSGIS more tightly than its non-phosphorylated counterpart, whereas this was not the case for DSAPGS.  These data suggest that DSGIS, but not DSAPGS, contains a functional GSK-3 phosphorylation site.  Activation of GSK-3 in Keap1-null mouse embryonic fibroblasts (MEFs), or in human lung A549 cells that contain mutant Keap1, by inhibition of the phosphoinositide 3-kinase (PI3K)-protein kinase B (PKB)/Akt pathway markedly reduced endogenous Nrf2 protein and decreased to 10-50% of normal the levels of mRNA for prototypic Nrf2-regulated enzymes, including the glutamate-cysteine ligase catalytic and modifier subunits, glutathione S-transferases Alpha-1 and Mu-1, haem oxygenase-1 and NAD(P)H:quinone oxidoreductase-1.  Pre-treatment of Keap1-/- MEFs or A549 cells with the LY294002 PI3K inhibitor or the MK-2206 PKB/Akt inhibitor increased their sensitivity to acrolein, chlorambucil and cisplatin between 1.9-fold and 3.1-fold, and this was substantially attenuated by simultaneous pre-treatment with the GSK-3 inhibitor CT99021.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPtz2Tkj8_7LVg90H21EOLACvtfcHk0ljPKRew_3gTsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlajsr3E&md5=459b0fb6a135228b2bef544fdbce870a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.388%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhry%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DSutherland%26aufirst%3DC.%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26atitle%3DNrf2%2520Is%2520Controlled%2520by%2520Two%2520Distinct%2520Beta-Trcp%2520Recognition%2520Motifs%2520in%2520Its%2520Neh6%2520Domain%252C%2520One%2520of%2520Which%2520Can%2520Be%2520Modulated%2520by%2520Gsk-3%2520Activity%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D3765%26epage%3D3781%26doi%3D10.1038%2Fonc.2012.388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rada, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evrard-Todeschi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innamorato, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaworski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobon-Velasco, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devijver, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Mayoral, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Leuven, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertho, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/Beta-Trcp Axis</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">3486</span>– <span class="NLM_lpage">3499</span>, <span class="refDoi"> DOI: 10.1128/MCB.00180-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.00180-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22751928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OlurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=3486-3499&author=P.+Radaauthor=A.+I.+Rojoauthor=N.+Evrard-Todeschiauthor=N.+G.+Innamoratoauthor=A.+Cotteauthor=T.+Jaworskiauthor=J.+C.+Tobon-Velascoauthor=H.+Devijverauthor=M.+F.+Garcia-Mayoralauthor=F.+Van+Leuvenauthor=J.+D.+Hayesauthor=G.+Berthoauthor=A.+Cuadrado&title=Structural+and+Functional+Characterization+of+Nrf2+Degradation+by+the+Glycogen+Synthase+Kinase+3%2FBeta-Trcp+Axis&doi=10.1128%2FMCB.00180-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis</span></div><div class="casAuthors">Rada, Patricia; Rojo, Ana I.; Evrard-Todeschi, Nathalie; Innamorato, Nadia G.; Cotte, Axelle; Jaworski, Tomasz; Tobon-Velasco, Julio C.; Devijver, Herman; Garcia-Mayoral, Maria Flor; Van Leuven, Fred; Hayes, John D.; Bertho, Gildas; Cuadrado, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3486-3499</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The transcription factor NF-E2-related factor 2 (Nrf2) is a master regulator of a genetic program, termed the phase 2 response, that controls redox homeostasis and participates in multiple aspects of physiol. and pathol.  Nrf2 protein stability is regulated by two E3 ubiquitin ligase adaptors, Keap1 and β-TrCP, the latter of which was only recently reported.  Here, two-dimensional (2D) gel electrophoresis and site-directed mutagenesis allowed us to identify two serines of Nrf2 that are phosphorylated by glycogen synthase kinase 3β (GSK-3β) in the sequence DSGISL.  NMR studies defined key residues of this phosphosequence involved in docking to the WD40 propeller of β-TrCP, through electrostatic and hydrophobic interactions.  We also identified three arginine residues of β-TrCP that participate in Nrf2 docking.  I.p. injection of the GSK-3 inhibitor SB216763 led to increased Nrf2 and heme oxygenase-1 levels in liver and hippocampus.  Moreover, mice with hippocampal absence of GSK-3β exhibited increased levels of Nrf2 and phase 2 gene products, reduced glutathione, and decreased levels of carbonylated proteins and malondialdehyde.  This study establishes the structural parameters of the interaction of Nrf2 with the GSK-3/β-TrCP axis and its functional relevance in the regulation of Nrf2 by the signaling pathways that impinge on GSK-3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreXtclgwX2_7Vg90H21EOLACvtfcHk0lieClhxC1pZTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OlurzF&md5=b1218f29af2afa1256dca41d148aac47</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1128%2FMCB.00180-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00180-12%26sid%3Dliteratum%253Aachs%26aulast%3DRada%26aufirst%3DP.%26aulast%3DRojo%26aufirst%3DA.%2BI.%26aulast%3DEvrard-Todeschi%26aufirst%3DN.%26aulast%3DInnamorato%26aufirst%3DN.%2BG.%26aulast%3DCotte%26aufirst%3DA.%26aulast%3DJaworski%26aufirst%3DT.%26aulast%3DTobon-Velasco%26aufirst%3DJ.%2BC.%26aulast%3DDevijver%26aufirst%3DH.%26aulast%3DGarcia-Mayoral%26aufirst%3DM.%2BF.%26aulast%3DVan%2BLeuven%26aufirst%3DF.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DBertho%26aufirst%3DG.%26aulast%3DCuadrado%26aufirst%3DA.%26atitle%3DStructural%2520and%2520Functional%2520Characterization%2520of%2520Nrf2%2520Degradation%2520by%2520the%2520Glycogen%2520Synthase%2520Kinase%25203%252FBeta-Trcp%2520Axis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2012%26volume%3D32%26spage%3D3486%26epage%3D3499%26doi%3D10.1128%2FMCB.00180-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rada, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span> <span> </span><span class="NLM_article-title">Scf/{Beta}-Trcp Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1128/MCB.01204-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.01204-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21245377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVWks7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=1121-1133&author=P.+Radaauthor=A.+I.+Rojoauthor=S.+Chowdhryauthor=M.+McMahonauthor=J.+D.+Hayesauthor=A.+Cuadrado&title=Scf%2F%7BBeta%7D-Trcp+Promotes+Glycogen+Synthase+Kinase+3-Dependent+Degradation+of+the+Nrf2+Transcription+Factor+in+a+Keap1-Independent+Manner&doi=10.1128%2FMCB.01204-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">SCF/β-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner</span></div><div class="casAuthors">Rada, Patricia; Rojo, Ana I.; Chowdhry, Sudhir; McMahon, Michael; Hayes, John D.; Cuadrado, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1121-1133</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Regulation of transcription factor Nrf2 (NF-E2-related factor 2) involves redox-sensitive proteasomal degrdn. via the E3 ubiquitin ligase Keap1/Cul3.  However, Nrf2 is controlled by other mechanisms that have not yet been elucidated.  We now show that glycogen synthase kinase 3 (GSK-3) phosphorylates a group of Ser residues in the Neh6 domain of mouse Nrf2 that overlap with an SCF/β-TrCP destruction motif (DSGIS, residues 334 to 338) and promotes its degrdn. in a Keap1-independent manner.  Nrf2 was stabilized by GSK-3 inhibitors in Keap1-null mouse embryo fibroblasts.  Similarly, an Nrf2ΔETGE mutant, which cannot be degraded via Keap1, accumulated when GSK-3 activity was blocked.  Phosphorylation of a Ser cluster in the Neh6 domain of Nrf2 stimulated its degrdn. because a mutant Nrf2ΔETGE 6S/6A protein, lacking these Ser residues, exhibited a longer half-life than Nrf2ΔETGE.  Moreover, Nrf2ΔETGE 6S/6A was insensitive to β-TrCP regulation and exhibited lower levels of ubiquitination than Nrf2ΔETGE.  GSK-3β enhanced ubiquitination of Nrf2ΔETGE but not that of Nrf2ΔETGE 6S/6A.  The Nrf2ΔETGE protein but not Nrf2ΔETGE 6S/6A coimmunopptd. with β-TrCP, and this assocn. was enhanced by GSK-3β.  Our results show for the first time that Nrf2 is targeted by GSK-3 for SCF/β-TrCP-dependent degrdn.  We propose a "dual degrdn." model to describe the regulation of Nrf2 under different pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy_9WaC_Wpx7Vg90H21EOLACvtfcHk0lieClhxC1pZTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVWks7nF&md5=df07f3fa2a729aeedd704bb7932ada83</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1128%2FMCB.01204-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01204-10%26sid%3Dliteratum%253Aachs%26aulast%3DRada%26aufirst%3DP.%26aulast%3DRojo%26aufirst%3DA.%2BI.%26aulast%3DChowdhry%26aufirst%3DS.%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DCuadrado%26aufirst%3DA.%26atitle%3DScf%252F%257BBeta%257D-Trcp%2520Promotes%2520Glycogen%2520Synthase%2520Kinase%25203-Dependent%2520Degradation%2520of%2520the%2520Nrf2%2520Transcription%2520Factor%2520in%2520a%2520Keap1-Independent%2520Manner%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2011%26volume%3D31%26spage%3D1121%26epage%3D1133%26doi%3D10.1128%2FMCB.01204-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagishita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Hrd1 Suppresses Nrf2-Mediated Cellular Protection During Liver Cirrhosis</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">708</span>– <span class="NLM_lpage">722</span>, <span class="refDoi"> DOI: 10.1101/gad.238246.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1101%2Fgad.238246.114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=708-722&author=T.+Wuauthor=F.+Zhaoauthor=B.+Gaoauthor=C.+Tanauthor=N.+Yagishitaauthor=T.+Nakajimaauthor=P.+K.+Wongauthor=E.+Chapmanauthor=D.+Fangauthor=D.+D.+Zhang&title=Hrd1+Suppresses+Nrf2-Mediated+Cellular+Protection+During+Liver+Cirrhosis&doi=10.1101%2Fgad.238246.114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1101%2Fgad.238246.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.238246.114%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGao%26aufirst%3DB.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DYagishita%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DP.%2BK.%26aulast%3DChapman%26aufirst%3DE.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DHrd1%2520Suppresses%2520Nrf2-Mediated%2520Cellular%2520Protection%2520During%2520Liver%2520Cirrhosis%26jtitle%3DGenes%2520Dev.%26date%3D2014%26volume%3D28%26spage%3D708%26epage%3D722%26doi%3D10.1101%2Fgad.238246.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niture, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaiswal, A. K.</span></span> <span> </span><span class="NLM_article-title">Regulation of Nrf2-an Update</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2013.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2013.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23434765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkt1Kmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=36-44&author=S.+K.+Nitureauthor=R.+Khatriauthor=A.+K.+Jaiswal&title=Regulation+of+Nrf2-an+Update&doi=10.1016%2Fj.freeradbiomed.2013.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Nrf2 - an update</span></div><div class="casAuthors">Niture, Suryakant K.; Khatri, Raju; Jaiswal, Anil K.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nrf2:INrf2 (Keap1) are cellular sensors of oxidative and electrophilic stress.  Nrf2 is a nuclear factor that controls the expression and coordinated induction of a battery of genes that encode detoxifying enzymes, drug transporters, antiapoptotic proteins, and proteasomes.  In the basal state, Nrf2 is constantly degraded in the cytoplasm by its inhibitor, INrf2.  INrf2 functions as an adapter for Cul3/Rbx1 E3 ubiquitin ligase-mediated degrdn. of Nrf2.  Chems., including antioxidants, tocopherols including α-tocopherol (vitamin E), and phytochems., and radiation antagonize the Nrf2:INrf2 interaction and lead to the stabilization and activation of Nrf2.  The signaling events involve preinduction, induction, and postinduction responses that tightly control Nrf2 activation and repression back to the basal state.  Oxidative/electrophilic signals activate unknown tyrosine kinases in a preinduction response that phosphorylates specific residues on Nrf2 neg. regulators, INrf2, Fyn, and Bach1, leading to their nuclear export, ubiquitination, and degrdn.  This preps. nuclei for unhindered import of Nrf2.  Oxidative/electrophilic modification of INrf2 cysteine 151 followed by PKC phosphorylation of Nrf2 serine 40 in the induction response results in the escape or release of Nrf2 from INrf2.  Nrf2 is thus stabilized and translocates to the nucleus, resulting in a coordinated activation of gene expression.  This is followed by a postinduction response that controls the "switching off" of Nrf2-activated gene expression.  GSK3β, under the control of AKT and PI3K, phosphorylates Fyn, leading to Fyn nuclear localization.  Fyn phosphorylates Nrf2 Y568, resulting in nuclear export and degrdn. of Nrf2.  The activation and repression of Nrf2 provide protection against oxidative/electrophilic stress and assocd. diseases, including cancer.  However, deregulation of INrf2 and Nrf2 due to mutations may lead to nuclear accumulation of Nrf2 that reduces apoptosis and promotes oncogenesis and drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxV9mVbc5P97Vg90H21EOLACvtfcHk0lieClhxC1pZTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkt1Kmtr0%253D&md5=088f5faca63ac2b3dbb09149ff8d3df5</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2013.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2013.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DNiture%26aufirst%3DS.%2BK.%26aulast%3DKhatri%26aufirst%3DR.%26aulast%3DJaiswal%26aufirst%3DA.%2BK.%26atitle%3DRegulation%2520of%2520Nrf2-an%2520Update%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2014%26volume%3D66%26spage%3D36%26epage%3D44%26doi%3D10.1016%2Fj.freeradbiomed.2013.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A. N.</span></span> <span> </span><span class="NLM_article-title">Epigenetic Regulation of Keap1-Nrf2 Signaling</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2015.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26117320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1GrsbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=337-349&author=Y.+Guoauthor=S.+Yuauthor=C.+Zhangauthor=A.+N.+Kong&title=Epigenetic+Regulation+of+Keap1-Nrf2+Signaling&doi=10.1016%2Fj.freeradbiomed.2015.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic regulation of Keap1-Nrf2 signaling</span></div><div class="casAuthors">Guo, Yue; Yu, Siwang; Zhang, Chengyue; Kong, Ah-Ng Tony</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">337-349</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The kelch-like ECH-assocd. protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2) signaling axis serves as a "master regulator" in response to oxidative/electrophilic stresses and chem. insults through the coordinated induction of a wide array of cytoprotective genes.  Therefore, activation of Nrf2 is considered to be an important approach for preventing chronic diseases triggered by stresses and toxins, including cancer.  Despite extensive studies suggested that the Keap1-Nrf2 signaling pathway is subject to multiple layers of regulation at the transcriptional, translational, and post-translational levels, the potential epigenetic regulation of Nrf2 and Keap1 has begun to be recognized only in recent years.  Epigenetic modifications, heritable alterations in gene expression that occur without changes in the primary DNA sequence, have been reported to be profoundly involved in oxidative stress responses.  In this review, we discuss the latest findings regarding the epigenetic regulation of Keap1-Nrf2 signaling by DNA methylation, histone modification, and microRNAs.  The crosstalk among these epigenetic modifications in the regulation of Keap1-Nrf2 signaling pathways is also discussed.  Studies of the epigenetic modification of Nrf2 and Keap1 have not only enhanced our understanding of this complex cellular defense system but have also provided potential new therapeutic targets for the prevention of certain diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMo2o8rEatfrVg90H21EOLACvtfcHk0lj45_Rq7glCqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1GrsbvN&md5=f33b702a4d7d5df682310f36d3671e70</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DA.%2BN.%26atitle%3DEpigenetic%2520Regulation%2520of%2520Keap1-Nrf2%2520Signaling%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D337%26epage%3D349%26doi%3D10.1016%2Fj.freeradbiomed.2015.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olayanju, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">The Nrf2 Cell Defence Pathway: Keap1-Dependent and -Independent Mechanisms of Regulation</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">717</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2012.11.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.bcp.2012.11.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23219527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotF2h" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=705-717&author=H.+K.+Bryanauthor=A.+Olayanjuauthor=C.+E.+Goldringauthor=B.+K.+Park&title=The+Nrf2+Cell+Defence+Pathway%3A+Keap1-Dependent+and+-Independent+Mechanisms+of+Regulation&doi=10.1016%2Fj.bcp.2012.11.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation</span></div><div class="casAuthors">Bryan, Holly K.; Olayanju, Adedamola; Goldring, Christopher E.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">705-717</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The transcription factor Nrf2 (NF-E2-related factor 2) plays a vital role in maintaining cellular homeostasis, esp. upon the exposure of cells to chem. or oxidative stress, through its ability to regulate the basal and inducible expression of a multitude of antioxidant proteins, detoxification enzymes and xenobiotic transporters.  In addn., Nrf2 contributes to diverse cellular functions including differentiation, proliferation, inflammation and lipid synthesis and there is an increasing assocn. of aberrant expression and/or function of Nrf2 with pathologies including cancer, neurodegeneration and cardiovascular disease.  The activity of Nrf2 is primarily regulated via its interaction with Keap1 (Kelch-like ECH-assocd. protein 1), which directs the transcription factor for proteasomal degrdn.  Although it is generally accepted that modification (e.g. chem. adduction, oxidn., nitrosylation or glutathionylation) of one or more crit. cysteine residues in Keap1 represents a likely chemico-biol. trigger for the activation of Nrf2, unequivocal evidence for such a phenomenon remains elusive.  An increasing body of literature has revealed alternative mechanisms of Nrf2 regulation, including phosphorylation of Nrf2 by various protein kinases (PKC, PI3K/Akt, GSK-3β, JNK), interaction with other protein partners (p21, caveolin-1) and epigenetic factors (micro-RNAs -144, -28 and -200a, and promoter methylation).  These and other processes are potentially important determinants of Nrf2 activity, and therefore may contribute to the maintenance of cellular homeostasis.  Here, we dissect evidence supporting these Keap1-dependent and -independent mechanisms of Nrf2 regulation.  Furthermore, we highlight key knowledge gaps in this important field of biol., and suggest how these may be addressed exptl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd0JvmAl5GNLVg90H21EOLACvtfcHk0lj45_Rq7glCqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotF2h&md5=e1b2ded3d46745cd9908655ef35ef962</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.11.016%26sid%3Dliteratum%253Aachs%26aulast%3DBryan%26aufirst%3DH.%2BK.%26aulast%3DOlayanju%26aufirst%3DA.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DThe%2520Nrf2%2520Cell%2520Defence%2520Pathway%253A%2520Keap1-Dependent%2520and%2520-Independent%2520Mechanisms%2520of%2520Regulation%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D705%26epage%3D717%26doi%3D10.1016%2Fj.bcp.2012.11.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span> <span> </span><span class="NLM_article-title">Nrf2 and Cancer: The Good, the Bad and the Importance of Context</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">564</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1038/nrc3278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fnrc3278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22810811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCltLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=564-571&author=M.+B.+Spornauthor=K.+T.+Liby&title=Nrf2+and+Cancer%3A+The+Good%2C+the+Bad+and+the+Importance+of+Context&doi=10.1038%2Fnrc3278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">NRF2 and cancer: the good, the bad and the importance of context</span></div><div class="casAuthors">Sporn, Michael B.; Liby, Karen T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">564-571</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many studies of chemopreventive drugs have suggested that their beneficial effects on suppression of carcinogenesis and many other chronic diseases are mediated through activation of the transcription factor NFE2-related factor 2 (NRF2).  More recently, genetic analyses of human tumors have indicated that NRF2 may conversely be oncogenic and cause resistance to chemotherapy.  It is therefore controversial whether the activation, or alternatively the inhibition, of NRF2 is a useful strategy for the prevention or treatment of cancer.  This Opinion article aims to rationalize these conflicting perspectives by critiquing the context dependence of NRF2 functions and the exptl. methods behind these conflicting data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgPeJ9hoVuW7Vg90H21EOLACvtfcHk0lj45_Rq7glCqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCltLjF&md5=69560f374540df748d28d83a15ae7ed4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnrc3278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3278%26sid%3Dliteratum%253Aachs%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26atitle%3DNrf2%2520and%2520Cancer%253A%2520The%2520Good%252C%2520the%2520Bad%2520and%2520the%2520Importance%2520of%2520Context%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D564%26epage%3D571%26doi%3D10.1038%2Fnrc3278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span> <span> </span><span class="NLM_article-title">The Double-Edged Sword of Nrf2: Subversion of Redox Homeostasis During the Evolution of Cancer</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">732</span>– <span class="NLM_lpage">734</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2006.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.molcel.2006.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=16543142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtVyjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=732-734&author=J.+D.+Hayesauthor=M.+McMahon&title=The+Double-Edged+Sword+of+Nrf2%3A+Subversion+of+Redox+Homeostasis+During+the+Evolution+of+Cancer&doi=10.1016%2Fj.molcel.2006.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The double-edged sword of Nrf2: subversion of redox homeostasis during the evolution of cancer</span></div><div class="casAuthors">Hayes, John D.; McMahon, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">732-734</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with refs.  Low levels of Nrf2 activity predispose cells to chem. carcinogenesis.  Surprisingly, Padmanabhan et al. (2006) provide evidence in a recent issue of Mol. Cell to support the notion that elevated Nrf2 activity may also play a role in the evolution of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzA1PMvMs4ZrVg90H21EOLACvtfcHk0lgONT8DW11AnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtVyjurg%253D&md5=22f24f71da82d2ce7fa2e573e993ed31</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2006.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2006.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DMcMahon%26aufirst%3DM.%26atitle%3DThe%2520Double-Edged%2520Sword%2520of%2520Nrf2%253A%2520Subversion%2520of%2520Redox%2520Homeostasis%2520During%2520the%2520Evolution%2520of%2520Cancer%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D21%26spage%3D732%26epage%3D734%26doi%3D10.1016%2Fj.molcel.2006.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Cancer Chemoprevention Mechanisms Mediated through the Keap1-Nrf2 Pathway</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1713</span>– <span class="NLM_lpage">1748</span>, <span class="refDoi"> DOI: 10.1089/ars.2010.3221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1089%2Fars.2010.3221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20446772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12ltL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1713-1748&author=J.+D.+Hayesauthor=M.+McMahonauthor=S.+Chowdhryauthor=A.+T.+Dinkova-Kostova&title=Cancer+Chemoprevention+Mechanisms+Mediated+through+the+Keap1-Nrf2+Pathway&doi=10.1089%2Fars.2010.3221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Chemoprevention Mechanisms Mediated Through the Keap1-Nrf2 Pathway</span></div><div class="casAuthors">Hayes, John D.; McMahon, Michael; Chowdhry, Sudhir; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1713-1748</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  The cap'n'collar (CNC) bZIP transcription factor Nrf2 controls expression of genes for antioxidant enzymes, metal-binding proteins, drug-metabolising enzymes, drug transporters, and mol. chaperones.  Many chems. that protect against carcinogenesis induce Nrf2-target genes.  These compds. are all thiol-reactive and stimulate an adaptive response to redox stress in cells.  Such agents induce the expression of genes that posses an antioxidant response element (ARE) in their regulatory regions.  Under normal homeostatic conditions, Nrf2 activity is restricted through a Keap1-dependent ubiquitylation by Cul3-Rbx1, which targets the CNC-bZIP transcription factor for proteasomal degrdn.  However, as the substrate adaptor function of Keap1 is redox-sensitive, Nrf2 protein evades ubiquitylation by Cul3-Rbx1 when cells are treated with chemopreventive agents.  As a consequence, Nrf2 accumulates in the nucleus where it heterodimerizes with small Maf proteins and transactivates genes regulated through an ARE.  In this review, we describe synthetic compds. and phytochems. from edible plants that induce Nrf2-target genes.  We also discuss evidence for the existence of different classes of ARE (a 16-bp 5'-TMAnnRTGABnnnGCR-3' vs. an 11-bp 5'-RTGABnnnGCR-3', with or without the embedded activator protein 1-binding site 5'-TGASTCA-3'), species differences in the ARE-gene battery, and the identity of crit. Cys residues in Keap1 required for de-repression of Nrf2 by chemopreventive agents.  Antioxid. Redox Signal. 13, 1713-1748.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLr-kyLU5xNbVg90H21EOLACvtfcHk0lgONT8DW11AnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12ltL7F&md5=a856d5c861ed530241eabb4b343d476a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3221%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DChowdhry%26aufirst%3DS.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DCancer%2520Chemoprevention%2520Mechanisms%2520Mediated%2520through%2520the%2520Keap1-Nrf2%2520Pathway%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2010%26volume%3D13%26spage%3D1713%26epage%3D1748%26doi%3D10.1089%2Fars.2010.3221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saw, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A. N.</span></span> <span> </span><span class="NLM_article-title">Regulation of Nf-E2-Related Factor 2 Signaling for Cancer Chemoprevention: Antioxidant Coupled with Antiinflammatory</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1679</span>– <span class="NLM_lpage">1698</span>, <span class="refDoi"> DOI: 10.1089/ars.2010.3276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1089%2Fars.2010.3276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20486765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12ltL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1679-1698&author=R.+Huauthor=C.+L.+Sawauthor=R.+Yuauthor=A.+N.+Kong&title=Regulation+of+Nf-E2-Related+Factor+2+Signaling+for+Cancer+Chemoprevention%3A+Antioxidant+Coupled+with+Antiinflammatory&doi=10.1089%2Fars.2010.3276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of NF-E2-Related Factor 2 Signaling for Cancer Chemoprevention: Antioxidant Coupled with Antiinflammatory</span></div><div class="casAuthors">Hu, Rong; Saw, Constance Lay-Lay; Yu, Rong; Kong, Ah-Ng Tony</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1679-1698</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Cancer chemoprevention is a process of using either natural or synthetic compds. to reduce the risk of developing cancer.  Observations that NF-E2-related factor 2 (Nrf2)-deficient mice lack response to some chemopreventive agents point to the important role of Nrf2 in chemoprevention.  Nrf2 is a member of basic-leucine zipper transcription factor family and has been shown to regulate gene expression by binding to a response element, antioxidant responsive element.  It is generally believed that activation of Nrf2 signaling is an adaptive response to the environmental and endogenous stresses.  Under homeostatic conditions, Nrf2 is suppressed by assocn. with Kelch-like ECH-assocd. protein 1 (Keap1), but is stimulated upon exposure to oxidative or electrophilic stress.  Once activated, Nrf2 translocates into nuclei and upregulates a group of genes that act in concert to combat oxidative stress.  Nrf2 is also shown to have protective function against inflammation, a pathol. process that could contribute to carcinogenesis.  In this review, we will discuss the current progress in the study of Nrf2 signaling, in particular, the mechanisms of Nrf2 activation by chemopreventive agents.  We will also discuss some of the potential caveats of Nrf2 in cancer treatment and future opportunity and challenges on regulation of Nrf2-mediated antioxidant and antiinflammatory signaling in the context of cancer prevention.  Antioxid. Redox Signal. 13, 1679-1698.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4FCMMKNcZKrVg90H21EOLACvtfcHk0lgONT8DW11AnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12ltL7O&md5=79e349ba62d1b0c849111cd50aa5987d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3276%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DR.%26aulast%3DSaw%26aufirst%3DC.%2BL.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DKong%26aufirst%3DA.%2BN.%26atitle%3DRegulation%2520of%2520Nf-E2-Related%2520Factor%25202%2520Signaling%2520for%2520Cancer%2520Chemoprevention%253A%2520Antioxidant%2520Coupled%2520with%2520Antiinflammatory%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2010%26volume%3D13%26spage%3D1679%26epage%3D1698%26doi%3D10.1089%2Fars.2010.3276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaramillo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">The Emerging Role of the Nrf2-Keap1 Signaling Pathway in Cancer</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2179</span>– <span class="NLM_lpage">2191</span>, <span class="refDoi"> DOI: 10.1101/gad.225680.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1101%2Fgad.225680.113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24142871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCjt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=2179-2191&author=M.+C.+Jaramilloauthor=D.+D.+Zhang&title=The+Emerging+Role+of+the+Nrf2-Keap1+Signaling+Pathway+in+Cancer&doi=10.1101%2Fgad.225680.113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging role of the Nrf2-Keap1 signaling pathway in cancer</span></div><div class="casAuthors">Jaramillo, Melba C.; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2179-2191</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  The Nrf2 (nuclear factor erythroid 2 [NF-E2]-related factor 2 [Nrf2])-Keap1 (Kelch-like erythroid cell-derived protein with CNC homol. [ECH]-assocd. protein 1) signaling pathway is one of the most important cell defense and survival pathways.  Nrf2 can protect cells and tissues from a variety of toxicants and carcinogens by increasing the expression of a no. of cytoprotective genes.  As a result, several Nrf2 activators are currently being tested as chemopreventive compds. in clin. trials.  Just as Nrf2 protects normal cells, studies have shown that Nrf2 may also protect cancer cells from chemotherapeutic agents and facilitate cancer progression.  Nrf2 is aberrantly accumulated in many types of cancer, and its expression is assocd. with a poor prognosis in patients.  In addn., Nrf2 expression is induced during the course of drug resistance.  Collectively, these studies suggest that Nrf2 contributes to both intrinsic and acquired chemoresistance.  This discovery has opened up a broad spectrum of research geared toward a better understanding of the role of Nrf2 in cancer.  This review provides an overview of (1) the Nrf2-Keap1 signaling pathway, (2) the dual role of Nrf2 in cancer, (3) the mol. basis of Nrf2 activation in cancer cells, and (4) the challenges in the development of Nrf2-based drugs for chemoprevention and chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7t_-Ngp_Zp7Vg90H21EOLACvtfcHk0li5g0GolHJsug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCjt7zN&md5=c2014cd362b1f5043b737b78fbb56a28</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1101%2Fgad.225680.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.225680.113%26sid%3Dliteratum%253Aachs%26aulast%3DJaramillo%26aufirst%3DM.%2BC.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DThe%2520Emerging%2520Role%2520of%2520the%2520Nrf2-Keap1%2520Signaling%2520Pathway%2520in%2520Cancer%26jtitle%3DGenes%2520Dev.%26date%3D2013%26volume%3D27%26spage%3D2179%26epage%3D2191%26doi%3D10.1101%2Fgad.225680.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tominaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuuchi, Y.</span></span> <span> </span><span class="NLM_article-title">Orally Active, Nonpeptide Vasopressin V2 Receptor Antagonists: A Novel Series of 1-[4-(Benzoylamino)Benzoyl]-2,3,4,5-Tetrahydro-1h-Benzazepines and Related Compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">3547</span>– <span class="NLM_lpage">3555</span>, <span class="refDoi"> DOI: 10.1021/jm960133o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960133o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=3547-3555&author=H.+Ogawaauthor=H.+Yamashitaauthor=K.+Kondoauthor=Y.+Yamamuraauthor=H.+Miyamotoauthor=K.+Kanauthor=K.+Kitanoauthor=M.+Tanakaauthor=K.+Nakayaauthor=S.+Nakamuraauthor=T.+Moriauthor=M.+Tominagaauthor=Y.+Yabuuchi&title=Orally+Active%2C+Nonpeptide+Vasopressin+V2+Receptor+Antagonists%3A+A+Novel+Series+of+1-%5B4-%28Benzoylamino%29Benzoyl%5D-2%2C3%2C4%2C5-Tetrahydro-1h-Benzazepines+and+Related+Compounds&doi=10.1021%2Fjm960133o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm960133o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960133o%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DYamashita%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DYamamura%26aufirst%3DY.%26aulast%3DMiyamoto%26aufirst%3DH.%26aulast%3DKan%26aufirst%3DK.%26aulast%3DKitano%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DNakaya%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DM.%26aulast%3DYabuuchi%26aufirst%3DY.%26atitle%3DOrally%2520Active%252C%2520Nonpeptide%2520Vasopressin%2520V2%2520Receptor%2520Antagonists%253A%2520A%2520Novel%2520Series%2520of%25201-%255B4-%2528Benzoylamino%2529Benzoyl%255D-2%252C3%252C4%252C5-Tetrahydro-1h-Benzazepines%2520and%2520Related%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D3547%26epage%3D3555%26doi%3D10.1021%2Fjm960133o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">The Nrf2-Keap1-Are Signaling Pathway: The Regulation and Dual Function of Nrf2 in Cancer</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1623</span>– <span class="NLM_lpage">1626</span>, <span class="refDoi"> DOI: 10.1089/ars.2010.3301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1089%2Fars.2010.3301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20486759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12ltL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1623-1626&author=D.+D.+Zhang&title=The+Nrf2-Keap1-Are+Signaling+Pathway%3A+The+Regulation+and+Dual+Function+of+Nrf2+in+Cancer&doi=10.1089%2Fars.2010.3301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The Nrf2-Keap1-ARE Signaling Pathway: The Regulation and Dual Function of Nrf2 in Cancer</span></div><div class="casAuthors">Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1623-1626</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  The NF-E2-related factor-2 (Nrf2) is a transcription factor that is ubiquitously expressed at low levels in all human organs.  As Nrf2 regulates a major cellular defense mechanism, tight regulation is crucial to maintain cellular homeostasis.  Activation of this pathway is important in preventing human diseases, such as cancer, neurodegenerative disease, cardiovascular diseases, ischemia, diabetes, pulmonary fibrosis, and inflammatory diseases.  Conversely, high constitutive levels of Nrf2 occur in many tumors or cancer cell lines.  Moreover, overexpression of Nrf2 in cancer cells protects them from the cytotoxic effects of anticancer therapies, resulting in chemo- and/or radioresistance.  Therefore, understanding Nrf2 regulation and identifying Nrf2 activators or inhibitors for disease prevention or as sensitizing agents during cancer therapy, resp., will have a significant impact on human health.  The growing interest in Nrf2 is reflected by an exponentially increasing no. of annual publications on this topic.  The present forum provides a comprehensive review on research conducted since the initial discovery of the Nrf2-Keap1 pathway in 1999, provides readers with insight into contemporary research in this field, and assesses current known biol. functions of this pathway.  Addnl., the forum will serve as an important resource for both graduate students and active researchers who are interested in the Nrf2 field.  Antioxid. Redox Signal. 13, 1623-1626.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxvgS4h_TXi7Vg90H21EOLACvtfcHk0li5g0GolHJsug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12ltL%252FP&md5=472c520fae20181c099ead28dc717e08</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3301%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DThe%2520Nrf2-Keap1-Are%2520Signaling%2520Pathway%253A%2520The%2520Regulation%2520and%2520Dual%2520Function%2520of%2520Nrf2%2520in%2520Cancer%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2010%26volume%3D13%26spage%3D1623%26epage%3D1626%26doi%3D10.1089%2Fars.2010.3301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rojo
de la Vega, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Nrf2 and the Hallmarks of Cancer</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2018.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.ccell.2018.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29731393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVyjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=21-43&author=M.+Rojo%0Ade+la+Vegaauthor=E.+Chapmanauthor=D.+D.+Zhang&title=Nrf2+and+the+Hallmarks+of+Cancer&doi=10.1016%2Fj.ccell.2018.03.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">NRF2 and the Hallmarks of Cancer</span></div><div class="casAuthors">Rojo de la Vega, Montserrat; Chapman, Eli; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-43</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The transcription factor NRF2 is the master regulator of the cellular antioxidant response.  Though recognized originally as a target of chemopreventive compds. that help prevent cancer and other maladies, accumulating evidence has established the NRF2 pathway as a driver of cancer progression, metastasis, and resistance to therapy.  Recent studies have identified new functions for NRF2 in the regulation of metab. and other essential cellular functions, establishing NRF2 as a truly pleiotropic transcription factor.  In this review, we explore the roles of NRF2 in the hallmarks of cancer, indicating both tumor suppressive and tumor-promoting effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsJ68CxevHh7Vg90H21EOLACvtfcHk0li5g0GolHJsug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVyjurs%253D&md5=17d4dde3000868c9e147915de1cc0b53</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2018.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2018.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DRojo%2Bde%2Bla%2BVega%26aufirst%3DM.%26aulast%3DChapman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DNrf2%2520and%2520the%2520Hallmarks%2520of%2520Cancer%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D34%26spage%3D21%26epage%3D43%26doi%3D10.1016%2Fj.ccell.2018.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Best, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Souza, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kersbergen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Policheni, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayalan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tull, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConville, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, K. D.</span></span> <span> </span><span class="NLM_article-title">Synergy between the Keap1/Nrf2 and Pi3k Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">943</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2018.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.cmet.2018.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29526543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlSgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=935-943&author=S.+A.+Bestauthor=D.+P.+De+Souzaauthor=A.+Kersbergenauthor=A.+N.+Policheniauthor=S.+Dayalanauthor=D.+Tullauthor=V.+Rathiauthor=D.+H.+Grayauthor=M.+E.+Ritchieauthor=M.+J.+McConvilleauthor=K.+D.+Sutherland&title=Synergy+between+the+Keap1%2FNrf2+and+Pi3k+Pathways+Drives+Non-Small-Cell+Lung+Cancer+with+an+Altered+Immune+Microenvironment&doi=10.1016%2Fj.cmet.2018.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment</span></div><div class="casAuthors">Best, Sarah A.; De Souza, David P.; Kersbergen, Ariena; Policheni, Antonia N.; Dayalan, Saravanan; Tull, Dedreia; Rathi, Vivek; Gray, Daniel H.; Ritchie, Matthew E.; McConville, Malcolm J.; Sutherland, Kate D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">935-943.e4</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The lung presents a highly oxidative environment, which is tolerated through engagement of tightly controlled stress response pathways.  A crit. stress response mediator is the transcription factor nuclear factor erythroid-2-related factor 2 (NFE2L2/NRF2), which is neg. regulated by Kelch-like ECH-assocd. protein 1 (KEAP1).  Alterations in the KEAP1/NRF2 pathway have been identified in 23% of lung adenocarcinomas, suggesting that deregulation of the pathway is a major cancer driver.  We demonstrate that inactivation of Keap1 and Pten in the mouse lung promotes adenocarcinoma formation.  Notably, metabolites identified in the plasma of Keap1f/f/Ptenf/f tumor-bearing mice indicate that tumorigenesis is assocd. with reprogramming of the pentose phosphate pathway.  Furthermore, the immune milieu was dramatically changed by Keap1 and Pten deletion, and tumor regression was achieved utilizing immune checkpoint inhibition.  Thus, our study highlights the ability to exploit both metabolic and immune characteristics in the detection and treatment of lung tumors harboring KEAP1/NRF2 pathway alterations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNMt_ih1lYf7Vg90H21EOLACvtfcHk0lji0NARF9-cSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlSgt7c%253D&md5=33a8c497917a047fa325db351975fc5d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2018.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2018.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DBest%26aufirst%3DS.%2BA.%26aulast%3DDe%2BSouza%26aufirst%3DD.%2BP.%26aulast%3DKersbergen%26aufirst%3DA.%26aulast%3DPolicheni%26aufirst%3DA.%2BN.%26aulast%3DDayalan%26aufirst%3DS.%26aulast%3DTull%26aufirst%3DD.%26aulast%3DRathi%26aufirst%3DV.%26aulast%3DGray%26aufirst%3DD.%2BH.%26aulast%3DRitchie%26aufirst%3DM.%2BE.%26aulast%3DMcConville%26aufirst%3DM.%2BJ.%26aulast%3DSutherland%26aufirst%3DK.%2BD.%26atitle%3DSynergy%2520between%2520the%2520Keap1%252FNrf2%2520and%2520Pi3k%2520Pathways%2520Drives%2520Non-Small-Cell%2520Lung%2520Cancer%2520with%2520an%2520Altered%2520Immune%2520Microenvironment%26jtitle%3DCell%2520Metab.%26date%3D2018%26volume%3D27%26spage%3D935%26epage%3D943%26doi%3D10.1016%2Fj.cmet.2018.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeNicola, G.</span></span> <span> </span><span class="NLM_article-title">The Regulation of Nrf2 by Nutrient Responsive Signaling and Its Role in Anabolic Cancer Metabolism</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1774</span>, <span class="refDoi"> DOI: 10.1089/ars.2017.7356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1089%2Fars.2017.7356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28899208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVSisbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=1774&author=S.+B.+Leeauthor=B.+Sellersauthor=G.+DeNicola&title=The+Regulation+of+Nrf2+by+Nutrient+Responsive+Signaling+and+Its+Role+in+Anabolic+Cancer+Metabolism&doi=10.1089%2Fars.2017.7356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The Regulation of NRF2 by Nutrient-Responsive Signaling and Its Role in Anabolic Cancer Metabolism</span></div><div class="casAuthors">Lee, Sae Bom; Sellers, Brianna N.; DeNicola, Gina M.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1774-1791</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Significance: The stress responsive transcription factor nuclear factor erythroid 2 p45-related factor 2, or NRF2, regulates the expression of many cytoprotective enzymes to mitigate oxidative stress under physiol. conditions.  NRF2 is activated in response to oxidative stress, growth factor signaling, and changes in nutrient status.  In addn., somatic mutations that disrupt the interaction between NRF2 and its neg. regulator Kelch-like erythroid cell-derived protein with CNC homol. (ECH)-assocd. 1 (KEAP1) commonly occur in cancer and are thought to promote tumorigenesis.  Recent Advances: While it is well established that aberrant NRF2 activation results in enhanced antioxidant capacity in cancer cells, recent exciting findings demonstrate a role for NRF2-mediated metabolic deregulation that supports cancer cell proliferation.  Crit. Issues: In this review, we describe how the NRF2-KEAP1 signaling pathway is altered in cancer, how NRF2 is regulated by changes in cellular metab., and how NRF2 reprograms cellular metab. to support proliferation.  Future Directions: Future studies will delineate the NRF2-regulated processes crit. for metabolic adaptation to nutrient availability, cellular proliferation, and tumorigenesis.  Antioxid. Redox Signal. 00, 000-000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4b0nVTquVDbVg90H21EOLACvtfcHk0lji0NARF9-cSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVSisbrO&md5=be1a7355dc90dd46fe48443dde1e45a7</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1089%2Fars.2017.7356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2017.7356%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BB.%26aulast%3DSellers%26aufirst%3DB.%26aulast%3DDeNicola%26aufirst%3DG.%26atitle%3DThe%2520Regulation%2520of%2520Nrf2%2520by%2520Nutrient%2520Responsive%2520Signaling%2520and%2520Its%2520Role%2520in%2520Anabolic%2520Cancer%2520Metabolism%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2018%26volume%3D29%26spage%3D1774%26doi%3D10.1089%2Fars.2017.7356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasti, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span> <span> </span><span class="NLM_article-title">Glutamine and Cancer: Cell Biology, Physiology, and Clinical Opportunities</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">3678</span>– <span class="NLM_lpage">3684</span>, <span class="refDoi"> DOI: 10.1172/JCI69600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1172%2FJCI69600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23999442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVenu7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=3678-3684&author=C.+T.+Hensleyauthor=A.+T.+Wastiauthor=R.+J.+DeBerardinis&title=Glutamine+and+Cancer%3A+Cell+Biology%2C+Physiology%2C+and+Clinical+Opportunities&doi=10.1172%2FJCI69600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamine and cancer: cell biology, physiology, and clinical opportunities</span></div><div class="casAuthors">Hensley, Christopher T.; Wasti, Ajla T.; DeBerardinis, Ralph J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3678-3684</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Glutamine is an abundant and versatile nutrient that participates in energy formation, redox homeostasis, macromol. synthesis, and signaling in cancer cells.  These characteristics make glutamine metab. an appealing target for new clin. strategies to detect, monitor, and treat cancer.  Here the authors review the metabolic functions of glutamine as a super nutrient and the surprising roles of glutamine in supporting the biol. hallmarks of malignancy.  The authors also review recent efforts in imaging and therapeutics to exploit tumor cell glutamine dependence, discuss some of the challenges in this arena, and suggest a disease-focused paradigm to deploy these emerging approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocNnK_GlTtRrVg90H21EOLACvtfcHk0lji0NARF9-cSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVenu7bL&md5=fb704a7773710a20add6edbf0da08616</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1172%2FJCI69600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI69600%26sid%3Dliteratum%253Aachs%26aulast%3DHensley%26aufirst%3DC.%2BT.%26aulast%3DWasti%26aufirst%3DA.%2BT.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26atitle%3DGlutamine%2520and%2520Cancer%253A%2520Cell%2520Biology%252C%2520Physiology%252C%2520and%2520Clinical%2520Opportunities%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D3678%26epage%3D3684%26doi%3D10.1172%2FJCI69600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Son, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssiotis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ying, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligorio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrone, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullarky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyh-Chang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardeesy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haigis, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePinho, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmelman, A. C.</span></span> <span> </span><span class="NLM_article-title">Glutamine Supports Pancreatic Cancer Growth through a Kras-Regulated Metabolic Pathway</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>496</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1038/nature12040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fnature12040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23535601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=496&publication_year=2013&pages=101-105&author=J.+Sonauthor=C.+A.+Lyssiotisauthor=H.+Yingauthor=X.+Wangauthor=S.+Huaauthor=M.+Ligorioauthor=R.+M.+Pereraauthor=C.+R.+Ferroneauthor=E.+Mullarkyauthor=N.+Shyh-Changauthor=Y.+Kangauthor=J.+B.+Flemingauthor=N.+Bardeesyauthor=J.+M.+Asaraauthor=M.+C.+Haigisauthor=R.+A.+DePinhoauthor=L.+C.+Cantleyauthor=A.+C.+Kimmelman&title=Glutamine+Supports+Pancreatic+Cancer+Growth+through+a+Kras-Regulated+Metabolic+Pathway&doi=10.1038%2Fnature12040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway</span></div><div class="casAuthors">Son, Jaekyoung; Lyssiotis, Costas A.; Ying, Haoqiang; Wang, Xiaoxu; Hua, Sujun; Ligorio, Matteo; Perera, Rushika M.; Ferrone, Cristina R.; Mullarky, Edouard; Ng, Shyh-Chang; Kang, Ya'an; Fleming, Jason B.; Bardeesy, Nabeel; Asara, John M.; Haigis, Marcia C.; DePinho, Ronald A.; Cantley, Lewis C.; Kimmelman, Alec C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">496</span>
        (<span class="NLM_cas:issue">7443</span>),
    <span class="NLM_cas:pages">101-105</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cancer cells have metabolic dependencies that distinguish them from their normal counterparts.  Among these dependencies is an increased use of the amino acid glutamine to fuel anabolic processes.  Indeed, the spectrum of glutamine-dependent tumors and the mechanisms whereby glutamine supports cancer metab. remain areas of active investigation.  Here we report the identification of a non-canonical pathway of glutamine use in human pancreatic ductal adenocarcinoma (PDAC) cells that is required for tumor growth.  Whereas most cells use glutamate dehydrogenase (GLUD1) to convert glutamine-derived glutamate into α-ketoglutarate in the mitochondria to fuel the tricarboxylic acid cycle, PDAC relies on a distinct pathway in which glutamine-derived aspartate is transported into the cytoplasm where it can be converted into oxaloacetate by aspartate transaminase (GOT1).  Subsequently, this oxaloacetate is converted into malate and then pyruvate, ostensibly increasing the NADPH/NADP+ ratio which can potentially maintain the cellular redox state.  Importantly, PDAC cells are strongly dependent on this series of reactions, as glutamine deprivation or genetic inhibition of any enzyme in this pathway leads to an increase in reactive oxygen species and a redn. in reduced glutathione.  Moreover, knockdown of any component enzyme in this series of reactions also results in a pronounced suppression of PDAC growth in vitro and in vivo.  Furthermore, we establish that the reprogramming of glutamine metab. is mediated by oncogenic KRAS, the signature genetic alteration in PDAC, through the transcriptional upregulation and repression of key metabolic enzymes in this pathway.  The essentiality of this pathway in PDAC and the fact that it is dispensable in normal cells may provide novel therapeutic approaches to treat these refractory tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzWAEWZvCWcbVg90H21EOLACvtfcHk0lhjS32qU3sFoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrc%253D&md5=162af18c1102745226aa2096179f1cc6</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnature12040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12040%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DJ.%26aulast%3DLyssiotis%26aufirst%3DC.%2BA.%26aulast%3DYing%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DLigorio%26aufirst%3DM.%26aulast%3DPerera%26aufirst%3DR.%2BM.%26aulast%3DFerrone%26aufirst%3DC.%2BR.%26aulast%3DMullarky%26aufirst%3DE.%26aulast%3DShyh-Chang%26aufirst%3DN.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DFleming%26aufirst%3DJ.%2BB.%26aulast%3DBardeesy%26aufirst%3DN.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DHaigis%26aufirst%3DM.%2BC.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26atitle%3DGlutamine%2520Supports%2520Pancreatic%2520Cancer%2520Growth%2520through%2520a%2520Kras-Regulated%2520Metabolic%2520Pathway%26jtitle%3DNature%26date%3D2013%26volume%3D496%26spage%3D101%26epage%3D105%26doi%3D10.1038%2Fnature12040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayin, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeBoeuf, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakousi, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhutkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Rivera, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbaraj, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prigge, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goparaju, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolgalev, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heguy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allaj, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander
Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papagiannakopoulos, T.</span></span> <span> </span><span class="NLM_article-title">Keap1 Loss Promotes Kras-Driven Lung Cancer and Results in Dependence on Glutaminolysis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1362</span>– <span class="NLM_lpage">1368</span>, <span class="refDoi"> DOI: 10.1038/nm.4407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fnm.4407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28967920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFylurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=1362-1368&author=R.+Romeroauthor=V.+I.+Sayinauthor=S.+M.+Davidsonauthor=M.+R.+Bauerauthor=S.+X.+Singhauthor=S.+E.+LeBoeufauthor=T.+R.+Karakousiauthor=D.+C.+Ellisauthor=A.+Bhutkarauthor=F.+J.+Sanchez-Riveraauthor=L.+Subbarajauthor=B.+Martinezauthor=R.+T.+Bronsonauthor=J.+R.+Priggeauthor=E.+E.+Schmidtauthor=C.+J.+Thomasauthor=C.+Goparajuauthor=A.+Daviesauthor=I.+Dolgalevauthor=A.+Heguyauthor=V.+Allajauthor=J.+T.+Poirierauthor=A.+L.+Moreiraauthor=C.+M.+Rudinauthor=H.+I.+Passauthor=M.+G.+Vander%0AHeidenauthor=T.+Jacksauthor=T.+Papagiannakopoulos&title=Keap1+Loss+Promotes+Kras-Driven+Lung+Cancer+and+Results+in+Dependence+on+Glutaminolysis&doi=10.1038%2Fnm.4407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis</span></div><div class="casAuthors">Romero, Rodrigo; Sayin, Volkan I.; Davidson, Shawn M.; Bauer, Matthew R.; Singh, Simranjit X.; Le Boeuf, Sarah E.; Karakousi, Triantafyllia R.; Ellis, Donald C.; Bhutkar, Arjun; Sanchez-Rivera, Francisco J.; Subbaraj, Lakshmipriya; Martinez, Britney; Bronson, Roderick T.; Prigge, Justin R.; Schmidt, Edward E.; Thomas, Craig J.; Goparaju, Chandra; Davies, Angela; Dolgalev, Igor; Heguy, Adriana; Allaj, Viola; Poirier, John T.; Moreira, Andre L.; Rudin, Charles M.; Pass, Harvey I.; Vander Heiden, Matthew G.; Jacks, Tyler; Papagiannakopoulos, Thales</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1362-1368</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Treating KRAS-mutant lung adenocarcinoma (LUAD) remains a major challenge in cancer treatment given the difficulties assocd. with directly inhibiting the KRAS oncoprotein.  One approach to addressing this challenge is to define mutations that frequently co-occur with those in KRAS, which themselves may lead to therapeutic vulnerabilities in tumors.  Approx. 20% of KRAS-mutant LUAD tumors carry loss-of-function mutations in the KEAP1 gene encoding Kelch-like ECH-assocd. protein 1 (refs. 2, 3, 4), a neg. regulator of nuclear factor erythroid 2-like 2 (NFE2L2; hereafter NRF2), which is the master transcriptional regulator of the endogenous antioxidant response.  The high frequency of mutations in KEAP1 suggests an important role for the oxidative stress response in lung tumorigenesis.  Using a CRISPR-Cas9-based approach in a mouse model of KRAS-driven LUAD, we examd. the effects of Keap1 loss in lung cancer progression.  We show that loss of Keap1 hyperactivates NRF2 and promotes KRAS-driven LUAD in mice.  Through a combination of CRISPR-Cas9-based genetic screening and metabolomic analyses, we show that Keap1- or Nrf2-mutant cancers are dependent on increased glutaminolysis, and this property can be therapeutically exploited through the pharmacol. inhibition of glutaminase.  Finally, we provide a rationale for stratification of human patients with lung cancer harboring KRAS/KEAP1- or KRAS/NRF2-mutant lung tumors as likely to respond to glutaminase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofWgHF0gdsW7Vg90H21EOLACvtfcHk0lhjS32qU3sFoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFylurrK&md5=2bc4122a4c757cc3a5fdab3eb62b26e3</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnm.4407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4407%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DR.%26aulast%3DSayin%26aufirst%3DV.%2BI.%26aulast%3DDavidson%26aufirst%3DS.%2BM.%26aulast%3DBauer%26aufirst%3DM.%2BR.%26aulast%3DSingh%26aufirst%3DS.%2BX.%26aulast%3DLeBoeuf%26aufirst%3DS.%2BE.%26aulast%3DKarakousi%26aufirst%3DT.%2BR.%26aulast%3DEllis%26aufirst%3DD.%2BC.%26aulast%3DBhutkar%26aufirst%3DA.%26aulast%3DSanchez-Rivera%26aufirst%3DF.%2BJ.%26aulast%3DSubbaraj%26aufirst%3DL.%26aulast%3DMartinez%26aufirst%3DB.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DPrigge%26aufirst%3DJ.%2BR.%26aulast%3DSchmidt%26aufirst%3DE.%2BE.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DGoparaju%26aufirst%3DC.%26aulast%3DDavies%26aufirst%3DA.%26aulast%3DDolgalev%26aufirst%3DI.%26aulast%3DHeguy%26aufirst%3DA.%26aulast%3DAllaj%26aufirst%3DV.%26aulast%3DPoirier%26aufirst%3DJ.%2BT.%26aulast%3DMoreira%26aufirst%3DA.%2BL.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DPass%26aufirst%3DH.%2BI.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DPapagiannakopoulos%26aufirst%3DT.%26atitle%3DKeap1%2520Loss%2520Promotes%2520Kras-Driven%2520Lung%2520Cancer%2520and%2520Results%2520in%2520Dependence%2520on%2520Glutaminolysis%26jtitle%3DNat.%2520Med.%26date%3D2017%26volume%3D23%26spage%3D1362%26epage%3D1368%26doi%3D10.1038%2Fnm.4407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeNicola, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullarky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudderth, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wistuba,  II</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Regulates Serine Biosynthesis in Non-Small Cell Lung Cancer</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1475</span>– <span class="NLM_lpage">1481</span>, <span class="refDoi"> DOI: 10.1038/ng.3421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fng.3421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26482881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslant7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2015&pages=1475-1481&author=G.+M.+DeNicolaauthor=P.+H.+Chenauthor=E.+Mullarkyauthor=J.+A.+Sudderthauthor=Z.+Huauthor=D.+Wuauthor=H.+Tangauthor=Y.+Xieauthor=J.+M.+Asaraauthor=K.+E.+Huffmanauthor=+Wistubaauthor=J.+D.+Minnaauthor=R.+J.+DeBerardinisauthor=L.+C.+Cantley&title=Nrf2+Regulates+Serine+Biosynthesis+in+Non-Small+Cell+Lung+Cancer&doi=10.1038%2Fng.3421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">NRF2 regulates serine biosynthesis in non-small cell lung cancer</span></div><div class="casAuthors">DeNicola, Gina M.; Chen, Pei-Hsuan; Mullarky, Edouard; Sudderth, Jessica A.; Hu, Zeping; Wu, David; Tang, Hao; Xie, Yang; Asara, John M.; Huffman, Kenneth E.; Wistuba, Ignacio I.; Minna, John D.; DeBerardinis, Ralph J.; Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1475-1481</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumors have high energetic and anabolic needs for rapid cell growth and proliferation, and the serine biosynthetic pathway was recently identified as an important source of metabolic intermediates for these processes.  We integrated metabolic tracing and transcriptional profiling of a large panel of non-small cell lung cancer (NSCLC) cell lines to characterize the activity and regulation of the serine/glycine biosynthetic pathway in NSCLC.  Here we show that the activity of this pathway is highly heterogeneous and is regulated by NRF2, a transcription factor frequently deregulated in NSCLC.  We found that NRF2 controls the expression of the key serine/glycine biosynthesis enzyme genes PHGDH, PSAT1 and SHMT2 via ATF4 to support glutathione and nucleotide prodn.  Moreover, we show that expression of these genes confers poor prognosis in human NSCLC.  Thus, a substantial fraction of human NSCLCs activates an NRF2-dependent transcriptional program that regulates serine and glycine metab. and is linked to clin. aggressiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSELAUW2hlmbVg90H21EOLACvtfcHk0lhjS32qU3sFoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslant7bO&md5=41d411b051f2e26da358c949585c0c5d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fng.3421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.3421%26sid%3Dliteratum%253Aachs%26aulast%3DDeNicola%26aufirst%3DG.%2BM.%26aulast%3DChen%26aufirst%3DP.%2BH.%26aulast%3DMullarky%26aufirst%3DE.%26aulast%3DSudderth%26aufirst%3DJ.%2BA.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DHuffman%26aufirst%3DK.%2BE.%26aulast%3DWistuba%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DNrf2%2520Regulates%2520Serine%2520Biosynthesis%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DNat.%2520Genet.%26date%3D2015%26volume%3D47%26spage%3D1475%26epage%3D1481%26doi%3D10.1038%2Fng.3421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gwinn, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briones-Martin-Del-Campo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweet-Cordero, E. A.</span></span> <span> </span><span class="NLM_article-title">Oncogenic Kras Regulates Amino Acid Homeostasis and Asparagine Biosynthesis Via Atf4 and Alters Sensitivity to L-Asparaginase</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2017.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.ccell.2017.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29316436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVejtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=91-107&author=D.+M.+Gwinnauthor=A.+G.+Leeauthor=M.+Briones-Martin-Del-Campoauthor=C.+S.+Connauthor=D.+R.+Simpsonauthor=A.+I.+Scottauthor=A.+Leauthor=T.+M.+Cowanauthor=D.+Ruggeroauthor=E.+A.+Sweet-Cordero&title=Oncogenic+Kras+Regulates+Amino+Acid+Homeostasis+and+Asparagine+Biosynthesis+Via+Atf4+and+Alters+Sensitivity+to+L-Asparaginase&doi=10.1016%2Fj.ccell.2017.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase</span></div><div class="casAuthors">Gwinn, Dana M.; Lee, Alex G.; Briones-Martin-del-Campo, Marcela; Conn, Crystal S.; Simpson, David R.; Scott, Anna I.; Le, Anthony; Cowan, Tina M.; Ruggero, Davide; Sweet-Cordero, E. Alejandro</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-107.e6</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">KRAS is a regulator of the nutrient stress response in non-small-cell lung cancer (NSCLC).  Induction of the ATF4 pathway during nutrient depletion requires AKT and NRF2 downstream of KRAS.  The tumor suppressor KEAP1 strongly influences the outcome of activation of this pathway during nutrient stress; loss of KEAP1 in KRAS mutant cells leads to apoptosis.  Through ATF4 regulation, KRAS alters amino acid uptake and asparagine biosynthesis.  The ATF4 target asparagine synthetase (ASNS) contributes to apoptotic suppression, protein biosynthesis, and mTORC1 activation.  Inhibition of AKT suppressed ASNS expression and, combined with depletion of extracellular asparagine, decreased tumor growth.  Therefore, KRAS is important for the cellular response to nutrient stress, and ASNS represents a promising therapeutic target in KRAS mutant NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1mgWB2XSqarVg90H21EOLACvtfcHk0ljHji50ga6pYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVejtA%253D%253D&md5=6a2265856fc1948a0743e75f8b5955e6</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2017.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2017.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DGwinn%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DA.%2BG.%26aulast%3DBriones-Martin-Del-Campo%26aufirst%3DM.%26aulast%3DConn%26aufirst%3DC.%2BS.%26aulast%3DSimpson%26aufirst%3DD.%2BR.%26aulast%3DScott%26aufirst%3DA.%2BI.%26aulast%3DLe%26aufirst%3DA.%26aulast%3DCowan%26aufirst%3DT.%2BM.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DSweet-Cordero%26aufirst%3DE.%2BA.%26atitle%3DOncogenic%2520Kras%2520Regulates%2520Amino%2520Acid%2520Homeostasis%2520and%2520Asparagine%2520Biosynthesis%2520Via%2520Atf4%2520and%2520Alters%2520Sensitivity%2520to%2520L-Asparaginase%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D33%26spage%3D91%26epage%3D107%26doi%3D10.1016%2Fj.ccell.2017.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornsveld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dansen, T. B.</span></span> <span> </span><span class="NLM_article-title">The Hallmarks of Cancer from a Redox Perspective</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1089/ars.2015.6580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1089%2Fars.2015.6580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27353526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlehsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=300-325&author=M.+Hornsveldauthor=T.+B.+Dansen&title=The+Hallmarks+of+Cancer+from+a+Redox+Perspective&doi=10.1089%2Fars.2015.6580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The Hallmarks of Cancer from a Redox Perspective</span></div><div class="casAuthors">Hornsveld, Marten; Dansen, Tobias B.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">300-325</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Significance: For a healthy cell to turn into a cancer cell and grow out to become a tumor, it needs to undergo a series of complex changes and acquire certain traits, summarized as "The Hallmarks of Cancer.  " These hallmarks can all be regarded as the result of altered signal transduction cascades and an understanding of these cascades is essential for cancer treatment.  Recent Advances: Redox signaling is a long overlooked form of signal transduction that proceeds through the reversible oxidn. of cysteines in proteins and that uses hydrogen peroxide as a second messenger.  Crit. Issues: In this article, we provide examples that show that redox signaling is involved in the regulation of proteins and signaling cascades that play roles in every hallmark of cancer.  Future Directions: An understanding of how redox signaling and "classical" signal transduction are intertwined could hold promising strategies for cancer therapy in the future.  Antioxid. Redox Signal. 25, 300-325.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg8Ibw049azbVg90H21EOLACvtfcHk0ljHji50ga6pYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlehsLrJ&md5=43a0fffc6b1765fff0d4b9ce34a04510</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1089%2Fars.2015.6580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2015.6580%26sid%3Dliteratum%253Aachs%26aulast%3DHornsveld%26aufirst%3DM.%26aulast%3DDansen%26aufirst%3DT.%2BB.%26atitle%3DThe%2520Hallmarks%2520of%2520Cancer%2520from%2520a%2520Redox%2520Perspective%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2016%26volume%3D25%26spage%3D300%26epage%3D325%26doi%3D10.1089%2Fars.2015.6580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span> <span> </span><span class="NLM_article-title">Nrf2: Friend or Foe for Chemoprevention?</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgp231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1093%2Fcarcin%2Fbgp231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=19793802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlCgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=90-99&author=T.+W.+Kenslerauthor=N.+Wakabayashi&title=Nrf2%3A+Friend+or+Foe+for+Chemoprevention%3F&doi=10.1093%2Fcarcin%2Fbgp231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2: friend or foe for chemoprevention?</span></div><div class="casAuthors">Kensler, Thomas W.; Wakabayashi, Nobunao</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-99</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Health reflects the ability of an organism to adapt to stress.  Stresses-metabolic, proteotoxic, mitotic, oxidative and DNA-damage stresses-not only contribute to the etiol. of cancer and other chronic degenerative diseases but are also hallmarks of the cancer phenotype.  Activation of the Kelch-like ECH-assocd. protein 1 (KEAP1)-NF-E2-related factor 2 (NRF2)-signaling pathway is an adaptive response to environmental and endogenous stresses and serves to render animals resistant to chem. carcinogenesis and other forms of toxicity, while disruption of the pathway exacerbates these outcomes.  This pathway can be induced by thiol-reactive small mols. that demonstrate protective efficacy in preclin. chemoprevention models and in clin. trials.  However, mutations and epigenetic modifications affecting the regulation and fate of NRF2 can lead to constitutive dominant hyperactivation of signaling that preserves rather than attenuates cancer phenotypes by providing selective resistance to stresses.  This review provides a synopsis of KEAP1-NRF2 signaling, compares the impact of genetic vs. pharmacol. activation and considers both the attributes and concerns of targeting the pathway in chemoprevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqshZPrMJ237bVg90H21EOLACvtfcHk0ljHji50ga6pYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlCgsQ%253D%253D&md5=dd79e8634cc9ca6ad8fde2d08f77a731</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgp231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgp231%26sid%3Dliteratum%253Aachs%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DWakabayashi%26aufirst%3DN.%26atitle%3DNrf2%253A%2520Friend%2520or%2520Foe%2520for%2520Chemoprevention%253F%26jtitle%3DCarcinogenesis%26date%3D2010%26volume%3D31%26spage%3D90%26epage%3D99%26doi%3D10.1093%2Fcarcin%2Fbgp231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tebay, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durant, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penning, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Activation of the Transcription Factor Nrf2 by Redox Stressors, Nutrient Cues, and Energy Status and the Pathways through Which It Attenuates Degenerative Disease</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2015.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26122708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCru7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=108-146&author=L.+E.+Tebayauthor=H.+Robertsonauthor=S.+T.+Durantauthor=S.+R.+Vitaleauthor=T.+M.+Penningauthor=A.+T.+Dinkova-Kostovaauthor=J.+D.+Hayes&title=Mechanisms+of+Activation+of+the+Transcription+Factor+Nrf2+by+Redox+Stressors%2C+Nutrient+Cues%2C+and+Energy+Status+and+the+Pathways+through+Which+It+Attenuates+Degenerative+Disease&doi=10.1016%2Fj.freeradbiomed.2015.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease</span></div><div class="casAuthors">Tebay, Lauren E.; Robertson, Holly; Durant, Stephen T.; Vitale, Steven R.; Penning, Trevor M.; Dinkova-Kostova, Albena T.; Hayes, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">108-146</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) regulates the basal and stress-inducible expression of a battery of genes encoding key components of the glutathione-based and thioredoxin-based antioxidant systems, as well as aldo-keto reductase, glutathione S-transferase, and NAD(P)H:quinone oxidoreductase-1 drug-metabolizing isoenzymes along with multidrug-resistance-assocd. efflux pumps.  It therefore plays a pivotal role in both intrinsic resistance and cellular adaptation to reactive oxygen species (ROS) and xenobiotics.  Activation of Nrf2 can, however, serve as a double-edged sword because some of the genes it induces may contribute to chem. carcinogenesis by promoting futile redox cycling of polycyclic arom. hydrocarbon metabolites or confer resistance to chemotherapeutic drugs by increasing the expression of efflux pumps, suggesting its cytoprotective effects will vary in a context-specific fashion.  In addn. to cytoprotection, Nrf2 also controls genes involved in intermediary metab., pos. regulating those involved in NADPH generation, purine biosynthesis, and the β-oxidn. of fatty acids, while suppressing those involved in lipogenesis and gluconeogenesis.  Nrf2 is subject to regulation at multiple levels.  Its ability to orchestrate adaptation to oxidants and electrophiles is due principally to stress-stimulated modification of thiols within one of its repressors, the Kelch-like ECH-assocd. protein 1 (Keap1), which is present in the cullin-3 RING ubiquitin ligase (CRL) complex CRLKeap1.  Thus modification of Cys residues in Keap1 blocks CRLKeap1 activity, allowing newly translated Nrf2 to accumulate rapidly and induce its target genes.  The ability of Keap1 to repress Nrf2 can be attenuated by p62/sequestosome-1 in a mechanistic target of rapamycin complex 1 (mTORC1)-dependent manner, thereby allowing refeeding after fasting to increase Nrf2-target gene expression.  In parallel with repression by Keap1, Nrf2 is also repressed by β-transducin repeat-contg. protein (β-TrCP), present in the Skp1-cullin-1-F-box protein (SCF) ubiquitin ligase complex SCFβ-TrCP.  The ability of SCFβ-TrCP to suppress Nrf2 activity is itself enhanced by prior phosphorylation of the transcription factor by glycogen synthase kinase-3 (GSK-3) through formation of a DSGIS-contg. phosphodegron.  However, formation of the phosphodegron in Nrf2 by GSK-3 is inhibited by stimuli that activate protein kinase B (PKB)/Akt.  In particular, PKB/Akt activity can be increased by phosphoinositide 3-kinase and mTORC2, thereby providing an explanation of why antioxidant-responsive element-driven genes are induced by growth factors and nutrients.  Thus Nrf2 activity is tightly controlled via CRLKeap1 and SCFβ-TrCP by oxidative stress and energy-based signals, allowing it to mediate adaptive responses that restore redox homeostasis and modulate intermediary metab.  Based on the fact that Nrf2 influences multiple biochem. pathways in both pos. and neg. ways, it is likely its dose-response curve, in terms of susceptibility to certain degenerative disease, is U-shaped.  Specifically, too little Nrf2 activity will lead to loss of cytoprotection, diminished antioxidant capacity, and lowered β-oxidn. of fatty acids, while conversely also exhibiting heightened sensitivity to ROS-based signaling that involves receptor tyrosine kinases and apoptosis signal-regulating kinase-1.  By contrast, too much Nrf2 activity disturbs the homeostatic balance in favor of redn., and so may have deleterious consequences including overprodn. of reduced glutathione and NADPH, the blunting of ROS-based signal transduction, epithelial cell hyperplasia, and failure of certain cell types to differentiate correctly.  We discuss the basis of a putative U-shaped Nrf2 dose-response curve in terms of potentially competing processes relevant to different stages of tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBWTEjfYelsLVg90H21EOLACvtfcHk0lgTeOhS6e8rbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCru7fE&md5=b7e3f1d49b709d72071bb9bcc0147320</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DTebay%26aufirst%3DL.%2BE.%26aulast%3DRobertson%26aufirst%3DH.%26aulast%3DDurant%26aufirst%3DS.%2BT.%26aulast%3DVitale%26aufirst%3DS.%2BR.%26aulast%3DPenning%26aufirst%3DT.%2BM.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26atitle%3DMechanisms%2520of%2520Activation%2520of%2520the%2520Transcription%2520Factor%2520Nrf2%2520by%2520Redox%2520Stressors%252C%2520Nutrient%2520Cues%252C%2520and%2520Energy%2520Status%2520and%2520the%2520Pathways%2520through%2520Which%2520It%2520Attenuates%2520Degenerative%2520Disease%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D108%26epage%3D146%26doi%3D10.1016%2Fj.freeradbiomed.2015.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penning, T. M.</span></span> <span> </span><span class="NLM_article-title">Aldo-Keto Reductase Regulation by the Nrf2 System: Implications for Stress Response, Chemotherapy Drug Resistance, and Carcinogenesis</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.6b00319</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.6b00319" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2017&pages=162-176&author=T.+M.+Penning&title=Aldo-Keto+Reductase+Regulation+by+the+Nrf2+System%3A+Implications+for+Stress+Response%2C+Chemotherapy+Drug+Resistance%2C+and+Carcinogenesis&doi=10.1021%2Facs.chemrestox.6b00319"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.6b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.6b00319%26sid%3Dliteratum%253Aachs%26aulast%3DPenning%26aufirst%3DT.%2BM.%26atitle%3DAldo-Keto%2520Reductase%2520Regulation%2520by%2520the%2520Nrf2%2520System%253A%2520Implications%2520for%2520Stress%2520Response%252C%2520Chemotherapy%2520Drug%2520Resistance%252C%2520and%2520Carcinogenesis%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2017%26volume%3D30%26spage%3D162%26epage%3D176%26doi%3D10.1021%2Facs.chemrestox.6b00319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arlt, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiborova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieler, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frei, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopko, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmeiser, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. H.</span></span> <span> </span><span class="NLM_article-title">Environmental Pollutant and Potent Mutagen 3-Nitrobenzanthrone Forms DNA Adducts after Reduction by Nad(P)H:Quinone Oxidoreductase and Conjugation by Acetyltransferases and Sulfotransferases in Human Hepatic Cytosols</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">2644</span>– <span class="NLM_lpage">2652</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-3544</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1158%2F0008-5472.CAN-04-3544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=15805261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtVeqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=2644-2652&author=V.+M.+Arltauthor=M.+Stiborovaauthor=C.+J.+Hendersonauthor=M.+R.+Osborneauthor=C.+A.+Bielerauthor=E.+Freiauthor=V.+Martinekauthor=B.+Sopkoauthor=C.+R.+Wolfauthor=H.+H.+Schmeiserauthor=D.+H.+Phillips&title=Environmental+Pollutant+and+Potent+Mutagen+3-Nitrobenzanthrone+Forms+DNA+Adducts+after+Reduction+by+Nad%28P%29H%3AQuinone+Oxidoreductase+and+Conjugation+by+Acetyltransferases+and+Sulfotransferases+in+Human+Hepatic+Cytosols&doi=10.1158%2F0008-5472.CAN-04-3544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Environmental pollutant and potent mutagen 3-nitrobenzanthrone forms DNA adducts after reduction by NAD(P)H:quinone oxidoreductase and conjugation by acetyltransferases and sulfotransferases in human hepatic cytosols</span></div><div class="casAuthors">Arlt, Volker M.; Stiborova, Marie; Henderson, Colin J.; Osborne, Martin R.; Bieler, Christian A.; Frei, Eva; Martinek, Vaclav; Sopko, Bruno; Wolf, C. Roland; Schmeiser, Heinz H.; Phillips, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2644-2652</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">3-Nitrobenzanthrone (3-nitro-7H-benz[de]anthracen-7-one, 3-NBA) is a potent mutagen and suspected human carcinogen identified in diesel exhaust and air pollution.  The authors compared the ability of human hepatic cytosolic samples to catalyze DNA adduct formation by 3-NBA.  Using the 32P-postlabeling method, the authors found that 12/12 hepatic cytosols activated 3-NBA to form multiple DNA adducts similar to those formed in vivo in rodents.  By comparing 3-NBA-DNA adduct formation in the presence of cofactors of NAD(P)H:quinone oxidoreductase (NQO1) and xanthine oxidase, most of the reductive activation of 3-NBA in human hepatic cytosols was attributed to NQO1.  Inhibition of adduct formation by dicoumarol, an NQO1 inhibitor, supported this finding and was confirmed with human recombinant NQO1.  When cofactors of N,O-acetyltransferases (NAT) and sulfotransferases (SULT) were added to cytosolic samples, 3-NBA-DNA adduct formation increased 10- to 35-fold.  Using human recombinant NQO1 and NATs or SULTs, the authors found that mainly NAT2, followed by SULT1A2, NAT1, and, to a lesser extent, SULT1A1 activate 3-NBA.  The authors also evaluated the role of hepatic NADPH:cytochrome P 450 oxidoreductase (POR) in the activation of 3-NBA in vivo by treating hepatic POR-null mice and wild-type littermates i.p. with 0.2 or 2 mg/kg body wt. of 3-NBA.  No difference in DNA binding was found in any tissue examd. (liver, lung, kidney, bladder, and colon) between null and wild-type mice, indicating that 3-NBA is predominantly activated by cytosolic nitroreductases rather than microsomal POR.  Collectively, these results show the role of human hepatic NQO1 to reduce 3-NBA to species being further activated by NATs and SULTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHsI2F1qMibbVg90H21EOLACvtfcHk0lgTeOhS6e8rbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtVeqsLw%253D&md5=c02f2c2f148ee21d1d910ee0dda6d50c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-3544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-3544%26sid%3Dliteratum%253Aachs%26aulast%3DArlt%26aufirst%3DV.%2BM.%26aulast%3DStiborova%26aufirst%3DM.%26aulast%3DHenderson%26aufirst%3DC.%2BJ.%26aulast%3DOsborne%26aufirst%3DM.%2BR.%26aulast%3DBieler%26aufirst%3DC.%2BA.%26aulast%3DFrei%26aufirst%3DE.%26aulast%3DMartinek%26aufirst%3DV.%26aulast%3DSopko%26aufirst%3DB.%26aulast%3DWolf%26aufirst%3DC.%2BR.%26aulast%3DSchmeiser%26aufirst%3DH.%2BH.%26aulast%3DPhillips%26aufirst%3DD.%2BH.%26atitle%3DEnvironmental%2520Pollutant%2520and%2520Potent%2520Mutagen%25203-Nitrobenzanthrone%2520Forms%2520DNA%2520Adducts%2520after%2520Reduction%2520by%2520Nad%2528P%2529H%253AQuinone%2520Oxidoreductase%2520and%2520Conjugation%2520by%2520Acetyltransferases%2520and%2520Sulfotransferases%2520in%2520Human%2520Hepatic%2520Cytosols%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D2644%26epage%3D2652%26doi%3D10.1158%2F0008-5472.CAN-04-3544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Padmanabhan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharlock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Defects of Keap1 Activity Provoked by Its Point Mutations in Lung Cancer</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">700</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2006.01.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.molcel.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=16507366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD28XislKqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=689-700&author=B.+Padmanabhanauthor=K.+I.+Tongauthor=T.+Ohtaauthor=Y.+Nakamuraauthor=M.+Scharlockauthor=M.+Ohtsujiauthor=M.-I.+Kangauthor=A.+Kobayashiauthor=S.+Yokoyamaauthor=M.+Yamamoto&title=Structural+Basis+for+Defects+of+Keap1+Activity+Provoked+by+Its+Point+Mutations+in+Lung+Cancer&doi=10.1016%2Fj.molcel.2006.01.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer</span></div><div class="casAuthors">Padmanabhan, Balasundaram; Tong, Kit I.; Ohta, Tsutomu; Nakamura, Yoshihiro; Scharlock, Maria; Ohtsuji, Makiko; Kang, Moon-Il; Kobayashi, Akira; Yokoyama, Shigeyuki; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">689-700</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nrf2 regulates the cellular oxidative stress response, whereas Keap1 represses Nrf2 through its mol. interaction.  To elucidate the mol. mechanism of the Keap1 and Nrf2 interaction, we resolved the six-bladed β propeller crystal structure of the Kelch/DGR and CTR domains of mouse Keap1 and revealed that extensive inter- and intrablade hydrogen bonds maintain the structural integrity and proper assocn. of Keap1 with Nrf2.  A peptide contg. the ETGE motif of Nrf2 binds the β propeller of Keap1 at the entrance of the central cavity on the bottom side via electrostatic interactions with conserved arginine residues.  We found a somatic mutation and a gene variation in human lung cancer cells that change glycine to cysteine in the DGR domain, introducing local conformational changes that reduce Keap1's affinity for Nrf2.  These results provide a structural basis for the loss of Keap1 function and gain of Nrf2 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouis9O43RTgbVg90H21EOLACvtfcHk0lgA6lE0CJa6yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislKqsLg%253D&md5=717ce921cba6994da720e40d71e1d543</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DPadmanabhan%26aufirst%3DB.%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DScharlock%26aufirst%3DM.%26aulast%3DOhtsuji%26aufirst%3DM.%26aulast%3DKang%26aufirst%3DM.-I.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DStructural%2520Basis%2520for%2520Defects%2520of%2520Keap1%2520Activity%2520Provoked%2520by%2520Its%2520Point%2520Mutations%2520in%2520Lung%2520Cancer%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D21%26spage%3D689%26epage%3D700%26doi%3D10.1016%2Fj.molcel.2006.01.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thimmulappa, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoque, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baylin, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrielson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brock, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswal, S.</span></span> <span> </span><span class="NLM_article-title">Dysfunctional Keap1-Nrf2 Interaction in Non-Small-Cell Lung Cancer</span>. <i>PLoS Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e420</span> <span class="refDoi"> DOI: 10.1371/journal.pmed.0030420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1371%2Fjournal.pmed.0030420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=17020408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A280%3ADC%252BD28npsFGruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&author=A.+Singhauthor=V.+Misraauthor=R.+K.+Thimmulappaauthor=H.+Leeauthor=S.+Amesauthor=M.+O.+Hoqueauthor=J.+G.+Hermanauthor=S.+B.+Baylinauthor=D.+Sidranskyauthor=E.+Gabrielsonauthor=M.+V.+Brockauthor=S.+Biswal&title=Dysfunctional+Keap1-Nrf2+Interaction+in+Non-Small-Cell+Lung+Cancer&doi=10.1371%2Fjournal.pmed.0030420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer</span></div><div class="casAuthors">Singh Anju; Misra Vikas; Thimmulappa Rajesh K; Lee Hannah; Ames Stephen; Hoque Mohammad O; Herman James G; Baylin Stephen B; Sidransky David; Gabrielson Edward; Brock Malcolm V; Biswal Shyam</div><div class="citationInfo"><span class="NLM_cas:title">PLoS medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e420</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Nuclear factor erythroid-2 related factor 2 (NRF2) is a redox-sensitive transcription factor that positively regulates the expression of genes encoding antioxidants, xenobiotic detoxification enzymes, and drug efflux pumps, and confers cytoprotection against oxidative stress and xenobiotics in normal cells.  Kelch-like ECH-associated protein 1 (KEAP1) negatively regulates NRF2 activity by targeting it to proteasomal degradation.  Increased expression of cellular antioxidants and xenobiotic detoxification enzymes has been implicated in resistance of tumor cells against chemotherapeutic drugs.  METHODS AND FINDINGS:  Here we report a systematic analysis of the KEAP1 genomic locus in lung cancer patients and cell lines that revealed deletion, insertion, and missense mutations in functionally important domains of KEAP1 and a very high percentage of loss of heterozygosity at 19p13.2, suggesting that biallelic inactivation of KEAP1 in lung cancer is a common event.  Sequencing of KEAP1 in 12 cell lines and 54 non-small-cell lung cancer (NSCLC) samples revealed somatic mutations in KEAP1 in a total of six cell lines and ten tumors at a frequency of 50% and 19%, respectively.  All the mutations were within highly conserved amino acid residues located in the Kelch or intervening region domain of the KEAP1 protein, suggesting that these mutations would likely abolish KEAP1 repressor activity.  Evaluation of loss of heterozygosity at 19p13.2 revealed allelic losses in 61% of the NSCLC cell lines and 41% of the tumor samples.  Decreased KEAP1 activity in cancer cells induced greater nuclear accumulation of NRF2, causing enhanced transcriptional induction of antioxidants, xenobiotic metabolism enzymes, and drug efflux pumps.  CONCLUSIONS:  This is the first study to our knowledge to demonstrate that biallelic inactivation of KEAP1 is a frequent genetic alteration in NSCLC.  Loss of KEAP1 function leading to constitutive activation of NRF2-mediated gene expression in cancer suggests that tumor cells manipulate the NRF2 pathway for their survival against chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRSF0z_BNLNYTC850By6mxpfW6udTcc2eZNyAnwdPxK77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28npsFGruw%253D%253D&md5=96b89c577f3aa8650a636cc320dcc289</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.0030420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.0030420%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DMisra%26aufirst%3DV.%26aulast%3DThimmulappa%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DAmes%26aufirst%3DS.%26aulast%3DHoque%26aufirst%3DM.%2BO.%26aulast%3DHerman%26aufirst%3DJ.%2BG.%26aulast%3DBaylin%26aufirst%3DS.%2BB.%26aulast%3DSidransky%26aufirst%3DD.%26aulast%3DGabrielson%26aufirst%3DE.%26aulast%3DBrock%26aufirst%3DM.%2BV.%26aulast%3DBiswal%26aufirst%3DS.%26atitle%3DDysfunctional%2520Keap1-Nrf2%2520Interaction%2520in%2520Non-Small-Cell%2520Lung%2520Cancer%26jtitle%3DPLoS%2520Med.%26date%3D2006%26volume%3D3%26doi%3D10.1371%2Fjournal.pmed.0030420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iijima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirohashi, S.</span></span> <span> </span><span class="NLM_article-title">Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1303</span>– <span class="NLM_lpage">1309</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-5003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1158%2F0008-5472.CAN-07-5003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1303-1309&author=T.+Ohtaauthor=K.+Iijimaauthor=M.+Miyamotoauthor=I.+Nakaharaauthor=H.+Tanakaauthor=M.+Ohtsujiauthor=T.+Suzukiauthor=A.+Kobayashiauthor=J.+Yokotaauthor=T.+Sakiyamaauthor=T.+Shibataauthor=M.+Yamamotoauthor=S.+Hirohashi&title=Loss+of+Keap1+Function+Activates+Nrf2+and+Provides+Advantages+for+Lung+Cancer+Cell+Growth&doi=10.1158%2F0008-5472.CAN-07-5003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-5003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-5003%26sid%3Dliteratum%253Aachs%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DIijima%26aufirst%3DK.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DNakahara%26aufirst%3DI.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DOhtsuji%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DYokota%26aufirst%3DJ.%26aulast%3DSakiyama%26aufirst%3DT.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHirohashi%26aufirst%3DS.%26atitle%3DLoss%2520of%2520Keap1%2520Function%2520Activates%2520Nrf2%2520and%2520Provides%2520Advantages%2520for%2520Lung%2520Cancer%2520Cell%2520Growth%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D1303%26epage%3D1309%26doi%3D10.1158%2F0008-5472.CAN-07-5003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonobe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menju, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mino, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwakiri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyahara, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okubo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Date, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, H.</span></span> <span> </span><span class="NLM_article-title">Mutations in Keap1 Are a Potential Prognostic Factor in Resected Non-Small Cell Lung Cancer</span>. <i>J. Surg. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">500</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1002/jso.21520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1002%2Fjso.21520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20213688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnt1art7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2010&pages=500-506&author=T.+Takahashiauthor=M.+Sonobeauthor=T.+Menjuauthor=E.+Nakayamaauthor=N.+Minoauthor=S.+Iwakiriauthor=S.+Nagaiauthor=K.+Satoauthor=R.+Miyaharaauthor=K.+Okuboauthor=T.+Hirataauthor=H.+Dateauthor=H.+Wada&title=Mutations+in+Keap1+Are+a+Potential+Prognostic+Factor+in+Resected+Non-Small+Cell+Lung+Cancer&doi=10.1002%2Fjso.21520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer</span></div><div class="casAuthors">Takahashi, Tsuyoshi; Sonobe, Makoto; Menju, Toshi; Nakayama, Ei; Mino, Nobuya; Iwakiri, Shotaro; Nagai, Shinjiro; Sato, Kiyoshi; Miyahara, Ryo; Okubo, Kenichi; Hirata, Toshiki; Date, Hiroshi; Wada, Hiromi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Surgical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">500-506</span>CODEN:
                <span class="NLM_cas:coden">JSONAU</span>;
        ISSN:<span class="NLM_cas:issn">0022-4790</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Background: Mutations in Kelch-like ECH-assocd. protein 1 (Keap1) have been reported to protect tumor cells from chemotherapeutic agents.  However, their prognostic significance in nonsmall cell lung cancer (NSCLC) is still unclear.  In this study, we examd. the effect of Keap1 gene mutations on survival and disease-free interval using resected primary NSCLC tissue.  Methods: We retrospectively analyzed the tumors from 79 patients with completely resected pathol. Stage I-II NSCLC for the presence of Keap1 gene mutations and examd. the prognosis of the patients.  Results: Keap1 gene mutations were detected in four patients (5.1%).  The postoperative 5-yr survival rate for patients with Keap1 mutations was significantly lower than those without a mutation (25% vs. 76%, P = 0.038).  The postoperative 5-yr disease-free survival rate for patients with a mutant Keap1 tumor was slightly lower than for patients with Keap1 wild-type tumors (25% vs. 66%, P = 0.057).  Conclusions: Keap1 gene mutations are likely to be assocd. with a worse prognosis and lower postoperative disease-free survival rates in pathol. Stage I-II NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpphNdvZ4R4brVg90H21EOLACvtfcHk0ljIJTY9wVhOJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnt1art7s%253D&md5=cf466727af78d365ae3905d4cbbcc1d7</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Fjso.21520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjso.21520%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DSonobe%26aufirst%3DM.%26aulast%3DMenju%26aufirst%3DT.%26aulast%3DNakayama%26aufirst%3DE.%26aulast%3DMino%26aufirst%3DN.%26aulast%3DIwakiri%26aufirst%3DS.%26aulast%3DNagai%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DMiyahara%26aufirst%3DR.%26aulast%3DOkubo%26aufirst%3DK.%26aulast%3DHirata%26aufirst%3DT.%26aulast%3DDate%26aufirst%3DH.%26aulast%3DWada%26aufirst%3DH.%26atitle%3DMutations%2520in%2520Keap1%2520Are%2520a%2520Potential%2520Prognostic%2520Factor%2520in%2520Resected%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DJ.%2520Surg.%2520Oncol.%26date%3D2010%26volume%3D101%26spage%3D500%26epage%3D506%26doi%3D10.1002%2Fjso.21520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span> <span> </span><span class="NLM_article-title">Hypermethylation of the Keap1 Gene in Human Lung Cancer Cell Lines and Lung Cancer Tissues</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2008.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.bbrc.2008.06.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2008&pages=151-154&author=R.+Wangauthor=J.+Anauthor=F.+Jiauthor=H.+Jiaoauthor=H.+Sunauthor=D.+Zhou&title=Hypermethylation+of+the+Keap1+Gene+in+Human+Lung+Cancer+Cell+Lines+and+Lung+Cancer+Tissues&doi=10.1016%2Fj.bbrc.2008.06.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2008.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2008.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DAn%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DF.%26aulast%3DJiao%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DD.%26atitle%3DHypermethylation%2520of%2520the%2520Keap1%2520Gene%2520in%2520Human%2520Lung%2520Cancer%2520Cell%2520Lines%2520and%2520Lung%2520Cancer%2520Tissues%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D373%26spage%3D151%26epage%3D154%26doi%3D10.1016%2Fj.bbrc.2008.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muscarella, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrella, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Alessandro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">la Torre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tancredi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarnieri, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balsamo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Bonis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisceglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaramuzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiello, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valori, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merla, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendemiale, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazio, V. M.</span></span> <span> </span><span class="NLM_article-title">Frequent Epigenetics Inactivation of Keap1 Gene in Non-Small Cell Lung Cancer</span>. <i>Epigenetics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.4161/epi.6.6.15773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.4161%2Fepi.6.6.15773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21610322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2gs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=710-719&author=L.+A.+Muscarellaauthor=P.+Parrellaauthor=V.+D%E2%80%99Alessandroauthor=A.+la+Torreauthor=R.+Barbanoauthor=A.+Fontanaauthor=A.+Tancrediauthor=V.+Guarnieriauthor=T.+Balsamoauthor=M.+Cocoauthor=M.+Copettiauthor=F.+Pellegriniauthor=P.+De+Bonisauthor=M.+Biscegliaauthor=G.+Scaramuzziauthor=E.+Maielloauthor=V.+M.+Valoriauthor=G.+Merlaauthor=G.+Vendemialeauthor=V.+M.+Fazio&title=Frequent+Epigenetics+Inactivation+of+Keap1+Gene+in+Non-Small+Cell+Lung+Cancer&doi=10.4161%2Fepi.6.6.15773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer</span></div><div class="casAuthors">Muscarella, Lucia Anna; Parrella, Paola; D'Alessandro, Vito; La Torre, Annamaria; Barbano, Raffaela; Fontana, Andrea; Tancredi, Antonio; Guarnieri, Vito; Balsamo, Teresa; Coco, Michelina; Copetti, Massimiliano; Pellegrini, Fabio; De Bonis, Patrizia; Bisceglia, Michele; Scaramuzzi, Gerardo; Maiello, Evaristo; Valori, Vanna Maria; Merla, Giuseppe; Vendemiale, Gianluigi; Fazio, Vito Michele</div><div class="citationInfo"><span class="NLM_cas:title">Epigenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">710-719</span>CODEN:
                <span class="NLM_cas:coden">EPIGB6</span>;
        ISSN:<span class="NLM_cas:issn">1559-2294</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">The KEAP1/Nrf2 pathway is a master regulator of several redox-sensitive genes implicated in resistance of tumor cells against chemotherapeutic drugs.  Recent data suggest that epigenetic mechanisms may play a pivotal role in the regulation of KEAP1 expression.  We performed a comprehensive genetic and epigenetic anal. of the KEAP1 gene in 47 non-small cell lung cancer tissues and normal specimens.  Promoter methylation anal. was performed using a quant. methylation specific PCR assay in real time.  Methylation at the KEAP1 promoter region was detected in 22 out of the 47 NSCLCs (47%) and in none of the normal tissues analyzed.  Somatic mutations were detected in 7 out of the 47 tumors (15%) and loss of heterozygosity (LOH) in 10 out of the 47 (21%) of the cases.  Overall, we found at least one mol. alteration in 57% of the cases.  Approx. one third of the tumors had two alterations and this feature was assocd. with higher risk of disease progression in univariate COX regression anal. (HR = 3.62; 95% CI 1.24-10.65, p = 0.02).  This result was confirmed by Kaplan-Meier anal., which demonstrated an assocn. between worst outcome and KEAP1 double alterations (p = 0.01, Log rank test).  Our results further suggest that deregulation of the NRF2/KEAP1 system could play a pivotal role in the cancerogenesis of NSCLC.  In addn. identifying patients with KEAP1 genetic and epigenetic abnormalities may contribute to disease progression prediction and response to therapy in lung cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_6f3ulmBJdLVg90H21EOLACvtfcHk0ljIJTY9wVhOJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2gs74%253D&md5=9f5e99821f389c112850383ac3d3478f</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.4161%2Fepi.6.6.15773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fepi.6.6.15773%26sid%3Dliteratum%253Aachs%26aulast%3DMuscarella%26aufirst%3DL.%2BA.%26aulast%3DParrella%26aufirst%3DP.%26aulast%3DD%25E2%2580%2599Alessandro%26aufirst%3DV.%26aulast%3Dla%2BTorre%26aufirst%3DA.%26aulast%3DBarbano%26aufirst%3DR.%26aulast%3DFontana%26aufirst%3DA.%26aulast%3DTancredi%26aufirst%3DA.%26aulast%3DGuarnieri%26aufirst%3DV.%26aulast%3DBalsamo%26aufirst%3DT.%26aulast%3DCoco%26aufirst%3DM.%26aulast%3DCopetti%26aufirst%3DM.%26aulast%3DPellegrini%26aufirst%3DF.%26aulast%3DDe%2BBonis%26aufirst%3DP.%26aulast%3DBisceglia%26aufirst%3DM.%26aulast%3DScaramuzzi%26aufirst%3DG.%26aulast%3DMaiello%26aufirst%3DE.%26aulast%3DValori%26aufirst%3DV.%2BM.%26aulast%3DMerla%26aufirst%3DG.%26aulast%3DVendemiale%26aufirst%3DG.%26aulast%3DFazio%26aufirst%3DV.%2BM.%26atitle%3DFrequent%2520Epigenetics%2520Inactivation%2520of%2520Keap1%2520Gene%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DEpigenetics%26date%3D2011%26volume%3D6%26spage%3D710%26epage%3D719%26doi%3D10.4161%2Fepi.6.6.15773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kijima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saijo, Y.</span></span> <span> </span><span class="NLM_article-title">Methylation of the Keap1 Gene Promoter Region in Human Colorectal Cancer</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">66</span>, <span class="refDoi"> DOI: 10.1186/1471-2407-12-66</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1186%2F1471-2407-12-66" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22325485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XksFGksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=66&author=N.+Hanadaauthor=T.+Takahataauthor=Q.+Zhouauthor=X.+Yeauthor=R.+Sunauthor=J.+Itohauthor=A.+Ishiguroauthor=H.+Kijimaauthor=J.+Mimuraauthor=K.+Itohauthor=S.+Fukudaauthor=Y.+Saijo&title=Methylation+of+the+Keap1+Gene+Promoter+Region+in+Human+Colorectal+Cancer&doi=10.1186%2F1471-2407-12-66"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Methylation of the KEAP1 gene promoter region in human colorectal cancer</span></div><div class="casAuthors">Hanada, Naoyuki; Takahata, Takenori; Zhou, Qiliang; Ye, Xulu; Sun, Ruowen; Itoh, Jugoh; Ishiguro, Atsushi; Kijima, Hiroshi; Mimura, Junsei; Itoh, Ken; Fukuda, Shinsaku; Saijo, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">66</span>CODEN:
                <span class="NLM_cas:coden">BCMACL</span>;
        ISSN:<span class="NLM_cas:issn">1471-2407</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The Keap1-Nrf2 pathway has been reported to be impaired in several cancers.  However, the status of Keap1-Nrf2 system in human colorectal cancer (CRC) has not been elucidated.  Methods: We used colorectal cancer (CRC) cell lines and surgical specimens to investigate the methylation status of the KEAP1 promoter region as well as expression of Nrf2 and its downstream antioxidative stress genes, NQO-1 and AKR1C1.  Results: DNA sequencing anal. indicated that all mutations detected were synonymous, with no amino acid substitutions.  We showed by bisulfite genomic sequencing and methylation-specific PCR that eight of 10 CRC cell lines had hypermethylated CpG islands in the KEAP1 promoter region.  HT29 cells with a hypermethylated KEAP1 promoter resulted in decreased mRNA and protein expression but unmethylated Colo320DM cells showed higher expression levels.  In addn., treatment with the DNA methyltransferase inhibitor 5-Aza-dC combined with the histone deacetylase inhibitor trichostatin A (TSA) increased KEAP1 mRNA expression.  These result suggested that methylation of the KEAP1 promoter regulates its mRNA level.  Time course anal. with the Nrf2-antioxidant response element (ARE) pathway activator t-BHQ treatment showed a rapid response within 24 h.  HT29 cells had higher basal expression levels of NQO-1 and AKR1C1 mRNA than Colo320DM cells.  Aberrant promoter methylation of KEAP1 was detected in 53% of tumor tissues and 25% of normal mucosae from 40 surgical CRC specimens, indicating that cancerous tissue showed increased methylation of the KEAP1 promoter region, conferring a protective effect against cytotoxic anticancer drugs.  Conclusion: Hypermethylation of the KEAP1 promoter region suppressed its mRNA expression and increased nuclear Nrf2 and downstream ARE gene expression in CRC cells and tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKmCDl3tb3yLVg90H21EOLACvtfcHk0ljIJTY9wVhOJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksFGksLg%253D&md5=13d2605a6b0cae5e5725b676b7f04b95</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-12-66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-12-66%26sid%3Dliteratum%253Aachs%26aulast%3DHanada%26aufirst%3DN.%26aulast%3DTakahata%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DR.%26aulast%3DItoh%26aufirst%3DJ.%26aulast%3DIshiguro%26aufirst%3DA.%26aulast%3DKijima%26aufirst%3DH.%26aulast%3DMimura%26aufirst%3DJ.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DFukuda%26aufirst%3DS.%26aulast%3DSaijo%26aufirst%3DY.%26atitle%3DMethylation%2520of%2520the%2520Keap1%2520Gene%2520Promoter%2520Region%2520in%2520Human%2520Colorectal%2520Cancer%26jtitle%3DBMC%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D66%26doi%3D10.1186%2F1471-2407-12-66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrestha, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouinard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccioni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamburov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imielinski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogstrom, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natoli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahr, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirosh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doench, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. S.</span></span> <span> </span><span class="NLM_article-title">High-Throughput Phenotyping of Lung Cancer Somatic Mutations</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2016.06.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.ccell.2016.06.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27478040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1KlsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=214-228&author=A.+H.+Bergerauthor=A.+N.+Brooksauthor=X.+Wuauthor=Y.+Shresthaauthor=C.+Chouinardauthor=F.+Piccioniauthor=M.+Bagulauthor=A.+Kamburovauthor=M.+Imielinskiauthor=L.+Hogstromauthor=C.+Zhuauthor=X.+Yangauthor=S.+Pantelauthor=R.+Sakaiauthor=J.+Watsonauthor=N.+Kaplanauthor=J.+D.+Campbellauthor=S.+Singhauthor=D.+E.+Rootauthor=R.+Narayanauthor=T.+Natoliauthor=D.+L.+Lahrauthor=I.+Tiroshauthor=P.+Tamayoauthor=G.+Getzauthor=B.+Wongauthor=J.+Doenchauthor=A.+Subramanianauthor=T.+R.+Golubauthor=M.+Meyersonauthor=J.+S.+Boehm&title=High-Throughput+Phenotyping+of+Lung+Cancer+Somatic+Mutations&doi=10.1016%2Fj.ccell.2016.06.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput Phenotyping of Lung Cancer Somatic Mutations</span></div><div class="casAuthors">Berger, Alice H.; Brooks, Angela N.; Wu, Xiaoyun; Shrestha, Yashaswi; Chouinard, Candace; Piccioni, Federica; Bagul, Mukta; Kamburov, Atanas; Imielinski, Marcin; Hogstrom, Larson; Zhu, Cong; Yang, Xiaoping; Pantel, Sasha; Sakai, Ryo; Watson, Jacqueline; Kaplan, Nathan; Campbell, Joshua D.; Singh, Shantanu; Root, David E.; Narayan, Rajiv; Natoli, Ted; Lahr, David L.; Tirosh, Itay; Tamayo, Pablo; Getz, Gad; Wong, Bang; Doench, John; Subramanian, Aravind; Golub, Todd R.; Meyerson, Matthew; Boehm, Jesse S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">214-228</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Recent genome sequencing efforts have identified millions of somatic mutations in cancer.  However, the functional impact of most variants is poorly understood.  Here we characterize 194 somatic mutations identified in primary lung adenocarcinomas.  We present an expression-based variant-impact phenotyping (eVIP) method that uses gene expression changes to distinguish impactful from neutral somatic mutations. eVIP identified 69% of mutations analyzed as impactful and 31% as functionally neutral.  A subset of the impactful mutations induces xenograft tumor formation in mice and/or confers resistance to cellular EGFR inhibition.  Among these impactful variants are rare somatic, clin. actionable variants including EGFR S645C, ARAF S214C and S214F, ERBB2 S418T, and multiple BRAF variants, demonstrating that rare mutations can be functionally important in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUjVXd62zmq7Vg90H21EOLACvtfcHk0ljLPpIpUSJo5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1KlsbvE&md5=63a79c06f1fdf148a0689231b9aab3ed</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2016.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2016.06.022%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DA.%2BH.%26aulast%3DBrooks%26aufirst%3DA.%2BN.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DShrestha%26aufirst%3DY.%26aulast%3DChouinard%26aufirst%3DC.%26aulast%3DPiccioni%26aufirst%3DF.%26aulast%3DBagul%26aufirst%3DM.%26aulast%3DKamburov%26aufirst%3DA.%26aulast%3DImielinski%26aufirst%3DM.%26aulast%3DHogstrom%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DPantel%26aufirst%3DS.%26aulast%3DSakai%26aufirst%3DR.%26aulast%3DWatson%26aufirst%3DJ.%26aulast%3DKaplan%26aufirst%3DN.%26aulast%3DCampbell%26aufirst%3DJ.%2BD.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DNarayan%26aufirst%3DR.%26aulast%3DNatoli%26aufirst%3DT.%26aulast%3DLahr%26aufirst%3DD.%2BL.%26aulast%3DTirosh%26aufirst%3DI.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DDoench%26aufirst%3DJ.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26atitle%3DHigh-Throughput%2520Phenotyping%2520of%2520Lung%2520Cancer%2520Somatic%2520Mutations%26jtitle%3DCancer%2520Cell%26date%3D2016%26volume%3D30%26spage%3D214%26epage%3D228%26doi%3D10.1016%2Fj.ccell.2016.06.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collisson, E. A.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Comprehensive Molecular Profiling of Lung Adenocarcinoma</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>511</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1038/nature13385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fnature13385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=25079552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ChurnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2014&pages=543-550&author=E.+A.+Collisson&title=Comprehensive+Molecular+Profiling+of+Lung+Adenocarcinoma&doi=10.1038%2Fnature13385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive molecular profiling of lung adenocarcinoma</span></div><div class="casAuthors">Collisson, Eric A.; Campbell, Joshua D.; Brooks, Angela N.; Berger, Alice H.; Lee, William; Chmielecki, Juliann; Beer, David G.; Cope, Leslie; Creighton, Chad J.; Danilova, Ludmila; Ding, Li; Getz, Gad; Hammerman, Peter S.; Hayes, D. Neil; Hernandez, Bryan; Herman, James G.; Heymach, John V.; Jurisica, Igor; Kucherlapati, Raju; Kwiatkowski, David; Ladanyi, Marc; Robertson, Gordon; Schultz, Nikolaus; Shen, Ronglai; Sinha, Rileen; Sougnez, Carrie; Tsao, Ming-Sound; Travis, William D.; Weinstein, John N.; Wigle, Dennis A.; Wilkerson, Matthew D.; Chu, Andy; Cherniack, Andrew D.; Hadjipanayis, Angela; Rosenberg, Mara; Weisenberger, Daniel J.; Laird, Peter W.; Radenbaugh, Amie; Ma, Singer; Stuart, Joshua M.; Byers, Lauren Averett; Baylin, Stephen B.; Govindan, Ramaswamy; Gabriel, Stacey B.; Cibulskis, Kristian; Kim, Jaegil; Stewart, Chip; Lichtenstein, Lee; Lander, Eric S.; Lawrence, Michael S.; Kandoth, Cyriac; Fulton, Robert; Fulton, Lucinda L.; McLellan, Michael D.; Wilson, Richard K.; Ye, Kai; Fronick, Catrina C.; Maher, Christopher A.; Miller, Christopher A.; Wendl, Michael C.; Cabanski, Christopher; Ding, Li; Mardis, Elaine; Wheeler, David; Balasundaram, Miruna; Butterfield, Yaron S. N.; Carlsen, Rebecca; Chuah, Eric; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Schein, Jacqueline E.; Sipahimalani, Payal; Tam, Angela; Varhol, Richard; Robertson, A. Gordon; Wye, Natasja; Thiessen, Nina; Holt, Robert A.; Jones, Steven J. M.; Marra, Marco A.; Imielinski, Marcin; Onofrio, Robert C.; Hodis, Eran; Zack, Travis; Helman, Elena; Sekhar Pedamallu, Chandra; Mesirov, Jill; Saksena, Gordon; Schumacher, Steven E.; Carter, Scott L.; Garraway, Levi; Beroukhim, Rameen; Lee, Semin; Mahadeshwar, Harshad S.; Pantazi, Angeliki; Protopopov, Alexei; Ren, Xiaojia; Seth, Sahil; Song, Xingzhi; Tang, Jiabin; Yang, Lixing; Zhang, Jianhua; Chen, Peng-Chieh; Parfenov, Michael; Xu, Andrew Wei; Santoso, Netty; Chin, Lynda; Park, Peter J.; Hoadley, Katherine A.; Todd Auman, J.; Meng, Shaowu; Shi, Yan; Buda, Elizabeth; Waring, Scot; Veluvolu, Umadevi; Tan, Donghui; Mieczkowski, Piotr A.; Jones, Corbin D.; Simons, Janae V.; Soloway, Matthew G.; Bodenheimer, Tom; Jefferys, Stuart R.; Roach, Jeffrey; Hoyle, Alan P.; Wu, Junyuan; Balu, Saianand; Singh, Darshan; Prins, Jan F.; Marron, J. S.; Parker, Joel S.; Hayes, D. Neil; Perou, Charles M.; Liu, Jinze; Maglinte, Dennis T.; Lai, Philip H.; Bootwalla, Moiz S.; Van Den Berg, David J.; Triche, Timothy, Jr.; Cho, Juok; Di Cara, Daniel; Heiman, David; Lin, Pei; Mallard, William; Voet, Douglas; Zhang, Hailei; Zou, Lihua; Noble, Michael S.; Gehlenborg, Nils; Thorvaldsdottir, Helga; Nazaire, Marc-Danie; Robinson, Jim; Arman Aksoy, B.; Ciriello, Giovanni; Taylor, Barry S.; Dresdner, Gideon; Gao, Jianjiong; Gross, Benjamin; Seshan, Venkatraman E.; Reva, Boris; Sinha, Rileen; Onur Sumer, S.; Weinhold, Nils; Schultz, Nikolaus; Sander, Chris; Ng, Sam; Zhu, Jingchun; Benz, Christopher C.; Yau, Christina; Haussler, David; Spellman, Paul T.; Kimes, Patrick K.; Broom, Bradley M.; Wang, Jing; Lu, Yiling; Ng, Patrick Kwok Shing; Diao, Lixia; Liu, Wenbin; Amos, Christopher I.; Akbani, Rehan; Mills, Gordon B.; Curley, Erin; Paulauskis, Joseph; Lau, Kevin; Morris, Scott; Shelton, Troy; Mallery, David; Gardner, Johanna; Penny, Robert; Saller, Charles; Tarvin, Katherine; Richards, William G.; Cerfolio, Robert; Bryant, Ayesha; Raymond, Daniel P.; Pennell, Nathan A.; Farver, Carol; Czerwinski, Christine; Huelsenbeck-Dill, Lori; Iacocca, Mary; Petrelli, Nicholas; Rabeno, Brenda; Brown, Jennifer; Bauer, Thomas; Dolzhanskiy, Oleg; Potapova, Olga; Rotin, Daniil; Voronina, Olga; Nemirovich-Danchenko, Elena; Fedosenko, Konstantin V.; Gal, Anthony; Behera, Madhusmita; Ramalingam, Suresh S.; Sica, Gabriel; Flieder, Douglas; Boyd, Jeff; Weaver, JoEllen; Kohl, Bernard; Thinh, Dang Huy Quoc; Sandusky, George; Juhl, Hartmut; Duhig, Edwina; Illei, Peter; Gabrielson, Edward; Shin, James; Lee, Beverly; Rodgers, Kristen; Trusty, Dante; Brock, Malcolm V.; Williamson, Christina; Burks, Eric; Rieger-Christ, Kimberly; Holway, Antonia; Sullivan, Travis; Asiedu, Michael K.; Kosari, Farhad; Rekhtman, Natasha; Zakowski, Maureen; Rusch, Valerie W.; Zippile, Paul; Suh, James; Pass, Harvey; Goparaju, Chandra; Owusu-Sarpong, Yvonne; Bartlett, John M. S.; Kodeeswaran, Sugy; Parfitt, Jeremy; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">7511</span>),
    <span class="NLM_cas:pages">543-550</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adenocarcinoma of the lung is the leading cause of cancer death worldwide.  Here we report mol. profiling of 230 resected lung adenocarcinomas using mRNA, microRNA and DNA sequencing integrated with copy no., methylation and proteomic analyses.  High rates of somatic mutation were seen (mean 8.9 mutations per megabase).  Eighteen genes were statistically significantly mutated, including RIT1 activating mutations and newly described loss-of-function MGA mutations which are mutually exclusive with focal MYC amplification.  EGFR mutations were more frequent in female patients, whereas mutations in RBM10 were more common in males.  Aberrations in NF1, MET, ERBB2 and RIT1 occurred in 13% of cases and were enriched in samples otherwise lacking an activated oncogene, suggesting a driver role for these events in certain tumors.  DNA and mRNA sequence from the same tumor highlighted splicing alterations driven by somatic genomic changes, including exon 14 skipping in MET mRNA in 4% of cases.  MAPK and PI(3)K pathway activity, when measured at the protein level, was explained by known mutations in only a fraction of cases, suggesting addnl., unexplained mechanisms of pathway activation.  These data establish a foundation for classification and further investigations of lung adenocarcinoma mol. pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsQbellbPHqLVg90H21EOLACvtfcHk0ljgBGiCmZcVZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ChurnI&md5=526fbb4b17b3d774e0de80680eee2539</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1038%2Fnature13385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13385%26sid%3Dliteratum%253Aachs%26aulast%3DCollisson%26aufirst%3DE.%2BA.%26atitle%3DComprehensive%2520Molecular%2520Profiling%2520of%2520Lung%2520Adenocarcinoma%26jtitle%3DNature%26date%3D2014%26volume%3D511%26spage%3D543%26epage%3D550%26doi%3D10.1038%2Fnature13385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokubu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odogawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirohashi, S.</span></span> <span> </span><span class="NLM_article-title">Cancer Related Mutations in Nrf2 Impair Its Recognition by Keap1-Cul3 E3 Ligase and Promote Malignancy</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">13568</span>– <span class="NLM_lpage">13573</span>, <span class="refDoi"> DOI: 10.1073/pnas.0806268105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1073%2Fpnas.0806268105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=13568-13573&author=T.+Shibataauthor=T.+Ohtaauthor=K.+I.+Tongauthor=A.+Kokubuauthor=R.+Odogawaauthor=K.+Tsutaauthor=H.+Asamuraauthor=M.+Yamamotoauthor=S.+Hirohashi&title=Cancer+Related+Mutations+in+Nrf2+Impair+Its+Recognition+by+Keap1-Cul3+E3+Ligase+and+Promote+Malignancy&doi=10.1073%2Fpnas.0806268105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0806268105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0806268105%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DKokubu%26aufirst%3DA.%26aulast%3DOdogawa%26aufirst%3DR.%26aulast%3DTsuta%26aufirst%3DK.%26aulast%3DAsamura%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHirohashi%26aufirst%3DS.%26atitle%3DCancer%2520Related%2520Mutations%2520in%2520Nrf2%2520Impair%2520Its%2520Recognition%2520by%2520Keap1-Cul3%2520E3%2520Ligase%2520and%2520Promote%2520Malignancy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D13568%26epage%3D13573%26doi%3D10.1073%2Fpnas.0806268105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokheim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta-Pardo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weerasinghe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colaprico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendl, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reardon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mularoni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubio-Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagarajan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes-Ciriano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yellapantula, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamborero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suphavilai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khurana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Allen, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Group, M. C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cancer Genome Atlas Research, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godzik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Bigas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazar, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karchin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span> <span> </span><span class="NLM_article-title">Comprehensive Characterization of Cancer Driver Genes and Mutations</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.02.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.cell.2018.02.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29625053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntFaiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2018&pages=371-385&author=M.+H.+Baileyauthor=C.+Tokheimauthor=E.+Porta-Pardoauthor=S.+Senguptaauthor=D.+Bertrandauthor=A.+Weerasingheauthor=A.+Colapricoauthor=M.+C.+Wendlauthor=J.+Kimauthor=B.+Reardonauthor=P.+K.+Ngauthor=K.+J.+Jeongauthor=S.+Caoauthor=Z.+Wangauthor=J.+Gaoauthor=Q.+Gaoauthor=F.+Wangauthor=E.+M.+Liuauthor=L.+Mularoniauthor=C.+Rubio-Perezauthor=N.+Nagarajanauthor=I.+Cortes-Cirianoauthor=D.+C.+Zhouauthor=W.+W.+Liangauthor=J.+M.+Hessauthor=V.+D.+Yellapantulaauthor=D.+Tamboreroauthor=A.+Gonzalez-Perezauthor=C.+Suphavilaiauthor=J.+Y.+Koauthor=E.+Khuranaauthor=P.+J.+Parkauthor=E.+M.+Van+Allenauthor=H.+Liangauthor=M.+C.+W.+Groupauthor=N.+Cancer+Genome+Atlas+Researchauthor=M.+S.+Lawrenceauthor=A.+Godzikauthor=N.+Lopez-Bigasauthor=J.+Stuartauthor=D.+Wheelerauthor=G.+Getzauthor=K.+Chenauthor=A.+J.+Lazarauthor=G.+B.+Millsauthor=R.+Karchinauthor=L.+Ding&title=Comprehensive+Characterization+of+Cancer+Driver+Genes+and+Mutations&doi=10.1016%2Fj.cell.2018.02.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive Characterization of Cancer Driver Genes and Mutations</span></div><div class="casAuthors">Bailey, Matthew H.; Tokheim, Collin; Porta-Pardo, Eduard; Sengupta, Sohini; Bertrand, Denis; Weerasinghe, Amila; Colaprico, Antonio; Wendl, Michael C.; Kim, Jaegil; Reardon, Brendan; Ng, Patrick Kwok-Shing; Jeong, Kang Jin; Cao, Song; Wang, Zixing; Gao, Jianjiong; Gao, Qingsong; Wang, Fang; Liu, Eric Minwei; Mularoni, Loris; Rubio-Perez, Carlota; Nagarajan, Niranjan; Cortes-Ciriano, Isidro; Zhou, Daniel Cui; Liang, Wen-Wei; Hess, Julian M.; Yellapantula, Venkata D.; Tamborero, David; Gonzalez-Perez, Abel; Suphavilai, Chayaporn; Ko, Jia Yu; Khurana, Ekta; Park, Peter J.; Van Allen, Eliezer M.; Liang, Han; Lawrence, Michael S.; Godzik, Adam; Lopez-Bigas, Nuria; Stuart, Josh; Wheeler, David; Getz, Gad; Chen, Ken; Lazar, Alexander J.; Mills, Gordon B.; Karchin, Rachel; Ding, Li</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">371-385.e18</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Identifying mol. cancer drivers is crit. for precision oncol.  Multiple advanced algorithms to identify drivers now exist, but systematic attempts to combine and optimize them on large datasets are few.  We report a PanCancer and PanSoftware anal. spanning 9,423 tumor exomes (comprising all 33 of The Cancer Genome Atlas projects) and using 26 computational tools to catalog driver genes and mutations.  We identify 299 driver genes with implications regarding their anatomical sites and cancer/cell types.  Sequence- and structure-based analyses identified >3,400 putative missense driver mutations supported by multiple lines of evidence.  Exptl. validation confirmed 60%-85% of predicted mutations as likely drivers.  We found that >300 MSI tumors are assocd. with high PD-1/PD-L1, and 57% of tumors analyzed harbor putative clin. actionable events.  Our study represents the most comprehensive discovery of cancer genes and mutations to date and will serve as a blueprint for future biol. and clin. endeavors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonwISc8tVS-LVg90H21EOLACvtfcHk0lgEEzdHUgSs9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntFaiu7c%253D&md5=6478ef37b82611e5687dcdc102cc6e98</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.02.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.02.060%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DM.%2BH.%26aulast%3DTokheim%26aufirst%3DC.%26aulast%3DPorta-Pardo%26aufirst%3DE.%26aulast%3DSengupta%26aufirst%3DS.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DWeerasinghe%26aufirst%3DA.%26aulast%3DColaprico%26aufirst%3DA.%26aulast%3DWendl%26aufirst%3DM.%2BC.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DReardon%26aufirst%3DB.%26aulast%3DNg%26aufirst%3DP.%2BK.%26aulast%3DJeong%26aufirst%3DK.%2BJ.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DE.%2BM.%26aulast%3DMularoni%26aufirst%3DL.%26aulast%3DRubio-Perez%26aufirst%3DC.%26aulast%3DNagarajan%26aufirst%3DN.%26aulast%3DCortes-Ciriano%26aufirst%3DI.%26aulast%3DZhou%26aufirst%3DD.%2BC.%26aulast%3DLiang%26aufirst%3DW.%2BW.%26aulast%3DHess%26aufirst%3DJ.%2BM.%26aulast%3DYellapantula%26aufirst%3DV.%2BD.%26aulast%3DTamborero%26aufirst%3DD.%26aulast%3DGonzalez-Perez%26aufirst%3DA.%26aulast%3DSuphavilai%26aufirst%3DC.%26aulast%3DKo%26aufirst%3DJ.%2BY.%26aulast%3DKhurana%26aufirst%3DE.%26aulast%3DPark%26aufirst%3DP.%2BJ.%26aulast%3DVan%2BAllen%26aufirst%3DE.%2BM.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DGroup%26aufirst%3DM.%2BC.%2BW.%26aulast%3DCancer%2BGenome%2BAtlas%2BResearch%26aufirst%3DN.%26aulast%3DLawrence%26aufirst%3DM.%2BS.%26aulast%3DGodzik%26aufirst%3DA.%26aulast%3DLopez-Bigas%26aufirst%3DN.%26aulast%3DStuart%26aufirst%3DJ.%26aulast%3DWheeler%26aufirst%3DD.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DLazar%26aufirst%3DA.%2BJ.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DKarchin%26aufirst%3DR.%26aulast%3DDing%26aufirst%3DL.%26atitle%3DComprehensive%2520Characterization%2520of%2520Cancer%2520Driver%2520Genes%2520and%2520Mutations%26jtitle%3DCell%26date%3D2018%26volume%3D173%26spage%3D371%26epage%3D385%26doi%3D10.1016%2Fj.cell.2018.02.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guichard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaddeo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbeaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladeiro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maad, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderaro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bioulac-Sage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letexier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurent, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couchy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letouze, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucman-Rossi, J.</span></span> <span> </span><span class="NLM_article-title">Integrated Analysis of Somatic Mutations and Focal Copy-Number Changes Identifies Key Genes and Pathways in Hepatocellular Carcinoma</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">694</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1038/ng.2256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fng.2256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22561517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFyjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=694-698&author=C.+Guichardauthor=G.+Amaddeoauthor=S.+Imbeaudauthor=Y.+Ladeiroauthor=L.+Pelletierauthor=I.+B.+Maadauthor=J.+Calderaroauthor=P.+Bioulac-Sageauthor=M.+Letexierauthor=F.+Degosauthor=B.+Clementauthor=C.+Balabaudauthor=E.+Chevetauthor=A.+Laurentauthor=G.+Couchyauthor=E.+Letouzeauthor=F.+Calvoauthor=J.+Zucman-Rossi&title=Integrated+Analysis+of+Somatic+Mutations+and+Focal+Copy-Number+Changes+Identifies+Key+Genes+and+Pathways+in+Hepatocellular+Carcinoma&doi=10.1038%2Fng.2256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma</span></div><div class="casAuthors">Guichard, Cecile; Amaddeo, Giuliana; Imbeaud, Sandrine; Ladeiro, Yannick; Pelletier, Laura; Ben Maad, Ichrafe; Calderaro, Julien; Bioulac-Sage, Paulette; Letexier, Melanie; Degos, Francoise; Clement, Bruno; Balabaud, Charles; Chevet, Eric; Laurent, Alexis; Couchy, Gabrielle; Letouze, Eric; Calvo, Fabien; Zucman-Rossi, Jessica</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">694-698</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is the most common primary liver malignancy.  Here, we performed high-resoln. copy-no. anal. on 125 HCC tumors and whole-exome sequencing on 24 of these tumors.  We identified 135 homozygous deletions and 994 somatic mutations of genes with predicted functional consequences.  We found new recurrent alterations in four genes (ARID1A, RPS6KA3, NFE2L2 and IRF2) not previously described in HCC.  Functional analyses showed tumor suppressor properties for IRF2, whose inactivation, exclusively found in hepatitis B virus (HBV)-related tumors, led to impaired TP53 function.  In contrast, inactivation of chromatin remodelers was frequent and predominant in alc.-related tumors.  Moreover, assocn. of mutations in specific genes (RPS6KA3-AXIN1 and NFE2L2-CTNNB1) suggested that Wnt/β-catenin signaling might cooperate in liver carcinogenesis with both oxidative stress metab. and Ras/mitogen-activated protein kinase (MAPK) pathways.  This study provides insight into the somatic mutational landscape in HCC and identifies interactions between mutations in oncogene and tumor suppressor gene mutations related to specific risk factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohIa_qTsarp7Vg90H21EOLACvtfcHk0lgEEzdHUgSs9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFyjtr0%253D&md5=e7ee98e34422b13c1a3bf0f4f366454f</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fng.2256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2256%26sid%3Dliteratum%253Aachs%26aulast%3DGuichard%26aufirst%3DC.%26aulast%3DAmaddeo%26aufirst%3DG.%26aulast%3DImbeaud%26aufirst%3DS.%26aulast%3DLadeiro%26aufirst%3DY.%26aulast%3DPelletier%26aufirst%3DL.%26aulast%3DMaad%26aufirst%3DI.%2BB.%26aulast%3DCalderaro%26aufirst%3DJ.%26aulast%3DBioulac-Sage%26aufirst%3DP.%26aulast%3DLetexier%26aufirst%3DM.%26aulast%3DDegos%26aufirst%3DF.%26aulast%3DClement%26aufirst%3DB.%26aulast%3DBalabaud%26aufirst%3DC.%26aulast%3DChevet%26aufirst%3DE.%26aulast%3DLaurent%26aufirst%3DA.%26aulast%3DCouchy%26aufirst%3DG.%26aulast%3DLetouze%26aufirst%3DE.%26aulast%3DCalvo%26aufirst%3DF.%26aulast%3DZucman-Rossi%26aufirst%3DJ.%26atitle%3DIntegrated%2520Analysis%2520of%2520Somatic%2520Mutations%2520and%2520Focal%2520Copy-Number%2520Changes%2520Identifies%2520Key%2520Genes%2520and%2520Pathways%2520in%2520Hepatocellular%2520Carcinoma%26jtitle%3DNat.%2520Genet.%26date%3D2012%26volume%3D44%26spage%3D694%26epage%3D698%26doi%3D10.1038%2Fng.2256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, H. K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surh, Y. J.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Mutagenic Activation Drives Hepatocarcinogenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">4797</span>– <span class="NLM_lpage">4808</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-3538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1158%2F0008-5472.CAN-16-3538" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=4797-4808&author=H.+K.+C.+Ngoauthor=D.+H.+Kimauthor=Y.+N.+Chaauthor=H.+K.+Naauthor=Y.+J.+Surh&title=Nrf2+Mutagenic+Activation+Drives+Hepatocarcinogenesis&doi=10.1158%2F0008-5472.CAN-16-3538"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-3538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-3538%26sid%3Dliteratum%253Aachs%26aulast%3DNgo%26aufirst%3DH.%2BK.%2BC.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DCha%26aufirst%3DY.%2BN.%26aulast%3DNa%26aufirst%3DH.%2BK.%26aulast%3DSurh%26aufirst%3DY.%2BJ.%26atitle%3DNrf2%2520Mutagenic%2520Activation%2520Drives%2520Hepatocarcinogenesis%26jtitle%3DCancer%2520Res.%26date%3D2017%26volume%3D77%26spage%3D4797%26epage%3D4808%26doi%3D10.1158%2F0008-5472.CAN-16-3538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zavattari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menegon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angioni, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Follenzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quagliata, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledda-Columbano, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracciano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Columbano, A.</span></span> <span> </span><span class="NLM_article-title">Nrf2, but Not Β-Catenin, Mutation Represents an Early Event in Rat Hepatocarcinogenesis</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">851</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1002/hep.27790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1002%2Fhep.27790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=25783764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVSnt7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2015&pages=851-862&author=P.+Zavattariauthor=A.+Perraauthor=S.+Menegonauthor=M.+A.+Kowalikauthor=A.+Petrelliauthor=M.+M.+Angioniauthor=A.+Follenziauthor=L.+Quagliataauthor=G.+M.+Ledda-Columbanoauthor=L.+Terraccianoauthor=S.+Giordanoauthor=A.+Columbano&title=Nrf2%2C+but+Not+%CE%92-Catenin%2C+Mutation+Represents+an+Early+Event+in+Rat+Hepatocarcinogenesis&doi=10.1002%2Fhep.27790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis</span></div><div class="casAuthors">Zavattari, Patrizia; Perra, Andrea; Menegon, Silvia; Kowalik, Marta Anna; Petrelli, Annalisa; Angioni, Maria Maddalena; Follenzi, Antonia; Quagliata, Luca; Ledda-Columbano, Giovanna Maria; Terracciano, Luigi; Giordano, Silvia; Columbano, Amedeo</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">851-862</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) develops through a multistage process, but the nature of the mol. changes assocd. with the different steps, the very early ones in particular, is largely unknown.  Recently, dysregulation of the NRF2/KEAP1 pathway and mutations of these genes have been obsd. in exptl. and human tumors, suggesting their possible role in cancer development.  To assess whether Nrf2/Keap1 mutations are early or late events in HCC development, we investigated their frequency in the rat Resistant Hepatocyte model, consisting of the administration of diethylnitrosamine followed by a brief exposure to 2-acetylaminofluorene.  This model enables the dissection of all stages of hepatocarcinogenesis.  We found that Nrf2/Keap1 mutations were present in 71% of early preneoplastic lesions and in 78.6% and 59.3% of early and advanced HCCs, resp.  Mutations of Nrf2 were more frequent, missense, and located in the Nrf2-Keap1 binding region.  Mutations of Keap1 occurred at a much lower frequency in both preneoplastic lesions and HCCs and were mutually exclusive with those of Nrf2.  Functional in vitro and in vivo studies showed that Nrf2 silencing inhibited the ability of tumorigenic rat cells to grow in soft agar and to form tumors.  Unlike Nrf2 mutations, those of Ctnnb1, which are frequent in human HCC, were a later event as they appeared only in fully advanced HCCs (18.5%).  Conclusion: In the Resistant Hepatocyte model of hepatocarcinogenesis the onset of Nrf2 mutations is a very early event, likely essential for the clonal expansion of preneoplastic hepatocytes to HCC, while Ctnnb1 mutations occur only at very late stages.  Moreover, functional expts. demonstrate that Nrf2 is an oncogene crit. for HCC progression and development. (Hepatol. 2015;62:851-862).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTBJPljMvk87Vg90H21EOLACvtfcHk0lhEhUvnZi6zMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVSnt7vN&md5=c51c7106071edc2e48fd4a208d4d8c64</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fhep.27790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.27790%26sid%3Dliteratum%253Aachs%26aulast%3DZavattari%26aufirst%3DP.%26aulast%3DPerra%26aufirst%3DA.%26aulast%3DMenegon%26aufirst%3DS.%26aulast%3DKowalik%26aufirst%3DM.%2BA.%26aulast%3DPetrelli%26aufirst%3DA.%26aulast%3DAngioni%26aufirst%3DM.%2BM.%26aulast%3DFollenzi%26aufirst%3DA.%26aulast%3DQuagliata%26aufirst%3DL.%26aulast%3DLedda-Columbano%26aufirst%3DG.%2BM.%26aulast%3DTerracciano%26aufirst%3DL.%26aulast%3DGiordano%26aufirst%3DS.%26aulast%3DColumbano%26aufirst%3DA.%26atitle%3DNrf2%252C%2520but%2520Not%2520%25CE%2592-Catenin%252C%2520Mutation%2520Represents%2520an%2520Early%2520Event%2520in%2520Rat%2520Hepatocarcinogenesis%26jtitle%3DHepatology%26date%3D2015%26volume%3D62%26spage%3D851%26epage%3D862%26doi%3D10.1002%2Fhep.27790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikor, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thu, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubaux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, W. L.</span></span> <span> </span><span class="NLM_article-title">Frequent Concerted Genetic Mechanisms Disrupt Multiple Components of the Nrf2 Inhibitor Keap1/Cul3/Rbx1 E3-Ubiquitin Ligase Complex in Thyroid Cancer</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">124</span>, <span class="refDoi"> DOI: 10.1186/1476-4598-12-124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1186%2F1476-4598-12-124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24138990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVGgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=124&author=V.+D.+Martinezauthor=E.+A.+Vucicauthor=L.+A.+Pikorauthor=K.+L.+Thuauthor=R.+Hubauxauthor=W.+L.+Lam&title=Frequent+Concerted+Genetic+Mechanisms+Disrupt+Multiple+Components+of+the+Nrf2+Inhibitor+Keap1%2FCul3%2FRbx1+E3-Ubiquitin+Ligase+Complex+in+Thyroid+Cancer&doi=10.1186%2F1476-4598-12-124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer</span></div><div class="casAuthors">Martinez, Victor D.; Vucic, Emily A.; Pikor, Larissa A.; Thu, Kelsie L.; Hubaux, Roland; Lam, Wan L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">124/1-124/6</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Reactive oxygen species contribute to normal thyroid function.  The NRF2 oxidative response pathway is frequently and constitutively activated in multiple tumor types, including papillary thyroid carcinoma (PTC).  Genetic mechanisms underlying NRF2 pathway activation in PTC are not fully understood.  Thus, we aimed to det. whether inactivating patterns of DNA-level alterations affect genes encoding for individual NRF2 inhibitor complex components (CUL3/KEAP1/RBX1) occur in PTC.  Findings: Combined patterns of epi/genetic alterations for KEAP1/CUL3/RBX1 E3 ubiquitin-ligase complex components were simultaneously interrogated for a panel of 310 PTC cases and 40 adjacent non-malignant tissues.  Data were obtained from The Cancer Genome Atlas project.  Enrichment of NRF2 pathway activation was assessed by gene-set enrichment anal. using transcriptome data.  Our analyses revealed that PTC sustain a strikingly high frequency (80.6%) of disruption to multiple component genes of the NRF2 inhibitor complex.  Hypermethylation is the predominant inactivating mechanism primarily affecting KEAP1 (70.6%) and CUL3 (20%), while copy no. loss mostly affects RBX1 (16.8%).  Concordantly, NRF2-assocd. gene expression signatures are pos. and significantly enriched in PTC.  Conclusions: The KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex is almost ubiquitously affected by multiple DNA-level mechanisms and downstream NRF2 pathway targets are activated in PTC.  Given the importance of this pathway to normal thyroid function as well as to cancer; targeted inhibition of NRF2 regulators may impact strategies for therapeutic intervention involving this pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWzoZ4Y6-_X7Vg90H21EOLACvtfcHk0lhEhUvnZi6zMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVGgs7k%253D&md5=b153b49ee58416bf7af63fc5031f0f8b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-12-124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-12-124%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DV.%2BD.%26aulast%3DVucic%26aufirst%3DE.%2BA.%26aulast%3DPikor%26aufirst%3DL.%2BA.%26aulast%3DThu%26aufirst%3DK.%2BL.%26aulast%3DHubaux%26aufirst%3DR.%26aulast%3DLam%26aufirst%3DW.%2BL.%26atitle%3DFrequent%2520Concerted%2520Genetic%2520Mechanisms%2520Disrupt%2520Multiple%2520Components%2520of%2520the%2520Nrf2%2520Inhibitor%2520Keap1%252FCul3%252FRbx1%2520E3-Ubiquitin%2520Ligase%2520Complex%2520in%2520Thyroid%2520Cancer%26jtitle%3DMol.%2520Cancer%26date%3D2013%26volume%3D12%26spage%3D124%26doi%3D10.1186%2F1476-4598-12-124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arbour, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dienstag, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Vega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lito, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solit, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellmann, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kris, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcila, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladanyi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riely, G. J.</span></span> <span> </span><span class="NLM_article-title">Effects of Co-Occurring Genomic Alterations on Outcomes in Patients with Kras-Mutant Non-Small Cell Lung Cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">334</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-17-1841</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1158%2F1078-0432.CCR-17-1841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29089357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXoslGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=334-340&author=K.+C.+Arbourauthor=E.+J.+Jordanauthor=H.+R.+Kimauthor=J.+Dienstagauthor=H.+Yuauthor=F.+Sanchez-Vegaauthor=P.+Litoauthor=M.+F.+Bergerauthor=D.+B.+Solitauthor=M.+D.+Hellmannauthor=M.+G.+Krisauthor=C.+M.+Rudinauthor=A.+Niauthor=M.+E.+Arcilaauthor=M.+Ladanyiauthor=G.+J.+Riely&title=Effects+of+Co-Occurring+Genomic+Alterations+on+Outcomes+in+Patients+with+Kras-Mutant+Non-Small+Cell+Lung+Cancer&doi=10.1158%2F1078-0432.CCR-17-1841"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer</span></div><div class="casAuthors">Arbour, Kathryn C.; Jordan, Emmett; Kim, Hyunjae Ryan; Dienstag, Jordan; Yu, Helena A.; Sanchez-Vega, Francisco; Lito, Piro; Berger, Michael; Solit, David B.; Hellmann, Matthew; Kris, Mark G.; Rudin, Charles M.; Ni, Ai; Arcila, Maria; Ladanyi, Marc; Riely, Gregory J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">334-340</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: KRAS mutations occur in approx. 25% of patients with non-small cell lung cancer (NSCLC).  Despite the uniform presence of KRAS mutations, patients with KRAS-mutant NSCLC can have a heterogeneous clin. course.  As the pattern of co-occurring mutations may describe different biol. subsets of patients with KRAS-mutant lung adenocarcinoma, we explored the effects of co-occurring mutations on patient outcomes and response to therapy.  Exptl. Design: We identified patients with advanced KRAS-mutant NSCLC and evaluated the most common co-occurring genomic alterations.  Multivariate analyses were performed incorporating the most frequent co-mutations and clin. characteristics to evaluate assocn. with overall survival as well as response to platinum-pemetrexed chemotherapy and immune checkpoint inhibitors.  Results: Among 330 patients with advanced KRAS-mutant lung cancers, the most frequent co-mutations were found in TP53 (42%), STK11 (29%), and KEAP1/NFE2L2 (27%).  In a multivariate anal., there was a significantly shorter survival in patients with co-mutations in KEAP1/NFE2L2 [HR, 1.96; 95% confidence interval (CI), 1.33-2.92; P ≤ 0.001].  STK11 (HR, 1.3; P = 0.22) and TP53 (HR 1.11, P = 0.58) co-mutation statuses were not assocd. with survival.  Co-mutation in KEAP1/NFE2L2 was also assocd. with shorter duration of initial chemotherapy (HR, 1.64; 95% CI, 1.04-2.59; P = 0.03) and shorter overall survival from initiation of immune therapy (HR, 3.54; 95% CI, 1.55-8.11; P = 0.003).  Conclusions: Among people with KRAS-mutant advanced NSCLC, TP53, STK11, and KEAP1/NFE2L2 are the most commonly co-occurring somatic genomic alterations.  Co-mutation of KRAS and KEAP1/ NFE2L2 is an independent prognostic factor, predicting shorter survival, duration of response to initial platinum-based chemotherapy, and survival from the start of immune therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQMLK6BVfWxrVg90H21EOLACvtfcHk0lhEhUvnZi6zMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXoslGhtQ%253D%253D&md5=8261b7881085bda276b4d73920392eab</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-17-1841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-17-1841%26sid%3Dliteratum%253Aachs%26aulast%3DArbour%26aufirst%3DK.%2BC.%26aulast%3DJordan%26aufirst%3DE.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BR.%26aulast%3DDienstag%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DSanchez-Vega%26aufirst%3DF.%26aulast%3DLito%26aufirst%3DP.%26aulast%3DBerger%26aufirst%3DM.%2BF.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DHellmann%26aufirst%3DM.%2BD.%26aulast%3DKris%26aufirst%3DM.%2BG.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DNi%26aufirst%3DA.%26aulast%3DArcila%26aufirst%3DM.%2BE.%26aulast%3DLadanyi%26aufirst%3DM.%26aulast%3DRiely%26aufirst%3DG.%2BJ.%26atitle%3DEffects%2520of%2520Co-Occurring%2520Genomic%2520Alterations%2520on%2520Outcomes%2520in%2520Patients%2520with%2520Kras-Mutant%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2018%26volume%3D24%26spage%3D334%26epage%3D340%26doi%3D10.1158%2F1078-0432.CCR-17-1841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krall, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederst, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruddy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redig, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainor, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doench, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janne, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, R. E.,  Iii</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlabach, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span> <span> </span><span class="NLM_article-title">Keap1 Loss Modulates Sensitivity to Kinase Targeted Therapy in Lung Cancer</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e18970</span> <span class="refDoi"> DOI: 10.7554/eLife.18970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.7554%2FeLife.18970" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&author=E.+B.+Krallauthor=B.+Wangauthor=D.+M.+Munozauthor=N.+Ilicauthor=S.+Raghavanauthor=M.+J.+Niederstauthor=K.+Yuauthor=D.+A.+Ruddyauthor=A.+J.+Aguirreauthor=J.+W.+Kimauthor=A.+J.+Redigauthor=J.+F.+Gainorauthor=J.+A.+Williamsauthor=J.+M.+Asaraauthor=J.+G.+Doenchauthor=P.+A.+Janneauthor=A.+T.+Shawauthor=R.+E.+McDonaldauthor=J.+A.+Engelmanauthor=F.+Stegmeierauthor=M.+R.+Schlabachauthor=W.+C.+Hahn&title=Keap1+Loss+Modulates+Sensitivity+to+Kinase+Targeted+Therapy+in+Lung+Cancer&doi=10.7554%2FeLife.18970"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.7554%2FeLife.18970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.18970%26sid%3Dliteratum%253Aachs%26aulast%3DKrall%26aufirst%3DE.%2BB.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMunoz%26aufirst%3DD.%2BM.%26aulast%3DIlic%26aufirst%3DN.%26aulast%3DRaghavan%26aufirst%3DS.%26aulast%3DNiederst%26aufirst%3DM.%2BJ.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DRuddy%26aufirst%3DD.%2BA.%26aulast%3DAguirre%26aufirst%3DA.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DRedig%26aufirst%3DA.%2BJ.%26aulast%3DGainor%26aufirst%3DJ.%2BF.%26aulast%3DWilliams%26aufirst%3DJ.%2BA.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DDoench%26aufirst%3DJ.%2BG.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DMcDonald%26aufirst%3DR.%2BE.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DSchlabach%26aufirst%3DM.%2BR.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26atitle%3DKeap1%2520Loss%2520Modulates%2520Sensitivity%2520to%2520Kinase%2520Targeted%2520Therapy%2520in%2520Lung%2520Cancer%26jtitle%3DeLife%26date%3D2017%26volume%3D6%26doi%3D10.7554%2FeLife.18970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-Y.</span></span> <span> </span><span class="NLM_article-title">Resistance to Gefitinib and Cross-Resistance to Irreversible Egfr-Tkis Mediated by Disruption of the Keap1-Nrf2 Pathway in Human Lung Cancer Cells</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">5862</span>, <span class="refDoi"> DOI: 10.1096/fj.201800011R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1096%2Ffj.201800011R" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=5862&author=S.-H.+Parkauthor=J.+H.+Kimauthor=E.+Koauthor=J.-Y.+Kimauthor=M.-J.+Parkauthor=M.+J.+Kimauthor=H.+Seoauthor=S.+Liauthor=J.-Y.+Lee&title=Resistance+to+Gefitinib+and+Cross-Resistance+to+Irreversible+Egfr-Tkis+Mediated+by+Disruption+of+the+Keap1-Nrf2+Pathway+in+Human+Lung+Cancer+Cells&doi=10.1096%2Ffj.201800011R"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1096%2Ffj.201800011R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201800011R%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.-H.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKo%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DJ.-Y.%26aulast%3DPark%26aufirst%3DM.-J.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DSeo%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.-Y.%26atitle%3DResistance%2520to%2520Gefitinib%2520and%2520Cross-Resistance%2520to%2520Irreversible%2520Egfr-Tkis%2520Mediated%2520by%2520Disruption%2520of%2520the%2520Keap1-Nrf2%2520Pathway%2520in%2520Human%2520Lung%2520Cancer%2520Cells%26jtitle%3DFASEB%2520J.%26date%3D2018%26volume%3D32%26spage%3D5862%26doi%3D10.1096%2Ffj.201800011R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeNicola, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karreth, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humpton, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopinathan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frese, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calhoun, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scrimieri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span> <span> </span><span class="NLM_article-title">Oncogene-Induced Nrf2 Transcription Promotes Ros Detoxification and Tumorigenesis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>475</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1038/nature10189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fnature10189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21734707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFemtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=106-109&author=G.+M.+DeNicolaauthor=F.+A.+Karrethauthor=T.+J.+Humptonauthor=A.+Gopinathanauthor=C.+Weiauthor=K.+Freseauthor=D.+Mangalauthor=K.+H.+Yuauthor=C.+J.+Yeoauthor=E.+S.+Calhounauthor=F.+Scrimieriauthor=J.+M.+Winterauthor=R.+H.+Hrubanauthor=C.+Iacobuzio-Donahueauthor=S.+E.+Kernauthor=I.+A.+Blairauthor=D.+A.+Tuveson&title=Oncogene-Induced+Nrf2+Transcription+Promotes+Ros+Detoxification+and+Tumorigenesis&doi=10.1038%2Fnature10189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis</span></div><div class="casAuthors">DeNicola, Gina M.; Karreth, Florian A.; Humpton, Timothy J.; Gopinathan, Aarthi; Wei, Cong; Frese, Kristopher; Mangal, Dipti; Yu, Kenneth H.; Yeo, Charles J.; Calhoun, Eric S.; Scrimieri, Francesca; Winter, Jordan M.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.; Blair, Ian A.; Tuveson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7354</span>),
    <span class="NLM_cas:pages">106-109</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) are mutagenic and may thereby promote cancer.  Normally, ROS levels are tightly controlled by an inducible antioxidant program that responds to cellular stressors and is predominantly regulated by the transcription factor Nrf2 (also known as Nfe2l2) and its repressor protein Keap1 (refs. 2-5).  In contrast to the acute physiol. regulation of Nrf2, in neoplasia there is evidence for increased basal activation of Nrf2.  Indeed, somatic mutations that disrupt the Nrf2-Keap1 interaction to stabilize Nrf2 and increase the constitutive transcription of Nrf2 target genes were recently identified, indicating that enhanced ROS detoxification and addnl. Nrf2 functions may in fact be pro-tumorigenic.  Here, we investigated ROS metab. in primary murine cells following the expression of endogenous oncogenic alleles of Kras, Braf and Myc, and found that ROS are actively suppressed by these oncogenes.  K-RasG12D, B-RafV619E and MycERT2 each increased the transcription of Nrf2 to stably elevate the basal Nrf2 antioxidant program and thereby lower intracellular ROS and confer a more reduced intracellular environment.  Oncogene-directed increased expression of Nrf2 is a new mechanism for the activation of the Nrf2 antioxidant program, and is evident in primary cells and tissues of mice expressing K-RasG12D and B-RafV619E, and in human pancreatic cancer.  Furthermore, genetic targeting of the Nrf2 pathway impairs K-RasG12D-induced proliferation and tumorigenesis in vivo.  Thus, the Nrf2 antioxidant and cellular detoxification program represents a previously unappreciated mediator of oncogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFpMbvjw2msLVg90H21EOLACvtfcHk0liNJCVHwsNwrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFemtr0%253D&md5=54d0e0b5940672a96bde0f8cfd9e7ff9</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fnature10189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10189%26sid%3Dliteratum%253Aachs%26aulast%3DDeNicola%26aufirst%3DG.%2BM.%26aulast%3DKarreth%26aufirst%3DF.%2BA.%26aulast%3DHumpton%26aufirst%3DT.%2BJ.%26aulast%3DGopinathan%26aufirst%3DA.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DFrese%26aufirst%3DK.%26aulast%3DMangal%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DK.%2BH.%26aulast%3DYeo%26aufirst%3DC.%2BJ.%26aulast%3DCalhoun%26aufirst%3DE.%2BS.%26aulast%3DScrimieri%26aufirst%3DF.%26aulast%3DWinter%26aufirst%3DJ.%2BM.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%26aulast%3DKern%26aufirst%3DS.%2BE.%26aulast%3DBlair%26aufirst%3DI.%2BA.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26atitle%3DOncogene-Induced%2520Nrf2%2520Transcription%2520Promotes%2520Ros%2520Detoxification%2520and%2520Tumorigenesis%26jtitle%3DNature%26date%3D2011%26volume%3D475%26spage%3D106%26epage%3D109%26doi%3D10.1038%2Fnature10189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span> <span> </span><span class="NLM_article-title">Keap Calm, and Carry on Covalently</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7463</span>– <span class="NLM_lpage">7476</span>, <span class="refDoi"> DOI: 10.1021/jm400224q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400224q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7463-7476&author=A.+J.+Wilsonauthor=J.+K.+Kernsauthor=J.+F.+Callahanauthor=C.+J.+Moody&title=Keap+Calm%2C+and+Carry+on+Covalently&doi=10.1021%2Fjm400224q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Keap Calm, and Carry on Covalently</span></div><div class="casAuthors">Wilson, Anthony J.; Kerns, Jeffrey K.; Callahan, James F.; Moody, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7463-7476</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The Nrf2-Keap1 system plays a major role in cellular defense against oxidative stress.  Upon exposure to electrophiles, the cysteine-rich protein Keap1 is covalently modified, and it is this modification of Keap1 that allows the accumulation and subsequent nuclear translocation of Nrf2 where it induces the transcription of over 100 protective genes.  This mechanism can be exploited in drug discovery approaches to diseases such as chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), asthma, and neurodegenerative diseases like multiple sclerosis (MS) and Parkinson's, utilizing the modification of Keap1 by electrophiles, compds. that would not normally be considered useful in drug discovery programs.  This Perspective discusses the development of potential therapies based on potent electrophiles, such as isothiocyanates and Michael acceptors, that, far from being assocd. with toxic events, can actually initiate a range of beneficial protective pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFM-f4P1ElOLVg90H21EOLACvtfcHk0liNJCVHwsNwrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtbvE&md5=ea907fb2ccd8c28142ab4fa2776d0195</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjm400224q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400224q%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DKeap%2520Calm%252C%2520and%2520Carry%2520on%2520Covalently%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7463%26epage%3D7476%26doi%3D10.1021%2Fjm400224q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Modulators of Keap1-Nrf2–ARe Pathway as Potential Preventive and Therapeutic Agents</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1002/med.21257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1002%2Fmed.21257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22549716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=687-726&author=S.+Mageshauthor=Y.+Chenauthor=L.+Hu&title=Small+Molecule+Modulators+of+Keap1-Nrf2%E2%80%93ARe+Pathway+as+Potential+Preventive+and+Therapeutic+Agents&doi=10.1002%2Fmed.21257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents</span></div><div class="casAuthors">Magesh, Sadagopan; Chen, Yu; Hu, Longqin</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">687-726</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Kelch-like ECH-assocd. protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response elements (ARE) pathway represents one of the most important cellular defense mechanisms against oxidative stress and xenobiotic damage.  Activation of Nrf2 signaling induces the transcriptional regulation of ARE-dependent expression of various detoxifying and antioxidant defense enzymes and proteins.  Keap1-Nrf2-ARE signaling has become an attractive target for the prevention and treatment of oxidative stress-related diseases and conditions including cancer, neurodegenerative, cardiovascular, metabolic, and inflammatory diseases.  Over the last few decades, numerous Nrf2 inducers have been developed and some of them are currently undergoing clin. trials.  Recently, overactivation of Nrf2 has been implicated in cancer progression as well as in drug resistance to cancer chemotherapy.  Thus, Nrf2 inhibitors could potentially be used to improve the effectiveness of cancer therapy.  Herein, we review the signaling mechanism of Keap1-Nrf2-ARE pathway, its disease relevance, and currently known classes of small mol. modulators.  We also discuss several aspects of Keap1-Nrf2 interaction, Nrf2-based peptide inhibitor design, and the screening assays currently used for the discovery of direct inhibitors of Keap1-Nrf2 interaction. © 2012 Wiley Periodicals, Inc.  Med Res Rev., 32, No. 4, 687-726, 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhLmdkuTSh7Vg90H21EOLACvtfcHk0ljQc7VuytEtnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D&md5=2104d731cb251e0d9b6d2ad73a735175</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1002%2Fmed.21257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21257%26sid%3Dliteratum%253Aachs%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DSmall%2520Molecule%2520Modulators%2520of%2520Keap1-Nrf2%25E2%2580%2593ARe%2520Pathway%2520as%2520Potential%2520Preventive%2520and%2520Therapeutic%2520Agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D687%26epage%3D726%26doi%3D10.1002%2Fmed.21257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
la Monte, S. M.</span></span> <span> </span><span class="NLM_article-title">Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer’s Disease</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1007/s40265-016-0674-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1007%2Fs40265-016-0674-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27988872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFensL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=47-65&author=S.+M.+de%0Ala+Monte&title=Insulin+Resistance+and+Neurodegeneration%3A+Progress+Towards+the+Development+of+New+Therapeutics+for+Alzheimer%E2%80%99s+Disease&doi=10.1007%2Fs40265-016-0674-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease</span></div><div class="casAuthors">de la Monte, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-65</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) should be regarded as a degenerative metabolic disease caused by brain insulin resistance and deficiency, and overlapping with the mol., biochem., pathophysiol., and metabolic dysfunctions in diabetes mellitus, non-alc. fatty liver disease, and metabolic syndrome.  Although most of the diagnostic and therapeutic approaches over the past several decades have focused on amyloid-beta (Aβ42) and aberrantly phosphorylated tau, which could be caused by consequences of brain insulin resistance, the broader array of pathologies including white matter atrophy with loss of myelinated fibrils and leukoaraiosis, non-Aβ42 microvascular disease, dysregulated lipid metab., mitochondrial dysfunction, astrocytic gliosis, neuro-inflammation, and loss of synapses vis-a´-vis growth of dystrophic neurites, is not readily accounted for by Aβ42 accumulations, but could be explained by dysregulated insulin/IGF-1 signaling with attendant impairments in signal transduction and gene expression.  This review covers the diverse range of brain abnormalities in AD and discusses how insulins, incretins, and insulin sensitizers could be utilized to treat at different stages of neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR5pvj20J9cbVg90H21EOLACvtfcHk0ljQc7VuytEtnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFensL7N&md5=e3f0d4e1d99a3ae67ea96fd0b6e2b736</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1007%2Fs40265-016-0674-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-016-0674-0%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Bla%2BMonte%26aufirst%3DS.%2BM.%26atitle%3DInsulin%2520Resistance%2520and%2520Neurodegeneration%253A%2520Progress%2520Towards%2520the%2520Development%2520of%2520New%2520Therapeutics%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DDrugs%26date%3D2017%26volume%3D77%26spage%3D47%26epage%3D65%26doi%3D10.1007%2Fs40265-016-0674-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurokawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sou, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iemura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natsume, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kominami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">The Selective Autophagy Substrate P62 Activates the Stress Responsive Transcription Factor Nrf2 through Inactivation of Keap1</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1038/ncb2021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fncb2021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20173742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFemsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=213-223&author=M.+Komatsuauthor=H.+Kurokawaauthor=S.+Waguriauthor=K.+Taguchiauthor=A.+Kobayashiauthor=Y.+Ichimuraauthor=Y.+S.+Souauthor=I.+Uenoauthor=A.+Sakamotoauthor=K.+I.+Tongauthor=M.+Kimauthor=Y.+Nishitoauthor=S.+Iemuraauthor=T.+Natsumeauthor=T.+Uenoauthor=E.+Kominamiauthor=H.+Motohashiauthor=K.+Tanakaauthor=M.+Yamamoto&title=The+Selective+Autophagy+Substrate+P62+Activates+the+Stress+Responsive+Transcription+Factor+Nrf2+through+Inactivation+of+Keap1&doi=10.1038%2Fncb2021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1</span></div><div class="casAuthors">Komatsu, Masaaki; Kurokawa, Hirofumi; Waguri, Satoshi; Taguchi, Keiko; Kobayashi, Akira; Ichimura, Yoshinobu; Sou, Yu-Shin; Ueno, Izumi; Sakamoto, Ayako; Tong, Kit I.; Kim, Mihee; Nishito, Yasumasa; Iemura, Shun-ichiro; Natsume, Tohru; Ueno, Takashi; Kominami, Eiki; Motohashi, Hozumi; Tanaka, Keiji; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-223</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Impaired selective turnover of p62 by autophagy causes severe liver injury accompanied by the formation of p62-pos. inclusions and upregulation of detoxifying enzymes.  These phenotypes correspond closely to the pathol. conditions seen in human liver diseases, including alc. hepatitis and hepatocellular carcinoma.  However, the mol. mechanisms and pathophysiol. processes in these events are still unknown.  Here we report the identification of a novel regulatory mechanism by p62 of the transcription factor Nrf2, whose target genes include antioxidant proteins and detoxification enzymes. p62 interacts with the Nrf2-binding site on Keap1, a component of Cullin-3-type ubiquitin ligase for Nrf2.  Thus, an overprodn. of p62 or a deficiency in autophagy competes with the interaction between Nrf2 and Keap1, resulting in stabilization of Nrf2 and transcriptional activation of Nrf2 target genes.  Our findings indicate that the pathol. process assocd. with p62 accumulation results in hyperactivation of Nrf2 and delineates unexpected roles of selective autophagy in controlling the transcription of cellular defense enzyme genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozHwUzLt-LiLVg90H21EOLACvtfcHk0ljQc7VuytEtnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFemsL8%253D&md5=f66692c056ff13937de3affac38f31c9</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1038%2Fncb2021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2021%26sid%3Dliteratum%253Aachs%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DKurokawa%26aufirst%3DH.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DSou%26aufirst%3DY.%2BS.%26aulast%3DUeno%26aufirst%3DI.%26aulast%3DSakamoto%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DNishito%26aufirst%3DY.%26aulast%3DIemura%26aufirst%3DS.%26aulast%3DNatsume%26aufirst%3DT.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DKominami%26aufirst%3DE.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DThe%2520Selective%2520Autophagy%2520Substrate%2520P62%2520Activates%2520the%2520Stress%2520Responsive%2520Transcription%2520Factor%2520Nrf2%2520through%2520Inactivation%2520of%2520Keap1%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26spage%3D213%26epage%3D223%26doi%3D10.1038%2Fncb2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">A Systematic Molecular Dynamics Approach to the Study of Peptide Keap1-Nrf2 Protein-Protein Interaction Inhibitors and Its Application to P62 Peptides</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1378</span>– <span class="NLM_lpage">1387</span>, <span class="refDoi"> DOI: 10.1039/C6MB00030D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1039%2FC6MB00030D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26935067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFOmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=1378-1387&author=M.-C.+Luauthor=Z.-W.+Yuanauthor=Y.-L.+Jiangauthor=Z.-Y.+Chenauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=A+Systematic+Molecular+Dynamics+Approach+to+the+Study+of+Peptide+Keap1-Nrf2+Protein-Protein+Interaction+Inhibitors+and+Its+Application+to+P62+Peptides&doi=10.1039%2FC6MB00030D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">A systematic molecular dynamics approach to the study of peptide Keap1-Nrf2 protein-protein interaction inhibitors and its application to p62 peptides</span></div><div class="casAuthors">Lu, Meng-Chen; Yuan, Zhen-Wei; Jiang, Yong-Lin; Chen, Zhi-Yun; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1378-1387</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Protein-protein interactions (PPIs) as drug targets have been gaining growing interest, though developing drug-like small mol. PPI inhibitors remains challenging.  Peptide PPI inhibitors, which can provide informative data on the PPI interface, are good starting points to develop small mol. modulators.  Computational methods combining mol. dynamics simulations and binding energy calcns. could give both the structural and the energetic perspective of peptide PPI inhibitors.  Herein, we set up a computational workflow to investigate Keap1-Nrf2 peptide PPI inhibitors and predict the activity of novel sequences.  Furthermore, we applied this method to investigate p62 peptides as PPI inhibitors of Keap1-Nrf2 and explored the activity change induced by the phosphorylation of serine.  Our results showed that because of the unfavorable solvation effects, the binding affinity of the phosphorylated p62 peptide is lower than the Nrf2 ETGE peptide.  Our research results not only provide a useful method to investigate the Keap1-Nrf2 peptide inhibitors, but also give a good example to show how to incorporate computational methods into the study of peptide PPI inhibitors.  Besides, applying this method to p62 peptides provides a detailed explanation for the expression of cytoprotective Nrf2 targets induced by p62 phosphorylation, which may benefit the further study of the crosstalk between the Keap1-Nrf2 pathway and p62-mediated selective autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTSi4VF8fkabVg90H21EOLACvtfcHk0lh2xlm5moh_iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFOmtrk%253D&md5=81ccd32348455f5a99993139c2cb1441</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1039%2FC6MB00030D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MB00030D%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DYuan%26aufirst%3DZ.-W.%26aulast%3DJiang%26aufirst%3DY.-L.%26aulast%3DChen%26aufirst%3DZ.-Y.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DA%2520Systematic%2520Molecular%2520Dynamics%2520Approach%2520to%2520the%2520Study%2520of%2520Peptide%2520Keap1-Nrf2%2520Protein-Protein%2520Interaction%2520Inhibitors%2520and%2520Its%2520Application%2520to%2520P62%2520Peptides%26jtitle%3DMol.%2520BioSyst.%26date%3D2016%26volume%3D12%26spage%3D1378%26epage%3D1387%26doi%3D10.1039%2FC6MB00030D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sou, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kageyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukutomi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoshii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of P62 Activates the Keap1-Nrf2 Pathway During Selective Autophagy</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">618</span>– <span class="NLM_lpage">631</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2013.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.molcel.2013.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24011591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWisrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2013&pages=618-631&author=Y.+Ichimuraauthor=S.+Waguriauthor=Y.+S.+Souauthor=S.+Kageyamaauthor=J.+Hasegawaauthor=R.+Ishimuraauthor=T.+Saitoauthor=Y.+Yangauthor=T.+Kounoauthor=T.+Fukutomiauthor=T.+Hoshiiauthor=A.+Hiraoauthor=K.+Takagiauthor=T.+Mizushimaauthor=H.+Motohashiauthor=M.+S.+Leeauthor=T.+Yoshimoriauthor=K.+Tanakaauthor=M.+Yamamotoauthor=M.+Komatsu&title=Phosphorylation+of+P62+Activates+the+Keap1-Nrf2+Pathway+During+Selective+Autophagy&doi=10.1016%2Fj.molcel.2013.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy</span></div><div class="casAuthors">Ichimura, Yoshinobu; Waguri, Satoshi; Sou, Yu-shin; Kageyama, Shun; Hasegawa, Jun; Ishimura, Ryosuke; Saito, Tetsuya; Yang, Yinjie; Kouno, Tsuguka; Fukutomi, Toshiaki; Hoshii, Takayuki; Hirao, Atsushi; Takagi, Kenji; Mizushima, Tsunehiro; Motohashi, Hozumi; Lee, Myung-Shik; Yoshimori, Tamotsu; Tanaka, Keiji; Yamamoto, Masayuki; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">618-631</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The Keap1-Nrf2 system and autophagy are both involved in the oxidative-stress response, metabolic pathways, and innate immunity, and dysregulation of these processes is assocd. with pathogenic processes.  However, the interplay between these two pathways remains largely unknown.  Here, we show that phosphorylation of the autophagy-adaptor protein p62 markedly increases p62's binding affinity for Keap1, an adaptor of the Cul3-ubiquitin E3 ligase complex responsible for degrading Nrf2.  Thus, p62 phosphorylation induces expression of cytoprotective Nrf2 targets.  P62 is assembled on selective autophagic cargos such as ubiquitinated organelles and subsequently phosphorylated in an mTORC1-dependent manner, implying coupling of the Keap1-Nrf2 system to autophagy.  Furthermore, persistent activation of Nrf2 through accumulation of phosphorylated p62 contributes to the growth of human hepatocellular carcinomas (HCCs).  These results demonstrate that selective autophagy and the Keap1-Nrf2 pathway are interdependent, and that inhibitors of the interaction between phosphorylated p62 and Keap1 have potential as therapeutic agents against human HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF8YrIIgNZobVg90H21EOLACvtfcHk0lh2xlm5moh_iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWisrzI&md5=35f19332a5d851412ff0ba8132f1c68f</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2013.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2013.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DSou%26aufirst%3DY.%2BS.%26aulast%3DKageyama%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DJ.%26aulast%3DIshimura%26aufirst%3DR.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DKouno%26aufirst%3DT.%26aulast%3DFukutomi%26aufirst%3DT.%26aulast%3DHoshii%26aufirst%3DT.%26aulast%3DHirao%26aufirst%3DA.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DMizushima%26aufirst%3DT.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DYoshimori%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DPhosphorylation%2520of%2520P62%2520Activates%2520the%2520Keap1-Nrf2%2520Pathway%2520During%2520Selective%2520Autophagy%26jtitle%3DMol.%2520Cell%26date%3D2013%26volume%3D51%26spage%3D618%26epage%3D631%26doi%3D10.1016%2Fj.molcel.2013.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">P62 in Cancer: Signaling Adaptor Beyond Autophagy</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">609</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.09.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.cell.2016.09.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27768885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCrsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2016&pages=606-609&author=J.+Moscatauthor=M.+Karinauthor=M.+T.+Diaz-Meco&title=P62+in+Cancer%3A+Signaling+Adaptor+Beyond+Autophagy&doi=10.1016%2Fj.cell.2016.09.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">p62 in Cancer: Signaling Adaptor Beyond Autophagy</span></div><div class="casAuthors">Moscat, Jorge; Karin, Michael; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">606-609</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Adaptor proteins participate in selective autophagy, which is crit. for cellular detoxification and stress relief.  However, new evidence supports an autophagy-independent key role of the adaptor p62 (encoded by the gene Sqstm1) in signaling functions central to tumor initiation in the epithelium and suppression of tumor progression in the stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfCL87hjyvcbVg90H21EOLACvtfcHk0lh2xlm5moh_iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCrsrjL&md5=cb962ea1adfd7935b4fbe0eba4b7049b</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3DP62%2520in%2520Cancer%253A%2520Signaling%2520Adaptor%2520Beyond%2520Autophagy%26jtitle%3DCell%26date%3D2016%26volume%3D167%26spage%3D606%26epage%3D609%26doi%3D10.1016%2Fj.cell.2016.09.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Umemura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamachika, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Font-Burgada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghunandan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linares, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reina-Campos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umemura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valasek, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">P62, Upregulated During Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed Hcc-Initiating Cells</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">948</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2016.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.ccell.2016.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27211490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28Xotlentro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=935-948&author=A.+Umemuraauthor=F.+Heauthor=K.+Taniguchiauthor=H.+Nakagawaauthor=S.+Yamachikaauthor=J.+Font-Burgadaauthor=Z.+Zhongauthor=S.+Subramaniamauthor=S.+Raghunandanauthor=A.+Duranauthor=J.+F.+Linaresauthor=M.+Reina-Camposauthor=S.+Umemuraauthor=M.+A.+Valasekauthor=E.+Sekiauthor=K.+Yamaguchiauthor=K.+Koikeauthor=Y.+Itohauthor=M.+T.+Diaz-Mecoauthor=J.+Moscatauthor=M.+Karin&title=P62%2C+Upregulated+During+Preneoplasia%2C+Induces+Hepatocellular+Carcinogenesis+by+Maintaining+Survival+of+Stressed+Hcc-Initiating+Cells&doi=10.1016%2Fj.ccell.2016.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells</span></div><div class="casAuthors">Umemura, Atsushi; He, Feng; Taniguchi, Koji; Nakagawa, Hayato; Yamachika, Shinichiro; Font-Burgada, Joan; Zhong, Zhenyu; Subramaniam, Shankar; Raghunandan, Sindhu; Duran, Angeles; Linares, Juan F.; Reina-Campos, Miguel; Umemura, Shiori; Valasek, Mark A.; Seki, Ekihiro; Yamaguchi, Kanji; Koike, Kazuhiko; Itoh, Yoshito; Diaz-Meco, Maria T.; Moscat, Jorge; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">935-948</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">P62 is a ubiquitin-binding autophagy receptor and signaling protein that accumulates in premalignant liver diseases and most hepatocellular carcinomas (HCCs).  Although p62 was proposed to participate in the formation of benign adenomas in autophagy-deficient livers, its role in HCC initiation was not explored.  Here we show that p62 is necessary and sufficient for HCC induction in mice and that its high expression in non-tumor human liver predicts rapid HCC recurrence after curative ablation.  High p62 expression is needed for activation of NRF2 and mTORC1, induction of c-Myc, and protection of HCC-initiating cells from oxidative stress-induced death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG3PmjQwQ86bVg90H21EOLACvtfcHk0lhLyhi8OOPEhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xotlentro%253D&md5=c8b15119ef52aacdc15ea7a9a3ee39e2</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2016.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2016.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DUmemura%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DTaniguchi%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DYamachika%26aufirst%3DS.%26aulast%3DFont-Burgada%26aufirst%3DJ.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DSubramaniam%26aufirst%3DS.%26aulast%3DRaghunandan%26aufirst%3DS.%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DLinares%26aufirst%3DJ.%2BF.%26aulast%3DReina-Campos%26aufirst%3DM.%26aulast%3DUmemura%26aufirst%3DS.%26aulast%3DValasek%26aufirst%3DM.%2BA.%26aulast%3DSeki%26aufirst%3DE.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DKoike%26aufirst%3DK.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DP62%252C%2520Upregulated%2520During%2520Preneoplasia%252C%2520Induces%2520Hepatocellular%2520Carcinogenesis%2520by%2520Maintaining%2520Survival%2520of%2520Stressed%2520Hcc-Initiating%2520Cells%26jtitle%3DCancer%2520Cell%26date%3D2016%26volume%3D29%26spage%3D935%26epage%3D948%26doi%3D10.1016%2Fj.ccell.2016.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuasa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashino, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Keap1-Phosphorylated P62 and Keap1-Nrf2 Protein-Protein Interaction Inhibitors and Their Inhibitory Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5956</span>– <span class="NLM_lpage">5959</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.bmcl.2016.10.083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27839920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVCitr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5956-5959&author=D.+Yasudaauthor=M.+Nakajimaauthor=A.+Yuasaauthor=R.+Obataauthor=K.+Takahashiauthor=T.+Oheauthor=Y.+Ichimuraauthor=M.+Komatsuauthor=M.+Yamamotoauthor=R.+Imamuraauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Naganoauthor=T.+Mashino&title=Synthesis+of+Keap1-Phosphorylated+P62+and+Keap1-Nrf2+Protein-Protein+Interaction+Inhibitors+and+Their+Inhibitory+Activity&doi=10.1016%2Fj.bmcl.2016.10.083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activity</span></div><div class="casAuthors">Yasuda, Daisuke; Nakajima, Mao; Yuasa, Akihiro; Obata, Rika; Takahashi, Kyoko; Ohe, Tomoyuki; Ichimura, Yoshinobu; Komatsu, Masaaki; Yamamoto, Masayuki; Imamura, Riyo; Kojima, Hirotatsu; Okabe, Takayoshi; Nagano, Tetsuo; Mashino, Tadahiko</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5956-5959</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Keap1-Nrf2 system is involved not only in biol. defense but also in malignancy progression and chemoresistance.  The ubiquitin-binding protein p62/Sqstm1 (p62), which is highly expressed in several cancers, competes with Nrf2 for Keap1 binding, leading to activation of Nrf2-mediated gene expression and survival of cancer cells.  The authors had previously identified an inhibitor for the Keap1-phosphorylated-p62 (p-p62) protein-protein interaction (PPI), the acetonyl naphthalene deriv. K67.  The authors established facile synthetic routes for K67 and derivs. with various side chains on the C-2 position of naphthalene ring.  K67 possessed high selectivity in the inhibition of Keap1-p-p62.  Other derivs. showed potent Keap1-Nrf2 and Keap1-p-p62 PPI inhibitory activities, though the selectivity between the two activities was lower than K67.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobdbq29sjZhbVg90H21EOLACvtfcHk0lhLyhi8OOPEhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVCitr3F&md5=a2122d98f2378ab2b167a246dc7f9408</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.083%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DNakajima%26aufirst%3DM.%26aulast%3DYuasa%26aufirst%3DA.%26aulast%3DObata%26aufirst%3DR.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DImamura%26aufirst%3DR.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DMashino%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520Keap1-Phosphorylated%2520P62%2520and%2520Keap1-Nrf2%2520Protein-Protein%2520Interaction%2520Inhibitors%2520and%2520Their%2520Inhibitory%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5956%26epage%3D5959%26doi%3D10.1016%2Fj.bmcl.2016.10.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Iaspp Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">561</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2017.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.ccell.2017.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29033244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjs7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=561&author=W.+Geauthor=K.+Zhaoauthor=X.+Wangauthor=H.+Liauthor=M.+Yuauthor=M.+Heauthor=X.+Xueauthor=Y.+Zhuauthor=C.+Zhangauthor=Y.+Chengauthor=S.+Jiangauthor=Y.+Hu&title=Iaspp+Is+an+Antioxidative+Factor+and+Drives+Cancer+Growth+and+Drug+Resistance+by+Competing+with+Nrf2+for+Keap1+Binding&doi=10.1016%2Fj.ccell.2017.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding</span></div><div class="casAuthors">Ge, Wenjie; Zhao, Kunming; Wang, Xingwen; Li, Huayi; Yu, Miao; He, Mengmeng; Xue, Xuting; Zhu, Yifu; Zhang, Cheng; Cheng, Yiwei; Jiang, Shijian; Hu, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">561-573.e6</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) have emerged as important signaling mols. that play crucial roles in carcinogenesis and cytotoxic responses.  Nrf2 is the master regulator of ROS balance.  Thus, uncovering mechanisms of Nrf2 regulation is important for the development of alternative treatment strategies for cancers.  Here, we demonstrate that iASPP, a known p53 inhibitor, lowers ROS independently of p53.  Mechanistically, iASPP competes with Nrf2 for Keap1 binding via a DLT motif, leading to decreased Nrf2 ubiquitination and increased Nrf2 accumulation, nuclear translocation, and antioxidative transactivation.  This iASPP-Keap1-Nrf2 axis promotes cancer growth and drug resistance both in vitro and in vivo.  Thus, iASPP is an antioxidative factor and represents a promising target to improve cancer treatment, regardless of p53 status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgG9GfPOFfIrVg90H21EOLACvtfcHk0lgeDl7MFztLXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjs7zE&md5=f2e27a7dee5602a3aba046c0efb34ef7</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2017.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2017.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DIaspp%2520Is%2520an%2520Antioxidative%2520Factor%2520and%2520Drives%2520Cancer%2520Growth%2520and%2520Drug%2520Resistance%2520by%2520Competing%2520with%2520Nrf2%2520for%2520Keap1%2520Binding%26jtitle%3DCancer%2520Cell%26date%3D2017%26volume%3D32%26spage%3D561%26doi%3D10.1016%2Fj.ccell.2017.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Oncogene-Stimulated Congestion at the Keap1 Stress Signaling Hub Allows Bypass of Nrf2 and Induction of Nrf2-Target Genes That Promote Tumor Survival</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2017.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.ccell.2017.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29136497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVShs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=539-541&author=J.+D.+Hayesauthor=A.+T.+Dinkova-Kostova&title=Oncogene-Stimulated+Congestion+at+the+Keap1+Stress+Signaling+Hub+Allows+Bypass+of+Nrf2+and+Induction+of+Nrf2-Target+Genes+That+Promote+Tumor+Survival&doi=10.1016%2Fj.ccell.2017.10.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogene-Stimulated Congestion at the KEAP1 Stress Signaling Hub Allows Bypass of NRF2 and Induction of NRF2-Target Genes that Promote Tumor Survival</span></div><div class="casAuthors">Hayes, John D.; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">539-541</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">In this issue of Cancer Cell, Ge et al. show that overexpression of the oncoprotein iASPP in cancer cells provokes NRF2-mediated induction of cytoprotective genes, because it logjams the ubiquitin ligase substrate adaptor function of KEAP1 by virtue of the fact that it possesses a novel DLT-contg. KEAP1-interaction motif.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv_cW2de-Oq7Vg90H21EOLACvtfcHk0lgeDl7MFztLXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVShs7fK&md5=7aeabf63a02ae6f51a7026d7682dd8a2</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2017.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2017.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DOncogene-Stimulated%2520Congestion%2520at%2520the%2520Keap1%2520Stress%2520Signaling%2520Hub%2520Allows%2520Bypass%2520of%2520Nrf2%2520and%2520Induction%2520of%2520Nrf2-Target%2520Genes%2520That%2520Promote%2520Tumor%2520Survival%26jtitle%3DCancer%2520Cell%26date%3D2017%26volume%3D32%26spage%3D539%26epage%3D541%26doi%3D10.1016%2Fj.ccell.2017.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lastres-Becker, I.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Targeting of Gsk-3 and Nrf2 Provides Neuroprotection in a Preclinical Model of Tauopathy</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">522</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2017.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.redox.2017.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29121589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslOisLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=522-534&author=A.+Cuadradoauthor=S.+Kuglerauthor=I.+Lastres-Becker&title=Pharmacological+Targeting+of+Gsk-3+and+Nrf2+Provides+Neuroprotection+in+a+Preclinical+Model+of+Tauopathy&doi=10.1016%2Fj.redox.2017.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy</span></div><div class="casAuthors">Cuadrado, Antonio; Kugler, Sebastian; Lastres-Becker, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">522-534</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tauopathies are a group of neurodegenerative disorders where TAU protein is presented as aggregates or is abnormally phosphorylated, leading to alterations of axonal transport, neuronal death and neuroinflammation.  Currently, there is no treatment to slow progression of these diseases.  Here, we have investigated whether di-Me fumarate (DMF), an inducer of the transcription factor NRF2, could mitigate tauopathy in a mouse model.  The signaling pathways modulated by DMF were also studied in mouse embryonic fibroblast (MEFs) from wild type or KEAP1-deficient mice.  The effect of DMF on neurodegeneration, astrocyte and microglial activation was examd. in Nrf2+/+ and Nrf2-/- mice stereotaxically injected in the right hippocampus with an adeno-assocd. vector expressing human TAUP301L and treated daily with DMF (100 mg/kg, i.g) during three weeks.  DMF induces the NRF2 transcriptional through a mechanism that involves KEAP1 but also PI3K/AKT/GSK-3-dependent pathways.  DMF modulates GSK-3β activity in mouse hippocampi.  Furthermore, DMF modulates TAU phosphorylation, neuronal impairment measured by calbindin-D28K and BDNF expression, and inflammatory processes involved in astrogliosis, microgliosis and pro-inflammatory cytokines prodn.  This study reveals neuroprotective effects of DMF beyond disruption of the KEAP1/NRF2 axis by inhibiting GSK3 in a mouse model of tauopathy.  Our results support repurposing of this drug for treatment of these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjcpkJLPUbpLVg90H21EOLACvtfcHk0lgeDl7MFztLXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslOisLfJ&md5=bdf40d78ab1261cddb8673fe0d9ffdd7</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2017.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DKugler%26aufirst%3DS.%26aulast%3DLastres-Becker%26aufirst%3DI.%26atitle%3DPharmacological%2520Targeting%2520of%2520Gsk-3%2520and%2520Nrf2%2520Provides%2520Neuroprotection%2520in%2520a%2520Preclinical%2520Model%2520of%2520Tauopathy%26jtitle%3DRedox%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D522%26epage%3D534%26doi%3D10.1016%2Fj.redox.2017.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gameiro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalska, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cores, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buendia, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgakopoulos, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Guijo, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teresa Ramos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menendez, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of the First Dual Gsk3beta Inhibitor/Nrf2 Inducer. A New Multitarget Therapeutic Strategy for Alzheimer’s Disease</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">45701</span>, <span class="refDoi"> DOI: 10.1038/srep45701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fsrep45701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28361919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A280%3ADC%252BC1cvjtVOqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=45701&author=I.+Gameiroauthor=P.+Michalskaauthor=G.+Tentiauthor=A.+Coresauthor=I.+Buendiaauthor=A.+I.+Rojoauthor=N.+D.+Georgakopoulosauthor=J.+M.+Hernandez-Guijoauthor=M.+Teresa+Ramosauthor=G.+Wellsauthor=M.+G.+Lopezauthor=A.+Cuadradoauthor=J.+C.+Menendezauthor=R.+Leon&title=Discovery+of+the+First+Dual+Gsk3beta+Inhibitor%2FNrf2+Inducer.+A+New+Multitarget+Therapeutic+Strategy+for+Alzheimer%E2%80%99s+Disease&doi=10.1038%2Fsrep45701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease</span></div><div class="casAuthors">Gameiro Isabel; Michalska Patrycja; Buendia Izaskun; Hernandez-Guijo Jesus M; Lopez Manuela G; Leon Rafael; Gameiro Isabel; Michalska Patrycja; Tenti Giammarco; Buendia Izaskun; Lopez Manuela G; Leon Rafael; Cores Angel; Teresa Ramos Maria; Menendez J Carlos; Rojo Ana I; Cuadrado Antonio; Georgakopoulos Nikolaos D; Wells Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45701</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The formation of neurofibrillary tangles (NFTs), oxidative stress and neuroinflammation have emerged as key targets for the treatment of Alzheimer's disease (AD), the most prevalent neurodegenerative disorder.  These pathological hallmarks are closely related to the over-activity of the enzyme GSK3β and the downregulation of the defense pathway Nrf2-EpRE observed in AD patients.  Herein, we report the synthesis and pharmacological evaluation of a new family of multitarget 2,4-dihydropyrano[2,3-c]pyrazoles as dual GSK3β inhibitors and Nrf2 inducers.  These compounds are able to inhibit GSK3β and induce the Nrf2 phase II antioxidant and anti-inflammatory pathway at micromolar concentrations, showing interesting structure-activity relationships.  The association of both activities has resulted in a remarkable anti-inflammatory ability with an interesting neuroprotective profile on in vitro models of neuronal death induced by oxidative stress and energy depletion and AD.  Furthermore, none of the compounds exhibited in vitro neurotoxicity or hepatotoxicity and hence they had improved safety profiles compared to the known electrophilic Nrf2 inducers.  In conclusion, the combination of both activities in this family of multitarget compounds confers them a notable interest for the development of lead compounds for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQb3GKov_JZAe2mnZh2OgS0fW6udTcc2ebfI2PplSdbDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvjtVOqsg%253D%253D&md5=539ae027ea7d8f7bc20356900383f90b</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1038%2Fsrep45701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep45701%26sid%3Dliteratum%253Aachs%26aulast%3DGameiro%26aufirst%3DI.%26aulast%3DMichalska%26aufirst%3DP.%26aulast%3DTenti%26aufirst%3DG.%26aulast%3DCores%26aufirst%3DA.%26aulast%3DBuendia%26aufirst%3DI.%26aulast%3DRojo%26aufirst%3DA.%2BI.%26aulast%3DGeorgakopoulos%26aufirst%3DN.%2BD.%26aulast%3DHernandez-Guijo%26aufirst%3DJ.%2BM.%26aulast%3DTeresa%2BRamos%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DG.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DMenendez%26aufirst%3DJ.%2BC.%26aulast%3DLeon%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520the%2520First%2520Dual%2520Gsk3beta%2520Inhibitor%252FNrf2%2520Inducer.%2520A%2520New%2520Multitarget%2520Therapeutic%2520Strategy%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D45701%26doi%3D10.1038%2Fsrep45701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Induced Protein Degradation: An Emerging Drug Discovery Paradigm</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fnrd.2016.211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27885283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCit7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=101-114&author=A.+C.+Laiauthor=C.+M.+Crews&title=Induced+Protein+Degradation%3A+An+Emerging+Drug+Discovery+Paradigm&doi=10.1038%2Fnrd.2016.211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Induced protein degradation: an emerging drug discovery paradigm</span></div><div class="casAuthors">Lai, Ashton C.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-114</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. drug discovery has traditionally focused on occupancy of a binding site that directly affects protein function, and this approach typically precludes targeting proteins that lack such amenable sites.  Furthermore, high systemic drug exposures may be needed to maintain sufficient target inhibition in vivo, increasing the risk of undesirable off-target effects.  Induced protein degrdn. is an alternative approach that is event-driven: upon drug binding, the target protein is tagged for elimination.  Emerging technologies based on proteolysis-targeting chimaeras (PROTACs) that exploit cellular quality control machinery to selectively degrade target proteins are attracting considerable attention in the pharmaceutical industry owing to the advantages they could offer over traditional small-mol. strategies.  These advantages include the potential to reduce systemic drug exposure, the ability to counteract increased target protein expression that often accompanies inhibition of protein function and the potential ability to target proteins that are not currently therapeutically tractable, such as transcription factors, scaffolding and regulatory proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj-O7zXGOpXLVg90H21EOLACvtfcHk0lhSx6zBay_P8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCit7rP&md5=a01ff43e9b696fe4dc03f0815158a98f</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.211%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DA.%2BC.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DInduced%2520Protein%2520Degradation%253A%2520An%2520Emerging%2520Drug%2520Discovery%2520Paradigm%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D101%26epage%3D114%26doi%3D10.1038%2Fnrd.2016.211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span> <span> </span><span class="NLM_article-title">The Histone Acetylranseferase Hmof Acetylates Nrf2 and Regulates Anti-Drug Responses in Human Non-Small Cell Lung Cancer</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">3196</span>– <span class="NLM_lpage">3211</span>, <span class="refDoi"> DOI: 10.1111/bph.12661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1111%2Fbph.12661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24571482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVKrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3196-3211&author=Z.+Chenauthor=X.+Yeauthor=N.+Tangauthor=S.+Shenauthor=Z.+Liauthor=X.+Niuauthor=S.+Luauthor=L.+Xu&title=The+Histone+Acetylranseferase+Hmof+Acetylates+Nrf2+and+Regulates+Anti-Drug+Responses+in+Human+Non-Small+Cell+Lung+Cancer&doi=10.1111%2Fbph.12661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer</span></div><div class="casAuthors">Chen, Zhiwei; Ye, Xiangyun; Tang, Naiwang; Shen, Shengping; Li, Ziming; Niu, Xiaomin; Lu, Shun; Xu, Ling</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3196-3211</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The histone acetyltransferase MOF is a member of the MYST family.  In mammals, MOF plays crit. roles by acetylating histone H4 at K16 and non-histone substrates such as p53.  Here we have investigated the role of MOF in human lung cancer and possible new substrates of hMOF.  Exptl. Approach : Samples of human non-small cell lung cancer (NSCLC) were used to correlate MOF with clinicopathol. parameters and NF-E2-related factor 2 (Nrf2) downstream genes.  293T-cells were used to study interactions between MOF and Nrf2, and acetylation of Nrf2 by MOF.  Mouse embryonic fibroblast and A549 cells were utilized to assess involvement of MOF in antioxidative and anti-drug responses.  A549 cells were used to anal. the role of MOF in anti-drug response in vitro and in vivo.  Key Results : hMOF was overexpressed in human NSCLC tissues and was assocd. with large tumor size, advanced disease stage and metastasis, and with poor prognosis.  HMOF levels were pos. correlated with Nrf2-downstream genes.  MOF/hMOF phys. interacted with and acetylated Nrf2 at Lys588.  MOF-mediated acetylation increased nuclear retention of Nrf2 and transcription of its downstream genes.  Importantly, MOF/hMOF was essential for anti-oxidative and anti-drug responses in vitro and regulated tumor growth and drug resistance in vivo in an Nrf2-dependent manner.  Conclusion and Implications : hMOF was overexpressed in human NSCLC and was a predictor of poor survival.  HMOF-mediated Nrf2 acetylation and nuclear retention are essential for anti-oxidative and anti-drug responses.  HMOF may provide a therapeutic target for the treatment of NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGVLqQZwX2CLVg90H21EOLACvtfcHk0lhSx6zBay_P8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVKrt7k%253D&md5=b1478b8ccd229cc59434f39509148e11</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1111%2Fbph.12661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12661%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DN.%26aulast%3DShen%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26atitle%3DThe%2520Histone%2520Acetylranseferase%2520Hmof%2520Acetylates%2520Nrf2%2520and%2520Regulates%2520Anti-Drug%2520Responses%2520in%2520Human%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D3196%26epage%3D3211%26doi%3D10.1111%2Fbph.12661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">The Polycomb Group Protein Ezh2 Inhibits Lung Cancer Cell Growth by Repressing the Transcription Factor Nrf2</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>588</i></span>,  <span class="NLM_fpage">3000</span>– <span class="NLM_lpage">3007</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2014.05.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.febslet.2014.05.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=588&publication_year=2014&pages=3000-3007&author=Z.+Liauthor=L.+Xuauthor=N.+Tangauthor=Y.+Xuauthor=X.+Yeauthor=S.+Shenauthor=X.+Niuauthor=S.+Luauthor=Z.+Chen&title=The+Polycomb+Group+Protein+Ezh2+Inhibits+Lung+Cancer+Cell+Growth+by+Repressing+the+Transcription+Factor+Nrf2&doi=10.1016%2Fj.febslet.2014.05.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2014.05.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2014.05.057%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DS.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DThe%2520Polycomb%2520Group%2520Protein%2520Ezh2%2520Inhibits%2520Lung%2520Cancer%2520Cell%2520Growth%2520by%2520Repressing%2520the%2520Transcription%2520Factor%2520Nrf2%26jtitle%3DFEBS%2520Lett.%26date%3D2014%26volume%3D588%26spage%3D3000%26epage%3D3007%26doi%3D10.1016%2Fj.febslet.2014.05.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Promoter Demethylation of Nuclear Factor-Erythroid 2-Related Factor 2 Gene in Drug-Resistant Colon Cancer Cells</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1287</span>– <span class="NLM_lpage">1292</span>, <span class="refDoi"> DOI: 10.3892/ol.2015.3468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.3892%2Fol.2015.3468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26622665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFOjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1287-1292&author=X.+Q.+Zhaoauthor=Y.+F.+Zhangauthor=Y.+F.+Xiaauthor=Z.+M.+Zhouauthor=Y.+Q.+Cao&title=Promoter+Demethylation+of+Nuclear+Factor-Erythroid+2-Related+Factor+2+Gene+in+Drug-Resistant+Colon+Cancer+Cells&doi=10.3892%2Fol.2015.3468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Promoter demethylation of nuclear factor-erythroid 2-related factor 2 gene in drug-resistant colon cancer cells</span></div><div class="casAuthors">Zhao, Xiao-Qian; Zhang, Yi-Fei; Xia, Yi-Fang; Zhou, Zhong-Mei; Cao, Ying-Qing</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1287-1292</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The mechanisms underlying drug resistance in colorectal cancer (CRC) treatment remain to be fully elucidated.  Therefore, the present study aimed to investigate the underlying mechanism resistance to a widely used anticancer drug, 5-Fluorouracil (5-FU).  Nuclear factor-erythroid 2-related factor 2 (Nrf2) is an important transcription factor involved in cellular protection.  In the present study, it was hypothesized that the epigenetic modification of Nrf2 may be a potential target for 5-FU resistance in CRC treatment.  Protein and mRNA levels of Nrf2, heme oxygenase-1 (HO-1), DNA methylases and DNA methyltransferases were detd. and DNA methylation anal. for the Nrf2 promoter was performed in a human CRC control (SNU-C5) and resistant (SNU-C5R) cell line.  The results demonstrated that Nrf2 expression levels, nuclear translocation and promoter binding were significantly increased in SNU-C5R cells compared with SNU-C5 cells.  Elevated levels of activated Nrf2 in SNU-C5R cells resulted in the increased protein expression and activity of HO-1.  In addn., increased prodn. of reactive oxygen species (ROS) and upregulation of ten-eleven translocation (TET)1 were obsd. in SNU-C5R cells compared with SNU-C5 cells.  Furthermore, methylation anal. revealed Nrf2 promoter cytosine-phosphate-guanine island hypomethylation in 5-FU-treated cells.  In conclusion, the results indicated that 5-FU-induced ROS prodn. resulted in the upregulation of TET1 expression and function.  In addn., these results indicated that TET-dependent demethylation of the Nrf2 promoter upregulated Nrf2 and HO-1 expression, which induced cellular protection mechanisms, ultimately leading to drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou9jjj5zCl4bVg90H21EOLACvtfcHk0liha9PZrFJ8XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFOjsbk%253D&md5=1f6c6be8e53475e6c92e7a3726cc2160</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.3892%2Fol.2015.3468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2015.3468%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BQ.%26aulast%3DZhang%26aufirst%3DY.%2BF.%26aulast%3DXia%26aufirst%3DY.%2BF.%26aulast%3DZhou%26aufirst%3DZ.%2BM.%26aulast%3DCao%26aufirst%3DY.%2BQ.%26atitle%3DPromoter%2520Demethylation%2520of%2520Nuclear%2520Factor-Erythroid%25202-Related%2520Factor%25202%2520Gene%2520in%2520Drug-Resistant%2520Colon%2520Cancer%2520Cells%26jtitle%3DOncol.%2520Lett.%26date%3D2015%26volume%3D10%26spage%3D1287%26epage%3D1292%26doi%3D10.3892%2Fol.2015.3468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salazar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sagarra, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span> <span> </span><span class="NLM_article-title">Glycogen Synthase Kinase-3beta Inhibits the Xenobiotic and Antioxidant Cell Response by Direct Phosphorylation and Nuclear Exclusion of the Transcription Factor Nrf2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">14841</span>– <span class="NLM_lpage">14851</span>, <span class="refDoi"> DOI: 10.1074/jbc.M513737200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1074%2Fjbc.M513737200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=14841-14851&author=M.+Salazarauthor=A.+I.+Rojoauthor=D.+Velascoauthor=R.+M.+de+Sagarraauthor=A.+Cuadrado&title=Glycogen+Synthase+Kinase-3beta+Inhibits+the+Xenobiotic+and+Antioxidant+Cell+Response+by+Direct+Phosphorylation+and+Nuclear+Exclusion+of+the+Transcription+Factor+Nrf2&doi=10.1074%2Fjbc.M513737200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M513737200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M513737200%26sid%3Dliteratum%253Aachs%26aulast%3DSalazar%26aufirst%3DM.%26aulast%3DRojo%26aufirst%3DA.%2BI.%26aulast%3DVelasco%26aufirst%3DD.%26aulast%3Dde%2BSagarra%26aufirst%3DR.%2BM.%26aulast%3DCuadrado%26aufirst%3DA.%26atitle%3DGlycogen%2520Synthase%2520Kinase-3beta%2520Inhibits%2520the%2520Xenobiotic%2520and%2520Antioxidant%2520Cell%2520Response%2520by%2520Direct%2520Phosphorylation%2520and%2520Nuclear%2520Exclusion%2520of%2520the%2520Transcription%2520Factor%2520Nrf2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D14841%26epage%3D14851%26doi%3D10.1074%2Fjbc.M513737200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Namani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span> <span> </span><span class="NLM_article-title">Modulation of Nrf2 Signaling Pathway by Nuclear Receptors: Implications for Cancer</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1843</i></span>,  <span class="NLM_fpage">1875</span>– <span class="NLM_lpage">1885</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2014.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.bbamcr.2014.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24851839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFansL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1843&publication_year=2014&pages=1875-1885&author=A.+Namaniauthor=Y.+Liauthor=X.+J.+Wangauthor=X.+Tang&title=Modulation+of+Nrf2+Signaling+Pathway+by+Nuclear+Receptors%3A+Implications+for+Cancer&doi=10.1016%2Fj.bbamcr.2014.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer</span></div><div class="casAuthors">Namani, Akhileshwar; Li, Yulong; Wang, Xiu Jun; Tang, Xiuwen</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1843</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1875-1885</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor-erythroid 2 p45-related factor 2 (NRF2, also known as Nfe2l2) plays a crit. role in regulating cellular defense against electrophilic and oxidative stress by activating the expression of an array of antioxidant response element-dependent genes.  On one hand, NRF2 activators have been used in clin. trials for cancer prevention and the treatment of diseases assocd. with oxidative stress; on the other hand, constitutive activation of NRF2 in many types of tumors contributes to the survival and growth of cancer cells, as well as resistance to anticancer therapy.  In this review, we provide an overview of the NRF2 signaling pathway and discuss its role in carcinogenesis.  We also introduce the inhibition of NRF2 by nuclear receptors.  Further, we address the biol. significance of regulation of the NRF2 signaling pathway by nuclear receptors in health and disease.  Finally, we discuss the possible impact of NRF2 inhibition by nuclear receptors on cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiL8VWtmL6X7Vg90H21EOLACvtfcHk0liha9PZrFJ8XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFansL3N&md5=9e2b9fa840842bb690068f2d7b574ea0</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2014.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2014.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DNamani%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DModulation%2520of%2520Nrf2%2520Signaling%2520Pathway%2520by%2520Nuclear%2520Receptors%253A%2520Implications%2520for%2520Cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2014%26volume%3D1843%26spage%3D1875%26epage%3D1885%26doi%3D10.1016%2Fj.bbamcr.2014.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span> <span> </span><span class="NLM_article-title">Rxralpha Inhibits the Nrf2-Are Signaling Pathway through a Direct Interaction with the Neh7 Domain of Nrf2</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">3097</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-12-3386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1158%2F0008-5472.CAN-12-3386" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=3097-3108&author=H.+Wangauthor=K.+Liuauthor=M.+Gengauthor=P.+Gaoauthor=X.+Wuauthor=Y.+Haiauthor=Y.+Liauthor=Y.+Liauthor=L.+Luoauthor=J.+D.+Hayesauthor=X.+J.+Wangauthor=X.+Tang&title=Rxralpha+Inhibits+the+Nrf2-Are+Signaling+Pathway+through+a+Direct+Interaction+with+the+Neh7+Domain+of+Nrf2&doi=10.1158%2F0008-5472.CAN-12-3386"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-3386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-3386%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DHai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DRxralpha%2520Inhibits%2520the%2520Nrf2-Are%2520Signaling%2520Pathway%2520through%2520a%2520Direct%2520Interaction%2520with%2520the%2520Neh7%2520Domain%2520of%2520Nrf2%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D3097%26epage%3D3108%26doi%3D10.1158%2F0008-5472.CAN-12-3386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span> <span> </span><span class="NLM_article-title">Rexinoid Inhibits Nrf2-Mediated Transcription through Retinoid X Receptor Alpha</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>452</i></span>,  <span class="NLM_fpage">554</span>– <span class="NLM_lpage">559</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2014.08.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.bbrc.2014.08.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=25172665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVOmsLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=452&publication_year=2014&pages=554-559&author=J.+Wuauthor=H.+Wangauthor=X.+Tang&title=Rexinoid+Inhibits+Nrf2-Mediated+Transcription+through+Retinoid+X+Receptor+Alpha&doi=10.1016%2Fj.bbrc.2014.08.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Rexinoid inhibits Nrf2-mediated transcription through retinoid X receptor alpha</span></div><div class="casAuthors">Wu, Jiaguo; Wang, Hongyan; Tang, Xiuwen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">452</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">554-559</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NF-E2 P45-related factor 2 (Nrf2) is a key transcription factor that controls genes encoding cytoprotective and detoxifying enzymes through antioxidant response elements (AREs) in their regulatory regions.  We reported recently that retinoid X receptor alpha (RXRα) inhibits Nrf2 function by direct interaction with the Neh7 domain of Nrf2 in a ligand-independent manner.  Here, we provide evidence that an RXRα-specific ligand, bexarotene, dose-dependently inhibits the mRNA expression of ARE-driven genes.  Knock-down of RXRα by siRNA abolished the inhibitory effect of bexarotene.  Conversely, the over-expression of RXRα enhanced the inhibition by bexarotene, indicating that the effect is mediated by RXRα.  The inhibition by bexarotene was also found in the non-small-cell lung cancer cell line A549, which carries a dysfunctional somatic mutation of Kelch-like ECH-assocd. protein 1 (KEAP1), suggesting that KEAP1 is not involved.  Our results demonstrate that rexinoid is able to inhibit the transcriptional activity of Nrf2, and that RXRα can repress the cytoprotection pathway in a ligand-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozT-3eGRcTD7Vg90H21EOLACvtfcHk0lgPqL6qREeBNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVOmsLbL&md5=38d5a58f44c359e38807238323e65c31</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.08.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.08.111%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DRexinoid%2520Inhibits%2520Nrf2-Mediated%2520Transcription%2520through%2520Retinoid%2520X%2520Receptor%2520Alpha%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D452%26spage%3D554%26epage%3D559%26doi%3D10.1016%2Fj.bbrc.2014.08.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, C. R.</span></span> <span> </span><span class="NLM_article-title">Identification of Retinoic Acid as an Inhibitor of Transcription Factor Nrf2 through Activation of Retinoic Acid Receptor Alpha</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">19589</span>, <span class="refDoi"> DOI: 10.1073/pnas.0709483104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1073%2Fpnas.0709483104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=19589&author=X.+J.+Wangauthor=J.+D.+Hayesauthor=C.+J.+Hendersonauthor=C.+R.+Wolf&title=Identification+of+Retinoic+Acid+as+an+Inhibitor+of+Transcription+Factor+Nrf2+through+Activation+of+Retinoic+Acid+Receptor+Alpha&doi=10.1073%2Fpnas.0709483104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0709483104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0709483104%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DHenderson%26aufirst%3DC.%2BJ.%26aulast%3DWolf%26aufirst%3DC.%2BR.%26atitle%3DIdentification%2520of%2520Retinoic%2520Acid%2520as%2520an%2520Inhibitor%2520of%2520Transcription%2520Factor%2520Nrf2%2520through%2520Activation%2520of%2520Retinoic%2520Acid%2520Receptor%2520Alpha%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D19589%26doi%3D10.1073%2Fpnas.0709483104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kou, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, J.</span></span> <span> </span><span class="NLM_article-title">An Overview of Chemical Inhibitors of the Nrf2-Are Signaling Pathway and Their Potential Applications in Cancer Therapy</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2016.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2016.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27634172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGmsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2016&pages=544-556&author=J.+Zhuauthor=H.+Wangauthor=F.+Chenauthor=J.+Fuauthor=Y.+Xuauthor=Y.+Houauthor=H.+H.+Kouauthor=C.+Zhaiauthor=M.+B.+Nelsonauthor=Q.+Zhangauthor=M.+E.+Andersenauthor=J.+Pi&title=An+Overview+of+Chemical+Inhibitors+of+the+Nrf2-Are+Signaling+Pathway+and+Their+Potential+Applications+in+Cancer+Therapy&doi=10.1016%2Fj.freeradbiomed.2016.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy</span></div><div class="casAuthors">Zhu, Jiayu; Wang, Huihui; Chen, Feng; Fu, Jingqi; Xu, Yuanyuan; Hou, Yongyong; Kou, Henry H.; Zhai, Cheng; Nelson, M. Bud; Zhang, Qiang; Andersen, Melvin E.; Pi, Jingbo</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">544-556</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key transcription factor regulating a wide array of genes for antioxidant and detoxification enzymes in response to oxidative and xenobiotic stress.  A large no. of Nrf2-antioxidant response element (ARE) activators have been screened for use as chemopreventive agents in oxidative stress-related diseases and even cancer.  However, constitutive activation of Nrf2 occurs in a variety of cancers.  Aberrant activation of Nrf2 is correlated with cancer progression, chemoresistance, and radioresistance.  In this review, the authors examine recent studies of Nrf2-ARE inhibitors in the context of cancer therapy.  The authors enumerate the possible Nrf2-inhibiting mechanisms of these compds., their effects sensitizing cancer cells to chemotherapeutic agents, and the prospect of applying them in clin. cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ct8Za1a2TbVg90H21EOLACvtfcHk0lgPqL6qREeBNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGmsL%252FP&md5=2fec4e9d9e7cb5e52fe1bb709a1e73b7</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2016.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2016.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DKou%26aufirst%3DH.%2BH.%26aulast%3DZhai%26aufirst%3DC.%26aulast%3DNelson%26aufirst%3DM.%2BB.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DAndersen%26aufirst%3DM.%2BE.%26aulast%3DPi%26aufirst%3DJ.%26atitle%3DAn%2520Overview%2520of%2520Chemical%2520Inhibitors%2520of%2520the%2520Nrf2-Are%2520Signaling%2520Pathway%2520and%2520Their%2520Potential%2520Applications%2520in%2520Cancer%2520Therapy%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2016%26volume%3D99%26spage%3D544%26epage%3D556%26doi%3D10.1016%2Fj.freeradbiomed.2016.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villeneuve, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toppin, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Brusatol Enhances the Efficacy of Chemotherapy by Inhibiting the Nrf2-Mediated Defense Mechanism</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1433</span>– <span class="NLM_lpage">1438</span>, <span class="refDoi"> DOI: 10.1073/pnas.1014275108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1073%2Fpnas.1014275108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21205897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Smtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=1433-1438&author=D.+Renauthor=N.+F.+Villeneuveauthor=T.+Jiangauthor=T.+Wuauthor=A.+Lauauthor=H.+A.+Toppinauthor=D.+D.+Zhang&title=Brusatol+Enhances+the+Efficacy+of+Chemotherapy+by+Inhibiting+the+Nrf2-Mediated+Defense+Mechanism&doi=10.1073%2Fpnas.1014275108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism</span></div><div class="casAuthors">Ren, Dongmei; Villeneuve, Nicole F.; Jiang, Tao; Wu, Tongde; Lau, Alexandria; Toppin, Henry A.; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1433-1438, S1433/1-S1433/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The major obstacle in cancer treatment is the resistance of cancer cells to therapies.  Nrf2 is a transcription factor that regulates a cellular defense response and is ubiquitously expressed at low basal levels in normal tissues due to Keap1-dependent ubiquitination and proteasomal degrdn.  Recently, Nrf2 has emerged as an important contributor to chemoresistance.  High constitutive expression of Nrf2 was found in many types of cancers, creating an environment conducive for cancer cell survival.  Here, we report the identification of brusatol as a unique inhibitor of the Nrf2 pathway that sensitizes a broad spectrum of cancer cells and A549 xenografts to cisplatin and other chemotherapeutic drugs.  Mechanistically, brusatol selectively reduces the protein level of Nrf2 through enhanced ubiquitination and degrdn. of Nrf2.  Consequently, expression of Nrf2-downstream genes is reduced and the Nrf2-dependent protective response is suppressed.  In A549 xenografts, brusatol and cisplatin cotreatment induced apoptosis, reduced cell proliferation, and inhibited tumor growth more substantially when compared with cisplatin treatment alone.  Addnl., A549-K xenografts, in which Nrf2 is expressed at very low levels due to ectopic expression of Keap1, do not respond to brusatol treatment, demonstrating that brusatol-mediated sensitization to cisplatin is Nrf2 dependent.  Moreover, a decrease in drug detoxification and impairment in drug removal may be the primary mechanisms by which brusatol enhances the efficacy of chemotherapeutic drugs.  Taken together, these results clearly demonstrate the effectiveness of using brusatol to combat chemoresistance and suggest that brusatol can be developed into an adjuvant chemotherapeutic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruj8dASN0Mv7Vg90H21EOLACvtfcHk0lgGETvewScNCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Smtrs%253D&md5=6d2cad037bc5db9e922d100338d6fdf9</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1014275108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1014275108%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DD.%26aulast%3DVilleneuve%26aufirst%3DN.%2BF.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DToppin%26aufirst%3DH.%2BA.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DBrusatol%2520Enhances%2520the%2520Efficacy%2520of%2520Chemotherapy%2520by%2520Inhibiting%2520the%2520Nrf2-Mediated%2520Defense%2520Mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D1433%26epage%3D1438%26doi%3D10.1073%2Fpnas.1014275108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vartanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haverty, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokoe, D.</span></span> <span> </span><span class="NLM_article-title">Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1220</span>– <span class="NLM_lpage">1231</span>, <span class="refDoi"> DOI: 10.1074/mcp.M115.055509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1074%2Fmcp.M115.055509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26711467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlansLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=1220-1231&author=S.+Vartanianauthor=T.+P.+Maauthor=J.+Leeauthor=P.+M.+Havertyauthor=D.+S.+Kirkpatrickauthor=K.+Yuauthor=D.+Stokoe&title=Application+of+Mass+Spectrometry+Profiling+to+Establish+Brusatol+as+an+Inhibitor+of+Global+Protein+Synthesis&doi=10.1074%2Fmcp.M115.055509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis</span></div><div class="casAuthors">Vartanian, Steffan; Ma, Taylur P.; Lee, James; Haverty, Peter M.; Kirkpatrick, Donald S.; Yu, Kebing; Stokoe, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Proteomics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1220-1231</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9484</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The KEAP1/Nrf2 pathway senses and responds to changes in intracellular oxidative stress.  Mutations that result in constitutive activation of Nrf2 are present in several human tumors, esp. non-small cell lung cancer.  Therefore, compds. that inhibit Nrf2 activity might be beneficial in treating patients whose tumors show activation of this pathway.  Recent reports suggest that the natural product brusatol can potently and selectively inhibit Nrf2 activity, resulting in cell cytotoxicity, and can be effectively combined with chemotherapeutic agents.  Here, we analyzed the effects of brusatol on the cellular proteome in the KEAP1 mutant non-small cell lung cancer cell line A549.  Brusatol was found to rapidly and potently decrease the expression of the majority of detected proteins, including Nrf2.  The most dramatically decreased proteins are those that display a short half-life, like Nrf2.  This effect was confirmed by restricting the anal. to newly synthesized proteins using a labeled methionine analog.  Moreover, brusatol increased the expression of multiple components of the ribosome, suggesting that it regulates the function of this macromol. complex.  Finally, we show that brusatol induces its potent cellular cytotoxicity effects on multiple cancer cell lines in a manner independent of KEAP1/Nrf2 activity and with a profile similar to the protein translation inhibitor silvestrol.  In conclusion, our data show that the activity of brusatol is not restricted to Nrf2 but, rather, functions as a global protein synthesis inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraWIVABhhpmrVg90H21EOLACvtfcHk0lgGETvewScNCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlansLw%253D&md5=93889d70b1c7a0fd32877926248a89cc</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M115.055509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M115.055509%26sid%3Dliteratum%253Aachs%26aulast%3DVartanian%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DT.%2BP.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHaverty%26aufirst%3DP.%2BM.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DStokoe%26aufirst%3DD.%26atitle%3DApplication%2520of%2520Mass%2520Spectrometry%2520Profiling%2520to%2520Establish%2520Brusatol%2520as%2520an%2520Inhibitor%2520of%2520Global%2520Protein%2520Synthesis%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2016%26volume%3D15%26spage%3D1220%26epage%3D1231%26doi%3D10.1074%2Fmcp.M115.055509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Clair, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Brusatol Overcomes Chemoresistance through Inhibition of Protein Translation</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1493</span>– <span class="NLM_lpage">1500</span>, <span class="refDoi"> DOI: 10.1002/mc.22609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1002%2Fmc.22609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28019675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1Wmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=1493-1500&author=B.+Harderauthor=W.+Tianauthor=J.+J.+La+Clairauthor=A.-C.+Tanauthor=A.+Ooiauthor=E.+Chapmanauthor=D.+D.+Zhang&title=Brusatol+Overcomes+Chemoresistance+through+Inhibition+of+Protein+Translation&doi=10.1002%2Fmc.22609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol overcomes chemoresistance through inhibition of protein translation</span></div><div class="casAuthors">Harder, Bryan; Tian, Wang; La Clair, James J.; Tan, Aik-Choon; Ooi, Aikseng; Chapman, Eli; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1493-1500</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The NRF2 pathway activates a cell survival response when cells are exposed to xenobiotics or are under oxidative stress.  Therapeutic activation of NRF2 can also be used prior to insult as a means of disease prevention.  However, prolonged expression of NRF2 has been shown to protect cancer cells by inducing the metab. and efflux of chemotherapeutics, leading to both intrinsic and acquired chemoresistance to cancer drugs.  This effect has been termed the "dark side" of NRF2.  In an effort to combat this chemoresistance, our group discovered the first NRF2 inhibitor, the natural product brusatol, however the mechanism of inhibition was previously unknown.  In this report, we show that brusatol's mode of action is not through direct inhibition of the NRF2 pathway, but through the inhibition of both cap-dependent and cap-independent protein translation, which has an impact on many short-lived proteins, including NRF2.  Therefore, there is still a need to develop a new generation of specific NRF2 inhibitors with limited toxicity and off-target effects that could be used as adjuvant therapies to sensitize cancers with high expression of NRF2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYEXTD-im3kLVg90H21EOLACvtfcHk0lgGETvewScNCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1Wmurw%253D&md5=ce13967747c43025a1287dce903f9831</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1002%2Fmc.22609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.22609%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DB.%26aulast%3DTian%26aufirst%3DW.%26aulast%3DLa%2BClair%26aufirst%3DJ.%2BJ.%26aulast%3DTan%26aufirst%3DA.-C.%26aulast%3DOoi%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DBrusatol%2520Overcomes%2520Chemoresistance%2520through%2520Inhibition%2520of%2520Protein%2520Translation%26jtitle%3DMol.%2520Carcinog.%26date%3D2017%26volume%3D56%26spage%3D1493%26epage%3D1500%26doi%3D10.1002%2Fmc.22609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ki, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. G.</span></span> <span> </span><span class="NLM_article-title">Glucocorticoid Receptor (Gr)-Associated Smrt Binding to C/Ebpbeta Tad and Nrf2 Neh4/5: Role of Smrt Recruited to Gr in Gsta2 Gene Repression</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4150</span>– <span class="NLM_lpage">4165</span>, <span class="refDoi"> DOI: 10.1128/MCB.25.10.4150-4165.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.25.10.4150-4165.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=15870285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlSmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=4150-4165&author=S.+H.+Kiauthor=I.+J.+Choauthor=D.+W.+Choiauthor=S.+G.+Kim&title=Glucocorticoid+Receptor+%28Gr%29-Associated+Smrt+Binding+to+C%2FEbpbeta+Tad+and+Nrf2+Neh4%2F5%3A+Role+of+Smrt+Recruited+to+Gr+in+Gsta2+Gene+Repression&doi=10.1128%2FMCB.25.10.4150-4165.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPβ TAD and Nrf2 Neh4/5: Role of SMRT recruited to GR in GSTA2 gene repression</span></div><div class="casAuthors">Ki, Sung Hwan; Cho, Il Je; Choi, Dal Woong; Kim, Sang Geon</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4150-4165</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The expression of the glutathione S-transferase gene (GST), whose induction accounts for cancer chemoprevention, is regulated by activation of CCAAT/enhancer binding protein β (C/EBPβ) and NF-E2-related factor 2 (Nrf2).  The present study investigated the repressing effects of activating glucocorticoid receptor (GR) on C/EBPβ- and Nrf2-mediated GSTA2 gene induction and the mechanism.  Dexamethasone that activates GR inhibited constitutive and oltipraz- or tert-butylhydroquinone (t-BHQ)-inducible GSTA2 expression in H4IIE cells.  Also, dexamethasone repressed GSTA2 promoter-luciferase gene activity.  Dexamethasone-GR activation did not inhibit nuclear translocation of C/EBPβ or Nrf2 nor their DNA binding activities induced by oltipraz or t-BHQ.  Deletion of the glucocorticoid response element (GRE) in the GSTA2 promoter abolished dexamethasone inhibition of the gene induction.  Immunopptn.-immunoblotting, chromatin immunopptn., and GST pull-down assays revealed that silencing mediator for retinoid and thyroid hormone receptors (SMRT), a corepressor recruited to steroid-GR complex for histone deacetylation, bound to TAD domain of C/EBPβ and Neh4/5 domain of Nrf2.  The GSTA2 promoter-luciferase activities were decreased by SMRT but not by truncated SMRTs.  The small interference RNA (siRNA) against SMRT abolished SMRT repression of the gene induction by C/EBPβ or Nrf2.  The plasmid transfection and siRNA expts. directly evidenced the functional role of SMRT in GSTA2 repression.  In conclusion, dexamethasone antagonizes C/EBPβ- and Nrf2-mediated GSTA2 gene induction via ligand-GR binding to the GRE, and steroid-mediated GSTA2 repression involves inactivation of C/EBPβ and Nrf2 by SMRT recruited to steroid-GR complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUWK-jbzzM1bVg90H21EOLACvtfcHk0lhhYguqooha_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlSmu7c%253D&md5=f270db6f70b46c19713e0f0d072d688b</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1128%2FMCB.25.10.4150-4165.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.25.10.4150-4165.2005%26sid%3Dliteratum%253Aachs%26aulast%3DKi%26aufirst%3DS.%2BH.%26aulast%3DCho%26aufirst%3DI.%2BJ.%26aulast%3DChoi%26aufirst%3DD.%2BW.%26aulast%3DKim%26aufirst%3DS.%2BG.%26atitle%3DGlucocorticoid%2520Receptor%2520%2528Gr%2529-Associated%2520Smrt%2520Binding%2520to%2520C%252FEbpbeta%2520Tad%2520and%2520Nrf2%2520Neh4%252F5%253A%2520Role%2520of%2520Smrt%2520Recruited%2520to%2520Gr%2520in%2520Gsta2%2520Gene%2520Repression%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D4150%26epage%3D4165%26doi%3D10.1128%2FMCB.25.10.4150-4165.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kratschmar, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lister, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appenzeller-Herzog, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odermatt, A.</span></span> <span> </span><span class="NLM_article-title">Suppression of the Nrf2-Dependent Antioxidant Response by Glucocorticoids and 11beta-Hsd1-Mediated Glucocorticoid Activation in Hepatic Cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e36774</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0036774</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1371%2Fjournal.pone.0036774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22606287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslOqsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=D.+V.+Kratschmarauthor=D.+Calabreseauthor=J.+Walshauthor=A.+Listerauthor=J.+Birkauthor=C.+Appenzeller-Herzogauthor=P.+Moulinauthor=C.+E.+Goldringauthor=A.+Odermatt&title=Suppression+of+the+Nrf2-Dependent+Antioxidant+Response+by+Glucocorticoids+and+11beta-Hsd1-Mediated+Glucocorticoid+Activation+in+Hepatic+Cells&doi=10.1371%2Fjournal.pone.0036774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of the Nrf2-dependent antioxidant response by glucocorticoids and 11β-HSD1-mediated glucocorticoid activation in hepatic cells</span></div><div class="casAuthors">Kratschmar, Denise V.; Calabrese, Diego; Walsh, Jo; Lister, Adam; Birk, Julia; Appenzeller-Herzog, Christian; Moulin, Pierre; Goldring, Chris E.; Odermatt, Alex</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e36774</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a key transcription factor regulating a plethora of detoxifying enzymes and antioxidant genes involved in drug metab. and defense against oxidative stress.  The glucocorticoid receptor (GR) is a ligand-induced transcription factor involved in the regulation of energy supply for metabolic needs to cope with various stressors.  GR activity is controlled by glucocorticoids, which are synthesized in the adrenal glands and regenerated mainly in the liver from inactive cortisone by 11β-hydroxysteroid dehydrogenase-1 (11β-HSD1).  Methods and Principal Findings: Using transfected HEK-293 cells and hepatic H4IIE cells we show that glucocorticoids, activated by 11β-HSD1 and acting through GR, suppress the Nrf2-dependent antioxidant response.  The expression of the marker genes NQO1, HMOX1 and GST2A was suppressed upon treatment of 11β-HSD1 expressing cells with cortisone, an effect that was reversed by 11β-HSD1 inhibitors.  Furthermore, our results demonstrate that elevated glucocorticoids lowered the ability of cells to detoxify H2O2.  Moreover, a comparison of gene expression in male and female rats revealed an opposite sexual dimorphism with an inverse relationship between 11β-HSD1 and Nrf2 target gene expression.  Conclusions: The results demonstrate a suppression of the cellular antioxidant defense capacity by glucocorticoids and suggest that elevated 11β-HSD1 activity may lead to impaired Nrf2-dependent antioxidant response.  The gender-specific differences in hepatic expression levels of 11β-HSD1 and Nrf2 target genes and the impact of pharmacol. inhibition of 11β-HSD1 on improving cellular capacity to cope with oxidative stress warrants further studies in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0We0cqLQJVbVg90H21EOLACvtfcHk0lhhYguqooha_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslOqsro%253D&md5=fa8d77b4de59cd56bd1a81f8a3a17688</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0036774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0036774%26sid%3Dliteratum%253Aachs%26aulast%3DKratschmar%26aufirst%3DD.%2BV.%26aulast%3DCalabrese%26aufirst%3DD.%26aulast%3DWalsh%26aufirst%3DJ.%26aulast%3DLister%26aufirst%3DA.%26aulast%3DBirk%26aufirst%3DJ.%26aulast%3DAppenzeller-Herzog%26aufirst%3DC.%26aulast%3DMoulin%26aufirst%3DP.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DOdermatt%26aufirst%3DA.%26atitle%3DSuppression%2520of%2520the%2520Nrf2-Dependent%2520Antioxidant%2520Response%2520by%2520Glucocorticoids%2520and%252011beta-Hsd1-Mediated%2520Glucocorticoid%2520Activation%2520in%2520Hepatic%2520Cells%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0036774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, S. M.</span></span> <span> </span><span class="NLM_article-title">A Clinical Drug Library Screen Identifies Clobetasol Propionate as an Nrf2 Inhibitor with Potential Therapeutic Efficacy in Keap1Mutant Lung Cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">5285</span>– <span class="NLM_lpage">5295</span>, <span class="refDoi"> DOI: 10.1038/onc.2017.153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fonc.2017.153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28504720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1KmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=5285-5295&author=E.+J.+Choiauthor=B.+J.+Jungauthor=S.+H.+Leeauthor=H.+S.+Yooauthor=E.+A.+Shinauthor=H.+J.+Koauthor=S.+Changauthor=S.+Y.+Kimauthor=S.+M.+Jeon&title=A+Clinical+Drug+Library+Screen+Identifies+Clobetasol+Propionate+as+an+Nrf2+Inhibitor+with+Potential+Therapeutic+Efficacy+in+Keap1Mutant+Lung+Cancer&doi=10.1038%2Fonc.2017.153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer</span></div><div class="casAuthors">Choi, E.-J.; Jung, B.-J.; Lee, S.-H.; Yoo, H.-S.; Shin, E.-A.; Ko, H.-J.; Chang, S.; Kim, S.-Y.; Jeon, S.-M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5285-5295</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The Kelch-like ECH-assocd. protein 1 (KEAP1)-nuclear factor E2-related factor 2 (NRF2)pathway has a central role in cellular antioxidant defense.  NRF2 activation due to KEAP1 or NRF2 mutations occurs frequently in many cancers, suggesting that NRF2 inhibition could be a promising therapeutic strategy.  However, no potent NRF2 inhibitors are clin. available to date.  To develop potent NRF2 inhibitors for therapeutic purpose, we screened ∼4000 clin. compds. and detd. clobetasol propionate (CP) as the most potent NRF2 inhibitor.  Mechanistically, CP prevented nuclear accumulation and promoted β-TrCP-dependent degrdn. of NRF2 in a glucocorticoid receptor- and a glycogen synthase kinase 3 (GSK3)-dependent manner.  As a result, CP induced oxidative stress and strongly suppressed the anchorage-independent growth of tumors with KEAP1 mutation, but not with the wild-type KEAP1.  Further, CP alone or in combination with rapamycin strongly inhibited the in vitro and in vivo growth of tumors harboring mutations in KEAP1 or both KEAP1 and LKB1 that are frequently obsd. in lung cancer.  Thus, CP could be a repurposed therapeutic agent for cancers with high NRF2 activity.  We also proposed that the use CP and rapamycin in combination could be a potential therapeutic strategy for tumors harboring both KEAP1 and LKB1 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXEhMDJKow9bVg90H21EOLACvtfcHk0lhhYguqooha_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1KmsrY%253D&md5=001ddc664eef87b8b60948266f27d11f</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fonc.2017.153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2017.153%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DE.%2BJ.%26aulast%3DJung%26aufirst%3DB.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DYoo%26aufirst%3DH.%2BS.%26aulast%3DShin%26aufirst%3DE.%2BA.%26aulast%3DKo%26aufirst%3DH.%2BJ.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DJeon%26aufirst%3DS.%2BM.%26atitle%3DA%2520Clinical%2520Drug%2520Library%2520Screen%2520Identifies%2520Clobetasol%2520Propionate%2520as%2520an%2520Nrf2%2520Inhibitor%2520with%2520Potential%2520Therapeutic%2520Efficacy%2520in%2520Keap1Mutant%2520Lung%2520Cancer%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D5285%26epage%3D5295%26doi%3D10.1038%2Fonc.2017.153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span> <span> </span><span class="NLM_article-title">Luteolin Inhibits Nrf2 Leading to Negative Regulation of the Nrf2/Are Pathway and Sensitization of Human Lung Carcinoma A549 Cells to Therapeutic Drugs</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1599</span>– <span class="NLM_lpage">1609</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2011.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21402146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVWhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=1599-1609&author=X.+Tangauthor=H.+Wangauthor=L.+Fanauthor=X.+Wuauthor=A.+Xinauthor=H.+Renauthor=X.+J.+Wang&title=Luteolin+Inhibits+Nrf2+Leading+to+Negative+Regulation+of+the+Nrf2%2FAre+Pathway+and+Sensitization+of+Human+Lung+Carcinoma+A549+Cells+to+Therapeutic+Drugs&doi=10.1016%2Fj.freeradbiomed.2011.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs</span></div><div class="casAuthors">Tang, Xiuwen; Wang, Hongyan; Fan, Longfang; Wu, Xiaoyuan; Xin, Ai; Ren, Huanyu; Wang, Xiu Jun</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1599-1609</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nuclear factor erythroid 2-related factor 2 (Nrf2) is a redox-sensitive transcription factor regulating the expression of a battery of cytoprotective genes.  Constitutive Nrf2 activation in many tumors enhances cell survival and resistance to anticancer drugs.  Using a cell-based ARE-reporter assay we discovered that the flavonoid luteolin is a potent Nrf2 inhibitor.  Luteolin inhibited ARE-driven gene expression redox-independently.  In non-small-cell lung cancer A549 cells, which possess constitutively active Nrf2, luteolin elicited a dramatic redn. in Nrf2 at both the mRNA and the protein levels, leading to decreased Nrf2 binding to AREs, down-regulation of ARE-driven genes, and depletion of reduced glutathione.  After transcription was blocked with actinomycin D, 1 μM luteolin decreased the Nrf2 mRNA level by 34% in 30 min, indicating its role in accelerating Nrf2 mRNA turnover.  At physiol. concns., luteolin significantly sensitized A549 cells to the anticancer drugs oxaliplatin, bleomycin, and doxorubicin.  However, knockdown of Nrf2 using siRNA essentially abolished the induced sensitivity by the flavonoid, implying the importance of inhibiting Nrf2 for its activity.  Our study demonstrates that an Nrf2 inhibitor can enhance the responsiveness of cancer cells to chemotherapeutic drugs and indicates the potential application of luteolin as a natural sensitizer in chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCZiZuGbdJwrVg90H21EOLACvtfcHk0lhuOzhjQv64dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVWhtb8%253D&md5=8e03500dd1d1e865661be2267dd95fca</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DXin%26aufirst%3DA.%26aulast%3DRen%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26atitle%3DLuteolin%2520Inhibits%2520Nrf2%2520Leading%2520to%2520Negative%2520Regulation%2520of%2520the%2520Nrf2%252FAre%2520Pathway%2520and%2520Sensitization%2520of%2520Human%2520Lung%2520Carcinoma%2520A549%2520Cells%2520to%2520Therapeutic%2520Drugs%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2011%26volume%3D50%26spage%3D1599%26epage%3D1609%26doi%3D10.1016%2Fj.freeradbiomed.2011.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thapa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span> <span> </span><span class="NLM_article-title">Luteolin Inhibits the Nrf2 Signaling Pathway and Tumor Growth in Vivo</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>447</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2014.04.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.bbrc.2014.04.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2014&pages=602-608&author=S.+Chianauthor=R.+Thapaauthor=Z.+Chiauthor=X.+J.+Wangauthor=X.+Tang&title=Luteolin+Inhibits+the+Nrf2+Signaling+Pathway+and+Tumor+Growth+in+Vivo&doi=10.1016%2Fj.bbrc.2014.04.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.04.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.04.039%26sid%3Dliteratum%253Aachs%26aulast%3DChian%26aufirst%3DS.%26aulast%3DThapa%26aufirst%3DR.%26aulast%3DChi%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DLuteolin%2520Inhibits%2520the%2520Nrf2%2520Signaling%2520Pathway%2520and%2520Tumor%2520Growth%2520in%2520Vivo%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D447%26spage%3D602%26epage%3D608%26doi%3D10.1016%2Fj.bbrc.2014.04.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baiyun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Regulation of Sirt1/Nrf2/Tnf-Alpha Signaling Pathway by Luteolin Is Critical to Attenuate Acute Mercuric Chloride Exposure Induced Hepatotoxicity</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">37157</span>, <span class="refDoi"> DOI: 10.1038/srep37157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fsrep37157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27853236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntlCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=37157&author=D.+Yangauthor=X.+Tanauthor=Z.+Lvauthor=B.+Liuauthor=R.+Baiyunauthor=J.+Luauthor=Z.+Zhang&title=Regulation+of+Sirt1%2FNrf2%2FTnf-Alpha+Signaling+Pathway+by+Luteolin+Is+Critical+to+Attenuate+Acute+Mercuric+Chloride+Exposure+Induced+Hepatotoxicity&doi=10.1038%2Fsrep37157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Sirt1/Nrf2/TNF-α signaling pathway by luteolin is critical to attenuate acute mercuric chloride exposure induced hepatotoxicity</span></div><div class="casAuthors">Yang, Daqian; Tan, Xiao; Lv, Zhanjun; Liu, Biying; Baiyun, Ruiqi; Lu, Jingjing; Zhang, Zhigang</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37157</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inorg. mercury, though a key component of pediatric vaccines, is an environmental toxicant threatening human health via accumulating oxidative stress in part.  Luteolin has been of great interest because of its antiinflammatory, anticarcinogenic and antioxidative effects.  Here we hypothesized that luteolin would attenuate hepatotoxicity induced by acute inorg. mercury exposure.  Kunming mice were treated with luteolin (100 mg/kg) 24 h after administration of 4 mg/kg mercuric chloride (HgCl2).  The results showed that luteolin ameliorated HgCl2 induced anemia and hepatotoxicity, regulating radical oxygen species (ROS) prodn. and hepatocyte viability in vitro and oxidative stress and apoptosis in vivo.  Furthermore, luteolin reversed the changes in levels of inflammation- and apoptosis-related proteins involving NF-κB, TNF-α, Sirt1, mTOR, Bax, p53, and Bcl-2, and inhibited p38 MAPK activation.  Luteolin enhanced antioxidant defense system based on Keap1, Nrf2, HO-1, NQO1, and KLF9.  Moreover, luteolin did not affect miRNA-146a expression.  Collectively, our findings, for the first time, elucidate a precise mechanism for attenuation of HgCl2-induced liver dysfunction by dietary luteolin via regulating Sirt1/Nrf2/TNF-α signaling pathway, and provide a foundation for further study of luteolin as a novel therapeutic agent against inorg. mercury poisoning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfb6Q3ya-QH7Vg90H21EOLACvtfcHk0lhuOzhjQv64dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntlCmsA%253D%253D&md5=0bcb6d85e32303d8df5e44c297de80b3</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1038%2Fsrep37157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep37157%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DBaiyun%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DRegulation%2520of%2520Sirt1%252FNrf2%252FTnf-Alpha%2520Signaling%2520Pathway%2520by%2520Luteolin%2520Is%2520Critical%2520to%2520Attenuate%2520Acute%2520Mercuric%2520Chloride%2520Exposure%2520Induced%2520Hepatotoxicity%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D37157%26doi%3D10.1038%2Fsrep37157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span> <span> </span><span class="NLM_article-title">Luteolin Provides Neuroprotection in Models of Traumatic Brain Injury Via the Nrf2-Are Pathway</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2014.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2014.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24642087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVKjt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=186-195&author=J.+Xuauthor=H.+Wangauthor=K.+Dingauthor=L.+Zhangauthor=C.+Wangauthor=T.+Liauthor=W.+Weiauthor=X.+Lu&title=Luteolin+Provides+Neuroprotection+in+Models+of+Traumatic+Brain+Injury+Via+the+Nrf2-Are+Pathway&doi=10.1016%2Fj.freeradbiomed.2014.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE pathway</span></div><div class="casAuthors">Xu, Jianguo; Wang, Handong; Ding, Ke; Zhang, Li; Wang, Chunxi; Li, Tao; Wei, Wuting; Lu, Xinyu</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">186-195</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Luteolin has recently been proven to exert neuroprotection in a variety of neurol. diseases; however, its roles and the underlying mechanisms in traumatic brain injury are not fully understood.  The present study was aimed to investigate the neuroprotective effects of luteolin in models of traumatic brain injury (TBI) and the possible role of the Nrf2-ARE pathway in the putative neuroprotection.  A modified Marmarou's wt.-drop model in mice and the scratch model in mice primary cultured neurons were used to induce TBI.  The authors detd. that luteolin significantly ameliorated secondary brain injury induced by TBI, including neurol. deficits, brain water content, and neuronal apoptosis.  Furthermore, the level of malondialdehyde (MDA) and the activity of glutathione peroxidase (GPx) were restored in the group with luteolin treatment.  In vitro studies showed that luteolin administration lowered the intracellular reactive oxygen species (ROS) level and increased the neuron survival.  Moreover, luteolin enhanced the translocation of Nrf2 to the nucleus both in vivo and in vitro, which was proved by the results of Western blot, immunohistochem., and electrophoretic mobility shift assay (EMSA).  Subsequently upregulation of the expression of the downstream factors such as heme oxygenase 1 (HO1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) was also examd.  However, luteolin treatment failed to provide neuroprotection after TBI in Nrf2-/- mice.  Taken together, these in vivo and in vitro data demonstrated that luteolin provided neuroprotective effects in the models of TBI, possibly through the activation of the Nrf2-ARE pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsB8nnWnoSALVg90H21EOLACvtfcHk0lhuOzhjQv64dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVKjt7k%253D&md5=d227b73f4b31df30b5f4ad8d9800be4b</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2014.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2014.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DX.%26atitle%3DLuteolin%2520Provides%2520Neuroprotection%2520in%2520Models%2520of%2520Traumatic%2520Brain%2520Injury%2520Via%2520the%2520Nrf2-Are%2520Pathway%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2014%26volume%3D71%26spage%3D186%26epage%3D195%26doi%3D10.1016%2Fj.freeradbiomed.2014.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, R.</span></span> <span> </span><span class="NLM_article-title">Wogonin-Enhanced Reactive Oxygen Species-Induced Apoptosis and Potentiated Cytotoxic Effects of Chemotherapeutic Agents by Suppression Nrf2-Mediated Signaling in Hepg2 Cells</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">607</span>– <span class="NLM_lpage">621</span>, <span class="refDoi"> DOI: 10.3109/10715762.2014.897342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.3109%2F10715762.2014.897342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24666416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltlyrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2014&pages=607-621&author=C.+Qianauthor=Y.+Wangauthor=Y.+Zhongauthor=J.+Tangauthor=J.+Zhangauthor=Z.+Liauthor=Q.+Wangauthor=R.+Hu&title=Wogonin-Enhanced+Reactive+Oxygen+Species-Induced+Apoptosis+and+Potentiated+Cytotoxic+Effects+of+Chemotherapeutic+Agents+by+Suppression+Nrf2-Mediated+Signaling+in+Hepg2+Cells&doi=10.3109%2F10715762.2014.897342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Wogonin-enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by suppression Nrf2-mediated signaling in HepG2 cells</span></div><div class="casAuthors">Qian, C.; Wang, Y.; Zhong, Y.; Tang, J.; Zhang, J.; Li, Z.; Wang, Q.; Hu, R.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">607-621</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1029-2470</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Cancer cells, compared with normal cells, are under increased oxidative stress with higher level of reactive oxygen species (ROS).  When exposed to environmental stresses such as ROS, NFE-related factor 2 (Nrf2) is the key to antioxidant response by transcriptionally activating various detoxification and antioxidant enzymes.  Previously, we have shown that wogonin, a flavonoid isolated from the root of Scutellaria baicalensis Georgi, could reverse drug resistance in MCF-7/DOX cells by blocking the translocation of Nrf2 into nucleus.  However, the exact mechanism underlying the effect remains unclear.  In this study, we obsd. that wogonin reduced the Nrf2 nuclear translocation, and therefore elevated the level of intracellular ROS to accomplish the purpose of killing malignant cells.  Furthermore, the suppression of Nrf2 by wogonin can potentiate cytotoxic effects of chemotherapeutic agents in HepG2 cells.  On one hand, down-regulation of Nrf2 lead to redn. of cytoprotective effect by inducing phage II enzymes which sensitize cells to chemotherapeutic agents.  On the other hand, inhibition of multidrug resistance-assocd. proteins (MRPs) by wogonin enhances the effective drug level in cancer cells and potentiates their chemotherapeutic effects.  Finally, we found that the decrease of Nrf2 may be related to overexpression of p53.  Using p53 siRNA to knock down the endogenous p53 expression, the levels of both c-myc and Nrf2 in nucleus increased when exposed to wogonin.  The present study indicates that wogonin can be used in chemotherapy not only because of its own antitumor ability, but also due to the enhanced cytotoxic effects of chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb7phGwK634bVg90H21EOLACvtfcHk0lgik7aCQncGdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltlyrsL0%253D&md5=1d58bc4620d4d71bea63228dd6c97f97</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.3109%2F10715762.2014.897342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10715762.2014.897342%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DR.%26atitle%3DWogonin-Enhanced%2520Reactive%2520Oxygen%2520Species-Induced%2520Apoptosis%2520and%2520Potentiated%2520Cytotoxic%2520Effects%2520of%2520Chemotherapeutic%2520Agents%2520by%2520Suppression%2520Nrf2-Mediated%2520Signaling%2520in%2520Hepg2%2520Cells%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2014%26volume%3D48%26spage%3D607%26epage%3D621%26doi%3D10.3109%2F10715762.2014.897342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, R.</span></span> <span> </span><span class="NLM_article-title">Drug Resistance Associates with Activation of Nrf2 in Mcf-7/Dox Cells, and Wogonin Reverses It by Down-Regulating Nrf2-Mediated Cellular Defense Response</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">824</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1002/mc.21921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1002%2Fmc.21921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22593043" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=824-834&author=Y.+Zhongauthor=F.+Zhangauthor=Z.+Sunauthor=W.+Zhouauthor=Z.+Y.+Liauthor=Q.+D.+Youauthor=Q.+L.+Guoauthor=R.+Hu&title=Drug+Resistance+Associates+with+Activation+of+Nrf2+in+Mcf-7%2FDox+Cells%2C+and+Wogonin+Reverses+It+by+Down-Regulating+Nrf2-Mediated+Cellular+Defense+Response&doi=10.1002%2Fmc.21921"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1002%2Fmc.21921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.21921%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%2BY.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DGuo%26aufirst%3DQ.%2BL.%26aulast%3DHu%26aufirst%3DR.%26atitle%3DDrug%2520Resistance%2520Associates%2520with%2520Activation%2520of%2520Nrf2%2520in%2520Mcf-7%252FDox%2520Cells%252C%2520and%2520Wogonin%2520Reverses%2520It%2520by%2520Down-Regulating%2520Nrf2-Mediated%2520Cellular%2520Defense%2520Response%26jtitle%3DMol.%2520Carcinog.%26date%3D2012%26volume%3D52%26spage%3D824%26epage%3D834%26doi%3D10.1002%2Fmc.21921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q. L.</span></span> <span> </span><span class="NLM_article-title">Nf-Kappab and Nrf2 Signaling Pathways Contribute to Wogonin-Mediated Inhibition of Inflammation-Associated Colorectal Carcinogenesis</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e1283</span> <span class="refDoi"> DOI: 10.1038/cddis.2014.221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fcddis.2014.221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24901054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVGqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=J.+Yaoauthor=L.+Zhaoauthor=Q.+Zhaoauthor=Y.+Zhaoauthor=Y.+Sunauthor=Y.+Zhangauthor=H.+Miaoauthor=Q.+D.+Youauthor=R.+Huauthor=Q.+L.+Guo&title=Nf-Kappab+and+Nrf2+Signaling+Pathways+Contribute+to+Wogonin-Mediated+Inhibition+of+Inflammation-Associated+Colorectal+Carcinogenesis&doi=10.1038%2Fcddis.2014.221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis</span></div><div class="casAuthors">Yao, J.; Zhao, L.; Zhao, Q.; Zhao, Y.; Sun, Y.; Zhang, Y.; Miao, H.; You, Q.-D.; Hu, R.; Guo, Q.-L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1283</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The transcriptional factors nuclear factor-κB (NF-κB) and NF-E2-related factor 2 (Nrf2) have been recently reported to have crit. roles in protecting various tissues against inflammation and colitis-assocd. colorectal cancer (aberrant crypt foci).  Our previous studies showed that wogonin (5,7-dihydroxy-8-methoxyflavone) possessed anti-neoplastic and anti-inflammatory activities.  The present study extended these important earlier findings by exploring the effect of wogonin on the initiation and development of colitis-assocd. cancer.  Wogonin lowered tumor incidence and inhibited the development of colorectal adenomas in azoxymethane- or dextran sulfate sodium-induced mice.  We found that wogonin significantly decreased the secretion and expression of IL-6 and IL-1β, reduced cell proliferation and nuclear expression of NF-κB in adenomas and surrounding tissues and promoted Nrf2 nuclear translocation in surrounding tissues, although overexpressed Nrf2 in tumor tissues was independent of wogonin administration.  Furthermore, wogonin inhibited the interaction between human monocytic THP-1 cells and human colon cancer HCT116 cells, and significantly downregulated lipopolysaccharide-induced secretion of prototypical pro-inflammatory cytokines IL-6 and IL-1β in THP-1 cells.  Further mechanism research revealed that wogonin inhibited the nuclear translocation of NF-κB and phosphorylation of IκB and IKKα/β, and promoted Nrf2 signaling pathway in HCT116 cells and THP-1 cells.  Taken together, the present results indicated that wogonin effectively suppressed inflammation-assocd. colon carcinogenesis and cancer development, suggesting its potential as a chemopreventive agent against colitis-assocd. colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo109avlHdLbLVg90H21EOLACvtfcHk0lgik7aCQncGdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVGqt7w%253D&md5=d0a74c9f17fddefdc0d2f377a24061e3</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.221%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DHu%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DQ.%2BL.%26atitle%3DNf-Kappab%2520and%2520Nrf2%2520Signaling%2520Pathways%2520Contribute%2520to%2520Wogonin-Mediated%2520Inhibition%2520of%2520Inflammation-Associated%2520Colorectal%2520Carcinogenesis%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26doi%3D10.1038%2Fcddis.2014.221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cavin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delatour, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin-Kuan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzhauser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezencon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guignard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junod, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richoz-Payot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gremaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nestler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilter, B.</span></span> <span> </span><span class="NLM_article-title">Reduction in Antioxidant Defenses May Contribute to Ochratoxin a Toxicity and Carcinogenicity</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfl169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1093%2Ftoxsci%2Fkfl169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=17110534" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2006&pages=30-39&author=C.+Cavinauthor=T.+Delatourauthor=M.+Marin-Kuanauthor=D.+Holzhauserauthor=L.+Higginsauthor=C.+Bezenconauthor=G.+Guignardauthor=S.+Junodauthor=J.+Richoz-Payotauthor=E.+Gremaudauthor=J.+D.+Hayesauthor=S.+Nestlerauthor=P.+Mantleauthor=B.+Schilter&title=Reduction+in+Antioxidant+Defenses+May+Contribute+to+Ochratoxin+a+Toxicity+and+Carcinogenicity&doi=10.1093%2Ftoxsci%2Fkfl169"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfl169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfl169%26sid%3Dliteratum%253Aachs%26aulast%3DCavin%26aufirst%3DC.%26aulast%3DDelatour%26aufirst%3DT.%26aulast%3DMarin-Kuan%26aufirst%3DM.%26aulast%3DHolzhauser%26aufirst%3DD.%26aulast%3DHiggins%26aufirst%3DL.%26aulast%3DBezencon%26aufirst%3DC.%26aulast%3DGuignard%26aufirst%3DG.%26aulast%3DJunod%26aufirst%3DS.%26aulast%3DRichoz-Payot%26aufirst%3DJ.%26aulast%3DGremaud%26aufirst%3DE.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DNestler%26aufirst%3DS.%26aulast%3DMantle%26aufirst%3DP.%26aulast%3DSchilter%26aufirst%3DB.%26atitle%3DReduction%2520in%2520Antioxidant%2520Defenses%2520May%2520Contribute%2520to%2520Ochratoxin%2520a%2520Toxicity%2520and%2520Carcinogenicity%26jtitle%3DToxicol.%2520Sci.%26date%3D2006%26volume%3D96%26spage%3D30%26epage%3D39%26doi%3D10.1093%2Ftoxsci%2Fkfl169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boesch-Saadatmandi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loboda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jozkowicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huebbe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolffram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimbach, G.</span></span> <span> </span><span class="NLM_article-title">Effect of Ochratoxin a on Redox-Regulated Transcription Factors, Antioxidant Enzymes and Glutathione-S-Transferase in Cultured Kidney Tubulus Cells</span>. <i>Food Chem. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2665</span>– <span class="NLM_lpage">2671</span>, <span class="refDoi"> DOI: 10.1016/j.fct.2008.04.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.fct.2008.04.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=18547704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCnsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=2665-2671&author=C.+Boesch-Saadatmandiauthor=A.+Lobodaauthor=A.+Jozkowiczauthor=P.+Huebbeauthor=R.+Blankauthor=S.+Wolfframauthor=J.+Dulakauthor=G.+Rimbach&title=Effect+of+Ochratoxin+a+on+Redox-Regulated+Transcription+Factors%2C+Antioxidant+Enzymes+and+Glutathione-S-Transferase+in+Cultured+Kidney+Tubulus+Cells&doi=10.1016%2Fj.fct.2008.04.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of ochratoxin A on redox-regulated transcription factors, antioxidant enzymes and glutathione-S-transferase in cultured kidney tubulus cells</span></div><div class="casAuthors">Boesch-Saadatmandi, C.; Loboda, A.; Jozkowicz, A.; Huebbe, P.; Blank, R.; Wolffram, S.; Dulak, J.; Rimbach, G.</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2665-2671</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ochratoxin A (OTA), a mycotoxin mostly produced by Aspergillus ochraceus and Penicillium verrucosum, is a worldwide contaminant of food and feedstuff.  OTA is nephrotoxic and a renal carcinogen in rodents.  The underlying mol. and cellular mechanisms by which OTA exhibits its toxicity have yet not been fully clarified.  In the present study the effects of ochratoxin A on the activity of redox-regulated transcription factors, antioxidant enzymes, as well as glutathione-S-transferase (GST) were studied in cultured kidney tubule cells (LLC-PK1).  Confluent LLC-PK1 cells were incubated with increasing concns. of OTA for 24 h.  OTA decreased SOD activity and enhanced intracellular levels of reactive oxygen species (ROS) as measured by flow cytometry.  Furthermore OTA resulted in a down-regulation of GST mRNA and activity levels.  Lower GST levels were accompanied by a decreased transactivation of activator protein-1 (AP-1) and NF-E2-related factor-2 (Nrf2), which mediate GST gene transcription.  Present data indicate that enhanced ROS prodn. and an impairment of GST activity, possibly due to an AP-1 and Nrf2 dependent signal transduction pathway, may be centrally involved in OTA induced nephrotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroefgu2kn9wbVg90H21EOLACvtfcHk0ljX6yOX9GkGog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCnsL8%253D&md5=34b02ba1296003e21cc337e512786b1c</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.fct.2008.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fct.2008.04.023%26sid%3Dliteratum%253Aachs%26aulast%3DBoesch-Saadatmandi%26aufirst%3DC.%26aulast%3DLoboda%26aufirst%3DA.%26aulast%3DJozkowicz%26aufirst%3DA.%26aulast%3DHuebbe%26aufirst%3DP.%26aulast%3DBlank%26aufirst%3DR.%26aulast%3DWolffram%26aufirst%3DS.%26aulast%3DDulak%26aufirst%3DJ.%26aulast%3DRimbach%26aufirst%3DG.%26atitle%3DEffect%2520of%2520Ochratoxin%2520a%2520on%2520Redox-Regulated%2520Transcription%2520Factors%252C%2520Antioxidant%2520Enzymes%2520and%2520Glutathione-S-Transferase%2520in%2520Cultured%2520Kidney%2520Tubulus%2520Cells%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D2008%26volume%3D46%26spage%3D2665%26epage%3D2671%26doi%3D10.1016%2Fj.fct.2008.04.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boesch-Saadatmandi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graeser, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundhausen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolffram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimbach, G.</span></span> <span> </span><span class="NLM_article-title">Ochratoxin a Impairs Nrf2-Dependent Gene Expression in Porcine Kidney Tubulus Cells</span>. <i>J. Anim. Physiol. Anim. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1111/j.1439-0396.2008.00838.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1111%2Fj.1439-0396.2008.00838.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=18547363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Oqs7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2009&pages=547-554&author=C.+Boesch-Saadatmandiauthor=A.+E.+Wagnerauthor=A.+C.+Graeserauthor=C.+Hundhausenauthor=S.+Wolfframauthor=G.+Rimbach&title=Ochratoxin+a+Impairs+Nrf2-Dependent+Gene+Expression+in+Porcine+Kidney+Tubulus+Cells&doi=10.1111%2Fj.1439-0396.2008.00838.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Ochratoxin A impairs Nrf2-dependent gene expression in pocine kidney tubulus cells</span></div><div class="casAuthors">Boesch-Saadatmandi, C.; Wagner, A. E.; Graeser, A. C.; Hundhausen, C.; Wolffram, S.; Rimbach, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Animal Physiology and Animal Nutrition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">547-554</span>CODEN:
                <span class="NLM_cas:coden">JAPNEF</span>;
        ISSN:<span class="NLM_cas:issn">0931-2439</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The mycotoxin, ochratoxin A (OTA), which is produced by Aspergillus and Penicillium subspecies, is frequently present in feedstuffs.  Ochratoxin A exhibits a wide range of toxic activities including nephrotoxicity.  However, the underlying mol. mechanisms of OTA-induced cellular nephrotoxicity have yet not been fully elucidated.  Nrf2 is a basic leucine zipper transcriptional activator essential for the coordinated transcriptional induction of antioxidant and xenobiotic metabolizing enzymes in the kidney.  Therefore, in the present study, the effects of OTA on the nuclear translocation and transactivation of the transcription factor Nrf2 as well as mRNA levels of Nrf2 target genes including glutathione-S-transferase and γ-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).  Nrf2 was induced by sulforaphane, a well-known activator of this transcription factor.  Ochratoxin A significantly decreased γ-glutamylcysteinyl synthetase and glutathione-S-transferase mRNA levels in LLC-PK1 cells.  Decreased mRNA levels of γ-glutamylcysteinyl synthetase and glutathione-S-transferase were accompanied by a lowered nuclear translocation and transactivation of Nrf2.  Furthermore, OTA also lowered Nrf2 mRNA levels.  Current data indicate that OTA nephrotoxicity may be, at least partly, mediated by an Nrf2-dependent signal transduction pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKLiYpKXcpa7Vg90H21EOLACvtfcHk0ljX6yOX9GkGog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Oqs7bN&md5=fb08918206fb04af5153deaebb0b9c8a</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1111%2Fj.1439-0396.2008.00838.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1439-0396.2008.00838.x%26sid%3Dliteratum%253Aachs%26aulast%3DBoesch-Saadatmandi%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DA.%2BE.%26aulast%3DGraeser%26aufirst%3DA.%2BC.%26aulast%3DHundhausen%26aufirst%3DC.%26aulast%3DWolffram%26aufirst%3DS.%26aulast%3DRimbach%26aufirst%3DG.%26atitle%3DOchratoxin%2520a%2520Impairs%2520Nrf2-Dependent%2520Gene%2520Expression%2520in%2520Porcine%2520Kidney%2520Tubulus%2520Cells%26jtitle%3DJ.%2520Anim.%2520Physiol.%2520Anim.%2520Nutr.%26date%3D2009%26volume%3D93%26spage%3D547%26epage%3D554%26doi%3D10.1111%2Fj.1439-0396.2008.00838.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansari, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhari, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhawan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwivedi, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, M.</span></span> <span> </span><span class="NLM_article-title">Topical Application of Ochratoxin a Causes DNA Damage and Tumor Initiation in Mouse Skin</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e47280</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0047280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1371%2Fjournal.pone.0047280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23071775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOku7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=R.+Kumarauthor=K.+M.+Ansariauthor=B.+P.+Chaudhariauthor=A.+Dhawanauthor=P.+D.+Dwivediauthor=S.+K.+Jainauthor=M.+Das&title=Topical+Application+of+Ochratoxin+a+Causes+DNA+Damage+and+Tumor+Initiation+in+Mouse+Skin&doi=10.1371%2Fjournal.pone.0047280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Topical application of Ochratoxin a causes DNA damage and tumor initiation in mouse skin</span></div><div class="casAuthors">Kumar, Rahul; Ansari, Kausar M.; Chaudhari, Bhushan P.; Dhawan, Alok; Dwivedi, Premendra D.; Jain, Swatantra K.; Das, Mukul</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e47280</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Skin cancer is one of the most common forms of cancer and 2-3 million new cases are being diagnosed globally each year.  Along with UV rays, environmental pollutants/chems. including mycotoxins, contaminants of various foods and feed stuffs, could be one of the etiol. factors of skin cancer.  In the present study, we evaluated the DNA damaging potential and dermal carcinogenicity of a mycotoxin, ochratoxin A (OTA), with the rationale that dermal exposure to OTA in workers may occur during their involvement in pre and post harvest stages of agriculture.  A single topical application of OTA (20-80 μg/mouse) resulted in significant DNA damage along with elevated γ-H2AX level in skin.  Alteration in oxidative stress markers such as lipid peroxidn., protein carbonyl, glutathione content and antioxidant enzymes was obsd. in a dose (20-80 μg/mouse) and time-dependent (12-72 h) manner.  The oxidative stress was further emphasized by the suppression of Nrf2 translocation to nucleus following a single topical application of OTA (80 μg/mouse) after 24 h.  OTA (80 μg/mouse) application for 12-72 h caused significant enhancement in- (a) reactive oxygen species generation, (b) activation of ERK1/2, p38 and JNK MAPKs, cell cycle arrest at G0/G1 phase (37-67 %), (d) induction of apoptosis (2.0-11.0 fold), (e) expression of p53, p21/waf1, (f) Bax/Bcl-2 ratio, (g) cytochrome c level, (h) activities of caspase 9 (1.2-1.8 fold) and 3 (1.7-2.2 fold) as well as poly ADP ribose polymerase cleavage.  In a two-stage mouse skin tumorigenesis protocol, it was obsd. that a single topical application of OTA (80 μg/mouse) followed by twice weekly application of 12-O-tetradecanoylphorbol-13-acetate for 24 wk leads to tumor formation.  These results suggest that OTA has skin tumor initiating property which may be related to oxidative stress, MAPKs signaling and DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY1-CsaY_2m7Vg90H21EOLACvtfcHk0lhXGrvWu6GTPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOku7fM&md5=70f81e5febf750dbdf1b2a70e6d1e2bd</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0047280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0047280%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DAnsari%26aufirst%3DK.%2BM.%26aulast%3DChaudhari%26aufirst%3DB.%2BP.%26aulast%3DDhawan%26aufirst%3DA.%26aulast%3DDwivedi%26aufirst%3DP.%2BD.%26aulast%3DJain%26aufirst%3DS.%2BK.%26aulast%3DDas%26aufirst%3DM.%26atitle%3DTopical%2520Application%2520of%2520Ochratoxin%2520a%2520Causes%2520DNA%2520Damage%2520and%2520Tumor%2520Initiation%2520in%2520Mouse%2520Skin%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0047280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Limonciel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, P.</span></span> <span> </span><span class="NLM_article-title">A Review of the Evidence That Ochratoxin a Is an Nrf2 Inhibitor: Implications for Nephrotoxicity and Renal Carcinogenicity</span>. <i>Toxins</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.3390/toxins6010371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.3390%2Ftoxins6010371" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=371-379&author=A.+Limoncielauthor=P.+Jennings&title=A+Review+of+the+Evidence+That+Ochratoxin+a+Is+an+Nrf2+Inhibitor%3A+Implications+for+Nephrotoxicity+and+Renal+Carcinogenicity&doi=10.3390%2Ftoxins6010371"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.3390%2Ftoxins6010371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Ftoxins6010371%26sid%3Dliteratum%253Aachs%26aulast%3DLimonciel%26aufirst%3DA.%26aulast%3DJennings%26aufirst%3DP.%26atitle%3DA%2520Review%2520of%2520the%2520Evidence%2520That%2520Ochratoxin%2520a%2520Is%2520an%2520Nrf2%2520Inhibitor%253A%2520Implications%2520for%2520Nephrotoxicity%2520and%2520Renal%2520Carcinogenicity%26jtitle%3DToxins%26date%3D2014%26volume%3D6%26spage%3D371%26epage%3D379%26doi%3D10.3390%2Ftoxins6010371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bud Nelson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, J.</span></span> <span> </span><span class="NLM_article-title">Camptothecin Suppresses Nrf2-Are Activity and Sensitises Hepatocellular Carcinoma Cells to Anticancer Drugs</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">1495</span>, <span class="refDoi"> DOI: 10.1038/bjc.2017.317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fbjc.2017.317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28910823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFSkt7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=1495&author=F.+Chenauthor=H.+Wangauthor=J.+Zhuauthor=R.+Zhaoauthor=P.+Xueauthor=Q.+Zhangauthor=M.+Bud+Nelsonauthor=W.+Quauthor=B.+Fengauthor=J.+Pi&title=Camptothecin+Suppresses+Nrf2-Are+Activity+and+Sensitises+Hepatocellular+Carcinoma+Cells+to+Anticancer+Drugs&doi=10.1038%2Fbjc.2017.317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Camptothecin suppresses NRF2-ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs</span></div><div class="casAuthors">Chen, Feng; Wang, Huihui; Zhu, Jiayu; Zhao, Rui; Xue, Peng; Zhang, Qiang; Bud Nelson, M.; Qu, Weidong; Feng, Bo; Pi, Jingbo</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1495-1506</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Background: Resistance to chemotherapy is a major obstacle in the treatment of human hepatocellular carcinoma (HCC).  Despite playing an important role in chemoprevention, nuclear factor erythroid 2-related factor 2 (NRF2) also contributes to chemo- and radio-resistance.  The current study focusses on camptothecin as a novel NRF2 inhibitor to sensitize HCC to chemotherapy.  Methods: The expression and transcriptional activity of NRF2 in human HCC biopsies and camptothecin-treated culture cells were detd. using immunostaining, western blot, reverse-transcription quant. real-time PCR (RT-qPCR) and luciferase reporter assay.  The effect of camptothecin on chemosensitivity of cancer cells was assessed in vitro and in xenografts.  Results: The expression and transcriptional activity of NRF2 were substantially elevated in HCC biopsies compared with corresponding adjacent tissues, and pos. correlated with serum α-fetoprotein, a clin. indicator of pathol. progression.  In searching chems. targeting NRF2 for chemotherapy, we discovered that camptothecin is a potent NRF2 inhibitor.  Camptothecin markedly suppressed NRF2 expression and transcriptional activity in different types of cancer cells including HepG2, SMMC-7721 and A549.  As a result, camptothecin sensitized these cells to chemotherapeutic drugs in vitro and in xenografts.  Conclusions: Camptothecin is a novel NRF2 inhibitor that may be repurposed in combination with other chemotherapeutics to enhance their efficacy in treating high NRF2-expressing cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxEAN7yhqgsbVg90H21EOLACvtfcHk0lhXGrvWu6GTPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFSkt7rP&md5=39312acc1334d539b5b2f2e06128a218</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2017.317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2017.317%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DXue%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DBud%2BNelson%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DPi%26aufirst%3DJ.%26atitle%3DCamptothecin%2520Suppresses%2520Nrf2-Are%2520Activity%2520and%2520Sensitises%2520Hepatocellular%2520Carcinoma%2520Cells%2520to%2520Anticancer%2520Drugs%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2017%26volume%3D117%26spage%3D1495%26doi%3D10.1038%2Fbjc.2017.317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, C. R.</span></span> <span> </span><span class="NLM_article-title">Identification of Retinoic Acid as an Inhibitor of Transcription Factor Nrf2 through Activation of Retinoic Acid Receptor Alpha</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">19589</span>– <span class="NLM_lpage">19594</span>, <span class="refDoi"> DOI: 10.1073/pnas.0709483104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1073%2Fpnas.0709483104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=19589-19594&author=X.+J.+Wangauthor=J.+D.+Hayesauthor=C.+J.+Hendersonauthor=C.+R.+Wolf&title=Identification+of+Retinoic+Acid+as+an+Inhibitor+of+Transcription+Factor+Nrf2+through+Activation+of+Retinoic+Acid+Receptor+Alpha&doi=10.1073%2Fpnas.0709483104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0709483104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0709483104%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DHenderson%26aufirst%3DC.%2BJ.%26aulast%3DWolf%26aufirst%3DC.%2BR.%26atitle%3DIdentification%2520of%2520Retinoic%2520Acid%2520as%2520an%2520Inhibitor%2520of%2520Transcription%2520Factor%2520Nrf2%2520through%2520Activation%2520of%2520Retinoic%2520Acid%2520Receptor%2520Alpha%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D19589%26epage%3D19594%26doi%3D10.1073%2Fpnas.0709483104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span> <span> </span><span class="NLM_article-title">Rexinoid Inhibits Nrf2-Mediated Transcription through Retinoid X Receptor Alpha</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>452</i></span>,  <span class="NLM_fpage">554</span>– <span class="NLM_lpage">559</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2014.08.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.bbrc.2014.08.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=25172665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVOmsLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=452&publication_year=2014&pages=554-559&author=J.+Wuauthor=H.+Wangauthor=X.+Tang&title=Rexinoid+Inhibits+Nrf2-Mediated+Transcription+through+Retinoid+X+Receptor+Alpha&doi=10.1016%2Fj.bbrc.2014.08.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Rexinoid inhibits Nrf2-mediated transcription through retinoid X receptor alpha</span></div><div class="casAuthors">Wu, Jiaguo; Wang, Hongyan; Tang, Xiuwen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">452</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">554-559</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NF-E2 P45-related factor 2 (Nrf2) is a key transcription factor that controls genes encoding cytoprotective and detoxifying enzymes through antioxidant response elements (AREs) in their regulatory regions.  We reported recently that retinoid X receptor alpha (RXRα) inhibits Nrf2 function by direct interaction with the Neh7 domain of Nrf2 in a ligand-independent manner.  Here, we provide evidence that an RXRα-specific ligand, bexarotene, dose-dependently inhibits the mRNA expression of ARE-driven genes.  Knock-down of RXRα by siRNA abolished the inhibitory effect of bexarotene.  Conversely, the over-expression of RXRα enhanced the inhibition by bexarotene, indicating that the effect is mediated by RXRα.  The inhibition by bexarotene was also found in the non-small-cell lung cancer cell line A549, which carries a dysfunctional somatic mutation of Kelch-like ECH-assocd. protein 1 (KEAP1), suggesting that KEAP1 is not involved.  Our results demonstrate that rexinoid is able to inhibit the transcriptional activity of Nrf2, and that RXRα can repress the cytoprotection pathway in a ligand-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozT-3eGRcTD7Vg90H21EOLACvtfcHk0lhXGrvWu6GTPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVOmsLbL&md5=38d5a58f44c359e38807238323e65c31</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.08.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.08.111%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DRexinoid%2520Inhibits%2520Nrf2-Mediated%2520Transcription%2520through%2520Retinoid%2520X%2520Receptor%2520Alpha%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D452%26spage%3D554%26epage%3D559%26doi%3D10.1016%2Fj.bbrc.2014.08.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valenzuela, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glorieux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sid, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felipe, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kviecinski, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrax, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buc Calderon, P.</span></span> <span> </span><span class="NLM_article-title">Retinoic Acid Synergizes Ato-Mediated Cytotoxicity by Precluding Nrf2 Activity in Aml Cells</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.1038/bjc.2014.380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fbjc.2014.380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=25003661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCkt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=874-882&author=M.+Valenzuelaauthor=C.+Glorieuxauthor=J.+Stockisauthor=B.+Sidauthor=J.+M.+Sandovalauthor=K.+B.+Felipeauthor=M.+R.+Kviecinskiauthor=J.+Verraxauthor=P.+Buc+Calderon&title=Retinoic+Acid+Synergizes+Ato-Mediated+Cytotoxicity+by+Precluding+Nrf2+Activity+in+Aml+Cells&doi=10.1038%2Fbjc.2014.380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells</span></div><div class="casAuthors">Valenzuela, M.; Glorieux, C.; Stockis, J.; Sid, B.; Sandoval, J. M.; Felipe, K. B.; Kviecinski, M. R.; Verrax, J.; Calderon, P. Buc</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">874-882</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Std. therapy for acute promyelocytic leukemia (APL) includes retinoic acid (all-trans retinoic acid (ATRA)), which promotes differentiation of promyelocytic blasts.  Although co-administration of arsenic trioxide (ATO) with ATRA has emerged as an effective option to treat APL, the mol. basis of this effect remains unclear.  Methods: Four leukemia cancer human models (HL60, THP-1, NBR4 and NBR4-R2 cells) were treated either with ATO alone or ATO plus ATRA.  Cancer cell survival was monitored by trypan blue exclusion and DEVDase activity assays.  Gene and protein expression changes were assessed by RT-PCR and western blot.  Results: ATO induced an antioxidant response characterized by Nrf2 nuclear translocation and enhanced transcription of downstream target genes (i.e., HO-1, NQO1, GCLM, ferritin).  In cells exposed to ATO plus ATRA, the Nrf2 nuclear translocation was prevented and cytotoxicity was enhanced.  HO-1 overexpression reversed partially the cytotoxicity by ATRA-ATO in HL60 cells.  The inhibitory effects of ATRA on ATO-mediated responses were not obsd. in either the ATRA-resistant NB4-R2 cells or in NB4 cells pre-incubated with the RARα antagonist Ro-41-52-53.  Conclusions: The augmented cytotoxicity obsd. in leukemia cells following combined ATO-ATRA treatment is likely due to inhibition of Nrf2 activity, thus explaining the efficacy of combined ATO-ATRA treatment in the APL therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNH0wnpc1DB7Vg90H21EOLACvtfcHk0lgtHQtGI9BSEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCkt73N&md5=be84cf3c074a9c885b5df06b3b17e6fa</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2014.380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2014.380%26sid%3Dliteratum%253Aachs%26aulast%3DValenzuela%26aufirst%3DM.%26aulast%3DGlorieux%26aufirst%3DC.%26aulast%3DStockis%26aufirst%3DJ.%26aulast%3DSid%26aufirst%3DB.%26aulast%3DSandoval%26aufirst%3DJ.%2BM.%26aulast%3DFelipe%26aufirst%3DK.%2BB.%26aulast%3DKviecinski%26aufirst%3DM.%2BR.%26aulast%3DVerrax%26aufirst%3DJ.%26aulast%3DBuc%2BCalderon%26aufirst%3DP.%26atitle%3DRetinoic%2520Acid%2520Synergizes%2520Ato-Mediated%2520Cytotoxicity%2520by%2520Precluding%2520Nrf2%2520Activity%2520in%2520Aml%2520Cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2014%26volume%3D111%26spage%3D874%26epage%3D882%26doi%3D10.1038%2Fbjc.2014.380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, J.</span></span> <span> </span><span class="NLM_article-title">Isoniazid Suppresses Antioxidant Response Element Activities and Impairs Adipogenesis in Mouse and Human Preadipocytes</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2013.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.taap.2013.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24128855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslOlt7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2013&pages=435-441&author=Y.+Chenauthor=P.+Xueauthor=Y.+Houauthor=H.+Zhangauthor=H.+Zhengauthor=T.+Zhouauthor=W.+Quauthor=W.+Tengauthor=Q.+Zhangauthor=M.+E.+Andersenauthor=J.+Pi&title=Isoniazid+Suppresses+Antioxidant+Response+Element+Activities+and+Impairs+Adipogenesis+in+Mouse+and+Human+Preadipocytes&doi=10.1016%2Fj.taap.2013.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Isoniazid suppresses antioxidant response element activities and impairs adipogenesis in mouse and human preadipocytes</span></div><div class="casAuthors">Chen, Yanyan; Xue, Peng; Hou, Yongyong; Zhang, Hao; Zheng, Hongzhi; Zhou, Tong; Qu, Weidong; Teng, Weiping; Zhang, Qiang; Andersen, Melvin E.; Pi, Jingbo</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">435-441</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Transcriptional signaling through the antioxidant response element (ARE), orchestrated by the Nuclear factor E2-related factor 2 (Nrf2), is a major cellular defense mechanism against oxidative or electrophilic stress.  Here, we reported that isoniazid (INH), a widely used antitubercular drug, displays a substantial inhibitory property against ARE activities in diverse mouse and human cells.  In 3T3-L1 preadipocytes, INH concn.-dependently suppressed the ARE-luciferase reporter activity and mRNA expression of various ARE-dependent antioxidant genes under basal and oxidative stressed conditions.  In keeping with our previous findings that Nrf2-ARE plays a crit. role in adipogenesis by regulating expression of CCAAT/enhancer-binding protein β (C/EBPβ) and peroxisome proliferator-activated receptor γ (PPARγ), suppression of ARE signaling by INH hampered adipogenic differentiation of 3T3-L1 cells and human adipose-derived stem cells (ADSCs).  Following adipogenesis induced by hormonal cocktails, INH-treated 3T3-L1 cells and ADSCs displayed significantly reduced levels of lipid accumulation and attenuated expression of C/EBPα and PPARγ.  Time-course studies in 3T3-L1 cells revealed that inhibition of adipogenesis by INH occurred in the early stage of terminal adipogenic differentiation, where reduced expression of C/EBPβ and C/EBPδ was obsd.  To our knowledge, the present study is the first to demonstrate that INH suppresses ARE signaling and interrupts with the transcriptional network of adipogenesis, leading to impaired adipogenic differentiation.  The inhibition of ARE signaling may be a potential underlying mechanism by which INH attenuates cellular antioxidant response contributing to various complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2kdrNxk5Y2LVg90H21EOLACvtfcHk0lgtHQtGI9BSEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslOlt7nN&md5=c22a9fd8cad1ab88542a99704fee0b16</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2013.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2013.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DP.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DTeng%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DAndersen%26aufirst%3DM.%2BE.%26aulast%3DPi%26aufirst%3DJ.%26atitle%3DIsoniazid%2520Suppresses%2520Antioxidant%2520Response%2520Element%2520Activities%2520and%2520Impairs%2520Adipogenesis%2520in%2520Mouse%2520and%2520Human%2520Preadipocytes%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2013%26volume%3D273%26spage%3D435%26epage%3D441%26doi%3D10.1016%2Fj.taap.2013.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewangan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, S. K.</span></span> <span> </span><span class="NLM_article-title">Isoniazid Prevents Nrf2 Translocation by Inhibiting Erk1 Phosphorylation and Induces Oxidative Stress and Apoptosis</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2015.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.redox.2015.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26202867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=80-92&author=A.+K.+Vermaauthor=A.+Yadavauthor=J.+Dewanganauthor=S.+V.+Singhauthor=M.+Mishraauthor=P.+K.+Singhauthor=S.+K.+Rath&title=Isoniazid+Prevents+Nrf2+Translocation+by+Inhibiting+Erk1+Phosphorylation+and+Induces+Oxidative+Stress+and+Apoptosis&doi=10.1016%2Fj.redox.2015.06.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Isoniazid prevents Nrf2 translocation by inhibiting ERK1 phosphorylation and induces oxidative stress and apoptosis</span></div><div class="casAuthors">Verma, Ajeet Kumar; Yadav, Arti; Dewangan, Jayant; Singh, Sarvendra Vikram; Mishra, Manisha; Singh, Pradhyumna Kumar; Rath, Srikanta Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">80-92</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Isoniazid is used either alone or in combination with other drugs for the treatment of tuberculosis.  It is also used for the prevention of tuberculosis.  Chronic treatment of Isoniazid may cause severe liver damage leading to acute liver failure.  The mechanism through which Isoniazid causes liver damage is investigated.  Isoniazid treatment generates reactive oxygen species and induces apoptosis in Hep3B cells.  It induces antioxidative and apoptotic genes leading to increase in mRNA expression and protein levels in Hep3B cells.  Whole genome expression anal. of Hep3B cells treated with Isoniazid has resulted in differential expression of various genes playing prime role in regulation of apoptotic, antioxidative, DNA damage, cell signaling, cell proliferation and differentiation pathways.  Isoniazid increased cytosolic Nrf2 protein level while decreased nuclear Nrf2 protein level.  It also decreased ERK1 phosphorylation and treatment of Hep3B cells with ERK inhibitor followed by Isoniazid resulting in increased apoptosis in these cells.  Two dimensional gel electrophoresis results have also shown differential expression of various protein species including heat shock proteins, proteins playing important role in oxidative stress, DNA damage, apoptosis, cell proliferation and differentiation.  Results suggest that Isoniazid induces apoptosis through oxidative stress and also prevents Nrf2 translocation into the nucleus by reducing ERK1 phosphorylation thus preventing cytoprotective effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZDPR3z0W077Vg90H21EOLACvtfcHk0lgtHQtGI9BSEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7jP&md5=7224d6d8974a2c6a5527d68ecc208bd6</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2015.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2015.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DA.%2BK.%26aulast%3DYadav%26aufirst%3DA.%26aulast%3DDewangan%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DS.%2BV.%26aulast%3DMishra%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DP.%2BK.%26aulast%3DRath%26aufirst%3DS.%2BK.%26atitle%3DIsoniazid%2520Prevents%2520Nrf2%2520Translocation%2520by%2520Inhibiting%2520Erk1%2520Phosphorylation%2520and%2520Induces%2520Oxidative%2520Stress%2520and%2520Apoptosis%26jtitle%3DRedox%2520Biol.%26date%3D2015%26volume%3D6%26spage%3D80%26epage%3D92%26doi%3D10.1016%2Fj.redox.2015.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmichael, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clewell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, J.</span></span> <span> </span><span class="NLM_article-title">Suppression of Nrf2-Are Activity Sensitizes Chemotherapeutic Agent-Induced Cytotoxicity in Human Acute Monocytic Leukemia Cells</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2015.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.taap.2015.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26708503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XislCnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2016&pages=1-7&author=H.+Pengauthor=H.+Wangauthor=P.+Xueauthor=Y.+Houauthor=J.+Dongauthor=T.+Zhouauthor=W.+Quauthor=S.+Pengauthor=J.+Liauthor=P.+L.+Carmichaelauthor=B.+Nelsonauthor=R.+Clewellauthor=Q.+Zhangauthor=M.+E.+Andersenauthor=J.+Pi&title=Suppression+of+Nrf2-Are+Activity+Sensitizes+Chemotherapeutic+Agent-Induced+Cytotoxicity+in+Human+Acute+Monocytic+Leukemia+Cells&doi=10.1016%2Fj.taap.2015.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of NRF2-ARE activity sensitizes chemotherapeutic agent-induced cytotoxicity in human acute monocytic leukemia cells</span></div><div class="casAuthors">Peng, Hui; Wang, Huihui; Xue, Peng; Hou, Yongyong; Dong, Jian; Zhou, Tong; Qu, Weidong; Peng, Shuangqing; Li, Jin; Carmichael, Paul L.; Nelson, Bud; Clewell, Rebecca; Zhang, Qiang; Andersen, Melvin E.; Pi, Jingbo</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Nuclear factor erythroid 2-related factor 2 (NRF2), a master regulator of the antioxidant response element (ARE)-dependent transcription, plays a pivotal role in chem. detoxification in normal and tumor cells.  Consistent with previous findings that NRF2-ARE contributes to chemotherapeutic resistance of cancer cells, we found that stable knockdown of NRF2 by lentiviral shRNA in human acute monocytic leukemia (AML) THP-1 cells enhanced the cytotoxicity of several chemotherapeutic agents, including arsenic trioxide (As2O3), etoposide and doxorubicin.  Using an ARE-luciferase reporter expressed in several human and mouse cells, we identified a set of compds., including isonicotinic acid amides, isoniazid and ethionamide, that inhibited NRF2-ARE activity.  Treatment of THP-1 cells with ethionamide, for instance, significantly reduced mRNA expression of multiple ARE-driven genes under either basal or As2O3-challenged conditions.  As detd. by cell viability and cell cycle, suppression of NRF2-ARE by ethionamide also significantly enhanced susceptibility of THP-1 and U937 cells to As2O3-induced cytotoxicity.  In THP-1 cells, the sensitizing effect of ethionamide on As2O3-induced cytotoxicity was highly dependent on NRF2.  To our knowledge, the present study is the first to demonstrate that ethionamide suppresses NRF2-ARE signaling and disrupts the transcriptional network of the antioxidant response in AML cells, leading to sensitization to chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5ihfz2oPhjrVg90H21EOLACvtfcHk0lhzXueusn3StA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislCnuw%253D%253D&md5=a4a5da283c61b9bb0b986c09f4f0ba95</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2015.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2015.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DXue%26aufirst%3DP.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCarmichael%26aufirst%3DP.%2BL.%26aulast%3DNelson%26aufirst%3DB.%26aulast%3DClewell%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DAndersen%26aufirst%3DM.%2BE.%26aulast%3DPi%26aufirst%3DJ.%26atitle%3DSuppression%2520of%2520Nrf2-Are%2520Activity%2520Sensitizes%2520Chemotherapeutic%2520Agent-Induced%2520Cytotoxicity%2520in%2520Human%2520Acute%2520Monocytic%2520Leukemia%2520Cells%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2016%26volume%3D292%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.taap.2015.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Do, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H. G.</span></span> <span> </span><span class="NLM_article-title">Metformin Inhibits Heme Oxygenase-1 Expression in Cancer Cells through Inactivation of Raf-Erk-Nrf2 Signaling and Ampk-Independent Pathways</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2013.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.taap.2013.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23707609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1aqt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=2013&pages=229-238&author=M.+T.+Doauthor=H.+G.+Kimauthor=T.+Khanalauthor=J.+H.+Choiauthor=D.+H.+Kimauthor=T.+C.+Jeongauthor=H.+G.+Jeong&title=Metformin+Inhibits+Heme+Oxygenase-1+Expression+in+Cancer+Cells+through+Inactivation+of+Raf-Erk-Nrf2+Signaling+and+Ampk-Independent+Pathways&doi=10.1016%2Fj.taap.2013.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways</span></div><div class="casAuthors">Do, Minh Truong; Kim, Hyung Gyun; Khanal, Tilak; Choi, Jae Ho; Kim, Dong Hee; Jeong, Tae Cheon; Jeong, Hye Gwang</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-238</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Resistance to therapy is the major obstacle to more effective cancer treatment.  Heme oxygenase-1 (HO-1) is often highly up-regulated in tumor tissues, and its expression is further increased in response to therapies.  It was suggested that inhibition of HO-1 expression is a potential therapeutic approach to sensitize tumors to chemotherapy and radiotherapy.  In this study, we tested the hypothesis that the anti-tumor effects of metformin are mediated by suppression of HO-1 expression in cancer cells.  Our results indicate that metformin strongly suppresses HO-1 mRNA and protein expression in human hepatic carcinoma HepG2, cervical cancer HeLa, and non-small-cell lung cancer A549 cells.  Metformin also markedly reduced Nrf2 mRNA and protein levels in whole cell lysates and suppressed tert-butylhydroquinone (tBHQ)-induced Nrf2 protein stability and antioxidant response element (ARE)-luciferase activity in HepG2 cells.  We also found that metformin regulation of Nrf2 expression is mediated by a Keap1-independent mechanism and that metformin significantly attenuated Raf-ERK signaling to suppress Nrf2 expression in cancer cells.  Inhibition of Raf-ERK signaling by PD98059 decreased Nrf2 mRNA expression in HepG2 cells, confirming that the inhibition of Nrf2 expression is mediated by an attenuation of Raf-ERK signaling in cancer cells.  The inactivation of AMPK by siRNA, DN-AMPK or the pharmacol. AMPK inhibitor compd. C, revealed that metformin reduced HO-1 expression in an AMPK-independent manner.  These results highlight the Raf-ERK-Nrf2 axis as a new mol. target in anticancer therapy in response to metformin treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYtX9XPC5YbVg90H21EOLACvtfcHk0lhzXueusn3StA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1aqt77F&md5=1277aa52cb23022682ecab32a24240d0</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2013.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2013.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DDo%26aufirst%3DM.%2BT.%26aulast%3DKim%26aufirst%3DH.%2BG.%26aulast%3DKhanal%26aufirst%3DT.%26aulast%3DChoi%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DJeong%26aufirst%3DT.%2BC.%26aulast%3DJeong%26aufirst%3DH.%2BG.%26atitle%3DMetformin%2520Inhibits%2520Heme%2520Oxygenase-1%2520Expression%2520in%2520Cancer%2520Cells%2520through%2520Inactivation%2520of%2520Raf-Erk-Nrf2%2520Signaling%2520and%2520Ampk-Independent%2520Pathways%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2013%26volume%3D271%26spage%3D229%26epage%3D238%26doi%3D10.1016%2Fj.taap.2013.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Do, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H. G.</span></span> <span> </span><span class="NLM_article-title">Metformin Induces Microrna-34a to Downregulate the Sirt1/Pgc-1alpha/Nrf2 Pathway, Leading to Increased Susceptibility of Wild-Type P53 Cancer Cells to Oxidative Stress and Therapeutic Agents</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2014.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2014.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24970682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A280%3ADC%252BC2cfntV2ntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=21-34&author=M.+T.+Doauthor=H.+G.+Kimauthor=J.+H.+Choiauthor=H.+G.+Jeong&title=Metformin+Induces+Microrna-34a+to+Downregulate+the+Sirt1%2FPgc-1alpha%2FNrf2+Pathway%2C+Leading+to+Increased+Susceptibility+of+Wild-Type+P53+Cancer+Cells+to+Oxidative+Stress+and+Therapeutic+Agents&doi=10.1016%2Fj.freeradbiomed.2014.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents</span></div><div class="casAuthors">Do Minh Truong; Kim Hyung Gyun; Choi Jae Ho; Jeong Hye Gwang</div><div class="citationInfo"><span class="NLM_cas:title">Free radical biology & medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sirtuin 1 (Sirt1) plays an important role in cellular redox balance and resistance to oxidative stress.  Sirt1 exhibits oncogenic properties in wild-type p53 cancer cells, whereas it acts as a tumor suppressor in p53-mutated cancer cells.  Here, we investigated the effects of metformin on Sirt1 expression in several cancer cell lines.  Using human cancer cell lines that exhibit differential expression of p53, we found that metformin reduced Sirt1 protein levels in cancer cells bearing wild-type p53, but did not affect Sirt1 protein levels in cancer cell lines harboring mutant forms of p53.  Metformin-induced p53 protein levels in wild-type p53 cancer cells resulted in upregulation of microRNA (miR)-34a.  The use of a miR-34a inhibitor confirmed that metformin-induced miR-34a was required for Sirt1 downregulation.  Metformin suppressed peroxisome proliferator-activated receptor γ (PPARγ) coactivator-1α (Pgc-1α) expression and its downstream target Nrf2 in MCF-7 cells.  Genetic tools demonstrated that the reduction of Sirt1 and Pgc-1α by metformin caused Nrf2 downregulation via suppression of PPARγ transcriptional activity.  Metformin reduced heme oxygenase-1 and superoxide dismutase 2 but upregulated catalase expression in MCF-7 cells.  Metformin-treated MCF-7 cells had no increase in basal levels of reactive oxygen species but were more susceptible to oxidative stress.  Furthermore, upregulation of death receptor 5 by metformin-mediated Sirt1 downregulation enhanced the sensitivity of wild-type p53 cancer cells to TRAIL-induced apoptosis.  Our results demonstrated that metformin induces miR-34a to suppress the Sirt1/Pgc-1α/Nrf2 pathway and increases susceptibility of wild-type p53 cancer cells to oxidative stress and TRAIL-induced apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvPBEjXDiwaoNpW7w2tapOfW6udTcc2eYb_GnwzJ03mrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfntV2ntg%253D%253D&md5=796479ce8d150e3fd36c3c26a7f0b6de</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2014.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2014.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DDo%26aufirst%3DM.%2BT.%26aulast%3DKim%26aufirst%3DH.%2BG.%26aulast%3DChoi%26aufirst%3DJ.%2BH.%26aulast%3DJeong%26aufirst%3DH.%2BG.%26atitle%3DMetformin%2520Induces%2520Microrna-34a%2520to%2520Downregulate%2520the%2520Sirt1%252FPgc-1alpha%252FNrf2%2520Pathway%252C%2520Leading%2520to%2520Increased%2520Susceptibility%2520of%2520Wild-Type%2520P53%2520Cancer%2520Cells%2520to%2520Oxidative%2520Stress%2520and%2520Therapeutic%2520Agents%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2014%26volume%3D74%26spage%3D21%26epage%3D34%26doi%3D10.1016%2Fj.freeradbiomed.2014.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashabi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalaj, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodagholi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudarzvand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkaki, A.</span></span> <span> </span><span class="NLM_article-title">Pre-Treatment with Metformin Activates Nrf2 Antioxidant Pathways and Inhibits Inflammatory Responses through Induction of Ampk after Transient Global Cerebral Ischemia</span>. <i>Metab. Brain Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">747</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1007/s11011-014-9632-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1007%2Fs11011-014-9632-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=25413451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=747-754&author=G.+Ashabiauthor=L.+Khalajauthor=F.+Khodagholiauthor=M.+Goudarzvandauthor=A.+Sarkaki&title=Pre-Treatment+with+Metformin+Activates+Nrf2+Antioxidant+Pathways+and+Inhibits+Inflammatory+Responses+through+Induction+of+Ampk+after+Transient+Global+Cerebral+Ischemia&doi=10.1007%2Fs11011-014-9632-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia</span></div><div class="casAuthors">Ashabi, Ghorbangol; Khalaj, Leila; Khodagholi, Fariba; Goudarzvand, Mahdi; Sarkaki, Alireza</div><div class="citationInfo"><span class="NLM_cas:title">Metabolic Brain Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">747-754</span>CODEN:
                <span class="NLM_cas:coden">MBDIEE</span>;
        ISSN:<span class="NLM_cas:issn">0885-7490</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Global cerebral ischemia arises in patients who have a variety of clin. conditions including cardiac arrest, shock and asphyxia.  In spite of advances in understanding of the brain ischemia and stroke etiol., therapeutic approaches to improve ischemic injury still remain limited.  It has been established that metformin can attenuate cell death in cerebral ischemia.  One of the main functions of metformin is proposed to be conducted via AMP-activated protein kinase (AMPK)-dependent pathway in the exptl. cerebral ischemia model.  It is also established that metformin can suppress inflammation and activate Nuclear factor erythroid 2-related factor (Nrf2) pathways in neurons.  In the current study, the role of metformin in regulating inflammatory and antioxidant pathways in the global cerebral ischemia was investigated.  Our results indicated that pretreatment of rats by metformin attenuated cellular levels of nuclear factor-κB, Tumor Necrosis Factor alpha and Cyclooxygenase-2 which are considered as three important proteins involved in the inflammation pathway.  Pretreatment by metformin increased the level of Nrf2 and heme oxygenase-1 in the hippocampus of ischemic rats compared with untreated ischemic group.  Moreover, pretreatment by metformin enhanced the level of glutathione and catalase activities compared with them in ischemic group.  Such protective changes detected by metformin pretreatment were reversed by injecting compd. c, an AMPK inhibitor.  These findings suggested that metformin might protect cells through modulating inflammatory and antioxidant pathways via induction of AMPK.  However, more exptl. and clin. trial studies regarding neuroprotective potential of metformin and the involved mechanisms, esp. in the context of cerebral ischemic injuries, are necessary.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi58kYaxS10rVg90H21EOLACvtfcHk0li9XHrtUU_bNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtb7K&md5=898be4cbcb0ac3ed59156e4a52c03e52</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1007%2Fs11011-014-9632-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11011-014-9632-2%26sid%3Dliteratum%253Aachs%26aulast%3DAshabi%26aufirst%3DG.%26aulast%3DKhalaj%26aufirst%3DL.%26aulast%3DKhodagholi%26aufirst%3DF.%26aulast%3DGoudarzvand%26aufirst%3DM.%26aulast%3DSarkaki%26aufirst%3DA.%26atitle%3DPre-Treatment%2520with%2520Metformin%2520Activates%2520Nrf2%2520Antioxidant%2520Pathways%2520and%2520Inhibits%2520Inflammatory%2520Responses%2520through%2520Induction%2520of%2520Ampk%2520after%2520Transient%2520Global%2520Cerebral%2520Ischemia%26jtitle%3DMetab.%2520Brain%2520Dis.%26date%3D2015%26volume%3D30%26spage%3D747%26epage%3D754%26doi%3D10.1007%2Fs11011-014-9632-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arlt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geismann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the Nrf2 Transcription Factor by the Alkaloid Trigonelline Renders Pancreatic Cancer Cells More Susceptible to Apoptosis through Decreased Proteasomal Gene Expression and Proteasome Activity</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">4825</span>– <span class="NLM_lpage">4835</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fonc.2012.493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23108405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFyjsrbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=4825-4835&author=A.+Arltauthor=S.+Sebensauthor=S.+Krebsauthor=C.+Geismannauthor=M.+Grossmannauthor=M.+L.+Kruseauthor=S.+Schreiberauthor=H.+Schafer&title=Inhibition+of+the+Nrf2+Transcription+Factor+by+the+Alkaloid+Trigonelline+Renders+Pancreatic+Cancer+Cells+More+Susceptible+to+Apoptosis+through+Decreased+Proteasomal+Gene+Expression+and+Proteasome+Activity&doi=10.1038%2Fonc.2012.493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity</span></div><div class="casAuthors">Arlt, A.; Sebens, S.; Krebs, S.; Geismann, C.; Grossmann, M.; Kruse, M-L.; Schreiber, S.; Schaefer, H.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">4825-4835</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Evidence accumulates that the transcription factor nuclear factor E2-related factor 2 (Nrf2) has an essential role in cancer development and chemoresistance, thus pointing to its potential as an anticancer target and undermining its suitability in chemoprevention.  Through the induction of cytoprotective and proteasomal genes, Nrf2 confers apoptosis protection in tumor cells, and inhibiting Nrf2 would therefore be an efficient strategy in anticancer therapy.  In the present study, pancreatic carcinoma cell lines (Panc1, Colo357 and MiaPaca2) and H6c7 pancreatic duct cells were analyzed for the Nrf2-inhibitory effect of the coffee alkaloid trigonelline (trig), as well as for its impact on Nrf2-dependent proteasome activity and resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and anticancer drug-induced apoptosis.  Chemoresistant Panc1 and Colo357 cells exhibit high constitutive Nrf2 activity, whereas chemosensitive MiaPaca2 and H6c7 cells display little basal but strong tert-butylhydroquinone (tBHQ)-inducible Nrf2 activity and drug resistance.  Trig efficiently decreased basal and tBHQ-induced Nrf2 activity in all cell lines, an effect relying on a reduced nuclear accumulation of the Nrf2 protein.  Along with Nrf2 inhibition, trig blocked the Nrf2-dependent expression of proteasomal genes (for example, s5a/psmd4 and α5/psma5) and reduced proteasome activity in all cell lines tested.  These blocking effects were absent after treatment with Nrf2 siRNA, a condition in which proteasomal gene expression and proteasome activity were already decreased, whereas siRNA against the related transcription factor Nrf1 did not affect proteasome activity and the inhibitory effect of trig.  Depending on both Nrf2 and proteasomal gene expression, the sensitivity of all cell lines to anticancer drugs and TRAIL-induced apoptosis was enhanced by trig.  Moreover, greater antitumor responses toward anticancer drug treatment were obsd. in tumor-bearing mice when receiving trig.  In conclusion, representing an efficient Nrf2 inhibitor capable of blocking Nrf2-dependent proteasome activity and thereby apoptosis protection in pancreatic cancer cells, trig might be beneficial in improving anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1uD5vWn0aALVg90H21EOLACvtfcHk0li9XHrtUU_bNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFyjsrbL&md5=3fb3a122c1cabe14251448dbdc0d7ec4</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.493%26sid%3Dliteratum%253Aachs%26aulast%3DArlt%26aufirst%3DA.%26aulast%3DSebens%26aufirst%3DS.%26aulast%3DKrebs%26aufirst%3DS.%26aulast%3DGeismann%26aufirst%3DC.%26aulast%3DGrossmann%26aufirst%3DM.%26aulast%3DKruse%26aufirst%3DM.%2BL.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DSchafer%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520the%2520Nrf2%2520Transcription%2520Factor%2520by%2520the%2520Alkaloid%2520Trigonelline%2520Renders%2520Pancreatic%2520Cancer%2520Cells%2520More%2520Susceptible%2520to%2520Apoptosis%2520through%2520Decreased%2520Proteasomal%2520Gene%2520Expression%2520and%2520Proteasome%2520Activity%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D4825%26epage%3D4835%26doi%3D10.1038%2Fonc.2012.493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bollong, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherwood, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lairson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span> <span> </span><span class="NLM_article-title">A Small Molecule Inhibits Deregulated Nrf2 Transcriptional Activity in Cancer</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2193</span>– <span class="NLM_lpage">2198</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00448</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00448" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=2193-2198&author=M.+J.+Bollongauthor=H.+Yunauthor=L.+Sherwoodauthor=A.+K.+Woodsauthor=L.+L.+Lairsonauthor=P.+G.+Schultz&title=A+Small+Molecule+Inhibits+Deregulated+Nrf2+Transcriptional+Activity+in+Cancer&doi=10.1021%2Facschembio.5b00448"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00448%26sid%3Dliteratum%253Aachs%26aulast%3DBollong%26aufirst%3DM.%2BJ.%26aulast%3DYun%26aufirst%3DH.%26aulast%3DSherwood%26aufirst%3DL.%26aulast%3DWoods%26aufirst%3DA.%2BK.%26aulast%3DLairson%26aufirst%3DL.%2BL.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DA%2520Small%2520Molecule%2520Inhibits%2520Deregulated%2520Nrf2%2520Transcriptional%2520Activity%2520in%2520Cancer%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D2193%26epage%3D2198%26doi%3D10.1021%2Facschembio.5b00448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Nrf2 Inhibitor That Induces Apoptosis of Human Acute Myeloid Leukemia Cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">7625</span>– <span class="NLM_lpage">7636</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.13825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.18632%2Foncotarget.13825" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=7625-7636&author=J.+Zhangauthor=L.+Suauthor=Q.+Yeauthor=S.+Zhangauthor=H.+Kungauthor=F.+Jiangauthor=G.+Jiangauthor=J.+Miaoauthor=B.+Zhao&title=Discovery+of+a+Novel+Nrf2+Inhibitor+That+Induces+Apoptosis+of+Human+Acute+Myeloid+Leukemia+Cells&doi=10.18632%2Foncotarget.13825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.13825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.13825%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DKung%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DMiao%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Nrf2%2520Inhibitor%2520That%2520Induces%2520Apoptosis%2520of%2520Human%2520Acute%2520Myeloid%2520Leukemia%2520Cells%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D7625%26epage%3D7636%26doi%3D10.18632%2Foncotarget.13825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmagadda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudini, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brimacombe, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajghate, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahane, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mensah, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrielson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastinejad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxer, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswal, S.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Inhibitor of Nrf2 Selectively Intervenes Therapeutic Resistance in Keap1-Deficient Nsclc Tumors</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3214</span>– <span class="NLM_lpage">3225</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00651</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00651" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlyls7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=3214-3225&author=A.+Singhauthor=S.+Venkannagariauthor=K.+H.+Ohauthor=Y.+Q.+Zhangauthor=J.+M.+Rohdeauthor=L.+Liuauthor=S.+Nimmagaddaauthor=K.+Sudiniauthor=K.+R.+Brimacombeauthor=S.+Gajghateauthor=J.+Maauthor=A.+Wangauthor=X.+Xuauthor=S.+A.+Shahaneauthor=M.+Xiaauthor=J.+Wooauthor=G.+A.+Mensahauthor=Z.+Wangauthor=M.+Ferrerauthor=E.+Gabrielsonauthor=Z.+Liauthor=F.+Rastinejadauthor=M.+Shenauthor=M.+B.+Boxerauthor=S.+Biswal&title=Small+Molecule+Inhibitor+of+Nrf2+Selectively+Intervenes+Therapeutic+Resistance+in+Keap1-Deficient+Nsclc+Tumors&doi=10.1021%2Facschembio.6b00651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors</span></div><div class="casAuthors">Singh, Anju; Venkannagari, Sreedhar; Oh, Kyu H.; Zhang, Ya-Qin; Rohde, Jason M.; Liu, Li; Nimmagadda, Sridhar; Sudini, Kuladeep; Brimacombe, Kyle R.; Gajghate, Sachin; Ma, Jinfang; Wang, Amy; Xu, Xin; Shahane, Sampada A.; Xia, Menghang; Woo, Juhyung; Mensah, George A.; Wang, Zhibin; Ferrer, Marc; Gabrielson, Edward; Li, Zhuyin; Rastinejad, Fraydoon; Shen, Min; Boxer, Matthew B.; Biswal, Shyam</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3214-3225</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Loss of function mutations in Kelch-like ECH Assocd. Protein 1 (KEAP1), or gain-of-function mutations in nuclear factor erythroid 2-related factor 2 (NRF2), are common in non-small cell lung cancer (NSCLC) and assocd. with therapeutic resistance.  To discover novel NRF2 inhibitors for targeted therapy, we conducted a quant. high-throughput screen using a diverse set of ∼400,000 small mols. (Mol. Libraries Small Mol. Repository Library, MLSMR) at the National Center for Advancing Translational Sciences.  We identified ML385 as a probe mol. that binds to NRF2 and inhibits its downstream target gene expression.  Specifically, ML385 binds to Neh1, the Cap 'N' Collar Basic Leucine Zipper (CNC-bZIP) domain of NRF2, and interferes with the binding of the V-Maf Avian Musculoaponeurotic Fibrosarcoma Oncogene Homolog G (MAFG)-NRF2 protein complex to regulatory DNA binding sequences.  In clonogenic assays, when used in combination with platinum-based drugs, doxorubicin or taxol, ML385 substantially enhances cytotoxicity in NSCLC cells, as compared to single agents.  ML385 shows specificity and selectivity for NSCLC cells with KEAP1 mutation, leading to gain of NRF2 function.  In preclin. models of NSCLC with gain of NRF2 function, ML385 in combination with carboplatin showed significant antitumor activity.  We demonstrate the discovery and validation of ML385 as a novel and specific NRF2 inhibitor and conclude that targeting NRF2 may represent a promising strategy for the treatment of advanced NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrugqkIWDWrPrVg90H21EOLACvtfcHk0lgDxiib5UtdZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlyls7jK&md5=9fc37434e55b1bef1a1f88ffd1da3006</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00651%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DVenkannagari%26aufirst%3DS.%26aulast%3DOh%26aufirst%3DK.%2BH.%26aulast%3DZhang%26aufirst%3DY.%2BQ.%26aulast%3DRohde%26aufirst%3DJ.%2BM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DNimmagadda%26aufirst%3DS.%26aulast%3DSudini%26aufirst%3DK.%26aulast%3DBrimacombe%26aufirst%3DK.%2BR.%26aulast%3DGajghate%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DShahane%26aufirst%3DS.%2BA.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DWoo%26aufirst%3DJ.%26aulast%3DMensah%26aufirst%3DG.%2BA.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DGabrielson%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DRastinejad%26aufirst%3DF.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DBoxer%26aufirst%3DM.%2BB.%26aulast%3DBiswal%26aufirst%3DS.%26atitle%3DSmall%2520Molecule%2520Inhibitor%2520of%2520Nrf2%2520Selectively%2520Intervenes%2520Therapeutic%2520Resistance%2520in%2520Keap1-Deficient%2520Nsclc%2520Tumors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D3214%26epage%3D3225%26doi%3D10.1021%2Facschembio.6b00651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">A Complementary Chemical and Genomic Screening Approach for Druggable Targets in the Nrf2 Pathway and Small Molecule Inhibitors to Overcome Cancer Cell Drug Resistance</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1189</span>– <span class="NLM_lpage">1199</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b01025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b01025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlt1Whs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1189-1199&author=J.+H.+Matthewsauthor=X.+Liangauthor=V.+J.+Paulauthor=H.+Luesch&title=A+Complementary+Chemical+and+Genomic+Screening+Approach+for+Druggable+Targets+in+the+Nrf2+Pathway+and+Small+Molecule+Inhibitors+to+Overcome+Cancer+Cell+Drug+Resistance&doi=10.1021%2Facschembio.7b01025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">A Complementary Chemical and Genomic Screening Approach for Druggable Targets in the Nrf2 Pathway and Small Molecule Inhibitors to Overcome Cancer Cell Drug Resistance</span></div><div class="casAuthors">Matthews, James H.; Liang, Xiao; Paul, Valerie J.; Luesch, Hendrik</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1189-1199</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Resistance to chemotherapy is a major obstacle in the treatment of a wide array of different types of cancer.  Chemotherapeutic drug resistance is achieved by cancer cells by a variety of different mechanisms, which can be either compd. specific or general.  An emerging mechanism for nonspecific chemotherapeutic drug resistance relies on hyperactivity of the transcription factor Nrf2.  Normally Nrf2 levels are tightly regulated by the ubiquitin-proteasome system; however, mutations in genes responsible for this regulation are common in many cancer types, resulting in increased expression of Nrf2, activation of its downstream target genes, and resistance to a variety of chemotherapeutic agents.  For this reason, there has been considerable interest in the discovery of small mol. inhibitors of Nrf2 capable of attenuating this resistance mechanism.  To this end, we have screened two com. available libraries of known biol. active small mols. to identify potential Nrf2 inhibitors.  To increase the breadth of this screen we have also screened an RNAi library that targets the majority of the druggable genome to also identify Nrf2-inhibitor targets that are not currently targeted by small mols.  To complement the com. chem. and genomic library screening, we screened a small collection of proprietary natural products isolated from marine cyanobacteria, which included actin targeting and uncharacterized but biol. active compds.  Through these efforts, we have identified three classes of compds.: cardiac glycosides, Stat3 inhibitors, and actin disrupting agents as Nrf2 inhibitors that are able to attenuate Nrf2 activity and synergize with chemotherapeutic agents in the non-small-cell lung cancer cell line A549.  In addn., we found that grassypeptolide A exerts Nrf2 modulatory activity via a thus far uncharacterized mechanism.  Moreover, we have identified a set of putative Nrf2 targets comprising the transcription factors TWIST1 and ELF4, the protein kinase NEK8, the TAK1 kinase regulator TAB1, and the dual-specific phosphatase DUSP4.  This study broadens the range of mechanisms through which inhibition of Nrf2 activity can be achieved, which will facilitate the characterization of novel Nrf2 inhibitors and allow the design of target specific screening procedures with which to identify more.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-J3rsITuwvrVg90H21EOLACvtfcHk0lgDxiib5UtdZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlt1Whs74%253D&md5=e01c2ef72bb71a6ec56184afb129d76b</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b01025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b01025%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DJ.%2BH.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DA%2520Complementary%2520Chemical%2520and%2520Genomic%2520Screening%2520Approach%2520for%2520Druggable%2520Targets%2520in%2520the%2520Nrf2%2520Pathway%2520and%2520Small%2520Molecule%2520Inhibitors%2520to%2520Overcome%2520Cancer%2520Cell%2520Drug%2520Resistance%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D1189%26epage%3D1199%26doi%3D10.1021%2Facschembio.7b01025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yanan Hou, Jie Li, Jun-Chen Wu, Quan-Xiang Wu, <span class="NLM_string-name hlFld-ContribAuthor">Jianguo Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of Cellular Antioxidant Defense System by Naturally Occurring Dibenzopyrone Derivatives Confers Neuroprotection against Oxidative Insults. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (15)
                                     , 2798-2809. <a href="https://doi.org/10.1021/acschemneuro.1c00023" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00023%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DActivation%252Bof%252BCellular%252BAntioxidant%252BDefense%252BSystem%252Bby%252BNaturally%252BOccurring%252BDibenzopyrone%252BDerivatives%252BConfers%252BNeuroprotection%252Bagainst%252BOxidative%252BInsults%26aulast%3DHou%26aufirst%3DYanan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D13012021%26date%3D13072021%26date%3D23072021%26volume%3D12%26issue%3D15%26spage%3D2798%26epage%3D2809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronica  Diez</span>, <span class="hlFld-ContribAuthor ">Sofia  Traikov</span>, <span class="hlFld-ContribAuthor ">Kathrin  Schmeisser</span>, <span class="hlFld-ContribAuthor ">Akshay Kumar Das  Adhikari</span>, <span class="hlFld-ContribAuthor ">Teymuras Vakhtang  Kurzchalia</span>. </span><span class="cited-content_cbyCitation_article-title">Glycolate combats massive oxidative stress by restoring redox potential in Caenorhabditis elegans. </span><span class="cited-content_cbyCitation_journal-name">Communications Biology</span><span> <strong>2021,</strong> <em>4 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s42003-021-01669-2" title="DOI URL">https://doi.org/10.1038/s42003-021-01669-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s42003-021-01669-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs42003-021-01669-2%26sid%3Dliteratum%253Aachs%26jtitle%3DCommunications%2520Biology%26atitle%3DGlycolate%252Bcombats%252Bmassive%252Boxidative%252Bstress%252Bby%252Brestoring%252Bredox%252Bpotential%252Bin%252BCaenorhabditis%252Belegans%26aulast%3DDiez%26aufirst%3DVeronica%26date%3D2021%26date%3D2021%26volume%3D4%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir  Simov</span>, <span class="hlFld-ContribAuthor ">Michael D.  Altman</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Bianchi</span>, <span class="hlFld-ContribAuthor ">Sonia  DelRizzo</span>, <span class="hlFld-ContribAuthor ">Edward N.  DiNunzio</span>, <span class="hlFld-ContribAuthor ">Guo  Feng</span>, <span class="hlFld-ContribAuthor ">Peter  Goldenblatt</span>, <span class="hlFld-ContribAuthor ">Raffaele  Ingenito</span>, <span class="hlFld-ContribAuthor ">Scott A.  Johnson</span>, <span class="hlFld-ContribAuthor ">My Sam  Mansueto</span>, <span class="hlFld-ContribAuthor ">Todd  Mayhood</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Mortison</span>, <span class="hlFld-ContribAuthor ">Victor  Serebrov</span>, <span class="hlFld-ContribAuthor ">Christopher  Sondey</span>, <span class="hlFld-ContribAuthor ">Venkat  Sriraman</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Tucker</span>, <span class="hlFld-ContribAuthor ">Abbas  Walji</span>, <span class="hlFld-ContribAuthor ">Hui  Wan</span>, <span class="hlFld-ContribAuthor ">Yingzi  Yue</span>, <span class="hlFld-ContribAuthor ">Alexander  Stoeck</span>, <span class="hlFld-ContribAuthor ">Erin F.  DiMauro</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and characterization of novel peptide inhibitors of the NRF2/MAFG/DNA ternary complex for the treatment of cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113686. <a href="https://doi.org/10.1016/j.ejmech.2021.113686" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113686</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113686%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bcharacterization%252Bof%252Bnovel%252Bpeptide%252Binhibitors%252Bof%252Bthe%252BNRF2%25252FMAFG%25252FDNA%252Bternary%252Bcomplex%252Bfor%252Bthe%252Btreatment%252Bof%252Bcancer%26aulast%3DSimov%26aufirst%3DVladimir%26date%3D2021%26volume%3D224%26spage%3D113686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tian  Liu</span>, <span class="hlFld-ContribAuthor ">Yi-Fei  Lv</span>, <span class="hlFld-ContribAuthor ">Jing-Long  Zhao</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Zheng-Yu  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of Nrf2 by phosphorylation: consequences for biological function and therapeutic implications. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Biology and Medicine</span><span> <strong>2021,</strong> <em>3 </em><a href="https://doi.org/10.1016/j.freeradbiomed.2021.03.034" title="DOI URL">https://doi.org/10.1016/j.freeradbiomed.2021.03.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.freeradbiomed.2021.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.freeradbiomed.2021.03.034%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Biology%2520and%2520Medicine%26atitle%3DRegulation%252Bof%252BNrf2%252Bby%252Bphosphorylation%25253A%252Bconsequences%252Bfor%252Bbiological%252Bfunction%252Band%252Btherapeutic%252Bimplications%26aulast%3DLiu%26aufirst%3DTian%26date%3D2021%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zi-Long  Song</span>, <span class="hlFld-ContribAuthor ">Yanan  Hou</span>, <span class="hlFld-ContribAuthor ">Feifei  Bai</span>, <span class="hlFld-ContribAuthor ">Jianguo  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of potent Nrf2 activators via tuning the electrophilicity and steric hindrance of vinyl sulfones for neuroprotection. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>107 </em>, 104520. <a href="https://doi.org/10.1016/j.bioorg.2020.104520" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104520%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DGeneration%252Bof%252Bpotent%252BNrf2%252Bactivators%252Bvia%252Btuning%252Bthe%252Belectrophilicity%252Band%252Bsteric%252Bhindrance%252Bof%252Bvinyl%252Bsulfones%252Bfor%252Bneuroprotection%26aulast%3DSong%26aufirst%3DZi-Long%26date%3D2021%26volume%3D107%26spage%3D104520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahdie  Rahban</span>, <span class="hlFld-ContribAuthor ">Mehran  Habibi-Rezaei</span>, <span class="hlFld-ContribAuthor ">Mansoureh  Mazaheri</span>, <span class="hlFld-ContribAuthor ">Luciano  Saso</span>, <span class="hlFld-ContribAuthor ">Ali A.  Moosavi-Movahedi</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-Viral Potential and Modulation of Nrf2 by Curcumin: Pharmacological Implications. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2020,</strong> <em>9 </em>
                                    (12)
                                     , 1228. <a href="https://doi.org/10.3390/antiox9121228" title="DOI URL">https://doi.org/10.3390/antiox9121228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox9121228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox9121228%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DAnti-Viral%252BPotential%252Band%252BModulation%252Bof%252BNrf2%252Bby%252BCurcumin%25253A%252BPharmacological%252BImplications%26aulast%3DRahban%26aufirst%3DMahdie%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D12%26spage%3D1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Orrù</span>, <span class="hlFld-ContribAuthor ">Silvia  Giordano</span>, <span class="hlFld-ContribAuthor ">Amedeo  Columbano</span>. </span><span class="cited-content_cbyCitation_article-title">Nrf2 in Neoplastic and Non-Neoplastic Liver Diseases. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (10)
                                     , 2932. <a href="https://doi.org/10.3390/cancers12102932" title="DOI URL">https://doi.org/10.3390/cancers12102932</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12102932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12102932%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DNrf2%252Bin%252BNeoplastic%252Band%252BNon-Neoplastic%252BLiver%252BDiseases%26aulast%3DOrr%25C3%25B9%26aufirst%3DClaudia%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D10%26spage%3D2932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Mou</span>, <span class="hlFld-ContribAuthor ">Shuai  Wen</span>, <span class="hlFld-ContribAuthor ">Yu-Xiu  Li</span>, <span class="hlFld-ContribAuthor ">Xin-Xing  Gao</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zheng-Yu  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112532. <a href="https://doi.org/10.1016/j.ejmech.2020.112532" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112532</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112532%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bin%252BKeap1-Nrf2%252Bprotein-protein%252Binteraction%252Binhibitors%26aulast%3DMou%26aufirst%3DYi%26date%3D2020%26volume%3D202%26spage%3D112532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengchen  Lu</span>, <span class="hlFld-ContribAuthor ">Xian  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Zhao</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions. </span><span class="cited-content_cbyCitation_journal-name">Redox Biology</span><span> <strong>2020,</strong> <em>34 </em>, 101565. <a href="https://doi.org/10.1016/j.redox.2020.101565" title="DOI URL">https://doi.org/10.1016/j.redox.2020.101565</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.redox.2020.101565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.redox.2020.101565%26sid%3Dliteratum%253Aachs%26jtitle%3DRedox%2520Biology%26atitle%3DA%252Bhydrogen%252Bperoxide%252Bresponsive%252Bprodrug%252Bof%252BKeap1-Nrf2%252Binhibitor%252Bfor%252Bimproving%252Boral%252Babsorption%252Band%252Bselective%252Bactivation%252Bin%252Binflammatory%252Bconditions%26aulast%3DLu%26aufirst%3DMengchen%26date%3D2020%26volume%3D34%26spage%3D101565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengmin  Tao</span>, <span class="hlFld-ContribAuthor ">Tian  Liu</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">p62 as a therapeutic target for tumor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>193 </em>, 112231. <a href="https://doi.org/10.1016/j.ejmech.2020.112231" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112231</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112231%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3Dp62%252Bas%252Ba%252Btherapeutic%252Btarget%252Bfor%252Btumor%26aulast%3DTao%26aufirst%3DMengmin%26date%3D2020%26volume%3D193%26spage%3D112231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haishan  Zhou</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (3)
                                     , 209-225. <a href="https://doi.org/10.1080/13543776.2020.1715365" title="DOI URL">https://doi.org/10.1080/13543776.2020.1715365</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1715365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1715365%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DRecent%252Bprogress%252Bin%252Bthe%252Bdevelopment%252Bof%252Bsmall%252Bmolecule%252BNrf2%252Bactivators%25253A%252Ba%252Bpatent%252Breview%252B%2525282017-present%252529%26aulast%3DZhou%26aufirst%3DHaishan%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D3%26spage%3D209%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eun-Ji  Choi</span>, <span class="hlFld-ContribAuthor ">Sang-Min  Jeon</span>. </span><span class="cited-content_cbyCitation_article-title">NRF2-driven redox metabolism takes center stage in cancer metabolism from an outside-in perspective. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2020,</strong> <em>43 </em>
                                    (3)
                                     , 321-336. <a href="https://doi.org/10.1007/s12272-020-01224-3" title="DOI URL">https://doi.org/10.1007/s12272-020-01224-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-020-01224-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-020-01224-3%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DNRF2-driven%252Bredox%252Bmetabolism%252Btakes%252Bcenter%252Bstage%252Bin%252Bcancer%252Bmetabolism%252Bfrom%252Ban%252Boutside-in%252Bperspective%26aulast%3DChoi%26aufirst%3DEun-Ji%26date%3D2020%26date%3D2020%26volume%3D43%26issue%3D3%26spage%3D321%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Xueyang  Jiang</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Degradation of proteins by PROTACs and other strategies. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (2)
                                     , 207-238. <a href="https://doi.org/10.1016/j.apsb.2019.08.001" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDegradation%252Bof%252Bproteins%252Bby%252BPROTACs%252Band%252Bother%252Bstrategies%26aulast%3DWang%26aufirst%3DYang%26date%3D2020%26volume%3D10%26issue%3D2%26spage%3D207%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soudeh  Ghafouri-Fard</span>, <span class="hlFld-ContribAuthor ">Asghar  Ashrafi Hafez</span>, <span class="hlFld-ContribAuthor ">Mohammad  Taheri</span>. </span><span class="cited-content_cbyCitation_article-title">Metastasis Associated Lung Adenocarcinoma Transcript 1: An update on expression pattern and functions in carcinogenesis. </span><span class="cited-content_cbyCitation_journal-name">Experimental and Molecular Pathology</span><span> <strong>2020,</strong> <em>112 </em>, 104330. <a href="https://doi.org/10.1016/j.yexmp.2019.104330" title="DOI URL">https://doi.org/10.1016/j.yexmp.2019.104330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.yexmp.2019.104330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.yexmp.2019.104330%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520and%2520Molecular%2520Pathology%26atitle%3DMetastasis%252BAssociated%252BLung%252BAdenocarcinoma%252BTranscript%252B1%25253A%252BAn%252Bupdate%252Bon%252Bexpression%252Bpattern%252Band%252Bfunctions%252Bin%252Bcarcinogenesis%26aulast%3DGhafouri-Fard%26aufirst%3DSoudeh%26date%3D2020%26volume%3D112%26spage%3D104330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongzhi  Lin</span>, <span class="hlFld-ContribAuthor ">Yuting  Qiao</span>, <span class="hlFld-ContribAuthor ">Hongyu  Yang</span>, <span class="hlFld-ContribAuthor ">Qin  Nan</span>, <span class="hlFld-ContribAuthor ">Wei  Qu</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecular Nrf2 inhibitors as chemosensitizers for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2020,</strong> <em>12 </em>
                                    (3)
                                     , 243-267. <a href="https://doi.org/10.4155/fmc-2019-0285" title="DOI URL">https://doi.org/10.4155/fmc-2019-0285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0285%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSmall%252Bmolecular%252BNrf2%252Binhibitors%252Bas%252Bchemosensitizers%252Bfor%252Bcancer%252Btherapy%26aulast%3DLin%26aufirst%3DHongzhi%26date%3D2020%26volume%3D12%26issue%3D3%26spage%3D243%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed  Hammad</span>, <span class="hlFld-ContribAuthor ">Akhileshwar  Namani</span>, <span class="hlFld-ContribAuthor ">Mohamed  Elshaer</span>, <span class="hlFld-ContribAuthor ">Xiu Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Xiuwen  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">“NRF2 addiction” in lung cancer cells and its impact on cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2019,</strong> <em>467 </em>, 40-49. <a href="https://doi.org/10.1016/j.canlet.2019.09.016" title="DOI URL">https://doi.org/10.1016/j.canlet.2019.09.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2019.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2019.09.016%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3D%2525E2%252580%25259CNRF2%252Baddiction%2525E2%252580%25259D%252Bin%252Blung%252Bcancer%252Bcells%252Band%252Bits%252Bimpact%252Bon%252Bcancer%252Btherapy%26aulast%3DHammad%26aufirst%3DAhmed%26date%3D2019%26volume%3D467%26spage%3D40%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariya B.  Aksenenko</span>, <span class="hlFld-ContribAuthor ">Nadezhda V.  Palkina</span>, <span class="hlFld-ContribAuthor ">Olga N.  Sergeeva</span>, <span class="hlFld-ContribAuthor ">Ekaterina  Yu Sergeeva</span>, <span class="hlFld-ContribAuthor ">Andrey K.  Kirichenko</span>, <span class="hlFld-ContribAuthor ">Tatiana G.  Ruksha</span>. </span><span class="cited-content_cbyCitation_article-title">miR‐155 overexpression is followed by downregulation of its target gene, NFE2L2, and altered pattern of VEGFA expression in the liver of melanoma B16‐bearing mice at the premetastatic stage. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Experimental Pathology</span><span> <strong>2019,</strong> <em>100 </em>
                                    (5-6)
                                     , 311-319. <a href="https://doi.org/10.1111/iep.12342" title="DOI URL">https://doi.org/10.1111/iep.12342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/iep.12342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fiep.12342%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Experimental%2520Pathology%26atitle%3DmiR%2525E2%252580%252590155%252Boverexpression%252Bis%252Bfollowed%252Bby%252Bdownregulation%252Bof%252Bits%252Btarget%252Bgene%25252C%252BNFE2L2%25252C%252Band%252Baltered%252Bpattern%252Bof%252BVEGFA%252Bexpression%252Bin%252Bthe%252Bliver%252Bof%252Bmelanoma%252BB16%2525E2%252580%252590bearing%252Bmice%252Bat%252Bthe%252Bpremetastatic%252Bstage%26aulast%3DAksenenko%26aufirst%3DMariya%2BB.%26date%3D2019%26date%3D2020%26volume%3D100%26issue%3D5-6%26spage%3D311%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anh B.  Hua</span>, <span class="hlFld-ContribAuthor ">Rebecca  Justiniano</span>, <span class="hlFld-ContribAuthor ">Jessica  Perer</span>, <span class="hlFld-ContribAuthor ">Sophia L.  Park</span>, <span class="hlFld-ContribAuthor ">Hui  Li</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Cabello</span>, <span class="hlFld-ContribAuthor ">Georg T.  Wondrak</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing the Electron Transfer Reactant Phenazine Methosulfate (PMS) for the Apoptotic Elimination of Malignant Melanoma Cells through Induction of Lethal Oxidative and Mitochondriotoxic Stress. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (5)
                                     , 590. <a href="https://doi.org/10.3390/cancers11050590" title="DOI URL">https://doi.org/10.3390/cancers11050590</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11050590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11050590%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DRepurposing%252Bthe%252BElectron%252BTransfer%252BReactant%252BPhenazine%252BMethosulfate%252B%252528PMS%252529%252Bfor%252Bthe%252BApoptotic%252BElimination%252Bof%252BMalignant%252BMelanoma%252BCells%252Bthrough%252BInduction%252Bof%252BLethal%252BOxidative%252Band%252BMitochondriotoxic%252BStress%26aulast%3DHua%26aufirst%3DAnh%2BB.%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D5%26spage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Biosynthesis and regeneration of glutathione. Nrf2 regulates glutathione biosynthesis, usage, and recycling enzymes (labeled by red color).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Nrf2 regulates NADPH and anabolic metabolism. Nrf2 reprograms the metabolic network to support cellular proliferation. Nrf2 can activate the key enzymes (labeled by red color) in the pentose phosphate pathway (G6PD, PGD, TALDO1, Tkt), nucleotide biosynthesis pathway (MTHFD2, PPAT), serine/glycine biosynthesis (PHGDH, PSAT1, SHMT), NADPH producing steps in the TCA cycle (ME1, IDH1), and TCA cycle replenishing (GLS, glutaminase; PC). Nrf2 also represses fatty acid synthesis and desaturation (ACL, ATP-citrate lyase; ACC1; FASN, fatty acid synthase; SCD1) to spare NADPH (labeled by blue color).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Domain structure of human Nrf2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Keap1-mediated regulation of Nrf2 under normal and stressed conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Regulation of Nrf2 ubiquitination by β-TrCP and Hrd1. GSK-3-mediated Nrf2 phosphorylation enhances the Nrf2−β-TrCP interaction, facilitating Nrf2 ubiquitination by β-TrCP–SKP1–Cul1–RBX1 E3 ligase and degradation by proteasome. Increased endoplasmic reticulum (ER) stress activates Hrd1, resulting in the ubiquitination-dependent Nrf2 degradation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Roles of Nrf2 in blocking (yellow dotted lines) or promoting (blue dotted lines) the emergence of the hallmarks of cancer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Possible ways and validated targets for inhibiting Nrf2 activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Representative natural products with Nrf2 inhibition activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Ultrasmall molecule with Nrf2 inhibition activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Discovery of AEM1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Discovery of <b>4f</b> with pyrazolyl hydroxamic acid scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Discovery of <b>ML385</b> with Nrf2-binding mechanism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/medium/jm-2018-01121n_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Discovery of emetine, ouabain, and stattic.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.8b01121/20190418/images/large/jm-2018-01121n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01121&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42233" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42233" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 143 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishizawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Cloning and Characterization of a Novel Erythroid Cell-Derived Cnc Family Transcription Factor Heterodimerizing with the Small Maf Family Proteins</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">4184</span>– <span class="NLM_lpage">4193</span>, <span class="refDoi"> DOI: 10.1128/MCB.15.8.4184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.15.8.4184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=7623813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADyaK2MXntVGit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=4184-4193&author=K.+Itohauthor=K.+Igarashiauthor=N.+Hayashiauthor=M.+Nishizawaauthor=M.+Yamamoto&title=Cloning+and+Characterization+of+a+Novel+Erythroid+Cell-Derived+Cnc+Family+Transcription+Factor+Heterodimerizing+with+the+Small+Maf+Family+Proteins&doi=10.1128%2FMCB.15.8.4184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins</span></div><div class="casAuthors">Itoh, Ken; Igarashi, Kazuhiko; Hayashi, Norio; Nishizawa, Makoto; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4184-93</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The chicken β-globin enhancer is crit. for the tissue- and developmental stage-specific expression of the β-globin genes.  This enhancer contains two indispensable cis elements, one contg. two GATA sites and the other contg. an NF-E2 site.  To identify the putative transcription factor acting through the NF-E2 motif in the chicken β-globin enhancer, we screened chicken cDNA libraries with a mouse p45 NF-E2 cDNA probe and isolated cDNA clones which encode a protein of 582 amino acid residues.  This protein contain a region that includes the basic region-leucine zipper domain which is well conserved among members of the CNC family proteins (Cap 'n' collar, p45 NF-E2, LCR-F1, Nrf1, and Nrf2).  Hence, the authors named this protein ECH (erythroid cell-derived protein with CNC homol.).  ECH is expressed abundantly in cultured erythroid cells undergoing terminal differentiation, peripheral erythrocytes, and some nonhematopoietic tissues.  Since most of the cDNA clones obtained from the chicken erythrocyte cDNA library encoded ECH, ECH is likely the predominant CNC family protein present in avian peripheral erythrocytes.  Like p45 NF-E2, ECH can heterodimerize with any of the small Maf family proteins and bind the NF-E2 site as a heterodimer in vitro.  In a transfection assay, ECH transactivates transcription depending on the presence of NF-E2 sites on the reporter gene plasmid.  These results indicate that ECH is likely a key regulator of avian erythropoiesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl-mjjhRr-fLVg90H21EOLACvtfcHk0lgZ3xAi2zw7wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntVGit78%253D&md5=6be978f36871a9e1dab0d44455285686</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1128%2FMCB.15.8.4184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.15.8.4184%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DK.%26aulast%3DHayashi%26aufirst%3DN.%26aulast%3DNishizawa%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DCloning%2520and%2520Characterization%2520of%2520a%2520Novel%2520Erythroid%2520Cell-Derived%2520Cnc%2520Family%2520Transcription%2520Factor%2520Heterodimerizing%2520with%2520the%2520Small%2520Maf%2520Family%2520Proteins%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1995%26volume%3D15%26spage%3D4184%26epage%3D4193%26doi%3D10.1128%2FMCB.15.8.4184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">The Cytoprotective Role of the Keap1-Nrf2 Pathway</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1007/s00204-011-0674-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1007%2Fs00204-011-0674-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21365312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFKks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2011&pages=241-272&author=L.+Bairdauthor=A.+T.+Dinkova-Kostova&title=The+Cytoprotective+Role+of+the+Keap1-Nrf2+Pathway&doi=10.1007%2Fs00204-011-0674-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The cytoprotective role of the Keap1-Nrf2 pathway</span></div><div class="casAuthors">Baird, Liam; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">241-272</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  An elaborate network of highly inducible proteins protects aerobic cells against the cumulative damaging effects of reactive oxygen intermediates and toxic electrophiles, which are the major causes of neoplastic and chronic degenerative diseases.  These cytoprotective proteins share common transcriptional regulation, through the Keap1-Nrf2 pathway, which can be activated by various exogenous and endogenous small mols. (inducers).  Inducers chem. react with crit. cysteine residues of the sensor protein Keap1, leading to stabilization and nuclear translocation of transcription factor Nrf2, and ultimately to coordinate enhanced expression of genes coding for cytoprotective proteins.  In addn., inducers inhibit pro-inflammatory responses, and there is a linear correlation spanning more than six orders of magnitude of concns. between inducer and anti-inflammatory activity.  Genetic deletion of transcription factor Nrf2 renders cells and animals much more sensitive to the damaging effects of electrophiles, oxidants and inflammatory agents in comparison with their wild-type counterparts.  Conversely, activation of the Keap1-Nrf2 pathway allows survival and adaptation under various conditions of stress and has protective effects in many animal models.  Cross-talks with other signalling pathways broadens the role of the Keap1-Nrf2 pathway in detg. the fate of the cell, impacting fundamental biol. processes such as proliferation, apoptosis, angiogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8uAt10znKgrVg90H21EOLACvtfcHk0lie6YR8150EWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFKks7w%253D&md5=cedf16d08f2f6d9ba8e2c5975251600e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00204-011-0674-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-011-0674-5%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DThe%2520Cytoprotective%2520Role%2520of%2520the%2520Keap1-Nrf2%2520Pathway%26jtitle%3DArch.%2520Toxicol.%26date%3D2011%26volume%3D85%26spage%3D241%26epage%3D272%26doi%3D10.1007%2Fs00204-011-0674-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chartoumpekis, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span> <span> </span><span class="NLM_article-title">Keap1/Nrf2 Pathway in the Frontiers of Cancer and Non-Cancer Cell Metabolism</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">639</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1042/BST20150049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1042%2FBST20150049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26551705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=639-644&author=D.+V.+Chartoumpekisauthor=N.+Wakabayashiauthor=T.+W.+Kensler&title=Keap1%2FNrf2+Pathway+in+the+Frontiers+of+Cancer+and+Non-Cancer+Cell+Metabolism&doi=10.1042%2FBST20150049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism</span></div><div class="casAuthors">Chartoumpekis, Dionysios V.; Wakabayashi, Nobunao; Kensler, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">639-644</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Cancer cells adapt their metab. to their increased needs for energy and substrates for protein, lipid and nucleic acid synthesis.  Nuclear erythroid factor 2-like 2 (Nrf2) pathway is usually activated in cancers and has been suggested to promote cancer cell survival mainly by inducing a large battery of cytoprotective genes.  This mini review focuses on metabolic pathways, beyond cytoprotection, which can be directly or indirectly regulated by Nrf2 in cancer cells to affect their survival.  The pentose phosphate pathway (PPP) is enhanced by Nrf2 in cancers and aids their growth.  PPP has also been found to be up-regulated in non-cancer tissues and other pathways, such as de novo lipogenesis, have been found to be repressed after activation of the Nrf2 pathway.  The importance of these Nrf2-regulated metabolic pathways in cancer compared with non-cancer state remains to be detd.  Last but not least, the importance of context about Nrf2 and cancer is highlighted as the Nrf2 pathway may be activated in cancers but its pharmacol. activators are useful in chemoprevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzz40oaoJy07Vg90H21EOLACvtfcHk0lie6YR8150EWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsb3O&md5=c3c19b8f4a889ff9b2d85c1220a6574b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1042%2FBST20150049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20150049%26sid%3Dliteratum%253Aachs%26aulast%3DChartoumpekis%26aufirst%3DD.%2BV.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26atitle%3DKeap1%252FNrf2%2520Pathway%2520in%2520the%2520Frontiers%2520of%2520Cancer%2520and%2520Non-Cancer%2520Cell%2520Metabolism%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2015%26volume%3D43%26spage%3D639%26epage%3D644%26doi%3D10.1042%2FBST20150049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span> <span> </span><span class="NLM_article-title">Nrf2 and Keap1Mutations: Permanent Activation of an Adaptive Response in Cancer</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2008.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.tibs.2008.12.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=176-188&author=J.+D.+Hayesauthor=M.+McMahon&title=Nrf2+and+Keap1Mutations%3A+Permanent+Activation+of+an+Adaptive+Response+in+Cancer&doi=10.1016%2Fj.tibs.2008.12.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2008.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2008.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DMcMahon%26aufirst%3DM.%26atitle%3DNrf2%2520and%2520Keap1Mutations%253A%2520Permanent%2520Activation%2520of%2520an%2520Adaptive%2520Response%2520in%2520Cancer%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2009%26volume%3D34%26spage%3D176%26epage%3D188%26doi%3D10.1016%2Fj.tibs.2008.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Toward Clinical Application of the Keap1–Nrf2 Pathway</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2013.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.tips.2013.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23664668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVylu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=340-346&author=T.+Suzukiauthor=H.+Motohashiauthor=M.+Yamamoto&title=Toward+Clinical+Application+of+the+Keap1%E2%80%93Nrf2+Pathway&doi=10.1016%2Fj.tips.2013.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Toward clinical application of the Keap1-Nrf2 pathway</span></div><div class="casAuthors">Suzuki, Takafumi; Motohashi, Hozumi; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">340-346</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The Keap1-Nrf2 pathway plays a crucial role in detg. the sensitivity of cells to chem. and/or oxidative insults by regulating the basal and inducible expression of detoxification and antioxidant enzymes, ABC transporters, and other stress response enzymes and/or proteins.  Increasing attention has been focused on the roles that the Keap1-Nrf2 pathway plays in the protection of our body against drug toxicity and stress-induced diseases.  Simultaneously, Nrf2 has been recognized to promote oncogenesis and resistance to chemotherapeutic drugs.  Cancer cells hijack Nrf2 activity to support their malignant growth and thus Nrf2 has emerged as a therapeutic target.  Translational studies of the Keap1-Nrf2 system, from mechanistic understanding to clin. applications, are now important to improve human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3LyyVFE7CB7Vg90H21EOLACvtfcHk0li1VhD7uxyG5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVylu7s%253D&md5=5834bbcb887101cbd4231e384e0580b6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DToward%2520Clinical%2520Application%2520of%2520the%2520Keap1%25E2%2580%2593Nrf2%2520Pathway%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D340%26epage%3D346%26doi%3D10.1016%2Fj.tips.2013.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menegon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Columbano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, S.</span></span> <span> </span><span class="NLM_article-title">The Dual Roles of Nrf2 in Cancer</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">593</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2016.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.molmed.2016.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27263465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVSnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=578-593&author=S.+Menegonauthor=A.+Columbanoauthor=S.+Giordano&title=The+Dual+Roles+of+Nrf2+in+Cancer&doi=10.1016%2Fj.molmed.2016.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Dual Roles of NRF2 in Cancer</span></div><div class="casAuthors">Menegon, Silvia; Columbano, Amedeo; Giordano, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">578-593</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  NRF2 has been traditionally considered as a tumor suppressor because its cytoprotective functions are deemed to be the main cellular defense mechanism against exogenous and endogenous insults, including xenobiotics and oxidative stress.  However, several recent studies demonstrate that hyperactivation of the NRF2 pathway creates an environment that favors the survival of normal as well as malignant cells, protecting them against oxidative stress, chemotherapeutic agents, and radiotherapy.  In a rapidly advancing field, this review summarizes some of the known mechanisms by which NRF2 can exert its oncogenic functions, and describes the current status of NRF2 inhibitors, providing a clear rationale for the consideration of NRF2 as a powerful putative therapeutic target in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw6FPL0WZuHbVg90H21EOLACvtfcHk0livvKj1dxeYEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVSnsL0%253D&md5=88b1ab6ed97e3f249fc5ea9e694b6d75</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2016.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2016.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DMenegon%26aufirst%3DS.%26aulast%3DColumbano%26aufirst%3DA.%26aulast%3DGiordano%26aufirst%3DS.%26atitle%3DThe%2520Dual%2520Roles%2520of%2520Nrf2%2520in%2520Cancer%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D578%26epage%3D593%26doi%3D10.1016%2Fj.molmed.2016.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. P.</span></span> <span> </span><span class="NLM_article-title">Oxidative Stress</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-061516-045037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1146%2Fannurev-biochem-061516-045037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28441057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFels70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2017&pages=715-748&author=H.+Siesauthor=C.+Berndtauthor=D.+P.+Jones&title=Oxidative+Stress&doi=10.1146%2Fannurev-biochem-061516-045037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress</span></div><div class="casAuthors">Sies, Helmut; Berndt, Carsten; Jones, Dean P.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">715-748</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">Oxidative stress is two sided: Whereas excessive oxidant challenge causes damage to biomols., maintenance of a physiol. level of oxidant challenge, termed oxidative eustress, is essential for governing life processes through redox signaling.  Recent interest has focused on the intricate ways by which redox signaling integrates these converse properties.  Redox balance is maintained by prevention, interception, and repair, and concomitantly the regulatory potential of mol. thiol-driven master switches such as Nrf2/Keap1 or NF-κB/IκB is used for system-wide oxidative stress response.  Nonradical species such as hydrogen peroxide (H2O2) or singlet mol. oxygen, rather than free-radical species, perform major second messenger functions.  Chemokine-controlled NADPH oxidases and metabolically controlled mitochondrial sources of H2O2 as well as glutathione- and thioredoxin-related pathways, with powerful enzymic back-up systems, are responsible for fine-tuning physiol. redox signaling.  This makes for a rich research field spanning from biochem. and cell biol. into nutritional sciences, environmental medicine, and mol. knowledge-based redox medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqYthGbEMU0LVg90H21EOLACvtfcHk0livvKj1dxeYEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFels70%253D&md5=910b7e9fa8ebd3b7dba6497f8212d4de</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-061516-045037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-061516-045037%26sid%3Dliteratum%253Aachs%26aulast%3DSies%26aufirst%3DH.%26aulast%3DBerndt%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DD.%2BP.%26atitle%3DOxidative%2520Stress%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2017%26volume%3D86%26spage%3D715%26epage%3D748%26doi%3D10.1146%2Fannurev-biochem-061516-045037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span> <span> </span><span class="NLM_article-title">The Keap1-Nrf2 System: A Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1169</span>– <span class="NLM_lpage">1203</span>, <span class="refDoi"> DOI: 10.1152/physrev.00023.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1152%2Fphysrev.00023.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29717933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvFektrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2018&pages=1169-1203&author=M.+Yamamotoauthor=T.+W.+Kenslerauthor=H.+Motohashi&title=The+Keap1-Nrf2+System%3A+A+Thiol-Based+Sensor-Effector+Apparatus+for+Maintaining+Redox+Homeostasis&doi=10.1152%2Fphysrev.00023.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis</span></div><div class="casAuthors">Yamamoto, Masayuki; Kensler, Thomas W.; Motohashi, Hozumi</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1169-1203</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">1522-1210</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The Kelch-like ECH-assocd. protein 1-NF-E2-related factor 2 (KEAP1-NRF2) system forms the major node of cellular and organismal defense against oxidative and electrophilic stresses of both exogenous and endogenous origins.  KEAP1 acts as a cysteine thiol-rich sensor of redox insults, whereas NRF2 is a transcription factor that robustly transduces chem. signals to regulate a battery of cytoprotective genes.  KEAP1 represses NRF2 activity under quiescent conditions, whereas NRF2 is liberated from KEAP1-mediated repression on exposure to stresses.  The rapid inducibility of a response based on a derepression mechanism is an important feature of the KEAP1-NRF2 system.  Recent studies have unveiled the complexities of the functional contributions of the KEAP1-NRF2 system and defined its broader involvement in biol. processes, including cell proliferation and differentiation, as well as cytoprotection.  In this review, we describe historical milestones in the initial characterization of the KEAP1-NRF2 system and provide a comprehensive overview of the mol. mechanisms governing the functions of KEAP1 and NRF2, as well as their roles in physiol. and pathol.  We also refer to the clin. significance of the KEAP1-NRF2 system as an important prophylactic and therapeutic target for various diseases, particularly aging-related disorders.  We believe that controlled harnessing of the KEAP1-NRF2 system is a key to healthy aging and well-being in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohbdKIhBBbkLVg90H21EOLACvtfcHk0livvKj1dxeYEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvFektrc%253D&md5=906947c8ad97c48f60e46bc44103664a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00023.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00023.2017%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DMotohashi%26aufirst%3DH.%26atitle%3DThe%2520Keap1-Nrf2%2520System%253A%2520A%2520Thiol-Based%2520Sensor-Effector%2520Apparatus%2520for%2520Maintaining%2520Redox%2520Homeostasis%26jtitle%3DPhysiol.%2520Rev.%26date%3D2018%26volume%3D98%26spage%3D1169%26epage%3D1203%26doi%3D10.1152%2Fphysrev.00023.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggleston, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span> <span> </span><span class="NLM_article-title">Transcription Factor Nrf2Mediates an Adaptive Response to Sulforaphane That Protects Fibroblasts in Vitro against the Cytotoxic Effects of Electrophiles, Peroxides and Redox-Cycling Agents</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2009.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.taap.2009.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=19303893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1Smtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=2009&pages=267-280&author=L.+G.+Higginsauthor=M.+O.+Kelleherauthor=I.+M.+Egglestonauthor=K.+Itohauthor=M.+Yamamotoauthor=J.+D.+Hayes&title=Transcription+Factor+Nrf2Mediates+an+Adaptive+Response+to+Sulforaphane+That+Protects+Fibroblasts+in+Vitro+against+the+Cytotoxic+Effects+of+Electrophiles%2C+Peroxides+and+Redox-Cycling+Agents&doi=10.1016%2Fj.taap.2009.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents</span></div><div class="casAuthors">Higgins, Larry G.; Kelleher, Michael O.; Eggleston, Ian M.; Itoh, Ken; Yamamoto, Masayuki; Hayes, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-280</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sulforaphane can stimulate cellular adaptation to redox stressors through transcription factor Nrf2.  Using mouse embryonic fibroblasts (MEFs) as a model, we show herein that the normal homeostatic level of glutathione in Nrf2-/- MEFs was only 20% of that in their wild-type counterparts.  Furthermore, the rate of glutathione synthesis following its acute depletion upon treatment with 3 μmol/l sulforaphane was very substantially lower in Nrf2-/- MEFs than in wild-type cells, and the rebound leading to a ∼ 1.9-fold increase in glutathione that occurred 12-24 h after Nrf2 +/+ MEFs were treated with sulforaphane was not obsd. in Nrf2-/- fibroblasts.  Wild-type MEFs that had been pre-treated for 24 h with 3 μmol/l sulforaphane exhibited between 1.4- and 3.2-fold resistance against thiol-reactive electrophiles, including isothiocyanates, α,β-unsatd. carbonyl compds. (e.g. acrolein), aryl halides and alkene epoxides.  Pre-treatment of Nrf2 +/+ MEFs with sulforaphane also protected against hydroperoxides (e.g. cumene hydroperoxide, CuOOH), free radical-generating compds. (e.g. menadione), and genotoxic electrophiles (e.g. chlorambucil).  By contrast, Nrf2-/- MEFs were typically ∼ 50% less tolerant of these agents than wild-type fibroblasts, and sulforaphane pre-treatment did not protect the mutant cells against xenobiotics.  To test whether Nrf2-mediated up-regulation of glutathione represents the major cytoprotective mechanism stimulated by sulforaphane, 5 μmol/l buthionine sulfoximine (BSO) was used to inhibit glutathione synthesis.  In Nrf2 +/+ MEFs pre-treated with sulforaphane, BSO diminished intrinsic resistance and abolished inducible resistance to acrolein, CuOOH and chlorambucil, but not menadione.  Thus Nrf2-dependent up-regulation of GSH is the principal mechanism by which sulforaphane pre-treatment induced resistance to acrolein, CuOOH and chlorambucil, but not menadione.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw-GENqs_5k7Vg90H21EOLACvtfcHk0lj-OwkGBePGAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1Smtrc%253D&md5=708a2dee7d620aeea44048eedfb073b2</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2009.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2009.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DL.%2BG.%26aulast%3DKelleher%26aufirst%3DM.%2BO.%26aulast%3DEggleston%26aufirst%3DI.%2BM.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26atitle%3DTranscription%2520Factor%2520Nrf2Mediates%2520an%2520Adaptive%2520Response%2520to%2520Sulforaphane%2520That%2520Protects%2520Fibroblasts%2520in%2520Vitro%2520against%2520the%2520Cytotoxic%2520Effects%2520of%2520Electrophiles%252C%2520Peroxides%2520and%2520Redox-Cycling%2520Agents%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2009%26volume%3D237%26spage%3D267%26epage%3D280%26doi%3D10.1016%2Fj.taap.2009.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. C.</span></span> <span> </span><span class="NLM_article-title">Regulation of Glutathione Synthesis</span>. <i>Curr. Top. Cell. Regul.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/S0070-2137(01)80004-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2FS0070-2137%2801%2980004-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2001&pages=95-116&author=S.+C.+Lu&title=Regulation+of+Glutathione+Synthesis&doi=10.1016%2FS0070-2137%2801%2980004-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0070-2137%2801%2980004-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0070-2137%252801%252980004-2%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DS.%2BC.%26atitle%3DRegulation%2520of%2520Glutathione%2520Synthesis%26jtitle%3DCurr.%2520Top.%2520Cell.%2520Regul.%26date%3D2001%26volume%3D36%26spage%3D95%26epage%3D116%26doi%3D10.1016%2FS0070-2137%2801%2980004-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malhotra, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portales-Casamar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenillas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Happel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasserman, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswal, S.</span></span> <span> </span><span class="NLM_article-title">Global Mapping of Binding Sites for Nrf2 Identifies Novel Targets in Cell Survival Response through Chip-Seq Profiling and Network Analysis</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">5718</span>– <span class="NLM_lpage">5734</span>, <span class="refDoi"> DOI: 10.1093/nar/gkq212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1093%2Fnar%2Fgkq212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20460467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1WhsLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=5718-5734&author=D.+Malhotraauthor=E.+Portales-Casamarauthor=A.+Singhauthor=S.+Srivastavaauthor=D.+Arenillasauthor=C.+Happelauthor=C.+Shyrauthor=N.+Wakabayashiauthor=T.+W.+Kenslerauthor=W.+W.+Wassermanauthor=S.+Biswal&title=Global+Mapping+of+Binding+Sites+for+Nrf2+Identifies+Novel+Targets+in+Cell+Survival+Response+through+Chip-Seq+Profiling+and+Network+Analysis&doi=10.1093%2Fnar%2Fgkq212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis</span></div><div class="casAuthors">Malhotra, Deepti; Portales-Casamar, Elodie; Singh, Anju; Srivastava, Siddhartha; Arenillas, David; Happel, Christine; Shyr, Casper; Wakabayashi, Nobunao; Kensler, Thomas W.; Wasserman, Wyeth W.; Biswal, Shyam</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5718-5734</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Nrf2 (nuclear factor E2 p45-related factor 2) transcription factor responds to diverse oxidative and electrophilic environmental stresses by circumventing repression by Keap1, translocating to the nucleus, and activating cytoprotective genes.  Nrf2 responses provide protection against chem. carcinogenesis, chronic inflammation, neurodegeneration, emphysema, asthma and sepsis in murine models.  Nrf2 regulates the expression of a plethora of genes that detoxify oxidants and electrophiles and repair or remove damaged macromols., such as through proteasomal processing.  However, many direct targets of Nrf2 remain undefined.  Here, mouse embryonic fibroblasts (MEF) with either constitutive nuclear accumulation (Keap1-/-) or depletion (Nrf2-/-) of Nrf2 were utilized to perform chromatin-immunopptn. with parallel sequencing (ChIP-Seq) and global transcription profiling.  This unique Nrf2 ChIP-Seq dataset is highly enriched for Nrf2-binding motifs.  Integrating ChIP-Seq and microarray analyses, we identified 645 basal and 654 inducible direct targets of Nrf2, with 244 genes at the intersection.  Modulated pathways in stress response and cell proliferation distinguish the inducible and basal programs.  Results were confirmed in an in vivo stress model of cigarette smoke-exposed mice.  This study reveals global circuitry of the Nrf2 stress response emphasizing Nrf2 as a central node in cell survival response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw6XLdwMj1Z7Vg90H21EOLACvtfcHk0lj-OwkGBePGAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1WhsLvJ&md5=31aa9c617ac76f9cf1ea4f5bfa080f45</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkq212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkq212%26sid%3Dliteratum%253Aachs%26aulast%3DMalhotra%26aufirst%3DD.%26aulast%3DPortales-Casamar%26aufirst%3DE.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DArenillas%26aufirst%3DD.%26aulast%3DHappel%26aufirst%3DC.%26aulast%3DShyr%26aufirst%3DC.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DWasserman%26aufirst%3DW.%2BW.%26aulast%3DBiswal%26aufirst%3DS.%26atitle%3DGlobal%2520Mapping%2520of%2520Binding%2520Sites%2520for%2520Nrf2%2520Identifies%2520Novel%2520Targets%2520in%2520Cell%2520Survival%2520Response%2520through%2520Chip-Seq%2520Profiling%2520and%2520Network%2520Analysis%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2010%26volume%3D38%26spage%3D5718%26epage%3D5734%26doi%3D10.1093%2Fnar%2Fgkq212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agyeman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaerkady, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visvanathan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T.</span></span> <span> </span><span class="NLM_article-title">Transcriptomic and Proteomic Profiling of Keap1 Disrupted and Sulforaphane-Treated Human Breast Epithelial Cells Reveals Common Expression Profiles</span>. <i>Breast Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1007/s10549-011-1536-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1007%2Fs10549-011-1536-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21597922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVSkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2012&pages=175-187&author=A.+Agyemanauthor=R.+Chaerkadyauthor=P.+Shawauthor=N.+Davidsonauthor=K.+Visvanathanauthor=A.+Pandeyauthor=T.+Kensler&title=Transcriptomic+and+Proteomic+Profiling+of+Keap1+Disrupted+and+Sulforaphane-Treated+Human+Breast+Epithelial+Cells+Reveals+Common+Expression+Profiles&doi=10.1007%2Fs10549-011-1536-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles</span></div><div class="casAuthors">Agyeman, Abena S.; Chaerkady, Raghothama; Shaw, Patrick G.; Davidson, Nancy E.; Visvanathan, Kala; Pandey, Akhilesh; Kensler, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-187</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Sulforaphane (SFN), an isothiocyanate found in cruciferous vegetables, is a potent inhibitor of exptl. mammary carcinogenesis and may be an effective, safe chemopreventive agent for use in humans.  SFN acts in part on the Keap1/Nrf2 pathway to regulate a battery of cytoprotective genes.  In this study, transcriptomic and proteomic changes in the estrogen receptor neg., non-tumorigenic human breast epithelial MCF10A cell line were analyzed following SFN treatment or KEAP1 knockdown with siRNA using microarray and stable isotopic labeling with amino acids in culture (SILAC), resp.  Changes in selected transcripts and proteins were confirmed by PCR and Western blot in MCF10A and MCF12A cells.  There was strong correlation between the transcriptomic and proteomic responses in both the SFN treatment (R = 0.679, P < 0.05) and KEAP1 knockdown (R = 0.853, P < 0.05) expts.  Common pathways for SFN treatment and KEAP1 knockdown were xenobiotic metab. and antioxidants, glutathione metab., carbohydrate metab., and NADH/NADPH regeneration.  Moreover, these pathways were most prominent in both the transcriptomic and the proteomic analyses.  The aldo-keto reductase family members, AKR1B10, AKR1C1, AKR1C2 and AKR1C3, as well as NQO1 and ALDH3A1, were highly upregulated at both the transcriptomic and the proteomic levels.  Collectively, these studies served to identify potential biomarkers that can be used in clin. trials to investigate the initial pharmacodynamic action of SFN in the breast.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8FEbuPtrVrbVg90H21EOLACvtfcHk0lj-OwkGBePGAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVSkt7s%253D&md5=d775fe08dbc87a2b368566f7427ced36</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs10549-011-1536-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-011-1536-9%26sid%3Dliteratum%253Aachs%26aulast%3DAgyeman%26aufirst%3DA.%26aulast%3DChaerkady%26aufirst%3DR.%26aulast%3DShaw%26aufirst%3DP.%26aulast%3DDavidson%26aufirst%3DN.%26aulast%3DVisvanathan%26aufirst%3DK.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DKensler%26aufirst%3DT.%26atitle%3DTranscriptomic%2520and%2520Proteomic%2520Profiling%2520of%2520Keap1%2520Disrupted%2520and%2520Sulforaphane-Treated%2520Human%2520Breast%2520Epithelial%2520Cells%2520Reveals%2520Common%2520Expression%2520Profiles%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2012%26volume%3D132%26spage%3D175%26epage%3D187%26doi%3D10.1007%2Fs10549-011-1536-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chorley, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karaca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bangura, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleeberger, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, D. A.</span></span> <span> </span><span class="NLM_article-title">Identification of Novel Nrf2-Regulated Genes by Chip-Seq: Influence on Retinoid X Receptor Alpha</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">7416</span>– <span class="NLM_lpage">7429</span>, <span class="refDoi"> DOI: 10.1093/nar/gks409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1093%2Fnar%2Fgks409" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=7416-7429&author=B.+N.+Chorleyauthor=M.+R.+Campbellauthor=X.+Wangauthor=M.+Karacaauthor=D.+Sambandanauthor=F.+Banguraauthor=P.+Xueauthor=J.+Piauthor=S.+R.+Kleebergerauthor=D.+A.+Bell&title=Identification+of+Novel+Nrf2-Regulated+Genes+by+Chip-Seq%3A+Influence+on+Retinoid+X+Receptor+Alpha&doi=10.1093%2Fnar%2Fgks409"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgks409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgks409%26sid%3Dliteratum%253Aachs%26aulast%3DChorley%26aufirst%3DB.%2BN.%26aulast%3DCampbell%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DKaraca%26aufirst%3DM.%26aulast%3DSambandan%26aufirst%3DD.%26aulast%3DBangura%26aufirst%3DF.%26aulast%3DXue%26aufirst%3DP.%26aulast%3DPi%26aufirst%3DJ.%26aulast%3DKleeberger%26aufirst%3DS.%2BR.%26aulast%3DBell%26aufirst%3DD.%2BA.%26atitle%3DIdentification%2520of%2520Novel%2520Nrf2-Regulated%2520Genes%2520by%2520Chip-Seq%253A%2520Influence%2520on%2520Retinoid%2520X%2520Receptor%2520Alpha%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3D7416%26epage%3D7429%26doi%3D10.1093%2Fnar%2Fgks409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirotsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuoka, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funayama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Nrf2-Mafg Heterodimers Contribute Globally to Antioxidant and Metabolic Networks</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">10228</span>– <span class="NLM_lpage">10239</span>, <span class="refDoi"> DOI: 10.1093/nar/gks827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1093%2Fnar%2Fgks827" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=10228-10239&author=Y.+Hirotsuauthor=F.+Katsuokaauthor=R.+Funayamaauthor=T.+Nagashimaauthor=Y.+Nishidaauthor=K.+Nakayamaauthor=J.+D.+Engelauthor=M.+Yamamoto&title=Nrf2-Mafg+Heterodimers+Contribute+Globally+to+Antioxidant+and+Metabolic+Networks&doi=10.1093%2Fnar%2Fgks827"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgks827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgks827%26sid%3Dliteratum%253Aachs%26aulast%3DHirotsu%26aufirst%3DY.%26aulast%3DKatsuoka%26aufirst%3DF.%26aulast%3DFunayama%26aufirst%3DR.%26aulast%3DNagashima%26aufirst%3DT.%26aulast%3DNishida%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DEngel%26aufirst%3DJ.%2BD.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DNrf2-Mafg%2520Heterodimers%2520Contribute%2520Globally%2520to%2520Antioxidant%2520and%2520Metabolic%2520Networks%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3D10228%26epage%3D10239%26doi%3D10.1093%2Fnar%2Fgks827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Q.</span></span> <span> </span><span class="NLM_article-title">Role of Nrf2 in Oxidative Stress and Toxicity</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-011112-140320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1146%2Fannurev-pharmtox-011112-140320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23294312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjt1Wguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=401-426&author=Q.+Ma&title=Role+of+Nrf2+in+Oxidative+Stress+and+Toxicity&doi=10.1146%2Fannurev-pharmtox-011112-140320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Nrf2 in oxidative stress and toxicity</span></div><div class="casAuthors">Ma, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">401-426</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Organismal life encounters reactive oxidants from internal metab. and environmental toxicant exposure.  Reactive oxygen and nitrogen species cause oxidative stress and are traditionally viewed as being harmful.  On the other hand, controlled prodn. of oxidants in normal cells serves useful purposes to regulate signaling pathways.  Reactive oxidants are counterbalanced by complex antioxidant defense systems regulated by a web of pathways to ensure that the response to oxidants is adequate for the body's needs.  A recurrent theme in oxidant signaling and antioxidant defense is reactive cysteine thiol-based redox signaling.  The nuclear factor erythroid 2-related factor 2 (Nrf2) is an emerging regulator of cellular resistance to oxidants.  Nrf2 controls the basal and induced expression of an array of antioxidant response element-dependent genes to regulate the physiol. and pathophysiol. outcomes of oxidant exposure.  This review discusses the impact of Nrf2 on oxidative stress and toxicity and how Nrf2 senses oxidants and regulates antioxidant defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3hN1BQDMlrbVg90H21EOLACvtfcHk0lh6QgRgerxfmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjt1Wguro%253D&md5=71d4fbc6734d49f3e9b2c262057d7288</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-011112-140320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-011112-140320%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DQ.%26atitle%3DRole%2520of%2520Nrf2%2520in%2520Oxidative%2520Stress%2520and%2520Toxicity%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2013%26volume%3D53%26spage%3D401%26epage%3D426%26doi%3D10.1146%2Fannurev-pharmtox-011112-140320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">The Nrf2 Regulatory Network Provides an Interface between Redox and Intermediary Metabolism</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2014.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.tibs.2014.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24647116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksVWrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=199-218&author=J.+D.+Hayesauthor=A.+T.+Dinkova-Kostova&title=The+Nrf2+Regulatory+Network+Provides+an+Interface+between+Redox+and+Intermediary+Metabolism&doi=10.1016%2Fj.tibs.2014.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The Nrf2 regulatory network provides an interface between redox and intermediary metabolism</span></div><div class="casAuthors">Hayes, John D.; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">199-218</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2, also called Nfe2l2) is a transcription factor that regulates the cellular redox status.  Nrf2 is controlled through a complex transcriptional/epigenetic and post-translational network that ensures its activity increases during redox perturbation, inflammation, growth factor stimulation and nutrient/energy fluxes, thereby enabling the factor to orchestrate adaptive responses to diverse forms of stress.  Besides mediating stress-stimulated induction of antioxidant and detoxification genes, Nrf2 contributes to adaptation by upregulating the repair and degrdn. of damaged macromols., and by modulating intermediary metab.  In the latter case, Nrf2 inhibits lipogenesis, supports β-oxidn. of fatty acids, facilitates flux through the pentose phosphate pathway, and increases NADPH regeneration and purine biosynthesis; these observations suggest Nrf2 directs metabolic reprogramming during stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLTtgJA1rMbVg90H21EOLACvtfcHk0lh6QgRgerxfmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksVWrtLg%253D&md5=790c66c48218229dc5531d24aefaceef</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2014.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2014.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DThe%2520Nrf2%2520Regulatory%2520Network%2520Provides%2520an%2520Interface%2520between%2520Redox%2520and%2520Intermediary%2520Metabolism%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2014%26volume%3D39%26spage%3D199%26epage%3D218%26doi%3D10.1016%2Fj.tibs.2014.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dieter, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleksunes, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slitt, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheffer, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manautou, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaassen, C. D.</span></span> <span> </span><span class="NLM_article-title">Oxidative and Electrophilic Stress Induces Multidrug Resistance-Associated Protein Transporters Via the Nuclear Factor-E2-Related Factor-2 Transcriptional Pathway</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1597</span>– <span class="NLM_lpage">1610</span>, <span class="refDoi"> DOI: 10.1002/hep.21831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1002%2Fhep.21831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=17668877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOhsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=1597-1610&author=J.+M.+Maherauthor=M.+Z.+Dieterauthor=L.+M.+Aleksunesauthor=A.+L.+Slittauthor=G.+Guoauthor=Y.+Tanakaauthor=G.+L.+Schefferauthor=J.+Y.+Chanauthor=J.+E.+Manautouauthor=Y.+Chenauthor=T.+P.+Daltonauthor=M.+Yamamotoauthor=C.+D.+Klaassen&title=Oxidative+and+Electrophilic+Stress+Induces+Multidrug+Resistance-Associated+Protein+Transporters+Via+the+Nuclear+Factor-E2-Related+Factor-2+Transcriptional+Pathway&doi=10.1002%2Fhep.21831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway</span></div><div class="casAuthors">Maher, Jonathan M.; Dieter, Matthew Z.; Aleksunes, Lauren M.; Slitt, Angela L.; Guo, Grace; Tanaka, Yuji; Scheffer, George L.; Chan, Jefferson Y.; Manautou, Jose E.; Chen, Ying; Dalton, Timothy P.; Yamamoto, Masayuki; Klaassen, Curtis D.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1597-1610</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Multidrug resistance-assocd. proteins (Mrps) are ATP-dependent transporters that efflux chems. out of cells.  In the liver, Mrp2 transports bilirubin-glucuronide, glutathione (GSH), and drug conjugates into bile, whereas Mrp3 and Mrp4 efflux these entities into blood.  The purpose of this study was to det. whether oxidative conditions (i.e., the disruption of hepatic GSH synthesis) or the administration of nuclear factor-E2-related factor-2 (Nrf2) activators (oltipraz and butylated hydroxyanisole) can induce hepatic Mrp transporters and whether that induction is through the Nrf2 transcriptional pathway.  Livers from hepatocyte-specific glutamate-cysteine ligase catalytic subunit-null mice had increased nuclear Nrf2 levels, marked gene and protein induction of the Nrf2 target gene NAD(P)H:quinone oxidoreductase 1, as well as Mrp2, Mrp3, and Mrp4 expression.  The treatment of wild-type and Nrf2-null mice with oltipraz and butylated hydroxyanisole demonstrated that the induction of Mrp2, Mrp3, and Mrp4 is Nrf2-dependent.  In Hepa1c1c7 cells treated with the Nrf2 activator tert-Bu hydroquinone, chromatin immunopptn. with Nrf2 antibodies revealed the binding of Nrf2 to antioxidant response elements in the promoter regions of mouse Mrp2 [-185 base pairs (bp)], Mrp3 (-9919 bp), and Mrp4 (-3767 bp).  Conclusion: The activation of the Nrf2 regulatory pathway stimulates the coordinated induction of hepatic Mrps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqro1b30E2bCLVg90H21EOLACvtfcHk0lhwrxYlEXXZUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOhsr7E&md5=1cfd276ce75a10f6d6cc1bb1bdc6016d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fhep.21831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.21831%26sid%3Dliteratum%253Aachs%26aulast%3DMaher%26aufirst%3DJ.%2BM.%26aulast%3DDieter%26aufirst%3DM.%2BZ.%26aulast%3DAleksunes%26aufirst%3DL.%2BM.%26aulast%3DSlitt%26aufirst%3DA.%2BL.%26aulast%3DGuo%26aufirst%3DG.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DScheffer%26aufirst%3DG.%2BL.%26aulast%3DChan%26aufirst%3DJ.%2BY.%26aulast%3DManautou%26aufirst%3DJ.%2BE.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDalton%26aufirst%3DT.%2BP.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKlaassen%26aufirst%3DC.%2BD.%26atitle%3DOxidative%2520and%2520Electrophilic%2520Stress%2520Induces%2520Multidrug%2520Resistance-Associated%2520Protein%2520Transporters%2520Via%2520the%2520Nuclear%2520Factor-E2-Related%2520Factor-2%2520Transcriptional%2520Pathway%26jtitle%3DHepatology%26date%3D2007%26volume%3D46%26spage%3D1597%26epage%3D1610%26doi%3D10.1002%2Fhep.21831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yates, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osburn, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCulloch, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silkworth, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutter, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span> <span> </span><span class="NLM_article-title">Genetic Versus Chemoprotective Activation of Nrf2 Signaling: Overlapping yet Distinct Gene Expression Profiles between Keap1 Knockout and Triterpenoid-Treated Mice</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1024</span>– <span class="NLM_lpage">1031</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgp100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1093%2Fcarcin%2Fbgp100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=19386581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVWjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=1024-1031&author=M.+S.+Yatesauthor=Q.+T.+Tranauthor=P.+M.+Dolanauthor=W.+O.+Osburnauthor=S.+Shinauthor=C.+C.+McCullochauthor=J.+B.+Silkworthauthor=K.+Taguchiauthor=M.+Yamamotoauthor=C.+R.+Williamsauthor=K.+T.+Libyauthor=M.+B.+Spornauthor=T.+R.+Sutterauthor=T.+W.+Kensler&title=Genetic+Versus+Chemoprotective+Activation+of+Nrf2+Signaling%3A+Overlapping+yet+Distinct+Gene+Expression+Profiles+between+Keap1+Knockout+and+Triterpenoid-Treated+Mice&doi=10.1093%2Fcarcin%2Fbgp100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice</span></div><div class="casAuthors">Yates, Melinda S.; Tran, Quynh T.; Dolan, Patrick M.; Osburn, William O.; Shin, Soona; McCulloch, Colin C.; Silkworth, Jay B.; Taguchi, Keiko; Yamamoto, Masayuki; Williams, Charlotte R.; Liby, Karen T.; Sporn, Michael B.; Sutter, Thomas R.; Kensler, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1024-1031</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Loss of NF-E2-related factor 2 (Nrf2) signaling increases susceptibility to acute toxicity, inflammation and carcinogenesis in mice due to the inability to mount adaptive responses.  In contrast, disruption of Keap1 (a cytoplasmic modifier of Nrf2 turnover) protects against these stresses in mice, although inactivating mutations in Keap1 have been identified recently in some human cancers.  Global characterization of Nrf2 activation is important to exploit this pathway for chemoprevention in healthy, yet at-risk individuals and also to elucidate the consequences of hijacking the pathway in Keap1-mutant human cancers.  Liver-targeted conditional Keap1-null, Albumin-Cre:Keap1(flox/-) (CKO) mice provide a model of genetic activation of Nrf2 signaling.  By coupling global gene expression anal. of CKO mice with anal. of pharmacol. activation using the synthetic oleanane triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im), we are able to gain insight into pathways affected by Nrf2 activation.  CDDO-Im is an extremely potent activator of Nrf2 signaling.  CKO mice were used to identify genes modulated by genetic activation of Nrf2 signaling.  The CKO response was compared with hepatic global gene expression changes in wild-type mice treated with CDDO-Im at a maximal Nrf2 activating dose.  The results show that genetic and pharmacol. activation of Nrf2 signaling modulates pathways beyond detoxication and cytoprotection, with the largest cluster of genes assocd. with lipid metab.  Genetic activation of Nrf2 results in much larger nos. of detoxication and lipid metab. gene changes.  Addnl., anal. of pharmacol. activation suggests that Nrf2 is the primary mediator of CDDO-Im activity, though other cell-signaling targets are also modulated following an oral dose of 30 μmol/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhb8rofVQOXrVg90H21EOLACvtfcHk0lhwrxYlEXXZUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVWjtr4%253D&md5=b23b7bef67f7ce9c82c0799d80264f06</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgp100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgp100%26sid%3Dliteratum%253Aachs%26aulast%3DYates%26aufirst%3DM.%2BS.%26aulast%3DTran%26aufirst%3DQ.%2BT.%26aulast%3DDolan%26aufirst%3DP.%2BM.%26aulast%3DOsburn%26aufirst%3DW.%2BO.%26aulast%3DShin%26aufirst%3DS.%26aulast%3DMcCulloch%26aufirst%3DC.%2BC.%26aulast%3DSilkworth%26aufirst%3DJ.%2BB.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DC.%2BR.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DSutter%26aufirst%3DT.%2BR.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26atitle%3DGenetic%2520Versus%2520Chemoprotective%2520Activation%2520of%2520Nrf2%2520Signaling%253A%2520Overlapping%2520yet%2520Distinct%2520Gene%2520Expression%2520Profiles%2520between%2520Keap1%2520Knockout%2520and%2520Triterpenoid-Treated%2520Mice%26jtitle%3DCarcinogenesis%26date%3D2009%26volume%3D30%26spage%3D1024%26epage%3D1031%26doi%3D10.1093%2Fcarcin%2Fbgp100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawatani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nukiwa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aburatani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.ccr.2012.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22789539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSltb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=66-79&author=Y.+Mitsuishiauthor=K.+Taguchiauthor=Y.+Kawataniauthor=T.+Shibataauthor=T.+Nukiwaauthor=H.+Aburataniauthor=M.+Yamamotoauthor=H.+Motohashi&title=Nrf2+Redirects+Glucose+and+Glutamine+into+Anabolic+Pathways+in+Metabolic+Reprogramming&doi=10.1016%2Fj.ccr.2012.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming</span></div><div class="casAuthors">Mitsuishi, Yoichiro; Taguchi, Keiko; Kawatani, Yukie; Shibata, Tatsuhiro; Nukiwa, Toshihiro; Aburatani, Hiroyuki; Yamamoto, Masayuki; Motohashi, Hozumi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-79</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Cancer cells consume large quantities of nutrients and maintain high levels of anabolism.  Recent studies revealed that various oncogenic pathways are involved in modulation of metab.  Nrf2, a key regulator for the maintenance of redox homeostasis, has been shown to contribute to malignant phenotypes of cancers including aggressive proliferation.  However, the mechanisms with which Nrf2 accelerates proliferation are not fully understood.  Here, we show that Nrf2 redirects glucose and glutamine into anabolic pathways, esp. under the sustained activation of PI3K-Akt signaling.  The active PI3K-Akt pathway augments the nuclear accumulation of Nrf2 and enables Nrf2 to promote metabolic activities that support cell proliferation in addn. to enhancing cytoprotection.  The functional expansion of Nrf2 reinforces the metabolic reprogramming triggered by proliferative signals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbor86fqwhKbVg90H21EOLACvtfcHk0lhwrxYlEXXZUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSltb3L&md5=e0efeee61bc55b50671f942e73d2da31</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DMitsuishi%26aufirst%3DY.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DKawatani%26aufirst%3DY.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DNukiwa%26aufirst%3DT.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DMotohashi%26aufirst%3DH.%26atitle%3DNrf2%2520Redirects%2520Glucose%2520and%2520Glutamine%2520into%2520Anabolic%2520Pathways%2520in%2520Metabolic%2520Reprogramming%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D22%26spage%3D66%26epage%3D79%26doi%3D10.1016%2Fj.ccr.2012.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaassen, C. D.</span></span> <span> </span><span class="NLM_article-title">Beneficial Role of Nrf2 in Regulating Nadph Generation and Consumption</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">590</span>– <span class="NLM_lpage">600</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfr183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1093%2Ftoxsci%2Fkfr183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21775727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1eiu7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2011&pages=590-600&author=K.+C.+Wuauthor=J.+Y.+Cuiauthor=C.+D.+Klaassen&title=Beneficial+Role+of+Nrf2+in+Regulating+Nadph+Generation+and+Consumption&doi=10.1093%2Ftoxsci%2Fkfr183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Beneficial Role of Nrf2 in Regulating NADPH Generation and Consumption</span></div><div class="casAuthors">Wu, Kai Connie; Cui, Julia Yue; Klaassen, Curtis D.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">590-600</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-0929</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that promotes the transcription of cytoprotective genes in response to oxidative and electrophilic stresses.  Most functions of Nrf2 were identified by studying biol. models with Nrf2 deficiency, however, little is known about the effects of graded Nrf2 activation.  In the present study, genomic gene expression profiles by microarray anal. were characterized with a "gene dose-response" model in livers of Nrf2-null mice, wild-type mice, Kelch-like ECH assocg. protein 1 (Keap1)-knockdown (Keap1-KD) mice with enhanced Nrf2 activation, and Keap1-hepatocyte knockout (Keap1-HKO) mice with max. hepatic Nrf2 activation.  Hepatic nuclear Nrf2 protein, glutathione concns., and known Nrf2 target genes were increased in a dose-dependent manner.  In total, 115 genes were identified to be constitutively induced and 80 genes suppressed with graded Nrf2 activation.  MRNA of genes encoding enzymes in the pentose phosphate pathway and enzyme were low with Nrf2 deficiency and high with Nrf2 activation, indicating that Nrf2 is important for NADPH prodn.  NADPH is the major reducing resource to scavenge oxidative stress, including regenerating glutathione and thioredoxin and is also used for anabolic pathways including lipid synthesis.  High performance liq. chromatog.-UV absorbance anal. confirmed that hepatic NADPH concn. was lowest in Nrf2-null mice and highest in Keap1-HKO mice.  In addn., genes involved in fatty acid synthesis and desatn. were downregulated with graded Nrf2 activation.  In conclusion, the present study suggests that Nrf2 protects against environmental insults by promoting the generation of NADPH, which is preferentially consumed by aiding scavenging of oxidative stress rather than fatty acid synthesis and desatn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwujrTdvxJRrVg90H21EOLACvtfcHk0lj6J-zvfaWMrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1eiu7nJ&md5=193847ff699d64b2b5b7975370731ffa</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfr183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfr183%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DK.%2BC.%26aulast%3DCui%26aufirst%3DJ.%2BY.%26aulast%3DKlaassen%26aufirst%3DC.%2BD.%26atitle%3DBeneficial%2520Role%2520of%2520Nrf2%2520in%2520Regulating%2520Nadph%2520Generation%2520and%2520Consumption%26jtitle%3DToxicol.%2520Sci.%26date%3D2011%26volume%3D123%26spage%3D590%26epage%3D600%26doi%3D10.1093%2Ftoxsci%2Fkfr183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdullah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sison, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Proteomic Analysis of Nrf2 Deficient Transgenic Mice Reveals Cellular Defence and Lipid Metabolism as Primary Nrf2-Dependent Pathways in the Liver</span>. <i>J. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">1612</span>– <span class="NLM_lpage">1631</span>, <span class="refDoi"> DOI: 10.1016/j.jprot.2010.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.jprot.2010.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20399915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlagt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2010&pages=1612-1631&author=N.+R.+Kitteringhamauthor=A.+Abdullahauthor=J.+Walshauthor=L.+Randleauthor=R.+E.+Jenkinsauthor=R.+Sisonauthor=C.+E.+Goldringauthor=H.+Powellauthor=C.+Sandersonauthor=S.+Williamsauthor=L.+Higginsauthor=M.+Yamamotoauthor=J.+Hayesauthor=B.+K.+Park&title=Proteomic+Analysis+of+Nrf2+Deficient+Transgenic+Mice+Reveals+Cellular+Defence+and+Lipid+Metabolism+as+Primary+Nrf2-Dependent+Pathways+in+the+Liver&doi=10.1016%2Fj.jprot.2010.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver</span></div><div class="casAuthors">Kitteringham, Neil R.; Abdullah, Azman; Walsh, Joanne; Randle, Laura; Jenkins, Rosalind E.; Sison, Rowena; Goldring, Christopher E. P.; Powell, Helen; Sanderson, Christopher; Williams, Samantha; Higgins, Larry; Yamamoto, Masayuki; Hayes, John; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1612-1631</span>CODEN:
                <span class="NLM_cas:coden">JPORFQ</span>;
        ISSN:<span class="NLM_cas:issn">1874-3919</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The transcription factor Nrf2 regulates expression of multiple cellular defense proteins through the antioxidant response element (ARE).  Nrf2-deficient mice (Nrf2-/-) are highly susceptible to xenobiotic-mediated toxicity, but the precise mol. basis of enhanced toxicity is unknown.  Oligonucleotide array studies suggest that a wide range of gene products is altered constitutively, however no equiv. proteomics analyses have been conducted.  To define the range of Nrf2-regulated proteins at the constitutive level, protein expression profiling of livers from Nrf2-/- and wild type mice was conducted using both stable isotope labeling (iTRAQ) and gel electrophoresis methods.  To establish a robust reproducible list of Nrf2-dependent proteins, three independent groups of mice were analyzed.  Correlative network anal. (MetaCore) identified two predominant groups of Nrf2-regulated proteins.  As expected, one group comprised proteins involved in phase II drug metab., which were down-regulated in the absence of Nrf2.  Surprisingly, the most profound changes were obsd. amongst proteins involved in the synthesis and metab. of fatty acids and other lipids.  Importantly, we show here for the first time, that the enzyme ATP-citrate lyase, responsible for acetyl-CoA prodn., is neg. regulated by Nrf2.  This latter finding suggests that Nrf2 is a major regulator of cellular lipid disposition in the liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0NT6X4SwYnrVg90H21EOLACvtfcHk0lj6J-zvfaWMrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlagt7c%253D&md5=1501f77a6ce057799e3a3e6a48b22459</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.jprot.2010.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jprot.2010.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DAbdullah%26aufirst%3DA.%26aulast%3DWalsh%26aufirst%3DJ.%26aulast%3DRandle%26aufirst%3DL.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DSison%26aufirst%3DR.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DPowell%26aufirst%3DH.%26aulast%3DSanderson%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DHiggins%26aufirst%3DL.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DProteomic%2520Analysis%2520of%2520Nrf2%2520Deficient%2520Transgenic%2520Mice%2520Reveals%2520Cellular%2520Defence%2520and%2520Lipid%2520Metabolism%2520as%2520Primary%2520Nrf2-Dependent%2520Pathways%2520in%2520the%2520Liver%26jtitle%3DJ.%2520Proteomics%26date%3D2010%26volume%3D73%26spage%3D1612%26epage%3D1631%26doi%3D10.1016%2Fj.jprot.2010.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touchard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boinapally, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, A. M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. L.</span></span> <span> </span><span class="NLM_article-title">Nrf2, a Cap’n’collar Transcription Factor, Regulates Induction of the Heme Oxygenase-1 Gene</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">26071</span>– <span class="NLM_lpage">26078</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.37.26071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1074%2Fjbc.274.37.26071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=26071-26078&author=J.+Alamauthor=D.+Stewartauthor=C.+Touchardauthor=S.+Boinapallyauthor=A.+M.+K.+Choiauthor=J.+L.+Cook&title=Nrf2%2C+a+Cap%E2%80%99n%E2%80%99collar+Transcription+Factor%2C+Regulates+Induction+of+the+Heme+Oxygenase-1+Gene&doi=10.1074%2Fjbc.274.37.26071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.37.26071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.37.26071%26sid%3Dliteratum%253Aachs%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DD.%26aulast%3DTouchard%26aufirst%3DC.%26aulast%3DBoinapally%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DA.%2BM.%2BK.%26aulast%3DCook%26aufirst%3DJ.%2BL.%26atitle%3DNrf2%252C%2520a%2520Cap%25E2%2580%2599n%25E2%2580%2599collar%2520Transcription%2520Factor%252C%2520Regulates%2520Induction%2520of%2520the%2520Heme%2520Oxygenase-1%2520Gene%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D26071%26epage%3D26078%26doi%3D10.1074%2Fjbc.274.37.26071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, T.</span></span> <span> </span><span class="NLM_article-title">Heme Oxygenase-1: A Novel Therapeutic Target for Gastrointestinal Diseases</span>. <i>J. Clin. Biochem. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.3164/jcbn.10-61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.3164%2Fjcbn.10-61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21373265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlekurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2011&pages=126-133&author=Y.+Naitoauthor=T.+Takagiauthor=K.+Uchiyamaauthor=T.+Yoshikawa&title=Heme+Oxygenase-1%3A+A+Novel+Therapeutic+Target+for+Gastrointestinal+Diseases&doi=10.3164%2Fjcbn.10-61"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Heme oxygenase-1: a novel therapeutic target for gastrointestinal diseases</span></div><div class="casAuthors">Naito, Yuji; Takagi, Tomohisa; Uchiyama, Kazuhiko; Yoshikawa, Toshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Biochemistry and Nutrition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-133</span>CODEN:
                <span class="NLM_cas:coden">JCBNER</span>;
        ISSN:<span class="NLM_cas:issn">0912-0009</span>.
    
            (<span class="NLM_cas:orgname">Society for Free Radical Research Japan</span>)
        </div><div class="casAbstract">A review.  Heme oxygenase-1 (HO-1) is the rate-limiting enzyme in the catabolism of heme, followed by prodn. of biliverdin, free iron and carbon monoxide (CO).  HO-1 is a stress-responsive protein induced by various oxidative agents.  Recent studies demonstrate that the expression of HO-1 in response to different inflammatory mediators may contribute to the resoln. of inflammation and has protective effects in several organs against oxidative injury.  Although the mechanism underlying the anti-inflammatory actions of HO-1 remains poorly defined, both CO and biliverdin/bilirubin have been implicated in this response.  In the gastrointestinal tract, HO-1 is shown to be transcriptionally induced in response to oxidative stress, preconditioning and acute inflammation.  Recent studies suggest that the induction of HO-1 expression plays a crit. protective role in intestinal damage models induced by ischemia-reperfusion, indomethacin, lipo-polysaccharide-assocd. sepsis, trinitrobenzene sulfonic acid, and dextran sulfate sodium, indicating that activation of HO-1 may act as an endogenous defensive mechanism to reduce inflammation and tissue injury in the gastrointestinal tract.  In addn., CO derived from HO-1 is shown to be involved in the regulation in gastrointestinal motility.  These in vitro and in vivo data suggest that HO-1 may be a novel therapeutic target in patients with gastrointestinal diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_G-zVRhg_nbVg90H21EOLACvtfcHk0lge1ZoP5tV15Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlekurw%253D&md5=c34d26f45a5a886813330e93fe82cee3</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3164%2Fjcbn.10-61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3164%252Fjcbn.10-61%26sid%3Dliteratum%253Aachs%26aulast%3DNaito%26aufirst%3DY.%26aulast%3DTakagi%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DK.%26aulast%3DYoshikawa%26aufirst%3DT.%26atitle%3DHeme%2520Oxygenase-1%253A%2520A%2520Novel%2520Therapeutic%2520Target%2520for%2520Gastrointestinal%2520Diseases%26jtitle%3DJ.%2520Clin.%2520Biochem.%2520Nutr.%26date%3D2011%26volume%3D48%26spage%3D126%26epage%3D133%26doi%3D10.3164%2Fjcbn.10-61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span> <span> </span><span class="NLM_article-title">Salvianolic Acid a Protects Rpe Cells against Oxidative Stress through Activation of Nrf2/Ho-1 Signaling</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2014.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2014.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24486344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksVWmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=219-228&author=H.+Zhangauthor=Y.+Y.+Liuauthor=Q.+Jiangauthor=K.+R.+Liauthor=Y.+X.+Zhaoauthor=C.+Caoauthor=J.+Yao&title=Salvianolic+Acid+a+Protects+Rpe+Cells+against+Oxidative+Stress+through+Activation+of+Nrf2%2FHo-1+Signaling&doi=10.1016%2Fj.freeradbiomed.2014.01.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Salvianolic acid A protects RPE cells against oxidative stress through activation of Nrf2/HO-1 signaling</span></div><div class="casAuthors">Zhang, Hui; Liu, Yuan-yuan; Jiang, Qin; Li, Ke-ran; Zhao, Yu-xia; Cao, Cong; Yao, Jin</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">219-228</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) impair the physiol. functions of retinal pigment epithelial (RPE) cells, which is known as one major cause of age-related macular degeneration.  Salvianolic acid A (Sal A) is the main effective aq. ext. of Salvia miltiorrhiza.  The aim of this study was to test the potential role of Sal A against oxidative stress in cultured RPE cells and to investigate the underlying mechanistic signaling pathways.  We obsd. that Sal A significantly inhibited hydrogen peroxide (H2O2)-induced primary and transformed RPE cell death and apoptosis.  H2O2-stimulated mitogen-activated protein kinase activation, ROS prodn., and subsequent proapoptotic AMP-activated protein kinase activation were largely inhibited by Sal A.  Further, Sal A stimulation resulted in a fast and dramatic activation of Akt/mammalian target of rapamycin complex 1 (mTORC1) signaling, followed by phosphorylation, accumulation, and nuclear translocation of the NF-E2-related factor 2 (Nrf2), along with increased expression of the antioxidant-response element-dependent gene heme oxygenase-1 (HO-1).  Both Nrf2 and HO-1 were required for Sal A-mediated cytoprotective effect, as Nrf2/HO-1 inhibition abolished Sal A-induced beneficial effects against H2O2.  Meanwhile, the PI3K/Akt/mTORC1 chem. inhibitors not only suppressed Sal A-induced Nrf2/HO-1 activation, but also eliminated its cytoprotective effect in RPE cells.  These observations suggest that Sal A activates the Nrf2/HO-1 axis in RPE cells and protects against oxidative stress via activation of Akt/mTORC1 signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFUzZiIqkflbVg90H21EOLACvtfcHk0lge1ZoP5tV15Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksVWmtrs%253D&md5=76fd8b58942995c170b8125c5957dfa3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2014.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2014.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%2BY.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DK.%2BR.%26aulast%3DZhao%26aufirst%3DY.%2BX.%26aulast%3DCao%26aufirst%3DC.%26aulast%3DYao%26aufirst%3DJ.%26atitle%3DSalvianolic%2520Acid%2520a%2520Protects%2520Rpe%2520Cells%2520against%2520Oxidative%2520Stress%2520through%2520Activation%2520of%2520Nrf2%252FHo-1%2520Signaling%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2014%26volume%3D69%26spage%3D219%26epage%3D228%26doi%3D10.1016%2Fj.freeradbiomed.2014.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agoston, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span> <span> </span><span class="NLM_article-title">Nrf2Modulates Aryl Hydrocarbon Receptor Signaling: Influence on Adipogenesis</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">7188</span>– <span class="NLM_lpage">7197</span>, <span class="refDoi"> DOI: 10.1128/MCB.00915-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.00915-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=17709388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKjsb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=7188-7197&author=S.+Shinauthor=N.+Wakabayashiauthor=V.+Misraauthor=S.+Biswalauthor=G.+H.+Leeauthor=E.+S.+Agostonauthor=M.+Yamamotoauthor=T.+W.+Kensler&title=Nrf2Modulates+Aryl+Hydrocarbon+Receptor+Signaling%3A+Influence+on+Adipogenesis&doi=10.1128%2FMCB.00915-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis</span></div><div class="casAuthors">Shin, Soona; Wakabayashi, Nobunao; Misra, Vikas; Biswal, Shyam; Lee, Gum Hwa; Agoston, Elin S.; Yamamoto, Masayuki; Kensler, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7188-7197</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The NF-E2 p45-related factor 2 (NRF2) and the aryl hydrocarbon receptor (AHR) are transcription factors controlling pathways modulating xenobiotic metab.  AHR has recently been shown to affect Nrf2 expression.  Conversely, this study demonstrates that NRF2 regulates expression of Ahr and subsequently modulates several downstream events of the AHR signaling cascade, including (i) transcriptional control of the xenobiotic metab. genes Cyp1a1 and Cyp1b1 and (ii) inhibition of adipogenesis in mouse embryonic fibroblasts (MEFs).  Constitutive expression of AHR was affected by Nrf2 genotype.  Moreover, a pharmacol. activator of NRF2 signaling, CDDO-IM {1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole}, induced Ahr, Cyp1a1, and Cyp1b1 transcription in Nrf2+/+ MEFs but not in Nrf2-/- MEFs.  Reporter anal. and chromatin immunopptn. assay revealed that NRF2 directly binds to one antioxidant response element (ARE) found in the -230-bp region of the promoter of Ahr.  Since AHR neg. controls adipocyte differentiation, we postulated that NRF2 would inhibit adipogenesis through the interaction with the AHR pathway.  Nrf2-/- MEFs showed markedly accelerated adipogenesis upon stimulation, while Keap1-/- MEFs (which exhibit higher NRF2 signaling) differentiated slowly compared to their congenic wild-type MEFs.  Ectopic expression of Ahr and dominant-pos. Nrf2 in Nrf2-/- MEFs also substantially delayed differentiation.  Thus, NRF2 directly modulates AHR signaling, highlighting bidirectional interactions of these pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXZNSeWW3XE7Vg90H21EOLACvtfcHk0lge1ZoP5tV15Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKjsb%252FF&md5=9a29fb294218db94a8f9fdf7e54610e8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FMCB.00915-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00915-07%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DS.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DMisra%26aufirst%3DV.%26aulast%3DBiswal%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DG.%2BH.%26aulast%3DAgoston%26aufirst%3DE.%2BS.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26atitle%3DNrf2Modulates%2520Aryl%2520Hydrocarbon%2520Receptor%2520Signaling%253A%2520Influence%2520on%2520Adipogenesis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2007%26volume%3D27%26spage%3D7188%26epage%3D7197%26doi%3D10.1128%2FMCB.00915-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwak, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span> <span> </span><span class="NLM_article-title">Enhanced Expression of the Transcription Factor Nrf2 by Cancer Chemopreventive Agents: Role of Antioxidant Response Element-Like Sequences in the Nrf2 Promoter</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2883</span>– <span class="NLM_lpage">2892</span>, <span class="refDoi"> DOI: 10.1128/MCB.22.9.2883-2892.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.22.9.2883-2892.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=11940647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFylsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=2883-2892&author=M.+K.+Kwakauthor=K.+Itohauthor=M.+Yamamotoauthor=T.+W.+Kensler&title=Enhanced+Expression+of+the+Transcription+Factor+Nrf2+by+Cancer+Chemopreventive+Agents%3A+Role+of+Antioxidant+Response+Element-Like+Sequences+in+the+Nrf2+Promoter&doi=10.1128%2FMCB.22.9.2883-2892.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: Role of antioxidant response element-like sequences in the nrf2 promoter</span></div><div class="casAuthors">Kwak, Mi-Kyoung; Itoh, Ken; Yamamoto, Masayuki; Kensler, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2883-2892</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Induction of phase 2 enzymes, which neutralize reactive electrophiles and act as indirect antioxidants, is an important mechanism for protection against carcinogenesis.  The transcription factor Nrf2, which binds to the antioxidant response element (ARE) found in the upstream regulatory region of many phase 2 genes, is essential for the induction of these enzymes.  We have investigated the effect of the potent enzyme inducer and anticarcinogen 3H-1,2-dithiole-3-thione (D3T) on the fate of Nrf2 in murine keratinocytes.  Both total and nuclear Nrf2 levels increased rapidly and persistently after treatment with D3T but could be blocked by cotreatment with cycloheximide.  Nrf2 mRNA levels increased ∼2-fold 6 h after D3T treatment.  To examine the transcriptional activation of Nrf2 by D3T, the proximal region (1 kb) of the nrf2 promoter was isolated.  Deletion and mutagenesis analyses demonstrated that nrf2 promoter-luciferase reporter activity was enhanced by treatment with D3T and that ARE-like sequences were required for this activation.  Gel shift assays with nuclear exts. from PE cells indicated that common factors bind to typical AREs and the ARE-like sequences of the nrf2 promoter.  Direct binding of Nrf2 to its own promoter was demonstrated by chromatin immuno-pptn. assay.  Overexpression of Nrf2 increased the activity of the nrf2 promoter-luciferase reporter, while expression of mutant Nrf2 protein repressed activity.  Thus, Nrf2 appears to autoregulate its own expression through an ARE-like element located in the proximal region of its promoter, leading to persistent nuclear accumulation of Nrf2 and protracted induction of phase 2 genes in response to chemopreventive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_sX0FZIyg87Vg90H21EOLACvtfcHk0lge1ZoP5tV15Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFylsL0%253D&md5=11b3b59568ef338a8355ee9bd6097ba3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FMCB.22.9.2883-2892.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.22.9.2883-2892.2002%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DM.%2BK.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26atitle%3DEnhanced%2520Expression%2520of%2520the%2520Transcription%2520Factor%2520Nrf2%2520by%2520Cancer%2520Chemopreventive%2520Agents%253A%2520Role%2520of%2520Antioxidant%2520Response%2520Element-Like%2520Sequences%2520in%2520the%2520Nrf2%2520Promoter%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D22%26spage%3D2883%26epage%3D2892%26doi%3D10.1128%2FMCB.22.9.2883-2892.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funayama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Suppresses Macrophage Inflammatory Response by Blocking Proinflammatory Cytokine Transcription</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11624</span>, <span class="refDoi"> DOI: 10.1038/ncomms11624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fncomms11624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27211851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos12ms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11624&author=E.+H.+Kobayashiauthor=T.+Suzukiauthor=R.+Funayamaauthor=T.+Nagashimaauthor=M.+Hayashiauthor=H.+Sekineauthor=N.+Tanakaauthor=T.+Moriguchiauthor=H.+Motohashiauthor=K.+Nakayamaauthor=M.+Yamamoto&title=Nrf2+Suppresses+Macrophage+Inflammatory+Response+by+Blocking+Proinflammatory+Cytokine+Transcription&doi=10.1038%2Fncomms11624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription</span></div><div class="casAuthors">Kobayashi, Eri H.; Suzuki, Takafumi; Funayama, Ryo; Nagashima, Takeshi; Hayashi, Makiko; Sekine, Hiroki; Tanaka, Nobuyuki; Moriguchi, Takashi; Motohashi, Hozumi; Nakayama, Keiko; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11624</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nrf2 (NF-E2-related factor-2) transcription factor regulates oxidative/xenobiotic stress response and also represses inflammation.  However, the mechanisms how Nrf2 alleviates inflammation are still unclear.  Here, we demonstrate that Nrf2 interferes with lipopolysaccharide-induced transcriptional upregulation of proinflammatory cytokines, including IL-6 and IL-1β.  Chromatin immunopptn. (ChIP)-seq and ChIP-qPCR analyses revealed that Nrf2 binds to the proximity of these genes in macrophages and inhibits RNA Pol II recruitment.  Further, we found that Nrf2-mediated inhibition is independent of the Nrf2-binding motif and reactive oxygen species level.  Murine inflammatory models further demonstrated that Nrf2 interferes with IL6 induction and inflammatory phenotypes in vivo.  Thus, contrary to the widely accepted view that Nrf2 suppresses inflammation through redox control, we demonstrate here that Nrf2 opposes transcriptional upregulation of proinflammatory cytokine genes.  This study identifies Nrf2 as the upstream regulator of cytokine prodn. and establishes a mol. basis for an Nrf2-mediated anti-inflammation approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNH2n5UpCBKLVg90H21EOLACvtfcHk0li-NbAWO_bNPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos12ms7w%253D&md5=95c2aebdf50ed1e8dbbdf983ff50b300</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fncomms11624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11624%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DE.%2BH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DFunayama%26aufirst%3DR.%26aulast%3DNagashima%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DM.%26aulast%3DSekine%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DMoriguchi%26aufirst%3DT.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DNrf2%2520Suppresses%2520Macrophage%2520Inflammatory%2520Response%2520by%2520Blocking%2520Proinflammatory%2520Cytokine%2520Transcription%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11624%26doi%3D10.1038%2Fncomms11624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keleku-Lukwete, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">An Overview of the Advantages of Keap1-Nrf2 System Activation During Inflammatory Disease Treatment</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1746</span>, <span class="refDoi"> DOI: 10.1089/ars.2017.7358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1089%2Fars.2017.7358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28899203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVSisbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=1746&author=N.+Keleku-Lukweteauthor=M.+Suzukiauthor=M.+Yamamoto&title=An+Overview+of+the+Advantages+of+Keap1-Nrf2+System+Activation+During+Inflammatory+Disease+Treatment&doi=10.1089%2Fars.2017.7358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment</span></div><div class="casAuthors">Keleku-Lukwete, Nadine; Suzuki, Mikiko; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1746-1755</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Significance: Inflammation can be defined as a protective immune response against harmful exogenous and endogenous stimuli.  Nevertheless, prolonged or autoimmune inflammatory responses are likely to cause pathol. states that are assocd. with a prodn. of inflammation-assocd. mols. along with reactive oxygen species (ROS).  Kelch-like ECH-assocd. protein 1-nuclear factor erythroid 2-related factor 2 (KEAP1-NRF2) signaling provides a cell protection mechanism against oxidative insults when endogenous stress defense mechanisms are imbalanced.  Understanding the roles of the KEAP1-NRF2 system in inflammation caused by various types of stimuli may aid in the development of new therapies.  Recent Advances: There have been tremendous advances in understanding the mechanism by which the KEAP1-NRF2 pathway abrogates inflammation.  In addn. to the well-established ROS-dependent pathway, recent studies have provided evidence of the direct repression of the transcription of pro-inflammatory cytokine genes, such as IL1b and IL6 (encoding Interleukin-1β and Interleukin-6, resp.).  Further, the expanding functions of NRF2 have elicited interest in the development of therapeutic modalities for inflammatory diseases, including multiple sclerosis and sickle cell disease.  Crit. Issues and Future Directions: Despite progress in the understanding of mol. mechanisms supporting the roles that NRF2 plays during inflammation, the relationship between NRF2 and other transcription factors and mediators of inflammation still remains ambiguous.  Further studies are required to address the effects of functional polymorphisms in KEAP1 and NRF2 that modify susceptibility to specific disease-related inflammation.  Comprehensive analyses in the future should explore tissue- or cell-type specific NRF2 activation to elaborate effects of NRF2 induction.  Antioxid. Redox Signal. 00, 000-000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPQBAVuG5z_7Vg90H21EOLACvtfcHk0li-NbAWO_bNPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVSisbrP&md5=d07791ace1a2d2ba45b88be8ad03345d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1089%2Fars.2017.7358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2017.7358%26sid%3Dliteratum%253Aachs%26aulast%3DKeleku-Lukwete%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DAn%2520Overview%2520of%2520the%2520Advantages%2520of%2520Keap1-Nrf2%2520System%2520Activation%2520During%2520Inflammatory%2520Disease%2520Treatment%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2018%26volume%3D29%26spage%3D1746%26doi%3D10.1089%2Fars.2017.7358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of the Negative Regulator of Nrf2, Keap1: A Historical Overview</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1665</span>– <span class="NLM_lpage">1678</span>, <span class="refDoi"> DOI: 10.1089/ars.2010.3222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1089%2Fars.2010.3222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20446768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12ltL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1665-1678&author=K.+Itohauthor=J.+Mimuraauthor=M.+Yamamoto&title=Discovery+of+the+Negative+Regulator+of+Nrf2%2C+Keap1%3A+A+Historical+Overview&doi=10.1089%2Fars.2010.3222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the negative regulator of Nrf2, Keap1: A historical overview</span></div><div class="casAuthors">Itoh, Ken; Mimura, Junsei; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1665-1678</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  An antioxidant response element (ARE) or an electrophile responsive element (EpRE) regulate the transcriptional induction of a battery of drug-detoxifying enzymes that are protective against electrophiles.  Based on the high similarity of the ARE consensus sequence to an erythroid gene regulatory element NF-E2 binding site, the authors have found that transcription factor Nrf2 is indispensable for the ARE-mediated induction of drug-metabolizing enzymes.  Recent genome-wide anal. demonstrated that Nrf2 regulates hundreds of genes that are involved in the cytoprotective response against oxidative stress.  In-depth anal. of Nrf2 regulatory mechanisms led the authors to the discovery of a novel protein, which they designated Keap1.  Keap1 suppresses Nrf2 activity by specifically binding to its evolutionarily conserved N-terminal Neh2 regulatory domain.  Here, the authors summarize findings and observations that have lead to the discovery of the Nrf2-Keap1 system.  Furthermore, the authors briefly discuss the function of the Nrf2-Keap1 system under the regulation of the endogenous electrophilic compd., 15-deoxy-Δ12,14-prostaglandin J2.  The authors propose that Nrf2-Keap1 plays a significant physiol. role in the response to endogenous, environmental, and pharmacol. electrophiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYEEgix9Qpi7Vg90H21EOLACvtfcHk0li-NbAWO_bNPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12ltL%252FK&md5=2c3e700515df4eb5bb8414c8d69bfc9f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3222%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DMimura%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520the%2520Negative%2520Regulator%2520of%2520Nrf2%252C%2520Keap1%253A%2520A%2520Historical%2520Overview%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2010%26volume%3D13%26spage%3D1665%26epage%3D1678%26doi%3D10.1089%2Fars.2010.3222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nioi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherratt, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, C. B.</span></span> <span> </span><span class="NLM_article-title">The Carboxy-Terminal Neh3 Domain of Nrf2 Is Required for Transcriptional Activation</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">10895</span>– <span class="NLM_lpage">10906</span>, <span class="refDoi"> DOI: 10.1128/MCB.25.24.10895-10906.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.25.24.10895-10906.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=16314513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlektr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10895-10906&author=P.+Nioiauthor=T.+Nguyenauthor=P.+J.+Sherrattauthor=C.+B.+Pickett&title=The+Carboxy-Terminal+Neh3+Domain+of+Nrf2+Is+Required+for+Transcriptional+Activation&doi=10.1128%2FMCB.25.24.10895-10906.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation</span></div><div class="casAuthors">Nioi, Paul; Nguyen, Truyen; Sherratt, Philip J.; Pickett, Cecil B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10895-10906</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Nrf2 is a transcription factor crit. for the maintenance of cellular redox homeostasis.  We have previously found that Nrf2 is a labile protein, and its activation in cells under stress involves mechanisms leading to its stabilization.  As a modular protein, Nrf2 possesses distinct transactivation and DNA binding domains essential for its transcriptional activity.  In this study, we found that the C-terminal "Neh3" domain of Nrf2 is also important for its activity.  Deletion of the last 16 amino acids of the protein completely abolishes its ability to activate both reporter and endogenous gene expression.  Using site-directed mutagenesis, we have identified a stretch of amino acids within this region that are essential for its activity and that are found to be conserved across species and among other members of the CNC-bZIP family.  Importantly, deletion of the final 16 amino acids of Nrf2 does not influence its dimerizing capability, DNA binding activity, or subcellular localization, although it does increase the half-life of the protein.  In addn., this region was found to be important for interaction with CHD6 (a chromo-ATPase/helicase DNA binding protein) in a yeast two-hybrid screen.  RNA interference-mediated knockdown of CHD6 reduced both the basal and tert-butylhydroquinone-inducible expression of NQO1, a prototypical Nrf2 target gene.  These data suggest that the Neh3 domain may act as a transactivation domain and that it is possibly involved in interaction with components of the transcriptional app. to affect its transcriptional activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSukid2fpRObVg90H21EOLACvtfcHk0liCxjNTJ_DzpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlektr%252FP&md5=6244da25302b473837c82c84c87d8699</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1128%2FMCB.25.24.10895-10906.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.25.24.10895-10906.2005%26sid%3Dliteratum%253Aachs%26aulast%3DNioi%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DSherratt%26aufirst%3DP.%2BJ.%26aulast%3DPickett%26aufirst%3DC.%2BB.%26atitle%3DThe%2520Carboxy-Terminal%2520Neh3%2520Domain%2520of%2520Nrf2%2520Is%2520Required%2520for%2520Transcriptional%2520Activation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D10895%26epage%3D10906%26doi%3D10.1128%2FMCB.25.24.10895-10906.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, C.</span></span> <span> </span><span class="NLM_article-title">Dual Regulation of Transcription Factor Nrf2 by Keap1 and by the Combined Actions of Beta-Trcp and Gsk-3</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1042/BST20150011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1042%2FBST20150011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26551701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=611-620&author=J.+D.+Hayesauthor=S.+Chowdhryauthor=A.+T.+Dinkova-Kostovaauthor=C.+Sutherland&title=Dual+Regulation+of+Transcription+Factor+Nrf2+by+Keap1+and+by+the+Combined+Actions+of+Beta-Trcp+and+Gsk-3&doi=10.1042%2FBST20150011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of β-TrCP and GSK-3</span></div><div class="casAuthors">Hayes, John D.; Chowdhry, Sudhir; Dinkova-Kostova, Albena T.; Sutherland, Calum</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">611-620</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Nuclear factor-erythroid 2 p45 (NF-E2 p45)-related factor 2 (Nrf2) is a master regulator of redox homoeostasis that allows cells to adapt to oxidative stress and also promotes cell proliferation.  In this review, we describe the mol. mechanisms by which oxidants/electrophilic agents and growth factors increase Nrf2 activity.  In the former case, oxidants/electrophiles increase the stability of Nrf2 by antagonizing the ability of Kelch-like ECH-assocd. protein 1 (Keap1) to target the transcription factor for proteasomal degrdn. via the cullin-3 (Cul3)-RING ubiquitin ligase CRLKeap1.  In the latter case, we speculate that growth factors increase the stability of Nrf2 by stimulating phosphoinositide 3-kinase (PI3K)-protein kinase B (PKB)/Akt signalling, which in turn results in inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) and in doing so prevents the formation of a DSGIS motif-contg. phosphodegron in Nrf2 that is recognized by the β-transducin repeat-contg. protein (β-TrCP) Cul1-based E3 ubiquitin ligase complex SCFβ-TrCP.  We present data showing that in the absence of Keap1, the electrophile tert-Bu hydroquinone (tBHQ) can stimulate Nrf2 activity and induce the Nrf2-target gene NAD(P)H:quinone oxidoreductase-1 (NQO1), while simultaneously causing inhibitory phosphorylation of GSK-3β at Ser9.  Together, these observations suggest that tBHQ can suppress the ability of SCFβ-TrCP to target Nrf2 for proteasomal degrdn. by increasing PI3K-PKB/Akt signalling.  We also propose a scheme that explains how other protein kinases that inhibit GSK-3 could stimulate induction of Nrf2-target genes by preventing formation of the DSGIS motif-contg. phosphodegron in Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5bqpkqNAhSbVg90H21EOLACvtfcHk0liCxjNTJ_DzpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsbzE&md5=5471439ca69381d4bed94f48a596055f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1042%2FBST20150011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20150011%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DChowdhry%26aufirst%3DS.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DSutherland%26aufirst%3DC.%26atitle%3DDual%2520Regulation%2520of%2520Transcription%2520Factor%2520Nrf2%2520by%2520Keap1%2520and%2520by%2520the%2520Combined%2520Actions%2520of%2520Beta-Trcp%2520and%2520Gsk-3%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2015%26volume%3D43%26spage%3D611%26epage%3D620%26doi%3D10.1042%2FBST20150011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Characterization of Nrf2 Degradation by Glycogen Synthase Kinase 3/Beta-Trcp</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.04.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2015.04.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=25937177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWrt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=147-157&author=A.+Cuadrado&title=Structural+and+Functional+Characterization+of+Nrf2+Degradation+by+Glycogen+Synthase+Kinase+3%2FBeta-Trcp&doi=10.1016%2Fj.freeradbiomed.2015.04.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional characterization of NRF2 degradation by glycogen synthase kinase 3/β-TrCP</span></div><div class="casAuthors">Cuadrado, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">147-157</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor (erythroid-derived 2)-like 2 (NRF2) is a master regulator of cellular homeostasis that controls the expression of more than 1% of human genes related to biotransformation reactions, redox homeostasis, energetic metab., DNA repair, and proteostasis.  Its activity has a tremendous impact on physiol. and pathol. and therefore it is very tightly regulated, mainly at the level of protein stability.  In addn. to the very well established regulation by the ubiquitin E3 ligase adapter KEAP1, recent advances have identified a novel mechanism based on signaling pathways that regulate glycogen synthase kinase-3 (GSK-3).  This kinase phosphorylates specific serine residues in the Neh6 domain of NRF2 to create a degrdn. domain that is then recognized by the ubiquitin ligase adapter β-TrCP and tagged for proteasome degrdn. by a Cullin1/Rbx1 complex.  Here we review the mechanistic elements and the signaling pathways that participate in this regulation by GSK-3/β-TrCP.  These pathways include those activated by ligands of tyrosine kinase, G protein-coupled, metabotropic, and ionotropic receptors that activate phosphatidyl inositol 3-kinase (PI3K)/ATK and by the canonical WNT signaling pathway, where a fraction of NRF2 interacts with Axin1/GSK-3.  Considering that free NRF2 protein is localized in the nucleus, we propose a model termed "double flux controller" to explain how KEAP1 and β-TrCP coordinate the stability of NRF2 in several scenarios.  The GSK-3/β-TrCP axis provides a novel therapeutic strategy to modulate NRF2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBD0QH5vyIm7Vg90H21EOLACvtfcHk0liCxjNTJ_DzpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWrt7nJ&md5=d26bee72ad5237c0138c9f4c003b527b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.04.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.04.029%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado%26aufirst%3DA.%26atitle%3DStructural%2520and%2520Functional%2520Characterization%2520of%2520Nrf2%2520Degradation%2520by%2520Glycogen%2520Synthase%2520Kinase%25203%252FBeta-Trcp%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D147%26epage%3D157%26doi%3D10.1016%2Fj.freeradbiomed.2015.04.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span> <span> </span><span class="NLM_article-title">Discovery and Development of Kelch-Like Ech-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (Keap1:Nrf2) Protein–Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10837</span>– <span class="NLM_lpage">10858</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00586</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00586" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10837-10858&author=Z.-Y.+Jiangauthor=M.-C.+Luauthor=Q.-D.+You&title=Discovery+and+Development+of+Kelch-Like+Ech-Associated+Protein+1.+Nuclear+Factor+Erythroid+2-Related+Factor+2+%28Keap1%3ANrf2%29+Protein%E2%80%93Protein+Interaction+Inhibitors%3A+Achievements%2C+Challenges%2C+and+Future+Directions&doi=10.1021%2Facs.jmedchem.6b00586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10837-10858</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The transcription factor Nrf2 is the primary regulator of the cellular defense system, and enhancing Nrf2 activity has potential usages in various diseases, esp. chronic age-related and inflammatory diseases.  Recently, directly targeting Keap1-Nrf2 protein-protein interaction (PPI) has been an emerging strategy to selectively and effectively activate Nrf2.  This Perspective summarizes the progress in the discovery and development of Keap1-Nrf2 PPI inhibitors, including the Keap1-Nrf2 regulatory mechanisms, biochem. techniques for inhibitor identification, and approaches for identifying peptide and small-mol. inhibitors, as well as discusses privileged structures and future directions for further development of Keap1-Nrf2 PPI inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCuMv4k9xi9LVg90H21EOLACvtfcHk0lhrJVGXX5dF7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO&md5=487aa677ae8a86d71e2b15561656b0b7</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00586%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.-Y.%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DYou%26aufirst%3DQ.-D.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Kelch-Like%2520Ech-Associated%2520Protein%25201.%2520Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528Keap1%253ANrf2%2529%2520Protein%25E2%2580%2593Protein%2520Interaction%2520Inhibitors%253A%2520Achievements%252C%2520Challenges%252C%2520and%2520Future%2520Directions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10837%26epage%3D10858%26doi%3D10.1021%2Facs.jmedchem.6b00586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canning, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorrell, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, A. N.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Keap1 Interactions with Nrf2</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.05.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2015.05.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26057936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=101-107&author=P.+Canningauthor=F.+J.+Sorrellauthor=A.+N.+Bullock&title=Structural+Basis+of+Keap1+Interactions+with+Nrf2&doi=10.1016%2Fj.freeradbiomed.2015.05.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of KEAP1 interactions with Nrf2</span></div><div class="casAuthors">Canning, Peter; Sorrell, Fiona J.; Bullock, Alex N.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">101-107</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  KEAP1 is a highly redox-sensitive member of the BTB-Kelch family that assembles with the Cul3 protein to form a Cullin-RING E3 ligase complex for the degrdn. of Nrf2.  Oxidative stress disables KEAP1, allowing Nrf2 protein levels to accumulate for the transactivation of crit. stress response genes.  Consequently, the KEAP1-Nrf2 system is extensively pursued for the development of protein-protein interaction inhibitors that will stabilize Nrf2 for therapeutic effect in conditions of neurodegeneration, inflammation, and cancer.  Here we review current progress toward the structure detn. of KEAP1 and its protein complexes with Cul3, Nrf2 substrate, and small-mol. antagonists.  Together the available structures establish a rational three-dimensional model to explain the two-site binding of Nrf2 as well as its efficient ubiquitination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwBBMS70b7hbVg90H21EOLACvtfcHk0lhrJVGXX5dF7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7rK&md5=12b7b36caa16cf3cd3d95d84162eed80</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DCanning%26aufirst%3DP.%26aulast%3DSorrell%26aufirst%3DF.%2BJ.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26atitle%3DStructural%2520Basis%2520of%2520Keap1%2520Interactions%2520with%2520Nrf2%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D101%26epage%3D107%26doi%3D10.1016%2Fj.freeradbiomed.2015.05.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuoka, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Two-Site Substrate Recognition Model for the Keap1-Nrf2 System: A Hinge and Latch Mechanism</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>387</i></span>,  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1320</span>, <span class="refDoi"> DOI: 10.1515/BC.2006.164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1515%2FBC.2006.164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=17081101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFygtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2006&pages=1311-1320&author=K.+I.+Tongauthor=A.+Kobayashiauthor=F.+Katsuokaauthor=M.+Yamamoto&title=Two-Site+Substrate+Recognition+Model+for+the+Keap1-Nrf2+System%3A+A+Hinge+and+Latch+Mechanism&doi=10.1515%2FBC.2006.164"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism</span></div><div class="casAuthors">Tong, Kit I.; Kobayashi, Akira; Katsuoka, Fumiki; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">10/11</span>),
    <span class="NLM_cas:pages">1311-1320</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  Cells are equipped with a no. of transcriptional factors that safeguard against various environmental insults.  Proteasomal protein degrdn. plays an important role in the Keap1-Nrf2 cytoprotection system, with mol. machinery similar to that for other environmental defense systems such as inflammatory and hypoxic responses.  While Nrf2 protein stabilization is known to be redox-sensitive, the transcription factors NF-κB and HIF-1α for inflammatory and hypoxic responses, resp., are also influenced by the cellular redox conditions.  In this review the authors present the recently proposed 2-site substrate recognition model of the Keap1-Nrf2 system, which regulates the cellular responses against oxidative and xenobiotic stresses.  The implications of 2 destructive motifs in Nrf2, the ETGE and DLG motifs, which appear to function as a hinge and latch attenuating Keap1 activity in different redox states, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7KwAAahYp3LVg90H21EOLACvtfcHk0lhrJVGXX5dF7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFygtLvF&md5=a7c36b5b1af9a559ca2b0c6e57449f70</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1515%2FBC.2006.164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2006.164%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DKatsuoka%26aufirst%3DF.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DTwo-Site%2520Substrate%2520Recognition%2520Model%2520for%2520the%2520Keap1-Nrf2%2520System%253A%2520A%2520Hinge%2520and%2520Latch%2520Mechanism%26jtitle%3DBiol.%2520Chem.%26date%3D2006%26volume%3D387%26spage%3D1311%26epage%3D1320%26doi%3D10.1515%2FBC.2006.164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurokawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 Is a Forked-Stem Dimer Structure with Two Large Spheres Enclosing the Intervening, Double Glycine Repeat, and C-Terminal Domains</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">2842</span>– <span class="NLM_lpage">2847</span>, <span class="refDoi"> DOI: 10.1073/pnas.0914036107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1073%2Fpnas.0914036107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20133743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXis1Cltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=2842-2847&author=T.+Oguraauthor=K.+I.+Tongauthor=K.+Mioauthor=Y.+Maruyamaauthor=H.+Kurokawaauthor=C.+Satoauthor=M.+Yamamoto&title=Keap1+Is+a+Forked-Stem+Dimer+Structure+with+Two+Large+Spheres+Enclosing+the+Intervening%2C+Double+Glycine+Repeat%2C+and+C-Terminal+Domains&doi=10.1073%2Fpnas.0914036107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains</span></div><div class="casAuthors">Ogura, Toshihiko; Tong, Kit I.; Mio, Kazuhiro; Maruyama, Yuusuke; Kurokawa, Hirofumi; Sato, Chikara; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2842-2847, S2842/1-S2842/3</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Keap1 is a substrate adaptor of a Cullin 3-based E3 ubiquitin ligase complex that recognizes Nrf2, and also acts as a cellular sensor for xenobiotics and oxidative stresses.  Nrf2 is a transcriptional factor regulating the expression of cytoprotective enzyme genes in response to such stresses.  Under unstressed conditions Keap1 binds Nrf2 and results in rapid degrdn. of Nrf2 through the proteasome pathway.  In contrast, upon exposure to oxidative and electrophilic stress, reactive cysteine residues in the IVR (intervening region) and BTB (Broad complex, Tramtrack, and Bric-a-Brac) domains of Keap1 are modified by electrophiles.  This modification prevents Nrf2 from rapid degrdn. and induces Nrf2 activity by repression of Keap1.  Here we report the structure of mouse Keap1 homodimer by single particle electron microscopy.  Three-dimensional reconstruction at 24-Å resoln. revealed two large spheres attached by short linker arms to the sides of a small forked-stem structure, resembling a cherry-bob.  Each sphere has a tunnel corresponding to the central hole of the β-propeller domain, as detd. by x-ray crystallog.  The IVR domain appears to surround the core of the β-propeller domain.  The unexpected proximity of IVR to the β-propeller domain suggests that any distortions generated during modification of reactive cysteine residues in the IVR domain may send a derepression signal to the p-propeller domain and thereby stabilize Nrf2.  This study thus provides a structural basis for the two-site binding and hinge-latch model of stress sensing by the Nrf2-Keap1 system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9F9fYqKP95LVg90H21EOLACvtfcHk0lhrJVGXX5dF7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXis1Cltrg%253D&md5=2801c7099d40a720ffc3be2162ef6b3d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0914036107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0914036107%26sid%3Dliteratum%253Aachs%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DMio%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DY.%26aulast%3DKurokawa%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DC.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DKeap1%2520Is%2520a%2520Forked-Stem%2520Dimer%2520Structure%2520with%2520Two%2520Large%2520Spheres%2520Enclosing%2520the%2520Intervening%252C%2520Double%2520Glycine%2520Repeat%252C%2520and%2520C-Terminal%2520Domains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D2842%26epage%3D2847%26doi%3D10.1073%2Fpnas.0914036107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusunoki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 Recruits Neh2 through Binding to Etge and Dlg Motifs: Characterization of the Two-Site Molecular Recognition Model</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2887</span>– <span class="NLM_lpage">2900</span>, <span class="refDoi"> DOI: 10.1128/MCB.26.8.2887-2900.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.26.8.2887-2900.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=16581765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1Slsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2887-2900&author=K.+I.+Tongauthor=Y.+Katohauthor=H.+Kusunokiauthor=K.+Itohauthor=T.+Tanakaauthor=M.+Yamamoto&title=Keap1+Recruits+Neh2+through+Binding+to+Etge+and+Dlg+Motifs%3A+Characterization+of+the+Two-Site+Molecular+Recognition+Model&doi=10.1128%2FMCB.26.8.2887-2900.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model</span></div><div class="casAuthors">Tong, Kit I.; Katoh, Yasutake; Kusunoki, Hideki; Itoh, Ken; Tanaka, Toshiyuki; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2887-2900</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The expression of the phase 2 detoxification enzymes and antioxidant proteins is induced at the transcriptional level by Nrf2 and neg. regulated at the posttranslational level by Keap1 through protein-protein interactions with Nrf2 and subsequent proteolysis of Nrf2.  We found that the Neh2 domain of Nrf2 is an intrinsically disordered but biol. active regulatory domain contg. a 33-residue central α-helix followed by a mini antiparallel β-sheet.  Isothermal calorimetry anal. indicated that one Neh2 mol. interacts with two mols. of Keap1 via two binding sites, the stronger binding ETGE motif and the weaker binding DLG motif.  NMR titrn. study showed that these two motifs of the Neh2 domain bind to an overlapping site on the bottom surface of the β-propeller structure of Keap1.  In contrast, the central α-helix of the Neh2 domain does not have any observable affinity to Keap1, suggesting that this region may serve as a bridge connecting the two motifs for the assocn. with the two β-propeller structures of a dimer of Keap1.  Based on these observations, we propose that Keap1 recruits Nrf2 by the ETGE motif and that the DLG motif of the Neh2 domain locks its lysine-rich central α-helix in a correct position to benefit ubiquitin (Ub) signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW4AlViBIZg7Vg90H21EOLACvtfcHk0lhZ2adsdO_xlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1Slsbw%253D&md5=f6a5af3be5757cd665f234562d48d727</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1128%2FMCB.26.8.2887-2900.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.26.8.2887-2900.2006%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DKusunoki%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DKeap1%2520Recruits%2520Neh2%2520through%2520Binding%2520to%2520Etge%2520and%2520Dlg%2520Motifs%253A%2520Characterization%2520of%2520the%2520Two-Site%2520Molecular%2520Recognition%2520Model%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D2887%26epage%3D2900%26doi%3D10.1128%2FMCB.26.8.2887-2900.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostov, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canning, P.</span></span> <span> </span><span class="NLM_article-title">Keap1, the Cysteine-Based Mammalian Intracellular Sensor for Electrophiles and Oxidants</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>617</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2016.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.abb.2016.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27497696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlags7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=617&publication_year=2017&pages=84-93&author=A.+T.+Dinkova-Kostovaauthor=R.+V.+Kostovauthor=P.+Canning&title=Keap1%2C+the+Cysteine-Based+Mammalian+Intracellular+Sensor+for+Electrophiles+and+Oxidants&doi=10.1016%2Fj.abb.2016.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Kostov, Rumen V.; Canning, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">617</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">84-93</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Kelch-like ECH assocd. protein 1 (Keap1) is a component of a Cullin3-based Cullin-RING E3 ubiquitin ligase (CRL) multisubunit protein complex.  Within the CRL, homodimeric Keap1 functions as the Cullin3 adaptor, and importantly, it is also the crit. component of the E3 ligase that performs the substrate recognition.  The best-characterized substrate of Keap1 is transcription factor NF-E2 p45-related factor 2 (Nrf2), which orchestrates an elaborate transcriptional program in response to environmental challenges caused by oxidants, electrophiles and pro-inflammatory agents, allowing adaptation and survival under stress conditions.  Keap1 is equipped with reactive cysteine residues that act as sensors for endogenously produced and exogenously encountered small mols. (termed inducers), which have a characteristic chem. signature, reactivity with sulfhydryl groups.  Inducers modify the cysteine sensors of Keap1 and impair its ability to target Nrf2 for ubiquitination and degrdn.  Consequently, Nrf2 accumulates, enters the nucleus and drives the transcription of its target genes, which encode a large network of cytoprotective proteins.  Here we summarize the early studies leading to the prediction of the existence of Keap1, followed by the discovery of Keap1 as the main neg. regulator of Nrf2.  We then describe the available structural information on Keap1, its assembly with Cullin3, and its interaction with Nrf2.  We also discuss the multiple cysteine sensors of Keap1 that allow for detection of a wide range of endogenous and environmental inducers, and provide fine-tuning and tight control of the Keap1/Nrf2 stress-sensing response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI8YYxE9xg4LVg90H21EOLACvtfcHk0lhZ2adsdO_xlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlags7jF&md5=eedfc91fa4e91f74df618231a01af182</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2016.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2016.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DKostov%26aufirst%3DR.%2BV.%26aulast%3DCanning%26aufirst%3DP.%26atitle%3DKeap1%252C%2520the%2520Cysteine-Based%2520Mammalian%2520Intracellular%2520Sensor%2520for%2520Electrophiles%2520and%2520Oxidants%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2017%26volume%3D617%26spage%3D84%26epage%3D93%26doi%3D10.1016%2Fj.abb.2016.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lleres, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Regulatory Flexibility in the Nrf2-Mediated Stress Response Is Conferred by Conformational Cycling of the Keap1-Nrf2 Protein Complex</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">15259</span>– <span class="NLM_lpage">15264</span>, <span class="refDoi"> DOI: 10.1073/pnas.1305687110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1073%2Fpnas.1305687110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23986495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOhsbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=15259-15264&author=L.+Bairdauthor=D.+Lleresauthor=S.+Swiftauthor=A.+T.+Dinkova-Kostova&title=Regulatory+Flexibility+in+the+Nrf2-Mediated+Stress+Response+Is+Conferred+by+Conformational+Cycling+of+the+Keap1-Nrf2+Protein+Complex&doi=10.1073%2Fpnas.1305687110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex</span></div><div class="casAuthors">Baird, Liam; Lleres, David; Swift, Sam; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">15259-15264,S15259/1-S15259/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The transcription factor NF-E2 p45-related factor 2 (Nrf2), a master regulator of cytoprotective genes, is controlled by dimeric Kelch-like ECH assocd. protein 1 (Keap1), a substrate adaptor protein for Cullin3/RING-box protein 1 ubiquitin ligase, which normally targets Nrf2 for ubiquitination and degrdn. but loses this ability in response to electrophiles and oxidants (inducers).  By using recombinant proteins and populations of cells, some of the general features of the regulation of Nrf2 by Keap1 have been outlined.  However, how the two proteins interact at a single-cell level is presently unknown.  We now report the development of a quant. Forster resonance energy transfer-based system using multiphoton fluorescence lifetime imaging microscopy and its application for investigating the interaction between Nrf2 and Keap1 in single live cells.  By using this approach, we found that under homeostatic conditions, the interaction between Keap1 and Nrf2 follows a cycle in which the complex sequentially adopts two distinct conformations: "open," in which Nrf2 interacts with a single mol. of Keap1, followed by "closed," in which Nrf2 binds to both members of the Keap1 dimer.  Inducers disrupt this cycle by causing accumulation of the complex in the closed conformation without release of Nrf2.  As a consequence, free Keap1 is not regenerated, and newly synthesized Nrf2 is stabilized.  On the basis of these findings, we propose a model we have named the "cyclic sequential attachment and regeneration model of Keap1-mediated degrdn. of Nrf2.".  This previously unanticipated dynamism allows rapid transcriptional responses to environmental changes and can accommodate multiple modes of regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxL86wHbn7G7Vg90H21EOLACvtfcHk0lhZ2adsdO_xlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOhsbbL&md5=70b4502b74247820154b693c077cfc66</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1305687110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1305687110%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DLleres%26aufirst%3DD.%26aulast%3DSwift%26aufirst%3DS.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DRegulatory%2520Flexibility%2520in%2520the%2520Nrf2-Mediated%2520Stress%2520Response%2520Is%2520Conferred%2520by%2520Conformational%2520Cycling%2520of%2520the%2520Keap1-Nrf2%2520Protein%2520Complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D15259%26epage%3D15264%26doi%3D10.1073%2Fpnas.1305687110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lleres, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Monitoring Keap1-Nrf2 Interactions in Single Live Cells</span>. <i>Biotechnol. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1133</span>– <span class="NLM_lpage">1144</span>, <span class="refDoi"> DOI: 10.1016/j.biotechadv.2014.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.biotechadv.2014.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24681086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=1133-1144&author=L.+Bairdauthor=S.+Swiftauthor=D.+Lleresauthor=A.+T.+Dinkova-Kostova&title=Monitoring+Keap1-Nrf2+Interactions+in+Single+Live+Cells&doi=10.1016%2Fj.biotechadv.2014.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring Keap1-Nrf2 interactions in single live cells</span></div><div class="casAuthors">Baird, Liam; Swift, Sam; Lleres, David; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology Advances</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1133-1144</span>CODEN:
                <span class="NLM_cas:coden">BIADDD</span>;
        ISSN:<span class="NLM_cas:issn">0734-9750</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The transcription factor NF-E2 p45-related factor 2 (Nrf2) and its neg. regulator Kelch-like ECH assocd. protein 1 (Keap1) control the expression of nearly 500 genes with diverse cytoprotective functions.  Keap1, a substrate adaptor protein for Cullin3/Rbx1 ubiquitin ligase, normally continuously targets Nrf2 for degrdn., but loses this ability in response to electrophiles and oxidants (termed inducers).  Consequently, Nrf2 accumulates and activates transcription of its downstream target genes.  Many inducers are phytochems., and cruciferous vegetables represent one of the richest sources of inducer activity among the most commonly used edible plants.  Here we summarize the discovery of the isothiocyanate sulforaphane as a potent inducer which reacts with cysteine sensors of Keap1, leading to activation of Nrf2.  We then describe the development of a quant. Forster resonance energy transfer (FRET)-based methodol. combined with multiphoton fluorescence lifetime imaging microscopy (FLIM) to investigate the interactions between Keap1 and Nrf2 in single live cells, and the effect of sulforaphane, and other cysteine-reactive inducers, on the dynamics of the Keap1-Nrf2 protein complex.  We present the exptl. evidence for the "cyclic sequential attachment and regeneration" or "conformation cycling" model of Keap1-mediated Nrf2 degrdn.  Finally, we discuss the implications of this mode of regulation of Nrf2 for achieving a fine balance under normal physiol. conditions, and the consequences and mechanisms of disrupting this balance for tumor biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4iA4Fe7Z2q7Vg90H21EOLACvtfcHk0lj6JBSTeE9ZJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSlsbc%253D&md5=f44b787f55a522b59013b15ca40f4659</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.biotechadv.2014.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biotechadv.2014.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DSwift%26aufirst%3DS.%26aulast%3DLleres%26aufirst%3DD.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DMonitoring%2520Keap1-Nrf2%2520Interactions%2520in%2520Single%2520Live%2520Cells%26jtitle%3DBiotechnol.%2520Adv.%26date%3D2014%26volume%3D32%26spage%3D1133%26epage%3D1144%26doi%3D10.1016%2Fj.biotechadv.2014.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebisine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, C.</span></span> <span> </span><span class="NLM_article-title">Regulation of the Cnc-Bzip Transcription Factor Nrf2 by Keap1 and the Axis between Gsk-3 and Β-Trcp</span>. <i>Current Opinion in Toxicology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.cotox.2016.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.cotox.2016.10.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2016&pages=92-103&author=J.+D.+Hayesauthor=K.+Ebisineauthor=R.+S.+Sharmaauthor=S.+Chowdhryauthor=A.+T.+Dinkova-Kostovaauthor=C.+Sutherland&title=Regulation+of+the+Cnc-Bzip+Transcription+Factor+Nrf2+by+Keap1+and+the+Axis+between+Gsk-3+and+%CE%92-Trcp&doi=10.1016%2Fj.cotox.2016.10.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.cotox.2016.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cotox.2016.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DEbisine%26aufirst%3DK.%26aulast%3DSharma%26aufirst%3DR.%2BS.%26aulast%3DChowdhry%26aufirst%3DS.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DSutherland%26aufirst%3DC.%26atitle%3DRegulation%2520of%2520the%2520Cnc-Bzip%2520Transcription%2520Factor%2520Nrf2%2520by%2520Keap1%2520and%2520the%2520Axis%2520between%2520Gsk-3%2520and%2520%25CE%2592-Trcp%26jtitle%3DCurrent%2520Opinion%2520in%2520Toxicology%26date%3D2016%26volume%3D1%26spage%3D92%26epage%3D103%26doi%3D10.1016%2Fj.cotox.2016.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Is Controlled by Two Distinct Beta-Trcp Recognition Motifs in Its Neh6 Domain, One of Which Can Be Modulated by Gsk-3 Activity</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">3765</span>– <span class="NLM_lpage">3781</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fonc.2012.388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22964642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlajsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=3765-3781&author=S.+Chowdhryauthor=Y.+Zhangauthor=M.+McMahonauthor=C.+Sutherlandauthor=A.+Cuadradoauthor=J.+D.+Hayes&title=Nrf2+Is+Controlled+by+Two+Distinct+Beta-Trcp+Recognition+Motifs+in+Its+Neh6+Domain%2C+One+of+Which+Can+Be+Modulated+by+Gsk-3+Activity&doi=10.1038%2Fonc.2012.388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity</span></div><div class="casAuthors">Chowdhry, S.; Zhang, Y.; McMahon, M.; Sutherland, C.; Cuadrado, A.; Hayes, J. D.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">3765-3781</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Identification of regulatable mechanisms by which transcription factor NF-E2 p45-related factor 2 (Nrf2) is repressed will allow strategies to be designed that counter drug resistance assocd. with its upregulation in tumors that harbor somatic mutations in Kelch-like ECH-assocd. protein-1 (Keap1), a gene that encodes a joint adaptor and substrate receptor for the Cul3-Rbx1/Roc1 ubiquitin ligase.  We now show that mouse Nrf2 contains two binding sites for β-transducin repeat-contg. protein (β-TrCP), which acts as a substrate receptor for the Skp1-Cul1-Rbx1/Roc1 ubiquitin ligase complex.  Deletion of either binding site in Nrf2 decreased β-TrCP-mediated ubiquitylation of the transcription factor.  The ability of one of the two β-TrCP-binding sites to serve as a degron could be both increased and decreased by manipulation of glycogen synthase kinase-3 (GSK-3) activity.  Biotinylated-peptide pull-down assays identified DSGIS338 and DSAPGS378 as the two β-TrCP-binding motifs in Nrf2.  Significantly, our pull-down assays indicated that β-TrCP binds a phosphorylated version of DSGIS more tightly than its non-phosphorylated counterpart, whereas this was not the case for DSAPGS.  These data suggest that DSGIS, but not DSAPGS, contains a functional GSK-3 phosphorylation site.  Activation of GSK-3 in Keap1-null mouse embryonic fibroblasts (MEFs), or in human lung A549 cells that contain mutant Keap1, by inhibition of the phosphoinositide 3-kinase (PI3K)-protein kinase B (PKB)/Akt pathway markedly reduced endogenous Nrf2 protein and decreased to 10-50% of normal the levels of mRNA for prototypic Nrf2-regulated enzymes, including the glutamate-cysteine ligase catalytic and modifier subunits, glutathione S-transferases Alpha-1 and Mu-1, haem oxygenase-1 and NAD(P)H:quinone oxidoreductase-1.  Pre-treatment of Keap1-/- MEFs or A549 cells with the LY294002 PI3K inhibitor or the MK-2206 PKB/Akt inhibitor increased their sensitivity to acrolein, chlorambucil and cisplatin between 1.9-fold and 3.1-fold, and this was substantially attenuated by simultaneous pre-treatment with the GSK-3 inhibitor CT99021.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPtz2Tkj8_7LVg90H21EOLACvtfcHk0lj6JBSTeE9ZJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlajsr3E&md5=459b0fb6a135228b2bef544fdbce870a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.388%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhry%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DSutherland%26aufirst%3DC.%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26atitle%3DNrf2%2520Is%2520Controlled%2520by%2520Two%2520Distinct%2520Beta-Trcp%2520Recognition%2520Motifs%2520in%2520Its%2520Neh6%2520Domain%252C%2520One%2520of%2520Which%2520Can%2520Be%2520Modulated%2520by%2520Gsk-3%2520Activity%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D3765%26epage%3D3781%26doi%3D10.1038%2Fonc.2012.388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rada, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evrard-Todeschi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innamorato, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaworski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobon-Velasco, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devijver, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Mayoral, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Leuven, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertho, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/Beta-Trcp Axis</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">3486</span>– <span class="NLM_lpage">3499</span>, <span class="refDoi"> DOI: 10.1128/MCB.00180-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.00180-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22751928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OlurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=3486-3499&author=P.+Radaauthor=A.+I.+Rojoauthor=N.+Evrard-Todeschiauthor=N.+G.+Innamoratoauthor=A.+Cotteauthor=T.+Jaworskiauthor=J.+C.+Tobon-Velascoauthor=H.+Devijverauthor=M.+F.+Garcia-Mayoralauthor=F.+Van+Leuvenauthor=J.+D.+Hayesauthor=G.+Berthoauthor=A.+Cuadrado&title=Structural+and+Functional+Characterization+of+Nrf2+Degradation+by+the+Glycogen+Synthase+Kinase+3%2FBeta-Trcp+Axis&doi=10.1128%2FMCB.00180-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis</span></div><div class="casAuthors">Rada, Patricia; Rojo, Ana I.; Evrard-Todeschi, Nathalie; Innamorato, Nadia G.; Cotte, Axelle; Jaworski, Tomasz; Tobon-Velasco, Julio C.; Devijver, Herman; Garcia-Mayoral, Maria Flor; Van Leuven, Fred; Hayes, John D.; Bertho, Gildas; Cuadrado, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3486-3499</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The transcription factor NF-E2-related factor 2 (Nrf2) is a master regulator of a genetic program, termed the phase 2 response, that controls redox homeostasis and participates in multiple aspects of physiol. and pathol.  Nrf2 protein stability is regulated by two E3 ubiquitin ligase adaptors, Keap1 and β-TrCP, the latter of which was only recently reported.  Here, two-dimensional (2D) gel electrophoresis and site-directed mutagenesis allowed us to identify two serines of Nrf2 that are phosphorylated by glycogen synthase kinase 3β (GSK-3β) in the sequence DSGISL.  NMR studies defined key residues of this phosphosequence involved in docking to the WD40 propeller of β-TrCP, through electrostatic and hydrophobic interactions.  We also identified three arginine residues of β-TrCP that participate in Nrf2 docking.  I.p. injection of the GSK-3 inhibitor SB216763 led to increased Nrf2 and heme oxygenase-1 levels in liver and hippocampus.  Moreover, mice with hippocampal absence of GSK-3β exhibited increased levels of Nrf2 and phase 2 gene products, reduced glutathione, and decreased levels of carbonylated proteins and malondialdehyde.  This study establishes the structural parameters of the interaction of Nrf2 with the GSK-3/β-TrCP axis and its functional relevance in the regulation of Nrf2 by the signaling pathways that impinge on GSK-3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreXtclgwX2_7Vg90H21EOLACvtfcHk0lj46ocl215Pvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OlurzF&md5=b1218f29af2afa1256dca41d148aac47</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1128%2FMCB.00180-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00180-12%26sid%3Dliteratum%253Aachs%26aulast%3DRada%26aufirst%3DP.%26aulast%3DRojo%26aufirst%3DA.%2BI.%26aulast%3DEvrard-Todeschi%26aufirst%3DN.%26aulast%3DInnamorato%26aufirst%3DN.%2BG.%26aulast%3DCotte%26aufirst%3DA.%26aulast%3DJaworski%26aufirst%3DT.%26aulast%3DTobon-Velasco%26aufirst%3DJ.%2BC.%26aulast%3DDevijver%26aufirst%3DH.%26aulast%3DGarcia-Mayoral%26aufirst%3DM.%2BF.%26aulast%3DVan%2BLeuven%26aufirst%3DF.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DBertho%26aufirst%3DG.%26aulast%3DCuadrado%26aufirst%3DA.%26atitle%3DStructural%2520and%2520Functional%2520Characterization%2520of%2520Nrf2%2520Degradation%2520by%2520the%2520Glycogen%2520Synthase%2520Kinase%25203%252FBeta-Trcp%2520Axis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2012%26volume%3D32%26spage%3D3486%26epage%3D3499%26doi%3D10.1128%2FMCB.00180-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rada, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span> <span> </span><span class="NLM_article-title">Scf/{Beta}-Trcp Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1128/MCB.01204-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.01204-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21245377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVWks7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=1121-1133&author=P.+Radaauthor=A.+I.+Rojoauthor=S.+Chowdhryauthor=M.+McMahonauthor=J.+D.+Hayesauthor=A.+Cuadrado&title=Scf%2F%7BBeta%7D-Trcp+Promotes+Glycogen+Synthase+Kinase+3-Dependent+Degradation+of+the+Nrf2+Transcription+Factor+in+a+Keap1-Independent+Manner&doi=10.1128%2FMCB.01204-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">SCF/β-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner</span></div><div class="casAuthors">Rada, Patricia; Rojo, Ana I.; Chowdhry, Sudhir; McMahon, Michael; Hayes, John D.; Cuadrado, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1121-1133</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Regulation of transcription factor Nrf2 (NF-E2-related factor 2) involves redox-sensitive proteasomal degrdn. via the E3 ubiquitin ligase Keap1/Cul3.  However, Nrf2 is controlled by other mechanisms that have not yet been elucidated.  We now show that glycogen synthase kinase 3 (GSK-3) phosphorylates a group of Ser residues in the Neh6 domain of mouse Nrf2 that overlap with an SCF/β-TrCP destruction motif (DSGIS, residues 334 to 338) and promotes its degrdn. in a Keap1-independent manner.  Nrf2 was stabilized by GSK-3 inhibitors in Keap1-null mouse embryo fibroblasts.  Similarly, an Nrf2ΔETGE mutant, which cannot be degraded via Keap1, accumulated when GSK-3 activity was blocked.  Phosphorylation of a Ser cluster in the Neh6 domain of Nrf2 stimulated its degrdn. because a mutant Nrf2ΔETGE 6S/6A protein, lacking these Ser residues, exhibited a longer half-life than Nrf2ΔETGE.  Moreover, Nrf2ΔETGE 6S/6A was insensitive to β-TrCP regulation and exhibited lower levels of ubiquitination than Nrf2ΔETGE.  GSK-3β enhanced ubiquitination of Nrf2ΔETGE but not that of Nrf2ΔETGE 6S/6A.  The Nrf2ΔETGE protein but not Nrf2ΔETGE 6S/6A coimmunopptd. with β-TrCP, and this assocn. was enhanced by GSK-3β.  Our results show for the first time that Nrf2 is targeted by GSK-3 for SCF/β-TrCP-dependent degrdn.  We propose a "dual degrdn." model to describe the regulation of Nrf2 under different pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy_9WaC_Wpx7Vg90H21EOLACvtfcHk0lj46ocl215Pvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVWks7nF&md5=df07f3fa2a729aeedd704bb7932ada83</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1128%2FMCB.01204-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01204-10%26sid%3Dliteratum%253Aachs%26aulast%3DRada%26aufirst%3DP.%26aulast%3DRojo%26aufirst%3DA.%2BI.%26aulast%3DChowdhry%26aufirst%3DS.%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DCuadrado%26aufirst%3DA.%26atitle%3DScf%252F%257BBeta%257D-Trcp%2520Promotes%2520Glycogen%2520Synthase%2520Kinase%25203-Dependent%2520Degradation%2520of%2520the%2520Nrf2%2520Transcription%2520Factor%2520in%2520a%2520Keap1-Independent%2520Manner%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2011%26volume%3D31%26spage%3D1121%26epage%3D1133%26doi%3D10.1128%2FMCB.01204-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagishita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Hrd1 Suppresses Nrf2-Mediated Cellular Protection During Liver Cirrhosis</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">708</span>– <span class="NLM_lpage">722</span>, <span class="refDoi"> DOI: 10.1101/gad.238246.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1101%2Fgad.238246.114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=708-722&author=T.+Wuauthor=F.+Zhaoauthor=B.+Gaoauthor=C.+Tanauthor=N.+Yagishitaauthor=T.+Nakajimaauthor=P.+K.+Wongauthor=E.+Chapmanauthor=D.+Fangauthor=D.+D.+Zhang&title=Hrd1+Suppresses+Nrf2-Mediated+Cellular+Protection+During+Liver+Cirrhosis&doi=10.1101%2Fgad.238246.114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1101%2Fgad.238246.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.238246.114%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGao%26aufirst%3DB.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DYagishita%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DP.%2BK.%26aulast%3DChapman%26aufirst%3DE.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DHrd1%2520Suppresses%2520Nrf2-Mediated%2520Cellular%2520Protection%2520During%2520Liver%2520Cirrhosis%26jtitle%3DGenes%2520Dev.%26date%3D2014%26volume%3D28%26spage%3D708%26epage%3D722%26doi%3D10.1101%2Fgad.238246.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niture, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaiswal, A. K.</span></span> <span> </span><span class="NLM_article-title">Regulation of Nrf2-an Update</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2013.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2013.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23434765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkt1Kmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=36-44&author=S.+K.+Nitureauthor=R.+Khatriauthor=A.+K.+Jaiswal&title=Regulation+of+Nrf2-an+Update&doi=10.1016%2Fj.freeradbiomed.2013.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Nrf2 - an update</span></div><div class="casAuthors">Niture, Suryakant K.; Khatri, Raju; Jaiswal, Anil K.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nrf2:INrf2 (Keap1) are cellular sensors of oxidative and electrophilic stress.  Nrf2 is a nuclear factor that controls the expression and coordinated induction of a battery of genes that encode detoxifying enzymes, drug transporters, antiapoptotic proteins, and proteasomes.  In the basal state, Nrf2 is constantly degraded in the cytoplasm by its inhibitor, INrf2.  INrf2 functions as an adapter for Cul3/Rbx1 E3 ubiquitin ligase-mediated degrdn. of Nrf2.  Chems., including antioxidants, tocopherols including α-tocopherol (vitamin E), and phytochems., and radiation antagonize the Nrf2:INrf2 interaction and lead to the stabilization and activation of Nrf2.  The signaling events involve preinduction, induction, and postinduction responses that tightly control Nrf2 activation and repression back to the basal state.  Oxidative/electrophilic signals activate unknown tyrosine kinases in a preinduction response that phosphorylates specific residues on Nrf2 neg. regulators, INrf2, Fyn, and Bach1, leading to their nuclear export, ubiquitination, and degrdn.  This preps. nuclei for unhindered import of Nrf2.  Oxidative/electrophilic modification of INrf2 cysteine 151 followed by PKC phosphorylation of Nrf2 serine 40 in the induction response results in the escape or release of Nrf2 from INrf2.  Nrf2 is thus stabilized and translocates to the nucleus, resulting in a coordinated activation of gene expression.  This is followed by a postinduction response that controls the "switching off" of Nrf2-activated gene expression.  GSK3β, under the control of AKT and PI3K, phosphorylates Fyn, leading to Fyn nuclear localization.  Fyn phosphorylates Nrf2 Y568, resulting in nuclear export and degrdn. of Nrf2.  The activation and repression of Nrf2 provide protection against oxidative/electrophilic stress and assocd. diseases, including cancer.  However, deregulation of INrf2 and Nrf2 due to mutations may lead to nuclear accumulation of Nrf2 that reduces apoptosis and promotes oncogenesis and drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxV9mVbc5P97Vg90H21EOLACvtfcHk0lj46ocl215Pvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkt1Kmtr0%253D&md5=088f5faca63ac2b3dbb09149ff8d3df5</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2013.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2013.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DNiture%26aufirst%3DS.%2BK.%26aulast%3DKhatri%26aufirst%3DR.%26aulast%3DJaiswal%26aufirst%3DA.%2BK.%26atitle%3DRegulation%2520of%2520Nrf2-an%2520Update%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2014%26volume%3D66%26spage%3D36%26epage%3D44%26doi%3D10.1016%2Fj.freeradbiomed.2013.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A. N.</span></span> <span> </span><span class="NLM_article-title">Epigenetic Regulation of Keap1-Nrf2 Signaling</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2015.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26117320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1GrsbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=337-349&author=Y.+Guoauthor=S.+Yuauthor=C.+Zhangauthor=A.+N.+Kong&title=Epigenetic+Regulation+of+Keap1-Nrf2+Signaling&doi=10.1016%2Fj.freeradbiomed.2015.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic regulation of Keap1-Nrf2 signaling</span></div><div class="casAuthors">Guo, Yue; Yu, Siwang; Zhang, Chengyue; Kong, Ah-Ng Tony</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">337-349</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The kelch-like ECH-assocd. protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2) signaling axis serves as a "master regulator" in response to oxidative/electrophilic stresses and chem. insults through the coordinated induction of a wide array of cytoprotective genes.  Therefore, activation of Nrf2 is considered to be an important approach for preventing chronic diseases triggered by stresses and toxins, including cancer.  Despite extensive studies suggested that the Keap1-Nrf2 signaling pathway is subject to multiple layers of regulation at the transcriptional, translational, and post-translational levels, the potential epigenetic regulation of Nrf2 and Keap1 has begun to be recognized only in recent years.  Epigenetic modifications, heritable alterations in gene expression that occur without changes in the primary DNA sequence, have been reported to be profoundly involved in oxidative stress responses.  In this review, we discuss the latest findings regarding the epigenetic regulation of Keap1-Nrf2 signaling by DNA methylation, histone modification, and microRNAs.  The crosstalk among these epigenetic modifications in the regulation of Keap1-Nrf2 signaling pathways is also discussed.  Studies of the epigenetic modification of Nrf2 and Keap1 have not only enhanced our understanding of this complex cellular defense system but have also provided potential new therapeutic targets for the prevention of certain diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMo2o8rEatfrVg90H21EOLACvtfcHk0lgHfsf6ubbwKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1GrsbvN&md5=f33b702a4d7d5df682310f36d3671e70</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DA.%2BN.%26atitle%3DEpigenetic%2520Regulation%2520of%2520Keap1-Nrf2%2520Signaling%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D337%26epage%3D349%26doi%3D10.1016%2Fj.freeradbiomed.2015.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olayanju, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">The Nrf2 Cell Defence Pathway: Keap1-Dependent and -Independent Mechanisms of Regulation</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">717</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2012.11.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.bcp.2012.11.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23219527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotF2h" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=705-717&author=H.+K.+Bryanauthor=A.+Olayanjuauthor=C.+E.+Goldringauthor=B.+K.+Park&title=The+Nrf2+Cell+Defence+Pathway%3A+Keap1-Dependent+and+-Independent+Mechanisms+of+Regulation&doi=10.1016%2Fj.bcp.2012.11.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation</span></div><div class="casAuthors">Bryan, Holly K.; Olayanju, Adedamola; Goldring, Christopher E.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">705-717</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The transcription factor Nrf2 (NF-E2-related factor 2) plays a vital role in maintaining cellular homeostasis, esp. upon the exposure of cells to chem. or oxidative stress, through its ability to regulate the basal and inducible expression of a multitude of antioxidant proteins, detoxification enzymes and xenobiotic transporters.  In addn., Nrf2 contributes to diverse cellular functions including differentiation, proliferation, inflammation and lipid synthesis and there is an increasing assocn. of aberrant expression and/or function of Nrf2 with pathologies including cancer, neurodegeneration and cardiovascular disease.  The activity of Nrf2 is primarily regulated via its interaction with Keap1 (Kelch-like ECH-assocd. protein 1), which directs the transcription factor for proteasomal degrdn.  Although it is generally accepted that modification (e.g. chem. adduction, oxidn., nitrosylation or glutathionylation) of one or more crit. cysteine residues in Keap1 represents a likely chemico-biol. trigger for the activation of Nrf2, unequivocal evidence for such a phenomenon remains elusive.  An increasing body of literature has revealed alternative mechanisms of Nrf2 regulation, including phosphorylation of Nrf2 by various protein kinases (PKC, PI3K/Akt, GSK-3β, JNK), interaction with other protein partners (p21, caveolin-1) and epigenetic factors (micro-RNAs -144, -28 and -200a, and promoter methylation).  These and other processes are potentially important determinants of Nrf2 activity, and therefore may contribute to the maintenance of cellular homeostasis.  Here, we dissect evidence supporting these Keap1-dependent and -independent mechanisms of Nrf2 regulation.  Furthermore, we highlight key knowledge gaps in this important field of biol., and suggest how these may be addressed exptl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd0JvmAl5GNLVg90H21EOLACvtfcHk0lgHfsf6ubbwKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotF2h&md5=e1b2ded3d46745cd9908655ef35ef962</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.11.016%26sid%3Dliteratum%253Aachs%26aulast%3DBryan%26aufirst%3DH.%2BK.%26aulast%3DOlayanju%26aufirst%3DA.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DThe%2520Nrf2%2520Cell%2520Defence%2520Pathway%253A%2520Keap1-Dependent%2520and%2520-Independent%2520Mechanisms%2520of%2520Regulation%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D705%26epage%3D717%26doi%3D10.1016%2Fj.bcp.2012.11.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liby, K. T.</span></span> <span> </span><span class="NLM_article-title">Nrf2 and Cancer: The Good, the Bad and the Importance of Context</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">564</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1038/nrc3278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fnrc3278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22810811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCltLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=564-571&author=M.+B.+Spornauthor=K.+T.+Liby&title=Nrf2+and+Cancer%3A+The+Good%2C+the+Bad+and+the+Importance+of+Context&doi=10.1038%2Fnrc3278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">NRF2 and cancer: the good, the bad and the importance of context</span></div><div class="casAuthors">Sporn, Michael B.; Liby, Karen T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">564-571</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many studies of chemopreventive drugs have suggested that their beneficial effects on suppression of carcinogenesis and many other chronic diseases are mediated through activation of the transcription factor NFE2-related factor 2 (NRF2).  More recently, genetic analyses of human tumors have indicated that NRF2 may conversely be oncogenic and cause resistance to chemotherapy.  It is therefore controversial whether the activation, or alternatively the inhibition, of NRF2 is a useful strategy for the prevention or treatment of cancer.  This Opinion article aims to rationalize these conflicting perspectives by critiquing the context dependence of NRF2 functions and the exptl. methods behind these conflicting data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgPeJ9hoVuW7Vg90H21EOLACvtfcHk0lgHfsf6ubbwKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCltLjF&md5=69560f374540df748d28d83a15ae7ed4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnrc3278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3278%26sid%3Dliteratum%253Aachs%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26atitle%3DNrf2%2520and%2520Cancer%253A%2520The%2520Good%252C%2520the%2520Bad%2520and%2520the%2520Importance%2520of%2520Context%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D564%26epage%3D571%26doi%3D10.1038%2Fnrc3278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span> <span> </span><span class="NLM_article-title">The Double-Edged Sword of Nrf2: Subversion of Redox Homeostasis During the Evolution of Cancer</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">732</span>– <span class="NLM_lpage">734</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2006.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.molcel.2006.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=16543142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtVyjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=732-734&author=J.+D.+Hayesauthor=M.+McMahon&title=The+Double-Edged+Sword+of+Nrf2%3A+Subversion+of+Redox+Homeostasis+During+the+Evolution+of+Cancer&doi=10.1016%2Fj.molcel.2006.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The double-edged sword of Nrf2: subversion of redox homeostasis during the evolution of cancer</span></div><div class="casAuthors">Hayes, John D.; McMahon, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">732-734</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with refs.  Low levels of Nrf2 activity predispose cells to chem. carcinogenesis.  Surprisingly, Padmanabhan et al. (2006) provide evidence in a recent issue of Mol. Cell to support the notion that elevated Nrf2 activity may also play a role in the evolution of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzA1PMvMs4ZrVg90H21EOLACvtfcHk0lgHfsf6ubbwKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtVyjurg%253D&md5=22f24f71da82d2ce7fa2e573e993ed31</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2006.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2006.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DMcMahon%26aufirst%3DM.%26atitle%3DThe%2520Double-Edged%2520Sword%2520of%2520Nrf2%253A%2520Subversion%2520of%2520Redox%2520Homeostasis%2520During%2520the%2520Evolution%2520of%2520Cancer%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D21%26spage%3D732%26epage%3D734%26doi%3D10.1016%2Fj.molcel.2006.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Cancer Chemoprevention Mechanisms Mediated through the Keap1-Nrf2 Pathway</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1713</span>– <span class="NLM_lpage">1748</span>, <span class="refDoi"> DOI: 10.1089/ars.2010.3221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1089%2Fars.2010.3221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20446772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12ltL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1713-1748&author=J.+D.+Hayesauthor=M.+McMahonauthor=S.+Chowdhryauthor=A.+T.+Dinkova-Kostova&title=Cancer+Chemoprevention+Mechanisms+Mediated+through+the+Keap1-Nrf2+Pathway&doi=10.1089%2Fars.2010.3221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Chemoprevention Mechanisms Mediated Through the Keap1-Nrf2 Pathway</span></div><div class="casAuthors">Hayes, John D.; McMahon, Michael; Chowdhry, Sudhir; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1713-1748</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  The cap'n'collar (CNC) bZIP transcription factor Nrf2 controls expression of genes for antioxidant enzymes, metal-binding proteins, drug-metabolising enzymes, drug transporters, and mol. chaperones.  Many chems. that protect against carcinogenesis induce Nrf2-target genes.  These compds. are all thiol-reactive and stimulate an adaptive response to redox stress in cells.  Such agents induce the expression of genes that posses an antioxidant response element (ARE) in their regulatory regions.  Under normal homeostatic conditions, Nrf2 activity is restricted through a Keap1-dependent ubiquitylation by Cul3-Rbx1, which targets the CNC-bZIP transcription factor for proteasomal degrdn.  However, as the substrate adaptor function of Keap1 is redox-sensitive, Nrf2 protein evades ubiquitylation by Cul3-Rbx1 when cells are treated with chemopreventive agents.  As a consequence, Nrf2 accumulates in the nucleus where it heterodimerizes with small Maf proteins and transactivates genes regulated through an ARE.  In this review, we describe synthetic compds. and phytochems. from edible plants that induce Nrf2-target genes.  We also discuss evidence for the existence of different classes of ARE (a 16-bp 5'-TMAnnRTGABnnnGCR-3' vs. an 11-bp 5'-RTGABnnnGCR-3', with or without the embedded activator protein 1-binding site 5'-TGASTCA-3'), species differences in the ARE-gene battery, and the identity of crit. Cys residues in Keap1 required for de-repression of Nrf2 by chemopreventive agents.  Antioxid. Redox Signal. 13, 1713-1748.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLr-kyLU5xNbVg90H21EOLACvtfcHk0lj0wSoJ42u6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12ltL7F&md5=a856d5c861ed530241eabb4b343d476a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3221%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DChowdhry%26aufirst%3DS.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DCancer%2520Chemoprevention%2520Mechanisms%2520Mediated%2520through%2520the%2520Keap1-Nrf2%2520Pathway%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2010%26volume%3D13%26spage%3D1713%26epage%3D1748%26doi%3D10.1089%2Fars.2010.3221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saw, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A. N.</span></span> <span> </span><span class="NLM_article-title">Regulation of Nf-E2-Related Factor 2 Signaling for Cancer Chemoprevention: Antioxidant Coupled with Antiinflammatory</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1679</span>– <span class="NLM_lpage">1698</span>, <span class="refDoi"> DOI: 10.1089/ars.2010.3276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1089%2Fars.2010.3276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20486765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12ltL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1679-1698&author=R.+Huauthor=C.+L.+Sawauthor=R.+Yuauthor=A.+N.+Kong&title=Regulation+of+Nf-E2-Related+Factor+2+Signaling+for+Cancer+Chemoprevention%3A+Antioxidant+Coupled+with+Antiinflammatory&doi=10.1089%2Fars.2010.3276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of NF-E2-Related Factor 2 Signaling for Cancer Chemoprevention: Antioxidant Coupled with Antiinflammatory</span></div><div class="casAuthors">Hu, Rong; Saw, Constance Lay-Lay; Yu, Rong; Kong, Ah-Ng Tony</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1679-1698</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Cancer chemoprevention is a process of using either natural or synthetic compds. to reduce the risk of developing cancer.  Observations that NF-E2-related factor 2 (Nrf2)-deficient mice lack response to some chemopreventive agents point to the important role of Nrf2 in chemoprevention.  Nrf2 is a member of basic-leucine zipper transcription factor family and has been shown to regulate gene expression by binding to a response element, antioxidant responsive element.  It is generally believed that activation of Nrf2 signaling is an adaptive response to the environmental and endogenous stresses.  Under homeostatic conditions, Nrf2 is suppressed by assocn. with Kelch-like ECH-assocd. protein 1 (Keap1), but is stimulated upon exposure to oxidative or electrophilic stress.  Once activated, Nrf2 translocates into nuclei and upregulates a group of genes that act in concert to combat oxidative stress.  Nrf2 is also shown to have protective function against inflammation, a pathol. process that could contribute to carcinogenesis.  In this review, we will discuss the current progress in the study of Nrf2 signaling, in particular, the mechanisms of Nrf2 activation by chemopreventive agents.  We will also discuss some of the potential caveats of Nrf2 in cancer treatment and future opportunity and challenges on regulation of Nrf2-mediated antioxidant and antiinflammatory signaling in the context of cancer prevention.  Antioxid. Redox Signal. 13, 1679-1698.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4FCMMKNcZKrVg90H21EOLACvtfcHk0lj0wSoJ42u6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12ltL7O&md5=79e349ba62d1b0c849111cd50aa5987d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3276%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DR.%26aulast%3DSaw%26aufirst%3DC.%2BL.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DKong%26aufirst%3DA.%2BN.%26atitle%3DRegulation%2520of%2520Nf-E2-Related%2520Factor%25202%2520Signaling%2520for%2520Cancer%2520Chemoprevention%253A%2520Antioxidant%2520Coupled%2520with%2520Antiinflammatory%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2010%26volume%3D13%26spage%3D1679%26epage%3D1698%26doi%3D10.1089%2Fars.2010.3276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaramillo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">The Emerging Role of the Nrf2-Keap1 Signaling Pathway in Cancer</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2179</span>– <span class="NLM_lpage">2191</span>, <span class="refDoi"> DOI: 10.1101/gad.225680.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1101%2Fgad.225680.113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24142871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCjt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=2179-2191&author=M.+C.+Jaramilloauthor=D.+D.+Zhang&title=The+Emerging+Role+of+the+Nrf2-Keap1+Signaling+Pathway+in+Cancer&doi=10.1101%2Fgad.225680.113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging role of the Nrf2-Keap1 signaling pathway in cancer</span></div><div class="casAuthors">Jaramillo, Melba C.; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2179-2191</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  The Nrf2 (nuclear factor erythroid 2 [NF-E2]-related factor 2 [Nrf2])-Keap1 (Kelch-like erythroid cell-derived protein with CNC homol. [ECH]-assocd. protein 1) signaling pathway is one of the most important cell defense and survival pathways.  Nrf2 can protect cells and tissues from a variety of toxicants and carcinogens by increasing the expression of a no. of cytoprotective genes.  As a result, several Nrf2 activators are currently being tested as chemopreventive compds. in clin. trials.  Just as Nrf2 protects normal cells, studies have shown that Nrf2 may also protect cancer cells from chemotherapeutic agents and facilitate cancer progression.  Nrf2 is aberrantly accumulated in many types of cancer, and its expression is assocd. with a poor prognosis in patients.  In addn., Nrf2 expression is induced during the course of drug resistance.  Collectively, these studies suggest that Nrf2 contributes to both intrinsic and acquired chemoresistance.  This discovery has opened up a broad spectrum of research geared toward a better understanding of the role of Nrf2 in cancer.  This review provides an overview of (1) the Nrf2-Keap1 signaling pathway, (2) the dual role of Nrf2 in cancer, (3) the mol. basis of Nrf2 activation in cancer cells, and (4) the challenges in the development of Nrf2-based drugs for chemoprevention and chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7t_-Ngp_Zp7Vg90H21EOLACvtfcHk0lj0wSoJ42u6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCjt7zN&md5=c2014cd362b1f5043b737b78fbb56a28</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1101%2Fgad.225680.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.225680.113%26sid%3Dliteratum%253Aachs%26aulast%3DJaramillo%26aufirst%3DM.%2BC.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DThe%2520Emerging%2520Role%2520of%2520the%2520Nrf2-Keap1%2520Signaling%2520Pathway%2520in%2520Cancer%26jtitle%3DGenes%2520Dev.%26date%3D2013%26volume%3D27%26spage%3D2179%26epage%3D2191%26doi%3D10.1101%2Fgad.225680.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tominaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuuchi, Y.</span></span> <span> </span><span class="NLM_article-title">Orally Active, Nonpeptide Vasopressin V2 Receptor Antagonists: A Novel Series of 1-[4-(Benzoylamino)Benzoyl]-2,3,4,5-Tetrahydro-1h-Benzazepines and Related Compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">3547</span>– <span class="NLM_lpage">3555</span>, <span class="refDoi"> DOI: 10.1021/jm960133o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960133o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=3547-3555&author=H.+Ogawaauthor=H.+Yamashitaauthor=K.+Kondoauthor=Y.+Yamamuraauthor=H.+Miyamotoauthor=K.+Kanauthor=K.+Kitanoauthor=M.+Tanakaauthor=K.+Nakayaauthor=S.+Nakamuraauthor=T.+Moriauthor=M.+Tominagaauthor=Y.+Yabuuchi&title=Orally+Active%2C+Nonpeptide+Vasopressin+V2+Receptor+Antagonists%3A+A+Novel+Series+of+1-%5B4-%28Benzoylamino%29Benzoyl%5D-2%2C3%2C4%2C5-Tetrahydro-1h-Benzazepines+and+Related+Compounds&doi=10.1021%2Fjm960133o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm960133o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960133o%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DYamashita%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DYamamura%26aufirst%3DY.%26aulast%3DMiyamoto%26aufirst%3DH.%26aulast%3DKan%26aufirst%3DK.%26aulast%3DKitano%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DNakaya%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DM.%26aulast%3DYabuuchi%26aufirst%3DY.%26atitle%3DOrally%2520Active%252C%2520Nonpeptide%2520Vasopressin%2520V2%2520Receptor%2520Antagonists%253A%2520A%2520Novel%2520Series%2520of%25201-%255B4-%2528Benzoylamino%2529Benzoyl%255D-2%252C3%252C4%252C5-Tetrahydro-1h-Benzazepines%2520and%2520Related%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D3547%26epage%3D3555%26doi%3D10.1021%2Fjm960133o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">The Nrf2-Keap1-Are Signaling Pathway: The Regulation and Dual Function of Nrf2 in Cancer</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1623</span>– <span class="NLM_lpage">1626</span>, <span class="refDoi"> DOI: 10.1089/ars.2010.3301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1089%2Fars.2010.3301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20486759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12ltL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1623-1626&author=D.+D.+Zhang&title=The+Nrf2-Keap1-Are+Signaling+Pathway%3A+The+Regulation+and+Dual+Function+of+Nrf2+in+Cancer&doi=10.1089%2Fars.2010.3301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The Nrf2-Keap1-ARE Signaling Pathway: The Regulation and Dual Function of Nrf2 in Cancer</span></div><div class="casAuthors">Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1623-1626</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  The NF-E2-related factor-2 (Nrf2) is a transcription factor that is ubiquitously expressed at low levels in all human organs.  As Nrf2 regulates a major cellular defense mechanism, tight regulation is crucial to maintain cellular homeostasis.  Activation of this pathway is important in preventing human diseases, such as cancer, neurodegenerative disease, cardiovascular diseases, ischemia, diabetes, pulmonary fibrosis, and inflammatory diseases.  Conversely, high constitutive levels of Nrf2 occur in many tumors or cancer cell lines.  Moreover, overexpression of Nrf2 in cancer cells protects them from the cytotoxic effects of anticancer therapies, resulting in chemo- and/or radioresistance.  Therefore, understanding Nrf2 regulation and identifying Nrf2 activators or inhibitors for disease prevention or as sensitizing agents during cancer therapy, resp., will have a significant impact on human health.  The growing interest in Nrf2 is reflected by an exponentially increasing no. of annual publications on this topic.  The present forum provides a comprehensive review on research conducted since the initial discovery of the Nrf2-Keap1 pathway in 1999, provides readers with insight into contemporary research in this field, and assesses current known biol. functions of this pathway.  Addnl., the forum will serve as an important resource for both graduate students and active researchers who are interested in the Nrf2 field.  Antioxid. Redox Signal. 13, 1623-1626.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxvgS4h_TXi7Vg90H21EOLACvtfcHk0lgL42QzQ5aliw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12ltL%252FP&md5=472c520fae20181c099ead28dc717e08</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3301%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DThe%2520Nrf2-Keap1-Are%2520Signaling%2520Pathway%253A%2520The%2520Regulation%2520and%2520Dual%2520Function%2520of%2520Nrf2%2520in%2520Cancer%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2010%26volume%3D13%26spage%3D1623%26epage%3D1626%26doi%3D10.1089%2Fars.2010.3301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rojo
de la Vega, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Nrf2 and the Hallmarks of Cancer</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2018.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.ccell.2018.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29731393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVyjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=21-43&author=M.+Rojo%0Ade+la+Vegaauthor=E.+Chapmanauthor=D.+D.+Zhang&title=Nrf2+and+the+Hallmarks+of+Cancer&doi=10.1016%2Fj.ccell.2018.03.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">NRF2 and the Hallmarks of Cancer</span></div><div class="casAuthors">Rojo de la Vega, Montserrat; Chapman, Eli; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-43</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The transcription factor NRF2 is the master regulator of the cellular antioxidant response.  Though recognized originally as a target of chemopreventive compds. that help prevent cancer and other maladies, accumulating evidence has established the NRF2 pathway as a driver of cancer progression, metastasis, and resistance to therapy.  Recent studies have identified new functions for NRF2 in the regulation of metab. and other essential cellular functions, establishing NRF2 as a truly pleiotropic transcription factor.  In this review, we explore the roles of NRF2 in the hallmarks of cancer, indicating both tumor suppressive and tumor-promoting effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsJ68CxevHh7Vg90H21EOLACvtfcHk0lgL42QzQ5aliw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVyjurs%253D&md5=17d4dde3000868c9e147915de1cc0b53</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2018.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2018.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DRojo%2Bde%2Bla%2BVega%26aufirst%3DM.%26aulast%3DChapman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DNrf2%2520and%2520the%2520Hallmarks%2520of%2520Cancer%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D34%26spage%3D21%26epage%3D43%26doi%3D10.1016%2Fj.ccell.2018.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Best, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Souza, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kersbergen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Policheni, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayalan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tull, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConville, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, K. D.</span></span> <span> </span><span class="NLM_article-title">Synergy between the Keap1/Nrf2 and Pi3k Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">943</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2018.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.cmet.2018.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29526543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlSgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=935-943&author=S.+A.+Bestauthor=D.+P.+De+Souzaauthor=A.+Kersbergenauthor=A.+N.+Policheniauthor=S.+Dayalanauthor=D.+Tullauthor=V.+Rathiauthor=D.+H.+Grayauthor=M.+E.+Ritchieauthor=M.+J.+McConvilleauthor=K.+D.+Sutherland&title=Synergy+between+the+Keap1%2FNrf2+and+Pi3k+Pathways+Drives+Non-Small-Cell+Lung+Cancer+with+an+Altered+Immune+Microenvironment&doi=10.1016%2Fj.cmet.2018.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment</span></div><div class="casAuthors">Best, Sarah A.; De Souza, David P.; Kersbergen, Ariena; Policheni, Antonia N.; Dayalan, Saravanan; Tull, Dedreia; Rathi, Vivek; Gray, Daniel H.; Ritchie, Matthew E.; McConville, Malcolm J.; Sutherland, Kate D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">935-943.e4</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The lung presents a highly oxidative environment, which is tolerated through engagement of tightly controlled stress response pathways.  A crit. stress response mediator is the transcription factor nuclear factor erythroid-2-related factor 2 (NFE2L2/NRF2), which is neg. regulated by Kelch-like ECH-assocd. protein 1 (KEAP1).  Alterations in the KEAP1/NRF2 pathway have been identified in 23% of lung adenocarcinomas, suggesting that deregulation of the pathway is a major cancer driver.  We demonstrate that inactivation of Keap1 and Pten in the mouse lung promotes adenocarcinoma formation.  Notably, metabolites identified in the plasma of Keap1f/f/Ptenf/f tumor-bearing mice indicate that tumorigenesis is assocd. with reprogramming of the pentose phosphate pathway.  Furthermore, the immune milieu was dramatically changed by Keap1 and Pten deletion, and tumor regression was achieved utilizing immune checkpoint inhibition.  Thus, our study highlights the ability to exploit both metabolic and immune characteristics in the detection and treatment of lung tumors harboring KEAP1/NRF2 pathway alterations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNMt_ih1lYf7Vg90H21EOLACvtfcHk0lgL42QzQ5aliw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlSgt7c%253D&md5=33a8c497917a047fa325db351975fc5d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2018.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2018.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DBest%26aufirst%3DS.%2BA.%26aulast%3DDe%2BSouza%26aufirst%3DD.%2BP.%26aulast%3DKersbergen%26aufirst%3DA.%26aulast%3DPolicheni%26aufirst%3DA.%2BN.%26aulast%3DDayalan%26aufirst%3DS.%26aulast%3DTull%26aufirst%3DD.%26aulast%3DRathi%26aufirst%3DV.%26aulast%3DGray%26aufirst%3DD.%2BH.%26aulast%3DRitchie%26aufirst%3DM.%2BE.%26aulast%3DMcConville%26aufirst%3DM.%2BJ.%26aulast%3DSutherland%26aufirst%3DK.%2BD.%26atitle%3DSynergy%2520between%2520the%2520Keap1%252FNrf2%2520and%2520Pi3k%2520Pathways%2520Drives%2520Non-Small-Cell%2520Lung%2520Cancer%2520with%2520an%2520Altered%2520Immune%2520Microenvironment%26jtitle%3DCell%2520Metab.%26date%3D2018%26volume%3D27%26spage%3D935%26epage%3D943%26doi%3D10.1016%2Fj.cmet.2018.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeNicola, G.</span></span> <span> </span><span class="NLM_article-title">The Regulation of Nrf2 by Nutrient Responsive Signaling and Its Role in Anabolic Cancer Metabolism</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1774</span>, <span class="refDoi"> DOI: 10.1089/ars.2017.7356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1089%2Fars.2017.7356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28899208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVSisbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=1774&author=S.+B.+Leeauthor=B.+Sellersauthor=G.+DeNicola&title=The+Regulation+of+Nrf2+by+Nutrient+Responsive+Signaling+and+Its+Role+in+Anabolic+Cancer+Metabolism&doi=10.1089%2Fars.2017.7356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The Regulation of NRF2 by Nutrient-Responsive Signaling and Its Role in Anabolic Cancer Metabolism</span></div><div class="casAuthors">Lee, Sae Bom; Sellers, Brianna N.; DeNicola, Gina M.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1774-1791</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Significance: The stress responsive transcription factor nuclear factor erythroid 2 p45-related factor 2, or NRF2, regulates the expression of many cytoprotective enzymes to mitigate oxidative stress under physiol. conditions.  NRF2 is activated in response to oxidative stress, growth factor signaling, and changes in nutrient status.  In addn., somatic mutations that disrupt the interaction between NRF2 and its neg. regulator Kelch-like erythroid cell-derived protein with CNC homol. (ECH)-assocd. 1 (KEAP1) commonly occur in cancer and are thought to promote tumorigenesis.  Recent Advances: While it is well established that aberrant NRF2 activation results in enhanced antioxidant capacity in cancer cells, recent exciting findings demonstrate a role for NRF2-mediated metabolic deregulation that supports cancer cell proliferation.  Crit. Issues: In this review, we describe how the NRF2-KEAP1 signaling pathway is altered in cancer, how NRF2 is regulated by changes in cellular metab., and how NRF2 reprograms cellular metab. to support proliferation.  Future Directions: Future studies will delineate the NRF2-regulated processes crit. for metabolic adaptation to nutrient availability, cellular proliferation, and tumorigenesis.  Antioxid. Redox Signal. 00, 000-000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4b0nVTquVDbVg90H21EOLACvtfcHk0ljFAtgNrMrYgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVSisbrO&md5=be1a7355dc90dd46fe48443dde1e45a7</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1089%2Fars.2017.7356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2017.7356%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BB.%26aulast%3DSellers%26aufirst%3DB.%26aulast%3DDeNicola%26aufirst%3DG.%26atitle%3DThe%2520Regulation%2520of%2520Nrf2%2520by%2520Nutrient%2520Responsive%2520Signaling%2520and%2520Its%2520Role%2520in%2520Anabolic%2520Cancer%2520Metabolism%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2018%26volume%3D29%26spage%3D1774%26doi%3D10.1089%2Fars.2017.7356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasti, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span> <span> </span><span class="NLM_article-title">Glutamine and Cancer: Cell Biology, Physiology, and Clinical Opportunities</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">3678</span>– <span class="NLM_lpage">3684</span>, <span class="refDoi"> DOI: 10.1172/JCI69600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1172%2FJCI69600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23999442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVenu7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=3678-3684&author=C.+T.+Hensleyauthor=A.+T.+Wastiauthor=R.+J.+DeBerardinis&title=Glutamine+and+Cancer%3A+Cell+Biology%2C+Physiology%2C+and+Clinical+Opportunities&doi=10.1172%2FJCI69600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamine and cancer: cell biology, physiology, and clinical opportunities</span></div><div class="casAuthors">Hensley, Christopher T.; Wasti, Ajla T.; DeBerardinis, Ralph J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3678-3684</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Glutamine is an abundant and versatile nutrient that participates in energy formation, redox homeostasis, macromol. synthesis, and signaling in cancer cells.  These characteristics make glutamine metab. an appealing target for new clin. strategies to detect, monitor, and treat cancer.  Here the authors review the metabolic functions of glutamine as a super nutrient and the surprising roles of glutamine in supporting the biol. hallmarks of malignancy.  The authors also review recent efforts in imaging and therapeutics to exploit tumor cell glutamine dependence, discuss some of the challenges in this arena, and suggest a disease-focused paradigm to deploy these emerging approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocNnK_GlTtRrVg90H21EOLACvtfcHk0ljFAtgNrMrYgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVenu7bL&md5=fb704a7773710a20add6edbf0da08616</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1172%2FJCI69600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI69600%26sid%3Dliteratum%253Aachs%26aulast%3DHensley%26aufirst%3DC.%2BT.%26aulast%3DWasti%26aufirst%3DA.%2BT.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26atitle%3DGlutamine%2520and%2520Cancer%253A%2520Cell%2520Biology%252C%2520Physiology%252C%2520and%2520Clinical%2520Opportunities%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D3678%26epage%3D3684%26doi%3D10.1172%2FJCI69600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Son, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssiotis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ying, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligorio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrone, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullarky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyh-Chang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardeesy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haigis, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePinho, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmelman, A. C.</span></span> <span> </span><span class="NLM_article-title">Glutamine Supports Pancreatic Cancer Growth through a Kras-Regulated Metabolic Pathway</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>496</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1038/nature12040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fnature12040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23535601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=496&publication_year=2013&pages=101-105&author=J.+Sonauthor=C.+A.+Lyssiotisauthor=H.+Yingauthor=X.+Wangauthor=S.+Huaauthor=M.+Ligorioauthor=R.+M.+Pereraauthor=C.+R.+Ferroneauthor=E.+Mullarkyauthor=N.+Shyh-Changauthor=Y.+Kangauthor=J.+B.+Flemingauthor=N.+Bardeesyauthor=J.+M.+Asaraauthor=M.+C.+Haigisauthor=R.+A.+DePinhoauthor=L.+C.+Cantleyauthor=A.+C.+Kimmelman&title=Glutamine+Supports+Pancreatic+Cancer+Growth+through+a+Kras-Regulated+Metabolic+Pathway&doi=10.1038%2Fnature12040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway</span></div><div class="casAuthors">Son, Jaekyoung; Lyssiotis, Costas A.; Ying, Haoqiang; Wang, Xiaoxu; Hua, Sujun; Ligorio, Matteo; Perera, Rushika M.; Ferrone, Cristina R.; Mullarky, Edouard; Ng, Shyh-Chang; Kang, Ya'an; Fleming, Jason B.; Bardeesy, Nabeel; Asara, John M.; Haigis, Marcia C.; DePinho, Ronald A.; Cantley, Lewis C.; Kimmelman, Alec C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">496</span>
        (<span class="NLM_cas:issue">7443</span>),
    <span class="NLM_cas:pages">101-105</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cancer cells have metabolic dependencies that distinguish them from their normal counterparts.  Among these dependencies is an increased use of the amino acid glutamine to fuel anabolic processes.  Indeed, the spectrum of glutamine-dependent tumors and the mechanisms whereby glutamine supports cancer metab. remain areas of active investigation.  Here we report the identification of a non-canonical pathway of glutamine use in human pancreatic ductal adenocarcinoma (PDAC) cells that is required for tumor growth.  Whereas most cells use glutamate dehydrogenase (GLUD1) to convert glutamine-derived glutamate into α-ketoglutarate in the mitochondria to fuel the tricarboxylic acid cycle, PDAC relies on a distinct pathway in which glutamine-derived aspartate is transported into the cytoplasm where it can be converted into oxaloacetate by aspartate transaminase (GOT1).  Subsequently, this oxaloacetate is converted into malate and then pyruvate, ostensibly increasing the NADPH/NADP+ ratio which can potentially maintain the cellular redox state.  Importantly, PDAC cells are strongly dependent on this series of reactions, as glutamine deprivation or genetic inhibition of any enzyme in this pathway leads to an increase in reactive oxygen species and a redn. in reduced glutathione.  Moreover, knockdown of any component enzyme in this series of reactions also results in a pronounced suppression of PDAC growth in vitro and in vivo.  Furthermore, we establish that the reprogramming of glutamine metab. is mediated by oncogenic KRAS, the signature genetic alteration in PDAC, through the transcriptional upregulation and repression of key metabolic enzymes in this pathway.  The essentiality of this pathway in PDAC and the fact that it is dispensable in normal cells may provide novel therapeutic approaches to treat these refractory tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzWAEWZvCWcbVg90H21EOLACvtfcHk0ljFAtgNrMrYgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrc%253D&md5=162af18c1102745226aa2096179f1cc6</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnature12040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12040%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DJ.%26aulast%3DLyssiotis%26aufirst%3DC.%2BA.%26aulast%3DYing%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DLigorio%26aufirst%3DM.%26aulast%3DPerera%26aufirst%3DR.%2BM.%26aulast%3DFerrone%26aufirst%3DC.%2BR.%26aulast%3DMullarky%26aufirst%3DE.%26aulast%3DShyh-Chang%26aufirst%3DN.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DFleming%26aufirst%3DJ.%2BB.%26aulast%3DBardeesy%26aufirst%3DN.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DHaigis%26aufirst%3DM.%2BC.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26atitle%3DGlutamine%2520Supports%2520Pancreatic%2520Cancer%2520Growth%2520through%2520a%2520Kras-Regulated%2520Metabolic%2520Pathway%26jtitle%3DNature%26date%3D2013%26volume%3D496%26spage%3D101%26epage%3D105%26doi%3D10.1038%2Fnature12040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayin, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeBoeuf, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakousi, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhutkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Rivera, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbaraj, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prigge, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goparaju, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolgalev, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heguy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allaj, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander
Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papagiannakopoulos, T.</span></span> <span> </span><span class="NLM_article-title">Keap1 Loss Promotes Kras-Driven Lung Cancer and Results in Dependence on Glutaminolysis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1362</span>– <span class="NLM_lpage">1368</span>, <span class="refDoi"> DOI: 10.1038/nm.4407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fnm.4407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28967920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFylurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=1362-1368&author=R.+Romeroauthor=V.+I.+Sayinauthor=S.+M.+Davidsonauthor=M.+R.+Bauerauthor=S.+X.+Singhauthor=S.+E.+LeBoeufauthor=T.+R.+Karakousiauthor=D.+C.+Ellisauthor=A.+Bhutkarauthor=F.+J.+Sanchez-Riveraauthor=L.+Subbarajauthor=B.+Martinezauthor=R.+T.+Bronsonauthor=J.+R.+Priggeauthor=E.+E.+Schmidtauthor=C.+J.+Thomasauthor=C.+Goparajuauthor=A.+Daviesauthor=I.+Dolgalevauthor=A.+Heguyauthor=V.+Allajauthor=J.+T.+Poirierauthor=A.+L.+Moreiraauthor=C.+M.+Rudinauthor=H.+I.+Passauthor=M.+G.+Vander%0AHeidenauthor=T.+Jacksauthor=T.+Papagiannakopoulos&title=Keap1+Loss+Promotes+Kras-Driven+Lung+Cancer+and+Results+in+Dependence+on+Glutaminolysis&doi=10.1038%2Fnm.4407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis</span></div><div class="casAuthors">Romero, Rodrigo; Sayin, Volkan I.; Davidson, Shawn M.; Bauer, Matthew R.; Singh, Simranjit X.; Le Boeuf, Sarah E.; Karakousi, Triantafyllia R.; Ellis, Donald C.; Bhutkar, Arjun; Sanchez-Rivera, Francisco J.; Subbaraj, Lakshmipriya; Martinez, Britney; Bronson, Roderick T.; Prigge, Justin R.; Schmidt, Edward E.; Thomas, Craig J.; Goparaju, Chandra; Davies, Angela; Dolgalev, Igor; Heguy, Adriana; Allaj, Viola; Poirier, John T.; Moreira, Andre L.; Rudin, Charles M.; Pass, Harvey I.; Vander Heiden, Matthew G.; Jacks, Tyler; Papagiannakopoulos, Thales</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1362-1368</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Treating KRAS-mutant lung adenocarcinoma (LUAD) remains a major challenge in cancer treatment given the difficulties assocd. with directly inhibiting the KRAS oncoprotein.  One approach to addressing this challenge is to define mutations that frequently co-occur with those in KRAS, which themselves may lead to therapeutic vulnerabilities in tumors.  Approx. 20% of KRAS-mutant LUAD tumors carry loss-of-function mutations in the KEAP1 gene encoding Kelch-like ECH-assocd. protein 1 (refs. 2, 3, 4), a neg. regulator of nuclear factor erythroid 2-like 2 (NFE2L2; hereafter NRF2), which is the master transcriptional regulator of the endogenous antioxidant response.  The high frequency of mutations in KEAP1 suggests an important role for the oxidative stress response in lung tumorigenesis.  Using a CRISPR-Cas9-based approach in a mouse model of KRAS-driven LUAD, we examd. the effects of Keap1 loss in lung cancer progression.  We show that loss of Keap1 hyperactivates NRF2 and promotes KRAS-driven LUAD in mice.  Through a combination of CRISPR-Cas9-based genetic screening and metabolomic analyses, we show that Keap1- or Nrf2-mutant cancers are dependent on increased glutaminolysis, and this property can be therapeutically exploited through the pharmacol. inhibition of glutaminase.  Finally, we provide a rationale for stratification of human patients with lung cancer harboring KRAS/KEAP1- or KRAS/NRF2-mutant lung tumors as likely to respond to glutaminase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofWgHF0gdsW7Vg90H21EOLACvtfcHk0liFkgAov-Q32A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFylurrK&md5=2bc4122a4c757cc3a5fdab3eb62b26e3</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnm.4407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4407%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DR.%26aulast%3DSayin%26aufirst%3DV.%2BI.%26aulast%3DDavidson%26aufirst%3DS.%2BM.%26aulast%3DBauer%26aufirst%3DM.%2BR.%26aulast%3DSingh%26aufirst%3DS.%2BX.%26aulast%3DLeBoeuf%26aufirst%3DS.%2BE.%26aulast%3DKarakousi%26aufirst%3DT.%2BR.%26aulast%3DEllis%26aufirst%3DD.%2BC.%26aulast%3DBhutkar%26aufirst%3DA.%26aulast%3DSanchez-Rivera%26aufirst%3DF.%2BJ.%26aulast%3DSubbaraj%26aufirst%3DL.%26aulast%3DMartinez%26aufirst%3DB.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DPrigge%26aufirst%3DJ.%2BR.%26aulast%3DSchmidt%26aufirst%3DE.%2BE.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DGoparaju%26aufirst%3DC.%26aulast%3DDavies%26aufirst%3DA.%26aulast%3DDolgalev%26aufirst%3DI.%26aulast%3DHeguy%26aufirst%3DA.%26aulast%3DAllaj%26aufirst%3DV.%26aulast%3DPoirier%26aufirst%3DJ.%2BT.%26aulast%3DMoreira%26aufirst%3DA.%2BL.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DPass%26aufirst%3DH.%2BI.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DPapagiannakopoulos%26aufirst%3DT.%26atitle%3DKeap1%2520Loss%2520Promotes%2520Kras-Driven%2520Lung%2520Cancer%2520and%2520Results%2520in%2520Dependence%2520on%2520Glutaminolysis%26jtitle%3DNat.%2520Med.%26date%3D2017%26volume%3D23%26spage%3D1362%26epage%3D1368%26doi%3D10.1038%2Fnm.4407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeNicola, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullarky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudderth, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wistuba,  II</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Regulates Serine Biosynthesis in Non-Small Cell Lung Cancer</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1475</span>– <span class="NLM_lpage">1481</span>, <span class="refDoi"> DOI: 10.1038/ng.3421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fng.3421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26482881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslant7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2015&pages=1475-1481&author=G.+M.+DeNicolaauthor=P.+H.+Chenauthor=E.+Mullarkyauthor=J.+A.+Sudderthauthor=Z.+Huauthor=D.+Wuauthor=H.+Tangauthor=Y.+Xieauthor=J.+M.+Asaraauthor=K.+E.+Huffmanauthor=+Wistubaauthor=J.+D.+Minnaauthor=R.+J.+DeBerardinisauthor=L.+C.+Cantley&title=Nrf2+Regulates+Serine+Biosynthesis+in+Non-Small+Cell+Lung+Cancer&doi=10.1038%2Fng.3421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">NRF2 regulates serine biosynthesis in non-small cell lung cancer</span></div><div class="casAuthors">DeNicola, Gina M.; Chen, Pei-Hsuan; Mullarky, Edouard; Sudderth, Jessica A.; Hu, Zeping; Wu, David; Tang, Hao; Xie, Yang; Asara, John M.; Huffman, Kenneth E.; Wistuba, Ignacio I.; Minna, John D.; DeBerardinis, Ralph J.; Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1475-1481</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumors have high energetic and anabolic needs for rapid cell growth and proliferation, and the serine biosynthetic pathway was recently identified as an important source of metabolic intermediates for these processes.  We integrated metabolic tracing and transcriptional profiling of a large panel of non-small cell lung cancer (NSCLC) cell lines to characterize the activity and regulation of the serine/glycine biosynthetic pathway in NSCLC.  Here we show that the activity of this pathway is highly heterogeneous and is regulated by NRF2, a transcription factor frequently deregulated in NSCLC.  We found that NRF2 controls the expression of the key serine/glycine biosynthesis enzyme genes PHGDH, PSAT1 and SHMT2 via ATF4 to support glutathione and nucleotide prodn.  Moreover, we show that expression of these genes confers poor prognosis in human NSCLC.  Thus, a substantial fraction of human NSCLCs activates an NRF2-dependent transcriptional program that regulates serine and glycine metab. and is linked to clin. aggressiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSELAUW2hlmbVg90H21EOLACvtfcHk0liFkgAov-Q32A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslant7bO&md5=41d411b051f2e26da358c949585c0c5d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fng.3421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.3421%26sid%3Dliteratum%253Aachs%26aulast%3DDeNicola%26aufirst%3DG.%2BM.%26aulast%3DChen%26aufirst%3DP.%2BH.%26aulast%3DMullarky%26aufirst%3DE.%26aulast%3DSudderth%26aufirst%3DJ.%2BA.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DHuffman%26aufirst%3DK.%2BE.%26aulast%3DWistuba%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DNrf2%2520Regulates%2520Serine%2520Biosynthesis%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DNat.%2520Genet.%26date%3D2015%26volume%3D47%26spage%3D1475%26epage%3D1481%26doi%3D10.1038%2Fng.3421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gwinn, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briones-Martin-Del-Campo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweet-Cordero, E. A.</span></span> <span> </span><span class="NLM_article-title">Oncogenic Kras Regulates Amino Acid Homeostasis and Asparagine Biosynthesis Via Atf4 and Alters Sensitivity to L-Asparaginase</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2017.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.ccell.2017.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29316436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVejtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=91-107&author=D.+M.+Gwinnauthor=A.+G.+Leeauthor=M.+Briones-Martin-Del-Campoauthor=C.+S.+Connauthor=D.+R.+Simpsonauthor=A.+I.+Scottauthor=A.+Leauthor=T.+M.+Cowanauthor=D.+Ruggeroauthor=E.+A.+Sweet-Cordero&title=Oncogenic+Kras+Regulates+Amino+Acid+Homeostasis+and+Asparagine+Biosynthesis+Via+Atf4+and+Alters+Sensitivity+to+L-Asparaginase&doi=10.1016%2Fj.ccell.2017.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase</span></div><div class="casAuthors">Gwinn, Dana M.; Lee, Alex G.; Briones-Martin-del-Campo, Marcela; Conn, Crystal S.; Simpson, David R.; Scott, Anna I.; Le, Anthony; Cowan, Tina M.; Ruggero, Davide; Sweet-Cordero, E. Alejandro</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-107.e6</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">KRAS is a regulator of the nutrient stress response in non-small-cell lung cancer (NSCLC).  Induction of the ATF4 pathway during nutrient depletion requires AKT and NRF2 downstream of KRAS.  The tumor suppressor KEAP1 strongly influences the outcome of activation of this pathway during nutrient stress; loss of KEAP1 in KRAS mutant cells leads to apoptosis.  Through ATF4 regulation, KRAS alters amino acid uptake and asparagine biosynthesis.  The ATF4 target asparagine synthetase (ASNS) contributes to apoptotic suppression, protein biosynthesis, and mTORC1 activation.  Inhibition of AKT suppressed ASNS expression and, combined with depletion of extracellular asparagine, decreased tumor growth.  Therefore, KRAS is important for the cellular response to nutrient stress, and ASNS represents a promising therapeutic target in KRAS mutant NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1mgWB2XSqarVg90H21EOLACvtfcHk0lj8cjUY53OqFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVejtA%253D%253D&md5=6a2265856fc1948a0743e75f8b5955e6</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2017.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2017.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DGwinn%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DA.%2BG.%26aulast%3DBriones-Martin-Del-Campo%26aufirst%3DM.%26aulast%3DConn%26aufirst%3DC.%2BS.%26aulast%3DSimpson%26aufirst%3DD.%2BR.%26aulast%3DScott%26aufirst%3DA.%2BI.%26aulast%3DLe%26aufirst%3DA.%26aulast%3DCowan%26aufirst%3DT.%2BM.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DSweet-Cordero%26aufirst%3DE.%2BA.%26atitle%3DOncogenic%2520Kras%2520Regulates%2520Amino%2520Acid%2520Homeostasis%2520and%2520Asparagine%2520Biosynthesis%2520Via%2520Atf4%2520and%2520Alters%2520Sensitivity%2520to%2520L-Asparaginase%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D33%26spage%3D91%26epage%3D107%26doi%3D10.1016%2Fj.ccell.2017.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornsveld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dansen, T. B.</span></span> <span> </span><span class="NLM_article-title">The Hallmarks of Cancer from a Redox Perspective</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1089/ars.2015.6580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1089%2Fars.2015.6580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27353526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlehsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=300-325&author=M.+Hornsveldauthor=T.+B.+Dansen&title=The+Hallmarks+of+Cancer+from+a+Redox+Perspective&doi=10.1089%2Fars.2015.6580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The Hallmarks of Cancer from a Redox Perspective</span></div><div class="casAuthors">Hornsveld, Marten; Dansen, Tobias B.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">300-325</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Significance: For a healthy cell to turn into a cancer cell and grow out to become a tumor, it needs to undergo a series of complex changes and acquire certain traits, summarized as "The Hallmarks of Cancer.  " These hallmarks can all be regarded as the result of altered signal transduction cascades and an understanding of these cascades is essential for cancer treatment.  Recent Advances: Redox signaling is a long overlooked form of signal transduction that proceeds through the reversible oxidn. of cysteines in proteins and that uses hydrogen peroxide as a second messenger.  Crit. Issues: In this article, we provide examples that show that redox signaling is involved in the regulation of proteins and signaling cascades that play roles in every hallmark of cancer.  Future Directions: An understanding of how redox signaling and "classical" signal transduction are intertwined could hold promising strategies for cancer therapy in the future.  Antioxid. Redox Signal. 25, 300-325.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg8Ibw049azbVg90H21EOLACvtfcHk0lhx3i_8hY7tYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlehsLrJ&md5=43a0fffc6b1765fff0d4b9ce34a04510</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1089%2Fars.2015.6580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2015.6580%26sid%3Dliteratum%253Aachs%26aulast%3DHornsveld%26aufirst%3DM.%26aulast%3DDansen%26aufirst%3DT.%2BB.%26atitle%3DThe%2520Hallmarks%2520of%2520Cancer%2520from%2520a%2520Redox%2520Perspective%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2016%26volume%3D25%26spage%3D300%26epage%3D325%26doi%3D10.1089%2Fars.2015.6580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span> <span> </span><span class="NLM_article-title">Nrf2: Friend or Foe for Chemoprevention?</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgp231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1093%2Fcarcin%2Fbgp231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=19793802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlCgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=90-99&author=T.+W.+Kenslerauthor=N.+Wakabayashi&title=Nrf2%3A+Friend+or+Foe+for+Chemoprevention%3F&doi=10.1093%2Fcarcin%2Fbgp231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2: friend or foe for chemoprevention?</span></div><div class="casAuthors">Kensler, Thomas W.; Wakabayashi, Nobunao</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-99</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Health reflects the ability of an organism to adapt to stress.  Stresses-metabolic, proteotoxic, mitotic, oxidative and DNA-damage stresses-not only contribute to the etiol. of cancer and other chronic degenerative diseases but are also hallmarks of the cancer phenotype.  Activation of the Kelch-like ECH-assocd. protein 1 (KEAP1)-NF-E2-related factor 2 (NRF2)-signaling pathway is an adaptive response to environmental and endogenous stresses and serves to render animals resistant to chem. carcinogenesis and other forms of toxicity, while disruption of the pathway exacerbates these outcomes.  This pathway can be induced by thiol-reactive small mols. that demonstrate protective efficacy in preclin. chemoprevention models and in clin. trials.  However, mutations and epigenetic modifications affecting the regulation and fate of NRF2 can lead to constitutive dominant hyperactivation of signaling that preserves rather than attenuates cancer phenotypes by providing selective resistance to stresses.  This review provides a synopsis of KEAP1-NRF2 signaling, compares the impact of genetic vs. pharmacol. activation and considers both the attributes and concerns of targeting the pathway in chemoprevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqshZPrMJ237bVg90H21EOLACvtfcHk0lhx3i_8hY7tYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlCgsQ%253D%253D&md5=dd79e8634cc9ca6ad8fde2d08f77a731</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgp231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgp231%26sid%3Dliteratum%253Aachs%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DWakabayashi%26aufirst%3DN.%26atitle%3DNrf2%253A%2520Friend%2520or%2520Foe%2520for%2520Chemoprevention%253F%26jtitle%3DCarcinogenesis%26date%3D2010%26volume%3D31%26spage%3D90%26epage%3D99%26doi%3D10.1093%2Fcarcin%2Fbgp231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tebay, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durant, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penning, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Activation of the Transcription Factor Nrf2 by Redox Stressors, Nutrient Cues, and Energy Status and the Pathways through Which It Attenuates Degenerative Disease</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2015.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26122708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCru7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=108-146&author=L.+E.+Tebayauthor=H.+Robertsonauthor=S.+T.+Durantauthor=S.+R.+Vitaleauthor=T.+M.+Penningauthor=A.+T.+Dinkova-Kostovaauthor=J.+D.+Hayes&title=Mechanisms+of+Activation+of+the+Transcription+Factor+Nrf2+by+Redox+Stressors%2C+Nutrient+Cues%2C+and+Energy+Status+and+the+Pathways+through+Which+It+Attenuates+Degenerative+Disease&doi=10.1016%2Fj.freeradbiomed.2015.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease</span></div><div class="casAuthors">Tebay, Lauren E.; Robertson, Holly; Durant, Stephen T.; Vitale, Steven R.; Penning, Trevor M.; Dinkova-Kostova, Albena T.; Hayes, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">108-146</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) regulates the basal and stress-inducible expression of a battery of genes encoding key components of the glutathione-based and thioredoxin-based antioxidant systems, as well as aldo-keto reductase, glutathione S-transferase, and NAD(P)H:quinone oxidoreductase-1 drug-metabolizing isoenzymes along with multidrug-resistance-assocd. efflux pumps.  It therefore plays a pivotal role in both intrinsic resistance and cellular adaptation to reactive oxygen species (ROS) and xenobiotics.  Activation of Nrf2 can, however, serve as a double-edged sword because some of the genes it induces may contribute to chem. carcinogenesis by promoting futile redox cycling of polycyclic arom. hydrocarbon metabolites or confer resistance to chemotherapeutic drugs by increasing the expression of efflux pumps, suggesting its cytoprotective effects will vary in a context-specific fashion.  In addn. to cytoprotection, Nrf2 also controls genes involved in intermediary metab., pos. regulating those involved in NADPH generation, purine biosynthesis, and the β-oxidn. of fatty acids, while suppressing those involved in lipogenesis and gluconeogenesis.  Nrf2 is subject to regulation at multiple levels.  Its ability to orchestrate adaptation to oxidants and electrophiles is due principally to stress-stimulated modification of thiols within one of its repressors, the Kelch-like ECH-assocd. protein 1 (Keap1), which is present in the cullin-3 RING ubiquitin ligase (CRL) complex CRLKeap1.  Thus modification of Cys residues in Keap1 blocks CRLKeap1 activity, allowing newly translated Nrf2 to accumulate rapidly and induce its target genes.  The ability of Keap1 to repress Nrf2 can be attenuated by p62/sequestosome-1 in a mechanistic target of rapamycin complex 1 (mTORC1)-dependent manner, thereby allowing refeeding after fasting to increase Nrf2-target gene expression.  In parallel with repression by Keap1, Nrf2 is also repressed by β-transducin repeat-contg. protein (β-TrCP), present in the Skp1-cullin-1-F-box protein (SCF) ubiquitin ligase complex SCFβ-TrCP.  The ability of SCFβ-TrCP to suppress Nrf2 activity is itself enhanced by prior phosphorylation of the transcription factor by glycogen synthase kinase-3 (GSK-3) through formation of a DSGIS-contg. phosphodegron.  However, formation of the phosphodegron in Nrf2 by GSK-3 is inhibited by stimuli that activate protein kinase B (PKB)/Akt.  In particular, PKB/Akt activity can be increased by phosphoinositide 3-kinase and mTORC2, thereby providing an explanation of why antioxidant-responsive element-driven genes are induced by growth factors and nutrients.  Thus Nrf2 activity is tightly controlled via CRLKeap1 and SCFβ-TrCP by oxidative stress and energy-based signals, allowing it to mediate adaptive responses that restore redox homeostasis and modulate intermediary metab.  Based on the fact that Nrf2 influences multiple biochem. pathways in both pos. and neg. ways, it is likely its dose-response curve, in terms of susceptibility to certain degenerative disease, is U-shaped.  Specifically, too little Nrf2 activity will lead to loss of cytoprotection, diminished antioxidant capacity, and lowered β-oxidn. of fatty acids, while conversely also exhibiting heightened sensitivity to ROS-based signaling that involves receptor tyrosine kinases and apoptosis signal-regulating kinase-1.  By contrast, too much Nrf2 activity disturbs the homeostatic balance in favor of redn., and so may have deleterious consequences including overprodn. of reduced glutathione and NADPH, the blunting of ROS-based signal transduction, epithelial cell hyperplasia, and failure of certain cell types to differentiate correctly.  We discuss the basis of a putative U-shaped Nrf2 dose-response curve in terms of potentially competing processes relevant to different stages of tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBWTEjfYelsLVg90H21EOLACvtfcHk0liNtxMXzz5o_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCru7fE&md5=b7e3f1d49b709d72071bb9bcc0147320</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DTebay%26aufirst%3DL.%2BE.%26aulast%3DRobertson%26aufirst%3DH.%26aulast%3DDurant%26aufirst%3DS.%2BT.%26aulast%3DVitale%26aufirst%3DS.%2BR.%26aulast%3DPenning%26aufirst%3DT.%2BM.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26atitle%3DMechanisms%2520of%2520Activation%2520of%2520the%2520Transcription%2520Factor%2520Nrf2%2520by%2520Redox%2520Stressors%252C%2520Nutrient%2520Cues%252C%2520and%2520Energy%2520Status%2520and%2520the%2520Pathways%2520through%2520Which%2520It%2520Attenuates%2520Degenerative%2520Disease%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D108%26epage%3D146%26doi%3D10.1016%2Fj.freeradbiomed.2015.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penning, T. M.</span></span> <span> </span><span class="NLM_article-title">Aldo-Keto Reductase Regulation by the Nrf2 System: Implications for Stress Response, Chemotherapy Drug Resistance, and Carcinogenesis</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.6b00319</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.6b00319" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2017&pages=162-176&author=T.+M.+Penning&title=Aldo-Keto+Reductase+Regulation+by+the+Nrf2+System%3A+Implications+for+Stress+Response%2C+Chemotherapy+Drug+Resistance%2C+and+Carcinogenesis&doi=10.1021%2Facs.chemrestox.6b00319"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.6b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.6b00319%26sid%3Dliteratum%253Aachs%26aulast%3DPenning%26aufirst%3DT.%2BM.%26atitle%3DAldo-Keto%2520Reductase%2520Regulation%2520by%2520the%2520Nrf2%2520System%253A%2520Implications%2520for%2520Stress%2520Response%252C%2520Chemotherapy%2520Drug%2520Resistance%252C%2520and%2520Carcinogenesis%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2017%26volume%3D30%26spage%3D162%26epage%3D176%26doi%3D10.1021%2Facs.chemrestox.6b00319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arlt, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiborova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieler, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frei, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopko, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmeiser, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. H.</span></span> <span> </span><span class="NLM_article-title">Environmental Pollutant and Potent Mutagen 3-Nitrobenzanthrone Forms DNA Adducts after Reduction by Nad(P)H:Quinone Oxidoreductase and Conjugation by Acetyltransferases and Sulfotransferases in Human Hepatic Cytosols</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">2644</span>– <span class="NLM_lpage">2652</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-3544</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1158%2F0008-5472.CAN-04-3544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=15805261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtVeqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=2644-2652&author=V.+M.+Arltauthor=M.+Stiborovaauthor=C.+J.+Hendersonauthor=M.+R.+Osborneauthor=C.+A.+Bielerauthor=E.+Freiauthor=V.+Martinekauthor=B.+Sopkoauthor=C.+R.+Wolfauthor=H.+H.+Schmeiserauthor=D.+H.+Phillips&title=Environmental+Pollutant+and+Potent+Mutagen+3-Nitrobenzanthrone+Forms+DNA+Adducts+after+Reduction+by+Nad%28P%29H%3AQuinone+Oxidoreductase+and+Conjugation+by+Acetyltransferases+and+Sulfotransferases+in+Human+Hepatic+Cytosols&doi=10.1158%2F0008-5472.CAN-04-3544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Environmental pollutant and potent mutagen 3-nitrobenzanthrone forms DNA adducts after reduction by NAD(P)H:quinone oxidoreductase and conjugation by acetyltransferases and sulfotransferases in human hepatic cytosols</span></div><div class="casAuthors">Arlt, Volker M.; Stiborova, Marie; Henderson, Colin J.; Osborne, Martin R.; Bieler, Christian A.; Frei, Eva; Martinek, Vaclav; Sopko, Bruno; Wolf, C. Roland; Schmeiser, Heinz H.; Phillips, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2644-2652</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">3-Nitrobenzanthrone (3-nitro-7H-benz[de]anthracen-7-one, 3-NBA) is a potent mutagen and suspected human carcinogen identified in diesel exhaust and air pollution.  The authors compared the ability of human hepatic cytosolic samples to catalyze DNA adduct formation by 3-NBA.  Using the 32P-postlabeling method, the authors found that 12/12 hepatic cytosols activated 3-NBA to form multiple DNA adducts similar to those formed in vivo in rodents.  By comparing 3-NBA-DNA adduct formation in the presence of cofactors of NAD(P)H:quinone oxidoreductase (NQO1) and xanthine oxidase, most of the reductive activation of 3-NBA in human hepatic cytosols was attributed to NQO1.  Inhibition of adduct formation by dicoumarol, an NQO1 inhibitor, supported this finding and was confirmed with human recombinant NQO1.  When cofactors of N,O-acetyltransferases (NAT) and sulfotransferases (SULT) were added to cytosolic samples, 3-NBA-DNA adduct formation increased 10- to 35-fold.  Using human recombinant NQO1 and NATs or SULTs, the authors found that mainly NAT2, followed by SULT1A2, NAT1, and, to a lesser extent, SULT1A1 activate 3-NBA.  The authors also evaluated the role of hepatic NADPH:cytochrome P 450 oxidoreductase (POR) in the activation of 3-NBA in vivo by treating hepatic POR-null mice and wild-type littermates i.p. with 0.2 or 2 mg/kg body wt. of 3-NBA.  No difference in DNA binding was found in any tissue examd. (liver, lung, kidney, bladder, and colon) between null and wild-type mice, indicating that 3-NBA is predominantly activated by cytosolic nitroreductases rather than microsomal POR.  Collectively, these results show the role of human hepatic NQO1 to reduce 3-NBA to species being further activated by NATs and SULTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHsI2F1qMibbVg90H21EOLACvtfcHk0lgcUwhesCDpzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtVeqsLw%253D&md5=c02f2c2f148ee21d1d910ee0dda6d50c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-3544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-3544%26sid%3Dliteratum%253Aachs%26aulast%3DArlt%26aufirst%3DV.%2BM.%26aulast%3DStiborova%26aufirst%3DM.%26aulast%3DHenderson%26aufirst%3DC.%2BJ.%26aulast%3DOsborne%26aufirst%3DM.%2BR.%26aulast%3DBieler%26aufirst%3DC.%2BA.%26aulast%3DFrei%26aufirst%3DE.%26aulast%3DMartinek%26aufirst%3DV.%26aulast%3DSopko%26aufirst%3DB.%26aulast%3DWolf%26aufirst%3DC.%2BR.%26aulast%3DSchmeiser%26aufirst%3DH.%2BH.%26aulast%3DPhillips%26aufirst%3DD.%2BH.%26atitle%3DEnvironmental%2520Pollutant%2520and%2520Potent%2520Mutagen%25203-Nitrobenzanthrone%2520Forms%2520DNA%2520Adducts%2520after%2520Reduction%2520by%2520Nad%2528P%2529H%253AQuinone%2520Oxidoreductase%2520and%2520Conjugation%2520by%2520Acetyltransferases%2520and%2520Sulfotransferases%2520in%2520Human%2520Hepatic%2520Cytosols%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D2644%26epage%3D2652%26doi%3D10.1158%2F0008-5472.CAN-04-3544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Padmanabhan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharlock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Defects of Keap1 Activity Provoked by Its Point Mutations in Lung Cancer</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">700</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2006.01.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.molcel.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=16507366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD28XislKqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=689-700&author=B.+Padmanabhanauthor=K.+I.+Tongauthor=T.+Ohtaauthor=Y.+Nakamuraauthor=M.+Scharlockauthor=M.+Ohtsujiauthor=M.-I.+Kangauthor=A.+Kobayashiauthor=S.+Yokoyamaauthor=M.+Yamamoto&title=Structural+Basis+for+Defects+of+Keap1+Activity+Provoked+by+Its+Point+Mutations+in+Lung+Cancer&doi=10.1016%2Fj.molcel.2006.01.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer</span></div><div class="casAuthors">Padmanabhan, Balasundaram; Tong, Kit I.; Ohta, Tsutomu; Nakamura, Yoshihiro; Scharlock, Maria; Ohtsuji, Makiko; Kang, Moon-Il; Kobayashi, Akira; Yokoyama, Shigeyuki; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">689-700</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nrf2 regulates the cellular oxidative stress response, whereas Keap1 represses Nrf2 through its mol. interaction.  To elucidate the mol. mechanism of the Keap1 and Nrf2 interaction, we resolved the six-bladed β propeller crystal structure of the Kelch/DGR and CTR domains of mouse Keap1 and revealed that extensive inter- and intrablade hydrogen bonds maintain the structural integrity and proper assocn. of Keap1 with Nrf2.  A peptide contg. the ETGE motif of Nrf2 binds the β propeller of Keap1 at the entrance of the central cavity on the bottom side via electrostatic interactions with conserved arginine residues.  We found a somatic mutation and a gene variation in human lung cancer cells that change glycine to cysteine in the DGR domain, introducing local conformational changes that reduce Keap1's affinity for Nrf2.  These results provide a structural basis for the loss of Keap1 function and gain of Nrf2 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouis9O43RTgbVg90H21EOLACvtfcHk0ljlP717XDjcdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislKqsLg%253D&md5=717ce921cba6994da720e40d71e1d543</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DPadmanabhan%26aufirst%3DB.%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DScharlock%26aufirst%3DM.%26aulast%3DOhtsuji%26aufirst%3DM.%26aulast%3DKang%26aufirst%3DM.-I.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DStructural%2520Basis%2520for%2520Defects%2520of%2520Keap1%2520Activity%2520Provoked%2520by%2520Its%2520Point%2520Mutations%2520in%2520Lung%2520Cancer%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D21%26spage%3D689%26epage%3D700%26doi%3D10.1016%2Fj.molcel.2006.01.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thimmulappa, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoque, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baylin, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrielson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brock, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswal, S.</span></span> <span> </span><span class="NLM_article-title">Dysfunctional Keap1-Nrf2 Interaction in Non-Small-Cell Lung Cancer</span>. <i>PLoS Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e420</span> <span class="refDoi"> DOI: 10.1371/journal.pmed.0030420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1371%2Fjournal.pmed.0030420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=17020408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A280%3ADC%252BD28npsFGruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&author=A.+Singhauthor=V.+Misraauthor=R.+K.+Thimmulappaauthor=H.+Leeauthor=S.+Amesauthor=M.+O.+Hoqueauthor=J.+G.+Hermanauthor=S.+B.+Baylinauthor=D.+Sidranskyauthor=E.+Gabrielsonauthor=M.+V.+Brockauthor=S.+Biswal&title=Dysfunctional+Keap1-Nrf2+Interaction+in+Non-Small-Cell+Lung+Cancer&doi=10.1371%2Fjournal.pmed.0030420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer</span></div><div class="casAuthors">Singh Anju; Misra Vikas; Thimmulappa Rajesh K; Lee Hannah; Ames Stephen; Hoque Mohammad O; Herman James G; Baylin Stephen B; Sidransky David; Gabrielson Edward; Brock Malcolm V; Biswal Shyam</div><div class="citationInfo"><span class="NLM_cas:title">PLoS medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e420</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Nuclear factor erythroid-2 related factor 2 (NRF2) is a redox-sensitive transcription factor that positively regulates the expression of genes encoding antioxidants, xenobiotic detoxification enzymes, and drug efflux pumps, and confers cytoprotection against oxidative stress and xenobiotics in normal cells.  Kelch-like ECH-associated protein 1 (KEAP1) negatively regulates NRF2 activity by targeting it to proteasomal degradation.  Increased expression of cellular antioxidants and xenobiotic detoxification enzymes has been implicated in resistance of tumor cells against chemotherapeutic drugs.  METHODS AND FINDINGS:  Here we report a systematic analysis of the KEAP1 genomic locus in lung cancer patients and cell lines that revealed deletion, insertion, and missense mutations in functionally important domains of KEAP1 and a very high percentage of loss of heterozygosity at 19p13.2, suggesting that biallelic inactivation of KEAP1 in lung cancer is a common event.  Sequencing of KEAP1 in 12 cell lines and 54 non-small-cell lung cancer (NSCLC) samples revealed somatic mutations in KEAP1 in a total of six cell lines and ten tumors at a frequency of 50% and 19%, respectively.  All the mutations were within highly conserved amino acid residues located in the Kelch or intervening region domain of the KEAP1 protein, suggesting that these mutations would likely abolish KEAP1 repressor activity.  Evaluation of loss of heterozygosity at 19p13.2 revealed allelic losses in 61% of the NSCLC cell lines and 41% of the tumor samples.  Decreased KEAP1 activity in cancer cells induced greater nuclear accumulation of NRF2, causing enhanced transcriptional induction of antioxidants, xenobiotic metabolism enzymes, and drug efflux pumps.  CONCLUSIONS:  This is the first study to our knowledge to demonstrate that biallelic inactivation of KEAP1 is a frequent genetic alteration in NSCLC.  Loss of KEAP1 function leading to constitutive activation of NRF2-mediated gene expression in cancer suggests that tumor cells manipulate the NRF2 pathway for their survival against chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRSF0z_BNLNYTC850By6mxpfW6udTcc2eag1srpjiHO2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28npsFGruw%253D%253D&md5=96b89c577f3aa8650a636cc320dcc289</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.0030420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.0030420%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DMisra%26aufirst%3DV.%26aulast%3DThimmulappa%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DAmes%26aufirst%3DS.%26aulast%3DHoque%26aufirst%3DM.%2BO.%26aulast%3DHerman%26aufirst%3DJ.%2BG.%26aulast%3DBaylin%26aufirst%3DS.%2BB.%26aulast%3DSidransky%26aufirst%3DD.%26aulast%3DGabrielson%26aufirst%3DE.%26aulast%3DBrock%26aufirst%3DM.%2BV.%26aulast%3DBiswal%26aufirst%3DS.%26atitle%3DDysfunctional%2520Keap1-Nrf2%2520Interaction%2520in%2520Non-Small-Cell%2520Lung%2520Cancer%26jtitle%3DPLoS%2520Med.%26date%3D2006%26volume%3D3%26doi%3D10.1371%2Fjournal.pmed.0030420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iijima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirohashi, S.</span></span> <span> </span><span class="NLM_article-title">Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1303</span>– <span class="NLM_lpage">1309</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-5003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1158%2F0008-5472.CAN-07-5003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1303-1309&author=T.+Ohtaauthor=K.+Iijimaauthor=M.+Miyamotoauthor=I.+Nakaharaauthor=H.+Tanakaauthor=M.+Ohtsujiauthor=T.+Suzukiauthor=A.+Kobayashiauthor=J.+Yokotaauthor=T.+Sakiyamaauthor=T.+Shibataauthor=M.+Yamamotoauthor=S.+Hirohashi&title=Loss+of+Keap1+Function+Activates+Nrf2+and+Provides+Advantages+for+Lung+Cancer+Cell+Growth&doi=10.1158%2F0008-5472.CAN-07-5003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-5003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-5003%26sid%3Dliteratum%253Aachs%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DIijima%26aufirst%3DK.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DNakahara%26aufirst%3DI.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DOhtsuji%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DYokota%26aufirst%3DJ.%26aulast%3DSakiyama%26aufirst%3DT.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHirohashi%26aufirst%3DS.%26atitle%3DLoss%2520of%2520Keap1%2520Function%2520Activates%2520Nrf2%2520and%2520Provides%2520Advantages%2520for%2520Lung%2520Cancer%2520Cell%2520Growth%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D1303%26epage%3D1309%26doi%3D10.1158%2F0008-5472.CAN-07-5003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonobe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menju, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mino, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwakiri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyahara, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okubo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Date, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, H.</span></span> <span> </span><span class="NLM_article-title">Mutations in Keap1 Are a Potential Prognostic Factor in Resected Non-Small Cell Lung Cancer</span>. <i>J. Surg. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">500</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1002/jso.21520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1002%2Fjso.21520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20213688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnt1art7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2010&pages=500-506&author=T.+Takahashiauthor=M.+Sonobeauthor=T.+Menjuauthor=E.+Nakayamaauthor=N.+Minoauthor=S.+Iwakiriauthor=S.+Nagaiauthor=K.+Satoauthor=R.+Miyaharaauthor=K.+Okuboauthor=T.+Hirataauthor=H.+Dateauthor=H.+Wada&title=Mutations+in+Keap1+Are+a+Potential+Prognostic+Factor+in+Resected+Non-Small+Cell+Lung+Cancer&doi=10.1002%2Fjso.21520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer</span></div><div class="casAuthors">Takahashi, Tsuyoshi; Sonobe, Makoto; Menju, Toshi; Nakayama, Ei; Mino, Nobuya; Iwakiri, Shotaro; Nagai, Shinjiro; Sato, Kiyoshi; Miyahara, Ryo; Okubo, Kenichi; Hirata, Toshiki; Date, Hiroshi; Wada, Hiromi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Surgical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">500-506</span>CODEN:
                <span class="NLM_cas:coden">JSONAU</span>;
        ISSN:<span class="NLM_cas:issn">0022-4790</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Background: Mutations in Kelch-like ECH-assocd. protein 1 (Keap1) have been reported to protect tumor cells from chemotherapeutic agents.  However, their prognostic significance in nonsmall cell lung cancer (NSCLC) is still unclear.  In this study, we examd. the effect of Keap1 gene mutations on survival and disease-free interval using resected primary NSCLC tissue.  Methods: We retrospectively analyzed the tumors from 79 patients with completely resected pathol. Stage I-II NSCLC for the presence of Keap1 gene mutations and examd. the prognosis of the patients.  Results: Keap1 gene mutations were detected in four patients (5.1%).  The postoperative 5-yr survival rate for patients with Keap1 mutations was significantly lower than those without a mutation (25% vs. 76%, P = 0.038).  The postoperative 5-yr disease-free survival rate for patients with a mutant Keap1 tumor was slightly lower than for patients with Keap1 wild-type tumors (25% vs. 66%, P = 0.057).  Conclusions: Keap1 gene mutations are likely to be assocd. with a worse prognosis and lower postoperative disease-free survival rates in pathol. Stage I-II NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpphNdvZ4R4brVg90H21EOLACvtfcHk0liogG-jrbA5xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnt1art7s%253D&md5=cf466727af78d365ae3905d4cbbcc1d7</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Fjso.21520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjso.21520%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DSonobe%26aufirst%3DM.%26aulast%3DMenju%26aufirst%3DT.%26aulast%3DNakayama%26aufirst%3DE.%26aulast%3DMino%26aufirst%3DN.%26aulast%3DIwakiri%26aufirst%3DS.%26aulast%3DNagai%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DMiyahara%26aufirst%3DR.%26aulast%3DOkubo%26aufirst%3DK.%26aulast%3DHirata%26aufirst%3DT.%26aulast%3DDate%26aufirst%3DH.%26aulast%3DWada%26aufirst%3DH.%26atitle%3DMutations%2520in%2520Keap1%2520Are%2520a%2520Potential%2520Prognostic%2520Factor%2520in%2520Resected%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DJ.%2520Surg.%2520Oncol.%26date%3D2010%26volume%3D101%26spage%3D500%26epage%3D506%26doi%3D10.1002%2Fjso.21520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span> <span> </span><span class="NLM_article-title">Hypermethylation of the Keap1 Gene in Human Lung Cancer Cell Lines and Lung Cancer Tissues</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2008.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.bbrc.2008.06.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2008&pages=151-154&author=R.+Wangauthor=J.+Anauthor=F.+Jiauthor=H.+Jiaoauthor=H.+Sunauthor=D.+Zhou&title=Hypermethylation+of+the+Keap1+Gene+in+Human+Lung+Cancer+Cell+Lines+and+Lung+Cancer+Tissues&doi=10.1016%2Fj.bbrc.2008.06.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2008.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2008.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DAn%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DF.%26aulast%3DJiao%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DD.%26atitle%3DHypermethylation%2520of%2520the%2520Keap1%2520Gene%2520in%2520Human%2520Lung%2520Cancer%2520Cell%2520Lines%2520and%2520Lung%2520Cancer%2520Tissues%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D373%26spage%3D151%26epage%3D154%26doi%3D10.1016%2Fj.bbrc.2008.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muscarella, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrella, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Alessandro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">la Torre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tancredi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarnieri, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balsamo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Bonis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisceglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaramuzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiello, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valori, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merla, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendemiale, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazio, V. M.</span></span> <span> </span><span class="NLM_article-title">Frequent Epigenetics Inactivation of Keap1 Gene in Non-Small Cell Lung Cancer</span>. <i>Epigenetics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.4161/epi.6.6.15773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.4161%2Fepi.6.6.15773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21610322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2gs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=710-719&author=L.+A.+Muscarellaauthor=P.+Parrellaauthor=V.+D%E2%80%99Alessandroauthor=A.+la+Torreauthor=R.+Barbanoauthor=A.+Fontanaauthor=A.+Tancrediauthor=V.+Guarnieriauthor=T.+Balsamoauthor=M.+Cocoauthor=M.+Copettiauthor=F.+Pellegriniauthor=P.+De+Bonisauthor=M.+Biscegliaauthor=G.+Scaramuzziauthor=E.+Maielloauthor=V.+M.+Valoriauthor=G.+Merlaauthor=G.+Vendemialeauthor=V.+M.+Fazio&title=Frequent+Epigenetics+Inactivation+of+Keap1+Gene+in+Non-Small+Cell+Lung+Cancer&doi=10.4161%2Fepi.6.6.15773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer</span></div><div class="casAuthors">Muscarella, Lucia Anna; Parrella, Paola; D'Alessandro, Vito; La Torre, Annamaria; Barbano, Raffaela; Fontana, Andrea; Tancredi, Antonio; Guarnieri, Vito; Balsamo, Teresa; Coco, Michelina; Copetti, Massimiliano; Pellegrini, Fabio; De Bonis, Patrizia; Bisceglia, Michele; Scaramuzzi, Gerardo; Maiello, Evaristo; Valori, Vanna Maria; Merla, Giuseppe; Vendemiale, Gianluigi; Fazio, Vito Michele</div><div class="citationInfo"><span class="NLM_cas:title">Epigenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">710-719</span>CODEN:
                <span class="NLM_cas:coden">EPIGB6</span>;
        ISSN:<span class="NLM_cas:issn">1559-2294</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">The KEAP1/Nrf2 pathway is a master regulator of several redox-sensitive genes implicated in resistance of tumor cells against chemotherapeutic drugs.  Recent data suggest that epigenetic mechanisms may play a pivotal role in the regulation of KEAP1 expression.  We performed a comprehensive genetic and epigenetic anal. of the KEAP1 gene in 47 non-small cell lung cancer tissues and normal specimens.  Promoter methylation anal. was performed using a quant. methylation specific PCR assay in real time.  Methylation at the KEAP1 promoter region was detected in 22 out of the 47 NSCLCs (47%) and in none of the normal tissues analyzed.  Somatic mutations were detected in 7 out of the 47 tumors (15%) and loss of heterozygosity (LOH) in 10 out of the 47 (21%) of the cases.  Overall, we found at least one mol. alteration in 57% of the cases.  Approx. one third of the tumors had two alterations and this feature was assocd. with higher risk of disease progression in univariate COX regression anal. (HR = 3.62; 95% CI 1.24-10.65, p = 0.02).  This result was confirmed by Kaplan-Meier anal., which demonstrated an assocn. between worst outcome and KEAP1 double alterations (p = 0.01, Log rank test).  Our results further suggest that deregulation of the NRF2/KEAP1 system could play a pivotal role in the cancerogenesis of NSCLC.  In addn. identifying patients with KEAP1 genetic and epigenetic abnormalities may contribute to disease progression prediction and response to therapy in lung cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_6f3ulmBJdLVg90H21EOLACvtfcHk0liE0GwjMrUBDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2gs74%253D&md5=9f5e99821f389c112850383ac3d3478f</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.4161%2Fepi.6.6.15773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fepi.6.6.15773%26sid%3Dliteratum%253Aachs%26aulast%3DMuscarella%26aufirst%3DL.%2BA.%26aulast%3DParrella%26aufirst%3DP.%26aulast%3DD%25E2%2580%2599Alessandro%26aufirst%3DV.%26aulast%3Dla%2BTorre%26aufirst%3DA.%26aulast%3DBarbano%26aufirst%3DR.%26aulast%3DFontana%26aufirst%3DA.%26aulast%3DTancredi%26aufirst%3DA.%26aulast%3DGuarnieri%26aufirst%3DV.%26aulast%3DBalsamo%26aufirst%3DT.%26aulast%3DCoco%26aufirst%3DM.%26aulast%3DCopetti%26aufirst%3DM.%26aulast%3DPellegrini%26aufirst%3DF.%26aulast%3DDe%2BBonis%26aufirst%3DP.%26aulast%3DBisceglia%26aufirst%3DM.%26aulast%3DScaramuzzi%26aufirst%3DG.%26aulast%3DMaiello%26aufirst%3DE.%26aulast%3DValori%26aufirst%3DV.%2BM.%26aulast%3DMerla%26aufirst%3DG.%26aulast%3DVendemiale%26aufirst%3DG.%26aulast%3DFazio%26aufirst%3DV.%2BM.%26atitle%3DFrequent%2520Epigenetics%2520Inactivation%2520of%2520Keap1%2520Gene%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DEpigenetics%26date%3D2011%26volume%3D6%26spage%3D710%26epage%3D719%26doi%3D10.4161%2Fepi.6.6.15773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kijima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saijo, Y.</span></span> <span> </span><span class="NLM_article-title">Methylation of the Keap1 Gene Promoter Region in Human Colorectal Cancer</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">66</span>, <span class="refDoi"> DOI: 10.1186/1471-2407-12-66</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1186%2F1471-2407-12-66" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22325485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XksFGksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=66&author=N.+Hanadaauthor=T.+Takahataauthor=Q.+Zhouauthor=X.+Yeauthor=R.+Sunauthor=J.+Itohauthor=A.+Ishiguroauthor=H.+Kijimaauthor=J.+Mimuraauthor=K.+Itohauthor=S.+Fukudaauthor=Y.+Saijo&title=Methylation+of+the+Keap1+Gene+Promoter+Region+in+Human+Colorectal+Cancer&doi=10.1186%2F1471-2407-12-66"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Methylation of the KEAP1 gene promoter region in human colorectal cancer</span></div><div class="casAuthors">Hanada, Naoyuki; Takahata, Takenori; Zhou, Qiliang; Ye, Xulu; Sun, Ruowen; Itoh, Jugoh; Ishiguro, Atsushi; Kijima, Hiroshi; Mimura, Junsei; Itoh, Ken; Fukuda, Shinsaku; Saijo, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">66</span>CODEN:
                <span class="NLM_cas:coden">BCMACL</span>;
        ISSN:<span class="NLM_cas:issn">1471-2407</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The Keap1-Nrf2 pathway has been reported to be impaired in several cancers.  However, the status of Keap1-Nrf2 system in human colorectal cancer (CRC) has not been elucidated.  Methods: We used colorectal cancer (CRC) cell lines and surgical specimens to investigate the methylation status of the KEAP1 promoter region as well as expression of Nrf2 and its downstream antioxidative stress genes, NQO-1 and AKR1C1.  Results: DNA sequencing anal. indicated that all mutations detected were synonymous, with no amino acid substitutions.  We showed by bisulfite genomic sequencing and methylation-specific PCR that eight of 10 CRC cell lines had hypermethylated CpG islands in the KEAP1 promoter region.  HT29 cells with a hypermethylated KEAP1 promoter resulted in decreased mRNA and protein expression but unmethylated Colo320DM cells showed higher expression levels.  In addn., treatment with the DNA methyltransferase inhibitor 5-Aza-dC combined with the histone deacetylase inhibitor trichostatin A (TSA) increased KEAP1 mRNA expression.  These result suggested that methylation of the KEAP1 promoter regulates its mRNA level.  Time course anal. with the Nrf2-antioxidant response element (ARE) pathway activator t-BHQ treatment showed a rapid response within 24 h.  HT29 cells had higher basal expression levels of NQO-1 and AKR1C1 mRNA than Colo320DM cells.  Aberrant promoter methylation of KEAP1 was detected in 53% of tumor tissues and 25% of normal mucosae from 40 surgical CRC specimens, indicating that cancerous tissue showed increased methylation of the KEAP1 promoter region, conferring a protective effect against cytotoxic anticancer drugs.  Conclusion: Hypermethylation of the KEAP1 promoter region suppressed its mRNA expression and increased nuclear Nrf2 and downstream ARE gene expression in CRC cells and tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKmCDl3tb3yLVg90H21EOLACvtfcHk0lguzYjBSanDZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksFGksLg%253D&md5=13d2605a6b0cae5e5725b676b7f04b95</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-12-66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-12-66%26sid%3Dliteratum%253Aachs%26aulast%3DHanada%26aufirst%3DN.%26aulast%3DTakahata%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DR.%26aulast%3DItoh%26aufirst%3DJ.%26aulast%3DIshiguro%26aufirst%3DA.%26aulast%3DKijima%26aufirst%3DH.%26aulast%3DMimura%26aufirst%3DJ.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DFukuda%26aufirst%3DS.%26aulast%3DSaijo%26aufirst%3DY.%26atitle%3DMethylation%2520of%2520the%2520Keap1%2520Gene%2520Promoter%2520Region%2520in%2520Human%2520Colorectal%2520Cancer%26jtitle%3DBMC%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D66%26doi%3D10.1186%2F1471-2407-12-66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrestha, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouinard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccioni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamburov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imielinski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogstrom, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natoli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahr, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirosh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doench, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. S.</span></span> <span> </span><span class="NLM_article-title">High-Throughput Phenotyping of Lung Cancer Somatic Mutations</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2016.06.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.ccell.2016.06.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27478040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1KlsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=214-228&author=A.+H.+Bergerauthor=A.+N.+Brooksauthor=X.+Wuauthor=Y.+Shresthaauthor=C.+Chouinardauthor=F.+Piccioniauthor=M.+Bagulauthor=A.+Kamburovauthor=M.+Imielinskiauthor=L.+Hogstromauthor=C.+Zhuauthor=X.+Yangauthor=S.+Pantelauthor=R.+Sakaiauthor=J.+Watsonauthor=N.+Kaplanauthor=J.+D.+Campbellauthor=S.+Singhauthor=D.+E.+Rootauthor=R.+Narayanauthor=T.+Natoliauthor=D.+L.+Lahrauthor=I.+Tiroshauthor=P.+Tamayoauthor=G.+Getzauthor=B.+Wongauthor=J.+Doenchauthor=A.+Subramanianauthor=T.+R.+Golubauthor=M.+Meyersonauthor=J.+S.+Boehm&title=High-Throughput+Phenotyping+of+Lung+Cancer+Somatic+Mutations&doi=10.1016%2Fj.ccell.2016.06.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput Phenotyping of Lung Cancer Somatic Mutations</span></div><div class="casAuthors">Berger, Alice H.; Brooks, Angela N.; Wu, Xiaoyun; Shrestha, Yashaswi; Chouinard, Candace; Piccioni, Federica; Bagul, Mukta; Kamburov, Atanas; Imielinski, Marcin; Hogstrom, Larson; Zhu, Cong; Yang, Xiaoping; Pantel, Sasha; Sakai, Ryo; Watson, Jacqueline; Kaplan, Nathan; Campbell, Joshua D.; Singh, Shantanu; Root, David E.; Narayan, Rajiv; Natoli, Ted; Lahr, David L.; Tirosh, Itay; Tamayo, Pablo; Getz, Gad; Wong, Bang; Doench, John; Subramanian, Aravind; Golub, Todd R.; Meyerson, Matthew; Boehm, Jesse S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">214-228</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Recent genome sequencing efforts have identified millions of somatic mutations in cancer.  However, the functional impact of most variants is poorly understood.  Here we characterize 194 somatic mutations identified in primary lung adenocarcinomas.  We present an expression-based variant-impact phenotyping (eVIP) method that uses gene expression changes to distinguish impactful from neutral somatic mutations. eVIP identified 69% of mutations analyzed as impactful and 31% as functionally neutral.  A subset of the impactful mutations induces xenograft tumor formation in mice and/or confers resistance to cellular EGFR inhibition.  Among these impactful variants are rare somatic, clin. actionable variants including EGFR S645C, ARAF S214C and S214F, ERBB2 S418T, and multiple BRAF variants, demonstrating that rare mutations can be functionally important in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUjVXd62zmq7Vg90H21EOLACvtfcHk0lj3acnm4LGOeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1KlsbvE&md5=63a79c06f1fdf148a0689231b9aab3ed</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2016.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2016.06.022%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DA.%2BH.%26aulast%3DBrooks%26aufirst%3DA.%2BN.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DShrestha%26aufirst%3DY.%26aulast%3DChouinard%26aufirst%3DC.%26aulast%3DPiccioni%26aufirst%3DF.%26aulast%3DBagul%26aufirst%3DM.%26aulast%3DKamburov%26aufirst%3DA.%26aulast%3DImielinski%26aufirst%3DM.%26aulast%3DHogstrom%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DPantel%26aufirst%3DS.%26aulast%3DSakai%26aufirst%3DR.%26aulast%3DWatson%26aufirst%3DJ.%26aulast%3DKaplan%26aufirst%3DN.%26aulast%3DCampbell%26aufirst%3DJ.%2BD.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DNarayan%26aufirst%3DR.%26aulast%3DNatoli%26aufirst%3DT.%26aulast%3DLahr%26aufirst%3DD.%2BL.%26aulast%3DTirosh%26aufirst%3DI.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DDoench%26aufirst%3DJ.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26atitle%3DHigh-Throughput%2520Phenotyping%2520of%2520Lung%2520Cancer%2520Somatic%2520Mutations%26jtitle%3DCancer%2520Cell%26date%3D2016%26volume%3D30%26spage%3D214%26epage%3D228%26doi%3D10.1016%2Fj.ccell.2016.06.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collisson, E. A.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Comprehensive Molecular Profiling of Lung Adenocarcinoma</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>511</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1038/nature13385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fnature13385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=25079552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ChurnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2014&pages=543-550&author=E.+A.+Collisson&title=Comprehensive+Molecular+Profiling+of+Lung+Adenocarcinoma&doi=10.1038%2Fnature13385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive molecular profiling of lung adenocarcinoma</span></div><div class="casAuthors">Collisson, Eric A.; Campbell, Joshua D.; Brooks, Angela N.; Berger, Alice H.; Lee, William; Chmielecki, Juliann; Beer, David G.; Cope, Leslie; Creighton, Chad J.; Danilova, Ludmila; Ding, Li; Getz, Gad; Hammerman, Peter S.; Hayes, D. Neil; Hernandez, Bryan; Herman, James G.; Heymach, John V.; Jurisica, Igor; Kucherlapati, Raju; Kwiatkowski, David; Ladanyi, Marc; Robertson, Gordon; Schultz, Nikolaus; Shen, Ronglai; Sinha, Rileen; Sougnez, Carrie; Tsao, Ming-Sound; Travis, William D.; Weinstein, John N.; Wigle, Dennis A.; Wilkerson, Matthew D.; Chu, Andy; Cherniack, Andrew D.; Hadjipanayis, Angela; Rosenberg, Mara; Weisenberger, Daniel J.; Laird, Peter W.; Radenbaugh, Amie; Ma, Singer; Stuart, Joshua M.; Byers, Lauren Averett; Baylin, Stephen B.; Govindan, Ramaswamy; Gabriel, Stacey B.; Cibulskis, Kristian; Kim, Jaegil; Stewart, Chip; Lichtenstein, Lee; Lander, Eric S.; Lawrence, Michael S.; Kandoth, Cyriac; Fulton, Robert; Fulton, Lucinda L.; McLellan, Michael D.; Wilson, Richard K.; Ye, Kai; Fronick, Catrina C.; Maher, Christopher A.; Miller, Christopher A.; Wendl, Michael C.; Cabanski, Christopher; Ding, Li; Mardis, Elaine; Wheeler, David; Balasundaram, Miruna; Butterfield, Yaron S. N.; Carlsen, Rebecca; Chuah, Eric; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Schein, Jacqueline E.; Sipahimalani, Payal; Tam, Angela; Varhol, Richard; Robertson, A. Gordon; Wye, Natasja; Thiessen, Nina; Holt, Robert A.; Jones, Steven J. M.; Marra, Marco A.; Imielinski, Marcin; Onofrio, Robert C.; Hodis, Eran; Zack, Travis; Helman, Elena; Sekhar Pedamallu, Chandra; Mesirov, Jill; Saksena, Gordon; Schumacher, Steven E.; Carter, Scott L.; Garraway, Levi; Beroukhim, Rameen; Lee, Semin; Mahadeshwar, Harshad S.; Pantazi, Angeliki; Protopopov, Alexei; Ren, Xiaojia; Seth, Sahil; Song, Xingzhi; Tang, Jiabin; Yang, Lixing; Zhang, Jianhua; Chen, Peng-Chieh; Parfenov, Michael; Xu, Andrew Wei; Santoso, Netty; Chin, Lynda; Park, Peter J.; Hoadley, Katherine A.; Todd Auman, J.; Meng, Shaowu; Shi, Yan; Buda, Elizabeth; Waring, Scot; Veluvolu, Umadevi; Tan, Donghui; Mieczkowski, Piotr A.; Jones, Corbin D.; Simons, Janae V.; Soloway, Matthew G.; Bodenheimer, Tom; Jefferys, Stuart R.; Roach, Jeffrey; Hoyle, Alan P.; Wu, Junyuan; Balu, Saianand; Singh, Darshan; Prins, Jan F.; Marron, J. S.; Parker, Joel S.; Hayes, D. Neil; Perou, Charles M.; Liu, Jinze; Maglinte, Dennis T.; Lai, Philip H.; Bootwalla, Moiz S.; Van Den Berg, David J.; Triche, Timothy, Jr.; Cho, Juok; Di Cara, Daniel; Heiman, David; Lin, Pei; Mallard, William; Voet, Douglas; Zhang, Hailei; Zou, Lihua; Noble, Michael S.; Gehlenborg, Nils; Thorvaldsdottir, Helga; Nazaire, Marc-Danie; Robinson, Jim; Arman Aksoy, B.; Ciriello, Giovanni; Taylor, Barry S.; Dresdner, Gideon; Gao, Jianjiong; Gross, Benjamin; Seshan, Venkatraman E.; Reva, Boris; Sinha, Rileen; Onur Sumer, S.; Weinhold, Nils; Schultz, Nikolaus; Sander, Chris; Ng, Sam; Zhu, Jingchun; Benz, Christopher C.; Yau, Christina; Haussler, David; Spellman, Paul T.; Kimes, Patrick K.; Broom, Bradley M.; Wang, Jing; Lu, Yiling; Ng, Patrick Kwok Shing; Diao, Lixia; Liu, Wenbin; Amos, Christopher I.; Akbani, Rehan; Mills, Gordon B.; Curley, Erin; Paulauskis, Joseph; Lau, Kevin; Morris, Scott; Shelton, Troy; Mallery, David; Gardner, Johanna; Penny, Robert; Saller, Charles; Tarvin, Katherine; Richards, William G.; Cerfolio, Robert; Bryant, Ayesha; Raymond, Daniel P.; Pennell, Nathan A.; Farver, Carol; Czerwinski, Christine; Huelsenbeck-Dill, Lori; Iacocca, Mary; Petrelli, Nicholas; Rabeno, Brenda; Brown, Jennifer; Bauer, Thomas; Dolzhanskiy, Oleg; Potapova, Olga; Rotin, Daniil; Voronina, Olga; Nemirovich-Danchenko, Elena; Fedosenko, Konstantin V.; Gal, Anthony; Behera, Madhusmita; Ramalingam, Suresh S.; Sica, Gabriel; Flieder, Douglas; Boyd, Jeff; Weaver, JoEllen; Kohl, Bernard; Thinh, Dang Huy Quoc; Sandusky, George; Juhl, Hartmut; Duhig, Edwina; Illei, Peter; Gabrielson, Edward; Shin, James; Lee, Beverly; Rodgers, Kristen; Trusty, Dante; Brock, Malcolm V.; Williamson, Christina; Burks, Eric; Rieger-Christ, Kimberly; Holway, Antonia; Sullivan, Travis; Asiedu, Michael K.; Kosari, Farhad; Rekhtman, Natasha; Zakowski, Maureen; Rusch, Valerie W.; Zippile, Paul; Suh, James; Pass, Harvey; Goparaju, Chandra; Owusu-Sarpong, Yvonne; Bartlett, John M. S.; Kodeeswaran, Sugy; Parfitt, Jeremy; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">7511</span>),
    <span class="NLM_cas:pages">543-550</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adenocarcinoma of the lung is the leading cause of cancer death worldwide.  Here we report mol. profiling of 230 resected lung adenocarcinomas using mRNA, microRNA and DNA sequencing integrated with copy no., methylation and proteomic analyses.  High rates of somatic mutation were seen (mean 8.9 mutations per megabase).  Eighteen genes were statistically significantly mutated, including RIT1 activating mutations and newly described loss-of-function MGA mutations which are mutually exclusive with focal MYC amplification.  EGFR mutations were more frequent in female patients, whereas mutations in RBM10 were more common in males.  Aberrations in NF1, MET, ERBB2 and RIT1 occurred in 13% of cases and were enriched in samples otherwise lacking an activated oncogene, suggesting a driver role for these events in certain tumors.  DNA and mRNA sequence from the same tumor highlighted splicing alterations driven by somatic genomic changes, including exon 14 skipping in MET mRNA in 4% of cases.  MAPK and PI(3)K pathway activity, when measured at the protein level, was explained by known mutations in only a fraction of cases, suggesting addnl., unexplained mechanisms of pathway activation.  These data establish a foundation for classification and further investigations of lung adenocarcinoma mol. pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsQbellbPHqLVg90H21EOLACvtfcHk0lj3acnm4LGOeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ChurnI&md5=526fbb4b17b3d774e0de80680eee2539</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1038%2Fnature13385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13385%26sid%3Dliteratum%253Aachs%26aulast%3DCollisson%26aufirst%3DE.%2BA.%26atitle%3DComprehensive%2520Molecular%2520Profiling%2520of%2520Lung%2520Adenocarcinoma%26jtitle%3DNature%26date%3D2014%26volume%3D511%26spage%3D543%26epage%3D550%26doi%3D10.1038%2Fnature13385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokubu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odogawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirohashi, S.</span></span> <span> </span><span class="NLM_article-title">Cancer Related Mutations in Nrf2 Impair Its Recognition by Keap1-Cul3 E3 Ligase and Promote Malignancy</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">13568</span>– <span class="NLM_lpage">13573</span>, <span class="refDoi"> DOI: 10.1073/pnas.0806268105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1073%2Fpnas.0806268105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=13568-13573&author=T.+Shibataauthor=T.+Ohtaauthor=K.+I.+Tongauthor=A.+Kokubuauthor=R.+Odogawaauthor=K.+Tsutaauthor=H.+Asamuraauthor=M.+Yamamotoauthor=S.+Hirohashi&title=Cancer+Related+Mutations+in+Nrf2+Impair+Its+Recognition+by+Keap1-Cul3+E3+Ligase+and+Promote+Malignancy&doi=10.1073%2Fpnas.0806268105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0806268105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0806268105%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DKokubu%26aufirst%3DA.%26aulast%3DOdogawa%26aufirst%3DR.%26aulast%3DTsuta%26aufirst%3DK.%26aulast%3DAsamura%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHirohashi%26aufirst%3DS.%26atitle%3DCancer%2520Related%2520Mutations%2520in%2520Nrf2%2520Impair%2520Its%2520Recognition%2520by%2520Keap1-Cul3%2520E3%2520Ligase%2520and%2520Promote%2520Malignancy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D13568%26epage%3D13573%26doi%3D10.1073%2Fpnas.0806268105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokheim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta-Pardo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weerasinghe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colaprico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendl, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reardon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mularoni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubio-Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagarajan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes-Ciriano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yellapantula, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamborero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suphavilai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khurana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Allen, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Group, M. C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cancer Genome Atlas Research, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godzik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Bigas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazar, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karchin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span> <span> </span><span class="NLM_article-title">Comprehensive Characterization of Cancer Driver Genes and Mutations</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.02.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.cell.2018.02.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29625053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntFaiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2018&pages=371-385&author=M.+H.+Baileyauthor=C.+Tokheimauthor=E.+Porta-Pardoauthor=S.+Senguptaauthor=D.+Bertrandauthor=A.+Weerasingheauthor=A.+Colapricoauthor=M.+C.+Wendlauthor=J.+Kimauthor=B.+Reardonauthor=P.+K.+Ngauthor=K.+J.+Jeongauthor=S.+Caoauthor=Z.+Wangauthor=J.+Gaoauthor=Q.+Gaoauthor=F.+Wangauthor=E.+M.+Liuauthor=L.+Mularoniauthor=C.+Rubio-Perezauthor=N.+Nagarajanauthor=I.+Cortes-Cirianoauthor=D.+C.+Zhouauthor=W.+W.+Liangauthor=J.+M.+Hessauthor=V.+D.+Yellapantulaauthor=D.+Tamboreroauthor=A.+Gonzalez-Perezauthor=C.+Suphavilaiauthor=J.+Y.+Koauthor=E.+Khuranaauthor=P.+J.+Parkauthor=E.+M.+Van+Allenauthor=H.+Liangauthor=M.+C.+W.+Groupauthor=N.+Cancer+Genome+Atlas+Researchauthor=M.+S.+Lawrenceauthor=A.+Godzikauthor=N.+Lopez-Bigasauthor=J.+Stuartauthor=D.+Wheelerauthor=G.+Getzauthor=K.+Chenauthor=A.+J.+Lazarauthor=G.+B.+Millsauthor=R.+Karchinauthor=L.+Ding&title=Comprehensive+Characterization+of+Cancer+Driver+Genes+and+Mutations&doi=10.1016%2Fj.cell.2018.02.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive Characterization of Cancer Driver Genes and Mutations</span></div><div class="casAuthors">Bailey, Matthew H.; Tokheim, Collin; Porta-Pardo, Eduard; Sengupta, Sohini; Bertrand, Denis; Weerasinghe, Amila; Colaprico, Antonio; Wendl, Michael C.; Kim, Jaegil; Reardon, Brendan; Ng, Patrick Kwok-Shing; Jeong, Kang Jin; Cao, Song; Wang, Zixing; Gao, Jianjiong; Gao, Qingsong; Wang, Fang; Liu, Eric Minwei; Mularoni, Loris; Rubio-Perez, Carlota; Nagarajan, Niranjan; Cortes-Ciriano, Isidro; Zhou, Daniel Cui; Liang, Wen-Wei; Hess, Julian M.; Yellapantula, Venkata D.; Tamborero, David; Gonzalez-Perez, Abel; Suphavilai, Chayaporn; Ko, Jia Yu; Khurana, Ekta; Park, Peter J.; Van Allen, Eliezer M.; Liang, Han; Lawrence, Michael S.; Godzik, Adam; Lopez-Bigas, Nuria; Stuart, Josh; Wheeler, David; Getz, Gad; Chen, Ken; Lazar, Alexander J.; Mills, Gordon B.; Karchin, Rachel; Ding, Li</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">371-385.e18</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Identifying mol. cancer drivers is crit. for precision oncol.  Multiple advanced algorithms to identify drivers now exist, but systematic attempts to combine and optimize them on large datasets are few.  We report a PanCancer and PanSoftware anal. spanning 9,423 tumor exomes (comprising all 33 of The Cancer Genome Atlas projects) and using 26 computational tools to catalog driver genes and mutations.  We identify 299 driver genes with implications regarding their anatomical sites and cancer/cell types.  Sequence- and structure-based analyses identified >3,400 putative missense driver mutations supported by multiple lines of evidence.  Exptl. validation confirmed 60%-85% of predicted mutations as likely drivers.  We found that >300 MSI tumors are assocd. with high PD-1/PD-L1, and 57% of tumors analyzed harbor putative clin. actionable events.  Our study represents the most comprehensive discovery of cancer genes and mutations to date and will serve as a blueprint for future biol. and clin. endeavors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonwISc8tVS-LVg90H21EOLACvtfcHk0lhPbvhtapn72g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntFaiu7c%253D&md5=6478ef37b82611e5687dcdc102cc6e98</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.02.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.02.060%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DM.%2BH.%26aulast%3DTokheim%26aufirst%3DC.%26aulast%3DPorta-Pardo%26aufirst%3DE.%26aulast%3DSengupta%26aufirst%3DS.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DWeerasinghe%26aufirst%3DA.%26aulast%3DColaprico%26aufirst%3DA.%26aulast%3DWendl%26aufirst%3DM.%2BC.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DReardon%26aufirst%3DB.%26aulast%3DNg%26aufirst%3DP.%2BK.%26aulast%3DJeong%26aufirst%3DK.%2BJ.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DE.%2BM.%26aulast%3DMularoni%26aufirst%3DL.%26aulast%3DRubio-Perez%26aufirst%3DC.%26aulast%3DNagarajan%26aufirst%3DN.%26aulast%3DCortes-Ciriano%26aufirst%3DI.%26aulast%3DZhou%26aufirst%3DD.%2BC.%26aulast%3DLiang%26aufirst%3DW.%2BW.%26aulast%3DHess%26aufirst%3DJ.%2BM.%26aulast%3DYellapantula%26aufirst%3DV.%2BD.%26aulast%3DTamborero%26aufirst%3DD.%26aulast%3DGonzalez-Perez%26aufirst%3DA.%26aulast%3DSuphavilai%26aufirst%3DC.%26aulast%3DKo%26aufirst%3DJ.%2BY.%26aulast%3DKhurana%26aufirst%3DE.%26aulast%3DPark%26aufirst%3DP.%2BJ.%26aulast%3DVan%2BAllen%26aufirst%3DE.%2BM.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DGroup%26aufirst%3DM.%2BC.%2BW.%26aulast%3DCancer%2BGenome%2BAtlas%2BResearch%26aufirst%3DN.%26aulast%3DLawrence%26aufirst%3DM.%2BS.%26aulast%3DGodzik%26aufirst%3DA.%26aulast%3DLopez-Bigas%26aufirst%3DN.%26aulast%3DStuart%26aufirst%3DJ.%26aulast%3DWheeler%26aufirst%3DD.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DLazar%26aufirst%3DA.%2BJ.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DKarchin%26aufirst%3DR.%26aulast%3DDing%26aufirst%3DL.%26atitle%3DComprehensive%2520Characterization%2520of%2520Cancer%2520Driver%2520Genes%2520and%2520Mutations%26jtitle%3DCell%26date%3D2018%26volume%3D173%26spage%3D371%26epage%3D385%26doi%3D10.1016%2Fj.cell.2018.02.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guichard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaddeo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbeaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladeiro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maad, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderaro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bioulac-Sage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letexier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurent, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couchy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letouze, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucman-Rossi, J.</span></span> <span> </span><span class="NLM_article-title">Integrated Analysis of Somatic Mutations and Focal Copy-Number Changes Identifies Key Genes and Pathways in Hepatocellular Carcinoma</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">694</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1038/ng.2256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fng.2256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22561517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFyjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=694-698&author=C.+Guichardauthor=G.+Amaddeoauthor=S.+Imbeaudauthor=Y.+Ladeiroauthor=L.+Pelletierauthor=I.+B.+Maadauthor=J.+Calderaroauthor=P.+Bioulac-Sageauthor=M.+Letexierauthor=F.+Degosauthor=B.+Clementauthor=C.+Balabaudauthor=E.+Chevetauthor=A.+Laurentauthor=G.+Couchyauthor=E.+Letouzeauthor=F.+Calvoauthor=J.+Zucman-Rossi&title=Integrated+Analysis+of+Somatic+Mutations+and+Focal+Copy-Number+Changes+Identifies+Key+Genes+and+Pathways+in+Hepatocellular+Carcinoma&doi=10.1038%2Fng.2256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma</span></div><div class="casAuthors">Guichard, Cecile; Amaddeo, Giuliana; Imbeaud, Sandrine; Ladeiro, Yannick; Pelletier, Laura; Ben Maad, Ichrafe; Calderaro, Julien; Bioulac-Sage, Paulette; Letexier, Melanie; Degos, Francoise; Clement, Bruno; Balabaud, Charles; Chevet, Eric; Laurent, Alexis; Couchy, Gabrielle; Letouze, Eric; Calvo, Fabien; Zucman-Rossi, Jessica</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">694-698</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is the most common primary liver malignancy.  Here, we performed high-resoln. copy-no. anal. on 125 HCC tumors and whole-exome sequencing on 24 of these tumors.  We identified 135 homozygous deletions and 994 somatic mutations of genes with predicted functional consequences.  We found new recurrent alterations in four genes (ARID1A, RPS6KA3, NFE2L2 and IRF2) not previously described in HCC.  Functional analyses showed tumor suppressor properties for IRF2, whose inactivation, exclusively found in hepatitis B virus (HBV)-related tumors, led to impaired TP53 function.  In contrast, inactivation of chromatin remodelers was frequent and predominant in alc.-related tumors.  Moreover, assocn. of mutations in specific genes (RPS6KA3-AXIN1 and NFE2L2-CTNNB1) suggested that Wnt/β-catenin signaling might cooperate in liver carcinogenesis with both oxidative stress metab. and Ras/mitogen-activated protein kinase (MAPK) pathways.  This study provides insight into the somatic mutational landscape in HCC and identifies interactions between mutations in oncogene and tumor suppressor gene mutations related to specific risk factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohIa_qTsarp7Vg90H21EOLACvtfcHk0lhPbvhtapn72g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFyjtr0%253D&md5=e7ee98e34422b13c1a3bf0f4f366454f</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fng.2256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2256%26sid%3Dliteratum%253Aachs%26aulast%3DGuichard%26aufirst%3DC.%26aulast%3DAmaddeo%26aufirst%3DG.%26aulast%3DImbeaud%26aufirst%3DS.%26aulast%3DLadeiro%26aufirst%3DY.%26aulast%3DPelletier%26aufirst%3DL.%26aulast%3DMaad%26aufirst%3DI.%2BB.%26aulast%3DCalderaro%26aufirst%3DJ.%26aulast%3DBioulac-Sage%26aufirst%3DP.%26aulast%3DLetexier%26aufirst%3DM.%26aulast%3DDegos%26aufirst%3DF.%26aulast%3DClement%26aufirst%3DB.%26aulast%3DBalabaud%26aufirst%3DC.%26aulast%3DChevet%26aufirst%3DE.%26aulast%3DLaurent%26aufirst%3DA.%26aulast%3DCouchy%26aufirst%3DG.%26aulast%3DLetouze%26aufirst%3DE.%26aulast%3DCalvo%26aufirst%3DF.%26aulast%3DZucman-Rossi%26aufirst%3DJ.%26atitle%3DIntegrated%2520Analysis%2520of%2520Somatic%2520Mutations%2520and%2520Focal%2520Copy-Number%2520Changes%2520Identifies%2520Key%2520Genes%2520and%2520Pathways%2520in%2520Hepatocellular%2520Carcinoma%26jtitle%3DNat.%2520Genet.%26date%3D2012%26volume%3D44%26spage%3D694%26epage%3D698%26doi%3D10.1038%2Fng.2256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, H. K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surh, Y. J.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Mutagenic Activation Drives Hepatocarcinogenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">4797</span>– <span class="NLM_lpage">4808</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-3538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1158%2F0008-5472.CAN-16-3538" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=4797-4808&author=H.+K.+C.+Ngoauthor=D.+H.+Kimauthor=Y.+N.+Chaauthor=H.+K.+Naauthor=Y.+J.+Surh&title=Nrf2+Mutagenic+Activation+Drives+Hepatocarcinogenesis&doi=10.1158%2F0008-5472.CAN-16-3538"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-3538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-3538%26sid%3Dliteratum%253Aachs%26aulast%3DNgo%26aufirst%3DH.%2BK.%2BC.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DCha%26aufirst%3DY.%2BN.%26aulast%3DNa%26aufirst%3DH.%2BK.%26aulast%3DSurh%26aufirst%3DY.%2BJ.%26atitle%3DNrf2%2520Mutagenic%2520Activation%2520Drives%2520Hepatocarcinogenesis%26jtitle%3DCancer%2520Res.%26date%3D2017%26volume%3D77%26spage%3D4797%26epage%3D4808%26doi%3D10.1158%2F0008-5472.CAN-16-3538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zavattari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menegon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angioni, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Follenzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quagliata, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledda-Columbano, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracciano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Columbano, A.</span></span> <span> </span><span class="NLM_article-title">Nrf2, but Not Β-Catenin, Mutation Represents an Early Event in Rat Hepatocarcinogenesis</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">851</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1002/hep.27790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1002%2Fhep.27790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=25783764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVSnt7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2015&pages=851-862&author=P.+Zavattariauthor=A.+Perraauthor=S.+Menegonauthor=M.+A.+Kowalikauthor=A.+Petrelliauthor=M.+M.+Angioniauthor=A.+Follenziauthor=L.+Quagliataauthor=G.+M.+Ledda-Columbanoauthor=L.+Terraccianoauthor=S.+Giordanoauthor=A.+Columbano&title=Nrf2%2C+but+Not+%CE%92-Catenin%2C+Mutation+Represents+an+Early+Event+in+Rat+Hepatocarcinogenesis&doi=10.1002%2Fhep.27790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis</span></div><div class="casAuthors">Zavattari, Patrizia; Perra, Andrea; Menegon, Silvia; Kowalik, Marta Anna; Petrelli, Annalisa; Angioni, Maria Maddalena; Follenzi, Antonia; Quagliata, Luca; Ledda-Columbano, Giovanna Maria; Terracciano, Luigi; Giordano, Silvia; Columbano, Amedeo</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">851-862</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) develops through a multistage process, but the nature of the mol. changes assocd. with the different steps, the very early ones in particular, is largely unknown.  Recently, dysregulation of the NRF2/KEAP1 pathway and mutations of these genes have been obsd. in exptl. and human tumors, suggesting their possible role in cancer development.  To assess whether Nrf2/Keap1 mutations are early or late events in HCC development, we investigated their frequency in the rat Resistant Hepatocyte model, consisting of the administration of diethylnitrosamine followed by a brief exposure to 2-acetylaminofluorene.  This model enables the dissection of all stages of hepatocarcinogenesis.  We found that Nrf2/Keap1 mutations were present in 71% of early preneoplastic lesions and in 78.6% and 59.3% of early and advanced HCCs, resp.  Mutations of Nrf2 were more frequent, missense, and located in the Nrf2-Keap1 binding region.  Mutations of Keap1 occurred at a much lower frequency in both preneoplastic lesions and HCCs and were mutually exclusive with those of Nrf2.  Functional in vitro and in vivo studies showed that Nrf2 silencing inhibited the ability of tumorigenic rat cells to grow in soft agar and to form tumors.  Unlike Nrf2 mutations, those of Ctnnb1, which are frequent in human HCC, were a later event as they appeared only in fully advanced HCCs (18.5%).  Conclusion: In the Resistant Hepatocyte model of hepatocarcinogenesis the onset of Nrf2 mutations is a very early event, likely essential for the clonal expansion of preneoplastic hepatocytes to HCC, while Ctnnb1 mutations occur only at very late stages.  Moreover, functional expts. demonstrate that Nrf2 is an oncogene crit. for HCC progression and development. (Hepatol. 2015;62:851-862).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTBJPljMvk87Vg90H21EOLACvtfcHk0lhwz4TcEjSM1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVSnt7vN&md5=c51c7106071edc2e48fd4a208d4d8c64</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fhep.27790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.27790%26sid%3Dliteratum%253Aachs%26aulast%3DZavattari%26aufirst%3DP.%26aulast%3DPerra%26aufirst%3DA.%26aulast%3DMenegon%26aufirst%3DS.%26aulast%3DKowalik%26aufirst%3DM.%2BA.%26aulast%3DPetrelli%26aufirst%3DA.%26aulast%3DAngioni%26aufirst%3DM.%2BM.%26aulast%3DFollenzi%26aufirst%3DA.%26aulast%3DQuagliata%26aufirst%3DL.%26aulast%3DLedda-Columbano%26aufirst%3DG.%2BM.%26aulast%3DTerracciano%26aufirst%3DL.%26aulast%3DGiordano%26aufirst%3DS.%26aulast%3DColumbano%26aufirst%3DA.%26atitle%3DNrf2%252C%2520but%2520Not%2520%25CE%2592-Catenin%252C%2520Mutation%2520Represents%2520an%2520Early%2520Event%2520in%2520Rat%2520Hepatocarcinogenesis%26jtitle%3DHepatology%26date%3D2015%26volume%3D62%26spage%3D851%26epage%3D862%26doi%3D10.1002%2Fhep.27790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikor, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thu, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubaux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, W. L.</span></span> <span> </span><span class="NLM_article-title">Frequent Concerted Genetic Mechanisms Disrupt Multiple Components of the Nrf2 Inhibitor Keap1/Cul3/Rbx1 E3-Ubiquitin Ligase Complex in Thyroid Cancer</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">124</span>, <span class="refDoi"> DOI: 10.1186/1476-4598-12-124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1186%2F1476-4598-12-124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24138990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVGgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=124&author=V.+D.+Martinezauthor=E.+A.+Vucicauthor=L.+A.+Pikorauthor=K.+L.+Thuauthor=R.+Hubauxauthor=W.+L.+Lam&title=Frequent+Concerted+Genetic+Mechanisms+Disrupt+Multiple+Components+of+the+Nrf2+Inhibitor+Keap1%2FCul3%2FRbx1+E3-Ubiquitin+Ligase+Complex+in+Thyroid+Cancer&doi=10.1186%2F1476-4598-12-124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer</span></div><div class="casAuthors">Martinez, Victor D.; Vucic, Emily A.; Pikor, Larissa A.; Thu, Kelsie L.; Hubaux, Roland; Lam, Wan L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">124/1-124/6</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Reactive oxygen species contribute to normal thyroid function.  The NRF2 oxidative response pathway is frequently and constitutively activated in multiple tumor types, including papillary thyroid carcinoma (PTC).  Genetic mechanisms underlying NRF2 pathway activation in PTC are not fully understood.  Thus, we aimed to det. whether inactivating patterns of DNA-level alterations affect genes encoding for individual NRF2 inhibitor complex components (CUL3/KEAP1/RBX1) occur in PTC.  Findings: Combined patterns of epi/genetic alterations for KEAP1/CUL3/RBX1 E3 ubiquitin-ligase complex components were simultaneously interrogated for a panel of 310 PTC cases and 40 adjacent non-malignant tissues.  Data were obtained from The Cancer Genome Atlas project.  Enrichment of NRF2 pathway activation was assessed by gene-set enrichment anal. using transcriptome data.  Our analyses revealed that PTC sustain a strikingly high frequency (80.6%) of disruption to multiple component genes of the NRF2 inhibitor complex.  Hypermethylation is the predominant inactivating mechanism primarily affecting KEAP1 (70.6%) and CUL3 (20%), while copy no. loss mostly affects RBX1 (16.8%).  Concordantly, NRF2-assocd. gene expression signatures are pos. and significantly enriched in PTC.  Conclusions: The KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex is almost ubiquitously affected by multiple DNA-level mechanisms and downstream NRF2 pathway targets are activated in PTC.  Given the importance of this pathway to normal thyroid function as well as to cancer; targeted inhibition of NRF2 regulators may impact strategies for therapeutic intervention involving this pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWzoZ4Y6-_X7Vg90H21EOLACvtfcHk0lhwz4TcEjSM1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVGgs7k%253D&md5=b153b49ee58416bf7af63fc5031f0f8b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-12-124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-12-124%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DV.%2BD.%26aulast%3DVucic%26aufirst%3DE.%2BA.%26aulast%3DPikor%26aufirst%3DL.%2BA.%26aulast%3DThu%26aufirst%3DK.%2BL.%26aulast%3DHubaux%26aufirst%3DR.%26aulast%3DLam%26aufirst%3DW.%2BL.%26atitle%3DFrequent%2520Concerted%2520Genetic%2520Mechanisms%2520Disrupt%2520Multiple%2520Components%2520of%2520the%2520Nrf2%2520Inhibitor%2520Keap1%252FCul3%252FRbx1%2520E3-Ubiquitin%2520Ligase%2520Complex%2520in%2520Thyroid%2520Cancer%26jtitle%3DMol.%2520Cancer%26date%3D2013%26volume%3D12%26spage%3D124%26doi%3D10.1186%2F1476-4598-12-124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arbour, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dienstag, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Vega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lito, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solit, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellmann, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kris, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcila, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladanyi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riely, G. J.</span></span> <span> </span><span class="NLM_article-title">Effects of Co-Occurring Genomic Alterations on Outcomes in Patients with Kras-Mutant Non-Small Cell Lung Cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">334</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-17-1841</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1158%2F1078-0432.CCR-17-1841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29089357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXoslGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=334-340&author=K.+C.+Arbourauthor=E.+J.+Jordanauthor=H.+R.+Kimauthor=J.+Dienstagauthor=H.+Yuauthor=F.+Sanchez-Vegaauthor=P.+Litoauthor=M.+F.+Bergerauthor=D.+B.+Solitauthor=M.+D.+Hellmannauthor=M.+G.+Krisauthor=C.+M.+Rudinauthor=A.+Niauthor=M.+E.+Arcilaauthor=M.+Ladanyiauthor=G.+J.+Riely&title=Effects+of+Co-Occurring+Genomic+Alterations+on+Outcomes+in+Patients+with+Kras-Mutant+Non-Small+Cell+Lung+Cancer&doi=10.1158%2F1078-0432.CCR-17-1841"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer</span></div><div class="casAuthors">Arbour, Kathryn C.; Jordan, Emmett; Kim, Hyunjae Ryan; Dienstag, Jordan; Yu, Helena A.; Sanchez-Vega, Francisco; Lito, Piro; Berger, Michael; Solit, David B.; Hellmann, Matthew; Kris, Mark G.; Rudin, Charles M.; Ni, Ai; Arcila, Maria; Ladanyi, Marc; Riely, Gregory J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">334-340</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: KRAS mutations occur in approx. 25% of patients with non-small cell lung cancer (NSCLC).  Despite the uniform presence of KRAS mutations, patients with KRAS-mutant NSCLC can have a heterogeneous clin. course.  As the pattern of co-occurring mutations may describe different biol. subsets of patients with KRAS-mutant lung adenocarcinoma, we explored the effects of co-occurring mutations on patient outcomes and response to therapy.  Exptl. Design: We identified patients with advanced KRAS-mutant NSCLC and evaluated the most common co-occurring genomic alterations.  Multivariate analyses were performed incorporating the most frequent co-mutations and clin. characteristics to evaluate assocn. with overall survival as well as response to platinum-pemetrexed chemotherapy and immune checkpoint inhibitors.  Results: Among 330 patients with advanced KRAS-mutant lung cancers, the most frequent co-mutations were found in TP53 (42%), STK11 (29%), and KEAP1/NFE2L2 (27%).  In a multivariate anal., there was a significantly shorter survival in patients with co-mutations in KEAP1/NFE2L2 [HR, 1.96; 95% confidence interval (CI), 1.33-2.92; P ≤ 0.001].  STK11 (HR, 1.3; P = 0.22) and TP53 (HR 1.11, P = 0.58) co-mutation statuses were not assocd. with survival.  Co-mutation in KEAP1/NFE2L2 was also assocd. with shorter duration of initial chemotherapy (HR, 1.64; 95% CI, 1.04-2.59; P = 0.03) and shorter overall survival from initiation of immune therapy (HR, 3.54; 95% CI, 1.55-8.11; P = 0.003).  Conclusions: Among people with KRAS-mutant advanced NSCLC, TP53, STK11, and KEAP1/NFE2L2 are the most commonly co-occurring somatic genomic alterations.  Co-mutation of KRAS and KEAP1/ NFE2L2 is an independent prognostic factor, predicting shorter survival, duration of response to initial platinum-based chemotherapy, and survival from the start of immune therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQMLK6BVfWxrVg90H21EOLACvtfcHk0lhbRw-46CKOmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXoslGhtQ%253D%253D&md5=8261b7881085bda276b4d73920392eab</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-17-1841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-17-1841%26sid%3Dliteratum%253Aachs%26aulast%3DArbour%26aufirst%3DK.%2BC.%26aulast%3DJordan%26aufirst%3DE.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BR.%26aulast%3DDienstag%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DSanchez-Vega%26aufirst%3DF.%26aulast%3DLito%26aufirst%3DP.%26aulast%3DBerger%26aufirst%3DM.%2BF.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DHellmann%26aufirst%3DM.%2BD.%26aulast%3DKris%26aufirst%3DM.%2BG.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DNi%26aufirst%3DA.%26aulast%3DArcila%26aufirst%3DM.%2BE.%26aulast%3DLadanyi%26aufirst%3DM.%26aulast%3DRiely%26aufirst%3DG.%2BJ.%26atitle%3DEffects%2520of%2520Co-Occurring%2520Genomic%2520Alterations%2520on%2520Outcomes%2520in%2520Patients%2520with%2520Kras-Mutant%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2018%26volume%3D24%26spage%3D334%26epage%3D340%26doi%3D10.1158%2F1078-0432.CCR-17-1841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krall, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederst, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruddy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redig, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainor, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doench, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janne, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, R. E.,  Iii</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlabach, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span> <span> </span><span class="NLM_article-title">Keap1 Loss Modulates Sensitivity to Kinase Targeted Therapy in Lung Cancer</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e18970</span> <span class="refDoi"> DOI: 10.7554/eLife.18970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.7554%2FeLife.18970" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&author=E.+B.+Krallauthor=B.+Wangauthor=D.+M.+Munozauthor=N.+Ilicauthor=S.+Raghavanauthor=M.+J.+Niederstauthor=K.+Yuauthor=D.+A.+Ruddyauthor=A.+J.+Aguirreauthor=J.+W.+Kimauthor=A.+J.+Redigauthor=J.+F.+Gainorauthor=J.+A.+Williamsauthor=J.+M.+Asaraauthor=J.+G.+Doenchauthor=P.+A.+Janneauthor=A.+T.+Shawauthor=R.+E.+McDonaldauthor=J.+A.+Engelmanauthor=F.+Stegmeierauthor=M.+R.+Schlabachauthor=W.+C.+Hahn&title=Keap1+Loss+Modulates+Sensitivity+to+Kinase+Targeted+Therapy+in+Lung+Cancer&doi=10.7554%2FeLife.18970"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.7554%2FeLife.18970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.18970%26sid%3Dliteratum%253Aachs%26aulast%3DKrall%26aufirst%3DE.%2BB.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMunoz%26aufirst%3DD.%2BM.%26aulast%3DIlic%26aufirst%3DN.%26aulast%3DRaghavan%26aufirst%3DS.%26aulast%3DNiederst%26aufirst%3DM.%2BJ.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DRuddy%26aufirst%3DD.%2BA.%26aulast%3DAguirre%26aufirst%3DA.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DRedig%26aufirst%3DA.%2BJ.%26aulast%3DGainor%26aufirst%3DJ.%2BF.%26aulast%3DWilliams%26aufirst%3DJ.%2BA.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DDoench%26aufirst%3DJ.%2BG.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DMcDonald%26aufirst%3DR.%2BE.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DSchlabach%26aufirst%3DM.%2BR.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26atitle%3DKeap1%2520Loss%2520Modulates%2520Sensitivity%2520to%2520Kinase%2520Targeted%2520Therapy%2520in%2520Lung%2520Cancer%26jtitle%3DeLife%26date%3D2017%26volume%3D6%26doi%3D10.7554%2FeLife.18970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-Y.</span></span> <span> </span><span class="NLM_article-title">Resistance to Gefitinib and Cross-Resistance to Irreversible Egfr-Tkis Mediated by Disruption of the Keap1-Nrf2 Pathway in Human Lung Cancer Cells</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">5862</span>, <span class="refDoi"> DOI: 10.1096/fj.201800011R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1096%2Ffj.201800011R" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=5862&author=S.-H.+Parkauthor=J.+H.+Kimauthor=E.+Koauthor=J.-Y.+Kimauthor=M.-J.+Parkauthor=M.+J.+Kimauthor=H.+Seoauthor=S.+Liauthor=J.-Y.+Lee&title=Resistance+to+Gefitinib+and+Cross-Resistance+to+Irreversible+Egfr-Tkis+Mediated+by+Disruption+of+the+Keap1-Nrf2+Pathway+in+Human+Lung+Cancer+Cells&doi=10.1096%2Ffj.201800011R"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1096%2Ffj.201800011R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201800011R%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.-H.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKo%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DJ.-Y.%26aulast%3DPark%26aufirst%3DM.-J.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DSeo%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.-Y.%26atitle%3DResistance%2520to%2520Gefitinib%2520and%2520Cross-Resistance%2520to%2520Irreversible%2520Egfr-Tkis%2520Mediated%2520by%2520Disruption%2520of%2520the%2520Keap1-Nrf2%2520Pathway%2520in%2520Human%2520Lung%2520Cancer%2520Cells%26jtitle%3DFASEB%2520J.%26date%3D2018%26volume%3D32%26spage%3D5862%26doi%3D10.1096%2Ffj.201800011R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeNicola, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karreth, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humpton, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopinathan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frese, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calhoun, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scrimieri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span> <span> </span><span class="NLM_article-title">Oncogene-Induced Nrf2 Transcription Promotes Ros Detoxification and Tumorigenesis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>475</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1038/nature10189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fnature10189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21734707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFemtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=106-109&author=G.+M.+DeNicolaauthor=F.+A.+Karrethauthor=T.+J.+Humptonauthor=A.+Gopinathanauthor=C.+Weiauthor=K.+Freseauthor=D.+Mangalauthor=K.+H.+Yuauthor=C.+J.+Yeoauthor=E.+S.+Calhounauthor=F.+Scrimieriauthor=J.+M.+Winterauthor=R.+H.+Hrubanauthor=C.+Iacobuzio-Donahueauthor=S.+E.+Kernauthor=I.+A.+Blairauthor=D.+A.+Tuveson&title=Oncogene-Induced+Nrf2+Transcription+Promotes+Ros+Detoxification+and+Tumorigenesis&doi=10.1038%2Fnature10189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis</span></div><div class="casAuthors">DeNicola, Gina M.; Karreth, Florian A.; Humpton, Timothy J.; Gopinathan, Aarthi; Wei, Cong; Frese, Kristopher; Mangal, Dipti; Yu, Kenneth H.; Yeo, Charles J.; Calhoun, Eric S.; Scrimieri, Francesca; Winter, Jordan M.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.; Blair, Ian A.; Tuveson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7354</span>),
    <span class="NLM_cas:pages">106-109</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) are mutagenic and may thereby promote cancer.  Normally, ROS levels are tightly controlled by an inducible antioxidant program that responds to cellular stressors and is predominantly regulated by the transcription factor Nrf2 (also known as Nfe2l2) and its repressor protein Keap1 (refs. 2-5).  In contrast to the acute physiol. regulation of Nrf2, in neoplasia there is evidence for increased basal activation of Nrf2.  Indeed, somatic mutations that disrupt the Nrf2-Keap1 interaction to stabilize Nrf2 and increase the constitutive transcription of Nrf2 target genes were recently identified, indicating that enhanced ROS detoxification and addnl. Nrf2 functions may in fact be pro-tumorigenic.  Here, we investigated ROS metab. in primary murine cells following the expression of endogenous oncogenic alleles of Kras, Braf and Myc, and found that ROS are actively suppressed by these oncogenes.  K-RasG12D, B-RafV619E and MycERT2 each increased the transcription of Nrf2 to stably elevate the basal Nrf2 antioxidant program and thereby lower intracellular ROS and confer a more reduced intracellular environment.  Oncogene-directed increased expression of Nrf2 is a new mechanism for the activation of the Nrf2 antioxidant program, and is evident in primary cells and tissues of mice expressing K-RasG12D and B-RafV619E, and in human pancreatic cancer.  Furthermore, genetic targeting of the Nrf2 pathway impairs K-RasG12D-induced proliferation and tumorigenesis in vivo.  Thus, the Nrf2 antioxidant and cellular detoxification program represents a previously unappreciated mediator of oncogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFpMbvjw2msLVg90H21EOLACvtfcHk0lhbRw-46CKOmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFemtr0%253D&md5=54d0e0b5940672a96bde0f8cfd9e7ff9</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fnature10189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10189%26sid%3Dliteratum%253Aachs%26aulast%3DDeNicola%26aufirst%3DG.%2BM.%26aulast%3DKarreth%26aufirst%3DF.%2BA.%26aulast%3DHumpton%26aufirst%3DT.%2BJ.%26aulast%3DGopinathan%26aufirst%3DA.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DFrese%26aufirst%3DK.%26aulast%3DMangal%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DK.%2BH.%26aulast%3DYeo%26aufirst%3DC.%2BJ.%26aulast%3DCalhoun%26aufirst%3DE.%2BS.%26aulast%3DScrimieri%26aufirst%3DF.%26aulast%3DWinter%26aufirst%3DJ.%2BM.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%26aulast%3DKern%26aufirst%3DS.%2BE.%26aulast%3DBlair%26aufirst%3DI.%2BA.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26atitle%3DOncogene-Induced%2520Nrf2%2520Transcription%2520Promotes%2520Ros%2520Detoxification%2520and%2520Tumorigenesis%26jtitle%3DNature%26date%3D2011%26volume%3D475%26spage%3D106%26epage%3D109%26doi%3D10.1038%2Fnature10189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span> <span> </span><span class="NLM_article-title">Keap Calm, and Carry on Covalently</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7463</span>– <span class="NLM_lpage">7476</span>, <span class="refDoi"> DOI: 10.1021/jm400224q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400224q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7463-7476&author=A.+J.+Wilsonauthor=J.+K.+Kernsauthor=J.+F.+Callahanauthor=C.+J.+Moody&title=Keap+Calm%2C+and+Carry+on+Covalently&doi=10.1021%2Fjm400224q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Keap Calm, and Carry on Covalently</span></div><div class="casAuthors">Wilson, Anthony J.; Kerns, Jeffrey K.; Callahan, James F.; Moody, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7463-7476</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The Nrf2-Keap1 system plays a major role in cellular defense against oxidative stress.  Upon exposure to electrophiles, the cysteine-rich protein Keap1 is covalently modified, and it is this modification of Keap1 that allows the accumulation and subsequent nuclear translocation of Nrf2 where it induces the transcription of over 100 protective genes.  This mechanism can be exploited in drug discovery approaches to diseases such as chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), asthma, and neurodegenerative diseases like multiple sclerosis (MS) and Parkinson's, utilizing the modification of Keap1 by electrophiles, compds. that would not normally be considered useful in drug discovery programs.  This Perspective discusses the development of potential therapies based on potent electrophiles, such as isothiocyanates and Michael acceptors, that, far from being assocd. with toxic events, can actually initiate a range of beneficial protective pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFM-f4P1ElOLVg90H21EOLACvtfcHk0li1iI-Wt78Rsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtbvE&md5=ea907fb2ccd8c28142ab4fa2776d0195</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjm400224q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400224q%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DKeap%2520Calm%252C%2520and%2520Carry%2520on%2520Covalently%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7463%26epage%3D7476%26doi%3D10.1021%2Fjm400224q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Modulators of Keap1-Nrf2–ARe Pathway as Potential Preventive and Therapeutic Agents</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1002/med.21257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1002%2Fmed.21257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22549716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=687-726&author=S.+Mageshauthor=Y.+Chenauthor=L.+Hu&title=Small+Molecule+Modulators+of+Keap1-Nrf2%E2%80%93ARe+Pathway+as+Potential+Preventive+and+Therapeutic+Agents&doi=10.1002%2Fmed.21257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents</span></div><div class="casAuthors">Magesh, Sadagopan; Chen, Yu; Hu, Longqin</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">687-726</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Kelch-like ECH-assocd. protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response elements (ARE) pathway represents one of the most important cellular defense mechanisms against oxidative stress and xenobiotic damage.  Activation of Nrf2 signaling induces the transcriptional regulation of ARE-dependent expression of various detoxifying and antioxidant defense enzymes and proteins.  Keap1-Nrf2-ARE signaling has become an attractive target for the prevention and treatment of oxidative stress-related diseases and conditions including cancer, neurodegenerative, cardiovascular, metabolic, and inflammatory diseases.  Over the last few decades, numerous Nrf2 inducers have been developed and some of them are currently undergoing clin. trials.  Recently, overactivation of Nrf2 has been implicated in cancer progression as well as in drug resistance to cancer chemotherapy.  Thus, Nrf2 inhibitors could potentially be used to improve the effectiveness of cancer therapy.  Herein, we review the signaling mechanism of Keap1-Nrf2-ARE pathway, its disease relevance, and currently known classes of small mol. modulators.  We also discuss several aspects of Keap1-Nrf2 interaction, Nrf2-based peptide inhibitor design, and the screening assays currently used for the discovery of direct inhibitors of Keap1-Nrf2 interaction. © 2012 Wiley Periodicals, Inc.  Med Res Rev., 32, No. 4, 687-726, 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhLmdkuTSh7Vg90H21EOLACvtfcHk0li1iI-Wt78Rsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D&md5=2104d731cb251e0d9b6d2ad73a735175</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1002%2Fmed.21257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21257%26sid%3Dliteratum%253Aachs%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DSmall%2520Molecule%2520Modulators%2520of%2520Keap1-Nrf2%25E2%2580%2593ARe%2520Pathway%2520as%2520Potential%2520Preventive%2520and%2520Therapeutic%2520Agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D687%26epage%3D726%26doi%3D10.1002%2Fmed.21257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
la Monte, S. M.</span></span> <span> </span><span class="NLM_article-title">Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer’s Disease</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1007/s40265-016-0674-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1007%2Fs40265-016-0674-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27988872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFensL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=47-65&author=S.+M.+de%0Ala+Monte&title=Insulin+Resistance+and+Neurodegeneration%3A+Progress+Towards+the+Development+of+New+Therapeutics+for+Alzheimer%E2%80%99s+Disease&doi=10.1007%2Fs40265-016-0674-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease</span></div><div class="casAuthors">de la Monte, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-65</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) should be regarded as a degenerative metabolic disease caused by brain insulin resistance and deficiency, and overlapping with the mol., biochem., pathophysiol., and metabolic dysfunctions in diabetes mellitus, non-alc. fatty liver disease, and metabolic syndrome.  Although most of the diagnostic and therapeutic approaches over the past several decades have focused on amyloid-beta (Aβ42) and aberrantly phosphorylated tau, which could be caused by consequences of brain insulin resistance, the broader array of pathologies including white matter atrophy with loss of myelinated fibrils and leukoaraiosis, non-Aβ42 microvascular disease, dysregulated lipid metab., mitochondrial dysfunction, astrocytic gliosis, neuro-inflammation, and loss of synapses vis-a´-vis growth of dystrophic neurites, is not readily accounted for by Aβ42 accumulations, but could be explained by dysregulated insulin/IGF-1 signaling with attendant impairments in signal transduction and gene expression.  This review covers the diverse range of brain abnormalities in AD and discusses how insulins, incretins, and insulin sensitizers could be utilized to treat at different stages of neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR5pvj20J9cbVg90H21EOLACvtfcHk0lgg8cSrKuVZOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFensL7N&md5=e3f0d4e1d99a3ae67ea96fd0b6e2b736</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1007%2Fs40265-016-0674-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-016-0674-0%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Bla%2BMonte%26aufirst%3DS.%2BM.%26atitle%3DInsulin%2520Resistance%2520and%2520Neurodegeneration%253A%2520Progress%2520Towards%2520the%2520Development%2520of%2520New%2520Therapeutics%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DDrugs%26date%3D2017%26volume%3D77%26spage%3D47%26epage%3D65%26doi%3D10.1007%2Fs40265-016-0674-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurokawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sou, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iemura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natsume, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kominami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">The Selective Autophagy Substrate P62 Activates the Stress Responsive Transcription Factor Nrf2 through Inactivation of Keap1</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1038/ncb2021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fncb2021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=20173742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFemsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=213-223&author=M.+Komatsuauthor=H.+Kurokawaauthor=S.+Waguriauthor=K.+Taguchiauthor=A.+Kobayashiauthor=Y.+Ichimuraauthor=Y.+S.+Souauthor=I.+Uenoauthor=A.+Sakamotoauthor=K.+I.+Tongauthor=M.+Kimauthor=Y.+Nishitoauthor=S.+Iemuraauthor=T.+Natsumeauthor=T.+Uenoauthor=E.+Kominamiauthor=H.+Motohashiauthor=K.+Tanakaauthor=M.+Yamamoto&title=The+Selective+Autophagy+Substrate+P62+Activates+the+Stress+Responsive+Transcription+Factor+Nrf2+through+Inactivation+of+Keap1&doi=10.1038%2Fncb2021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1</span></div><div class="casAuthors">Komatsu, Masaaki; Kurokawa, Hirofumi; Waguri, Satoshi; Taguchi, Keiko; Kobayashi, Akira; Ichimura, Yoshinobu; Sou, Yu-Shin; Ueno, Izumi; Sakamoto, Ayako; Tong, Kit I.; Kim, Mihee; Nishito, Yasumasa; Iemura, Shun-ichiro; Natsume, Tohru; Ueno, Takashi; Kominami, Eiki; Motohashi, Hozumi; Tanaka, Keiji; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-223</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Impaired selective turnover of p62 by autophagy causes severe liver injury accompanied by the formation of p62-pos. inclusions and upregulation of detoxifying enzymes.  These phenotypes correspond closely to the pathol. conditions seen in human liver diseases, including alc. hepatitis and hepatocellular carcinoma.  However, the mol. mechanisms and pathophysiol. processes in these events are still unknown.  Here we report the identification of a novel regulatory mechanism by p62 of the transcription factor Nrf2, whose target genes include antioxidant proteins and detoxification enzymes. p62 interacts with the Nrf2-binding site on Keap1, a component of Cullin-3-type ubiquitin ligase for Nrf2.  Thus, an overprodn. of p62 or a deficiency in autophagy competes with the interaction between Nrf2 and Keap1, resulting in stabilization of Nrf2 and transcriptional activation of Nrf2 target genes.  Our findings indicate that the pathol. process assocd. with p62 accumulation results in hyperactivation of Nrf2 and delineates unexpected roles of selective autophagy in controlling the transcription of cellular defense enzyme genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozHwUzLt-LiLVg90H21EOLACvtfcHk0lgg8cSrKuVZOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFemsL8%253D&md5=f66692c056ff13937de3affac38f31c9</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1038%2Fncb2021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2021%26sid%3Dliteratum%253Aachs%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DKurokawa%26aufirst%3DH.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DSou%26aufirst%3DY.%2BS.%26aulast%3DUeno%26aufirst%3DI.%26aulast%3DSakamoto%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DNishito%26aufirst%3DY.%26aulast%3DIemura%26aufirst%3DS.%26aulast%3DNatsume%26aufirst%3DT.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DKominami%26aufirst%3DE.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DThe%2520Selective%2520Autophagy%2520Substrate%2520P62%2520Activates%2520the%2520Stress%2520Responsive%2520Transcription%2520Factor%2520Nrf2%2520through%2520Inactivation%2520of%2520Keap1%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26spage%3D213%26epage%3D223%26doi%3D10.1038%2Fncb2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">A Systematic Molecular Dynamics Approach to the Study of Peptide Keap1-Nrf2 Protein-Protein Interaction Inhibitors and Its Application to P62 Peptides</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1378</span>– <span class="NLM_lpage">1387</span>, <span class="refDoi"> DOI: 10.1039/C6MB00030D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1039%2FC6MB00030D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26935067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFOmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=1378-1387&author=M.-C.+Luauthor=Z.-W.+Yuanauthor=Y.-L.+Jiangauthor=Z.-Y.+Chenauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=A+Systematic+Molecular+Dynamics+Approach+to+the+Study+of+Peptide+Keap1-Nrf2+Protein-Protein+Interaction+Inhibitors+and+Its+Application+to+P62+Peptides&doi=10.1039%2FC6MB00030D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">A systematic molecular dynamics approach to the study of peptide Keap1-Nrf2 protein-protein interaction inhibitors and its application to p62 peptides</span></div><div class="casAuthors">Lu, Meng-Chen; Yuan, Zhen-Wei; Jiang, Yong-Lin; Chen, Zhi-Yun; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1378-1387</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Protein-protein interactions (PPIs) as drug targets have been gaining growing interest, though developing drug-like small mol. PPI inhibitors remains challenging.  Peptide PPI inhibitors, which can provide informative data on the PPI interface, are good starting points to develop small mol. modulators.  Computational methods combining mol. dynamics simulations and binding energy calcns. could give both the structural and the energetic perspective of peptide PPI inhibitors.  Herein, we set up a computational workflow to investigate Keap1-Nrf2 peptide PPI inhibitors and predict the activity of novel sequences.  Furthermore, we applied this method to investigate p62 peptides as PPI inhibitors of Keap1-Nrf2 and explored the activity change induced by the phosphorylation of serine.  Our results showed that because of the unfavorable solvation effects, the binding affinity of the phosphorylated p62 peptide is lower than the Nrf2 ETGE peptide.  Our research results not only provide a useful method to investigate the Keap1-Nrf2 peptide inhibitors, but also give a good example to show how to incorporate computational methods into the study of peptide PPI inhibitors.  Besides, applying this method to p62 peptides provides a detailed explanation for the expression of cytoprotective Nrf2 targets induced by p62 phosphorylation, which may benefit the further study of the crosstalk between the Keap1-Nrf2 pathway and p62-mediated selective autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTSi4VF8fkabVg90H21EOLACvtfcHk0li0rZTueUUUtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFOmtrk%253D&md5=81ccd32348455f5a99993139c2cb1441</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1039%2FC6MB00030D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MB00030D%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DYuan%26aufirst%3DZ.-W.%26aulast%3DJiang%26aufirst%3DY.-L.%26aulast%3DChen%26aufirst%3DZ.-Y.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DA%2520Systematic%2520Molecular%2520Dynamics%2520Approach%2520to%2520the%2520Study%2520of%2520Peptide%2520Keap1-Nrf2%2520Protein-Protein%2520Interaction%2520Inhibitors%2520and%2520Its%2520Application%2520to%2520P62%2520Peptides%26jtitle%3DMol.%2520BioSyst.%26date%3D2016%26volume%3D12%26spage%3D1378%26epage%3D1387%26doi%3D10.1039%2FC6MB00030D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sou, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kageyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukutomi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoshii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of P62 Activates the Keap1-Nrf2 Pathway During Selective Autophagy</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">618</span>– <span class="NLM_lpage">631</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2013.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.molcel.2013.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24011591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWisrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2013&pages=618-631&author=Y.+Ichimuraauthor=S.+Waguriauthor=Y.+S.+Souauthor=S.+Kageyamaauthor=J.+Hasegawaauthor=R.+Ishimuraauthor=T.+Saitoauthor=Y.+Yangauthor=T.+Kounoauthor=T.+Fukutomiauthor=T.+Hoshiiauthor=A.+Hiraoauthor=K.+Takagiauthor=T.+Mizushimaauthor=H.+Motohashiauthor=M.+S.+Leeauthor=T.+Yoshimoriauthor=K.+Tanakaauthor=M.+Yamamotoauthor=M.+Komatsu&title=Phosphorylation+of+P62+Activates+the+Keap1-Nrf2+Pathway+During+Selective+Autophagy&doi=10.1016%2Fj.molcel.2013.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy</span></div><div class="casAuthors">Ichimura, Yoshinobu; Waguri, Satoshi; Sou, Yu-shin; Kageyama, Shun; Hasegawa, Jun; Ishimura, Ryosuke; Saito, Tetsuya; Yang, Yinjie; Kouno, Tsuguka; Fukutomi, Toshiaki; Hoshii, Takayuki; Hirao, Atsushi; Takagi, Kenji; Mizushima, Tsunehiro; Motohashi, Hozumi; Lee, Myung-Shik; Yoshimori, Tamotsu; Tanaka, Keiji; Yamamoto, Masayuki; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">618-631</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The Keap1-Nrf2 system and autophagy are both involved in the oxidative-stress response, metabolic pathways, and innate immunity, and dysregulation of these processes is assocd. with pathogenic processes.  However, the interplay between these two pathways remains largely unknown.  Here, we show that phosphorylation of the autophagy-adaptor protein p62 markedly increases p62's binding affinity for Keap1, an adaptor of the Cul3-ubiquitin E3 ligase complex responsible for degrading Nrf2.  Thus, p62 phosphorylation induces expression of cytoprotective Nrf2 targets.  P62 is assembled on selective autophagic cargos such as ubiquitinated organelles and subsequently phosphorylated in an mTORC1-dependent manner, implying coupling of the Keap1-Nrf2 system to autophagy.  Furthermore, persistent activation of Nrf2 through accumulation of phosphorylated p62 contributes to the growth of human hepatocellular carcinomas (HCCs).  These results demonstrate that selective autophagy and the Keap1-Nrf2 pathway are interdependent, and that inhibitors of the interaction between phosphorylated p62 and Keap1 have potential as therapeutic agents against human HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF8YrIIgNZobVg90H21EOLACvtfcHk0li0rZTueUUUtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWisrzI&md5=35f19332a5d851412ff0ba8132f1c68f</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2013.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2013.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DSou%26aufirst%3DY.%2BS.%26aulast%3DKageyama%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DJ.%26aulast%3DIshimura%26aufirst%3DR.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DKouno%26aufirst%3DT.%26aulast%3DFukutomi%26aufirst%3DT.%26aulast%3DHoshii%26aufirst%3DT.%26aulast%3DHirao%26aufirst%3DA.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DMizushima%26aufirst%3DT.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DYoshimori%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DPhosphorylation%2520of%2520P62%2520Activates%2520the%2520Keap1-Nrf2%2520Pathway%2520During%2520Selective%2520Autophagy%26jtitle%3DMol.%2520Cell%26date%3D2013%26volume%3D51%26spage%3D618%26epage%3D631%26doi%3D10.1016%2Fj.molcel.2013.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">P62 in Cancer: Signaling Adaptor Beyond Autophagy</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">609</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.09.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.cell.2016.09.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27768885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCrsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2016&pages=606-609&author=J.+Moscatauthor=M.+Karinauthor=M.+T.+Diaz-Meco&title=P62+in+Cancer%3A+Signaling+Adaptor+Beyond+Autophagy&doi=10.1016%2Fj.cell.2016.09.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">p62 in Cancer: Signaling Adaptor Beyond Autophagy</span></div><div class="casAuthors">Moscat, Jorge; Karin, Michael; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">606-609</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Adaptor proteins participate in selective autophagy, which is crit. for cellular detoxification and stress relief.  However, new evidence supports an autophagy-independent key role of the adaptor p62 (encoded by the gene Sqstm1) in signaling functions central to tumor initiation in the epithelium and suppression of tumor progression in the stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfCL87hjyvcbVg90H21EOLACvtfcHk0ljr5B0VaNL9Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCrsrjL&md5=cb962ea1adfd7935b4fbe0eba4b7049b</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3DP62%2520in%2520Cancer%253A%2520Signaling%2520Adaptor%2520Beyond%2520Autophagy%26jtitle%3DCell%26date%3D2016%26volume%3D167%26spage%3D606%26epage%3D609%26doi%3D10.1016%2Fj.cell.2016.09.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Umemura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamachika, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Font-Burgada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghunandan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linares, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reina-Campos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umemura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valasek, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">P62, Upregulated During Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed Hcc-Initiating Cells</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">948</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2016.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.ccell.2016.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27211490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28Xotlentro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=935-948&author=A.+Umemuraauthor=F.+Heauthor=K.+Taniguchiauthor=H.+Nakagawaauthor=S.+Yamachikaauthor=J.+Font-Burgadaauthor=Z.+Zhongauthor=S.+Subramaniamauthor=S.+Raghunandanauthor=A.+Duranauthor=J.+F.+Linaresauthor=M.+Reina-Camposauthor=S.+Umemuraauthor=M.+A.+Valasekauthor=E.+Sekiauthor=K.+Yamaguchiauthor=K.+Koikeauthor=Y.+Itohauthor=M.+T.+Diaz-Mecoauthor=J.+Moscatauthor=M.+Karin&title=P62%2C+Upregulated+During+Preneoplasia%2C+Induces+Hepatocellular+Carcinogenesis+by+Maintaining+Survival+of+Stressed+Hcc-Initiating+Cells&doi=10.1016%2Fj.ccell.2016.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells</span></div><div class="casAuthors">Umemura, Atsushi; He, Feng; Taniguchi, Koji; Nakagawa, Hayato; Yamachika, Shinichiro; Font-Burgada, Joan; Zhong, Zhenyu; Subramaniam, Shankar; Raghunandan, Sindhu; Duran, Angeles; Linares, Juan F.; Reina-Campos, Miguel; Umemura, Shiori; Valasek, Mark A.; Seki, Ekihiro; Yamaguchi, Kanji; Koike, Kazuhiko; Itoh, Yoshito; Diaz-Meco, Maria T.; Moscat, Jorge; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">935-948</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">P62 is a ubiquitin-binding autophagy receptor and signaling protein that accumulates in premalignant liver diseases and most hepatocellular carcinomas (HCCs).  Although p62 was proposed to participate in the formation of benign adenomas in autophagy-deficient livers, its role in HCC initiation was not explored.  Here we show that p62 is necessary and sufficient for HCC induction in mice and that its high expression in non-tumor human liver predicts rapid HCC recurrence after curative ablation.  High p62 expression is needed for activation of NRF2 and mTORC1, induction of c-Myc, and protection of HCC-initiating cells from oxidative stress-induced death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG3PmjQwQ86bVg90H21EOLACvtfcHk0ljr5B0VaNL9Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xotlentro%253D&md5=c8b15119ef52aacdc15ea7a9a3ee39e2</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2016.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2016.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DUmemura%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DTaniguchi%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DYamachika%26aufirst%3DS.%26aulast%3DFont-Burgada%26aufirst%3DJ.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DSubramaniam%26aufirst%3DS.%26aulast%3DRaghunandan%26aufirst%3DS.%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DLinares%26aufirst%3DJ.%2BF.%26aulast%3DReina-Campos%26aufirst%3DM.%26aulast%3DUmemura%26aufirst%3DS.%26aulast%3DValasek%26aufirst%3DM.%2BA.%26aulast%3DSeki%26aufirst%3DE.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DKoike%26aufirst%3DK.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DP62%252C%2520Upregulated%2520During%2520Preneoplasia%252C%2520Induces%2520Hepatocellular%2520Carcinogenesis%2520by%2520Maintaining%2520Survival%2520of%2520Stressed%2520Hcc-Initiating%2520Cells%26jtitle%3DCancer%2520Cell%26date%3D2016%26volume%3D29%26spage%3D935%26epage%3D948%26doi%3D10.1016%2Fj.ccell.2016.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuasa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashino, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Keap1-Phosphorylated P62 and Keap1-Nrf2 Protein-Protein Interaction Inhibitors and Their Inhibitory Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5956</span>– <span class="NLM_lpage">5959</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.bmcl.2016.10.083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27839920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVCitr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5956-5959&author=D.+Yasudaauthor=M.+Nakajimaauthor=A.+Yuasaauthor=R.+Obataauthor=K.+Takahashiauthor=T.+Oheauthor=Y.+Ichimuraauthor=M.+Komatsuauthor=M.+Yamamotoauthor=R.+Imamuraauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Naganoauthor=T.+Mashino&title=Synthesis+of+Keap1-Phosphorylated+P62+and+Keap1-Nrf2+Protein-Protein+Interaction+Inhibitors+and+Their+Inhibitory+Activity&doi=10.1016%2Fj.bmcl.2016.10.083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activity</span></div><div class="casAuthors">Yasuda, Daisuke; Nakajima, Mao; Yuasa, Akihiro; Obata, Rika; Takahashi, Kyoko; Ohe, Tomoyuki; Ichimura, Yoshinobu; Komatsu, Masaaki; Yamamoto, Masayuki; Imamura, Riyo; Kojima, Hirotatsu; Okabe, Takayoshi; Nagano, Tetsuo; Mashino, Tadahiko</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5956-5959</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Keap1-Nrf2 system is involved not only in biol. defense but also in malignancy progression and chemoresistance.  The ubiquitin-binding protein p62/Sqstm1 (p62), which is highly expressed in several cancers, competes with Nrf2 for Keap1 binding, leading to activation of Nrf2-mediated gene expression and survival of cancer cells.  The authors had previously identified an inhibitor for the Keap1-phosphorylated-p62 (p-p62) protein-protein interaction (PPI), the acetonyl naphthalene deriv. K67.  The authors established facile synthetic routes for K67 and derivs. with various side chains on the C-2 position of naphthalene ring.  K67 possessed high selectivity in the inhibition of Keap1-p-p62.  Other derivs. showed potent Keap1-Nrf2 and Keap1-p-p62 PPI inhibitory activities, though the selectivity between the two activities was lower than K67.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobdbq29sjZhbVg90H21EOLACvtfcHk0lglJ-Z_Bkez1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVCitr3F&md5=a2122d98f2378ab2b167a246dc7f9408</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.083%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DNakajima%26aufirst%3DM.%26aulast%3DYuasa%26aufirst%3DA.%26aulast%3DObata%26aufirst%3DR.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DImamura%26aufirst%3DR.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DMashino%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520Keap1-Phosphorylated%2520P62%2520and%2520Keap1-Nrf2%2520Protein-Protein%2520Interaction%2520Inhibitors%2520and%2520Their%2520Inhibitory%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5956%26epage%3D5959%26doi%3D10.1016%2Fj.bmcl.2016.10.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Iaspp Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">561</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2017.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.ccell.2017.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29033244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjs7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=561&author=W.+Geauthor=K.+Zhaoauthor=X.+Wangauthor=H.+Liauthor=M.+Yuauthor=M.+Heauthor=X.+Xueauthor=Y.+Zhuauthor=C.+Zhangauthor=Y.+Chengauthor=S.+Jiangauthor=Y.+Hu&title=Iaspp+Is+an+Antioxidative+Factor+and+Drives+Cancer+Growth+and+Drug+Resistance+by+Competing+with+Nrf2+for+Keap1+Binding&doi=10.1016%2Fj.ccell.2017.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding</span></div><div class="casAuthors">Ge, Wenjie; Zhao, Kunming; Wang, Xingwen; Li, Huayi; Yu, Miao; He, Mengmeng; Xue, Xuting; Zhu, Yifu; Zhang, Cheng; Cheng, Yiwei; Jiang, Shijian; Hu, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">561-573.e6</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) have emerged as important signaling mols. that play crucial roles in carcinogenesis and cytotoxic responses.  Nrf2 is the master regulator of ROS balance.  Thus, uncovering mechanisms of Nrf2 regulation is important for the development of alternative treatment strategies for cancers.  Here, we demonstrate that iASPP, a known p53 inhibitor, lowers ROS independently of p53.  Mechanistically, iASPP competes with Nrf2 for Keap1 binding via a DLT motif, leading to decreased Nrf2 ubiquitination and increased Nrf2 accumulation, nuclear translocation, and antioxidative transactivation.  This iASPP-Keap1-Nrf2 axis promotes cancer growth and drug resistance both in vitro and in vivo.  Thus, iASPP is an antioxidative factor and represents a promising target to improve cancer treatment, regardless of p53 status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgG9GfPOFfIrVg90H21EOLACvtfcHk0lglJ-Z_Bkez1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjs7zE&md5=f2e27a7dee5602a3aba046c0efb34ef7</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2017.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2017.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DIaspp%2520Is%2520an%2520Antioxidative%2520Factor%2520and%2520Drives%2520Cancer%2520Growth%2520and%2520Drug%2520Resistance%2520by%2520Competing%2520with%2520Nrf2%2520for%2520Keap1%2520Binding%26jtitle%3DCancer%2520Cell%26date%3D2017%26volume%3D32%26spage%3D561%26doi%3D10.1016%2Fj.ccell.2017.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Oncogene-Stimulated Congestion at the Keap1 Stress Signaling Hub Allows Bypass of Nrf2 and Induction of Nrf2-Target Genes That Promote Tumor Survival</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2017.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.ccell.2017.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29136497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVShs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=539-541&author=J.+D.+Hayesauthor=A.+T.+Dinkova-Kostova&title=Oncogene-Stimulated+Congestion+at+the+Keap1+Stress+Signaling+Hub+Allows+Bypass+of+Nrf2+and+Induction+of+Nrf2-Target+Genes+That+Promote+Tumor+Survival&doi=10.1016%2Fj.ccell.2017.10.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogene-Stimulated Congestion at the KEAP1 Stress Signaling Hub Allows Bypass of NRF2 and Induction of NRF2-Target Genes that Promote Tumor Survival</span></div><div class="casAuthors">Hayes, John D.; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">539-541</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">In this issue of Cancer Cell, Ge et al. show that overexpression of the oncoprotein iASPP in cancer cells provokes NRF2-mediated induction of cytoprotective genes, because it logjams the ubiquitin ligase substrate adaptor function of KEAP1 by virtue of the fact that it possesses a novel DLT-contg. KEAP1-interaction motif.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv_cW2de-Oq7Vg90H21EOLACvtfcHk0lglJ-Z_Bkez1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVShs7fK&md5=7aeabf63a02ae6f51a7026d7682dd8a2</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2017.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2017.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DOncogene-Stimulated%2520Congestion%2520at%2520the%2520Keap1%2520Stress%2520Signaling%2520Hub%2520Allows%2520Bypass%2520of%2520Nrf2%2520and%2520Induction%2520of%2520Nrf2-Target%2520Genes%2520That%2520Promote%2520Tumor%2520Survival%26jtitle%3DCancer%2520Cell%26date%3D2017%26volume%3D32%26spage%3D539%26epage%3D541%26doi%3D10.1016%2Fj.ccell.2017.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lastres-Becker, I.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Targeting of Gsk-3 and Nrf2 Provides Neuroprotection in a Preclinical Model of Tauopathy</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">522</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2017.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.redox.2017.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=29121589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslOisLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=522-534&author=A.+Cuadradoauthor=S.+Kuglerauthor=I.+Lastres-Becker&title=Pharmacological+Targeting+of+Gsk-3+and+Nrf2+Provides+Neuroprotection+in+a+Preclinical+Model+of+Tauopathy&doi=10.1016%2Fj.redox.2017.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy</span></div><div class="casAuthors">Cuadrado, Antonio; Kugler, Sebastian; Lastres-Becker, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">522-534</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tauopathies are a group of neurodegenerative disorders where TAU protein is presented as aggregates or is abnormally phosphorylated, leading to alterations of axonal transport, neuronal death and neuroinflammation.  Currently, there is no treatment to slow progression of these diseases.  Here, we have investigated whether di-Me fumarate (DMF), an inducer of the transcription factor NRF2, could mitigate tauopathy in a mouse model.  The signaling pathways modulated by DMF were also studied in mouse embryonic fibroblast (MEFs) from wild type or KEAP1-deficient mice.  The effect of DMF on neurodegeneration, astrocyte and microglial activation was examd. in Nrf2+/+ and Nrf2-/- mice stereotaxically injected in the right hippocampus with an adeno-assocd. vector expressing human TAUP301L and treated daily with DMF (100 mg/kg, i.g) during three weeks.  DMF induces the NRF2 transcriptional through a mechanism that involves KEAP1 but also PI3K/AKT/GSK-3-dependent pathways.  DMF modulates GSK-3β activity in mouse hippocampi.  Furthermore, DMF modulates TAU phosphorylation, neuronal impairment measured by calbindin-D28K and BDNF expression, and inflammatory processes involved in astrogliosis, microgliosis and pro-inflammatory cytokines prodn.  This study reveals neuroprotective effects of DMF beyond disruption of the KEAP1/NRF2 axis by inhibiting GSK3 in a mouse model of tauopathy.  Our results support repurposing of this drug for treatment of these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjcpkJLPUbpLVg90H21EOLACvtfcHk0ljRxD21d1qnUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslOisLfJ&md5=bdf40d78ab1261cddb8673fe0d9ffdd7</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2017.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DKugler%26aufirst%3DS.%26aulast%3DLastres-Becker%26aufirst%3DI.%26atitle%3DPharmacological%2520Targeting%2520of%2520Gsk-3%2520and%2520Nrf2%2520Provides%2520Neuroprotection%2520in%2520a%2520Preclinical%2520Model%2520of%2520Tauopathy%26jtitle%3DRedox%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D522%26epage%3D534%26doi%3D10.1016%2Fj.redox.2017.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gameiro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalska, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cores, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buendia, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgakopoulos, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Guijo, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teresa Ramos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menendez, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of the First Dual Gsk3beta Inhibitor/Nrf2 Inducer. A New Multitarget Therapeutic Strategy for Alzheimer’s Disease</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">45701</span>, <span class="refDoi"> DOI: 10.1038/srep45701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fsrep45701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28361919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A280%3ADC%252BC1cvjtVOqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=45701&author=I.+Gameiroauthor=P.+Michalskaauthor=G.+Tentiauthor=A.+Coresauthor=I.+Buendiaauthor=A.+I.+Rojoauthor=N.+D.+Georgakopoulosauthor=J.+M.+Hernandez-Guijoauthor=M.+Teresa+Ramosauthor=G.+Wellsauthor=M.+G.+Lopezauthor=A.+Cuadradoauthor=J.+C.+Menendezauthor=R.+Leon&title=Discovery+of+the+First+Dual+Gsk3beta+Inhibitor%2FNrf2+Inducer.+A+New+Multitarget+Therapeutic+Strategy+for+Alzheimer%E2%80%99s+Disease&doi=10.1038%2Fsrep45701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease</span></div><div class="casAuthors">Gameiro Isabel; Michalska Patrycja; Buendia Izaskun; Hernandez-Guijo Jesus M; Lopez Manuela G; Leon Rafael; Gameiro Isabel; Michalska Patrycja; Tenti Giammarco; Buendia Izaskun; Lopez Manuela G; Leon Rafael; Cores Angel; Teresa Ramos Maria; Menendez J Carlos; Rojo Ana I; Cuadrado Antonio; Georgakopoulos Nikolaos D; Wells Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45701</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The formation of neurofibrillary tangles (NFTs), oxidative stress and neuroinflammation have emerged as key targets for the treatment of Alzheimer's disease (AD), the most prevalent neurodegenerative disorder.  These pathological hallmarks are closely related to the over-activity of the enzyme GSK3β and the downregulation of the defense pathway Nrf2-EpRE observed in AD patients.  Herein, we report the synthesis and pharmacological evaluation of a new family of multitarget 2,4-dihydropyrano[2,3-c]pyrazoles as dual GSK3β inhibitors and Nrf2 inducers.  These compounds are able to inhibit GSK3β and induce the Nrf2 phase II antioxidant and anti-inflammatory pathway at micromolar concentrations, showing interesting structure-activity relationships.  The association of both activities has resulted in a remarkable anti-inflammatory ability with an interesting neuroprotective profile on in vitro models of neuronal death induced by oxidative stress and energy depletion and AD.  Furthermore, none of the compounds exhibited in vitro neurotoxicity or hepatotoxicity and hence they had improved safety profiles compared to the known electrophilic Nrf2 inducers.  In conclusion, the combination of both activities in this family of multitarget compounds confers them a notable interest for the development of lead compounds for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQb3GKov_JZAe2mnZh2OgS0fW6udTcc2eaxvi4GMtLyCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvjtVOqsg%253D%253D&md5=539ae027ea7d8f7bc20356900383f90b</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1038%2Fsrep45701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep45701%26sid%3Dliteratum%253Aachs%26aulast%3DGameiro%26aufirst%3DI.%26aulast%3DMichalska%26aufirst%3DP.%26aulast%3DTenti%26aufirst%3DG.%26aulast%3DCores%26aufirst%3DA.%26aulast%3DBuendia%26aufirst%3DI.%26aulast%3DRojo%26aufirst%3DA.%2BI.%26aulast%3DGeorgakopoulos%26aufirst%3DN.%2BD.%26aulast%3DHernandez-Guijo%26aufirst%3DJ.%2BM.%26aulast%3DTeresa%2BRamos%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DG.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DMenendez%26aufirst%3DJ.%2BC.%26aulast%3DLeon%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520the%2520First%2520Dual%2520Gsk3beta%2520Inhibitor%252FNrf2%2520Inducer.%2520A%2520New%2520Multitarget%2520Therapeutic%2520Strategy%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D45701%26doi%3D10.1038%2Fsrep45701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Induced Protein Degradation: An Emerging Drug Discovery Paradigm</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fnrd.2016.211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27885283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCit7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=101-114&author=A.+C.+Laiauthor=C.+M.+Crews&title=Induced+Protein+Degradation%3A+An+Emerging+Drug+Discovery+Paradigm&doi=10.1038%2Fnrd.2016.211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Induced protein degradation: an emerging drug discovery paradigm</span></div><div class="casAuthors">Lai, Ashton C.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-114</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. drug discovery has traditionally focused on occupancy of a binding site that directly affects protein function, and this approach typically precludes targeting proteins that lack such amenable sites.  Furthermore, high systemic drug exposures may be needed to maintain sufficient target inhibition in vivo, increasing the risk of undesirable off-target effects.  Induced protein degrdn. is an alternative approach that is event-driven: upon drug binding, the target protein is tagged for elimination.  Emerging technologies based on proteolysis-targeting chimaeras (PROTACs) that exploit cellular quality control machinery to selectively degrade target proteins are attracting considerable attention in the pharmaceutical industry owing to the advantages they could offer over traditional small-mol. strategies.  These advantages include the potential to reduce systemic drug exposure, the ability to counteract increased target protein expression that often accompanies inhibition of protein function and the potential ability to target proteins that are not currently therapeutically tractable, such as transcription factors, scaffolding and regulatory proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj-O7zXGOpXLVg90H21EOLACvtfcHk0ljRxD21d1qnUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCit7rP&md5=a01ff43e9b696fe4dc03f0815158a98f</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.211%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DA.%2BC.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DInduced%2520Protein%2520Degradation%253A%2520An%2520Emerging%2520Drug%2520Discovery%2520Paradigm%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D101%26epage%3D114%26doi%3D10.1038%2Fnrd.2016.211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span> <span> </span><span class="NLM_article-title">The Histone Acetylranseferase Hmof Acetylates Nrf2 and Regulates Anti-Drug Responses in Human Non-Small Cell Lung Cancer</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">3196</span>– <span class="NLM_lpage">3211</span>, <span class="refDoi"> DOI: 10.1111/bph.12661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1111%2Fbph.12661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24571482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVKrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3196-3211&author=Z.+Chenauthor=X.+Yeauthor=N.+Tangauthor=S.+Shenauthor=Z.+Liauthor=X.+Niuauthor=S.+Luauthor=L.+Xu&title=The+Histone+Acetylranseferase+Hmof+Acetylates+Nrf2+and+Regulates+Anti-Drug+Responses+in+Human+Non-Small+Cell+Lung+Cancer&doi=10.1111%2Fbph.12661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer</span></div><div class="casAuthors">Chen, Zhiwei; Ye, Xiangyun; Tang, Naiwang; Shen, Shengping; Li, Ziming; Niu, Xiaomin; Lu, Shun; Xu, Ling</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3196-3211</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The histone acetyltransferase MOF is a member of the MYST family.  In mammals, MOF plays crit. roles by acetylating histone H4 at K16 and non-histone substrates such as p53.  Here we have investigated the role of MOF in human lung cancer and possible new substrates of hMOF.  Exptl. Approach : Samples of human non-small cell lung cancer (NSCLC) were used to correlate MOF with clinicopathol. parameters and NF-E2-related factor 2 (Nrf2) downstream genes.  293T-cells were used to study interactions between MOF and Nrf2, and acetylation of Nrf2 by MOF.  Mouse embryonic fibroblast and A549 cells were utilized to assess involvement of MOF in antioxidative and anti-drug responses.  A549 cells were used to anal. the role of MOF in anti-drug response in vitro and in vivo.  Key Results : hMOF was overexpressed in human NSCLC tissues and was assocd. with large tumor size, advanced disease stage and metastasis, and with poor prognosis.  HMOF levels were pos. correlated with Nrf2-downstream genes.  MOF/hMOF phys. interacted with and acetylated Nrf2 at Lys588.  MOF-mediated acetylation increased nuclear retention of Nrf2 and transcription of its downstream genes.  Importantly, MOF/hMOF was essential for anti-oxidative and anti-drug responses in vitro and regulated tumor growth and drug resistance in vivo in an Nrf2-dependent manner.  Conclusion and Implications : hMOF was overexpressed in human NSCLC and was a predictor of poor survival.  HMOF-mediated Nrf2 acetylation and nuclear retention are essential for anti-oxidative and anti-drug responses.  HMOF may provide a therapeutic target for the treatment of NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGVLqQZwX2CLVg90H21EOLACvtfcHk0liG46kTNNhhRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVKrt7k%253D&md5=b1478b8ccd229cc59434f39509148e11</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1111%2Fbph.12661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12661%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DN.%26aulast%3DShen%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26atitle%3DThe%2520Histone%2520Acetylranseferase%2520Hmof%2520Acetylates%2520Nrf2%2520and%2520Regulates%2520Anti-Drug%2520Responses%2520in%2520Human%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D3196%26epage%3D3211%26doi%3D10.1111%2Fbph.12661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">The Polycomb Group Protein Ezh2 Inhibits Lung Cancer Cell Growth by Repressing the Transcription Factor Nrf2</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>588</i></span>,  <span class="NLM_fpage">3000</span>– <span class="NLM_lpage">3007</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2014.05.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.febslet.2014.05.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=588&publication_year=2014&pages=3000-3007&author=Z.+Liauthor=L.+Xuauthor=N.+Tangauthor=Y.+Xuauthor=X.+Yeauthor=S.+Shenauthor=X.+Niuauthor=S.+Luauthor=Z.+Chen&title=The+Polycomb+Group+Protein+Ezh2+Inhibits+Lung+Cancer+Cell+Growth+by+Repressing+the+Transcription+Factor+Nrf2&doi=10.1016%2Fj.febslet.2014.05.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2014.05.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2014.05.057%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DS.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DThe%2520Polycomb%2520Group%2520Protein%2520Ezh2%2520Inhibits%2520Lung%2520Cancer%2520Cell%2520Growth%2520by%2520Repressing%2520the%2520Transcription%2520Factor%2520Nrf2%26jtitle%3DFEBS%2520Lett.%26date%3D2014%26volume%3D588%26spage%3D3000%26epage%3D3007%26doi%3D10.1016%2Fj.febslet.2014.05.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Promoter Demethylation of Nuclear Factor-Erythroid 2-Related Factor 2 Gene in Drug-Resistant Colon Cancer Cells</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1287</span>– <span class="NLM_lpage">1292</span>, <span class="refDoi"> DOI: 10.3892/ol.2015.3468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.3892%2Fol.2015.3468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26622665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFOjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1287-1292&author=X.+Q.+Zhaoauthor=Y.+F.+Zhangauthor=Y.+F.+Xiaauthor=Z.+M.+Zhouauthor=Y.+Q.+Cao&title=Promoter+Demethylation+of+Nuclear+Factor-Erythroid+2-Related+Factor+2+Gene+in+Drug-Resistant+Colon+Cancer+Cells&doi=10.3892%2Fol.2015.3468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Promoter demethylation of nuclear factor-erythroid 2-related factor 2 gene in drug-resistant colon cancer cells</span></div><div class="casAuthors">Zhao, Xiao-Qian; Zhang, Yi-Fei; Xia, Yi-Fang; Zhou, Zhong-Mei; Cao, Ying-Qing</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1287-1292</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The mechanisms underlying drug resistance in colorectal cancer (CRC) treatment remain to be fully elucidated.  Therefore, the present study aimed to investigate the underlying mechanism resistance to a widely used anticancer drug, 5-Fluorouracil (5-FU).  Nuclear factor-erythroid 2-related factor 2 (Nrf2) is an important transcription factor involved in cellular protection.  In the present study, it was hypothesized that the epigenetic modification of Nrf2 may be a potential target for 5-FU resistance in CRC treatment.  Protein and mRNA levels of Nrf2, heme oxygenase-1 (HO-1), DNA methylases and DNA methyltransferases were detd. and DNA methylation anal. for the Nrf2 promoter was performed in a human CRC control (SNU-C5) and resistant (SNU-C5R) cell line.  The results demonstrated that Nrf2 expression levels, nuclear translocation and promoter binding were significantly increased in SNU-C5R cells compared with SNU-C5 cells.  Elevated levels of activated Nrf2 in SNU-C5R cells resulted in the increased protein expression and activity of HO-1.  In addn., increased prodn. of reactive oxygen species (ROS) and upregulation of ten-eleven translocation (TET)1 were obsd. in SNU-C5R cells compared with SNU-C5 cells.  Furthermore, methylation anal. revealed Nrf2 promoter cytosine-phosphate-guanine island hypomethylation in 5-FU-treated cells.  In conclusion, the results indicated that 5-FU-induced ROS prodn. resulted in the upregulation of TET1 expression and function.  In addn., these results indicated that TET-dependent demethylation of the Nrf2 promoter upregulated Nrf2 and HO-1 expression, which induced cellular protection mechanisms, ultimately leading to drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou9jjj5zCl4bVg90H21EOLACvtfcHk0liG46kTNNhhRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFOjsbk%253D&md5=1f6c6be8e53475e6c92e7a3726cc2160</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.3892%2Fol.2015.3468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2015.3468%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BQ.%26aulast%3DZhang%26aufirst%3DY.%2BF.%26aulast%3DXia%26aufirst%3DY.%2BF.%26aulast%3DZhou%26aufirst%3DZ.%2BM.%26aulast%3DCao%26aufirst%3DY.%2BQ.%26atitle%3DPromoter%2520Demethylation%2520of%2520Nuclear%2520Factor-Erythroid%25202-Related%2520Factor%25202%2520Gene%2520in%2520Drug-Resistant%2520Colon%2520Cancer%2520Cells%26jtitle%3DOncol.%2520Lett.%26date%3D2015%26volume%3D10%26spage%3D1287%26epage%3D1292%26doi%3D10.3892%2Fol.2015.3468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salazar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sagarra, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span> <span> </span><span class="NLM_article-title">Glycogen Synthase Kinase-3beta Inhibits the Xenobiotic and Antioxidant Cell Response by Direct Phosphorylation and Nuclear Exclusion of the Transcription Factor Nrf2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">14841</span>– <span class="NLM_lpage">14851</span>, <span class="refDoi"> DOI: 10.1074/jbc.M513737200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1074%2Fjbc.M513737200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=14841-14851&author=M.+Salazarauthor=A.+I.+Rojoauthor=D.+Velascoauthor=R.+M.+de+Sagarraauthor=A.+Cuadrado&title=Glycogen+Synthase+Kinase-3beta+Inhibits+the+Xenobiotic+and+Antioxidant+Cell+Response+by+Direct+Phosphorylation+and+Nuclear+Exclusion+of+the+Transcription+Factor+Nrf2&doi=10.1074%2Fjbc.M513737200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M513737200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M513737200%26sid%3Dliteratum%253Aachs%26aulast%3DSalazar%26aufirst%3DM.%26aulast%3DRojo%26aufirst%3DA.%2BI.%26aulast%3DVelasco%26aufirst%3DD.%26aulast%3Dde%2BSagarra%26aufirst%3DR.%2BM.%26aulast%3DCuadrado%26aufirst%3DA.%26atitle%3DGlycogen%2520Synthase%2520Kinase-3beta%2520Inhibits%2520the%2520Xenobiotic%2520and%2520Antioxidant%2520Cell%2520Response%2520by%2520Direct%2520Phosphorylation%2520and%2520Nuclear%2520Exclusion%2520of%2520the%2520Transcription%2520Factor%2520Nrf2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D14841%26epage%3D14851%26doi%3D10.1074%2Fjbc.M513737200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Namani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span> <span> </span><span class="NLM_article-title">Modulation of Nrf2 Signaling Pathway by Nuclear Receptors: Implications for Cancer</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1843</i></span>,  <span class="NLM_fpage">1875</span>– <span class="NLM_lpage">1885</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2014.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.bbamcr.2014.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24851839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFansL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1843&publication_year=2014&pages=1875-1885&author=A.+Namaniauthor=Y.+Liauthor=X.+J.+Wangauthor=X.+Tang&title=Modulation+of+Nrf2+Signaling+Pathway+by+Nuclear+Receptors%3A+Implications+for+Cancer&doi=10.1016%2Fj.bbamcr.2014.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer</span></div><div class="casAuthors">Namani, Akhileshwar; Li, Yulong; Wang, Xiu Jun; Tang, Xiuwen</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1843</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1875-1885</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor-erythroid 2 p45-related factor 2 (NRF2, also known as Nfe2l2) plays a crit. role in regulating cellular defense against electrophilic and oxidative stress by activating the expression of an array of antioxidant response element-dependent genes.  On one hand, NRF2 activators have been used in clin. trials for cancer prevention and the treatment of diseases assocd. with oxidative stress; on the other hand, constitutive activation of NRF2 in many types of tumors contributes to the survival and growth of cancer cells, as well as resistance to anticancer therapy.  In this review, we provide an overview of the NRF2 signaling pathway and discuss its role in carcinogenesis.  We also introduce the inhibition of NRF2 by nuclear receptors.  Further, we address the biol. significance of regulation of the NRF2 signaling pathway by nuclear receptors in health and disease.  Finally, we discuss the possible impact of NRF2 inhibition by nuclear receptors on cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiL8VWtmL6X7Vg90H21EOLACvtfcHk0lhcEk-gsn_bkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFansL3N&md5=9e2b9fa840842bb690068f2d7b574ea0</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2014.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2014.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DNamani%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DModulation%2520of%2520Nrf2%2520Signaling%2520Pathway%2520by%2520Nuclear%2520Receptors%253A%2520Implications%2520for%2520Cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2014%26volume%3D1843%26spage%3D1875%26epage%3D1885%26doi%3D10.1016%2Fj.bbamcr.2014.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span> <span> </span><span class="NLM_article-title">Rxralpha Inhibits the Nrf2-Are Signaling Pathway through a Direct Interaction with the Neh7 Domain of Nrf2</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">3097</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-12-3386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1158%2F0008-5472.CAN-12-3386" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=3097-3108&author=H.+Wangauthor=K.+Liuauthor=M.+Gengauthor=P.+Gaoauthor=X.+Wuauthor=Y.+Haiauthor=Y.+Liauthor=Y.+Liauthor=L.+Luoauthor=J.+D.+Hayesauthor=X.+J.+Wangauthor=X.+Tang&title=Rxralpha+Inhibits+the+Nrf2-Are+Signaling+Pathway+through+a+Direct+Interaction+with+the+Neh7+Domain+of+Nrf2&doi=10.1158%2F0008-5472.CAN-12-3386"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-3386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-3386%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DHai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DRxralpha%2520Inhibits%2520the%2520Nrf2-Are%2520Signaling%2520Pathway%2520through%2520a%2520Direct%2520Interaction%2520with%2520the%2520Neh7%2520Domain%2520of%2520Nrf2%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D3097%26epage%3D3108%26doi%3D10.1158%2F0008-5472.CAN-12-3386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span> <span> </span><span class="NLM_article-title">Rexinoid Inhibits Nrf2-Mediated Transcription through Retinoid X Receptor Alpha</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>452</i></span>,  <span class="NLM_fpage">554</span>– <span class="NLM_lpage">559</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2014.08.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.bbrc.2014.08.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=25172665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVOmsLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=452&publication_year=2014&pages=554-559&author=J.+Wuauthor=H.+Wangauthor=X.+Tang&title=Rexinoid+Inhibits+Nrf2-Mediated+Transcription+through+Retinoid+X+Receptor+Alpha&doi=10.1016%2Fj.bbrc.2014.08.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Rexinoid inhibits Nrf2-mediated transcription through retinoid X receptor alpha</span></div><div class="casAuthors">Wu, Jiaguo; Wang, Hongyan; Tang, Xiuwen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">452</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">554-559</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NF-E2 P45-related factor 2 (Nrf2) is a key transcription factor that controls genes encoding cytoprotective and detoxifying enzymes through antioxidant response elements (AREs) in their regulatory regions.  We reported recently that retinoid X receptor alpha (RXRα) inhibits Nrf2 function by direct interaction with the Neh7 domain of Nrf2 in a ligand-independent manner.  Here, we provide evidence that an RXRα-specific ligand, bexarotene, dose-dependently inhibits the mRNA expression of ARE-driven genes.  Knock-down of RXRα by siRNA abolished the inhibitory effect of bexarotene.  Conversely, the over-expression of RXRα enhanced the inhibition by bexarotene, indicating that the effect is mediated by RXRα.  The inhibition by bexarotene was also found in the non-small-cell lung cancer cell line A549, which carries a dysfunctional somatic mutation of Kelch-like ECH-assocd. protein 1 (KEAP1), suggesting that KEAP1 is not involved.  Our results demonstrate that rexinoid is able to inhibit the transcriptional activity of Nrf2, and that RXRα can repress the cytoprotection pathway in a ligand-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozT-3eGRcTD7Vg90H21EOLACvtfcHk0lhcEk-gsn_bkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVOmsLbL&md5=38d5a58f44c359e38807238323e65c31</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.08.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.08.111%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DRexinoid%2520Inhibits%2520Nrf2-Mediated%2520Transcription%2520through%2520Retinoid%2520X%2520Receptor%2520Alpha%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D452%26spage%3D554%26epage%3D559%26doi%3D10.1016%2Fj.bbrc.2014.08.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, C. R.</span></span> <span> </span><span class="NLM_article-title">Identification of Retinoic Acid as an Inhibitor of Transcription Factor Nrf2 through Activation of Retinoic Acid Receptor Alpha</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">19589</span>, <span class="refDoi"> DOI: 10.1073/pnas.0709483104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1073%2Fpnas.0709483104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=19589&author=X.+J.+Wangauthor=J.+D.+Hayesauthor=C.+J.+Hendersonauthor=C.+R.+Wolf&title=Identification+of+Retinoic+Acid+as+an+Inhibitor+of+Transcription+Factor+Nrf2+through+Activation+of+Retinoic+Acid+Receptor+Alpha&doi=10.1073%2Fpnas.0709483104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0709483104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0709483104%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DHenderson%26aufirst%3DC.%2BJ.%26aulast%3DWolf%26aufirst%3DC.%2BR.%26atitle%3DIdentification%2520of%2520Retinoic%2520Acid%2520as%2520an%2520Inhibitor%2520of%2520Transcription%2520Factor%2520Nrf2%2520through%2520Activation%2520of%2520Retinoic%2520Acid%2520Receptor%2520Alpha%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D19589%26doi%3D10.1073%2Fpnas.0709483104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kou, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, J.</span></span> <span> </span><span class="NLM_article-title">An Overview of Chemical Inhibitors of the Nrf2-Are Signaling Pathway and Their Potential Applications in Cancer Therapy</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2016.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2016.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27634172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGmsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2016&pages=544-556&author=J.+Zhuauthor=H.+Wangauthor=F.+Chenauthor=J.+Fuauthor=Y.+Xuauthor=Y.+Houauthor=H.+H.+Kouauthor=C.+Zhaiauthor=M.+B.+Nelsonauthor=Q.+Zhangauthor=M.+E.+Andersenauthor=J.+Pi&title=An+Overview+of+Chemical+Inhibitors+of+the+Nrf2-Are+Signaling+Pathway+and+Their+Potential+Applications+in+Cancer+Therapy&doi=10.1016%2Fj.freeradbiomed.2016.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy</span></div><div class="casAuthors">Zhu, Jiayu; Wang, Huihui; Chen, Feng; Fu, Jingqi; Xu, Yuanyuan; Hou, Yongyong; Kou, Henry H.; Zhai, Cheng; Nelson, M. Bud; Zhang, Qiang; Andersen, Melvin E.; Pi, Jingbo</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">544-556</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key transcription factor regulating a wide array of genes for antioxidant and detoxification enzymes in response to oxidative and xenobiotic stress.  A large no. of Nrf2-antioxidant response element (ARE) activators have been screened for use as chemopreventive agents in oxidative stress-related diseases and even cancer.  However, constitutive activation of Nrf2 occurs in a variety of cancers.  Aberrant activation of Nrf2 is correlated with cancer progression, chemoresistance, and radioresistance.  In this review, the authors examine recent studies of Nrf2-ARE inhibitors in the context of cancer therapy.  The authors enumerate the possible Nrf2-inhibiting mechanisms of these compds., their effects sensitizing cancer cells to chemotherapeutic agents, and the prospect of applying them in clin. cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ct8Za1a2TbVg90H21EOLACvtfcHk0liNi_WP7f6g1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGmsL%252FP&md5=2fec4e9d9e7cb5e52fe1bb709a1e73b7</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2016.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2016.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DKou%26aufirst%3DH.%2BH.%26aulast%3DZhai%26aufirst%3DC.%26aulast%3DNelson%26aufirst%3DM.%2BB.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DAndersen%26aufirst%3DM.%2BE.%26aulast%3DPi%26aufirst%3DJ.%26atitle%3DAn%2520Overview%2520of%2520Chemical%2520Inhibitors%2520of%2520the%2520Nrf2-Are%2520Signaling%2520Pathway%2520and%2520Their%2520Potential%2520Applications%2520in%2520Cancer%2520Therapy%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2016%26volume%3D99%26spage%3D544%26epage%3D556%26doi%3D10.1016%2Fj.freeradbiomed.2016.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villeneuve, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toppin, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Brusatol Enhances the Efficacy of Chemotherapy by Inhibiting the Nrf2-Mediated Defense Mechanism</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1433</span>– <span class="NLM_lpage">1438</span>, <span class="refDoi"> DOI: 10.1073/pnas.1014275108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1073%2Fpnas.1014275108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21205897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Smtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=1433-1438&author=D.+Renauthor=N.+F.+Villeneuveauthor=T.+Jiangauthor=T.+Wuauthor=A.+Lauauthor=H.+A.+Toppinauthor=D.+D.+Zhang&title=Brusatol+Enhances+the+Efficacy+of+Chemotherapy+by+Inhibiting+the+Nrf2-Mediated+Defense+Mechanism&doi=10.1073%2Fpnas.1014275108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism</span></div><div class="casAuthors">Ren, Dongmei; Villeneuve, Nicole F.; Jiang, Tao; Wu, Tongde; Lau, Alexandria; Toppin, Henry A.; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1433-1438, S1433/1-S1433/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The major obstacle in cancer treatment is the resistance of cancer cells to therapies.  Nrf2 is a transcription factor that regulates a cellular defense response and is ubiquitously expressed at low basal levels in normal tissues due to Keap1-dependent ubiquitination and proteasomal degrdn.  Recently, Nrf2 has emerged as an important contributor to chemoresistance.  High constitutive expression of Nrf2 was found in many types of cancers, creating an environment conducive for cancer cell survival.  Here, we report the identification of brusatol as a unique inhibitor of the Nrf2 pathway that sensitizes a broad spectrum of cancer cells and A549 xenografts to cisplatin and other chemotherapeutic drugs.  Mechanistically, brusatol selectively reduces the protein level of Nrf2 through enhanced ubiquitination and degrdn. of Nrf2.  Consequently, expression of Nrf2-downstream genes is reduced and the Nrf2-dependent protective response is suppressed.  In A549 xenografts, brusatol and cisplatin cotreatment induced apoptosis, reduced cell proliferation, and inhibited tumor growth more substantially when compared with cisplatin treatment alone.  Addnl., A549-K xenografts, in which Nrf2 is expressed at very low levels due to ectopic expression of Keap1, do not respond to brusatol treatment, demonstrating that brusatol-mediated sensitization to cisplatin is Nrf2 dependent.  Moreover, a decrease in drug detoxification and impairment in drug removal may be the primary mechanisms by which brusatol enhances the efficacy of chemotherapeutic drugs.  Taken together, these results clearly demonstrate the effectiveness of using brusatol to combat chemoresistance and suggest that brusatol can be developed into an adjuvant chemotherapeutic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruj8dASN0Mv7Vg90H21EOLACvtfcHk0liNi_WP7f6g1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Smtrs%253D&md5=6d2cad037bc5db9e922d100338d6fdf9</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1014275108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1014275108%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DD.%26aulast%3DVilleneuve%26aufirst%3DN.%2BF.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DToppin%26aufirst%3DH.%2BA.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DBrusatol%2520Enhances%2520the%2520Efficacy%2520of%2520Chemotherapy%2520by%2520Inhibiting%2520the%2520Nrf2-Mediated%2520Defense%2520Mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D1433%26epage%3D1438%26doi%3D10.1073%2Fpnas.1014275108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vartanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haverty, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokoe, D.</span></span> <span> </span><span class="NLM_article-title">Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1220</span>– <span class="NLM_lpage">1231</span>, <span class="refDoi"> DOI: 10.1074/mcp.M115.055509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1074%2Fmcp.M115.055509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26711467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlansLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=1220-1231&author=S.+Vartanianauthor=T.+P.+Maauthor=J.+Leeauthor=P.+M.+Havertyauthor=D.+S.+Kirkpatrickauthor=K.+Yuauthor=D.+Stokoe&title=Application+of+Mass+Spectrometry+Profiling+to+Establish+Brusatol+as+an+Inhibitor+of+Global+Protein+Synthesis&doi=10.1074%2Fmcp.M115.055509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis</span></div><div class="casAuthors">Vartanian, Steffan; Ma, Taylur P.; Lee, James; Haverty, Peter M.; Kirkpatrick, Donald S.; Yu, Kebing; Stokoe, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Proteomics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1220-1231</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9484</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The KEAP1/Nrf2 pathway senses and responds to changes in intracellular oxidative stress.  Mutations that result in constitutive activation of Nrf2 are present in several human tumors, esp. non-small cell lung cancer.  Therefore, compds. that inhibit Nrf2 activity might be beneficial in treating patients whose tumors show activation of this pathway.  Recent reports suggest that the natural product brusatol can potently and selectively inhibit Nrf2 activity, resulting in cell cytotoxicity, and can be effectively combined with chemotherapeutic agents.  Here, we analyzed the effects of brusatol on the cellular proteome in the KEAP1 mutant non-small cell lung cancer cell line A549.  Brusatol was found to rapidly and potently decrease the expression of the majority of detected proteins, including Nrf2.  The most dramatically decreased proteins are those that display a short half-life, like Nrf2.  This effect was confirmed by restricting the anal. to newly synthesized proteins using a labeled methionine analog.  Moreover, brusatol increased the expression of multiple components of the ribosome, suggesting that it regulates the function of this macromol. complex.  Finally, we show that brusatol induces its potent cellular cytotoxicity effects on multiple cancer cell lines in a manner independent of KEAP1/Nrf2 activity and with a profile similar to the protein translation inhibitor silvestrol.  In conclusion, our data show that the activity of brusatol is not restricted to Nrf2 but, rather, functions as a global protein synthesis inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraWIVABhhpmrVg90H21EOLACvtfcHk0liNi_WP7f6g1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlansLw%253D&md5=93889d70b1c7a0fd32877926248a89cc</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M115.055509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M115.055509%26sid%3Dliteratum%253Aachs%26aulast%3DVartanian%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DT.%2BP.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHaverty%26aufirst%3DP.%2BM.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DStokoe%26aufirst%3DD.%26atitle%3DApplication%2520of%2520Mass%2520Spectrometry%2520Profiling%2520to%2520Establish%2520Brusatol%2520as%2520an%2520Inhibitor%2520of%2520Global%2520Protein%2520Synthesis%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2016%26volume%3D15%26spage%3D1220%26epage%3D1231%26doi%3D10.1074%2Fmcp.M115.055509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Clair, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Brusatol Overcomes Chemoresistance through Inhibition of Protein Translation</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1493</span>– <span class="NLM_lpage">1500</span>, <span class="refDoi"> DOI: 10.1002/mc.22609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1002%2Fmc.22609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28019675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1Wmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=1493-1500&author=B.+Harderauthor=W.+Tianauthor=J.+J.+La+Clairauthor=A.-C.+Tanauthor=A.+Ooiauthor=E.+Chapmanauthor=D.+D.+Zhang&title=Brusatol+Overcomes+Chemoresistance+through+Inhibition+of+Protein+Translation&doi=10.1002%2Fmc.22609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol overcomes chemoresistance through inhibition of protein translation</span></div><div class="casAuthors">Harder, Bryan; Tian, Wang; La Clair, James J.; Tan, Aik-Choon; Ooi, Aikseng; Chapman, Eli; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1493-1500</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The NRF2 pathway activates a cell survival response when cells are exposed to xenobiotics or are under oxidative stress.  Therapeutic activation of NRF2 can also be used prior to insult as a means of disease prevention.  However, prolonged expression of NRF2 has been shown to protect cancer cells by inducing the metab. and efflux of chemotherapeutics, leading to both intrinsic and acquired chemoresistance to cancer drugs.  This effect has been termed the "dark side" of NRF2.  In an effort to combat this chemoresistance, our group discovered the first NRF2 inhibitor, the natural product brusatol, however the mechanism of inhibition was previously unknown.  In this report, we show that brusatol's mode of action is not through direct inhibition of the NRF2 pathway, but through the inhibition of both cap-dependent and cap-independent protein translation, which has an impact on many short-lived proteins, including NRF2.  Therefore, there is still a need to develop a new generation of specific NRF2 inhibitors with limited toxicity and off-target effects that could be used as adjuvant therapies to sensitize cancers with high expression of NRF2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYEXTD-im3kLVg90H21EOLACvtfcHk0lgI-ZchRpJErQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1Wmurw%253D&md5=ce13967747c43025a1287dce903f9831</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1002%2Fmc.22609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.22609%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DB.%26aulast%3DTian%26aufirst%3DW.%26aulast%3DLa%2BClair%26aufirst%3DJ.%2BJ.%26aulast%3DTan%26aufirst%3DA.-C.%26aulast%3DOoi%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DBrusatol%2520Overcomes%2520Chemoresistance%2520through%2520Inhibition%2520of%2520Protein%2520Translation%26jtitle%3DMol.%2520Carcinog.%26date%3D2017%26volume%3D56%26spage%3D1493%26epage%3D1500%26doi%3D10.1002%2Fmc.22609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ki, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. G.</span></span> <span> </span><span class="NLM_article-title">Glucocorticoid Receptor (Gr)-Associated Smrt Binding to C/Ebpbeta Tad and Nrf2 Neh4/5: Role of Smrt Recruited to Gr in Gsta2 Gene Repression</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4150</span>– <span class="NLM_lpage">4165</span>, <span class="refDoi"> DOI: 10.1128/MCB.25.10.4150-4165.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1128%2FMCB.25.10.4150-4165.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=15870285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlSmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=4150-4165&author=S.+H.+Kiauthor=I.+J.+Choauthor=D.+W.+Choiauthor=S.+G.+Kim&title=Glucocorticoid+Receptor+%28Gr%29-Associated+Smrt+Binding+to+C%2FEbpbeta+Tad+and+Nrf2+Neh4%2F5%3A+Role+of+Smrt+Recruited+to+Gr+in+Gsta2+Gene+Repression&doi=10.1128%2FMCB.25.10.4150-4165.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPβ TAD and Nrf2 Neh4/5: Role of SMRT recruited to GR in GSTA2 gene repression</span></div><div class="casAuthors">Ki, Sung Hwan; Cho, Il Je; Choi, Dal Woong; Kim, Sang Geon</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4150-4165</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The expression of the glutathione S-transferase gene (GST), whose induction accounts for cancer chemoprevention, is regulated by activation of CCAAT/enhancer binding protein β (C/EBPβ) and NF-E2-related factor 2 (Nrf2).  The present study investigated the repressing effects of activating glucocorticoid receptor (GR) on C/EBPβ- and Nrf2-mediated GSTA2 gene induction and the mechanism.  Dexamethasone that activates GR inhibited constitutive and oltipraz- or tert-butylhydroquinone (t-BHQ)-inducible GSTA2 expression in H4IIE cells.  Also, dexamethasone repressed GSTA2 promoter-luciferase gene activity.  Dexamethasone-GR activation did not inhibit nuclear translocation of C/EBPβ or Nrf2 nor their DNA binding activities induced by oltipraz or t-BHQ.  Deletion of the glucocorticoid response element (GRE) in the GSTA2 promoter abolished dexamethasone inhibition of the gene induction.  Immunopptn.-immunoblotting, chromatin immunopptn., and GST pull-down assays revealed that silencing mediator for retinoid and thyroid hormone receptors (SMRT), a corepressor recruited to steroid-GR complex for histone deacetylation, bound to TAD domain of C/EBPβ and Neh4/5 domain of Nrf2.  The GSTA2 promoter-luciferase activities were decreased by SMRT but not by truncated SMRTs.  The small interference RNA (siRNA) against SMRT abolished SMRT repression of the gene induction by C/EBPβ or Nrf2.  The plasmid transfection and siRNA expts. directly evidenced the functional role of SMRT in GSTA2 repression.  In conclusion, dexamethasone antagonizes C/EBPβ- and Nrf2-mediated GSTA2 gene induction via ligand-GR binding to the GRE, and steroid-mediated GSTA2 repression involves inactivation of C/EBPβ and Nrf2 by SMRT recruited to steroid-GR complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUWK-jbzzM1bVg90H21EOLACvtfcHk0lgI-ZchRpJErQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlSmu7c%253D&md5=f270db6f70b46c19713e0f0d072d688b</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1128%2FMCB.25.10.4150-4165.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.25.10.4150-4165.2005%26sid%3Dliteratum%253Aachs%26aulast%3DKi%26aufirst%3DS.%2BH.%26aulast%3DCho%26aufirst%3DI.%2BJ.%26aulast%3DChoi%26aufirst%3DD.%2BW.%26aulast%3DKim%26aufirst%3DS.%2BG.%26atitle%3DGlucocorticoid%2520Receptor%2520%2528Gr%2529-Associated%2520Smrt%2520Binding%2520to%2520C%252FEbpbeta%2520Tad%2520and%2520Nrf2%2520Neh4%252F5%253A%2520Role%2520of%2520Smrt%2520Recruited%2520to%2520Gr%2520in%2520Gsta2%2520Gene%2520Repression%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D4150%26epage%3D4165%26doi%3D10.1128%2FMCB.25.10.4150-4165.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kratschmar, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lister, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appenzeller-Herzog, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odermatt, A.</span></span> <span> </span><span class="NLM_article-title">Suppression of the Nrf2-Dependent Antioxidant Response by Glucocorticoids and 11beta-Hsd1-Mediated Glucocorticoid Activation in Hepatic Cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e36774</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0036774</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1371%2Fjournal.pone.0036774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22606287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslOqsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=D.+V.+Kratschmarauthor=D.+Calabreseauthor=J.+Walshauthor=A.+Listerauthor=J.+Birkauthor=C.+Appenzeller-Herzogauthor=P.+Moulinauthor=C.+E.+Goldringauthor=A.+Odermatt&title=Suppression+of+the+Nrf2-Dependent+Antioxidant+Response+by+Glucocorticoids+and+11beta-Hsd1-Mediated+Glucocorticoid+Activation+in+Hepatic+Cells&doi=10.1371%2Fjournal.pone.0036774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of the Nrf2-dependent antioxidant response by glucocorticoids and 11β-HSD1-mediated glucocorticoid activation in hepatic cells</span></div><div class="casAuthors">Kratschmar, Denise V.; Calabrese, Diego; Walsh, Jo; Lister, Adam; Birk, Julia; Appenzeller-Herzog, Christian; Moulin, Pierre; Goldring, Chris E.; Odermatt, Alex</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e36774</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a key transcription factor regulating a plethora of detoxifying enzymes and antioxidant genes involved in drug metab. and defense against oxidative stress.  The glucocorticoid receptor (GR) is a ligand-induced transcription factor involved in the regulation of energy supply for metabolic needs to cope with various stressors.  GR activity is controlled by glucocorticoids, which are synthesized in the adrenal glands and regenerated mainly in the liver from inactive cortisone by 11β-hydroxysteroid dehydrogenase-1 (11β-HSD1).  Methods and Principal Findings: Using transfected HEK-293 cells and hepatic H4IIE cells we show that glucocorticoids, activated by 11β-HSD1 and acting through GR, suppress the Nrf2-dependent antioxidant response.  The expression of the marker genes NQO1, HMOX1 and GST2A was suppressed upon treatment of 11β-HSD1 expressing cells with cortisone, an effect that was reversed by 11β-HSD1 inhibitors.  Furthermore, our results demonstrate that elevated glucocorticoids lowered the ability of cells to detoxify H2O2.  Moreover, a comparison of gene expression in male and female rats revealed an opposite sexual dimorphism with an inverse relationship between 11β-HSD1 and Nrf2 target gene expression.  Conclusions: The results demonstrate a suppression of the cellular antioxidant defense capacity by glucocorticoids and suggest that elevated 11β-HSD1 activity may lead to impaired Nrf2-dependent antioxidant response.  The gender-specific differences in hepatic expression levels of 11β-HSD1 and Nrf2 target genes and the impact of pharmacol. inhibition of 11β-HSD1 on improving cellular capacity to cope with oxidative stress warrants further studies in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0We0cqLQJVbVg90H21EOLACvtfcHk0lgI-ZchRpJErQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslOqsro%253D&md5=fa8d77b4de59cd56bd1a81f8a3a17688</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0036774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0036774%26sid%3Dliteratum%253Aachs%26aulast%3DKratschmar%26aufirst%3DD.%2BV.%26aulast%3DCalabrese%26aufirst%3DD.%26aulast%3DWalsh%26aufirst%3DJ.%26aulast%3DLister%26aufirst%3DA.%26aulast%3DBirk%26aufirst%3DJ.%26aulast%3DAppenzeller-Herzog%26aufirst%3DC.%26aulast%3DMoulin%26aufirst%3DP.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DOdermatt%26aufirst%3DA.%26atitle%3DSuppression%2520of%2520the%2520Nrf2-Dependent%2520Antioxidant%2520Response%2520by%2520Glucocorticoids%2520and%252011beta-Hsd1-Mediated%2520Glucocorticoid%2520Activation%2520in%2520Hepatic%2520Cells%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0036774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, S. M.</span></span> <span> </span><span class="NLM_article-title">A Clinical Drug Library Screen Identifies Clobetasol Propionate as an Nrf2 Inhibitor with Potential Therapeutic Efficacy in Keap1Mutant Lung Cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">5285</span>– <span class="NLM_lpage">5295</span>, <span class="refDoi"> DOI: 10.1038/onc.2017.153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fonc.2017.153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28504720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1KmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=5285-5295&author=E.+J.+Choiauthor=B.+J.+Jungauthor=S.+H.+Leeauthor=H.+S.+Yooauthor=E.+A.+Shinauthor=H.+J.+Koauthor=S.+Changauthor=S.+Y.+Kimauthor=S.+M.+Jeon&title=A+Clinical+Drug+Library+Screen+Identifies+Clobetasol+Propionate+as+an+Nrf2+Inhibitor+with+Potential+Therapeutic+Efficacy+in+Keap1Mutant+Lung+Cancer&doi=10.1038%2Fonc.2017.153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer</span></div><div class="casAuthors">Choi, E.-J.; Jung, B.-J.; Lee, S.-H.; Yoo, H.-S.; Shin, E.-A.; Ko, H.-J.; Chang, S.; Kim, S.-Y.; Jeon, S.-M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5285-5295</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The Kelch-like ECH-assocd. protein 1 (KEAP1)-nuclear factor E2-related factor 2 (NRF2)pathway has a central role in cellular antioxidant defense.  NRF2 activation due to KEAP1 or NRF2 mutations occurs frequently in many cancers, suggesting that NRF2 inhibition could be a promising therapeutic strategy.  However, no potent NRF2 inhibitors are clin. available to date.  To develop potent NRF2 inhibitors for therapeutic purpose, we screened ∼4000 clin. compds. and detd. clobetasol propionate (CP) as the most potent NRF2 inhibitor.  Mechanistically, CP prevented nuclear accumulation and promoted β-TrCP-dependent degrdn. of NRF2 in a glucocorticoid receptor- and a glycogen synthase kinase 3 (GSK3)-dependent manner.  As a result, CP induced oxidative stress and strongly suppressed the anchorage-independent growth of tumors with KEAP1 mutation, but not with the wild-type KEAP1.  Further, CP alone or in combination with rapamycin strongly inhibited the in vitro and in vivo growth of tumors harboring mutations in KEAP1 or both KEAP1 and LKB1 that are frequently obsd. in lung cancer.  Thus, CP could be a repurposed therapeutic agent for cancers with high NRF2 activity.  We also proposed that the use CP and rapamycin in combination could be a potential therapeutic strategy for tumors harboring both KEAP1 and LKB1 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXEhMDJKow9bVg90H21EOLACvtfcHk0ligAdGIRT06tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1KmsrY%253D&md5=001ddc664eef87b8b60948266f27d11f</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fonc.2017.153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2017.153%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DE.%2BJ.%26aulast%3DJung%26aufirst%3DB.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DYoo%26aufirst%3DH.%2BS.%26aulast%3DShin%26aufirst%3DE.%2BA.%26aulast%3DKo%26aufirst%3DH.%2BJ.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DJeon%26aufirst%3DS.%2BM.%26atitle%3DA%2520Clinical%2520Drug%2520Library%2520Screen%2520Identifies%2520Clobetasol%2520Propionate%2520as%2520an%2520Nrf2%2520Inhibitor%2520with%2520Potential%2520Therapeutic%2520Efficacy%2520in%2520Keap1Mutant%2520Lung%2520Cancer%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D5285%26epage%3D5295%26doi%3D10.1038%2Fonc.2017.153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span> <span> </span><span class="NLM_article-title">Luteolin Inhibits Nrf2 Leading to Negative Regulation of the Nrf2/Are Pathway and Sensitization of Human Lung Carcinoma A549 Cells to Therapeutic Drugs</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1599</span>– <span class="NLM_lpage">1609</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2011.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=21402146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVWhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=1599-1609&author=X.+Tangauthor=H.+Wangauthor=L.+Fanauthor=X.+Wuauthor=A.+Xinauthor=H.+Renauthor=X.+J.+Wang&title=Luteolin+Inhibits+Nrf2+Leading+to+Negative+Regulation+of+the+Nrf2%2FAre+Pathway+and+Sensitization+of+Human+Lung+Carcinoma+A549+Cells+to+Therapeutic+Drugs&doi=10.1016%2Fj.freeradbiomed.2011.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs</span></div><div class="casAuthors">Tang, Xiuwen; Wang, Hongyan; Fan, Longfang; Wu, Xiaoyuan; Xin, Ai; Ren, Huanyu; Wang, Xiu Jun</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1599-1609</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nuclear factor erythroid 2-related factor 2 (Nrf2) is a redox-sensitive transcription factor regulating the expression of a battery of cytoprotective genes.  Constitutive Nrf2 activation in many tumors enhances cell survival and resistance to anticancer drugs.  Using a cell-based ARE-reporter assay we discovered that the flavonoid luteolin is a potent Nrf2 inhibitor.  Luteolin inhibited ARE-driven gene expression redox-independently.  In non-small-cell lung cancer A549 cells, which possess constitutively active Nrf2, luteolin elicited a dramatic redn. in Nrf2 at both the mRNA and the protein levels, leading to decreased Nrf2 binding to AREs, down-regulation of ARE-driven genes, and depletion of reduced glutathione.  After transcription was blocked with actinomycin D, 1 μM luteolin decreased the Nrf2 mRNA level by 34% in 30 min, indicating its role in accelerating Nrf2 mRNA turnover.  At physiol. concns., luteolin significantly sensitized A549 cells to the anticancer drugs oxaliplatin, bleomycin, and doxorubicin.  However, knockdown of Nrf2 using siRNA essentially abolished the induced sensitivity by the flavonoid, implying the importance of inhibiting Nrf2 for its activity.  Our study demonstrates that an Nrf2 inhibitor can enhance the responsiveness of cancer cells to chemotherapeutic drugs and indicates the potential application of luteolin as a natural sensitizer in chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCZiZuGbdJwrVg90H21EOLACvtfcHk0ligAdGIRT06tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVWhtb8%253D&md5=8e03500dd1d1e865661be2267dd95fca</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DXin%26aufirst%3DA.%26aulast%3DRen%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26atitle%3DLuteolin%2520Inhibits%2520Nrf2%2520Leading%2520to%2520Negative%2520Regulation%2520of%2520the%2520Nrf2%252FAre%2520Pathway%2520and%2520Sensitization%2520of%2520Human%2520Lung%2520Carcinoma%2520A549%2520Cells%2520to%2520Therapeutic%2520Drugs%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2011%26volume%3D50%26spage%3D1599%26epage%3D1609%26doi%3D10.1016%2Fj.freeradbiomed.2011.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thapa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span> <span> </span><span class="NLM_article-title">Luteolin Inhibits the Nrf2 Signaling Pathway and Tumor Growth in Vivo</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>447</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2014.04.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.bbrc.2014.04.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2014&pages=602-608&author=S.+Chianauthor=R.+Thapaauthor=Z.+Chiauthor=X.+J.+Wangauthor=X.+Tang&title=Luteolin+Inhibits+the+Nrf2+Signaling+Pathway+and+Tumor+Growth+in+Vivo&doi=10.1016%2Fj.bbrc.2014.04.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.04.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.04.039%26sid%3Dliteratum%253Aachs%26aulast%3DChian%26aufirst%3DS.%26aulast%3DThapa%26aufirst%3DR.%26aulast%3DChi%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DLuteolin%2520Inhibits%2520the%2520Nrf2%2520Signaling%2520Pathway%2520and%2520Tumor%2520Growth%2520in%2520Vivo%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D447%26spage%3D602%26epage%3D608%26doi%3D10.1016%2Fj.bbrc.2014.04.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baiyun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Regulation of Sirt1/Nrf2/Tnf-Alpha Signaling Pathway by Luteolin Is Critical to Attenuate Acute Mercuric Chloride Exposure Induced Hepatotoxicity</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">37157</span>, <span class="refDoi"> DOI: 10.1038/srep37157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fsrep37157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=27853236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntlCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=37157&author=D.+Yangauthor=X.+Tanauthor=Z.+Lvauthor=B.+Liuauthor=R.+Baiyunauthor=J.+Luauthor=Z.+Zhang&title=Regulation+of+Sirt1%2FNrf2%2FTnf-Alpha+Signaling+Pathway+by+Luteolin+Is+Critical+to+Attenuate+Acute+Mercuric+Chloride+Exposure+Induced+Hepatotoxicity&doi=10.1038%2Fsrep37157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Sirt1/Nrf2/TNF-α signaling pathway by luteolin is critical to attenuate acute mercuric chloride exposure induced hepatotoxicity</span></div><div class="casAuthors">Yang, Daqian; Tan, Xiao; Lv, Zhanjun; Liu, Biying; Baiyun, Ruiqi; Lu, Jingjing; Zhang, Zhigang</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37157</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inorg. mercury, though a key component of pediatric vaccines, is an environmental toxicant threatening human health via accumulating oxidative stress in part.  Luteolin has been of great interest because of its antiinflammatory, anticarcinogenic and antioxidative effects.  Here we hypothesized that luteolin would attenuate hepatotoxicity induced by acute inorg. mercury exposure.  Kunming mice were treated with luteolin (100 mg/kg) 24 h after administration of 4 mg/kg mercuric chloride (HgCl2).  The results showed that luteolin ameliorated HgCl2 induced anemia and hepatotoxicity, regulating radical oxygen species (ROS) prodn. and hepatocyte viability in vitro and oxidative stress and apoptosis in vivo.  Furthermore, luteolin reversed the changes in levels of inflammation- and apoptosis-related proteins involving NF-κB, TNF-α, Sirt1, mTOR, Bax, p53, and Bcl-2, and inhibited p38 MAPK activation.  Luteolin enhanced antioxidant defense system based on Keap1, Nrf2, HO-1, NQO1, and KLF9.  Moreover, luteolin did not affect miRNA-146a expression.  Collectively, our findings, for the first time, elucidate a precise mechanism for attenuation of HgCl2-induced liver dysfunction by dietary luteolin via regulating Sirt1/Nrf2/TNF-α signaling pathway, and provide a foundation for further study of luteolin as a novel therapeutic agent against inorg. mercury poisoning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfb6Q3ya-QH7Vg90H21EOLACvtfcHk0ljHHYugWyDYFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntlCmsA%253D%253D&md5=0bcb6d85e32303d8df5e44c297de80b3</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1038%2Fsrep37157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep37157%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DBaiyun%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DRegulation%2520of%2520Sirt1%252FNrf2%252FTnf-Alpha%2520Signaling%2520Pathway%2520by%2520Luteolin%2520Is%2520Critical%2520to%2520Attenuate%2520Acute%2520Mercuric%2520Chloride%2520Exposure%2520Induced%2520Hepatotoxicity%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D37157%26doi%3D10.1038%2Fsrep37157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span> <span> </span><span class="NLM_article-title">Luteolin Provides Neuroprotection in Models of Traumatic Brain Injury Via the Nrf2-Are Pathway</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2014.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2014.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24642087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVKjt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=186-195&author=J.+Xuauthor=H.+Wangauthor=K.+Dingauthor=L.+Zhangauthor=C.+Wangauthor=T.+Liauthor=W.+Weiauthor=X.+Lu&title=Luteolin+Provides+Neuroprotection+in+Models+of+Traumatic+Brain+Injury+Via+the+Nrf2-Are+Pathway&doi=10.1016%2Fj.freeradbiomed.2014.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE pathway</span></div><div class="casAuthors">Xu, Jianguo; Wang, Handong; Ding, Ke; Zhang, Li; Wang, Chunxi; Li, Tao; Wei, Wuting; Lu, Xinyu</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">186-195</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Luteolin has recently been proven to exert neuroprotection in a variety of neurol. diseases; however, its roles and the underlying mechanisms in traumatic brain injury are not fully understood.  The present study was aimed to investigate the neuroprotective effects of luteolin in models of traumatic brain injury (TBI) and the possible role of the Nrf2-ARE pathway in the putative neuroprotection.  A modified Marmarou's wt.-drop model in mice and the scratch model in mice primary cultured neurons were used to induce TBI.  The authors detd. that luteolin significantly ameliorated secondary brain injury induced by TBI, including neurol. deficits, brain water content, and neuronal apoptosis.  Furthermore, the level of malondialdehyde (MDA) and the activity of glutathione peroxidase (GPx) were restored in the group with luteolin treatment.  In vitro studies showed that luteolin administration lowered the intracellular reactive oxygen species (ROS) level and increased the neuron survival.  Moreover, luteolin enhanced the translocation of Nrf2 to the nucleus both in vivo and in vitro, which was proved by the results of Western blot, immunohistochem., and electrophoretic mobility shift assay (EMSA).  Subsequently upregulation of the expression of the downstream factors such as heme oxygenase 1 (HO1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) was also examd.  However, luteolin treatment failed to provide neuroprotection after TBI in Nrf2-/- mice.  Taken together, these in vivo and in vitro data demonstrated that luteolin provided neuroprotective effects in the models of TBI, possibly through the activation of the Nrf2-ARE pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsB8nnWnoSALVg90H21EOLACvtfcHk0ljHHYugWyDYFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVKjt7k%253D&md5=d227b73f4b31df30b5f4ad8d9800be4b</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2014.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2014.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DX.%26atitle%3DLuteolin%2520Provides%2520Neuroprotection%2520in%2520Models%2520of%2520Traumatic%2520Brain%2520Injury%2520Via%2520the%2520Nrf2-Are%2520Pathway%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2014%26volume%3D71%26spage%3D186%26epage%3D195%26doi%3D10.1016%2Fj.freeradbiomed.2014.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, R.</span></span> <span> </span><span class="NLM_article-title">Wogonin-Enhanced Reactive Oxygen Species-Induced Apoptosis and Potentiated Cytotoxic Effects of Chemotherapeutic Agents by Suppression Nrf2-Mediated Signaling in Hepg2 Cells</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">607</span>– <span class="NLM_lpage">621</span>, <span class="refDoi"> DOI: 10.3109/10715762.2014.897342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.3109%2F10715762.2014.897342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24666416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltlyrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2014&pages=607-621&author=C.+Qianauthor=Y.+Wangauthor=Y.+Zhongauthor=J.+Tangauthor=J.+Zhangauthor=Z.+Liauthor=Q.+Wangauthor=R.+Hu&title=Wogonin-Enhanced+Reactive+Oxygen+Species-Induced+Apoptosis+and+Potentiated+Cytotoxic+Effects+of+Chemotherapeutic+Agents+by+Suppression+Nrf2-Mediated+Signaling+in+Hepg2+Cells&doi=10.3109%2F10715762.2014.897342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Wogonin-enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by suppression Nrf2-mediated signaling in HepG2 cells</span></div><div class="casAuthors">Qian, C.; Wang, Y.; Zhong, Y.; Tang, J.; Zhang, J.; Li, Z.; Wang, Q.; Hu, R.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">607-621</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1029-2470</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Cancer cells, compared with normal cells, are under increased oxidative stress with higher level of reactive oxygen species (ROS).  When exposed to environmental stresses such as ROS, NFE-related factor 2 (Nrf2) is the key to antioxidant response by transcriptionally activating various detoxification and antioxidant enzymes.  Previously, we have shown that wogonin, a flavonoid isolated from the root of Scutellaria baicalensis Georgi, could reverse drug resistance in MCF-7/DOX cells by blocking the translocation of Nrf2 into nucleus.  However, the exact mechanism underlying the effect remains unclear.  In this study, we obsd. that wogonin reduced the Nrf2 nuclear translocation, and therefore elevated the level of intracellular ROS to accomplish the purpose of killing malignant cells.  Furthermore, the suppression of Nrf2 by wogonin can potentiate cytotoxic effects of chemotherapeutic agents in HepG2 cells.  On one hand, down-regulation of Nrf2 lead to redn. of cytoprotective effect by inducing phage II enzymes which sensitize cells to chemotherapeutic agents.  On the other hand, inhibition of multidrug resistance-assocd. proteins (MRPs) by wogonin enhances the effective drug level in cancer cells and potentiates their chemotherapeutic effects.  Finally, we found that the decrease of Nrf2 may be related to overexpression of p53.  Using p53 siRNA to knock down the endogenous p53 expression, the levels of both c-myc and Nrf2 in nucleus increased when exposed to wogonin.  The present study indicates that wogonin can be used in chemotherapy not only because of its own antitumor ability, but also due to the enhanced cytotoxic effects of chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb7phGwK634bVg90H21EOLACvtfcHk0ljHHYugWyDYFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltlyrsL0%253D&md5=1d58bc4620d4d71bea63228dd6c97f97</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.3109%2F10715762.2014.897342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10715762.2014.897342%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DR.%26atitle%3DWogonin-Enhanced%2520Reactive%2520Oxygen%2520Species-Induced%2520Apoptosis%2520and%2520Potentiated%2520Cytotoxic%2520Effects%2520of%2520Chemotherapeutic%2520Agents%2520by%2520Suppression%2520Nrf2-Mediated%2520Signaling%2520in%2520Hepg2%2520Cells%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2014%26volume%3D48%26spage%3D607%26epage%3D621%26doi%3D10.3109%2F10715762.2014.897342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, R.</span></span> <span> </span><span class="NLM_article-title">Drug Resistance Associates with Activation of Nrf2 in Mcf-7/Dox Cells, and Wogonin Reverses It by Down-Regulating Nrf2-Mediated Cellular Defense Response</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">824</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1002/mc.21921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1002%2Fmc.21921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=22593043" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=824-834&author=Y.+Zhongauthor=F.+Zhangauthor=Z.+Sunauthor=W.+Zhouauthor=Z.+Y.+Liauthor=Q.+D.+Youauthor=Q.+L.+Guoauthor=R.+Hu&title=Drug+Resistance+Associates+with+Activation+of+Nrf2+in+Mcf-7%2FDox+Cells%2C+and+Wogonin+Reverses+It+by+Down-Regulating+Nrf2-Mediated+Cellular+Defense+Response&doi=10.1002%2Fmc.21921"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1002%2Fmc.21921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.21921%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%2BY.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DGuo%26aufirst%3DQ.%2BL.%26aulast%3DHu%26aufirst%3DR.%26atitle%3DDrug%2520Resistance%2520Associates%2520with%2520Activation%2520of%2520Nrf2%2520in%2520Mcf-7%252FDox%2520Cells%252C%2520and%2520Wogonin%2520Reverses%2520It%2520by%2520Down-Regulating%2520Nrf2-Mediated%2520Cellular%2520Defense%2520Response%26jtitle%3DMol.%2520Carcinog.%26date%3D2012%26volume%3D52%26spage%3D824%26epage%3D834%26doi%3D10.1002%2Fmc.21921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q. L.</span></span> <span> </span><span class="NLM_article-title">Nf-Kappab and Nrf2 Signaling Pathways Contribute to Wogonin-Mediated Inhibition of Inflammation-Associated Colorectal Carcinogenesis</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e1283</span> <span class="refDoi"> DOI: 10.1038/cddis.2014.221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fcddis.2014.221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24901054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVGqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=J.+Yaoauthor=L.+Zhaoauthor=Q.+Zhaoauthor=Y.+Zhaoauthor=Y.+Sunauthor=Y.+Zhangauthor=H.+Miaoauthor=Q.+D.+Youauthor=R.+Huauthor=Q.+L.+Guo&title=Nf-Kappab+and+Nrf2+Signaling+Pathways+Contribute+to+Wogonin-Mediated+Inhibition+of+Inflammation-Associated+Colorectal+Carcinogenesis&doi=10.1038%2Fcddis.2014.221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis</span></div><div class="casAuthors">Yao, J.; Zhao, L.; Zhao, Q.; Zhao, Y.; Sun, Y.; Zhang, Y.; Miao, H.; You, Q.-D.; Hu, R.; Guo, Q.-L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1283</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The transcriptional factors nuclear factor-κB (NF-κB) and NF-E2-related factor 2 (Nrf2) have been recently reported to have crit. roles in protecting various tissues against inflammation and colitis-assocd. colorectal cancer (aberrant crypt foci).  Our previous studies showed that wogonin (5,7-dihydroxy-8-methoxyflavone) possessed anti-neoplastic and anti-inflammatory activities.  The present study extended these important earlier findings by exploring the effect of wogonin on the initiation and development of colitis-assocd. cancer.  Wogonin lowered tumor incidence and inhibited the development of colorectal adenomas in azoxymethane- or dextran sulfate sodium-induced mice.  We found that wogonin significantly decreased the secretion and expression of IL-6 and IL-1β, reduced cell proliferation and nuclear expression of NF-κB in adenomas and surrounding tissues and promoted Nrf2 nuclear translocation in surrounding tissues, although overexpressed Nrf2 in tumor tissues was independent of wogonin administration.  Furthermore, wogonin inhibited the interaction between human monocytic THP-1 cells and human colon cancer HCT116 cells, and significantly downregulated lipopolysaccharide-induced secretion of prototypical pro-inflammatory cytokines IL-6 and IL-1β in THP-1 cells.  Further mechanism research revealed that wogonin inhibited the nuclear translocation of NF-κB and phosphorylation of IκB and IKKα/β, and promoted Nrf2 signaling pathway in HCT116 cells and THP-1 cells.  Taken together, the present results indicated that wogonin effectively suppressed inflammation-assocd. colon carcinogenesis and cancer development, suggesting its potential as a chemopreventive agent against colitis-assocd. colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo109avlHdLbLVg90H21EOLACvtfcHk0lh-yAO8zLC6BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVGqt7w%253D&md5=d0a74c9f17fddefdc0d2f377a24061e3</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.221%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DHu%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DQ.%2BL.%26atitle%3DNf-Kappab%2520and%2520Nrf2%2520Signaling%2520Pathways%2520Contribute%2520to%2520Wogonin-Mediated%2520Inhibition%2520of%2520Inflammation-Associated%2520Colorectal%2520Carcinogenesis%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26doi%3D10.1038%2Fcddis.2014.221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cavin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delatour, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin-Kuan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzhauser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezencon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guignard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junod, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richoz-Payot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gremaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nestler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilter, B.</span></span> <span> </span><span class="NLM_article-title">Reduction in Antioxidant Defenses May Contribute to Ochratoxin a Toxicity and Carcinogenicity</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfl169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1093%2Ftoxsci%2Fkfl169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=17110534" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2006&pages=30-39&author=C.+Cavinauthor=T.+Delatourauthor=M.+Marin-Kuanauthor=D.+Holzhauserauthor=L.+Higginsauthor=C.+Bezenconauthor=G.+Guignardauthor=S.+Junodauthor=J.+Richoz-Payotauthor=E.+Gremaudauthor=J.+D.+Hayesauthor=S.+Nestlerauthor=P.+Mantleauthor=B.+Schilter&title=Reduction+in+Antioxidant+Defenses+May+Contribute+to+Ochratoxin+a+Toxicity+and+Carcinogenicity&doi=10.1093%2Ftoxsci%2Fkfl169"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfl169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfl169%26sid%3Dliteratum%253Aachs%26aulast%3DCavin%26aufirst%3DC.%26aulast%3DDelatour%26aufirst%3DT.%26aulast%3DMarin-Kuan%26aufirst%3DM.%26aulast%3DHolzhauser%26aufirst%3DD.%26aulast%3DHiggins%26aufirst%3DL.%26aulast%3DBezencon%26aufirst%3DC.%26aulast%3DGuignard%26aufirst%3DG.%26aulast%3DJunod%26aufirst%3DS.%26aulast%3DRichoz-Payot%26aufirst%3DJ.%26aulast%3DGremaud%26aufirst%3DE.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DNestler%26aufirst%3DS.%26aulast%3DMantle%26aufirst%3DP.%26aulast%3DSchilter%26aufirst%3DB.%26atitle%3DReduction%2520in%2520Antioxidant%2520Defenses%2520May%2520Contribute%2520to%2520Ochratoxin%2520a%2520Toxicity%2520and%2520Carcinogenicity%26jtitle%3DToxicol.%2520Sci.%26date%3D2006%26volume%3D96%26spage%3D30%26epage%3D39%26doi%3D10.1093%2Ftoxsci%2Fkfl169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boesch-Saadatmandi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loboda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jozkowicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huebbe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolffram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimbach, G.</span></span> <span> </span><span class="NLM_article-title">Effect of Ochratoxin a on Redox-Regulated Transcription Factors, Antioxidant Enzymes and Glutathione-S-Transferase in Cultured Kidney Tubulus Cells</span>. <i>Food Chem. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2665</span>– <span class="NLM_lpage">2671</span>, <span class="refDoi"> DOI: 10.1016/j.fct.2008.04.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.fct.2008.04.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=18547704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCnsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=2665-2671&author=C.+Boesch-Saadatmandiauthor=A.+Lobodaauthor=A.+Jozkowiczauthor=P.+Huebbeauthor=R.+Blankauthor=S.+Wolfframauthor=J.+Dulakauthor=G.+Rimbach&title=Effect+of+Ochratoxin+a+on+Redox-Regulated+Transcription+Factors%2C+Antioxidant+Enzymes+and+Glutathione-S-Transferase+in+Cultured+Kidney+Tubulus+Cells&doi=10.1016%2Fj.fct.2008.04.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of ochratoxin A on redox-regulated transcription factors, antioxidant enzymes and glutathione-S-transferase in cultured kidney tubulus cells</span></div><div class="casAuthors">Boesch-Saadatmandi, C.; Loboda, A.; Jozkowicz, A.; Huebbe, P.; Blank, R.; Wolffram, S.; Dulak, J.; Rimbach, G.</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2665-2671</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ochratoxin A (OTA), a mycotoxin mostly produced by Aspergillus ochraceus and Penicillium verrucosum, is a worldwide contaminant of food and feedstuff.  OTA is nephrotoxic and a renal carcinogen in rodents.  The underlying mol. and cellular mechanisms by which OTA exhibits its toxicity have yet not been fully clarified.  In the present study the effects of ochratoxin A on the activity of redox-regulated transcription factors, antioxidant enzymes, as well as glutathione-S-transferase (GST) were studied in cultured kidney tubule cells (LLC-PK1).  Confluent LLC-PK1 cells were incubated with increasing concns. of OTA for 24 h.  OTA decreased SOD activity and enhanced intracellular levels of reactive oxygen species (ROS) as measured by flow cytometry.  Furthermore OTA resulted in a down-regulation of GST mRNA and activity levels.  Lower GST levels were accompanied by a decreased transactivation of activator protein-1 (AP-1) and NF-E2-related factor-2 (Nrf2), which mediate GST gene transcription.  Present data indicate that enhanced ROS prodn. and an impairment of GST activity, possibly due to an AP-1 and Nrf2 dependent signal transduction pathway, may be centrally involved in OTA induced nephrotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroefgu2kn9wbVg90H21EOLACvtfcHk0lh-yAO8zLC6BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCnsL8%253D&md5=34b02ba1296003e21cc337e512786b1c</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.fct.2008.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fct.2008.04.023%26sid%3Dliteratum%253Aachs%26aulast%3DBoesch-Saadatmandi%26aufirst%3DC.%26aulast%3DLoboda%26aufirst%3DA.%26aulast%3DJozkowicz%26aufirst%3DA.%26aulast%3DHuebbe%26aufirst%3DP.%26aulast%3DBlank%26aufirst%3DR.%26aulast%3DWolffram%26aufirst%3DS.%26aulast%3DDulak%26aufirst%3DJ.%26aulast%3DRimbach%26aufirst%3DG.%26atitle%3DEffect%2520of%2520Ochratoxin%2520a%2520on%2520Redox-Regulated%2520Transcription%2520Factors%252C%2520Antioxidant%2520Enzymes%2520and%2520Glutathione-S-Transferase%2520in%2520Cultured%2520Kidney%2520Tubulus%2520Cells%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D2008%26volume%3D46%26spage%3D2665%26epage%3D2671%26doi%3D10.1016%2Fj.fct.2008.04.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boesch-Saadatmandi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graeser, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundhausen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolffram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimbach, G.</span></span> <span> </span><span class="NLM_article-title">Ochratoxin a Impairs Nrf2-Dependent Gene Expression in Porcine Kidney Tubulus Cells</span>. <i>J. Anim. Physiol. Anim. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1111/j.1439-0396.2008.00838.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1111%2Fj.1439-0396.2008.00838.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=18547363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Oqs7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2009&pages=547-554&author=C.+Boesch-Saadatmandiauthor=A.+E.+Wagnerauthor=A.+C.+Graeserauthor=C.+Hundhausenauthor=S.+Wolfframauthor=G.+Rimbach&title=Ochratoxin+a+Impairs+Nrf2-Dependent+Gene+Expression+in+Porcine+Kidney+Tubulus+Cells&doi=10.1111%2Fj.1439-0396.2008.00838.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Ochratoxin A impairs Nrf2-dependent gene expression in pocine kidney tubulus cells</span></div><div class="casAuthors">Boesch-Saadatmandi, C.; Wagner, A. E.; Graeser, A. C.; Hundhausen, C.; Wolffram, S.; Rimbach, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Animal Physiology and Animal Nutrition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">547-554</span>CODEN:
                <span class="NLM_cas:coden">JAPNEF</span>;
        ISSN:<span class="NLM_cas:issn">0931-2439</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The mycotoxin, ochratoxin A (OTA), which is produced by Aspergillus and Penicillium subspecies, is frequently present in feedstuffs.  Ochratoxin A exhibits a wide range of toxic activities including nephrotoxicity.  However, the underlying mol. mechanisms of OTA-induced cellular nephrotoxicity have yet not been fully elucidated.  Nrf2 is a basic leucine zipper transcriptional activator essential for the coordinated transcriptional induction of antioxidant and xenobiotic metabolizing enzymes in the kidney.  Therefore, in the present study, the effects of OTA on the nuclear translocation and transactivation of the transcription factor Nrf2 as well as mRNA levels of Nrf2 target genes including glutathione-S-transferase and γ-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).  Nrf2 was induced by sulforaphane, a well-known activator of this transcription factor.  Ochratoxin A significantly decreased γ-glutamylcysteinyl synthetase and glutathione-S-transferase mRNA levels in LLC-PK1 cells.  Decreased mRNA levels of γ-glutamylcysteinyl synthetase and glutathione-S-transferase were accompanied by a lowered nuclear translocation and transactivation of Nrf2.  Furthermore, OTA also lowered Nrf2 mRNA levels.  Current data indicate that OTA nephrotoxicity may be, at least partly, mediated by an Nrf2-dependent signal transduction pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKLiYpKXcpa7Vg90H21EOLACvtfcHk0ljGhuPssbokTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Oqs7bN&md5=fb08918206fb04af5153deaebb0b9c8a</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1111%2Fj.1439-0396.2008.00838.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1439-0396.2008.00838.x%26sid%3Dliteratum%253Aachs%26aulast%3DBoesch-Saadatmandi%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DA.%2BE.%26aulast%3DGraeser%26aufirst%3DA.%2BC.%26aulast%3DHundhausen%26aufirst%3DC.%26aulast%3DWolffram%26aufirst%3DS.%26aulast%3DRimbach%26aufirst%3DG.%26atitle%3DOchratoxin%2520a%2520Impairs%2520Nrf2-Dependent%2520Gene%2520Expression%2520in%2520Porcine%2520Kidney%2520Tubulus%2520Cells%26jtitle%3DJ.%2520Anim.%2520Physiol.%2520Anim.%2520Nutr.%26date%3D2009%26volume%3D93%26spage%3D547%26epage%3D554%26doi%3D10.1111%2Fj.1439-0396.2008.00838.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansari, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhari, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhawan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwivedi, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, M.</span></span> <span> </span><span class="NLM_article-title">Topical Application of Ochratoxin a Causes DNA Damage and Tumor Initiation in Mouse Skin</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e47280</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0047280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1371%2Fjournal.pone.0047280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23071775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOku7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=R.+Kumarauthor=K.+M.+Ansariauthor=B.+P.+Chaudhariauthor=A.+Dhawanauthor=P.+D.+Dwivediauthor=S.+K.+Jainauthor=M.+Das&title=Topical+Application+of+Ochratoxin+a+Causes+DNA+Damage+and+Tumor+Initiation+in+Mouse+Skin&doi=10.1371%2Fjournal.pone.0047280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Topical application of Ochratoxin a causes DNA damage and tumor initiation in mouse skin</span></div><div class="casAuthors">Kumar, Rahul; Ansari, Kausar M.; Chaudhari, Bhushan P.; Dhawan, Alok; Dwivedi, Premendra D.; Jain, Swatantra K.; Das, Mukul</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e47280</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Skin cancer is one of the most common forms of cancer and 2-3 million new cases are being diagnosed globally each year.  Along with UV rays, environmental pollutants/chems. including mycotoxins, contaminants of various foods and feed stuffs, could be one of the etiol. factors of skin cancer.  In the present study, we evaluated the DNA damaging potential and dermal carcinogenicity of a mycotoxin, ochratoxin A (OTA), with the rationale that dermal exposure to OTA in workers may occur during their involvement in pre and post harvest stages of agriculture.  A single topical application of OTA (20-80 μg/mouse) resulted in significant DNA damage along with elevated γ-H2AX level in skin.  Alteration in oxidative stress markers such as lipid peroxidn., protein carbonyl, glutathione content and antioxidant enzymes was obsd. in a dose (20-80 μg/mouse) and time-dependent (12-72 h) manner.  The oxidative stress was further emphasized by the suppression of Nrf2 translocation to nucleus following a single topical application of OTA (80 μg/mouse) after 24 h.  OTA (80 μg/mouse) application for 12-72 h caused significant enhancement in- (a) reactive oxygen species generation, (b) activation of ERK1/2, p38 and JNK MAPKs, cell cycle arrest at G0/G1 phase (37-67 %), (d) induction of apoptosis (2.0-11.0 fold), (e) expression of p53, p21/waf1, (f) Bax/Bcl-2 ratio, (g) cytochrome c level, (h) activities of caspase 9 (1.2-1.8 fold) and 3 (1.7-2.2 fold) as well as poly ADP ribose polymerase cleavage.  In a two-stage mouse skin tumorigenesis protocol, it was obsd. that a single topical application of OTA (80 μg/mouse) followed by twice weekly application of 12-O-tetradecanoylphorbol-13-acetate for 24 wk leads to tumor formation.  These results suggest that OTA has skin tumor initiating property which may be related to oxidative stress, MAPKs signaling and DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY1-CsaY_2m7Vg90H21EOLACvtfcHk0ljGhuPssbokTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOku7fM&md5=70f81e5febf750dbdf1b2a70e6d1e2bd</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0047280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0047280%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DAnsari%26aufirst%3DK.%2BM.%26aulast%3DChaudhari%26aufirst%3DB.%2BP.%26aulast%3DDhawan%26aufirst%3DA.%26aulast%3DDwivedi%26aufirst%3DP.%2BD.%26aulast%3DJain%26aufirst%3DS.%2BK.%26aulast%3DDas%26aufirst%3DM.%26atitle%3DTopical%2520Application%2520of%2520Ochratoxin%2520a%2520Causes%2520DNA%2520Damage%2520and%2520Tumor%2520Initiation%2520in%2520Mouse%2520Skin%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0047280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Limonciel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, P.</span></span> <span> </span><span class="NLM_article-title">A Review of the Evidence That Ochratoxin a Is an Nrf2 Inhibitor: Implications for Nephrotoxicity and Renal Carcinogenicity</span>. <i>Toxins</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.3390/toxins6010371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.3390%2Ftoxins6010371" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=371-379&author=A.+Limoncielauthor=P.+Jennings&title=A+Review+of+the+Evidence+That+Ochratoxin+a+Is+an+Nrf2+Inhibitor%3A+Implications+for+Nephrotoxicity+and+Renal+Carcinogenicity&doi=10.3390%2Ftoxins6010371"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.3390%2Ftoxins6010371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Ftoxins6010371%26sid%3Dliteratum%253Aachs%26aulast%3DLimonciel%26aufirst%3DA.%26aulast%3DJennings%26aufirst%3DP.%26atitle%3DA%2520Review%2520of%2520the%2520Evidence%2520That%2520Ochratoxin%2520a%2520Is%2520an%2520Nrf2%2520Inhibitor%253A%2520Implications%2520for%2520Nephrotoxicity%2520and%2520Renal%2520Carcinogenicity%26jtitle%3DToxins%26date%3D2014%26volume%3D6%26spage%3D371%26epage%3D379%26doi%3D10.3390%2Ftoxins6010371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bud Nelson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, J.</span></span> <span> </span><span class="NLM_article-title">Camptothecin Suppresses Nrf2-Are Activity and Sensitises Hepatocellular Carcinoma Cells to Anticancer Drugs</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">1495</span>, <span class="refDoi"> DOI: 10.1038/bjc.2017.317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fbjc.2017.317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=28910823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFSkt7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=1495&author=F.+Chenauthor=H.+Wangauthor=J.+Zhuauthor=R.+Zhaoauthor=P.+Xueauthor=Q.+Zhangauthor=M.+Bud+Nelsonauthor=W.+Quauthor=B.+Fengauthor=J.+Pi&title=Camptothecin+Suppresses+Nrf2-Are+Activity+and+Sensitises+Hepatocellular+Carcinoma+Cells+to+Anticancer+Drugs&doi=10.1038%2Fbjc.2017.317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Camptothecin suppresses NRF2-ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs</span></div><div class="casAuthors">Chen, Feng; Wang, Huihui; Zhu, Jiayu; Zhao, Rui; Xue, Peng; Zhang, Qiang; Bud Nelson, M.; Qu, Weidong; Feng, Bo; Pi, Jingbo</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1495-1506</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Background: Resistance to chemotherapy is a major obstacle in the treatment of human hepatocellular carcinoma (HCC).  Despite playing an important role in chemoprevention, nuclear factor erythroid 2-related factor 2 (NRF2) also contributes to chemo- and radio-resistance.  The current study focusses on camptothecin as a novel NRF2 inhibitor to sensitize HCC to chemotherapy.  Methods: The expression and transcriptional activity of NRF2 in human HCC biopsies and camptothecin-treated culture cells were detd. using immunostaining, western blot, reverse-transcription quant. real-time PCR (RT-qPCR) and luciferase reporter assay.  The effect of camptothecin on chemosensitivity of cancer cells was assessed in vitro and in xenografts.  Results: The expression and transcriptional activity of NRF2 were substantially elevated in HCC biopsies compared with corresponding adjacent tissues, and pos. correlated with serum α-fetoprotein, a clin. indicator of pathol. progression.  In searching chems. targeting NRF2 for chemotherapy, we discovered that camptothecin is a potent NRF2 inhibitor.  Camptothecin markedly suppressed NRF2 expression and transcriptional activity in different types of cancer cells including HepG2, SMMC-7721 and A549.  As a result, camptothecin sensitized these cells to chemotherapeutic drugs in vitro and in xenografts.  Conclusions: Camptothecin is a novel NRF2 inhibitor that may be repurposed in combination with other chemotherapeutics to enhance their efficacy in treating high NRF2-expressing cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxEAN7yhqgsbVg90H21EOLACvtfcHk0ljGhuPssbokTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFSkt7rP&md5=39312acc1334d539b5b2f2e06128a218</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2017.317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2017.317%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DXue%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DBud%2BNelson%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DPi%26aufirst%3DJ.%26atitle%3DCamptothecin%2520Suppresses%2520Nrf2-Are%2520Activity%2520and%2520Sensitises%2520Hepatocellular%2520Carcinoma%2520Cells%2520to%2520Anticancer%2520Drugs%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2017%26volume%3D117%26spage%3D1495%26doi%3D10.1038%2Fbjc.2017.317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, C. R.</span></span> <span> </span><span class="NLM_article-title">Identification of Retinoic Acid as an Inhibitor of Transcription Factor Nrf2 through Activation of Retinoic Acid Receptor Alpha</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">19589</span>– <span class="NLM_lpage">19594</span>, <span class="refDoi"> DOI: 10.1073/pnas.0709483104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1073%2Fpnas.0709483104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=19589-19594&author=X.+J.+Wangauthor=J.+D.+Hayesauthor=C.+J.+Hendersonauthor=C.+R.+Wolf&title=Identification+of+Retinoic+Acid+as+an+Inhibitor+of+Transcription+Factor+Nrf2+through+Activation+of+Retinoic+Acid+Receptor+Alpha&doi=10.1073%2Fpnas.0709483104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0709483104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0709483104%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DHenderson%26aufirst%3DC.%2BJ.%26aulast%3DWolf%26aufirst%3DC.%2BR.%26atitle%3DIdentification%2520of%2520Retinoic%2520Acid%2520as%2520an%2520Inhibitor%2520of%2520Transcription%2520Factor%2520Nrf2%2520through%2520Activation%2520of%2520Retinoic%2520Acid%2520Receptor%2520Alpha%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D19589%26epage%3D19594%26doi%3D10.1073%2Fpnas.0709483104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span> <span> </span><span class="NLM_article-title">Rexinoid Inhibits Nrf2-Mediated Transcription through Retinoid X Receptor Alpha</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>452</i></span>,  <span class="NLM_fpage">554</span>– <span class="NLM_lpage">559</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2014.08.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.bbrc.2014.08.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=25172665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVOmsLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=452&publication_year=2014&pages=554-559&author=J.+Wuauthor=H.+Wangauthor=X.+Tang&title=Rexinoid+Inhibits+Nrf2-Mediated+Transcription+through+Retinoid+X+Receptor+Alpha&doi=10.1016%2Fj.bbrc.2014.08.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Rexinoid inhibits Nrf2-mediated transcription through retinoid X receptor alpha</span></div><div class="casAuthors">Wu, Jiaguo; Wang, Hongyan; Tang, Xiuwen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">452</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">554-559</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">NF-E2 P45-related factor 2 (Nrf2) is a key transcription factor that controls genes encoding cytoprotective and detoxifying enzymes through antioxidant response elements (AREs) in their regulatory regions.  We reported recently that retinoid X receptor alpha (RXRα) inhibits Nrf2 function by direct interaction with the Neh7 domain of Nrf2 in a ligand-independent manner.  Here, we provide evidence that an RXRα-specific ligand, bexarotene, dose-dependently inhibits the mRNA expression of ARE-driven genes.  Knock-down of RXRα by siRNA abolished the inhibitory effect of bexarotene.  Conversely, the over-expression of RXRα enhanced the inhibition by bexarotene, indicating that the effect is mediated by RXRα.  The inhibition by bexarotene was also found in the non-small-cell lung cancer cell line A549, which carries a dysfunctional somatic mutation of Kelch-like ECH-assocd. protein 1 (KEAP1), suggesting that KEAP1 is not involved.  Our results demonstrate that rexinoid is able to inhibit the transcriptional activity of Nrf2, and that RXRα can repress the cytoprotection pathway in a ligand-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozT-3eGRcTD7Vg90H21EOLACvtfcHk0lj0tPJtWt75Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVOmsLbL&md5=38d5a58f44c359e38807238323e65c31</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.08.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.08.111%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DRexinoid%2520Inhibits%2520Nrf2-Mediated%2520Transcription%2520through%2520Retinoid%2520X%2520Receptor%2520Alpha%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D452%26spage%3D554%26epage%3D559%26doi%3D10.1016%2Fj.bbrc.2014.08.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valenzuela, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glorieux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sid, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felipe, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kviecinski, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrax, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buc Calderon, P.</span></span> <span> </span><span class="NLM_article-title">Retinoic Acid Synergizes Ato-Mediated Cytotoxicity by Precluding Nrf2 Activity in Aml Cells</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.1038/bjc.2014.380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fbjc.2014.380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=25003661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCkt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=874-882&author=M.+Valenzuelaauthor=C.+Glorieuxauthor=J.+Stockisauthor=B.+Sidauthor=J.+M.+Sandovalauthor=K.+B.+Felipeauthor=M.+R.+Kviecinskiauthor=J.+Verraxauthor=P.+Buc+Calderon&title=Retinoic+Acid+Synergizes+Ato-Mediated+Cytotoxicity+by+Precluding+Nrf2+Activity+in+Aml+Cells&doi=10.1038%2Fbjc.2014.380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells</span></div><div class="casAuthors">Valenzuela, M.; Glorieux, C.; Stockis, J.; Sid, B.; Sandoval, J. M.; Felipe, K. B.; Kviecinski, M. R.; Verrax, J.; Calderon, P. Buc</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">874-882</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Std. therapy for acute promyelocytic leukemia (APL) includes retinoic acid (all-trans retinoic acid (ATRA)), which promotes differentiation of promyelocytic blasts.  Although co-administration of arsenic trioxide (ATO) with ATRA has emerged as an effective option to treat APL, the mol. basis of this effect remains unclear.  Methods: Four leukemia cancer human models (HL60, THP-1, NBR4 and NBR4-R2 cells) were treated either with ATO alone or ATO plus ATRA.  Cancer cell survival was monitored by trypan blue exclusion and DEVDase activity assays.  Gene and protein expression changes were assessed by RT-PCR and western blot.  Results: ATO induced an antioxidant response characterized by Nrf2 nuclear translocation and enhanced transcription of downstream target genes (i.e., HO-1, NQO1, GCLM, ferritin).  In cells exposed to ATO plus ATRA, the Nrf2 nuclear translocation was prevented and cytotoxicity was enhanced.  HO-1 overexpression reversed partially the cytotoxicity by ATRA-ATO in HL60 cells.  The inhibitory effects of ATRA on ATO-mediated responses were not obsd. in either the ATRA-resistant NB4-R2 cells or in NB4 cells pre-incubated with the RARα antagonist Ro-41-52-53.  Conclusions: The augmented cytotoxicity obsd. in leukemia cells following combined ATO-ATRA treatment is likely due to inhibition of Nrf2 activity, thus explaining the efficacy of combined ATO-ATRA treatment in the APL therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNH0wnpc1DB7Vg90H21EOLACvtfcHk0lj0tPJtWt75Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCkt73N&md5=be84cf3c074a9c885b5df06b3b17e6fa</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2014.380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2014.380%26sid%3Dliteratum%253Aachs%26aulast%3DValenzuela%26aufirst%3DM.%26aulast%3DGlorieux%26aufirst%3DC.%26aulast%3DStockis%26aufirst%3DJ.%26aulast%3DSid%26aufirst%3DB.%26aulast%3DSandoval%26aufirst%3DJ.%2BM.%26aulast%3DFelipe%26aufirst%3DK.%2BB.%26aulast%3DKviecinski%26aufirst%3DM.%2BR.%26aulast%3DVerrax%26aufirst%3DJ.%26aulast%3DBuc%2BCalderon%26aufirst%3DP.%26atitle%3DRetinoic%2520Acid%2520Synergizes%2520Ato-Mediated%2520Cytotoxicity%2520by%2520Precluding%2520Nrf2%2520Activity%2520in%2520Aml%2520Cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2014%26volume%3D111%26spage%3D874%26epage%3D882%26doi%3D10.1038%2Fbjc.2014.380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, J.</span></span> <span> </span><span class="NLM_article-title">Isoniazid Suppresses Antioxidant Response Element Activities and Impairs Adipogenesis in Mouse and Human Preadipocytes</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2013.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.taap.2013.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24128855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslOlt7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2013&pages=435-441&author=Y.+Chenauthor=P.+Xueauthor=Y.+Houauthor=H.+Zhangauthor=H.+Zhengauthor=T.+Zhouauthor=W.+Quauthor=W.+Tengauthor=Q.+Zhangauthor=M.+E.+Andersenauthor=J.+Pi&title=Isoniazid+Suppresses+Antioxidant+Response+Element+Activities+and+Impairs+Adipogenesis+in+Mouse+and+Human+Preadipocytes&doi=10.1016%2Fj.taap.2013.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Isoniazid suppresses antioxidant response element activities and impairs adipogenesis in mouse and human preadipocytes</span></div><div class="casAuthors">Chen, Yanyan; Xue, Peng; Hou, Yongyong; Zhang, Hao; Zheng, Hongzhi; Zhou, Tong; Qu, Weidong; Teng, Weiping; Zhang, Qiang; Andersen, Melvin E.; Pi, Jingbo</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">435-441</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Transcriptional signaling through the antioxidant response element (ARE), orchestrated by the Nuclear factor E2-related factor 2 (Nrf2), is a major cellular defense mechanism against oxidative or electrophilic stress.  Here, we reported that isoniazid (INH), a widely used antitubercular drug, displays a substantial inhibitory property against ARE activities in diverse mouse and human cells.  In 3T3-L1 preadipocytes, INH concn.-dependently suppressed the ARE-luciferase reporter activity and mRNA expression of various ARE-dependent antioxidant genes under basal and oxidative stressed conditions.  In keeping with our previous findings that Nrf2-ARE plays a crit. role in adipogenesis by regulating expression of CCAAT/enhancer-binding protein β (C/EBPβ) and peroxisome proliferator-activated receptor γ (PPARγ), suppression of ARE signaling by INH hampered adipogenic differentiation of 3T3-L1 cells and human adipose-derived stem cells (ADSCs).  Following adipogenesis induced by hormonal cocktails, INH-treated 3T3-L1 cells and ADSCs displayed significantly reduced levels of lipid accumulation and attenuated expression of C/EBPα and PPARγ.  Time-course studies in 3T3-L1 cells revealed that inhibition of adipogenesis by INH occurred in the early stage of terminal adipogenic differentiation, where reduced expression of C/EBPβ and C/EBPδ was obsd.  To our knowledge, the present study is the first to demonstrate that INH suppresses ARE signaling and interrupts with the transcriptional network of adipogenesis, leading to impaired adipogenic differentiation.  The inhibition of ARE signaling may be a potential underlying mechanism by which INH attenuates cellular antioxidant response contributing to various complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2kdrNxk5Y2LVg90H21EOLACvtfcHk0lgCzqFA2MRwqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslOlt7nN&md5=c22a9fd8cad1ab88542a99704fee0b16</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2013.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2013.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DP.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DTeng%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DAndersen%26aufirst%3DM.%2BE.%26aulast%3DPi%26aufirst%3DJ.%26atitle%3DIsoniazid%2520Suppresses%2520Antioxidant%2520Response%2520Element%2520Activities%2520and%2520Impairs%2520Adipogenesis%2520in%2520Mouse%2520and%2520Human%2520Preadipocytes%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2013%26volume%3D273%26spage%3D435%26epage%3D441%26doi%3D10.1016%2Fj.taap.2013.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewangan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, S. K.</span></span> <span> </span><span class="NLM_article-title">Isoniazid Prevents Nrf2 Translocation by Inhibiting Erk1 Phosphorylation and Induces Oxidative Stress and Apoptosis</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2015.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.redox.2015.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26202867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=80-92&author=A.+K.+Vermaauthor=A.+Yadavauthor=J.+Dewanganauthor=S.+V.+Singhauthor=M.+Mishraauthor=P.+K.+Singhauthor=S.+K.+Rath&title=Isoniazid+Prevents+Nrf2+Translocation+by+Inhibiting+Erk1+Phosphorylation+and+Induces+Oxidative+Stress+and+Apoptosis&doi=10.1016%2Fj.redox.2015.06.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Isoniazid prevents Nrf2 translocation by inhibiting ERK1 phosphorylation and induces oxidative stress and apoptosis</span></div><div class="casAuthors">Verma, Ajeet Kumar; Yadav, Arti; Dewangan, Jayant; Singh, Sarvendra Vikram; Mishra, Manisha; Singh, Pradhyumna Kumar; Rath, Srikanta Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">80-92</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Isoniazid is used either alone or in combination with other drugs for the treatment of tuberculosis.  It is also used for the prevention of tuberculosis.  Chronic treatment of Isoniazid may cause severe liver damage leading to acute liver failure.  The mechanism through which Isoniazid causes liver damage is investigated.  Isoniazid treatment generates reactive oxygen species and induces apoptosis in Hep3B cells.  It induces antioxidative and apoptotic genes leading to increase in mRNA expression and protein levels in Hep3B cells.  Whole genome expression anal. of Hep3B cells treated with Isoniazid has resulted in differential expression of various genes playing prime role in regulation of apoptotic, antioxidative, DNA damage, cell signaling, cell proliferation and differentiation pathways.  Isoniazid increased cytosolic Nrf2 protein level while decreased nuclear Nrf2 protein level.  It also decreased ERK1 phosphorylation and treatment of Hep3B cells with ERK inhibitor followed by Isoniazid resulting in increased apoptosis in these cells.  Two dimensional gel electrophoresis results have also shown differential expression of various protein species including heat shock proteins, proteins playing important role in oxidative stress, DNA damage, apoptosis, cell proliferation and differentiation.  Results suggest that Isoniazid induces apoptosis through oxidative stress and also prevents Nrf2 translocation into the nucleus by reducing ERK1 phosphorylation thus preventing cytoprotective effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZDPR3z0W077Vg90H21EOLACvtfcHk0lgCzqFA2MRwqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7jP&md5=7224d6d8974a2c6a5527d68ecc208bd6</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2015.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2015.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DA.%2BK.%26aulast%3DYadav%26aufirst%3DA.%26aulast%3DDewangan%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DS.%2BV.%26aulast%3DMishra%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DP.%2BK.%26aulast%3DRath%26aufirst%3DS.%2BK.%26atitle%3DIsoniazid%2520Prevents%2520Nrf2%2520Translocation%2520by%2520Inhibiting%2520Erk1%2520Phosphorylation%2520and%2520Induces%2520Oxidative%2520Stress%2520and%2520Apoptosis%26jtitle%3DRedox%2520Biol.%26date%3D2015%26volume%3D6%26spage%3D80%26epage%3D92%26doi%3D10.1016%2Fj.redox.2015.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmichael, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clewell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, J.</span></span> <span> </span><span class="NLM_article-title">Suppression of Nrf2-Are Activity Sensitizes Chemotherapeutic Agent-Induced Cytotoxicity in Human Acute Monocytic Leukemia Cells</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2015.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.taap.2015.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=26708503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28XislCnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2016&pages=1-7&author=H.+Pengauthor=H.+Wangauthor=P.+Xueauthor=Y.+Houauthor=J.+Dongauthor=T.+Zhouauthor=W.+Quauthor=S.+Pengauthor=J.+Liauthor=P.+L.+Carmichaelauthor=B.+Nelsonauthor=R.+Clewellauthor=Q.+Zhangauthor=M.+E.+Andersenauthor=J.+Pi&title=Suppression+of+Nrf2-Are+Activity+Sensitizes+Chemotherapeutic+Agent-Induced+Cytotoxicity+in+Human+Acute+Monocytic+Leukemia+Cells&doi=10.1016%2Fj.taap.2015.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of NRF2-ARE activity sensitizes chemotherapeutic agent-induced cytotoxicity in human acute monocytic leukemia cells</span></div><div class="casAuthors">Peng, Hui; Wang, Huihui; Xue, Peng; Hou, Yongyong; Dong, Jian; Zhou, Tong; Qu, Weidong; Peng, Shuangqing; Li, Jin; Carmichael, Paul L.; Nelson, Bud; Clewell, Rebecca; Zhang, Qiang; Andersen, Melvin E.; Pi, Jingbo</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Nuclear factor erythroid 2-related factor 2 (NRF2), a master regulator of the antioxidant response element (ARE)-dependent transcription, plays a pivotal role in chem. detoxification in normal and tumor cells.  Consistent with previous findings that NRF2-ARE contributes to chemotherapeutic resistance of cancer cells, we found that stable knockdown of NRF2 by lentiviral shRNA in human acute monocytic leukemia (AML) THP-1 cells enhanced the cytotoxicity of several chemotherapeutic agents, including arsenic trioxide (As2O3), etoposide and doxorubicin.  Using an ARE-luciferase reporter expressed in several human and mouse cells, we identified a set of compds., including isonicotinic acid amides, isoniazid and ethionamide, that inhibited NRF2-ARE activity.  Treatment of THP-1 cells with ethionamide, for instance, significantly reduced mRNA expression of multiple ARE-driven genes under either basal or As2O3-challenged conditions.  As detd. by cell viability and cell cycle, suppression of NRF2-ARE by ethionamide also significantly enhanced susceptibility of THP-1 and U937 cells to As2O3-induced cytotoxicity.  In THP-1 cells, the sensitizing effect of ethionamide on As2O3-induced cytotoxicity was highly dependent on NRF2.  To our knowledge, the present study is the first to demonstrate that ethionamide suppresses NRF2-ARE signaling and disrupts the transcriptional network of the antioxidant response in AML cells, leading to sensitization to chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5ihfz2oPhjrVg90H21EOLACvtfcHk0lgCzqFA2MRwqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislCnuw%253D%253D&md5=a4a5da283c61b9bb0b986c09f4f0ba95</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2015.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2015.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DXue%26aufirst%3DP.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCarmichael%26aufirst%3DP.%2BL.%26aulast%3DNelson%26aufirst%3DB.%26aulast%3DClewell%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DAndersen%26aufirst%3DM.%2BE.%26aulast%3DPi%26aufirst%3DJ.%26atitle%3DSuppression%2520of%2520Nrf2-Are%2520Activity%2520Sensitizes%2520Chemotherapeutic%2520Agent-Induced%2520Cytotoxicity%2520in%2520Human%2520Acute%2520Monocytic%2520Leukemia%2520Cells%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2016%26volume%3D292%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.taap.2015.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Do, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H. G.</span></span> <span> </span><span class="NLM_article-title">Metformin Inhibits Heme Oxygenase-1 Expression in Cancer Cells through Inactivation of Raf-Erk-Nrf2 Signaling and Ampk-Independent Pathways</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2013.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.taap.2013.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23707609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1aqt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=2013&pages=229-238&author=M.+T.+Doauthor=H.+G.+Kimauthor=T.+Khanalauthor=J.+H.+Choiauthor=D.+H.+Kimauthor=T.+C.+Jeongauthor=H.+G.+Jeong&title=Metformin+Inhibits+Heme+Oxygenase-1+Expression+in+Cancer+Cells+through+Inactivation+of+Raf-Erk-Nrf2+Signaling+and+Ampk-Independent+Pathways&doi=10.1016%2Fj.taap.2013.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways</span></div><div class="casAuthors">Do, Minh Truong; Kim, Hyung Gyun; Khanal, Tilak; Choi, Jae Ho; Kim, Dong Hee; Jeong, Tae Cheon; Jeong, Hye Gwang</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-238</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Resistance to therapy is the major obstacle to more effective cancer treatment.  Heme oxygenase-1 (HO-1) is often highly up-regulated in tumor tissues, and its expression is further increased in response to therapies.  It was suggested that inhibition of HO-1 expression is a potential therapeutic approach to sensitize tumors to chemotherapy and radiotherapy.  In this study, we tested the hypothesis that the anti-tumor effects of metformin are mediated by suppression of HO-1 expression in cancer cells.  Our results indicate that metformin strongly suppresses HO-1 mRNA and protein expression in human hepatic carcinoma HepG2, cervical cancer HeLa, and non-small-cell lung cancer A549 cells.  Metformin also markedly reduced Nrf2 mRNA and protein levels in whole cell lysates and suppressed tert-butylhydroquinone (tBHQ)-induced Nrf2 protein stability and antioxidant response element (ARE)-luciferase activity in HepG2 cells.  We also found that metformin regulation of Nrf2 expression is mediated by a Keap1-independent mechanism and that metformin significantly attenuated Raf-ERK signaling to suppress Nrf2 expression in cancer cells.  Inhibition of Raf-ERK signaling by PD98059 decreased Nrf2 mRNA expression in HepG2 cells, confirming that the inhibition of Nrf2 expression is mediated by an attenuation of Raf-ERK signaling in cancer cells.  The inactivation of AMPK by siRNA, DN-AMPK or the pharmacol. AMPK inhibitor compd. C, revealed that metformin reduced HO-1 expression in an AMPK-independent manner.  These results highlight the Raf-ERK-Nrf2 axis as a new mol. target in anticancer therapy in response to metformin treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYtX9XPC5YbVg90H21EOLACvtfcHk0lhPQh2d3FDn7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1aqt77F&md5=1277aa52cb23022682ecab32a24240d0</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2013.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2013.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DDo%26aufirst%3DM.%2BT.%26aulast%3DKim%26aufirst%3DH.%2BG.%26aulast%3DKhanal%26aufirst%3DT.%26aulast%3DChoi%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DJeong%26aufirst%3DT.%2BC.%26aulast%3DJeong%26aufirst%3DH.%2BG.%26atitle%3DMetformin%2520Inhibits%2520Heme%2520Oxygenase-1%2520Expression%2520in%2520Cancer%2520Cells%2520through%2520Inactivation%2520of%2520Raf-Erk-Nrf2%2520Signaling%2520and%2520Ampk-Independent%2520Pathways%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2013%26volume%3D271%26spage%3D229%26epage%3D238%26doi%3D10.1016%2Fj.taap.2013.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Do, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H. G.</span></span> <span> </span><span class="NLM_article-title">Metformin Induces Microrna-34a to Downregulate the Sirt1/Pgc-1alpha/Nrf2 Pathway, Leading to Increased Susceptibility of Wild-Type P53 Cancer Cells to Oxidative Stress and Therapeutic Agents</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2014.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1016%2Fj.freeradbiomed.2014.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=24970682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A280%3ADC%252BC2cfntV2ntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=21-34&author=M.+T.+Doauthor=H.+G.+Kimauthor=J.+H.+Choiauthor=H.+G.+Jeong&title=Metformin+Induces+Microrna-34a+to+Downregulate+the+Sirt1%2FPgc-1alpha%2FNrf2+Pathway%2C+Leading+to+Increased+Susceptibility+of+Wild-Type+P53+Cancer+Cells+to+Oxidative+Stress+and+Therapeutic+Agents&doi=10.1016%2Fj.freeradbiomed.2014.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents</span></div><div class="casAuthors">Do Minh Truong; Kim Hyung Gyun; Choi Jae Ho; Jeong Hye Gwang</div><div class="citationInfo"><span class="NLM_cas:title">Free radical biology & medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sirtuin 1 (Sirt1) plays an important role in cellular redox balance and resistance to oxidative stress.  Sirt1 exhibits oncogenic properties in wild-type p53 cancer cells, whereas it acts as a tumor suppressor in p53-mutated cancer cells.  Here, we investigated the effects of metformin on Sirt1 expression in several cancer cell lines.  Using human cancer cell lines that exhibit differential expression of p53, we found that metformin reduced Sirt1 protein levels in cancer cells bearing wild-type p53, but did not affect Sirt1 protein levels in cancer cell lines harboring mutant forms of p53.  Metformin-induced p53 protein levels in wild-type p53 cancer cells resulted in upregulation of microRNA (miR)-34a.  The use of a miR-34a inhibitor confirmed that metformin-induced miR-34a was required for Sirt1 downregulation.  Metformin suppressed peroxisome proliferator-activated receptor γ (PPARγ) coactivator-1α (Pgc-1α) expression and its downstream target Nrf2 in MCF-7 cells.  Genetic tools demonstrated that the reduction of Sirt1 and Pgc-1α by metformin caused Nrf2 downregulation via suppression of PPARγ transcriptional activity.  Metformin reduced heme oxygenase-1 and superoxide dismutase 2 but upregulated catalase expression in MCF-7 cells.  Metformin-treated MCF-7 cells had no increase in basal levels of reactive oxygen species but were more susceptible to oxidative stress.  Furthermore, upregulation of death receptor 5 by metformin-mediated Sirt1 downregulation enhanced the sensitivity of wild-type p53 cancer cells to TRAIL-induced apoptosis.  Our results demonstrated that metformin induces miR-34a to suppress the Sirt1/Pgc-1α/Nrf2 pathway and increases susceptibility of wild-type p53 cancer cells to oxidative stress and TRAIL-induced apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvPBEjXDiwaoNpW7w2tapOfW6udTcc2eYguAWyVcis0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfntV2ntg%253D%253D&md5=796479ce8d150e3fd36c3c26a7f0b6de</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2014.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2014.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DDo%26aufirst%3DM.%2BT.%26aulast%3DKim%26aufirst%3DH.%2BG.%26aulast%3DChoi%26aufirst%3DJ.%2BH.%26aulast%3DJeong%26aufirst%3DH.%2BG.%26atitle%3DMetformin%2520Induces%2520Microrna-34a%2520to%2520Downregulate%2520the%2520Sirt1%252FPgc-1alpha%252FNrf2%2520Pathway%252C%2520Leading%2520to%2520Increased%2520Susceptibility%2520of%2520Wild-Type%2520P53%2520Cancer%2520Cells%2520to%2520Oxidative%2520Stress%2520and%2520Therapeutic%2520Agents%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2014%26volume%3D74%26spage%3D21%26epage%3D34%26doi%3D10.1016%2Fj.freeradbiomed.2014.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashabi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalaj, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodagholi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudarzvand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkaki, A.</span></span> <span> </span><span class="NLM_article-title">Pre-Treatment with Metformin Activates Nrf2 Antioxidant Pathways and Inhibits Inflammatory Responses through Induction of Ampk after Transient Global Cerebral Ischemia</span>. <i>Metab. Brain Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">747</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1007/s11011-014-9632-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1007%2Fs11011-014-9632-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=25413451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=747-754&author=G.+Ashabiauthor=L.+Khalajauthor=F.+Khodagholiauthor=M.+Goudarzvandauthor=A.+Sarkaki&title=Pre-Treatment+with+Metformin+Activates+Nrf2+Antioxidant+Pathways+and+Inhibits+Inflammatory+Responses+through+Induction+of+Ampk+after+Transient+Global+Cerebral+Ischemia&doi=10.1007%2Fs11011-014-9632-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia</span></div><div class="casAuthors">Ashabi, Ghorbangol; Khalaj, Leila; Khodagholi, Fariba; Goudarzvand, Mahdi; Sarkaki, Alireza</div><div class="citationInfo"><span class="NLM_cas:title">Metabolic Brain Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">747-754</span>CODEN:
                <span class="NLM_cas:coden">MBDIEE</span>;
        ISSN:<span class="NLM_cas:issn">0885-7490</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Global cerebral ischemia arises in patients who have a variety of clin. conditions including cardiac arrest, shock and asphyxia.  In spite of advances in understanding of the brain ischemia and stroke etiol., therapeutic approaches to improve ischemic injury still remain limited.  It has been established that metformin can attenuate cell death in cerebral ischemia.  One of the main functions of metformin is proposed to be conducted via AMP-activated protein kinase (AMPK)-dependent pathway in the exptl. cerebral ischemia model.  It is also established that metformin can suppress inflammation and activate Nuclear factor erythroid 2-related factor (Nrf2) pathways in neurons.  In the current study, the role of metformin in regulating inflammatory and antioxidant pathways in the global cerebral ischemia was investigated.  Our results indicated that pretreatment of rats by metformin attenuated cellular levels of nuclear factor-κB, Tumor Necrosis Factor alpha and Cyclooxygenase-2 which are considered as three important proteins involved in the inflammation pathway.  Pretreatment by metformin increased the level of Nrf2 and heme oxygenase-1 in the hippocampus of ischemic rats compared with untreated ischemic group.  Moreover, pretreatment by metformin enhanced the level of glutathione and catalase activities compared with them in ischemic group.  Such protective changes detected by metformin pretreatment were reversed by injecting compd. c, an AMPK inhibitor.  These findings suggested that metformin might protect cells through modulating inflammatory and antioxidant pathways via induction of AMPK.  However, more exptl. and clin. trial studies regarding neuroprotective potential of metformin and the involved mechanisms, esp. in the context of cerebral ischemic injuries, are necessary.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi58kYaxS10rVg90H21EOLACvtfcHk0lhPQh2d3FDn7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtb7K&md5=898be4cbcb0ac3ed59156e4a52c03e52</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1007%2Fs11011-014-9632-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11011-014-9632-2%26sid%3Dliteratum%253Aachs%26aulast%3DAshabi%26aufirst%3DG.%26aulast%3DKhalaj%26aufirst%3DL.%26aulast%3DKhodagholi%26aufirst%3DF.%26aulast%3DGoudarzvand%26aufirst%3DM.%26aulast%3DSarkaki%26aufirst%3DA.%26atitle%3DPre-Treatment%2520with%2520Metformin%2520Activates%2520Nrf2%2520Antioxidant%2520Pathways%2520and%2520Inhibits%2520Inflammatory%2520Responses%2520through%2520Induction%2520of%2520Ampk%2520after%2520Transient%2520Global%2520Cerebral%2520Ischemia%26jtitle%3DMetab.%2520Brain%2520Dis.%26date%3D2015%26volume%3D30%26spage%3D747%26epage%3D754%26doi%3D10.1007%2Fs11011-014-9632-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arlt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geismann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the Nrf2 Transcription Factor by the Alkaloid Trigonelline Renders Pancreatic Cancer Cells More Susceptible to Apoptosis through Decreased Proteasomal Gene Expression and Proteasome Activity</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">4825</span>– <span class="NLM_lpage">4835</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.1038%2Fonc.2012.493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=23108405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFyjsrbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=4825-4835&author=A.+Arltauthor=S.+Sebensauthor=S.+Krebsauthor=C.+Geismannauthor=M.+Grossmannauthor=M.+L.+Kruseauthor=S.+Schreiberauthor=H.+Schafer&title=Inhibition+of+the+Nrf2+Transcription+Factor+by+the+Alkaloid+Trigonelline+Renders+Pancreatic+Cancer+Cells+More+Susceptible+to+Apoptosis+through+Decreased+Proteasomal+Gene+Expression+and+Proteasome+Activity&doi=10.1038%2Fonc.2012.493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity</span></div><div class="casAuthors">Arlt, A.; Sebens, S.; Krebs, S.; Geismann, C.; Grossmann, M.; Kruse, M-L.; Schreiber, S.; Schaefer, H.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">4825-4835</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Evidence accumulates that the transcription factor nuclear factor E2-related factor 2 (Nrf2) has an essential role in cancer development and chemoresistance, thus pointing to its potential as an anticancer target and undermining its suitability in chemoprevention.  Through the induction of cytoprotective and proteasomal genes, Nrf2 confers apoptosis protection in tumor cells, and inhibiting Nrf2 would therefore be an efficient strategy in anticancer therapy.  In the present study, pancreatic carcinoma cell lines (Panc1, Colo357 and MiaPaca2) and H6c7 pancreatic duct cells were analyzed for the Nrf2-inhibitory effect of the coffee alkaloid trigonelline (trig), as well as for its impact on Nrf2-dependent proteasome activity and resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and anticancer drug-induced apoptosis.  Chemoresistant Panc1 and Colo357 cells exhibit high constitutive Nrf2 activity, whereas chemosensitive MiaPaca2 and H6c7 cells display little basal but strong tert-butylhydroquinone (tBHQ)-inducible Nrf2 activity and drug resistance.  Trig efficiently decreased basal and tBHQ-induced Nrf2 activity in all cell lines, an effect relying on a reduced nuclear accumulation of the Nrf2 protein.  Along with Nrf2 inhibition, trig blocked the Nrf2-dependent expression of proteasomal genes (for example, s5a/psmd4 and α5/psma5) and reduced proteasome activity in all cell lines tested.  These blocking effects were absent after treatment with Nrf2 siRNA, a condition in which proteasomal gene expression and proteasome activity were already decreased, whereas siRNA against the related transcription factor Nrf1 did not affect proteasome activity and the inhibitory effect of trig.  Depending on both Nrf2 and proteasomal gene expression, the sensitivity of all cell lines to anticancer drugs and TRAIL-induced apoptosis was enhanced by trig.  Moreover, greater antitumor responses toward anticancer drug treatment were obsd. in tumor-bearing mice when receiving trig.  In conclusion, representing an efficient Nrf2 inhibitor capable of blocking Nrf2-dependent proteasome activity and thereby apoptosis protection in pancreatic cancer cells, trig might be beneficial in improving anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1uD5vWn0aALVg90H21EOLACvtfcHk0lhDIsxF-W_ZRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFyjsrbL&md5=3fb3a122c1cabe14251448dbdc0d7ec4</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.493%26sid%3Dliteratum%253Aachs%26aulast%3DArlt%26aufirst%3DA.%26aulast%3DSebens%26aufirst%3DS.%26aulast%3DKrebs%26aufirst%3DS.%26aulast%3DGeismann%26aufirst%3DC.%26aulast%3DGrossmann%26aufirst%3DM.%26aulast%3DKruse%26aufirst%3DM.%2BL.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DSchafer%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520the%2520Nrf2%2520Transcription%2520Factor%2520by%2520the%2520Alkaloid%2520Trigonelline%2520Renders%2520Pancreatic%2520Cancer%2520Cells%2520More%2520Susceptible%2520to%2520Apoptosis%2520through%2520Decreased%2520Proteasomal%2520Gene%2520Expression%2520and%2520Proteasome%2520Activity%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D4825%26epage%3D4835%26doi%3D10.1038%2Fonc.2012.493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bollong, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherwood, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lairson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span> <span> </span><span class="NLM_article-title">A Small Molecule Inhibits Deregulated Nrf2 Transcriptional Activity in Cancer</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2193</span>– <span class="NLM_lpage">2198</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00448</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00448" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=2193-2198&author=M.+J.+Bollongauthor=H.+Yunauthor=L.+Sherwoodauthor=A.+K.+Woodsauthor=L.+L.+Lairsonauthor=P.+G.+Schultz&title=A+Small+Molecule+Inhibits+Deregulated+Nrf2+Transcriptional+Activity+in+Cancer&doi=10.1021%2Facschembio.5b00448"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00448%26sid%3Dliteratum%253Aachs%26aulast%3DBollong%26aufirst%3DM.%2BJ.%26aulast%3DYun%26aufirst%3DH.%26aulast%3DSherwood%26aufirst%3DL.%26aulast%3DWoods%26aufirst%3DA.%2BK.%26aulast%3DLairson%26aufirst%3DL.%2BL.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DA%2520Small%2520Molecule%2520Inhibits%2520Deregulated%2520Nrf2%2520Transcriptional%2520Activity%2520in%2520Cancer%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D2193%26epage%3D2198%26doi%3D10.1021%2Facschembio.5b00448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Nrf2 Inhibitor That Induces Apoptosis of Human Acute Myeloid Leukemia Cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">7625</span>– <span class="NLM_lpage">7636</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.13825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=10.18632%2Foncotarget.13825" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=7625-7636&author=J.+Zhangauthor=L.+Suauthor=Q.+Yeauthor=S.+Zhangauthor=H.+Kungauthor=F.+Jiangauthor=G.+Jiangauthor=J.+Miaoauthor=B.+Zhao&title=Discovery+of+a+Novel+Nrf2+Inhibitor+That+Induces+Apoptosis+of+Human+Acute+Myeloid+Leukemia+Cells&doi=10.18632%2Foncotarget.13825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.13825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.13825%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DKung%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DMiao%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Nrf2%2520Inhibitor%2520That%2520Induces%2520Apoptosis%2520of%2520Human%2520Acute%2520Myeloid%2520Leukemia%2520Cells%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D7625%26epage%3D7636%26doi%3D10.18632%2Foncotarget.13825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmagadda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudini, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brimacombe, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajghate, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahane, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mensah, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrielson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastinejad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxer, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswal, S.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Inhibitor of Nrf2 Selectively Intervenes Therapeutic Resistance in Keap1-Deficient Nsclc Tumors</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3214</span>– <span class="NLM_lpage">3225</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00651</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00651" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlyls7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=3214-3225&author=A.+Singhauthor=S.+Venkannagariauthor=K.+H.+Ohauthor=Y.+Q.+Zhangauthor=J.+M.+Rohdeauthor=L.+Liuauthor=S.+Nimmagaddaauthor=K.+Sudiniauthor=K.+R.+Brimacombeauthor=S.+Gajghateauthor=J.+Maauthor=A.+Wangauthor=X.+Xuauthor=S.+A.+Shahaneauthor=M.+Xiaauthor=J.+Wooauthor=G.+A.+Mensahauthor=Z.+Wangauthor=M.+Ferrerauthor=E.+Gabrielsonauthor=Z.+Liauthor=F.+Rastinejadauthor=M.+Shenauthor=M.+B.+Boxerauthor=S.+Biswal&title=Small+Molecule+Inhibitor+of+Nrf2+Selectively+Intervenes+Therapeutic+Resistance+in+Keap1-Deficient+Nsclc+Tumors&doi=10.1021%2Facschembio.6b00651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors</span></div><div class="casAuthors">Singh, Anju; Venkannagari, Sreedhar; Oh, Kyu H.; Zhang, Ya-Qin; Rohde, Jason M.; Liu, Li; Nimmagadda, Sridhar; Sudini, Kuladeep; Brimacombe, Kyle R.; Gajghate, Sachin; Ma, Jinfang; Wang, Amy; Xu, Xin; Shahane, Sampada A.; Xia, Menghang; Woo, Juhyung; Mensah, George A.; Wang, Zhibin; Ferrer, Marc; Gabrielson, Edward; Li, Zhuyin; Rastinejad, Fraydoon; Shen, Min; Boxer, Matthew B.; Biswal, Shyam</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3214-3225</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Loss of function mutations in Kelch-like ECH Assocd. Protein 1 (KEAP1), or gain-of-function mutations in nuclear factor erythroid 2-related factor 2 (NRF2), are common in non-small cell lung cancer (NSCLC) and assocd. with therapeutic resistance.  To discover novel NRF2 inhibitors for targeted therapy, we conducted a quant. high-throughput screen using a diverse set of ∼400,000 small mols. (Mol. Libraries Small Mol. Repository Library, MLSMR) at the National Center for Advancing Translational Sciences.  We identified ML385 as a probe mol. that binds to NRF2 and inhibits its downstream target gene expression.  Specifically, ML385 binds to Neh1, the Cap 'N' Collar Basic Leucine Zipper (CNC-bZIP) domain of NRF2, and interferes with the binding of the V-Maf Avian Musculoaponeurotic Fibrosarcoma Oncogene Homolog G (MAFG)-NRF2 protein complex to regulatory DNA binding sequences.  In clonogenic assays, when used in combination with platinum-based drugs, doxorubicin or taxol, ML385 substantially enhances cytotoxicity in NSCLC cells, as compared to single agents.  ML385 shows specificity and selectivity for NSCLC cells with KEAP1 mutation, leading to gain of NRF2 function.  In preclin. models of NSCLC with gain of NRF2 function, ML385 in combination with carboplatin showed significant antitumor activity.  We demonstrate the discovery and validation of ML385 as a novel and specific NRF2 inhibitor and conclude that targeting NRF2 may represent a promising strategy for the treatment of advanced NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrugqkIWDWrPrVg90H21EOLACvtfcHk0lhDIsxF-W_ZRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlyls7jK&md5=9fc37434e55b1bef1a1f88ffd1da3006</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00651%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DVenkannagari%26aufirst%3DS.%26aulast%3DOh%26aufirst%3DK.%2BH.%26aulast%3DZhang%26aufirst%3DY.%2BQ.%26aulast%3DRohde%26aufirst%3DJ.%2BM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DNimmagadda%26aufirst%3DS.%26aulast%3DSudini%26aufirst%3DK.%26aulast%3DBrimacombe%26aufirst%3DK.%2BR.%26aulast%3DGajghate%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DShahane%26aufirst%3DS.%2BA.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DWoo%26aufirst%3DJ.%26aulast%3DMensah%26aufirst%3DG.%2BA.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DGabrielson%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DRastinejad%26aufirst%3DF.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DBoxer%26aufirst%3DM.%2BB.%26aulast%3DBiswal%26aufirst%3DS.%26atitle%3DSmall%2520Molecule%2520Inhibitor%2520of%2520Nrf2%2520Selectively%2520Intervenes%2520Therapeutic%2520Resistance%2520in%2520Keap1-Deficient%2520Nsclc%2520Tumors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D3214%26epage%3D3225%26doi%3D10.1021%2Facschembio.6b00651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">A Complementary Chemical and Genomic Screening Approach for Druggable Targets in the Nrf2 Pathway and Small Molecule Inhibitors to Overcome Cancer Cell Drug Resistance</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1189</span>– <span class="NLM_lpage">1199</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b01025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b01025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlt1Whs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1189-1199&author=J.+H.+Matthewsauthor=X.+Liangauthor=V.+J.+Paulauthor=H.+Luesch&title=A+Complementary+Chemical+and+Genomic+Screening+Approach+for+Druggable+Targets+in+the+Nrf2+Pathway+and+Small+Molecule+Inhibitors+to+Overcome+Cancer+Cell+Drug+Resistance&doi=10.1021%2Facschembio.7b01025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">A Complementary Chemical and Genomic Screening Approach for Druggable Targets in the Nrf2 Pathway and Small Molecule Inhibitors to Overcome Cancer Cell Drug Resistance</span></div><div class="casAuthors">Matthews, James H.; Liang, Xiao; Paul, Valerie J.; Luesch, Hendrik</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1189-1199</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Resistance to chemotherapy is a major obstacle in the treatment of a wide array of different types of cancer.  Chemotherapeutic drug resistance is achieved by cancer cells by a variety of different mechanisms, which can be either compd. specific or general.  An emerging mechanism for nonspecific chemotherapeutic drug resistance relies on hyperactivity of the transcription factor Nrf2.  Normally Nrf2 levels are tightly regulated by the ubiquitin-proteasome system; however, mutations in genes responsible for this regulation are common in many cancer types, resulting in increased expression of Nrf2, activation of its downstream target genes, and resistance to a variety of chemotherapeutic agents.  For this reason, there has been considerable interest in the discovery of small mol. inhibitors of Nrf2 capable of attenuating this resistance mechanism.  To this end, we have screened two com. available libraries of known biol. active small mols. to identify potential Nrf2 inhibitors.  To increase the breadth of this screen we have also screened an RNAi library that targets the majority of the druggable genome to also identify Nrf2-inhibitor targets that are not currently targeted by small mols.  To complement the com. chem. and genomic library screening, we screened a small collection of proprietary natural products isolated from marine cyanobacteria, which included actin targeting and uncharacterized but biol. active compds.  Through these efforts, we have identified three classes of compds.: cardiac glycosides, Stat3 inhibitors, and actin disrupting agents as Nrf2 inhibitors that are able to attenuate Nrf2 activity and synergize with chemotherapeutic agents in the non-small-cell lung cancer cell line A549.  In addn., we found that grassypeptolide A exerts Nrf2 modulatory activity via a thus far uncharacterized mechanism.  Moreover, we have identified a set of putative Nrf2 targets comprising the transcription factors TWIST1 and ELF4, the protein kinase NEK8, the TAK1 kinase regulator TAB1, and the dual-specific phosphatase DUSP4.  This study broadens the range of mechanisms through which inhibition of Nrf2 activity can be achieved, which will facilitate the characterization of novel Nrf2 inhibitors and allow the design of target specific screening procedures with which to identify more.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-J3rsITuwvrVg90H21EOLACvtfcHk0ljDn0kWKkPdRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlt1Whs74%253D&md5=e01c2ef72bb71a6ec56184afb129d76b</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b01025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b01025%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DJ.%2BH.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DA%2520Complementary%2520Chemical%2520and%2520Genomic%2520Screening%2520Approach%2520for%2520Druggable%2520Targets%2520in%2520the%2520Nrf2%2520Pathway%2520and%2520Small%2520Molecule%2520Inhibitors%2520to%2520Overcome%2520Cancer%2520Cell%2520Drug%2520Resistance%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D1189%26epage%3D1199%26doi%3D10.1021%2Facschembio.7b01025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01121&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01121%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-8" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01121" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679968976b8d24b2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
